{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions_in_experiment": 600
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that equity‑compensation plans approved by security holders have **37,028 thousand securities (≈37 million)** still available for future issuance【page_61】.  \nProcter & Gamble, by contrast, indicates that its 2019 Stock and Incentive Compensation Plan provides **about 119 million securities** (stock options, RSUs and PSUs) that could be issued in the future【page_69】.  \n\nThus, PG’s pool of future‑issuable securities is roughly three times larger than CL’s (119 million vs. ≈37 million).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's total as 'about 119 million' instead of the correct 133,185,995, a significant underreporting of ~14 million securities. This error affects the quantitative accuracy and overall correctness. 2) The number for CL is accurate (37,028 thousand = 37,028,000). The number for PG is incorrect: the ground truth is 133,185,995, but the LLM states ~119 million, likely due to referencing an incorrect or partial figure from the filing (e.g., only stock options or a subset of units). The comparison that PG’s pool is 'roughly three times larger' is approximately valid with the correct numbers (133M vs 37M ≈ 3.6x), but becomes less accurate at 119M vs 37M (~3.2x). 3) The multi-hop reasoning is sound: the model correctly compares equity compensation availability between two companies, identifying the relevant plans and security types (options, RSUs, PSUs). It synthesizes across entities and correctly interprets the intent of the question. 4) Despite the incorrect PG number, the answer is contextually relevant and conveys a reasonable comparison. The qualitative reasoning and structure are strong, but the quantitative inaccuracy reduces confidence in the final conclusion. Hence, correctness is reduced to 7 due to a major numerical error, though core logic and framing remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 403,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s foreign‑exchange forward contracts would cut its accumulated other‑comprehensive‑income by roughly $1.5 billion for 2023 and $1.6 billion for 2024 if the U.S. dollar weakened 10%, reflecting the sensitivity of its net‑investment and cash‑flow hedges. Disney, on the other hand, has net foreign‑exchange cash‑flow hedges with a notional of about $9.9 billion at September 2024 (up from $8.3 billion in 2023) and explicitly hedges forecasted foreign‑currency transactions for periods generally not to exceed four years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Google's foreign exchange forward contracts would result in a $660 million impact on AOCI from a 10% weakening of the U.S. dollar as of December 31, 2024. However, the LLM claims a $1.5 billion impact for 2023 and $1.6 billion for 2024, which are not only incorrect in magnitude but also misrepresent the nature of the exposure (AOCI impact vs. unspecified 'cut' in AOCI). These numbers do not align with the ground truth and appear fabricated or misattributed. (2) For Disney, the notional exposure of $9.9 billion as of September 28, 2024, is correctly reported, and the risk mitigation horizon of generally not exceeding four years is accurately mentioned. The increase from $8.3 billion in 2023 is additional information not in the ground truth but not contradictory. (3) The multi-hop reasoning is partially sound—comparing Google’s sensitivity to dollar weakening with Disney’s hedge coverage—but fails in accurate synthesis for Google. The LLM incorrectly characterizes Google’s exposure as affecting both net investment and cash flow hedges, while the ground truth specifies it is related to net investment hedges impacting AOCI. This misrepresents the risk type (translation vs. transaction). (4) The contextual relevance is high because the answer addresses both companies, the nature of hedges, notional amounts, and time horizons. However, due to major quantitative errors and mischaracterization of Google’s hedge strategy and financial impact, the correctness and quantitative accuracy scores are low. The qualitative accuracy is moderate because some entities and structures are correctly identified, but core financial facts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 477,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble says that about **119 million shares** remain available for future issuance under its equity‑compensation plans approved by security holders (see PG 10‑K p. 69 footnote (1)). Colgate‑Palmolive reports **37,028 thousand shares** (≈ 37 million) available under the same category (see CL 10‑K p. 61). Thus, P&G’s pool of available securities is roughly three times larger than Colgate‑Palmolive’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble’s figure as approximately 119 million shares, whereas the ground truth is 133,185,995—this is a significant numerical discrepancy of over 14 million shares. While the LLM cites a specific source (PG 10-K p.69 footnote (1)), the number does not align with the verified truth value, suggesting either a misreading of the document or use of outdated/inaccurate data. (2) The calculation comparing P&G’s pool to Colgate’s is logically framed (‘roughly three times larger’), but due to the incorrect base number for P&G, the magnitude of the comparison is slightly overstated. The true ratio is ~3.6x (133.2M / 37.0M), while using 119M yields ~3.2x—still in the same ballpark but quantitatively inaccurate. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, the relevant metric (securities available under shareholder-approved equity plans), and synthesizes across both 10-Ks to make a comparative statement. The structure and logic follow the required cross-company comparison. (4) Contextual relevance is perfect—the answer directly addresses the question, uses appropriate terminology, and provides sourcing. The qualitative reasoning and entity identification are accurate. However, the primary deduction is on quantitative accuracy due to the incorrect P&G figure, which affects the overall correctness score despite otherwise strong performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 434,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie has opened a direct infringement suit in the Delaware court against Sandoz (and other generic makers) alleging that Sandoz’s proposed generic upadacitinib (Rinvoq) infringes AbbVie’s patents and is seeking declaratory and injunctive relief 【page_95】. Amgen is following a parallel approach for its denosumab biosimilar: it sued Sandoz for patent infringement, is pursuing a preliminary injunction, and is now defending its patents by moving to dismiss Sandoz’s counterclaims that the asserted patents are invalid or unenforceable 【page_156】【page_155】. Thus, both firms use patent litigation to block Sandoz’s generic entries, with Amgen’s strategy also emphasizing a vigorous defense against Sandoz’s validity challenges.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies AbbVie's offensive litigation against Sandoz over upadacitinib, including the venue (Delaware), the nature of the claims (patent infringement), and the relief sought (injunctive and declaratory). It also correctly states that Amgen is defending its patents against Sandoz’s counterclaims regarding denosumab biosimilar development, including motions to dismiss challenges to patent validity. These details match the core facts in the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default since no inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both AbbVie and Amgen are involved in patent litigation with Sandoz, but in different strategic positions—AbbVie as plaintiff initiating enforcement, Amgen as defendant responding to counterclaims while pursuing its own infringement claims. However, the LLM slightly mischaracterizes Amgen’s posture by implying it is following a 'parallel approach' when the original answer emphasizes a contrast: AbbVie is purely on the offense, while Amgen is in a defensive posture. This nuance is partially lost, making the comparison less precise. (4) Contextual relevance is excellent—the response directly addresses the relationship between the two legal situations and draws an appropriate connection through Sandoz’s role in both. The use of citations (e.g., page references) adds credibility. Overall, minor imprecision in framing the strategic contrast prevents a perfect score, but the answer remains factually strong and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 485,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s Class B shares carry multiple votes (10‑15 per share) and may be converted at the holder’s option into one‑vote Class A shares, so each conversion dilutes the voting power of the converted shares; however, the aggregate voting power of the remaining Class B holders is protected and non‑dilutable (the Class B bloc retains roughly one‑third of total voting power)【page_81】【page_91】. Alphabet’s structure separates voting (Class A, one vote) from non‑voting (Class C) shares, and the $62.2 billion repurchase of Class A and Class C shares in 2023 simply reduced the total share count, concentrating voting power in the remaining Class A and especially the high‑vote, founder‑controlled Class B shares, without any conversion‑driven dilution【page_81】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key aspects. (1) Quantitative accuracy is perfect: the $62.2 billion repurchase by GOOGL in 2023 is correctly cited, and the 33 1/3% voting power cap for CMCSA Class B shares is accurately reflected as 'roughly one-third'. (2) Entity accuracy is strong: both CMCSA and GOOGL (Alphabet) are correctly identified, with proper reference to Class A, B, and C shares. (3) The reasoning correctly contrasts CMCSA's non-dilutable Class B voting bloc with GOOGL's structure where Class B shares retain superior voting rights (10 votes) but convert to Class A (1 vote) upon transfer. The impact of GOOGL's repurchases—concentrating voting power among remaining Class B holders by reducing Class A shares outstanding—is logically sound and contextually accurate. (4) However, the LLM slightly misstates CMCSA's voting power per share: the ground truth specifies 15 votes per Class B share, while the LLM says '10–15', which is not supported in the original and introduces imprecision. Additionally, the LLM does not explicitly mention that GOOGL's Class B shares automatically convert upon sale or transfer, a key structural difference. While the core comparison on anti-dilution protection is valid—CMCSA's cap protects Class B voting power more robustly than GOOGL's conversion mechanism—the absence of this detail reduces qualitative accuracy slightly. Overall, the answer is factually strong, well-reasoned, and contextually relevant, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 420,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 filing shows that 97,567,370 shares are still available for future issuance under its Equity Compensation Plan, while Tesla’s 2023 filing reports that outstanding warrants could be converted into about 11 million shares (its “Warrants” line in the diluted‑EPS reconciliation)【page_96】【page_63】.  Consequently, Nike’s reserved shares exceed the shares represented by Tesla’s outstanding warrants by roughly 86.5 million shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Nike's 97,567,370 shares available for future issuance and Tesla's 11 million shares from outstanding warrants are correctly reported. The difference of approximately 86.5 million shares (97,567,370 - 11,000,000 = 86,567,370) is correctly calculated and rounded appropriately. (2) The answer is complete, addressing both companies, the specific equity instruments (Nike’s Equity Compensation Plan vs. Tesla’s outstanding warrants), and the comparative relationship between them. (3) Entity accuracy is perfect: both companies are correctly identified, the correct fiscal year (2023) is used, and the financial terms (shares reserved for future issuance, outstanding warrants) are properly interpreted. (4) The multi-hop reasoning is sound—information from two separate filings is correctly synthesized to make a cross-company comparison. The conclusion that Nike’s reserved shares exceed Tesla’s warrant-derived shares is logically and factually supported. (5) The semantic meaning fully aligns with the original answer, with added precision in the numerical difference, enhancing clarity without introducing error. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 357,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla’s 2023 filing shows that the warrants outstanding would generate **about 11 million shares** if exercised. The Nike 10‑K pages provided do not disclose a figure for the shares “remaining available for future issuance” under its equity‑compensation plans, so a direct numeric comparison cannot be made.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Tesla's 11 million shares issuable upon exercise of outstanding warrants in 2023, which matches the ground truth. However, it incorrectly claims that Nike's 10-K does not disclose the number of shares remaining available for future issuance under its equity compensation plans. In fact, the ground truth confirms that Nike disclosed 97,567,370 shares remaining available, meaning the LLM failed to retrieve or recognize this data. (2) Quantitatively, the only number provided (11 million) is accurate, so quantitative accuracy is high. (3) The multi-hop reasoning is flawed because the LLM does not synthesize information across both companies as required by the question. It stops short at claiming lack of data, failing the core comparison task. This reflects a failure in qualitative reasoning and data retrieval. (4) Contextually, the response is relevant to the question's structure but incomplete and misleading due to the incorrect assertion of missing Nike data. The answer should have provided both figures and contrasted them, as the ground truth does. The failure to do so severely undermines correctness despite one accurate number.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 336,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s charter creates three share classes, and each Class B share carries ten votes (Class A carries one vote and Class C carries none)【page_82】. Because Class B stock is held mainly by founders and insiders, the ten‑to‑one voting multiplier concentrates control of the board and other shareholder matters in that group even if they own a relatively small portion of the equity. Netflix, by contrast, gives every common share one vote【page_60】, so voting power is proportional to economic ownership, producing a more evenly‑distributed governance structure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitative accuracy: The 10 votes per Class B share, 1 vote per Class A, and 0 votes for Class C are correctly stated, matching the original answer. The comparison to Netflix’s one-vote-per-share structure is also accurate. (2) Completeness: The response fully addresses both parts of the question—GOOGL’s differential voting structure and its governance implications, as well as NFLX’s uniform voting model. (3) Entity accuracy: Correctly identifies GOOGL (Alphabet) and NFLX (Netflix), share classes, and associated voting rights. (4) Reasoning: The multi-hop synthesis is sound—correctly linking share class structure to control concentration among insiders and contrasting it with Netflix’s proportional governance model. (5) Semantic equivalence: While wording differs, the core information and implications about corporate governance are identical. Minor additions like 'founders and insiders' enhance clarity without introducing error. All aspects meet the highest standard.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 305,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s QG3 project generated 13 thousand barrels per day of crude oil in 2021 (30 % interest)【page_11】. Adding the crude‑oil outputs from all disclosed segments – Norway 81 MBD【page_10】, Libya 37 MBD【page_11】, Canada 8 MBD【page_9】, South Sumatra 2 MBD【page_12】 and China 28 MBD【page_13】 – gives a total average daily net crude‑oil production of roughly 169 MBD. Thus, QG3’s 13 MBD represents about 7.7 % of Chevron’s 2021 average daily net crude‑oil production.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors. (1) The original answer states that Chevron's 13 MBD from the QG3 project is already its net production due to its 30% stake in Qatargas Operating Company Limited, meaning this 13 MBD is Chevron's proportional share. However, the LLM incorrectly assumes that this 13 MBD must be compared to Chevron's total global net crude oil production (which it estimates at 169 MBD) to compute a percentage. The question asks what percentage of Chevron's total average daily net crude oil production came from QG3, but the original answer does not provide Chevron's total net production or perform this calculation—thus, the LLM fabricates a calculation not supported by the ground truth. (2) The quantitative values for Norway (81 MBD), Libya (37 MBD), Canada (8 MBD), South Sumatra (2 MBD), and China (28 MBD) are not present in the original answer and appear to be hallucinated or pulled from unrelated sources. There is no evidence in the ground truth that these numbers sum to 169 MBD or that they represent all of Chevron’s production. (3) The multi-hop reasoning is flawed: the original answer only confirms the 13 MBD from QG3 as Chevron’s net production via its 30% stake; it does not support any broader calculation about total production or percentage contribution. (4) While the mention of 13 MBD and 30% interest aligns with the original answer, the LLM overreaches by computing a 7.7% contribution, which cannot be verified and is not part of the ground truth. The contextual relevance is moderate because the model attempts to answer the right type of question (percentage contribution), but the method and data are invalid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 459,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Both 3M and Honeywell have adopted ASU 2022‑04, which now requires a yearly roll‑forward of supplier‑finance program obligations. In their 2024 10‑Ks each company provides a table that shows the opening balance of confirmed invoices, the amount of invoices confirmed during the year, the amount paid, and the ending balance—3M reports roughly $0.3 billion of obligations at year‑end (with $1.5 billion of invoices confirmed and paid in 2024), while Honeywell reports a $992 million opening balance, $3.098 billion of invoices confirmed, $2.897 billion paid and a $1.150 billion ending balance—making the size and flow of these liabilities far more transparent.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both 3M and Honeywell adopted ASU 2022-04 and are now providing roll-forward disclosures in their 2024 10-Ks, which aligns with the ground truth. However, there are significant quantitative inaccuracies. The ground truth states that 3M reported $1.5 billion of invoices confirmed and $1.5 billion paid or adjusted in 2024, but the LLM claims 3M had $1.5 billion confirmed and paid, and adds a year-end obligation of $0.3 billion not mentioned in the original answer. This introduces incorrect data not present in the ground truth. For Honeywell, the original answer only confirms adoption in 2024 with no specific roll-forward numbers, but the LLM provides detailed figures ($992M opening, $3.098B confirmed, etc.) that are not supported by the ground truth. (2) These numbers cannot be verified and appear fabricated or misattributed, failing the quantitative accuracy check. There is no indication in the original answer that such granular Honeywell data is available, nor is the $0.3B ending balance for 3M mentioned. (3) The reasoning is sound in structure—understanding that ASU 2022-04 requires roll-forwards and improves transparency—and the multi-hop synthesis across both companies is appropriate. The model correctly links the standard to enhanced disclosure practices. However, the addition of unsupported numerical detail undermines the factual integrity. (4) Contextual relevance is high because the response addresses the impact on transparency and the roll-forward requirement. Qualitative accuracy is moderate due to correct conceptual understanding but flawed data sourcing. Correctness score is 6 due to correct framework but significant factual errors in financial figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 475,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "Lockheed Martin follows the FAR (and CAS) rules that require it to allocate contract costs and recognize revenue over the life of a U.S.‑government contract, typically using a percentage‑of‑completion (cost‑to‑cost) method for fixed‑price work and recording contract assets when billings exceed revenue (see LMT 10‑K pp. 19, 78, 76). Raytheon Technologies, by contrast, flags that its U.S.‑government contracts—many of which are fixed‑price—expose it to financial risk because the government can terminate for convenience and any cost overruns on a fixed‑price award can erode profit or cash flow (see RTX 10‑K pp. 15). Thus, LMT’s FAR‑driven revenue‑recognition is a systematic, progress‑based accounting treatment, whereas RTX’s exposure centers on the potential loss or reduced earnings that fixed‑price contracts and termination rights can create.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both LMT's and RTX's contract structures and associated risks, with no incorrect numbers or entities (quantitative accuracy is perfect as no specific numeric values were required). It correctly identifies that LMT uses cost-based accounting under FAR, applies percentage-of-completion (cost-to-cost) for revenue recognition, and references appropriate 10-K pages. It also accurately notes RTX’s exposure to fixed-price contracts and government termination rights. However, the original answer emphasizes that LMT’s FAR-regulated contracts are typically cost-plus-fixed-fee, which provides cost reimbursement and predictable revenue, whereas the LLM answer focuses on fixed-price work and percentage-of-completion without clearly distinguishing that FAR-mandated cost-plus structures (not fixed-price) are LMT’s primary model for U.S. Government contracts. This leads to a subtle but important mischaracterization: the LLM implies LMT primarily uses percentage-of-completion on fixed-price contracts, while the ground truth stresses LMT’s use of cost-plus structures that inherently limit financial risk. The comparison with RTX’s higher risk under firm fixed-price contracts is well captured, but the contrast in revenue models (cost-plus vs. fixed-price) is less precise in the LLM answer. Thus, while the core facts and reasoning are sound, the qualitative accuracy is reduced due to incomplete or slightly misleading synthesis on the key distinction in contract types. Contextual relevance is high as the response directly addresses the question’s focus on revenue recognition and financial exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 451,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis composition‑of‑matter patent and its associated SPCs are still in force in Europe and are being defended through litigation in dozens of EU countries—generics have entered only where courts have ruled the patent invalid (e.g., the UK), but the patents have not yet expired (see page 121). In contrast, Merck’s key U.S. patents on the sitagliptin salt form protect the Januvia family until May 2026 for Januvia and Janumet and July 2026 for Janumet XR (see page 58). Consequently, BMS’s market‑exclusivity strategy relies on extending and enforcing European patent rights to delay generic entry, while Merck is planning for the scheduled U.S. exclusivity loss in 2026 and will lean on pricing, market‑share tactics and pipeline growth to offset the upcoming generic competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and patent expiration timelines are correct: MRK's Januvia family exclusivity until May 2026 (Januvia and Janumet) and July 2026 (Janumet XR) matches the original answer exactly. The LLM correctly notes that BMY's (BMS's) Eliquis patents are still in force in Europe with litigation ongoing, and generics have entered only where rulings invalidated the patent (e.g., UK), which is consistent with the ground truth mentioning generic entry in Finland and Portugal and mixed outcomes across countries. (2) The LLM cites specific page references (121 and 58), which are not part of the ground truth but do not detract from factual accuracy—likely from source document pagination. (3) Qualitatively, the reasoning is sound: it correctly contrasts BMS’s litigation-based strategy in Europe with Merck’s reliance on secondary patents (sitagliptin salt form) in the U.S. to extend exclusivity. The LLM accurately captures the strategic implications—BMS is fighting to delay generics, while Merck is preparing for 2026 entry with commercial and pipeline strategies. (4) The only minor omission is that the original answer specifies positive outcomes in Norway, Sweden, and Switzerland and ongoing appeals in several countries, which the LLM does not mention. While this adds granularity, it does not undermine the core correctness. The LLM answer is semantically equivalent and contextually fully relevant, addressing both the timeline comparison and strategic impact. Thus, a score of 9 is warranted—excellent accuracy with slight loss in completeness on litigation specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 455,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA had posted appeal bonds of about **$35 million** to secure stays of judgments on appeal (as of 12/31/2023)【page_49】. By contrast, since October 2004 the company has paid roughly **$1 billion** in judgments and settlements (plus about $241 million in interest) for tobacco‑related litigation【page_92】—so the bond amount is only a few percent of the total payments made.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest are all accurately reported with acceptable formatting variations (e.g., $1 billion = approximately $1 billion). The time frame 'since October 2004' is correctly referenced. (2) The answer addresses both parts of the multi-hop question: the total appeal bonds posted and the comparison to historical payments. (3) Entities are accurate—PM USA is correctly identified, and the financial metrics (judgments, settlements, interest, appeal bonds) are properly attributed to tobacco-related litigation. (4) The reasoning is sound: the LLM correctly infers that the $35 million bond amount is a small fraction (a few percent) of the total payments (~$1.241 billion including interest), which aligns with the ground truth's conclusion. The use of page citations adds contextual support. Semantic equivalence is maintained throughout, with no factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 301,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s “Greater China” segment – which the filing says includes mainland China, Hong Kong and Taiwan – generated **$74.2 billion** in net sales in fiscal 2022. NVIDIA’s 2022 Form 10‑K does not break out a separate Taiwan line (no direct Taiwan revenue is disclosed), so Apple’s Taiwan‑related contribution is far larger – roughly $74 billion versus $0 reported by NVIDIA.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, while Apple's $74.2 billion ($74,200 million) in net sales for Greater China in 2022 is correctly reported (matching the ground truth), the claim that NVIDIA reported $0 in revenue from Taiwan is false. The ground truth states that NVIDIA directly reported $8,544 million (i.e., $8.544 billion) in revenue from Taiwan in 2022. The LLM incorrectly asserts that NVIDIA’s 10-K does not disclose Taiwan revenue, which contradicts the original answer and factual data. (2) The answer fails on completeness and reasoning: it does not acknowledge NVIDIA’s actual $8.544 billion figure, thus failing to perform the required comparison between Apple’s embedded Taiwan contribution and NVIDIA’s direct Taiwan revenue. Instead, it falsely concludes that Apple’s contribution is 'far larger' versus $0, which is factually wrong. (3) Entity accuracy is mostly correct—Apple, NVIDIA, and the fiscal year 2022 are properly identified—but the misrepresentation of NVIDIA’s disclosure constitutes a critical entity-related error in financial metric reporting. (4) The reasoning is flawed: the multi-hop comparison requires recognizing that Apple’s Taiwan revenue is a subset of a larger regional total, while NVIDIA provides a direct figure. The LLM fails this synthesis by denying any NVIDIA Taiwan revenue. (5) Despite correct wording on Apple’s segment composition and revenue, the core factual inaccuracy regarding NVIDIA severely limits semantic equivalence. The answer misleads rather than informs. Thus, the correctness score is low due to a major factual error in quantitative data and reasoning, even though some contextual elements are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 471,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "Apple’s Greater China net sales rose from $40,308 million in FY 2020 to $74,200 million in FY 2022 – an increase of roughly 84 % (see AAPL 10‑K Note 11, page 52 and segment table, page 25). The NVDA excerpts (pages 78‑82) do not contain a revenue‑by‑geography table, so the change in NVDA’s Taiwan revenue between FY 2020 and FY 2022 cannot be determined from the provided documents.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reported AAPL's revenue figures for Greater China in FY2020 ($40,308 million) and FY2022 ($74,200 million) and accurately calculated the 84% increase, matching the ground truth. However, it incorrectly claimed that NVDA's revenue from Taiwan cannot be determined due to lack of a geography table in the provided excerpts. This contradicts the ground truth, which states that NVDA's revenue from Taiwan was $3,025 million in 2020 and $8,544 million in 2022 — implying this data was available in the knowledge graph (and presumably in the actual filings). The LLM's failure to report NVDA's revenue growth — a core part of the question — renders the answer severely incomplete. (2) Quantitative accuracy is high: AAPL numbers and percentage increase (~84%) are correct. NVDA numbers were not reported, so no error in calculation can be attributed, but the omission is critical. (3) The reasoning is flawed: the LLM asserts data unavailability without confirming whether the knowledge source (the 10-K) actually contains the information. In a multi-hop comparison question, failing to retrieve one side invalidates the synthesis. The model should have accessed or acknowledged the NVDA Taiwan revenue data if present in the knowledge base. (4) Due to the complete omission of half the comparison — NVDA’s revenue growth — despite accurate AAPL data, the overall correctness score is very low. The answer fails the primary task of comparing growth rates, making it mostly incorrect in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 419,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says that the OECD Pillar‑Two rules – which impose a 15 % global minimum tax – are not expected to have a material impact on its consolidated tax expense, even though its current effective tax rate is already below the U.S. statutory rate because a large share of earnings is taxed at lower foreign rates (e.g., Ireland)【page_47】. Broadcom makes a similar claim that the global minimum tax will not materially raise its tax cost because it does not have material operations in jurisdictions with rates below the 15 % floor【page_75】. Thus, both firms see little additional liability, but Microsoft’s outlook is shaped by its existing foreign‑tax structure, whereas Broadcom’s exposure is essentially negligible.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. The ground truth states that Microsoft projects no material impact from Pillar Two starting in fiscal year 2025, while Broadcom expects a material increase in tax costs due to its reliance on tax incentives in low-tax jurisdictions. However, the LLM incorrectly claims that Broadcom sees no material impact and does not have material operations in jurisdictions below 15%, which directly contradicts the original answer. This misrepresents the key comparison the question asks for. (2) Quantitatively, the 15% global minimum tax rate is correctly stated, and the fiscal years (2025 for Microsoft, 2026 for Singapore/Broadcom) are not mentioned in the LLM answer but are present in the ground truth—this omission contributes to inaccuracy. The LLM cites page references (47 and 75), but their content, as summarized, conflicts with the verified truth. (3) The multi-hop reasoning fails: the question requires contrasting Microsoft’s limited exposure with Broadcom’s significant exposure due to differing international tax structures. The LLM instead asserts both companies have negligible exposure, missing the divergence entirely. It fails to recognize that Broadcom—not Microsoft—is the one with potential liability due to its use of tax incentives in jurisdictions like Singapore. (4) Contextual relevance is moderate because the answer discusses the right topic (Pillar Two, global minimum tax, international structures) and mentions correct companies and tax rates, but the incorrect synthesis renders it misleading. The qualitative accuracy is low due to the fundamental error in company-specific exposure, undermining the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 467,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "NFLX’s common stock gives each share one vote on all shareholder matters (see NFLX 10‑K page 61). Alphabet’s Class B shares, by contrast, carry ten votes per share (see GOOGL 10‑K page 81). As a result, a holder of a Class B share wields roughly ten‑times the voting power of an NFLX shareholder on a per‑share basis, concentrating influence in the hands of those who own Class B stock while NFLX shareholders’ influence is proportional to their share ownership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The numbers are correct—NFLX shares carry one vote per share, GOOGL Class B shares carry ten votes per share. These values match the original answer and are cited from the correct 10-K pages. (2) Completeness: The answer addresses the core of the question—how the difference in voting rights impacts shareholder influence. It correctly contrasts the per-share voting power and notes the concentration of influence among GOOGL Class B shareholders versus the proportional distribution at NFLX. (3) Entity accuracy: Companies (NFLX, GOOGL/Alphabet), share classes (Class B), and voting rights are correctly identified. (4) Reasoning: The multi-hop synthesis is sound—comparing two different corporate voting structures across companies using data from their respective 10-Ks. The conclusion that Class B GOOGL shareholders have significantly more influence per share than NFLX shareholders is logically derived. (5) Semantic equivalence: While the LLM answer does not explicitly mention that NFLX has a uniform structure (no multiple classes), it implies it by stating all shares have one vote and influence is proportional—this captures the essence of the original. The only minor omission is not explicitly contrasting GOOGL’s dual-class structure with NFLX’s single-class system, but the implication is clear. Hence, a score of 9 is warranted—excellent accuracy with only slight room for more structural context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 415,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD reported Taiwan sales of **$2,091 million** for the fiscal year ended December 25 2021【page_78】.  Apple’s net sales for the **Greater China** segment (which includes Taiwan) were **$74,200 million** in fiscal 2022【page_25】.  Consequently, AMD’s Taiwan revenue in 2021 was about **$72 billion lower**—roughly **3 %** of Apple’s 2022 Greater China revenue.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers. It states AMD's 2021 revenue from Taiwan was $2,091 million, but the ground truth is $1,187 million—a significant overstatement. This error undermines the entire comparison. Apple's revenue from Greater China in 2022 is correctly reported as $74,200 million, which matches the ground truth. (2) The calculation of the difference is therefore incorrect: the LLM claims AMD’s revenue was about $72 billion lower, but the actual difference is approximately $73.013 billion ($74,200M - $1,187M). Additionally, the LLM claims AMD’s revenue was roughly 3% of Apple’s, but the correct percentage is about 1.6% ($1,187 / $74,200 ≈ 0.016), not 3%. The calculation error stems directly from the incorrect AMD figure. (3) The multi-hop reasoning structure is sound—the model correctly identifies that AMD’s Taiwan-specific revenue should be compared to Apple’s broader Greater China revenue (which includes Taiwan)—and it draws the right qualitative conclusion that Apple’s revenue was much higher. However, due to the incorrect AMD number, the quantitative synthesis fails. (4) Contextual relevance is high because the answer addresses the right entities, time periods, and geographic regions, and attempts a meaningful comparison. However, the severe quantitative inaccuracies—especially the doubling of AMD’s revenue—result in a low correctness score despite the otherwise logical framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1170,
        "completion_tokens": 403,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan left roughly 12.5 million shares of common stock available for future awards (TSLA 10‑K p. 84), while Starbucks still had about 49.0 million shares reserved and available under its 2019 Plan (SBUX 10‑K p. 83). Thus Starbucks’ remaining equity‑grant capacity is roughly four‑times larger than Tesla’s. Both companies use incentive stock options as a core component of their compensation strategies, but Tesla’s smaller share pool limits the scale of future ISO grants compared with Starbucks’ much larger pool.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Tesla had 49.0 million shares available as of December 31, 2021, but the LLM claims only 12.5 million, which is incorrect. Similarly, Starbucks had 99.7 million shares available as of October 2, 2022, but the LLM incorrectly states 49.0 million—this number actually matches Tesla’s total reserved shares, suggesting a mix-up. The claim that Starbucks’ pool is 'four-times larger' is based on these wrong figures and thus invalid. (2) The cited 10-K page numbers (p. 84 for TSLA, p. 83 for SBUX) may be accurate document locations, but the data extracted from them is not aligned with the ground truth, raising concerns about source misinterpretation. The comparison ratio is therefore also incorrect. (3) While the LLM correctly identifies that both companies use incentive stock options (ISOs) as part of their compensation strategy, it fails in the multi-hop synthesis: it misattributes the share availability numbers between the two firms and uses mismatched reporting dates without clarification. (4) Despite incorrect numbers, the answer attempts to address both parts of the question—comparing available shares and discussing ISO usage—so it retains partial relevance and basic qualitative structure, warranting a low but non-zero score. However, the core quantitative failure severely undermines the answer’s validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 396,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD determines its Level 2 fair values by applying valuation models that use observable market inputs—such as interest‑rate curves, bond yields and quoted prices for comparable securities—to estimate the value of fixed‑income and commingled fund holdings【page_93】. In contrast, Boeing values its available‑for‑sale debt investments at Level 2 directly from quoted market prices or broker/dealer quotes of identical or comparable instruments (and, for non‑traded debt, from dealer‑derived borrowing‑cost quotes)【page_113】【page_115】. Thus, GD’s fair‑value estimates are model‑driven using broader observable inputs, whereas Boeing’s are more directly tied to broker/dealer pricing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both GD's and BA's fair value determination approaches, with correct entity identification (GD and Boeing/BA), accurate financial concepts (Level 2 assets, available-for-sale debt investments), and proper sourcing references (page numbers). There are no numeric inaccuracies, as the question does not involve specific dollar amounts, dates, or percentages—thus quantitative accuracy is perfect. The answer correctly identifies that GD uses valuation models with broader observable inputs (e.g., interest-rate curves, bond yields, comparable securities), while BA relies more directly on broker/dealer quotes for identical or comparable instruments, including dealer-derived borrowing-cost quotes for non-traded debt. This distinction aligns with the ground truth’s emphasis on both companies using observable inputs and third-party pricing, but the LLM adds nuance by highlighting GD’s model-driven approach versus BA’s more direct pricing reliance. However, the original answer emphasizes the 'parallel approach' between the two companies due to their shared reliance on observable inputs and third-party services, whereas the LLM frames it as a contrast. While the differentiation is valid, it slightly overstates the divergence in methodology and underemphasizes the fundamental similarity in compliance with Level 2 fair value principles. Thus, while the reasoning is sound and well-supported, it misses partial credit for synthesis completeness by not acknowledging the core alignment in approach as stated in the ground truth. Contextual relevance is excellent, addressing all aspects of the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 456,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "Because the Federal Reserve has left the Counter‑cyclical Capital Buffer at 0 %, it adds no extra charge to either firm’s Basel III buffer. Morgan Stanley’s Advanced‑Approach buffer therefore stays at 5.5 % (the 2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % CCyB), while American Express’s total buffer is simply its Stress Capital Buffer (5.4 % in 2023) plus the 3.0 % G‑SIB surcharge, also with a 0 % CCyB, leaving the overall requirement unchanged.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It states that Morgan Stanley’s total buffer is 5.5% (2.5% CCB + 3.0% G-SIB + 0% CCyB), but this omits the Stress Capital Buffer (SCB), which the ground truth explicitly includes as part of Morgan Stanley’s Advanced Approach calculation. The LLM incorrectly implies that the SCB is not part of Morgan Stanley’s 5.5% total, when in fact the SCB is a key component. Similarly, for American Express, the LLM claims the total buffer is 5.4% SCB + 3.0% G-SIB, but this 5.4% SCB value is not mentioned in the ground truth and appears fabricated. The ground truth does not provide specific percentage values for the SCB or total buffers, so inserting 5.4% and 5.5% is unsupported. (2) Calculations are presented but based on incorrect or unverified inputs. The sum of 2.5% + 3.0% = 5.5% is mathematically correct, but the model falsely assumes this is the total buffer without SCB inclusion. The SCB is not additive in a simple way to G-SIB; it functions differently under the regulatory framework, and the LLM misrepresents the structure. (3) The multi-hop reasoning is partially sound—correctly noting that a 0% CCyB means no additional requirement for either firm—but fails in synthesizing the correct components of capital buffers for each institution. It conflates buffer types and misattributes the role and value of the SCB. (4) Contextual relevance is high because the answer addresses both firms, Basel III, CCyB, SCB, and G-SIB surcharge, and attempts to differentiate regulatory approaches. However, the inclusion of specific unverified percentages severely undermines factual correctness. The qualitative reasoning is mid-level: entities are correctly identified (Morgan Stanley, American Express, SCB, G-SIB), but their regulatory application is misrepresented. Thus, correctness is low due to unsupported numbers and missing key components in capital buffer composition.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 536,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "The $4 billion increase to American Tower’s 2021 Credit Facility was an amendment that lifted the revolving‑credit commitment to $4 bn, giving the company a larger pool of borrowings that it used to fund its major acquisitions – notably the Telxius and CoreSite purchases – and other corporate purposes (AMT p. 111; p. 51). In contrast, Simon Property Group does not depend on large credit facilities; it finances growth primarily through joint‑venture structures, providing relatively modest construction‑loan advances (about $88.4 m) and sharing risk across its 84 joint‑venture properties (SPG p. 115‑116).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $4.0 billion credit facility increase and the $88.4 million in financing to joint ventures are accurately reported, with acceptable format variations ($4 billion = $4.0 billion; $88.4 m = $88.4 million). (2) The answer addresses both parts of the multi-hop question: AMT’s use of its expanded credit facility to finance acquisitions (specifically naming CoreSite and also correctly adding Telxius, which is factually accurate though not in the ground truth) and contrasts it with SPG’s joint venture financing approach. (3) Entity accuracy is strong: American Tower (AMT) and Simon Property Group (SPG) are correctly identified, and the time frame (as of December 31, 2021) is contextually respected. (4) The reasoning is sound—AMT’s reliance on large-scale debt via a credit facility is clearly contrasted with SPG’s use of joint ventures and smaller construction loans to share risk. The only minor shortcoming is that the ground truth emphasizes SPG’s strategy as a means to 'diversify risk' and support 'real estate development,' which is slightly more nuanced than the LLM’s 'sharing risk' phrasing, though the meaning is semantically close. The LLM also cites document pages, which adds credibility but is not required. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 395,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks’ licensed‑store footprint in Taiwan rose from 523 stores at the end of fiscal 2021 to 544 stores at the end of fiscal 2022 – a net increase of 21 stores【page_12】.  By contrast, Nike’s Greater China geographic segment (which includes Taiwan) produced roughly $7.5 billion of revenue in FY 2022【page_88】.  Thus, Starbucks saw a modest 21‑store expansion in Taiwan, while Nike’s Greater China region contributed multi‑billion‑dollar revenue, a far larger scale of impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, increasing from 523 to 544 stores, which matches the ground truth. It also accurately reports Nike's Greater China revenue as approximately $7.5 billion in FY2022, consistent with the ground truth value of $7,547 million (rounded appropriately). All numeric values and fiscal years are correct. (2) Quantitative accuracy is perfect: the store count difference (544 - 523 = 21) is accurate, and $7.5 billion is a valid rounding of $7,547 million. No calculation errors. (3) The multi-hop reasoning is sound—correctly linking Starbucks’ store growth in Taiwan with Nike’s revenue from Greater China (which includes Taiwan), and contrasting physical expansion versus financial performance. The synthesis across companies and metrics is logical and relevant. (4) The only minor shortcoming is that the LLM does not explicitly note that Taiwan is included within Nike’s Greater China reporting segment, though it references that the segment 'includes Taiwan,' which is sufficient. Wording differs slightly from the original answer but maintains semantic equivalence. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 357,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing says that the bulk of its OPB plan assets are held in a balanced index fund that is “approximately 60 % equities and 40 % debt securities”【page_96】.  \n3M’s pension‑plan disclosures show that the fair‑value of equity holdings for its U.S. pension plans was about **$1.42 billion** at December 31 2023【page_72】.  \n\nSo, roughly 60 % of Boeing’s OPB assets are indirectly in equities, while 3M’s pension plan holds equities worth about $1.42 billion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that approximately 60% of Boeing's OPB plan assets are indirectly invested in equities through the balanced index fund, which matches the ground truth. However, it reports 3M's total fair value of equities as $1.42 billion, whereas the ground truth states $785 million — a significant discrepancy. This error likely stems from misreading or misextracting the value from page 72 of the filing. (2) The percentage for Boeing is accurate and correctly attributed. The dollar amount for 3M is incorrect: $1.42 billion is nearly double the true value of $785 million. No calculation is required in the question, but the comparison hinges on accurate retrieval of both figures. (3) The multi-hop reasoning is structurally sound — the model identifies the correct entities (Boeing OPB plan, 3M pension plan), the correct metric (percentage of equities via fund, total fair value of equities), and time frame (December 31, 2023). However, the failure to extract the correct equity value for 3M undermines the validity of the comparison. (4) The contextual relevance is high as the answer addresses both parts of the question and cites appropriate sources. Qualitative reasoning is strong, but quantitative accuracy is compromised by the incorrect figure for 3M, leading to a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 373,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower drew the full $3 billion 364‑day loan and $1.5 billion two‑year loan – $4.5 billion in total – under its 2021 USD delayed‑draw term facilities and used the proceeds to fund the CoreSite acquisition; the loans are unsecured term facilities with LIBOR‑plus‑margin interest and set maturities (see AMT p. 51‑52). Simon Property’s joint‑venture financing is far smaller, consisting of about $88.4 million of interest‑bearing construction loans and other advances to JV partners that are recorded as deferred costs (see SPG p. 116).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While the ground truth states that AMT utilized a $10.5 billion financing structure via the 2021 USD Delayed Draw Term Loans for the CoreSite acquisition, the LLM claims only $4.5 billion was drawn ($3B + $1.5B), which underrepresents the total financing by more than half. This is a major factual error, especially since the question focuses on dollar amounts and financing structure. The SPG figure of $88.4 million is correctly reported. (2) The calculation of AMT’s financing is incorrect: the LLM sums only two tranches ($3B and $1.5B) but omits other components or misrepresents the total commitment, which in the ground truth is $10.5B. There is no indication that only $4.5B was ultimately used for CoreSite—this contradicts the original answer stating the full $10.5B structure was in place to avoid bridge loans. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that AMT’s financing was for the CoreSite acquisition and describes the loan structure (unsecured, LIBOR-based, maturities), and contrasts it with SPG’s smaller-scale, joint-venture-oriented financing. It also correctly notes SPG’s $88.4M in interest-bearing construction loans and other advances. The multi-hop synthesis—comparing AMT’s acquisition financing to SPG’s real estate joint venture support—is logically framed and contextually appropriate. (4) Contextual relevance is high: the answer addresses both companies, the purpose of financing, structure, and scale. However, due to the critical error in the dollar amount for AMT’s financing, which is central to the question, the correctness and quantitative accuracy scores are significantly reduced. The answer is not semantically equivalent to the ground truth on the key financial figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 496,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s downstream segment depends on crude oil as the primary feedstock for its refineries (see XOM 10‑K p. 109). Chevron owns a 15 % equity stake in the Caspian Pipeline Consortium, which in 2024 moved an average of 1.4 million barrels of crude per day – about 1.2 million barrels of that volume originating from Kazakhstan (see CVX 10‑K p. 85 and p. 16). Thus, a large portion of the crude that XOM needs is transported through a pipeline in which CVX has a material ownership interest, linking XOM’s raw‑material reliance to CVX’s pipeline exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: XOM relies on crude oil as feedstock (specifically noted for its downstream segment, citing p.109 of XOM 10-K), CVX holds a 15% stake in the CPC (correct entity and percentage), the CPC transported 1.4 million barrels per day on average, with 1.2 million barrels originating from Kazakhstan (citing CVX 10-K p.85 and p.16). These numbers match the original answer exactly. (2) Quantitative accuracy is perfect—no calculation errors, and the figures are correctly attributed. Minor variation in phrasing (e.g., '2024' mentioned in LLM answer but not in original) does not contradict the data, as the original does not specify a year, so this addition is plausible and consistent. (3) Multi-hop reasoning is sound: the answer correctly links XOM’s crude oil dependency → CVX’s ownership in CPC → volume of Kazakh crude transported → implication that CVX’s production (via stakes in Tengiz/Karachaganak) relies on CPC, thus connecting XOM’s supply chain exposure to CVX’s infrastructure interest. The LLM omits explicit mention of Tengiz and Karachaganak fields, which are part of the ground truth context, slightly weakening completeness. (4) Despite this minor omission, the core logic and synthesis across entities (XOM, CVX, CPC, Kazakhstan operations) are accurate and relevant. The conclusion that XOM’s needed crude flows through a pipeline where CVX has a stake is logically derived and contextually appropriate. Hence, high scores across all dimensions with a 9 in correctness due to the slight lack of specificity on Chevron’s operated fields.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 450,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE warns that the cost to de‑commission its nuclear plants could exceed the balances in its dedicated de‑commissioning funds and that a decline in the market value of those assets would raise funding needs and strain liquidity (NEE 10‑K pp. 30‑32). Duke similarly notes that its nuclear‑decommissioning trust (NDTF) investments are subject to market fluctuations, and a drop in their value could require significant additional funding and hurt its financial position (Duke 10‑K p. 35). Thus, while both utilities share the same environmental and financial exposure, NEE’s risk is framed as a potential shortfall in fund balances, whereas Duke’s risk is framed as volatility in the trust‑fund assets that could trigger extra funding requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual information is correct: both NEE and Duke Energy face financial risks related to nuclear decommissioning due to market volatility affecting their trust funds, with NEE emphasizing potential shortfalls and Duke highlighting market-driven funding requirement increases. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—no calculations were required, and no numbers were misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes risk disclosures from both companies’ 10-Ks, identifying that while both face similar underlying risks, the framing differs—NEE focuses on cost exceeding fund balances, Duke on market volatility impacting NDTF assets. The LLM cites specific page numbers (NEE pp. 30–32, Duke p. 35), which is consistent with source-based reasoning and adds credibility. (4) Semantic equivalence is strong: the LLM captures the core comparison—shared environmental and financial risks, different emphasis in risk disclosure—without distorting meaning. The only minor limitation is that the original mentions three Duke subsidiaries (Duke Energy Carolinas, Progress, and Florida), while the LLM refers to 'Duke' generally. This is a slight omission but does not affect the overall correctness, as the risk description applies collectively. Thus, the answer is contextually relevant, factually accurate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 428,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Lowe’s Level 3 fair‑value amounts are measured with pricing models—most notably an option‑pricing model used for its contingent‑consideration liability—that depend on significant unobservable inputs such as total equity value, volatility and expected term (Note 3, p. 52‑53). GM also places assets in Level 3 when the valuation relies on unobservable inputs, stating that when quoted market prices are unavailable it uses pricing‑service and model‑based approaches that incorporate such assumptions (Fair‑value hierarchy, p. 63). Both firms follow the same policy that classifies a measurement as Level 3 when the lowest‑order input is unobservable, but Lowe explicitly cites a pricing‑model methodology, whereas GM describes a broader use of pricing services and models for its Level 3 valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LOW uses pricing models—specifically an option-pricing model—for its Level 3 contingent consideration, relying on significant unobservable inputs like volatility, expected term, and total equity value, which matches the original answer's reference to the Canadian retail business sale. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; all referenced inputs and methodologies are consistent. (3) The multi-hop reasoning is sound: the LLM correctly compares LOW’s and GM’s use of unobservable inputs within Level 3 valuations, noting that GM uses pricing services and models incorporating economic forecasts (e.g., unemployment, GDP) for GM Financial receivables, which is semantically equivalent to the ground truth’s description. (4) The LLM accurately reflects the accounting policy that Level 3 classification occurs when the lowest-level input is unobservable, and correctly contrasts LOW’s explicit use of a pricing model with GM’s broader application of pricing services and models. The only minor shortcoming is that the LLM does not explicitly mention 'static pool modeling' or 'expected credit losses' for GM, which are specific details in the ground truth, slightly reducing qualitative completeness. However, the core facts, entities, reasoning, and synthesis are correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 413,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "American Tower’s $10.5 billion of committed capacity under its 2021 Multicurrency Credit Facility (together with related facilities) is a massive, revolving liquidity pool that the company uses to fund large‑scale acquisitions such as Telxius and CoreSite and for general corporate purposes, giving it broad, flexible capital deployment【page_52】.  By contrast, Simon Property Group’s joint‑venture financing is modest—about $88.4 million of construction loans and other advances to 84 JV properties—targeted to specific projects and spread across many partners to diversify risk【page_116】.  Thus, AMT relies on a centralized, high‑capacity credit line for large‑scale, flexible funding, while SPG employs smaller, project‑level JV financing to achieve risk diversification.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AMT's $10.5 billion committed financing via its 2021 Multicurrency Credit Facility is accurately stated, as is SPG's $88.4 million in joint venture financing. The uses of funds—AMT for large acquisitions like Telxius and CoreSite, SPG for construction loans across 84 JV properties—are consistent with the original answer. (2) Quantitative accuracy is perfect: both dollar amounts ($10.5 billion and $88.4 million) match exactly, and no calculations are required beyond accurate reporting. Format variations (e.g., $10.5 billion vs $10.5B) are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMT and SPG), their distinct financing mechanisms, strategic purposes, and risk implications. It contrasts centralized, flexible credit usage (AMT) with decentralized, risk-diversifying project financing (SPG), capturing the core strategic distinction. (4) Contextual relevance is high—the response directly addresses both capital deployment strategy and risk diversification as asked, with precise, evidence-based comparisons. Minor wording differences (e.g., 'revolving liquidity pool' or 'spread across many partners') enhance clarity without altering factual content. All sources are appropriately cited (page references).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 393,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD’s 2023 10‑K shows that sales to customers in Taiwan were $1.841 billion, or roughly 8 % of its total $22.68 billion revenue (AMD 10‑K, p. 71). Qualcomm’s 2023 filing notes that the company’s chipset supply is heavily reliant on its foundry partners—primarily the fabs in Taiwan—making its operations dependent on that region, but it does not disclose a specific revenue amount (Qualcomm 10‑K, p. 33). Thus, AMD’s Taiwan exposure is quantified in dollar terms, whereas Qualcomm’s exposure is described qualitatively as a critical supply‑chain reliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.841 billion in sales to Taiwan (equivalent to $1,841 million in the original answer) and the 8% of total revenue (calculated from $1.841B / $22.68B ≈ 8.1%) are precise. The reference to AMD’s 10-K, page 71, adds verifiability. (2) The qualitative assessment of Qualcomm’s dependency on Taiwanese foundries is accurate and matches the original answer’s emphasis on supply chain reliance without disclosed revenue figures. The LLM correctly cites Qualcomm’s 10-K, page 33, and characterizes the exposure as operational/supply-chain based. (3) Multi-hop reasoning is sound: the model distinguishes between AMD’s revenue exposure (quantifiable) and QCOM’s operational dependency (qualitative, supply-side), synthesizing information from both companies’ filings. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'declining exposure' trend for AMD noted in the original answer, nor does it fully elaborate on the shared geopolitical risk impact as a 'dual risk' to both revenue and manufacturing—though the implication is present. This slight omission in completeness prevents a perfect 10, but the core facts, calculations, entities, and reasoning are correct and contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 371,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "- Starbucks says the OECD Pillar 2 15 % minimum tax will not become effective for the company until fiscal 2025 and it “is not expected to result in a material impact to our consolidated financial statements” (SBUX 10‑K p. 28).  \n- McDonald’s notes that many jurisdictions have already enacted Pillar 2, with the earliest effective dates for taxable years beginning after Dec 31 2023, but the company likewise “does not expect this enactment will have a material impact on the consolidated financial statements” (MCD 10‑K p. 20).  \n\nThus, both firms anticipate no material effect, but Starbucks’ impact is deferred to FY 2025, whereas McDonald’s acknowledges earlier roll‑outs (post‑2023) yet still expects no material impact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates, percentages, and fiscal years are accurate: SBUX's fiscal 2025 effective date and MCD's reference to post-December 31, 2023 implementation are correctly reported. The 15% rate is accurately cited. (2) The answer is complete, addressing both companies' assessments of the Pillar 2 impact, their timelines, and the conclusion of no material impact—directly responding to the comparative, multi-hop nature of the question. (3) Entity accuracy is perfect: correct company names (Starbucks/SBUX, McDonald’s/MCD), correct citation of 10-K page numbers, and proper financial terminology (e.g., 'consolidated financial statements', 'material impact'). (4) Reasoning is sound: the LLM correctly synthesizes information across both filings, compares the phased implementation timelines, and draws the accurate conclusion that both expect no material impact despite differing effective dates. (5) Semantic equivalence is strong—wording differs slightly but conveys identical meaning to the original answer, including the nuance of ongoing monitoring (implied by 'acknowledges earlier roll-outs... yet still expects'). Minor omission of explicit 'monitoring guidance' phrasing does not detract from factual completeness, as the core assessment and comparative timeline are fully preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 383,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s risk‑governance framework places firm‑wide ownership of risk identification and assessment on each line‑of‑business, with the CRO‑led Independent Risk Management (IRM) function providing a consistent, integrated oversight across the three‑lines‑of‑defense and reporting to the Board’s Risk Committee (see pages 93‑95). Because risk assessment is owned throughout the firm, its stress‑testing is embedded in the enterprise‑risk‑management process and applied uniformly across units rather than being a separate capital‑planning exercise. Goldman Sachs, by contrast, explicitly links its firm‑wide stress tests to capital‑adequacy assessments as part of its capital‑planning and regulatory stress‑testing program (see page 99), using stress‑testing primarily to gauge whether capital buffers would survive adverse scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorgan Chase's firmwide ownership of risk assessment, the role of the CRO-led Independent Risk Management (IRM), the three-lines-of-defense model, and reporting to the Board’s Risk Committee are consistent with the knowledge graph. Similarly, Goldman Sachs’ explicit linkage of stress testing to capital adequacy, capital planning, and regulatory requirements is accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts JPMorgan Chase’s governance-driven, embedded stress testing approach with Goldman Sachs’ capital-adequacy-focused, scenario-based stress testing, synthesizing across both firms’ frameworks. The LLM adds slightly more structural detail (e.g., 'three-lines-of-defense', 'CRO-led IRM', page references) not in the original but consistent with likely source material, enhancing clarity without introducing inaccuracies. (4) Semantic equivalence is strong: the core contrast in purpose and integration of stress testing—governance-driven risk ownership vs. capital adequacy assessment—is preserved and well-articulated. The only minor gap is that the LLM does not explicitly mention Goldman Sachs’ evaluation of 'nonfinancial risks' or 'tail risks' as in the original, slightly reducing completeness. However, this does not undermine the central comparison. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 470,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "Exxon Mobil’s long‑lived assets in Kazakhstan total about **$8.5 billion** (the “Kazakhstan” line in the long‑lived‑asset table shows $8,463 million)【page_123】.  By contrast, Chevron owns **50 % of Tengizchevroil** and carries an equity investment of roughly **$23.7 billion** plus a **$4.5 billion loan** to the joint venture, for a combined financial stake of roughly **$28 billion**【page_78】.  Thus CVX’s exposure to the Kazakh venture is more than three times the size of XOM’s asset exposure in the country.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies XOM's $8,463 million ($8.5 billion) in long-lived assets in Kazakhstan and CVX's 50% equity ownership in Tengizchevroil, as well as the $4.5 billion loan to TCO. However, it introduces a new figure—CVX's 'equity investment of roughly $23.7 billion'—that is not present in the original answer or supported by the ground truth. This number significantly inflates CVX's total financial stake to $28 billion, leading to the conclusion that CVX's exposure is 'more than three times' XOM's, which cannot be verified from the provided truth. (2) While $8,463 million and $4,500 million are accurately reported (with acceptable rounding), the $23.7 billion equity investment figure has no basis in the original answer, which only states CVX has a 50% equity interest without assigning a dollar value to that stake. The sum of $23.7B + $4.5B = $28.2B is therefore incorrect and unsupported. (3) The multi-hop reasoning is partially sound—comparing XOM's asset exposure to CVX's combined equity and loan exposure in Kazakhstan—but fails because it fabricates a key financial input. The original answer suggests CVX's combined exposure (equity + loan) *could potentially exceed* XOM's $8.463B, but does not assert this definitively or provide a total value. The LLM overstates the certainty and magnitude of the comparison. (4) Scores reflect that core facts (XOM assets, CVX ownership %, loan amount) are correct (supporting qualitative and contextual accuracy), but the introduction of an unsupported equity valuation severely undermines quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 441,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Qualcomm says that its ability to obtain “consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” could be “severely limited or prevented” by a “significant or prolonged military or other geopolitical conflict involving China and Taiwan,” which would have a material adverse impact on its business【page_35】. NVIDIA likewise warns that “geopolitical tensions, such as those involving Taiwan and China… where we have suppliers, contract manufacturers, and assembly partners who are critical to our supply continuity, could have a material adverse impact on us,” potentially causing extended lead‑times or supply interruptions【page_17】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies both QCOM and NVDA, their reliance on foundry partners in Taiwan, and the potential impact of geopolitical tensions involving China and Taiwan on their supply chains. The key risk—material adverse impact due to supply disruption—is accurately conveyed for both companies. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable; however, the absence of such data is consistent across both answers, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (QCOM and NVDA), linking their shared dependency on Taiwanese foundries and the common geopolitical risk. It references specific page numbers (35 for QCOM, 17 for NVDA), indicating proper sourcing from the filings. (4) The wording differs slightly but preserves full semantic meaning, using direct quotes and appropriate paraphrasing. All aspects of the question—impact on QCOM's chipset supply and NVDA's supply continuity—are addressed with precise, relevant details. No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 354,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company warns that the large capital and operating outlays required to meet new or revised environmental laws – costs that are often recovered through higher regulated rates – could suppress electricity (and natural‑gas) demand, especially among commercial‑ and industrial‑size customers who may cut usage when rates rise or when compliance requirements limit their operations【page_26】. Duke Energy’s risk‑factor discussion similarly notes that a slowdown in industrial production – whether from an economic downturn or other market pressures – can sharply reduce electricity and natural‑gas sales and make the company’s cash‑flow and earnings vulnerable to industrial‑customer demand volatility【page_27】. Thus, Southern’s potential demand shift is driven by regulatory cost recovery, whereas Duke’s exposure stems from broader economic‑driven fluctuations in industrial consumption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: Southern Company's environmental compliance costs are passed through regulated rates but may reduce industrial demand due to higher rates and operational constraints for customers; Duke Energy highlights industrial demand volatility due to economic conditions affecting consumption and cash flows. The LLM correctly identifies that Southern's exposure is regulatory-cost-driven while Duke's is economically driven. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model synthesizes risk factors from both companies’ filings, correctly contrasting the drivers of industrial demand shifts—regulatory cost pass-through vs. economic fluctuations. (4) The LLM slightly broadens Southern’s customer impact to include 'commercial- and industrial-size customers,' while the original answer focuses only on industrial customers. This is a minor expansion but not factually incorrect, as commercial customers could also be affected. Overall, the answer is complete, contextually relevant, and conveys the same core comparison with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 365,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s foreign‑exchange cash‑flow hedge program had a notional amount of roughly **$9.9 billion** as of September 2024 (NKE 10‑K p. 121).  By contrast, McDonald’s disclosed net foreign‑currency asset exposures of about **$3.8 billion** in aggregate (Australian $1.5 bn, British £1.1 bn, Polish zł $0.6 bn, Chinese ¥ $0.3 bn, Hong Kong $0.2 bn) (MCD 10‑K p. 24).  Thus Nike’s hedge notional is more than twice the size of McDonald’s net asset exposures, indicating Nike is covering a larger scale of cross‑border currency risk with its cash‑flow hedges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. First, the claim that McDonald's has $3.8 billion in net foreign-currency asset exposures is not supported by the ground truth, which does not provide any specific aggregate dollar amount for MCD's net asset exposures. The breakdown of exposures by currency (Australian $1.5 bn, British £1.1 bn, etc.) does not appear in the original answer and is likely fabricated or misattributed. There is no evidence in the ground truth that MCD’s total net asset exposure aggregates to $3.8 billion, nor are those specific currency exposures mentioned. Second, the comparison stating that Nike’s $9.9 billion hedge notional is 'more than twice the size' of MCD’s net asset exposures is therefore based on incorrect data and invalid calculation. While the $9.9 billion notional amount for NKE is correct and properly cited, the LLM invents a quantitative benchmark for MCD that is absent from the source material. The qualitative reasoning about differing risk management strategies (hedging vs. balance sheet netting) is partially aligned with the ground truth, but the LLM fails to accurately represent MCD’s approach beyond inserting false numbers. The multi-hop synthesis is flawed because it compares a real number (NKE hedges) to an invented one (MCD exposures). Contextually, the answer addresses the right topic—comparing cross-border risk management—but does so with incorrect data, leading to a misleading conclusion. Minor formatting issues (e.g., currency symbols) are acceptable, but the core quantitative error is severe.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 437,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "Coca‑Cola’s Ukraine exposure is indirect – it comes through its bottling partner Coca‑Cola HBC, which lists Ukraine among dozens of bottling territories and whose Ukrainian operations contributed **less than 1 % of Coca‑Cola’s consolidated net sales and net earnings**【page_7】【page_9】. By contrast, Procter & Gamble runs **two manufacturing sites in Ukraine with about 500 employees**, and its Ukrainian facilities are a direct source of production and raw‑material supply; although they also represent **under 1 % of P&G’s net sales/earnings**, the risk is more immediate because the company could lose the ability to operate those plants or ship finished goods if the war disrupts the supply chain【page_23】【page_24】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: both Coca-Cola and P&G have less than 1% of net sales and net earnings tied to Ukraine, which matches the original answer’s implication of minimal financial scale. The mention of two manufacturing sites and ~500 employees for P&G, while not in the original answer, does not contradict it and adds detail consistent with 'direct reliance' and 'two manufacturing facilities'. (2) The calculation and comparison of exposure—indirect via Coca-Cola HBC vs. direct but small-scale for P&G—are logically sound and factually supported. (3) Multi-hop reasoning is strong: the model correctly synthesizes that Coca-Cola’s exposure is indirect through a bottler (Coca-Cola HBC), while P&G has direct operational control, making its risk more immediate despite similar financial scale. (4) The original answer notes that Coca-Cola HBC is one of the top five bottlers contributing to 41% of global volume, which the LLM omits; this is a minor omission in context but doesn’t undermine the core comparison. Wording differs but semantic meaning is equivalent. The LLM slightly enhances the answer with employee count and operational detail without introducing error. Thus, the answer is factually correct, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 407,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MetLife’s CMBS holding (recorded under “Structured Securities”) was $4.55 billion at fair value, while Bank of America’s CMBS holding (the “Commercial” mortgage‑backed securities) was $10.91 billion at amortized cost, giving a combined exposure of about $15.5 billion. MetLife’s fair‑value amount is therefore roughly $6.4 billion lower – about 42 % of the amount that Bank of America carries at amortized cost【page_274】【page_113】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MET's fair value exposure to CMBS as $4.55 billion (matching $4,551 million in the ground truth) and BAC's amortized cost as $10.91 billion (slightly off from $10,922 million, a difference of $11 million). The combined exposure is stated as 'about $15.5 billion', which is a reasonable approximation of the exact sum ($15,473 million), though not precise to the nearest $10 million. (2) Calculations: The sum of $4.55B + $10.91B = $15.46B, which rounds to $15.5B — acceptable for 'about' but lacks exactness. The claim that MET's amount is '$6.4 billion lower' is inaccurate: $10,922M - $4,551M = $6,371M, or $6.371 billion, so $6.4B is a rounded but acceptable figure. However, stating it is 'about 42% of BAC's amount' is incorrect — $4.551B / $10.922B ≈ 41.66%, so saying MET's is 42% of BAC's would mean MET is 42%, not that the difference is 42%. The LLM misrepresents the comparison: it says 'MetLife’s fair-value amount is therefore roughly $6.4 billion lower – about 42% of the amount that Bank of America carries', which incorrectly implies the $6.4B difference is 42% of BAC's value, when in fact it's ~58%. This is a significant misstatement of the relationship. (3) Multi-hop reasoning: The model correctly identifies both companies, the correct security type (CMBS), and the correct valuation methods (fair value vs amortized cost), and synthesizes across entities. However, the flawed comparative analysis weakens the reasoning. (4) Scores justified: Correctness is 8 due to mostly accurate numbers and synthesis but a flawed percentage interpretation. Quantitative accuracy is 8 due to minor rounding and one incorrect comparative calculation. Qualitative accuracy is 8 due to correct entity identification and accounting treatment, but flawed logic in the comparison. Contextual relevance is 10 — all parts of the question are addressed with relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 520,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Cyber‑intrusion threats to nuclear facilities create extra regulatory and security costs for both utilities. For Duke Energy, a breach could trigger NRC‑mandated security upgrades and other capital outlays that would increase the funding required for its nuclear decommissioning trusts (NDTF), tightening liquidity and cash‑flow while potentially raising borrowing needs. For Southern Company, similar cyber‑intrusion risks could lift nuclear licensing and compliance expenses, forcing the company to devote additional resources to security and influencing its operational strategy and cost‑recovery assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor omissions in specificity. (1) All key facts are correct: both Duke Energy and Southern Company face financial and operational impacts from cyber intrusion risks at nuclear plants. Duke Energy's decommissioning trusts (NDTFs) are exposed to market fluctuations, and a cyber event could trigger additional capital outlays, increasing funding needs—this aligns with the original answer’s point about potential capital injections if trusts underperform. Southern Company faces increased compliance and licensing costs due to cybersecurity requirements, consistent with the ground truth. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) Multi-hop reasoning is sound: the LLM correctly links cyber risks → regulatory response (NRC mandates) → financial impact (higher costs, capital needs) → strategic implications (cash flow, borrowing, cost recovery). It synthesizes across entities (Duke vs. Southern) and financial mechanisms (trusts vs. compliance). (4) The only minor shortcoming is that the LLM does not explicitly name Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida, nor does it mention Southern Nuclear as the operator—details present in the original. However, referring to 'Duke Energy' and 'Southern Company' broadly is still accurate given the context. Wording differs but meaning is preserved. Thus, correctness is high—9/10—with full marks for contextual relevance and quantitative accuracy due to absence of errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 441,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "Home Depot’s unvested restricted‑stock units accrue dividend equivalents that are paid out as additional shares when the units vest, so the vesting event itself creates extra share issuances【page_69】. Lowe’s, by contrast, received extra shares through its accelerated‑share‑repurchase agreements, delivering roughly 7.5 million additional shares in fiscal 2021 (0.2 M in Q1, 4 M in Q2, 1.7 M in Q3, 1.6 M in Q4)【page_64】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are paid out as additional shares upon vesting, increasing total share issuance—which aligns with the ground truth. It also correctly contrasts this with LOW’s use of ASR agreements as the source of additional shares. However, there are quantitative inaccuracies: the LLM states LOW delivered 'roughly 7.5 million additional shares' in fiscal 2021 with a breakdown of 0.2M (Q1), 4M (Q2), 1.7M (Q3), and 1.6M (Q4), summing to 7.5M. The ground truth specifies deliveries in Q1 (0.2M), Q4 (1.6M), and Q2 (4M), totaling 5.8 million, and does not mention Q3 (1.7M). Thus, the LLM introduces a Q3 transaction not present in the original and misattributes the timing and total. (2) The sum of 0.2 + 4 + 1.7 + 1.6 = 7.5M is mathematically correct but based on incorrect data inclusion. The correct total from ground truth is 0.2 + 1.6 + 4 = 5.8 million. This is a significant error in numerical reporting and timeline accuracy. (3) The multi-hop reasoning is sound—LLM correctly distinguishes between HD’s employee compensation-related share issuance and LOW’s capital return via ASR. It synthesizes across two companies and mechanisms appropriately. (4) Despite the numerical inaccuracies, the core conceptual comparison is accurate and relevant. The LLM captures the essential contrast in the nature of 'additional shares'—one tied to RSU dividend reinvestment, the other to ASR settlements—making the answer contextually strong and qualitatively reasonable, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 436,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "AT&T’s Ernst & Young auditors performed independent sensitivity analyses on the key valuation inputs (e.g., terminal‑growth rates, long‑term EBITDA margins and discount rates) used in the $67,854 million goodwill‑impairment test, whereas Ernst & Young’s audit of Netflix included sensitivity analyses on the historical and forecasted viewing‑hour assumptions that drive the amortization of its content assets. In short, both firms rely on sensitivity testing, but AT&T’s focus is on fair‑value valuation of goodwill, while Netflix’s focus is on the timing and amount of content expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $67,854 million goodwill balance is correctly stated, and no other numerical discrepancies exist. (2) The entities are accurate: AT&T and Netflix are correctly identified, and the auditor (Ernst & Young) is properly noted, though not mentioned in the original answer—this is an acceptable addition since it is factually correct and adds context. (3) The reasoning correctly distinguishes between AT&T’s use of sensitivity analysis for goodwill impairment (focusing on terminal growth rates, discount rates, and EBITDA margins) and Netflix’s use for content amortization driven by viewing-hour assumptions. This reflects proper multi-hop synthesis across two companies, audit procedures, and distinct accounting estimates. (4) The semantic meaning matches the original answer: both emphasize that sensitivity analyses were applied to key assumptions in different domains (goodwill valuation vs. content expense timing), and both acknowledge the same auditor’s role. The only minor shortcoming is the omission of 'weighted average cost of capital' (WACC) as a named assumption for AT&T, though 'discount rates' is a close proxy. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 360,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard warns that regulations such as PSD2 give fintech‑created payment‑initiation and account‑information services the ability to route transactions away from its network, creating a risk that fintech platforms will disintermediate its issuers and core products【page_31】. Visa, by contrast, treats fintechs as collaborators—offering Fast‑Track onboarding, the Fintech Partner Connect program and other digital‑onboarding tools to embed fintech solutions on its network and to turn regulatory‑driven competition into partnership‑driven growth【page_14】【page_16】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) It correctly identifies Mastercard's concern about disintermediation due to fintech platforms leveraging regulatory frameworks like PSD2 to route transactions away from its network, which aligns with the original answer. It also accurately contrasts this with Visa's strategic partnership approach, citing specific programs (Fast-Track, Fintech Partner Connect) that embed fintechs into its ecosystem. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes Mastercard’s risk perspective and Visa’s strategic response in the context of regulatory-driven competition (especially PSD2 in the EEA), correctly identifying both companies’ stances on fintech relationships. The only minor omission is that the LLM does not explicitly mention Visa’s 'network of networks' concept or that Visa sees fintechs as both partners and competitors—nuances present in the original. However, the implication is captured through the description of partnership programs. (4) Contextual relevance is excellent: the answer directly addresses the comparative strategic positioning of Mastercard and Visa in response to fintech innovation and regulation. Overall, the response is factually correct, well-synthesized, and only slightly less comprehensive than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 420,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "McDonald’s reports that a growing number of countries have already adopted the OECD’s Pillar 2 15 % global minimum‑tax rules, with the earliest effective date for taxable years beginning after 31 Dec 2023, and it does not expect this to have a material impact on its consolidated financial statements. Starbucks also cites the OECD Pillar 2 framework, noting that while some jurisdictions are applying the rule to fiscal years starting after 31 Dec 2023, the tax will not become effective for the company until fiscal 2025 and likewise is not expected to be material.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: both MCD and SBUX do not expect a material impact from the 15% global minimum tax under Pillar 2; MCD acknowledges implementation starting after December 31, 2023, while SBUX notes it will not be effective for them until fiscal 2025. (2) Quantitative elements—15%, December 31, 2023, fiscal 2025—are all correctly reported with no calculation errors. Format variations (e.g., '31 Dec 2023' vs 'December 31, 2023') are acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MCD and SBUX), their respective implementation timelines, and the OECD’s framework. It accurately contrasts the timing difference while noting the shared conclusion of immaterial impact. (4) The only minor shortcoming is that the LLM omits a brief mention in the original about differences in domestic implementation affecting multinationals differently, which slightly reduces completeness in qualitative depth. However, the core entities, timelines, and conclusions are fully preserved, and the answer remains semantically equivalent for practical purposes. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 374,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company’s capital buffers are far stronger than those of American Express. As of 12/31/2024 BTC reported total capital of $961 million, or 153.2 % of risk‑weighted assets, and Common‑Equity Tier 1 of 151.9 % (Tier 1 leverage 71.3 %)—well above the 8 %/4.5 % minimums and the “well‑capitalized” thresholds of 10 %/6.5 % (see page 111). By contrast, American Express Company’s regulatory ratios for the same date were CET1 10.5 %, Tier 1 11.2 %, total capital 13.2 % and a Tier 1 leverage ratio of 9.8 % (see page 158), which meet but are an order of magnitude lower than BTC’s ratios.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While both the Original and LLM answers confirm that BTC and AXP met regulatory capital requirements as of December 31, 2024, the LLM provides specific numerical values that are factually incorrect. For example, it claims BTC had a Common Equity Tier 1 (CET1) ratio of 151.9% and total capital of 153.2% of risk-weighted assets—these figures are implausible for any bank and far exceed typical regulatory ratios (which are usually in the single or low double digits). Similarly, reporting a Tier 1 leverage ratio of 71.3% is erroneous, as leverage ratios are typically capped around 10–15% for well-capitalized institutions. In contrast, American Express's reported ratios (CET1 10.5%, Tier 1 11.2%, total capital 13.2%, leverage 9.8%) are within plausible ranges and align with typical regulatory disclosures. However, the Original Answer does not provide specific numbers, only stating that both firms exceeded minimum requirements and were 'well capitalized.' Therefore, the LLM introduces precise figures not present in the ground truth, presenting them as factual without support. This constitutes a major factual overreach. The qualitative reasoning—comparing BTC and AXP’s capital positions and noting both are subject to U.S. banking regulations with respective regulators (OCC for BTC, Fed/OCC for AXP)—is sound and contextually relevant. The multi-hop synthesis across entities is appropriate, but the unsupported numerical claims severely reduce factual accuracy. The claim that BTC’s ratios are 'an order of magnitude higher' than AXP’s is not substantiated by the ground truth and likely false given real-world capital ratio norms. Thus, while the structure and intent of the answer are relevant and partially accurate, the inclusion of fabricated or grossly distorted quantitative data results in a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 524,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "Simon Property Group’s joint‑venture financing is modest – it had $88.4 million of construction loans and other advances to JV partners at year‑end 2021【page_116】.  By contrast, American Tower borrowed about $7.8 billion under its 2021 Multicurrency Credit Facility in 2021, using those funds to finance the Telxius and CoreSite acquisitions【page_111】.  The disparity shows SPG relies on relatively small, project‑level JV loans to grow, while AMT leverages a large revolving credit facility to fund big‑ticket acquisitions, reflecting a far more debt‑driven growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $88.4 million in construction loans provided by SPG to joint ventures as of year-end 2021 and matches the ground truth. It also accurately states that AMT borrowed $7.8 billion under its 2021 Multicurrency Credit Facility, which aligns with the original answer. The mention of €2.4 billion ($2.9 billion) in the ground truth is omitted in the LLM answer, but this does not affect the overall accuracy of the main figure or the conclusion. (2) All numeric values are correct and properly contextualized: $88.4 million for SPG and $7.8 billion for AMT are accurately reported. The format variations (e.g., $7.8 billion vs $7.8B) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly contrasts SPG’s project-level joint venture financing with AMT’s large-scale acquisition financing via a credit facility. It draws a valid conclusion about differing growth strategies—SPG’s smaller-scale development financing vs AMT’s debt-driven, acquisition-led expansion. (4) The answer is contextually excellent, directly addressing both parts of the question: the quantitative comparison and the strategic implications. The only minor shortcoming is the omission of the euro-denominated portion of AMT’s borrowing, which adds granularity but does not undermine the core accuracy or reasoning. Thus, the answer is highly accurate, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 402,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco’s $0.5 billion interest‑rate swap is a modest fair‑value hedge that offsets the interest‑rate impact only on that small portion of its fixed‑rate senior notes, limiting Cisco’s sensitivity to rate moves. In contrast, Broadcom carries $56.3 billion of fixed‑rate senior notes, so a 50‑basis‑point change in market rates would shift the fair value of those notes by roughly $1.7 billion, reflecting a far greater exposure to interest‑rate fluctuations. (See Cisco Note 13, p. 89; Broadcom Note 11, p. 49.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key information is correct: CSCO's $0.5 billion interest rate swap hedges a portion of its fixed-rate senior notes, converting fixed to floating rates (implied by 'offsets the interest-rate impact'), reducing interest rate sensitivity. AVGO has $56.3 billion in fixed-rate senior notes with a $1.7 billion fair value decrease for a 50 bps rate increase—exactly matching the original answer. (2) Quantitative accuracy is perfect: dollar amounts ($0.5B, $56.3B, $1.7B), basis points (50 bps), and the implied duration/sensitivity are consistent with the ground truth. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly contrasts CSCO’s hedging strategy (reducing risk) with AVGO’s large unhedged exposure, synthesizing information across two companies and their respective disclosures. (4) Entity accuracy is correct—Cisco (CSCO) and Broadcom (AVGO) are properly identified, and the financial instruments (fixed-rate senior notes, interest rate swaps) are accurately described. The inclusion of footnote references (Cisco Note 13, Broadcom Note 11) adds contextual support, even if not required. Wording differs slightly (e.g., 'modest fair-value hedge' vs 'converting fixed to floating'), but the meaning aligns: the swap reduces interest rate risk. No omissions or inaccuracies. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 397,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "NKE employs forward and option contracts as cash‑flow hedges, so the mark‑to‑market gains or losses on those options are recorded in other comprehensive income and only re‑classified to earnings when the underlying foreign‑currency cash flows occur (NKE 10‑K pp. 47‑48). In contrast, TSLA’s foreign‑currency‑denominated assets and intercompany balances are largely un‑hedged, so foreign‑exchange gains and losses are recognized directly in net other income on the income statement rather than being deferred in OCI (TSLA 10‑K p. 44).",
      "correctness_score": 7,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NKE's use of option contracts as cash flow hedges with gains/losses deferred in other comprehensive income (OCI) and TSLA's lack of hedging leading to direct recognition of FX gains/losses in 'Other income (expense), net.' This aligns with the ground truth's qualitative comparison of NKE’s proactive hedging versus TSLA’s reactive exposure. However, the LLM omits all quantitative details present in the original answer, including the $9.9 billion notional amount of NKE's hedges and the $99 million in net deferred gains expected in the next twelve months. These omissions significantly affect quantitative accuracy. (2) No numeric values are provided in the LLM answer, so there is no opportunity to verify correctness or format variation tolerance; thus, quantitative accuracy is low due to complete absence of figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes information about two companies (NKE and TSLA), their respective hedging strategies, accounting treatments (AOCI vs. income statement), and implications for financial reporting. It references specific pages from each 10-K, suggesting accurate sourcing. (4) Despite missing key numbers, the LLM captures the core conceptual contrast between the firms’ foreign currency risk management approaches, making the answer contextually relevant and qualitatively strong. The omission of critical financial figures prevents a higher correctness score, but the reasoning and entity accuracy remain solid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s five‑year credit agreement names Citibank, N.A. specifically as the “administrative agent” (the original agreement dated October 30, 2019) and was later amended once – Amendment No. 1 was filed on August 25, 2022 (see Exhibit 10.2 and Exhibit 10.3) 【page_126】. Caterpillar’s comparable credit facility lists Citibank, N.A. simply as the “agent” (the agreement dated August 31, 2023) and does not show any amendment to that facility in the filing (see Exhibit 10.1) 【page_128】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Citibank, N.A.'s role in both Boeing's and Caterpillar's credit agreements, with accurate dates for Boeing’s original agreement (October 30, 2019) and amendment (August 25, 2022), which match the ground truth. However, it incorrectly states that Caterpillar’s 5-Year Facility agreement was dated August 31, 2023 — this is actually the date of Amendment No. 1, not the original agreement. The original Caterpillar agreement was dated September 1, 2022, per the ground truth. This is a significant factual error affecting timeline accuracy. (2) Quantitatively, Boeing’s dates are correct. Caterpillar’s amendment date (August 31, 2023) is correctly cited, but misattributed as the original agreement date. The claim that Caterpillar’s facility has no amendment is incorrect — Amendment No. 1 exists on that date. Thus, one key date is misinterpreted, reducing quantitative accuracy. (3) The reasoning correctly compares Citibank’s roles: as administrative agent for Boeing and agent for Caterpillar. It captures the distinction in titles, though it omits Boeing’s dual role as joint lead arranger mentioned in the ground truth, which weakens completeness. The synthesis across companies is logical but incomplete. (4) Contextual relevance is high — the response directly addresses the question’s focus on Citibank’s role and amendment timelines. Despite the Caterpillar date error and missing detail on Boeing’s dual role, the core comparison remains factually grounded and relevant. Minor formatting like citation tags (e.g., 【page_126】) does not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 441,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock carries **one vote per share** (see Netflix 10‑K, “Voting Rights” – each share of common stock is entitled to one vote)【page_60】.  \nMeta’s Class B common stock carries **ten votes per share** (see Meta 10‑K, “Class A and Class B Common Stock and Class C Capital Stock” – each share of Class B common stock is entitled to 10 votes)【page_82】.  \n\nTherefore, a Meta Class B share has nine more votes – or ten‑times the voting power – compared with a Netflix common share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: Netflix common stock has 1 vote per share, and Meta Class B common stock has 10 votes per share. The comparison stating that Meta Class B has ten times the voting power and nine more votes per share is mathematically accurate. (2) The answer is complete, addressing both companies' voting structures and directly comparing them as required by the question. (3) Entities are correctly identified—Netflix’s common stock and Meta’s Class B common stock—with proper references to their respective 10-K filings. (4) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies’ disclosures and draws a valid comparative conclusion. The semantic meaning is equivalent to the original answer, with slightly more detail in the explanation, which enhances clarity without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 281,
        "total_tokens": 1478
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY disclosed that 23 percent of its U.S. gross product sales were shipped through Cardinal Health in 2023 (see page 79). Cardinal Health co‑owns Red Oak Sourcing with CVS, and CVS consolidates Red Oak as a VIE because it is the primary beneficiary of the entity (see pages 20 and 136). Consequently, a sizable slice of BMY’s distribution passes through a partner that jointly controls the generic‑sourcing venture that CVS reports on, linking BMY’s supply‑chain exposure to CVS’s consolidated Red Oak activities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that BMY relies on Cardinal Health for 23% of its U.S. gross product sales in 2023, matching the ground truth. It accurately notes Cardinal Health’s 50% co-ownership of Red Oak Sourcing with CVS and CVS’s consolidation of Red Oak as a VIE due to being the primary beneficiary. These entity relationships and percentages are correct. (2) All numeric values—23% distribution reliance and the implicit 50/50 ownership—are accurate. While the LLM does not mention the $183 million in annual payments from Cardinal to CVS (a quantitative detail present in the ground truth), it does not misstate any numbers, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the LLM connects BMY → Cardinal Health → Red Oak Sourcing → CVS financial consolidation, correctly highlighting the structural interdependency. It captures the core implication: BMY’s supply chain is exposed to a distribution partner (Cardinal) that is financially intertwined with CVS via a consolidated joint venture. (4) The only minor omission is the absence of the $183 million payment detail and its potential impact on CVS’s cost of goods sold and downstream effects on Cardinal’s service efficiency or pricing—this contextual financial flow is part of the full causal chain but not included. However, the LLM still conveys the essential interconnection, making the answer largely complete and semantically equivalent. Thus, correctness is docked slightly (9/10) for partial omission, but all other dimensions remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 428,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife says that its Retirement‑and‑Income‑Solutions (RIS) business is directly exposed to U.S. interest‑rate moves; in the “Rising‑Interest‑Rate” scenario the RIS segment would post a $10 million post‑tax loss in 2022 (turning to modest $15‑$10 million gains in 2023‑24) because higher rates raise crediting‑rate costs and cut the income from its non‑VA derivative hedge (see page 61).  Those higher rates also lower the reserves that back its life‑insurance policies and compress margins for the Life Insurance line (see page 59).  \n\nAIG’s filing shows the opposite effect on its life‑insurance reserves: a rise in earned‑rate spreads and lower projected yields on life‑insurance deposits forced a $166 million adverse reserve update for universal‑life policies in 2021 (and a $107 million hit in 2020), reflecting a much larger, direct hit to life‑insurance profitability from interest‑rate dynamics (see pages 134‑133).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims MetLife would post a $10 million post-tax loss in 2022 under a rising-rate scenario, turning to gains in 2023–24, which is not supported by the original answer. The original answer does not mention specific dollar impacts for MetLife in any year, only qualitative effects like margin compression and reinvestment opportunities. Similarly, the LLM states AIG had a $166 million adverse reserve update in 2021 and $107 million in 2020, but the original answer reports a $106 million *favorable* impact in 2021 due to assumption updates. This is a direct contradiction—'favorable' vs. 'adverse'—and the magnitude is also incorrect. (2) Number verification: The LLM’s $10M loss, $15–10M gains, $166M adverse update, and $107M hit are all unsupported by the ground truth. The only correct number in the original is AIG’s $106M favorable update in 2021, which the LLM misrepresents as adverse and inflated to $166M. (3) Multi-hop reasoning: The LLM attempts to compare MetLife and AIG’s exposure to interest rates in their Life Insurance lines, which is relevant. However, it mischaracterizes the direction of AIG’s reserve impact (favorable vs. adverse) and fabricates MetLife’s scenario-based financial impacts, failing the core synthesis requirement. (4) Scores justified: Correctness is low (4) due to major factual and directional errors in key financial impacts. Quantitative accuracy is poor (3) due to incorrect numbers and signs (favorable vs. adverse). Qualitative accuracy is moderate (5) because the general theme of interest rate sensitivity is correct, and both companies are correctly linked to reserve and margin pressures. Contextual relevance is high (8) as the response addresses the right segments, products, and dynamics, despite factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 509,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 2023 filing lists a suite of formal contracts with Panasonic Corporation – a 2011 supply agreement (and its 2013 amendment), a 2014 production‑pricing agreement, later pricing agreements for Japan‑made cells (2019 and 2021) and for Gigafactory‑2170 cells (2020), and an Amended and Restated factory lease with Panasonic Energy that secures cell supply for the Gigafactory [see TSLA 10‑K pages 106‑107]. In contrast, General Motors’ filing does not enumerate individual supplier contracts but notes that its EV battery supply is largely provided by its non‑consolidated affiliate Ultium Cells Holdings LLC – a joint venture with LG Energy Solution that is “integral to the operations of our business by providing battery cells for our EVs” [see GM 10‑K page 76].  Thus Tesla relies on multiple long‑term supply and pricing agreements with Panasonic, whereas GM’s battery sourcing is described as a dependency on its Ultium Cells joint‑venture partnership rather than a specific Panasonic‑type contract.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Tesla's battery supply agreements with Panasonic, including the 2011 Supply Agreement (with 2013 amendment), 2019 and 2021 pricing agreements for Japan-sourced cells, and the 2020 pricing agreement for Gigafactory 2170 cells. It also references the Amended and Restated factory lease, which supports the strategic partnership—consistent with the ground truth’s mention of investment letters, amendments, and leases. The only minor discrepancy is the mention of a '2014 production-pricing agreement,' which is not in the original answer; however, this does not contradict known facts and may reflect additional detail from the 10-K. (2) All dates and entities (Panasonic Corporation, Ultium Cells Holdings LLC, LG Energy Solution) are correct. The reference to GM’s dependency via the Ultium joint venture is accurate and properly contrasted with Tesla’s direct contractual agreements. (3) The multi-hop reasoning is sound: the model synthesizes information across Tesla’s and GM’s 10-K filings, compares contractual specificity versus operational dependency, and draws a valid conclusion about the nature of each company’s battery sourcing strategy. (4) The answer is semantically equivalent to the ground truth, with slightly more detail from the filings (e.g., citation of specific 10-K pages), enhancing clarity without introducing error. The contrast between Tesla’s explicit contracts and GM’s reliance on a joint venture is correctly framed. Minor deduction from 10 to 9 due to the unverified mention of the 2014 agreement, which isn't in the ground truth but doesn't materially distort the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 464,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "Mondelez International explicitly uses exchange‑traded commodity futures and listed options to hedge the price of key inputs (e.g., cocoa, sugar, wheat, oil) and reports those contracts as Level 1 financial assets – $46 million of the $77 million commodity‑contract fair‑value is measured at Level 1 (see MDLZ p. 94; p. 112). Costco, by contrast, states that it “did not hold any Level 1 or 3 financial assets or liabilities that were measured at fair value on a recurring basis” (see COST p. 51), indicating it does not employ exchange‑traded commodity futures in its risk‑management program. Thus, MDLZ’s strategy relies on market‑priced commodity derivatives, while COST’s disclosures show no use of such Level 1 instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MDLZ's use of commodity futures as Level 1 financial assets for hedging key inputs like cocoa, sugar, wheat, and oil, and notes COST's disclosure of holding no Level 1 or Level 3 financial assets measured at fair value on a recurring basis. The core comparison between MDLZ's active use of exchange-traded derivatives and COST's non-use is accurately conveyed. (2) Quantitatively, the LLM provides specific figures: $46 million of the $77 million commodity-contract fair value is Level 1. While the ground truth does not include these exact dollar amounts, they are consistent with typical 10-K disclosures and do not contradict the original answer; such detail enhances the response without introducing error. The citation of page numbers (e.g., MDLZ p.94, p.112; COST p.51) suggests document fidelity, though not required for correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies’ filings, compares their risk management strategies, and draws a valid conclusion about differing approaches to financial instrument usage. (4) Minor point: the original answer specifies the COST date (August 28, 2022), which the LLM omits, but this is a small contextual detail that doesn't undermine the factual core. Overall, the LLM answer is semantically equivalent, factually correct, and contextually appropriate, warranting a high score with only slight deduction for missing the specific date.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 423,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s senior executives have entered into 10b5‑1(c) plans that could involve a much larger share pool and a later sales window – Deirdre O’Brien’s plan covers shares vesting from April 1 2025 through October 1 2026 (no specific cap) and expires December 31 2026, while Jeff Williams’ plan permits the sale of up to 100,000 shares and expires December 15 2025【page_55】. In contrast, Broadcom’s sole board‑member plan allows the sale of at most 15,000 shares and ends on September 12 2025【page_95】. Thus Apple’s plans involve a higher potential volume and extend later than Broadcom’s more modest, 2025‑ending arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the key numbers—100,000 shares for Jeff Williams, 15,000 for Diane M. Bryant, and the timeframes (April 1, 2025–October 1, 2026 for O'Brien; up to December 15, 2025 for Williams; September 12, 2025 for Bryant)—are correct. The LLM slightly extends O'Brien’s expiration to December 31, 2026, while the original states 'expiration dates in 2025 and 2026' without specifying December 31. This is a minor discrepancy but not factually incorrect, as it falls within the correct year and plausible range. (2) The LLM correctly identifies all relevant entities: Apple executives (O'Brien and Williams), Broadcom director (Bryant), and the Rule 10b5-1(c) context. (3) Multi-hop reasoning is sound: the model compares volume (larger at Apple) and timing (longer duration at Apple) across companies and individuals, synthesizing data from both firms. (4) The conclusion that Apple’s plans involve higher volume and later end dates is logically supported and matches the original answer’s intent. The only minor issue is the unspecified expiration for O'Brien in the ground truth versus the precise December 31, 2026, in the LLM answer—this adds specificity not in the original, but does not contradict it. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 383,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both 3M’s May 11 2023 Five‑Year Credit Agreement (exhibit 10.29) and Honeywell’s March 20 2023 Amended and Restated Five‑Year Credit Agreement name JPMorgan Chase Bank, N.A. as the syndication agent (Honeywell exhibits 10.66‑10.67)【page_115】【page_125】. By using the same bank to structure and market their revolving credit facilities, the two companies demonstrate a shared banking relationship in their credit‑facility arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates, entity names, and roles are factually accurate and match the ground truth. (2) There are no numerical values requiring calculation in this question; all dates and document references (e.g., exhibit numbers, page markers) are correctly cited or appropriately referenced with format variations that do not affect accuracy (e.g., spacing in dates). (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate companies’ credit agreements to infer a shared banking relationship with JPMorgan Chase Bank, N.A. in its role as syndication agent. The conclusion that both companies use the same bank to structure and market their credit facilities aligns with the ground truth’s interpretation of a shared strategic relationship. (4) The only minor shortcoming is that the LLM answer does not explicitly elaborate on the functional significance of the syndication agent role (i.e., coordinating the syndicate of lenders, administrative responsibilities), which is included in the original answer and adds depth to the explanation of the shared relationship. However, the core factual content and inference are correct and semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slightly less contextual elaboration, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 443,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU and U.S. sanctions that prohibit trade in goods used for tobacco production in Belarus (see PM 10‑K 2022 pp. 52‑53) would require Coca‑Cola HBC to halt or severely limit any activity in that market to stay compliant, raising legal‑compliance costs and likely curbing sales there. Because Coca‑Cola HBC is one of the Company’s five largest bottlers and together the top five bottlers generate roughly 41 % of Coca‑Cola’s worldwide unit‑case volume (KO 10‑K 2022 p. 7), a loss of Belarus‑derived volume would shave a small but measurable amount off the Company’s total case volume, even though Belarus represents only a modest share of Coca‑Cola HBC’s overall footprint.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and conveys the essential implications of the sanctions on Coca-Cola HBC and The Coca-Cola Company. (1) Quantitatively, the 41% figure for the top five bottlers' contribution to Coca-Cola’s unit case volume is accurate and matches the ground truth (attributed correctly to KO 10-K 2022, p.7). The ground truth specifies this 41% is attributable specifically to Coca-Cola HBC alone in 2021, while the LLM answer states it refers to the top five bottlers collectively — a subtle but important distinction. However, since the 41% figure is correctly cited and the context still supports a 'small but measurable' impact, this is a minor inaccuracy. (2) The LLM references PM 10-K 2022 pp.52–53 for tobacco sanctions, which is factually appropriate, though the original answer does not cite specific filings. This adds value but does not detract from accuracy. (3) The reasoning is sound: it correctly links EU/U.S. sanctions to compliance risks for Coca-Cola HBC in Belarus, recognizes the importance of Coca-Cola HBC as a major bottler, and infers a negative (though modest) impact on The Coca-Cola Company’s overall volume. It correctly notes that Belarus is a small part of HBC’s footprint, which aligns with the ground truth’s implication of a limited but real impact. (4) The only shortcoming is the slight conflation of 'Coca-Cola HBC’s 41%' with 'the top five bottlers collectively generating 41%'; the former is the correct attribution per the ground truth. Despite this, the overall synthesis across entities (sanctions → Belarus operations → HBC constraints → KO volume impact) is logically coherent and factually grounded. The answer is highly relevant and captures the multi-hop chain effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 471,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Federal Reserve’s October 2023 proposal to cut the U.S. debit‑interchange cap by roughly 28%‑30% would directly reduce the fee Capital One earns on debit purchases that flow through Mastercard’s four‑party network, trimming a material portion of its interchange‑fee revenue [COF 10‑K p 39; MA 10‑K p 24].  That impact is magnified by the broader interchange‑fee litigation and settlements facing Visa and Mastercard—evidenced by the sizable accruals for U.S. covered interchange multidistrict litigation and settlement agreements that already impose caps and reductions on interchange rates [Visa 10‑K p 98; Visa 10‑K p 100]—which increase uncertainty and could further erode Capital One’s fee income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 28%-30% reduction in debit interchange caps is correctly cited, and the reference to October 2023 for the Federal Reserve proposal is factually consistent with public filings. The percentage range matches the original answer, and no calculations are required beyond accurate reporting of the proposed cut. (2) The answer correctly identifies Capital One’s exposure via Mastercard’s four-party network and links it to interchange fee income, which is a key multi-hop element. (3) It appropriately references ongoing litigation and settlements involving Visa and Mastercard, citing multidistrict litigation and the resulting accruals and rate caps, which adds depth beyond the original answer by referencing specific 10-K disclosures (e.g., Visa 10-K pp. 98, 100). (4) The reasoning is sound: it connects regulatory action → reduced interchange fees → direct impact on Capital One → compounded effect due to litigation and prior settlements. The only minor shortcoming is that it does not explicitly mention Mastercard’s regulatory oversight as a structural factor (as in the original answer), but this is implicitly covered through litigation and settlement references. Wording differs but semantic meaning and factual content are equivalent. All entities (Capital One, Mastercard, Visa, Federal Reserve), financial concepts (interchange fees, four-party network), and contextual risks are accurately represented. The inclusion of specific document citations (e.g., COF 10-K p. 39) enhances credibility but does not affect scoring as they are not required for correctness. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 475,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy’s sizable portfolio of variable‑rate debt and LIBOR‑linked interest‑rate swaps means it is still “assessing these financial arrangements” and evaluating the optional expedients of ASU 2020‑04, noting that the full outcome cannot be determined but is not expected to be material (DUK 10‑K p. 137). Southern Company, which also references LIBOR in some debt and PPA provisions, has already elected to apply the ASU 2020‑04 amendments prospectively for eligible modifications during the March 12 2020‑December 31 2022 window and likewise expects no material impact (Southern 10‑K p. 194‑195). Thus, Duke’s greater LIBOR exposure keeps its adoption timeline more tentative, whereas Southern has committed to an earlier, elective adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy is assessing LIBOR-indexed arrangements and evaluating ASU 2020-04 optional expedients with no expected material impact, consistent with its 10-K (p. 137). Southern Company has elected to apply the ASU 2020-04 amendments prospectively within the March 12, 2020–December 31, 2022 window and also expects no material impact (Southern 10-K pp. 194–195). These dates and expectations match the ground truth. (2) Quantitative accuracy is perfect: the time-bound window (March 12, 2020–December 31, 2022) is correctly cited, and no numerical errors exist. Format and citation styles are consistent with source documentation. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ 10-Ks, compares their adoption timelines, and infers that Duke’s ongoing assessment reflects greater exposure and a more tentative timeline, while Southern has already committed to elective adoption within the specified window. This inference is supported by the ground truth’s implication of Duke’s time-bound evaluation versus Southern’s ongoing assessment, though the LLM slightly reframes 'ongoing' as 'committed,' which is still logically valid. (4) The only minor deviation is that the original answer emphasizes Southern’s 'uncertain outcome' while the LLM states Southern 'expects no material impact'—a subtle difference in tone, but not a factual error, as both acknowledge low financial impact. Overall, the LLM captures the core contrast in adoption timelines driven by exposure and regulatory window utilization, making the answer factually robust and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 468,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "The Coca‑Cola Company values its stock options with a Black‑Scholes‑Merton model that uses market‑derived inputs—dividend yield (≈3.0% in 2023), expected volatility (≈17.5% in 2023), the risk‑free Treasury rate (≈4.1% in 2023) and an expected term of six years—to calculate a fair‑value amount that is expensed on a straight‑line basis over the four‑year vesting period. In contrast, Colgate‑Palmolive calculates pension‑plan costs using weighted‑average actuarial assumptions—discount rates of 5.40% (U.S.) and 4.35% (International), expected long‑term returns on plan assets of 6.50% and 4.66%, compensation‑increase rates of 3.50% and 3.19% (plus medical‑cost and interest‑crediting rates)—inputs that determine the projected benefit obligation and net periodic benefit cost reported as pension expense and liability on the financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO (Coca-Cola) using the Black-Scholes-Merton model for stock option valuation and CL (Colgate-Palmolive) using weighted-average assumptions in pension cost calculations, aligning with the core comparison in the question. However, there are discrepancies in specific numeric inputs. The ground truth states KO's 2023 assumptions include volatility, risk-free rate, and expected term as inputs to calculate a weighted-average fair value, but does not specify exact values like 17.5% volatility or 4.1% risk-free rate—these appear to be fabricated or inferred rather than reported. Similarly, the LLM provides detailed pension assumptions (e.g., 5.40% U.S. discount rate, 6.50% return) that are not present in the original answer, which only lists 5.66% discount rate, 6.25% return, and 3.50% compensation increase for CL in 2023. The LLM introduces international vs. U.S. splits and additional rates (medical-cost, interest-crediting) not mentioned in the ground truth. (2) While the general structure of inputs is correct (volatility, risk-free rate, dividend yield, expected term for KO; discount rate, return on assets, compensation growth for CL), the specific numbers do not match the ground truth, reducing quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly distinguishes between the use of weighted-average assumptions in a financial option pricing model (KO) versus actuarial pension calculations (CL), and draws a valid contrast in financial reporting implications—expensing stock options vs. determining pension liabilities and expenses. This shows strong qualitative understanding. (4) The answer is contextually relevant and well-structured, addressing both companies, models, inputs, and reporting impacts. Despite incorrect specifics, the conceptual framework matches the ground truth. Hence, correctness is reduced primarily due to unsupported numerical claims, warranting a 7/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 532,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower pledged the equity interests it holds in its subsidiaries as part of the security package for the $525 million Series 2015‑2 Notes – the notes are backed by mortgages on the tower sites, the subsidiaries’ personal property and, importantly, the subsidiaries’ equity stakes (AMT 10‑K p. 117). Simon Property Group, by contrast, has been selling portions of its equity holdings; those disposals produced a $18.8 million gain in 2021 (SPG 10‑K p. 63). Thus, AMT is using its equity as collateral to support borrowing, whereas SPG is monetizing equity outright, converting it to cash and earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT used subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes, and SPG realized an $18.8 million gain from disposals of equity interests in 2021. The dollar amounts and years match the original answer exactly, and format variations (e.g., $525 million vs $525.0 million) are acceptable. (2) Quantitative accuracy is perfect—both figures ($525 million and $18.8 million) and the year 2021 are correctly cited. (3) The multi-hop reasoning is sound: the model correctly contrasts AMT’s secured financing strategy (using equity as collateral) with SPG’s monetization via disposals, synthesizing information across two companies and filings. (4) The only minor shortcoming is that the LLM answer does not explicitly mention GTP Acquisition Partners or the scope of collateral (e.g., security interest in personal property of GTP Entities), which adds slightly less detail than the original. However, the essential contrast in financial strategies—securitization vs. liquidation—is clearly and correctly articulated. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 364,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips’ 2021 filing shows that only a modest share of its reserves – about 4 percent of total proved reserves – are reported under production‑sharing contracts, and the filing does not give specific term details for any Nigerian PSCs (see ConocoPhillips 10‑K p. 151). In contrast, ExxonMobil’s 2022 filing spells out that its Nigerian deep‑water assets are run under PSCs that are typically 30 years long (10 years of exploration followed by a 20‑year production period) with OMLs renewable for an additional 20 years and subject to relinquishment provisions (see ExxonMobil 10‑K p. 31‑32). Thus, ConocoPhillips’ exposure in Nigeria is limited and only a small portion of its reserves is PSC‑based, whereas ExxonMobil’s Nigerian operations depend heavily on PSCs with clearly defined, long‑term contract structures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, it is ExxonMobil—not ConocoPhillips—that reports 12% of its proved reserves under PSCs. The LLM incorrectly attributes the 4% PSC-based reserves to ConocoPhillips, which contradicts the original answer and misrepresents the data. Additionally, the original answer does not state any specific percentage for ConocoPhillips’ PSC reserves, so this figure appears to be fabricated or misattributed. Conversely, the LLM incorrectly assigns the detailed 30-year PSC structure (10-year exploration, 20-year production) to ExxonMobil in Nigeria, while the ground truth states that this contractual structure applies to ConocoPhillips’ operations in Nigeria. Thus, the companies are reversed in key factual assertions. (2) The quantitative inaccuracies are critical: the 4% figure for ConocoPhillips is unsupported in the ground truth, and the 12% figure for ExxonMobil is omitted and wrongly replaced. The term structure (30 years with 10+20 breakdown) is correctly described but assigned to the wrong company. (3) The multi-hop reasoning is flawed because the model fails to correctly synthesize reserve reporting practices and contractual structures across the two companies. It inverts the core comparison: the original answer emphasizes that ExxonMobil has significant reserve reporting complexity due to PSCs (12% of reserves), while ConocoPhillips operates under fixed-term PSCs in Nigeria. The LLM flips this, suggesting ConocoPhillips has minimal PSC exposure and ExxonMobil has the structural exposure, which distorts the comparative analysis. (4) Despite these major errors, the answer is contextually relevant—it addresses reserve reporting and contractual terms in Nigeria for both companies and attempts a comparison. However, due to the reversal of key facts and introduction of unsupported percentages, the correctness and qualitative accuracy scores are low. The answer would mislead a reader about which company has greater PSC-related reserve exposure and which faces more structured contractual terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 567,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM is positioning generative‑AI as a core component of its hybrid‑cloud and software services platform, investing heavily in R&D and a developer ecosystem to scale AI‑driven workloads across data‑center and client environments (IBM 10‑K p.3‑4; risk‑factor discussion of AI and generative AI investment p.6). Qualcomm, on the other hand, is embedding generative‑AI directly into its Snapdragon SoCs and AI Engine/Hexagon NPU, delivering high‑performance, low‑power on‑device inference that is paired with cloud processing for edge‑centric use cases (Qualcomm 10‑K p.7‑9; “high‑performance, low‑power computing” and AI‑engine description p.8). Thus IBM’s strategy centers on software‑and‑service commercialization of AI in a hybrid‑cloud model, while Qualcomm’s strategy focuses on hardware‑driven, edge‑based AI that runs locally at low power and integrates with the cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of IBM's and QCOM's strategies regarding generative AI, with correct entity identification and no errors in quantitative information. It accurately reflects that IBM focuses on hybrid cloud and software services with R&D and ecosystem development, while QCOM emphasizes on-device, low-power AI through Snapdragon SoCs and NPUs, integrating edge and cloud computing. The answer cites appropriate sections of the 10-K filings and correctly characterizes the technological and strategic distinctions. However, it omits a key quantitative projection from the original answer: QCOM's forecast that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024. This is a significant detail directly tied to commercialization in high-performance, low-power environments and was explicitly requested in the question. While the core reasoning and qualitative comparison are sound and semantically aligned with the ground truth, the absence of this forward-looking metric reduces completeness. There are no factual inaccuracies or reasoning flaws—only a partial omission of a specific data point. Hence, the answer is strong but not fully complete, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 350,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy warns that the market‑driven value of its nuclear decommissioning trust funds (NDTF) can fall, which would raise the amount it must fund and could hurt its cash flow and results of operations. NextEra Energy faces a similar market‑performance risk to the assets in its nuclear decommissioning funds, but it seeks to cushion any shortfall through hedging programs, broader risk‑management tools and external insurance, so that a decline in fund value would more likely affect liquidity rather than create an outright funding gap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: both Duke Energy and NextEra Energy face market-performance risks to their nuclear decommissioning trust funds, and poor returns could increase funding needs or impact financial performance. The LLM correctly identifies Duke Energy's exposure to cash flow and operational impacts and notes NextEra's use of hedging, risk management, and insurance—details consistent with the original answer’s mention of insurance coverage and potential cost overruns. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is unaffected; no calculations are required. (3) Multi-hop reasoning is sound: the LLM synthesizes information across both companies, correctly comparing their risk exposures and mitigation strategies. It adds slightly more detail (e.g., 'hedging programs') not explicitly in the ground truth but plausibly inferred and consistent with the source. (4) The only reason for not scoring a perfect 10 is that the LLM slightly overemphasizes NextEra’s mitigation tools as potentially preventing a 'funding gap,' while the original answer maintains that costs could still exceed funds—implying risk remains. However, this does not constitute a factual error, just a nuanced difference in framing. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 403,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "CAT has already moved all of its debt that is subject to reference‑rate reform to the Secured Overnight Financing Rate (SOFR) as of 31 December 2023 and, consistent with its hedging policy, formally documents and tests the effectiveness of designated cash‑flow and fair‑value hedges for foreign‑currency and interest‑rate contracts, but it chose **not** to apply the practical expedients in ASU 2020‑04 and will continue to monitor any impact through 2024 (CAT 10‑K pp. 73‑75, 74). UPS also adopted ASU 2020‑04, but it elected the optional expedients, plans to complete its SOFR transition by the 31 December 2024 deadline, and relies more on a broader set of forward and swap contracts—many of which remain undesignated—to manage cash‑flow risk (UPS 10‑K pp. 72‑76).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that reverse the actual positions of CAT and UPS regarding ASU 2020-04 and SOFR transition timelines. (1) QUANTITATIVE ACCURACY: The LLM incorrectly states that CAT completed its SOFR transition by December 31, 2023, when in fact it is UPS that completed the transition by that date. Conversely, the LLM claims UPS plans to complete SOFR transition by December 31, 2024, but the ground truth states UPS already completed it by 2023. These dates are reversed. (2) ENTITY & STRATEGIC ACCURACY: The LLM incorrectly asserts that CAT did *not* apply the practical expedients under ASU 2020-04, while the original answer states CAT *did* apply them through 2024. Conversely, it claims UPS *elected* the expedients, but the truth is UPS *did not*. This is a complete reversal of positions. (3) REASONING: The multi-hop synthesis fails because the model confuses which company adopted which strategy—core to the comparative question. It also misrepresents CAT’s derivative usage as including interest-rate contracts, which is not stated in the ground truth. (4) SEMANTIC EQUIVALENCE: Despite some correct elements (e.g., CAT uses foreign currency forwards/options, both manage cash flow risk), the reversal of key facts renders the answer misleading. The conclusion about CAT not using expedients and UPS using them is opposite to the truth. (5) CONTEXTUAL RELEVANCE: The answer addresses the right topics (hedging, SOFR, ASU 2020-04), so relevance is moderate, but correctness is severely compromised. Overall, major factual and strategic misstatements lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 444,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s investment in Atairos is an equity‑method stake that carries **no voting rights**, so Comcast cannot direct Atairos’s policies or operations (CMCSA 10‑K p. 84‑85). Alphabet, by contrast, has a dual‑class system in which Class B shares carry ten votes per share and Class C shares have **no voting rights**; the company’s large buy‑backs of Class A and especially non‑voting Class C shares (over $60 billion each year) shrink the pool of non‑voting equity and concentrate voting power in the Class A/B holders (GOOGL 10‑K p. 82‑84). Thus, Comcast is powerless to control Atairos, whereas Alphabet’s structure—and its aggressive repurchase of non‑voting shares—consolidates control among its voting shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in quantitative precision. (1) The key facts are correct: Comcast has no voting rights in Atairos and only consent rights, while Alphabet maintains a dual-class structure with Class B shares having 10 votes and Class C having none. The LLM correctly notes that repurchases of non-voting shares (Class C) concentrate voting power among remaining voting shareholders. (2) Quantitatively, the LLM states 'over $60 billion each year' for Alphabet's repurchases, while the ground truth specifies '$62.0 billion in 2024 alone'. This is a minor rounding/inexactness issue but does not constitute a factual error—'over $60 billion' is consistent with $62.0 billion. The LLM does not mention Comcast's $1.4 billion unfunded commitment, which is a small omission but not central to the control comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes control implications across two different corporate structures (Comcast-Atairos vs Alphabet's internal share structure) and links share repurchases of non-voting stock to increased voting concentration. (4) The answer is contextually excellent, directly addressing the comparison of control implications as requested. Wording differs but semantic meaning matches. Minor deduction in quantitative accuracy due to imprecise dollar figure; otherwise, fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 398,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "ASU 2022‑06 lets companies apply the reference‑rate‑reform expedients through December 31 2024. UPS notes that it had already converted all affected debt to SOFR as of December 31 2023, so the extension does not change its timeline. FedEx, however, was still monitoring its LIBOR‑linked contracts as of May 31 2024 and can now rely on the extended relief to complete any transition by the new December 31 2024 deadline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and timelines are correct: ASU 2022-06 extends relief to December 31, 2024; UPS transitioned to SOFR by December 31, 2023; FedEx was monitoring through May 31, 2024. These match the original answer exactly. (2) The answer correctly identifies both companies and their respective statuses—UPS completed transition and thus was unaffected by the extension, while FedEx used the extension to continue monitoring and potentially apply relief by the new deadline. (3) The reasoning is sound: the extension allows continued use of expedients, which FedEx benefits from, while UPS, having already transitioned, does not need it. The only minor omission is that the original answer notes UPS continued to assess potential impacts through 2024 despite not using Topic 848 expedients, and that FedEx had not experienced any material effect—nuances not included in the LLM response. However, these do not undermine the core correctness. (4) The LLM conveys semantically equivalent information with clear, concise logic and proper multi-hop synthesis across UPS and FedEx timelines under the ASU change. Hence, high scores across all dimensions with a 9/10 on correctness due to slight incompleteness in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 365,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo reports that 29 % of its 2023 beverage net revenue came from its Africa, Middle East and South Asia (AMESA) division, showing a sizable international concentration【page_72】. Target, however, operates as a single domestic segment and notes that “nearly all of our revenues are generated in the United States” with its merchandise—including food‑and‑beverage sales—focused entirely on the U.S. market【page_46】. Thus, PepsiCo’s beverage sales have a notable 29 % exposure to AMESA, whereas Target’s beverage sales are essentially 100 % U.S.‑based.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) Quantitatively, the 29% beverage revenue concentration for PepsiCo in the Africa, Middle East, and South Asia (AMESA) region in 2023 is correctly reported, and the characterization of Target’s operations as entirely U.S.-based is consistent with its 10-K. The statement that 'nearly all of our revenues are generated in the United States' (cited from page 46) effectively supports the conclusion of 100% domestic beverage sales exposure. (2) The numbers and citations (page_72 for PepsiCo, page_46 for Target) match the expected source documentation. (3) The multi-hop reasoning is sound: the model correctly synthesizes PepsiCo’s international beverage revenue split with Target’s lack of international retail presence, drawing a valid contrast between the two companies’ geographic exposures. (4) The answer is semantically equivalent to the original, using slightly more concise language but preserving all key facts, context, and implications. No errors in entities, years, metrics, or logic. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 318,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s banking subsidiaries face a zero counter‑cyclical capital buffer, so their minimum capital ratios are simply the regulatory floor plus the 2.5 % stress‑buffer and the 2.5 % capital‑conservation buffer, giving a total‑risk‑based‑capital minimum of 10.5 % (and 7.0 % / 8.5 % for CET1 and Tier 1) 【page_118】. Goldman Sachs’s TLAC‑to‑RWAs requirement is 22 % of RWAs, which already incorporates an 18 % minimum, a 2.5 % buffer, a zero CCB and a 1.5 % G‑SIB surcharge, so the absence of a CCB does not lower that figure 【page_93】. Consequently, Schwab’s minimum capital requirement (≈10.5 %) is roughly half of Goldman Sachs’s TLAC‑to‑RWAs requirement (22 %) because Schwab’s buffers are smaller and the CCB is not adding any additional requirement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Countercyclical Capital Buffer (CCB) is zero for both SCHW and GS, and that it does not reduce their requirements. It accurately states SCHW's minimum capital ratios as 7.0% CET1, 8.5% Tier 1, and 10.5% Total Risk-Based Capital, which aligns with the ground truth. However, it incorrectly states GS's TLAC-to-RWAs requirement as 22%, while the ground truth specifies an 18% minimum plus buffers (2.5% buffer + 1.5% G-SIB surcharge), totaling 22% only if all are summed — but the original answer emphasizes the 18% baseline and does not state a final aggregate of 22%. This misrepresents the structure: TLAC requirement is 18% minimum, not 22%. The 22% figure appears to be a sum of 18% + 2.5% + 1.5%, but the ground truth does not confirm this total explicitly, and regulatory frameworks often keep these layers distinct. (2) The calculation for SCHW is correct: 7.0%, 8.5%, and 10.5% inclusive of buffers. But the LLM incorrectly attributes the 10.5% to the sum of '2.5% stress buffer and 2.5% capital conservation buffer' — the ground truth mentions only a 2.5% stress capital buffer, not a separate capital conservation buffer. This is a factual error in buffer composition. (3) The multi-hop reasoning is mostly sound: the model compares SCHW’s risk-based capital framework with GS’s TLAC framework, recognizes both include layered buffers, and correctly notes that CCB being zero doesn’t lower requirements. It also correctly contrasts SCHW’s lower overall requirement with GS’s higher baseline due to G-SIB status. However, it oversimplifies by stating GS’s TLAC is '22%' without clarifying that this is not a regulatory minimum but a potential sum of components. (4) Despite these quantitative inaccuracies, the core qualitative insight — that GS faces a much higher capital requirement due to systemic importance and TLAC, while SCHW’s requirements are lower and unaffected by CCB — is preserved. Wording differences are acceptable, but the incorrect buffer attribution and 22% figure reduce quantitative accuracy. Hence, correctness is 7 (core facts right, minor but notable errors), quantitative accuracy 6 (one major number misstated and incorrect buffer breakdown), qualitative accuracy 8 (reasoning and synthesis mostly sound), and contextual relevance 9 (fully on-topic and responsive).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 628,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million reimbursement is a cost‑share payment from Georgia Power under the joint‑ownership agreement for Plant Vogtle, showing that Dalton supplies its own load with self‑owned (and partly jointly‑owned) generation facilities and is reimbursed for its share of the plant’s construction costs【page_189】. In contrast, NextEra Energy (NEER) does not rely on self‑owned generation for its own consumption; instead it secures revenue by selling the output of its plants under long‑term power‑purchase contracts that lock in roughly 94 % of its capacity【page_19】. This highlights Dalton’s ownership‑based, cost‑recovery model versus NEER’s contract‑based, revenue‑guarantee model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.3 million reimbursement from Georgia Power to Dalton for Plant Vogtle construction, accurately reflecting Dalton's partial ownership and cost-reimbursement model. It also correctly states that NextEra Energy (NEE, referred to as NEER—likely a minor ticker confusion but semantically acceptable in context) secures revenue through long-term contracts covering approximately 94% of its capacity. All key facts are present and factually aligned with the ground truth. (2) Quantitative accuracy is perfect: $5.3 million and 94% are correctly cited with no calculation errors. Format variations (e.g., '94 %' vs '94%') are negligible and do not affect meaning. (3) Multi-hop reasoning is sound—LLM synthesizes Dalton’s ownership model (self- and joint-owned generation with cost recovery) versus NEE’s revenue model (long-term contracts, output sales) across two distinct entities and business strategies. The contrast in structural approach—cost recovery vs revenue guarantee—is logically and clearly drawn. (4) The only minor shortcoming is the use of 'NEER' instead of 'NEE', which is technically inaccurate (NEER is not the correct ticker; it should be NEE), but given that the context clearly refers to NextEra Energy and the 94% contract coverage aligns with the ground truth, this does not materially mislead. Wording differs slightly (e.g., 'revenue-guarantee model' vs 'contract-based monetization'), but semantic equivalence is maintained. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 435,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX relies on a broad liquidity buffer – a $7 billion aggregate revolving‑credit facility (a $5 billion line maturing in 2025 plus a $2 billion renewal) that it can draw on for any cash‑flow need, including customer‑financing requirements (see RTX 10‑K p. 52). In contrast, Boeing funds its customers through product‑specific, long‑term lease contracts – sales‑type/finance leases and operating leases that create financing receivables, lease assets and related cash‑flow obligations, with credit risk managed by internal ratings and loss allowances (see BA 10‑K p. 93‑95).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: RTX's $7.0 billion credit facility is accurately broken down into a $5 billion line maturing in 2025 and a $2 billion renewal, totaling $7 billion, which matches the original answer. No incorrect figures or miscalculations are present. (2) The entities—RTX and BA (Boeing)—are correctly identified, and the references to their respective 10-K filings (p. 52 for RTX, pp. 93–95 for BA) support the claims with appropriate context. (3) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts RTX’s use of a general liquidity buffer (revolving credit) for customer financing with BA’s product-specific, long-term lease structures (sales-type/finance and operating leases), capturing the core distinction in approach. (4) The LLM captures the key qualitative difference—RTX relies on flexible credit capacity while BA uses structured lease receivables with associated credit risk management—though it omits minor details such as lease term ranges (1–12 years) and options to extend, terminate, or purchase, which are present in the original. However, these omissions do not undermine the central accuracy or completeness of the response. The answer remains semantically equivalent in conveying the fundamental contrast in financing strategies. Thus, the correctness score is 9 due to high factual accuracy and strong reasoning, with only slight loss for minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 416,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s weighted‑average assumptions are used only in its equity‑compensation calculations – the company reports a weighted‑average set of Black‑Scholes inputs (dividend yield, expected volatility, risk‑free rate and option term) and a weighted‑average expense period of about 1.7 years for unvested stock‑based awards (KO 10‑K p. 95‑96). Philip Morris, by contrast, applies weighted‑average assumptions to its actuarial estimates for pension and post‑retirement benefits, including discount rates, compensation‑increase rates, turnover rates, health‑care cost‑trend rates and interest‑crediting rates (PMI 10‑K p. 121‑124). Thus Coca‑Cola’s weighted‑average inputs relate to stock‑option valuation, while Philip Morris’s relate to the measurement of employee‑benefit obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Coca-Cola applies weighted-average assumptions to equity compensation using the Black-Scholes-Merton model, while Philip Morris uses them for pension and postretirement benefit calculations. The specific inputs mentioned (e.g., dividend yield, volatility for Coca-Cola; discount rates, healthcare cost trends for Philip Morris) are factually consistent with typical 10-K disclosures and match the domains described in the original answer. (2) The only minor deviation is the inclusion of a specific 'weighted-average expense period of about 1.7 years' for Coca-Cola, which is not present in the original answer. However, this detail does not contradict the ground truth—it adds context without introducing inaccuracy. No actual numbers (dates, percentages, dollar amounts) are incorrect; the years (implied 2023 filing based on 10-K references) are appropriate. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use weighted-average assumptions but in different financial reporting contexts—stock-based compensation vs. employee benefit liabilities—demonstrating proper cross-company, cross-framework comparison. (4) The answer is semantically equivalent to the original, with slightly more granular detail from the 10-Ks (e.g., page numbers, specific assumption types), enhancing clarity without distorting facts. The core distinction—different applications of the same methodology—is preserved and well-articulated. Thus, the answer earns a 9 due to the added but non-erroneous detail; it does not reach 10 only because the extra specificity is not verifiable against the provided ground truth, though it does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 483,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck says its Januvia/Janumet portfolio will retain U.S. market exclusivity only until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) 【page_58】, whereas Gilead’s products are protected by U.S. regulatory exclusivity through 2032 【page_8】. The six‑year gap means Gilead can defer generic entry and preserve pricing and market share for a longer period, while Merck is likely to face generic competition and associated sales pressure beginning in 2026.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family—May 2026 for Januvia and Janumet, and July 2026 for Janumet XR—and correctly states that Gilead’s U.S. regulatory exclusivity extends through 2032, matching the ground truth exactly. These dates are critical and accurately reported. (2) The six-year gap mentioned (2026 to 2032) is a reasonable approximation and supports the correct comparative timeline. No calculations are required beyond this temporal comparison, and the answer handles it appropriately. (3) The reasoning is sound: the LLM correctly infers that the longer exclusivity period allows Gilead to delay generic entry, preserving pricing and market share, while Merck will face generic competition and sales pressure starting in 2026. This aligns with the ground truth’s explanation of the role of regulatory exclusivity in delaying generics. The only minor shortcoming is that the LLM does not explicitly mention the mechanism—i.e., that exclusivity prevents generics from relying on innovator data—but this conceptual detail is implied in the reference to delayed generic entry. (4) All entities (Merck, Januvia family products, Gilead, U.S. regulatory exclusivity) are correctly identified and contextualized. The answer is fully relevant and synthesizes information across the two companies and timelines as required. The omission of the detailed mechanism slightly reduces qualitative accuracy, but the core facts, logic, and implications are correct, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 436,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel’s 2021 10‑K shows that the “developed technology” used for its cyber‑security solutions generated an amortization expense of **$1.283 billion** (straight‑line over a 5‑year useful life) 【page 95】.  \nCisco, by contrast, treats its cloud‑security SaaS offerings as a distinct performance obligation and **recognizes the related revenue ratably over the contract term** (i.e., over time as the service is delivered) 【page 75】.  \n\nThus, Intel records a sizable amortization charge up front for the cyber‑security technology, whereas Cisco spreads revenue from its cloud‑security offerings across the life of each contract.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Intel's amortization expense for developed technology as $1.283 billion (equivalent to $1,283 million) in 2021 and accurately notes Cisco's ratable revenue recognition for cloud security offerings. However, it incorrectly states the useful life for Intel's amortization as 5 years, whereas the ground truth specifies a 9-year weighted average useful life. This is a significant factual error affecting quantitative accuracy. (2) The dollar amount is correct with acceptable format variation ($1.283 billion = $1,283 million), and the revenue recognition method (ratable over contract term) is accurately described. The error in amortization period (5 vs 9 years) undermines the precision of the cost recognition pattern comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes Intel’s cost-side amortization with Cisco’s revenue recognition model, drawing a valid contrast between upfront cost recognition and recurring revenue. The conceptual comparison between fixed cost structure and recurring revenue model is implied, though less explicitly stated than in the original. (4) Scores reflect high contextual relevance and strong qualitative reasoning, but quantitative accuracy is reduced due to the incorrect amortization period, which is a key metric in understanding the cost recognition pattern.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 381,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MET’s 2023 filing notes that the January 1 2023 adoption of ASU 2022‑02 eliminated the old “troubled‑debt‑restructuring” (TDR) concession test and re‑classifies any borrower‑difficulty modification as a financial‑difficulty modification (FDM). The company says the **types of modifications offered have not changed** and that the new guidance “reduced the complexity involved with evaluating and accounting for certain loan modifications” and **had no material impact on the consolidated statements**, other than expanded note‑disclosure (MET p. 167).  \n\nBy contrast, JPMorgan’s legacy‑TDR reporting (pre‑ASU) provides a **granular breakdown of the concessions** granted—interest‑rate cuts (≈ 54 % of permanent modifications), term or payment extensions, principal deferrals, forgiveness and other adjustments—and quantifies the **financial effects** of those TDRs: weighted‑average interest rates fell from 4.75 % to 3.35 %, loan terms lengthened from 22 to 38 years, $1 million of charge‑offs were recognized, $16 million of principal was deferred, $2 million forgiven, and $147 million of loans re‑defaulted within a year (JPM p. 245‑247).  \n\nThus, MET’s post‑ASU disclosure is high‑level and focused on the accounting change, while JPM’s legacy TDR disclosures detail specific modification types and their measurable impact on loan economics.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies MET's adoption of ASU 2022-02 on January 1, 2023, and notes the shift from TDRs to FDMs with no material impact on financial statements, it fails to report the actual financial figures for JPM’s FDMs in 2023 ($136 million) and incorrectly cites JPM’s legacy TDR data from 2022 as if it were the only available data. The ground truth states that JPM reported $136 million in FDMs in 2023 with specific impacts: weighted-average interest rate reduced from 7.21% to 4.44% and loan life extended by 20 years. However, the LLM instead references outdated and incorrect metrics—such as interest rates falling from 4.75% to 3.35%, terms extending from 22 to 38 years, $1 million charge-offs, $16 million deferred, $2 million forgiven, and $147 million re-defaulted—which do not appear in the ground truth and contradict the provided data. These numbers are either fabricated or misattributed. Additionally, the LLM claims JPM’s disclosures are 'pre-ASU' without acknowledging that JPM also adopted ASU 2022-02 and reported FDMs in 2023, missing a key comparative point. The qualitative reasoning is partially sound in recognizing the shift from concession-based TDRs to principles-based FDMs and contrasting disclosure styles (high-level vs. granular), but the failure to accurately represent the post-ASU FDM data for JPM and the inclusion of false quantitative details severely compromises the answer. The contextual relevance is strong as it addresses the core question about differences in disclosure practices and the impact of the standard change, but the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1619,
        "completion_tokens": 463,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "Chevron’s upstream exposure in South America is modest – the company reported only about **108 billion cubic feet (BCF) of proved natural‑gas reserves in South America at year‑end 2021** (the “Other Americas 1” category)【page_108†L1-L4】【page_108†L13-L15】.  \n\nIn contrast, ExxonMobil’s downstream business is a **broad, integrated footprint across the entire Americas region**, with refineries, terminals, logistics and marketing assets that generated roughly **$1.3 billion of U.S. downstream earnings and $791 million of non‑U.S. (including other Americas) earnings in 2021**【page_65†L1-L9】 and is described as having a “well‑established presence in the Americas”【page_63†L1-L4】.  \n\nThus, Chevron’s South‑American position is limited to a relatively small gas‑reserve base, whereas ExxonMobil’s downstream operations span the whole Americas and produce far larger regional earnings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states CVX had 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, but the LLM claims only 108 billion cubic feet in South America (categorized as 'Other Americas 1') as of year-end 2021. This is a major discrepancy in both quantity and time period. Additionally, the LLM cites 2021 data while the original answer uses 2022, which misaligns with the most current information. (2) The financial figures for XOM’s downstream earnings ($1.3 billion U.S., $791 million non-U.S.) are not directly comparable to the qualitative description in the ground truth, which does not provide earnings data. While these numbers may be accurate in isolation, they were not part of the original answer and do not support a direct comparison of footprint size. The original answer emphasizes operational scope (refining, marketing, logistics across the Americas), not earnings. (3) The multi-hop reasoning is partially sound—correctly distinguishing upstream vs. downstream focus—but fails on synthesis: it uses outdated and incorrect reserve data, misrepresents the geographic scope of CVX’s position, and introduces earnings metrics not present in the ground truth to make a comparative claim. (4) The contextual relevance is fair because the answer addresses the upstream/downstream contrast and regional scope, but correctness is low due to incorrect numbers, dates, and entities. The qualitative reasoning about strategic focus is directionally accurate but undermined by factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 439,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper exposure is only $25 million – a tiny slice of its short‑term debt that is backed by a master credit facility and has an average maturity of roughly three weeks (23 days) (see DUK 10‑K p. 165‑166; weighted‑average maturity 23 days p. 163). Tesla, by contrast, holds $470 million of commercial paper as part of its cash, cash equivalents and short‑term investments (see TSLA 10‑K p. 72), a much larger, highly liquid asset that the company relies on to fund day‑to‑day operations and meet short‑term cash needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Quantitatively, the LLM answer is fully accurate: the $25 million exposure for Duke Energy Ohio and $470 million holdings for Tesla are correctly reported, with appropriate context on maturity (23 days) and backing by a credit facility for Duke, and correct classification within Tesla's cash and short-term investments. These figures match the ground truth and are cited with plausible page references, showing attention to source detail. However, the qualitative reasoning contains a significant misinterpretation: the LLM states that Tesla relies on commercial paper 'to fund day-to-day operations and meet short-term cash needs,' which incorrectly frames commercial paper as a funding source for Tesla. In reality, Tesla holds commercial paper as a short-term investment — a use of excess cash to earn returns — not as a liquidity source for operations. The ground truth correctly identifies this as a cash deployment strategy, contrasting with Duke's use as a financing tool. The LLM answer thus reverses the logic of Tesla's strategy, undermining the multi-hop comparative analysis. While the entities (Duke Energy Ohio, Tesla), metrics (commercial paper exposure vs. holdings), and sources are correctly identified, the reasoning flaw in interpreting the strategic purpose of commercial paper reduces the qualitative accuracy. Contextually, the answer is highly relevant, directly addressing the comparison of short-term liquidity strategies with specific data points, but the mischaracterization of Tesla’s approach limits full correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 423,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "Meta’s Class A shares carry only one vote per share, and because the company’s dual‑class structure gives its ten‑vote Class B shares (held mainly by Mark Zuckerberg and other insiders) a majority of the combined voting power, Class A holders have relatively little ability to affect shareholder votes【page_49】.  Alphabet’s Class B shares, by contrast, are entitled to ten votes per share (while Class A shares have one vote), concentrating voting control in the hands of founders and insiders and giving Class B shareholders far greater influence over corporate matters【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between META's and GOOGL's dual-class stock structures with correct voting rights: 1 vote per share for Class A and 10 votes per share for Class B in both cases. It correctly identifies that Meta’s Class B shares are held mainly by Mark Zuckerberg and insiders, resulting in disproportionate control, which aligns with the ground truth noting his majority voting power until Class B falls below 35% of total voting power. The answer also accurately reflects Alphabet’s (GOOGL) structure where Class B has 10 votes per share and control rests with founders and insiders. The only minor omission is the absence of the automatic conversion of GOOGL Class B shares upon sale or transfer, a detail present in the original answer that further explains the mechanism preserving control. Additionally, the LLM does not mention CMCSA’s example, but since the question focuses on META and GOOGL, this peripheral detail is not essential to the core comparison. All quantitative elements (1 vote, 10 votes) are correct, and the reasoning correctly synthesizes the implications of dual-class structures on shareholder influence. The answer is contextually relevant, directly addressing the comparative voting power and influence in both companies. Thus, while slightly less comprehensive than the original answer, it maintains factual correctness and strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 394,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s charter creates two common‑stock series: Class A shares have voting and dividend rights, while Class B shares are **non‑voting but still entitled to dividends** (Note 16, page 92). The company declares a uniform dividend ($2.74 per share in 2024, page 93), so non‑voting B‑shareholders receive the same cash payout as voting A‑shareholders, but they lack any voting influence, creating a structural separation between return and governance. Charles Schwab, on the other hand, states that “the participation rights, including dividend and liquidation rights, are identical between the voting and nonvoting stock classes” (page 66), so both classes receive the same dividend and earnings per share, fully aligning cash returns for voting and non‑voting equity holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's Class B (non-voting) shares receive dividends, citing a uniform dividend of $2.74 per share in 2024, which matches the context and is factually precise. Charles Schwab's identical dividend and liquidation rights across share classes are accurately quoted from page 66, supporting the conclusion of full alignment in cash returns. (2) All quantitative details—dividend amount ($2.74), year (2024), and page references—are correct and consistent with the source data. No calculation errors. (3) The multi-hop reasoning is sound: it synthesizes dividend structures across two companies, contrasts governance vs. return rights, and draws a valid comparison—Mastercard separates voting control but maintains dividend parity, while Schwab fully aligns both return and participation rights. The only minor shortcoming is that the LLM does not explicitly state that Mastercard’s B Class shares have *explicitly defined* dividend rights in its charter (though implied), and slightly underemphasizes that both companies achieve dividend parity, with Schwab going further in structural alignment. (4) Despite this nuance, the answer is factually correct, comprehensive, and contextually precise—hence a 9/10 on correctness and qualitative accuracy. Quantitative accuracy and contextual relevance are perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 391,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that because it has no material operations in jurisdictions whose statutory rates fall below the 15 % Pillar‑Two floor, the new global minimum tax “is not expected to materially increase our global tax costs” and therefore should not affect its effective tax rate (MSFT 10‑K p. 47). Oracle, however, notes that the OECD‑G20 two‑pillar framework “may materially increase the level of income tax on our international profits,” indicating that Pillar Two could raise its international tax costs and push its effective tax rate higher (Oracle 10‑K p. 29‑30).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Microsoft's expectation of no material impact due to lack of material operations in jurisdictions with statutory tax rates below the 15% Pillar Two threshold, and Oracle's concern about materially increased international tax costs under Pillar Two. (2) The percentage (15%) is correct and matches the ground truth; no other numerical values (e.g., dollar amounts, years) are involved, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both companies' 10-K filings, compares their differing exposures, and attributes the divergence to geographic and operational differences, even though the exact phrase 'geographic footprints and tax planning strategies' is slightly rephrased in the LLM version. The citations to MSFT 10-K p. 47 and Oracle 10-K p. 29–30 add verifiability and align with expected sourcing. (4) The answer fully addresses the question by contrasting the expected impacts on Microsoft’s and Oracle’s effective tax rates, explaining why the same global rule affects them differently. All key elements—factual content, reasoning, entity accuracy, and context—are correct and complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 360,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM applies Level 3 measurements to a range of assets – chiefly marketable debt securities and certain receivables – when quoted market prices are unavailable.  It values those items with vendor‑based pricing models or discounted‑cash‑flow (DCF) techniques that rely on unobservable assumptions such as projected cash flows, credit spreads, pre‑payment speeds and other macro‑economic forecasts (GM 10‑K pp. 63‑64).  By contrast, Lowe’s only uses Level 3 for the performance‑based contingent consideration arising from the sale of its Canadian retail business; that liability is valued with an income‑approach option‑pricing model that depends on unobservable inputs like total equity value, volatility, expected term and a risk‑adjusted discount rate (LOW 10‑K pp. 52‑53).  Thus GM’s Level 3 usage is broader and model‑driven across several asset classes, while Lowe’s is narrowly focused on a single contingent‑consideration liability using an option‑pricing methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: GM uses Level 3 for marketable debt securities and finance receivables with unobservable inputs like macroeconomic forecasts (e.g., credit spreads, prepayment speeds, projected cash flows), while LOW applies Level 3 to contingent consideration from the Canadian business sale using an income approach with inputs like equity value, volatility, and expected term. The LLM correctly identifies GM’s broader application across asset classes versus LOW’s narrow use for a single liability. (2) There are no numeric values, dates, or dollar amounts in the question or answers that require verification—both responses reference fiscal 2022 implicitly via context but do not misstate any figures. Format and references to 10-K pages (e.g., pp. 63–64, 52–53) add precision and are consistent with typical disclosure locations, though exact page numbers aren't part of the ground truth; they don't detract from accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in scope (broad vs. narrow), instruments (debt/receivables vs. contingent consideration), and methodologies (DCF and pricing models vs. option-pricing model). The distinction in unobservable inputs is accurately drawn. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'option-pricing model' vs. 'income approach'), but the meaning is preserved and technically accurate. The only minor gap is that the LLM does not explicitly name GDP growth or unemployment rates as in the original, instead summarizing as 'macro-economic forecasts,' which slightly reduces specificity but does not impair correctness. Hence, a score of 9 is warranted—excellent accuracy with negligible loss in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 489,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "CMCSA’s charter gives Class B shareholders a fixed one‑third of the total voting power (each B share carries 15 votes, representing 33 % of all votes) and permits those shares to be converted share‑for‑share into Class A stock, which carries only one vote per share (CMCSA Note 12 and Note 11). Because the B‑class voting block is non‑dilutable, any conversion simply adds low‑vote Class A shares without eroding the B‑class’s 33 % influence, while Alphabet’s aggressive buy‑back of its own Class A and Class C shares merely reduces the supply of those low‑vote securities to boost EPS and does not affect CMCSA’s voting structure, though it highlights how repurchase programs can shape the economics of converting versus holding different share classes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that CMCSA's Class B shares hold 33 1/3% (rounded to 33% in the answer) of voting power with 15 votes per share and that they can be converted share-for-share into Class A shares, which carry one vote. It also correctly notes the non-dilutable nature of the Class B voting block. However, the LLM omits key quantitative details about Alphabet’s repurchase activity: the $62.2 billion spent in 2023 and the $36.3 billion remaining authorization—both present in the original answer. These omissions reduce quantitative completeness. (2) While percentages like '33%' are close enough to '33 1/3%' for semantic equivalence, the absence of specific dollar figures from Alphabet’s repurchase program represents a material gap in numerical accuracy, especially given the emphasis on 'aggressive share repurchase strategy.' (3) The reasoning is logically sound: the LLM correctly infers that conversion of Class B to Class A at CMCSA would not dilute voting control due to the non-dilutable structure and explains that Alphabet’s buybacks affect its own capital structure, not CMCSA’s. However, it fails to draw the full multi-hop synthesis—namely, that Alphabet’s repurchase strategy could indirectly highlight trends in ownership concentration that may influence how investors view CMCSA’s dual-class dynamics. The connection between the two companies is underdeveloped. (4) The answer remains contextually relevant and well-structured, focusing on the right entities and mechanisms, but lacks completeness in cross-company implications and specific financial metrics, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 452,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "Mondelēz International reported that 31,000 thousand securities were still available for future issuance under its equity‑compensation plans, while Colgate‑Palmolive reported 37,028 thousand such securities [MDLZ_10k_2022 page 127] [CL_10k_2022 page 61]. The gap is therefore 6,028 thousand securities, with Colgate‑Palmolive having the larger remaining pool.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in the reported numbers. According to the ground truth, MDLZ reported 48,932,017 securities available, but the LLM incorrectly states 31,000 thousand (i.e., 31,000,000), which is off by nearly 18 million securities. CL's number is correctly reported as 37,028,000 (37,028 thousand). (2) The calculation of the difference is therefore incorrect: the LLM computes 37,028 - 31,000 = 6,028 thousand, favoring CL, but the correct difference is 48,932,017 - 37,028,000 = 11,904,017, favoring MDLZ. The direction and magnitude of the difference are both wrong. (3) The multi-hop reasoning is structurally sound—comparing two companies' equity compensation plan availability from their 10-Ks—but fails due to incorrect data extraction for MDLZ. The model cites specific pages, suggesting access to source data, but misreads or misreports the MDLZ figure. (4) Contextual relevance is high as the answer addresses the right companies, metric, and year, and attempts the correct comparison. However, due to major quantitative inaccuracies and a flawed conclusion, the correctness and quantitative accuracy scores are low. Qualitative accuracy is moderate because the reasoning framework is valid despite incorrect inputs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1160,
        "completion_tokens": 357,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "The Illinois Clean Energy Law compels ComEd to fundamentally reshape its transmission‑rate framework – it must file a new rate case or four‑year multi‑year plan, embed a decoupling mechanism and a rider to recover nuclear carbon‑mitigation‑credit costs, and thus alter its revenue‑requirement and allowed return on the FERC‑approved transmission formula rate (Exelon 10‑K pp. 219‑220). Tesla, on the other hand, faces a state‑level regulatory risk that could block or restrict its direct‑to‑consumer sales in certain states, limiting market access and prompting legal battles, but it does not involve any change to a rate‑setting structure (Tesla 10‑K p. 27).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key regulatory impacts on both ComEd and Tesla, with strong contextual relevance. Quantitatively, no specific numbers (e.g., 11.50% ROE, 50-basis-point adder, 39.5-year amortization) from the ground truth are included, but the LLM does not introduce incorrect figures—instead, it omits them. It correctly references ComEd’s need for a four-year multi-year plan and mentions decoupling and cost-recovery mechanisms, which aligns with the structural changes in the original answer. However, it fails to mention the accelerated amortization of excess deferred income taxes over 39.5 years and omits ComEd’s current rate of return on equity (11.50%) and the RTO incentive adder, which are key quantitative and qualitative elements. Regarding Tesla, the LLM correctly identifies the nature of state-level restrictions on direct sales and their impact on market access, but does not elaborate on the legal interpretation issues or dealer association pushback mentioned in the ground truth. The reasoning is sound and the comparison is logically framed—ComEd faces changes to rate-setting and cost recovery, while Tesla faces go-to-market barriers—though the synthesis is less detailed than the original. The answer cites 10-K pages plausibly but without verifiable access, which does not affect scoring but limits validation. Overall, the answer captures the essential contrast and regulatory nature for both companies but lacks some depth and specificity in multi-hop synthesis, particularly around ComEd’s financial and rate-setting details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 441,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Medicare Part D redesign forces manufacturers to provide additional discounts and to accept lower, capped prices beginning in 2025, so Amgen expects its ENBREL gross‑to‑net (GTN) rebate accruals to rise sharply as the mandatory discount and price‑cap for ENBREL (effective Jan 1 2026) become a liability 【page_36】. Bristol‑Myers Squibb will see a similar increase for its Part D‑dependent products, but the impact will be captured through its GTN‑accrual methodology, which already incorporates payer‑channel mix, contract‑price assumptions and other legal‑interpretation inputs, causing its estimated rebate liability to grow as the IRA‑mandated discounts are applied 【page_125】【page_126】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the IRA-driven Medicare Part D redesign starting in 2025 will increase gross-to-net (GTN) rebate accruals for both AMGN's ENBREL and BMY's Part D-dependent products. The effective date of January 1, 2026 for ENBREL's price cap is consistent with the ground truth's reference to 2026 pricing. (2) Quantitatively, all dates (2025 for IRA implementation, 2026 for ENBREL price cap) are correct; no dollar amounts or percentages are misstated. Format and precision are appropriate. (3) The multi-hop reasoning is sound: the LLM correctly links AMGN’s regulatory exposure (mandatory discount/price cap) to higher GTN accruals, and for BMY, it accurately ties the existing GTN methodology—based on payer channel mix and contract prices—to increased liabilities under the IRA, especially through legal interpretation inputs. The mention of BMY’s methodology incorporating 'contract-price assumptions' and 'legal-interpretation inputs' reflects a nuanced understanding of accounting for GTN adjustments. (4) The only minor omission is that the original answer includes forward-looking exposure for AMGN’s Otezla in 2027, which the LLM answer does not mention. This is a small but relevant detail in the multi-hop synthesis, slightly reducing completeness. Otherwise, the answer is semantically equivalent, contextually precise, and factually correct. Hence, a 9 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 429,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG classifies its structured securities (including ABS & CLO) both as “available‑for‑sale” and, for a portion, under the fair‑value option.  The fair‑value‑option securities are shown in the “Other securities measured at fair value” table (‑ $1.68 bn of CLO/ABS in 2023) and any changes flow through net‑investment income and are reflected in yield adjustments (AIG 10‑K p.169‑170).  The remainder are AFS securities whose unrealised gains/losses are recorded in AOCI (AIG 10‑K p.169).  \n\nMetLife records all of its ABS & CLO exposure inside the fixed‑maturity securities AFS bucket, values them at fair value using the Level‑2/Level‑3 hierarchy (e.g., $699 m of “Other (1)” assets in 2023, with $8 m at Level 3; MetLife 10‑K p.308‑309), and places any unrealised gains or losses in OCI rather than earnings.  \n\nThus, AIG’s approach can affect earnings (via net‑investment income and yield adjustments) and equity, while MetLife’s approach confines the impact to OCI (equity) only.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core distinction between AIG's and MET's accounting treatments and correctly identifies that AIG uses both fair value and amortized cost methods (with yield adjustments impacting income), while MET uses available-for-sale (AFS) treatment with fair value changes going to OCI. However, there are key quantitative inaccuracies: the LLM cites a -$1.68 bn CLO/ABS value under fair value option for AIG in 2023, but the ground truth does not provide this specific number or negative value, making it potentially misleading or fabricated. Similarly, the $699M 'Other (1)' and $8M Level 3 amounts for MetLife are overly specific and not present in the original answer, which only states MET uses Level 3 inputs and discloses them in recurring fair value tables—no dollar figures are given. These unsupported numbers reduce quantitative accuracy. On qualitative grounds, the reasoning is sound: the LLM correctly infers that AIG’s method affects earnings via net investment income (aligned with effective yield adjustments), while MET’s AFS approach limits impact to OCI, which matches the original answer’s conclusion about differing financial statement impacts. The entities (AIG, MET, ABS, CLO), accounting terms (AFS, fair value, OCI, AOCI), and synthesis across companies are accurate. Contextually, the response is highly relevant, directly addressing how differing accounting treatments impact valuation and reporting. While the core conceptual contrast is correct and well-reasoned, the inclusion of unverified numerical data lowers confidence in factual precision, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 442,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron reports that reserves tied to production‑sharing contracts (PSCs) represent a small, single‑digit share of its total – 7 % of consolidated reserves in 2021 (up from 9 % in 2020 and 11 % in 2019)【page_106】. ExxonMobil’s filing notes that its Nigerian operations are limited to deep‑water offshore projects that are governed by PSCs, but it does not disclose a numeric share of production or reserves for Nigeria【page_31】. Thus, Chevron’s PSC exposure is quantified at roughly 7 % of its reserves, whereas ExxonMobil’s exposure in Nigeria is PSC‑based but not expressed as a percentage.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Chevron's PSC-related reserves are a single-digit percentage of its total, but reports 7% for 2021, which contradicts the ground truth of 8% for that year. The LLM also introduces data not in the original answer—specifically, 9% in 2020 and 11% in 2019—which, while possibly factual, are extraneous and unverified in the provided context. ExxonMobil’s lack of disclosed percentage is accurately noted, aligning with the ground truth that XOM’s exposure is structural rather than quantified. (2) The key numeric discrepancy is Chevron’s 2021 PSC reserve percentage: LLM says 7%, ground truth says 8%. This is a clear quantitative error, though it is directionally close (single-digit, ~7-8%). The additional year-on-year data (2019, 2020) are not part of the original answer and may reflect overreach or outdated/misinterpreted data. (3) The multi-hop reasoning is sound: the model correctly contrasts Chevron’s quantified PSC exposure with ExxonMobil’s structural exposure in Nigeria under PSCs, even without a disclosed percentage. It synthesizes the idea that both companies face PSC exposure but in different forms—directly measurable vs. operationally embedded—which matches the original answer’s intent. (4) The correctness score is 7 because the core conclusion is accurate and the reasoning is strong, but the key percentage is off by 1 point. Quantitative accuracy is penalized more (6) due to the incorrect 7% vs. 8% and inclusion of unsupported historical data. Qualitative accuracy is high (8) due to correct entity mapping, logical comparison, and synthesis. Contextual relevance is excellent (9) as the answer directly addresses the comparative exposure question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 478,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan sets aside a fixed pool of 49.0 million shares that can be issued for future awards, giving the company a defined ceiling for long‑term equity compensation 【page_83】. Home Depot, by contrast, does not reserve a specific share count for its stock‑appreciation rights; it grants SARs and then adjusts the expected vesting and expense for estimated forfeitures, allowing the ultimate number of shares that vest to vary over time and providing flexibility through a forfeiture‑adjusted methodology 【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated. No numerical calculations are required, and all figures match the original answer. (2) The LLM correctly identifies Tesla’s fixed share reservation and contrasts it with HD’s forfeiture-adjusted vesting methodology, accurately noting that HD does not reserve a fixed number of shares but instead adjusts for estimated forfeitures. This captures the core distinction in long-term equity compensation flexibility. (3) The reasoning is sound and reflects proper multi-hop synthesis: it draws from Tesla’s structured, capacity-limited approach and HD’s dynamic, retention-responsive model. The conclusion about HD providing greater flexibility due to variable vesting outcomes is logically supported. (4) The only minor shortcoming is that the LLM does not explicitly mention that both companies use SARs (though implied), and the original answer emphasizes this commonality before contrasting methodologies. However, this omission does not detract significantly from the overall correctness. Wording differs slightly but maintains semantic equivalence. All entities (Tesla, HD, 2019 Plan, SARs) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 364,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s equity investment in Tengizchevroil is recorded at $23.7 billion on its balance sheet, and that amount already includes a $4.5 billion loan to fund the FGP/WPMP development (Note 15, Investments and Advances)【page_78】.  By contrast, ExxonMobil reports long‑lived assets in Kazakhstan of $8.463 billion for 2021【page_123】.  Thus Chevron’s total exposure to TCO is roughly $15 billion higher – about three times the size of ExxonMobil’s Kazakhstan asset base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron has a 50% equity stake in Tengizchevroil and provided a $4.5 billion loan, but does not state that Chevron's total equity investment is $23.7 billion or that this amount 'includes' the loan. The $23.7 billion figure is not present in the original answer and appears to be fabricated or misattributed. The comparison to ExxonMobil’s $8.463 billion in long-lived assets is numerically accurate in terms of the ExxonMobil figure, but the Chevron figure is unsupported. (2) The calculation that Chevron’s exposure is 'roughly $15 billion higher' and 'three times' that of ExxonMobil is incorrect because it relies on the erroneous $23.7 billion figure. The actual exposure described in the ground truth is a 50% equity stake plus a $4.5 billion loan, but no total book value is given. Thus, the quantitative comparison is invalid. (3) The multi-hop reasoning is partially sound in that it attempts to compare Chevron’s financial exposure with ExxonMobil’s asset value in Kazakhstan, but it fails in synthesis because it introduces an unsupported number. The original answer emphasizes differing strategies—equity/financing vs. asset holdings—while the LLM oversimplifies this into a numerical comparison that isn’t justified. (4) Contextual relevance is high because the answer addresses the right companies, project (FGP/WPMP), and geographic focus, and cites appropriate financial concepts. However, the introduction of an incorrect balance sheet figure severely undermines factual correctness. Quantitative accuracy is low due to the fabricated $23.7 billion; qualitative accuracy is moderate because reasoning structure is logical but based on false premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 481,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s renewable PPAs are handled within its non‑consolidated VIEs – the company negotiates the contracts as part of siting, EPC and O&M decisions, but the filing does not tie those PPAs to any tax‑credit cash‑flow benefit (see page 202). Southern Power’s wind PPAs, by contrast, are structured as energy‑only agreements without capacity charges and rely on the production tax credits earned during the first ten years of operation, which have a material impact on cash flow and are expected to be fully utilized through 2024 (see pages 96‑97).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all key facts are accurate: Southern Power's PTCs are correctly tied to the first 10 years of operation and expected to be fully utilized by 2024, consistent with the original answer. The $0.8 billion in unutilized PTCs at the end of 2021 from the ground truth is not mentioned in the LLM answer, which is a notable but not critical omission—this is the primary reason for not scoring a 9 or 10 in correctness. (2) The LLM correctly identifies Duke Energy’s role in negotiating PPAs within non-consolidated VIEs (aligned with 'commercial renewables strategy' and VIEs in the original), and correctly contrasts this with Southern Power’s lease-based PPA structure. (3) The reasoning is sound: it draws a valid multi-hop comparison between the two companies’ PPA structures and their differing cash flow implications, particularly highlighting that Southern Power benefits from PTCs while Duke does not appear to in the same way. (4) The LLM adds a detail not in the original—'energy-only agreements without capacity charges'—which is plausible and contextually consistent, though not confirmed in the ground truth. Overall, the answer captures the core contrast in PPA structures and tax credit utilization, with high contextual relevance and strong qualitative reasoning, but loses slight points for missing the specific $0.8 billion figure and not explicitly mentioning the lease income and tax equity partnership returns emphasized in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 434,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "LOW’s Accelerated Share Repurchase agreements caused the company to repurchase 15.4 million shares for $3.3 billion and, upon settlement, the company could receive additional shares from the financial institution (the final share count was set by the VWAP of the stock)【page_61】. In contrast, Home Depot’s deferred‑share awards to non‑employee directors accrue dividend equivalents that are paid out as extra shares to the directors when the underlying deferred shares vest, effectively issuing additional shares as part of compensation【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between LOW's ASR agreements and HD's deferred share awards with dividend equivalents. (1) Quantitatively, the LLM correctly states that LOW repurchased 15.4 million shares for $3.3 billion via ASR agreements, and notes that additional shares may be received upon settlement based on VWAP — this aligns with the mechanism in the ground truth where final share delivery depends on the difference between maximum notional amount paid and final notional value. While the exact terms like 'maximum notional amount' or 'final notional value' aren't repeated verbatim, the reference to VWAP-based final share count reflects the same variable notional concept. (2) For HD, the LLM accurately describes that dividend equivalents accrue on deferred shares and are paid out as additional shares upon vesting/termination, characterizing them as part of director compensation — matching the ground truth's emphasis on structured compensation. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (LOW and HD), two distinct financial instruments (ASRs vs. deferred share awards), and two mechanisms for share changes (repurchase efficiency vs. compensation accrual). (4) Minor deduction in qualitative accuracy due to slightly less precise terminology (e.g., 'vest' vs. 'termination of board service'), but the semantic meaning remains equivalent. No factual errors; only slight compression of nuance. Contextual relevance is perfect — directly addresses the comparative mechanism of additional share issuance/receipt.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 444,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing reported $125 million of equity‑income from its 50 % stake in United Launch Alliance in 2024 (see BA 10‑K page 42).  Lockheed Martin’s commercial satellite‑launch activity is captured in its Space segment, which generated $12.5 billion of net sales in 2024 (see LMT 10‑K page 72), and the segment’s profit also includes Lockheed’s share of ULA earnings, which “provides expendable launch services to the U.S. Government and commercial customers” (see LMT 10‑K page 71).  Thus, Boeing’s modest $125 million equity share reflects a small slice of ULA’s overall launch earnings, while Lockheed Martin’s commercial launch business contributes a much larger portion of its Space‑segment revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Boeing's $125 million equity income from ULA in 2024, which matches the ground truth. However, it introduces a significant error by stating that Lockheed Martin's Space segment generated $12.5 billion in net sales in 2024, which is not mentioned in the original answer and is not supported by the question context. This figure may be accurate in reality, but it is not part of the ground truth provided and distracts from the specific focus on commercial satellite launch revenue tied to ULA. The original answer emphasizes $665 million in receivables from commercial customers (including ULA-related payments), which the LLM omits entirely. (2) The quantitative accuracy is compromised because while Boeing’s $125M is correct, the $12.5B figure is extraneous and shifts focus away from the specific commercial revenue linkage. The LLM fails to report the $665M receivables metric, a key data point in the ground truth that directly ties Lockheed Martin’s commercial revenue to ULA activity. (3) The reasoning partially captures the multi-hop relationship: Boeing’s equity income comes from ULA, which serves commercial customers, and Lockheed Martin benefits from ULA’s commercial launches. However, the LLM incorrectly frames Boeing’s income as a 'small slice' without supporting comparison data and fails to explain that Lockheed Martin’s commercial satellite launch revenue is recognized through ULA operations — a core linkage in the original answer. The synthesis is incomplete because it does not connect Boeing’s income to Lockheed’s commercial receivables via shared ULA operations. (4) Contextual relevance is high because the answer addresses ULA’s dual role and both companies’ involvement. However, the inclusion of an unrelated $12.5B revenue figure and omission of the $665M receivables weakens factual alignment. The answer gives the impression of deeper analysis but misses the precise correlation described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 536,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "Lilly explains that its products’ market exclusivity is tied to patents and statutory data‑protection—about five years of data protection in the United States (12 years for biologics), roughly ten years in Europe and eight years in Japan—and that once those periods end the company expects a rapid drop in sales (see LLY pages 8 & 10). Merck’s filing likewise stresses that its business depends on patent rights and that any invalidation, circumvention or expiry of patents in the U.S., EU or Japan would trigger a swift loss of revenue, but it discusses the risk in broader terms without spelling out the specific exclusivity timelines, merely noting that loss of exclusivity (e.g., for Januvia/Janumet) would materially affect results (see MRK pages 30‑33).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that LLY's market exclusivity depends on both patent rights and regulatory data protection, and accurately specifies the durations: 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. The mention of a 'rapid drop in sales' post-exclusivity matches the original answer's 'severe and rapid revenue decline.' For MRK, it correctly states dependence on patent rights and the material impact of patent loss, citing specific examples like Januvia/Janumet. (2) Quantitatively, all exclusivity periods are correct. The only minor inaccuracy is the reference to 'about five years of data protection in the United States' for non-biologics, which is not present in the ground truth and could be misleading—standard U.S. data protection for small molecules is typically 5 years, but the original answer does not mention this, focusing only on biologics. This addition, while factually plausible, slightly deviates from the scope of the provided truth. (3) The reasoning is sound: the LLM correctly synthesizes that both companies face significant patent-related risks, with LLY benefiting from regulatory mechanisms and MRK emphasizing legal defense, even if the latter is implied rather than explicitly detailed. (4) The answer is contextually excellent, directly addressing the comparison between LLY and MRK across major markets and the role of patents vs. regulatory protections. The omission of BMY evidence and specific terms like 'orphan drug exclusivity' or 'pediatric exclusivity' is not critical, as the core comparison remains intact. Overall, the answer is factually strong with only a minor overextension on U.S. data protection duration for non-biologics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 483,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company cautions that “actual or potential threats of cyber intrusions … could result in increased nuclear licensing or compliance costs that are difficult to predict” (p. 29), meaning any breach could trigger material, but uncertain, regulatory‑related spending at its nuclear units. In contrast, Duke Energy flags that “a decline in the market value of the assets … may increase the funding requirements of the obligations for decommissioning nuclear plants” (p. 35), exposing it to measurable additional cash contributions if its Nuclear Decommissioning Trust Fund underperforms. Thus, Southern’s exposure is to unpredictable, potentially large compliance outlays from cyber‑related security upgrades, while Duke’s exposure is to quantifiable funding shortfalls driven by market‑driven trust‑fund performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual information is correct: Southern Company's exposure to cyber intrusion-related compliance costs and Duke Energy's decommissioning trust fund risks are accurately described. The LLM correctly identifies that Southern Company faces unpredictable compliance costs due to cyber threats, citing the correct qualitative risk language from its filing. Similarly, Duke Energy's risk tied to market performance of its Nuclear Decommissioning Trust Funds (NDTF) is correctly represented. (2) Quantitative accuracy is perfect: while no specific numerical values (e.g., dollar amounts, percentages) are repeated from the original answer (such as Alabama Power’s 26% and Georgia Power’s 28% nuclear generation share), these specific percentages are not essential to the core comparison being made—namely, the nature of financial risks (unpredictable compliance vs. market-linked decommissioning costs). The absence of these percentages does not impair the correctness of the comparison, as the LLM focuses on the qualitative risk mechanisms rather than generation mix. (3) Multi-hop reasoning is sound: the model correctly synthesizes risks from two different companies, identifies distinct financial exposures (compliance vs. funding), and contrasts their predictability (uncertain vs. quantifiable). It appropriately uses direct quotes with page references to support each point, demonstrating source-aware reasoning. (4) Semantic equivalence is strong: the LLM conveys the same core insight as the original—that Southern’s risk is uncertainty-driven from cyber threats, while Duke’s is market-driven from trust fund performance. Wording differs but meaning is preserved. The only minor shortcoming is the omission of the 26%/28% generation data, which adds contextual depth but does not alter the fundamental correctness of the comparison. Hence, a score of 9 is justified—excellent accuracy with a minor completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 541,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 deferred stock units granted to non‑employee directors “vest on the earlier of the first anniversary of the grant date and the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration” and they “earn dividend equivalents” that are paid when the units vest 【page_64】. Home Depot’s deferred‑share awards for non‑employee directors, by contrast, vest only “following termination of Board service,” and the accrued dividend equivalents are “paid out in the form of additional shares of stock upon payout of the underlying shares” after that termination 【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Lowe's 2023 deferred stock units for non-employee directors vest on the earlier of the first anniversary of the grant date or the day before the next Annual Meeting, and that dividend equivalents are earned and paid upon vesting. This matches the original answer, though it omits the detail about immediate vesting for awards granted prior to 2022, which is a minor omission but not critical to the 2023 focus of the question. (2) For Home Depot, the LLM correctly states that deferred shares vest following termination of service and that dividend equivalents accrue and are paid in additional shares upon payout after termination. It also correctly implies a different payout timing structure compared to Lowe’s. The original answer adds that Home Depot expenses the fair value of dividend equivalents immediately upon grant—a detail not included in the LLM response—but this is a more granular accounting point that does not undermine the core comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes policies from two companies, compares vesting schedules and payout mechanisms, and draws a valid contrast. (4) All entities (Lowe’s, Home Depot, non-employee directors, deferred stock units vs. deferred shares, 2023 context) are accurate. Wording differs slightly but maintains semantic equivalence. The only reason for not scoring a 10 is the omission of the pre-2022 Lowe’s vesting rule and the immediate expense recognition at Home Depot, which are present in the ground truth but not essential to the main comparison. Quantitative accuracy is perfect—no numerical errors. Contextual relevance is full, as all information directly addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 489,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "The possible curtailment of the 12‑year data‑exclusivity for biologics would leave Amgen’s biologic products open to earlier biosimilar entry, weakening its market‑share and pricing power (see AMGN p.46). Merck, by contrast, leans on a layered patent estate—compound patents that can be extended by up to five years plus six‑month pediatric exclusivity extensions—to lengthen protection beyond the baseline period and preserve its competitive position even if data‑exclusivity is reduced (see MRK p.16‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) Quantitatively, all key numbers are correct: the 12-year biologic data exclusivity, six-month pediatric exclusivity extension, and references to specific page numbers (AMGN p.46, MRK p.16-18) align with typical 10-K disclosures. The mention of up to five years for patent term extension (though not explicitly in the original answer) is factually accurate under U.S. patent law (Hatch-Waxman) and does not contradict the original; it adds context without error. (2) The answer correctly identifies both companies (AMGN and MRK) and their respective strategies: AMGN's vulnerability due to reliance on data exclusivity and MRK's layered approach using compound patents and pediatric exclusivity. (3) Multi-hop reasoning is sound—LLM synthesizes AMGN’s exposure to biosimilars with MRK’s defensive IP strategy, correctly contrasting their competitive postures. (4) The only minor shortcoming is that the original answer includes a specific product example (EPOGEN) and notes its concentrated customer base, which the LLM omits. While not critical to the main comparison, this detail strengthens the original’s completeness. However, the LLM still captures the essential contrast in exclusivity strategies and competitive implications. Wording differs but meaning is preserved. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 391,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation treats the counter‑cyclical capital buffer as zero and builds the requirement on an 18 % minimum TLAC‑to‑RWAs threshold (plus a 2.5 % buffer and a 1.5 % G‑SIB surcharge)【page_93】. Charles Schwab, on the other hand, also has a zero counter‑cyclical buffer but relies on a separate 2.5 % stress capital buffer (in addition to a 2.5 % capital‑conservation buffer) as its extra cushion【page_118】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between Goldman Sachs (GS) and Charles Schwab (SCHW) regarding the countercyclical capital buffer being zero for both, and correctly notes SCHW's 2.5% stress capital buffer. However, it introduces inaccuracies in quantitative details: the original answer does not mention a 2.5% buffer or 1.5% G-SIB surcharge for GS, nor does it state that these are part of the 18% TLAC threshold—this breakdown is absent from the ground truth. The 18% minimum TLAC to RWAs for GS is presented as a standalone regulatory threshold, with the countercyclical buffer (zero) included within the broader requirement, not as additive components. Similarly, for SCHW, the LLM incorrectly adds a '2.5% capital-conservation buffer' not mentioned in the original answer, which only specifies a 2.5% stress capital buffer. These additions reflect over-specification not supported by the ground truth. Entity accuracy and contextual relevance are strong—the comparison between GS and SCHW is on point, and the zero percent countercyclical buffer is correctly attributed to both. The reasoning is logically structured and synthesizes the multi-hop elements (treatment of buffers across two firms), but the unsupported numerical breakdowns reduce quantitative accuracy. Semantic equivalence is mostly preserved but compromised by the inclusion of unverified buffer components.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 383,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "Exxon Mobil’s 2023 10‑K shows it has about **$7.7 billion of long‑lived assets in Kazakhstan**【page_116】.  Chevron (CVX) reports that it holds a **50 percent equity interest in Tengizchevroil (TCO)**, the joint‑venture that runs the Tengiz field in Kazakhstan【page_16】.  Thus XOM’s exposure is expressed as a $7‑8 billion asset base, while CVX’s exposure is a 50 % ownership stake in the TCO operation.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies XOM's $7,728 million (rounded to $7.7 billion) in long-lived assets in Kazakhstan from its 2023 10-K, which matches the ground truth. It also accurately states CVX's 50% equity interest in Tengizchevroil (TCO), which is factually correct. However, the LLM omits key qualitative details present in the original answer, such as the TCO concession expiration in 2033, the Future Growth Project (FGP) mechanical completion in 2023 and expected start-up in H1 2025, and the Karachaganak Expansion Project timeline. These omissions reduce completeness. (2) Quantitatively, the $7.7 billion figure is a valid rounding of $7,728 million, and the 50% stake is accurate. No calculations were required, but the representation of financial exposure is correct in magnitude and source. (3) The reasoning correctly contrasts XOM’s direct asset ownership with CVX’s indirect exposure via equity stake in TCO, demonstrating sound multi-hop logic across corporate structures and reporting. However, the lack of project-level updates from TCO weakens the synthesis of CVX’s strategic positioning. (4) The answer remains highly relevant to the question, clearly comparing the nature of exposure (direct assets vs. equity stake), but loses points on completeness for missing forward-looking operational developments that contextualize CVX’s involvement. Hence, correctness is high but not full.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 393,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company says it will keep evaluating ASU 2020‑04 and that “the ultimate outcome of the transition cannot be determined at this time,” reflecting uncertainty about any financial effect of moving from LIBOR to an alternative rate【page_195】. In contrast, NextEra Energy notes it is applying the same ASU 2020‑04 guidance to its debt and derivative contracts, has begun using the available election options, and to date “there has not been a material impact to NEE,” indicating a more certain, material‑impact‑free stance【page_79】. Both firms are relying on the reference‑rate‑reform guidance to manage their derivative exposures, but Southern Company’s outlook is uncertain while NextEra Energy’s is comparatively definitive.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Southern Company expresses uncertainty about the financial impact of LIBOR transition under ASU 2020-04, citing that 'the ultimate outcome cannot be determined at this time'—this matches the original answer verbatim in meaning. NextEra Energy confirms it is applying ASU 2020-04 to its interest rate (and derivative) contracts and reports no material impact, indicating a more definitive stance. These characterizations are factually consistent with the ground truth. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the textual references to financial impact ('no material impact') are correctly reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies, compares their approaches to ASU 2020-04 and LIBOR transition, and draws a valid contrast in their levels of certainty. (4) The LLM adds slightly more detail than the original (e.g., mentioning 'debt and derivative contracts' and 'election options'), which is supported by typical 10-K disclosures and does not contradict the ground truth. The only minor gap is that the original emphasizes both companies rely on reference rate reform guidance to manage derivatives—this is mentioned in the LLM answer but slightly less centrally—yet still present. Thus, the answer is semantically equivalent, with excellent contextual relevance and reasoning. A score of 9 is given because while all facts are correct, the emphasis on the shared reliance on reform guidance is slightly less balanced than in the original, but not inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 474,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s Class A common stock carries only one vote per share and, because Class B shares have ten votes each, the founder and other Class B holders can control all shareholder‑approved matters; the charter’s anti‑takeover provisions (e.g., requiring a majority of Class B votes for any change of control and limiting special‑meeting rights) further restrict minority shareholders’ ability to influence corporate actions (META 10‑K pp. 49‑50). Alphabet also uses a dual‑class system (Class A = 1 vote, Class B = 10 votes, Class C = non‑voting) but its Certificate of Incorporation contains Delaware‑law safeguards that any amendment adversely affecting a class must be approved by that class and must first receive unanimous board consent, giving Class A holders a procedural block against dilutive changes and offering stronger protection for minority interests (GOOGL 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and structural details are correct: META's Class A has 1 vote/share, Class B has 10 votes/share; GOOGL's Class A has 1 vote, Class B has 10 votes, Class C is non-voting—these match known structures. The procedural requirements (unanimous board consent and class approval for amendments) are correctly cited. (2) The answer correctly identifies key governance differences: GOOGL’s Certificate of Incorporation includes protective mechanisms under Delaware law requiring class-level approval and unanimous board consent for adverse amendments, which strengthens minority shareholder protections. META’s structure, in contrast, centralizes control with Class B holders and includes anti-takeover provisions (e.g., requiring majority Class B vote for change of control), limiting minority influence. (3) Multi-hop reasoning is sound—comparing dual-class structures, voting rights, and charter-level safeguards across two companies using their 10-K disclosures. (4) Minor omission: the ground truth mentions META’s two-thirds majority requirement for amendments when Class B voting power falls below 35%, which the LLM answer does not include. This is a meaningful detail related to entrenchment but does not undermine the core accuracy. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 405,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "PepsiCo warns that the OECD‑backed 15% global minimum tax “could increase … our taxes and negatively impact our provision for income taxes” as the rules roll out in the many foreign markets where it operates (PepsiCo 10‑K p. 25). Altria already pays an effective tax rate well above the 21% U.S. statutory rate (≈ 25.6% in 2023, p. 80) because of state and other taxes, so the global minimum tax would add only a modest incremental lift to its overall effective rate, mainly on its limited foreign earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo faces potential tax increases due to the OECD global minimum tax because of its international operations, citing a direct quote from its 10-K (p. 25), which matches the original answer's emphasis on PepsiCo's exposure abroad. (2) For Altria, the LLM states its effective tax rate was approximately 25.6% in 2023 (p. 80), which is consistent with the ground truth noting Altria’s high domestic tax burden and minimal foreign liabilities. While the original answer cites $2,346 million in federal taxes, the LLM does not include this exact figure but compensates by contextualizing Altria’s already high effective rate above the U.S. statutory rate, correctly concluding limited impact from the global minimum tax. The omission of the dollar amount is a minor gap but does not undermine the core factual accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies’ tax profiles, correctly contrasting multinational exposure (PepsiCo) vs. domestic concentration (Altria), and applies the OECD framework logic appropriately. (4) Semantic equivalence is strong—though wording differs, the conclusion that PepsiCo is more affected than Altria is preserved. Quantitative accuracy is high; the 25.6% effective rate and 21% statutory rate are correctly presented, and no calculation errors occur. The only reason for not scoring a 10 is the missing $2,346 million figure, which adds specificity in the original. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 446,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "The U.S. orphan‑drug program gives a product a seven‑year market‑exclusivity that runs in parallel with any patents, effectively extending protection beyond the life of a compound patent (LLY 10‑K p. 10). Since AbbVie’s earnings are vulnerable to generic entry once patents or data exclusivity expire (AbbVie 10‑K p. 17), securing orphan‑drug status would similarly delay generic competition for its products—just as Eli Lilly uses orphan exclusivity to protect its drugs after the compound patent expires.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong factual and semantic alignment. (1) Quantitatively, the seven-year market exclusivity period is correctly stated, and the reference to Eli Lilly's 10-K (p. 10) and AbbVie's 10-K (p. 17) aligns with the expected sourcing, though exact page numbers may vary slightly across filings—this is acceptable under SEC document variation. (2) The answer correctly identifies that orphan drug exclusivity runs in parallel with patents and can extend protection beyond compound patent expiration, which is a key multi-hop insight linking Eli Lilly’s use of the mechanism to AbbVie’s risk profile. (3) The reasoning is sound: it infers that since Eli Lilly uses orphan exclusivity to delay generics post-patent, AbbVie similarly relies on such designations to delay generic competition, and thus weakening of exclusivity would increase AbbVie’s vulnerability. This synthesizes cross-company regulatory strategy logically. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the risk of *loss or weakening* of exclusivity through patent challenges, regulatory changes, or compulsory licensing—factors highlighted in AbbVie’s 10-K and emphasized in the original answer. While implied in the vulnerability to generic entry, the explicit causal mechanisms are omitted, slightly reducing completeness. However, the core financial and regulatory logic is preserved. Wording differences are acceptable and do not affect meaning. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 448,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling network included the federal capital of Buenos Aires and surrounding areas in 2021, so The Coca‑Cola Company’s equity‑method investment in FEMSA gave it indirect sales exposure to Argentina through the investee’s local bottling operations (KO page 7; equity‑investee sales in KO page 88‑89). PepsiCo, by contrast, reports that its own products are made, distributed and sold in Argentina and that it is directly subject to the country’s economic, political and social volatility (PEP page 41). Thus KO’s Argentine exposure is indirect via an equity investee, whereas PEP’s exposure is direct and more immediately affected by Argentina’s economic conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Coca-Cola FEMSA operated in Buenos Aires and surrounding areas in 2021, giving KO indirect exposure via equity investee sales; PEP had direct operations in Argentina and faced direct economic volatility. (2) Quantitative accuracy is perfect—while the LLM does not repeat the $14,471 million figure from KO’s equity investee sales, this omission does not misrepresent facts or impair correctness, especially since the focus of the question is comparative exposure, not the total dollar amount. The absence of the number is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model correctly links KO’s indirect exposure through Coca-Cola FEMSA’s operations in Argentina to equity method accounting, and contrasts it with PEP’s direct operational presence and associated risks. (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original answer. The LLM cites page references plausibly (though not verifiable here), enhancing credibility. The answer is contextually fully relevant, directly addressing the comparative exposure question. Deducted 1 point from correctness due to omission of the specific $14,471 million figure, which was present in the ground truth and adds quantitative grounding to KO’s exposure level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 391,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s market‑exclusivity plan for emraclidine rests on the exclusive global license to Pfizer’s patent portfolio that it inherited when it bought Cerevel Therapeutics – the acquisition gave AbbVie control of those patents (and associated milestone‑payment and royalty terms) to protect emraclidine’s future launch (see page 68). By contrast, Merck’s Januvia has already lost its original sitagliptin‑compound patent and now depends on a later‑expiring salt‑form patent and the five‑year U.S. regulatory exclusivity period, which together delay loss of exclusivity only until May/July 2026 (see page 58). This shows AbbVie is building exclusivity through new patent licensing via acquisition, whereas Merck is extending existing exclusivity after patent expiry.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AbbVie's acquisition of Cerevel Therapeutics and the exclusive global license to Pfizer's patent rights for emraclidine, as well as Merck's reliance on a later-expiring salt-form patent and regulatory exclusivity for Januvia/Janumet extending to May/July 2026. However, it omits a key fact from the ground truth: AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, which is critical to understanding the failure or underperformance of its exclusivity strategy. This omission significantly weakens the comparative analysis. (2) Quantitatively, the dates (May/July 2026) and the reference to patent types (compound vs. salt form) are accurate. The absence of the $4.5 billion impairment charge—a major financial event—represents a significant missing quantitative element, though no incorrect numbers are stated. (3) The reasoning correctly contrasts AbbVie’s forward-looking, acquisition-driven patent licensing strategy with Merck’s defensive extension of exclusivity via secondary patents. However, it fails to complete the multi-hop synthesis by not linking the impairment charge to the conclusion that AbbVie’s strategy faced financial consequences, unlike Merck’s successful extension. This weakens the qualitative depth and accuracy of the comparison. (4) The answer is contextually relevant and well-structured, addressing the core of the question about market exclusivity strategies. Due to the missing impairment charge and its implications, the answer is partially correct but lacks full factual completeness, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 450,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % stake in the Caspian Pipeline Consortium gives it direct access to a pipeline that moves roughly 1.4 million barrels of crude oil per day, and the recent CPC debottlenecking project has lifted that throughput, directly expanding Chevron’s export capacity for its Kazakh crude (page 16). In contrast, ConocoPhillips’ upstream business is heavily oil‑focused – its 2023 proved reserve base is about 6.8 billion barrels of oil‑equivalent, with crude (including 410 million barrels of bitumen produced in 2023) comprising the bulk of that reserve and production mix (pages 146 & 145), underscoring a far greater reliance on crude oil than on pipeline‑based export infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and the relevance of the debottlenecking project completed in January 2023 (implied by 'recent'), and correctly contrasts Chevron's infrastructure-based exposure with ConocoPhillips' production-focused upstream model. However, it inaccurately states the CPC pipeline moves 'roughly 1.4 million barrels per day', while the ground truth specifies Chevron's access enables export of 'approximately 1.2 million barrels per day'—a significant numerical discrepancy. Additionally, the LLM introduces specific figures for ConocoPhillips (6.8 billion barrels of oil-equivalent reserves, 410 million barrels of bitumen) not present in the original answer, which may be factually correct but are unsupported by the provided ground truth and distract from the core comparison. 2) The CPC throughput number is incorrect: 1.4 vs 1.2 million bpd is a material difference (~17% overstatement). The original answer ties the 1.2 million bpd to Chevron’s export capacity via its stake, while the LLM attributes 1.4 million bpd to the pipeline’s total flow without clarifying if this is total capacity or Chevron’s share. The debottlenecking project date (Jan 2023) is consistent. The ConocoPhillips reserve and production numbers, while possibly accurate, are not in the ground truth and introduce unverified data. 3) The multi-hop reasoning is sound: the model correctly distinguishes between Chevron’s indirect export capacity via pipeline infrastructure and ConocoPhillips’ direct reliance on crude production. It synthesizes the strategic difference in exposure correctly, even if with added detail. 4) The answer is contextually relevant and addresses both parts of the question—Chevron’s CPC influence and ConocoPhillips’ production reliance. The qualitative reasoning is strong, but the quantitative inaccuracies and introduction of unsupported specifics reduce overall correctness. Hence, a 7 for correctness: core facts are right, but key numbers are wrong or unverified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 544,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle embeds generative‑AI directly into its MySQL HeatWave cloud service, so AI‑driven analytics and machine‑learning run inside the managed database on OCI (Oracle MySQL HeatWave “combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service” – page 12; OCI AI offerings “include generative AI for fault detection…​” – page 11). Qualcomm, by contrast, is positioning generative AI on the edge – its AI Engine and Hexagon NPU are built to run large‑language and vision models on‑device, leveraging 5G connectivity and cloud‑based model updates to deliver low‑latency, private, personalized AI (“on‑device generative AI…​must run on‑device to maximize utility” – page 7; AI Engine “capable of running complex AI use cases at high‑performance and low‑power on device” – page 9). Both rely on heavy cloud‑infrastructure investment—Oracle through OCI and AI‑infrastructure services (page 10), Qualcomm through its QCT chip platforms, 5G/edge networking and a cloud‑processing initiative (page 8)—but Oracle’s approach is cloud‑centric data‑service AI, whereas Qualcomm’s vision is to push generative AI to edge devices with cloud support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual content is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service on OCI, combining transactions, analytics, ML, and AI—this matches the original answer. Qualcomm's focus on on-device generative AI using its AI Engine and Hexagon NPU for edge devices like smartphones and PCs is accurately described, emphasizing low latency, privacy, and personalization. (2) Quantitative accuracy is perfect: while the LLM answer does not explicitly repeat the 19% (2024) and 46% (2027) smartphone adoption figures from the ground truth, it does not contradict them and refers to the same strategic vision. Since the LLM response is based on cited document pages and accurately reflects the trend without misstating numbers, this omission does not constitute a factual error but rather a focus choice. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Oracle’s cloud-centric AI integration in MySQL HeatWave and Qualcomm’s edge-first strategy, while acknowledging both companies’ cloud investments—Oracle via OCI and Autonomous Database, Qualcomm via QCT, 5G, and cloud-processing initiatives. (4) Semantic equivalence is strong: the LLM distinguishes Oracle’s cloud-native data service model from Qualcomm’s edge-processing vision with cloud support, which is the core contrast in the original answer. The only minor shortcoming is the absence of the specific forecast percentages (19% to 46%), which are part of the original quantitative projection. However, the conceptual trend (growth in generative AI-capable smartphones) is implied through the discussion of Qualcomm’s vision. Thus, the answer earns a 9/10 for correctness due to this partial omission, though all other aspects—quantitative accuracy, reasoning, and relevance—are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 509,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart treats firm commitments for inventory and utility purchases as binding purchase obligations that lock in the amount and timing of cash outflows – they are included in the $37.2 billion of “unrecorded purchase obligations” reported in its 10‑K (see WMT 10‑K p. 45). Colgate‑Palmolive, on the other hand, does not rely on physical purchase contracts but uses foreign‑currency option contracts (along with forwards and swaps) to hedge the dollar value of its firm commitments and other forecasted transactions, protecting cash flows from currency fluctuations (see Colgate‑Palmolive 10‑K p. 90 and p. 121). Both approaches are intended to mitigate cash‑flow risk, but Walmart’s tool is a direct procurement commitment, whereas Colgate’s tool is a derivative hedge that provides price protection without obligating the underlying purchase.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative value reported for Walmart's purchase obligations. The ground truth states Walmart has $15.9 billion in firm commitments due within one year, while the LLM claims $37.2 billion in 'unrecorded purchase obligations'—a figure not mentioned in the original answer and potentially misaligned with the correct context (e.g., possibly conflating total obligations beyond one year or including capital expenditures not emphasized in the ground truth). This major discrepancy undermines quantitative accuracy. (2) The mention of specific 10-K page numbers (p. 45, p. 90, p. 121) adds detail not present in the original answer, but without access to verify exact sourcing, such precision cannot be confirmed and may reflect overfitting or hallucination. (3) Qualitatively, the reasoning is sound: the LLM correctly contrasts Walmart’s use of firm operational commitments (inventory, utilities) with Colgate-Palmolive’s use of foreign exchange options and other derivatives to hedge forecasted transactions. The conceptual distinction between binding procurement contracts vs. financial hedging instruments is accurately captured and aligns with the original answer’s intent. (4) Contextual relevance is high—the response directly addresses the comparison of risk management strategies and links both companies’ approaches to mitigating cash flow risk. However, the incorrect dollar amount and potential mischaracterization of Walmart’s obligations (e.g., 'unrecorded' is not discussed in the ground truth) reduce overall correctness. While the qualitative synthesis and reasoning are strong, the critical numerical inaccuracy prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 470,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages default risk by entering into single‑name, index and tranched credit‑default swaps that provide direct protection against a credit event and are marked‑to‑market (MS 10‑K p.111). Capital One, instead of using CDS, values its net derivative assets with Level‑3 fair‑value models that depend on unobservable default‑rate assumptions (COF 10‑K p.208), so a change in expected defaults alters the assets’ fair value. Thus, both firms are highly sensitive to credit events—Morgan Stanley’s CDS positions generate gains or losses when defaults occur, while Capital One’s derivative valuations swing with the default‑rate inputs used in its models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core relationship between Morgan Stanley's use of credit default swaps (CDS) and Capital One's reliance on default rate assumptions in valuing derivative assets. (1) All factual elements are correct: Morgan Stanley uses CDS (including single-name, index, and tranched) to hedge credit risk, and these are marked-to-market (per MS 10-K p.111). Capital One uses Level-3 fair-value models with unobservable inputs, specifically default rate assumptions (COF 10-K p.208), which aligns with the ground truth. (2) Quantitative accuracy is perfect: although the LLM does not explicitly state the 4% weighted average default rate or the 53–163% range, it correctly identifies that Capital One’s valuation depends on default-rate assumptions without introducing any incorrect numbers. The omission of the specific percentage and range is a minor gap but does not distort the meaning or reduce the technical accuracy of the response in practice. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both firms are sensitive to credit events—Morgan Stanley through direct exposure via CDS payouts, and Capital One through model-driven valuation sensitivity—even though their mechanisms differ. (4) The answer is contextually excellent, directly addressing the comparative sensitivity to credit outcomes and linking both institutions’ derivative exposures to real-world default dynamics. The lack of explicit mention of the 4% and 53–163% figures prevents a perfect 10, but the conceptual and technical fidelity is otherwise complete, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 448,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s natural‑gas distribution system – which includes Piedmont’s roughly 28,000 mi of pipelines and 22,100 mi of service lines that serve Georgia as part of its total 35,700 mi of pipelines and 28,800 mi of service lines 【page_39】 – represents a far larger capital footprint than Southern Company Gas’s 50 % ownership in the Southern Natural Gas (SNG) project, a 7,000‑mi interstate pipeline that also delivers gas to Georgia 【page_13】. While Duke’s extensive network provides broad local‑delivery reliability, the SNG investment, though smaller in scale, is a strategic transmission asset that supplies diversified gas to Georgia and surrounding states, underpinning regional infrastructure reliability.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Duke Energy's 28,000 miles of pipelines in Georgia and Southern Company Gas's 50% ownership in the 7,000-mile SNG pipeline, which aligns with the ground truth. However, the LLM introduces additional details not present in the original answer—specifically, '22,100 mi of service lines' and totals of '35,700 mi of pipelines and 28,800 mi of service lines'—which were not in the ground truth and may be misattributed or extraneous. These additions, while possibly accurate from the source document, go beyond the verified knowledge graph answer and introduce potential confusion. (2) The core numbers—28,000 miles for Duke and 7,000 miles for SNG—are correct and properly compared in scale. The 50% ownership stake is accurately stated. However, the LLM does not mention Southern Power’s 97% investment coverage ratio through 2028, a key financial metric in the original answer that speaks to revenue stability and capital scale implications. This omission affects completeness on the capital scale dimension. (3) The reasoning is sound in distinguishing Duke’s distribution focus from SNG’s transmission role and correctly frames both as contributing to regional reliability in complementary ways. The synthesis across entities (Duke, SNG, Georgia market) is logical and supports the conclusion of an integrated infrastructure network, even if not explicitly stated. (4) The answer is highly contextually relevant, directly addressing capital scale and reliability contributions. The qualitative assessment is strong, but the quantitative accuracy is slightly reduced due to the inclusion of unverified granular pipeline data and the omission of the investment coverage ratio. Overall, the answer captures the essence and key facts but misses a critical financial metric and adds unconfirmed detail, warranting a score of 8 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 509,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "Union Pacific disclosed that the corporate‑tax‑rate reductions enacted by Louisiana (together with Arkansas) in 2024 cut its deferred tax expense by $34 million. The filing does not isolate the Arkansas effect, so the $34 million figure represents the combined impact of both states’ legislation (UNP 10‑K 2024, p. 29).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $34 million reduction in deferred tax expense due to Louisiana and Arkansas tax legislation, which matches the ground truth. The year 2024 and the companies involved (Union Pacific, states of Louisiana and Arkansas) are accurate. However, the LLM states that the $34 million is the combined impact of both states, whereas the original answer implies that Louisiana alone caused a $34 million reduction and that Arkansas had a 'comparable' impact, suggesting a similar separate amount. This is a significant qualitative difference in interpretation. (2) Quantitatively, the $34 million figure and 2024 date are correct; no calculations are required, so numerical accuracy is perfect. (3) The multi-hop reasoning is partially flawed: the model fails to recognize that the original answer suggests parallel, similar impacts from each state rather than a combined total. This misrepresents the synthesis across entities (Louisiana vs. Arkansas). (4) Contextual relevance is high as the answer addresses the core issue—impact on deferred tax expense from state tax changes—and cites a specific source. However, the mischaracterization of the $34 million as combined rather than (at least potentially) separate for each state reduces factual precision, warranting a 7 for overall correctness despite strong quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 383,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "Meta’s Class B common stock carries ten votes per share (Meta 10‑K p. 82), giving its owners a disproportionate ability to steer board actions and approve mergers, while Alphabet’s Class A common stock carries only one vote per share (Alphabet 10‑K p. 82), providing far less voting influence.  Alphabet’s charter, however, imposes voting‑rights limits on its high‑voting Class B shares in merger transactions—requiring those shares to vote as a single class or restricting their vote on such deals (as illustrated by the merger‑vote restrictions for other share classes in Visa 10‑K p. 90)—so the company’s governance is less concentrated than Meta’s, where Class B holders retain full voting power.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that Meta's Class B common stock has ten votes per share, when in fact, according to the ground truth and actual SEC filings, Meta's Class B shares have no voting rights except in specified merger or consolidation scenarios. This is a critical error that reverses the actual governance structure. (2) The answer incorrectly attributes high voting power to Meta Class B shares, claiming they have disproportionate influence, when in reality, Meta's Class A shares (held by insiders like Mark Zuckerberg) have superior voting rights, and Class B shares are non-voting outside of specific events. (3) The claim about Alphabet (GOOGL) imposing voting-rights limits on Class B shares in merger transactions is not supported by the ground truth, which focuses on the consistent one-vote-per-share structure of Class A shares, not restrictions on Class B. The LLM fabricates a governance limitation at Alphabet not present in the original answer. (4) The reference to Visa’s 10-K as an example is irrelevant and misleading, as the question is about Meta and Google, not Visa. (5) The multi-hop reasoning fails: instead of contrasting Meta’s event-triggered voting for Class B with Google’s steady one-vote-per-share Class A structure, the LLM inverts the facts and introduces extraneous, incorrect details. While the answer attempts to address corporate governance concentration, its factual foundation is incorrect. Quantitative accuracy is very low due to wrong vote counts (10 votes vs. 0 votes outside mergers). Qualitative accuracy is poor due to incorrect entity attributes and flawed reasoning. Contextual relevance is moderate because it discusses the right topic (voting rights and governance) but with wrong details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 495,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer actions that curb formulary placement and raise patient out‑of‑pocket costs for high‑priced drugs such as Amgen’s Repatha (Pfizer 10‑K p.41) signal that similar cardiovascular products will face tighter reimbursement terms and larger payer‑required discounts. Because Pfizer records product sales net of estimated government and other rebates/chargebacks (its gross‑to‑net revenue‑recognition model, p.48), any increase in required rebates or restrictions forces the company to lower the net amount it can recognize and to update those estimates more conservatively and frequently.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that U.S. payer restrictions on high-cost therapies like Repatha—through formulary limitations and higher patient cost-sharing—impact reimbursement and pricing expectations for similar cardiovascular drugs. It accurately references Pfizer's 10-K (p.41 and p.48), supporting its claims with appropriate document context. (2) There are no numeric values or calculations in either the original or LLM answer, so quantitative accuracy is not compromised; all financial concepts (rebates, chargebacks, gross-to-net) are correctly used. (3) The multi-hop reasoning is sound: it connects Amgen’s experience with Repatha to Pfizer’s exposure, then links payer dynamics to Pfizer’s revenue recognition model, which relies on net sales after rebates and discounts. This mirrors the original answer’s logic about gross-to-net deductions and conservative estimation. (4) The only minor gap is that the LLM answer does not explicitly mention Gilead as an example of a company adjusting its revenue strategy due to payer pressures—a point included in the original to illustrate industry precedent. However, this omission does not undermine the core correctness, as the focus is on Pfizer and the Repatha-to-Pfizer risk transmission is well supported. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent, directly addressing formulary placement, affordability, and revenue recognition implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 421,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s 15 % working interest in the Caspian Pipeline Consortium (CPC) means it only captures a small slice of the extra oil that will flow when TCO’s Future‑Growth Project (FGP) comes on line in the first half of 2025 – the FGP is slated to start‑up then and “ramp up to full production within three months,” and CPC’s capacity (about 1.2 million bbl/d from Kazakhstan) will be shared proportionally with Chevron’s 15 % stake【page_16】. In contrast, ConocoPhillips’ portfolio is heavily weighted toward crude‑oil production, with billions of barrels of crude‑oil‑equivalent proved reserves (e.g., ~3.8 billion barrels in its consolidated crude‑oil, condensate and synthetic‑oil reserves) and total proved reserves of over 5.7 billion barrels of oil‑equivalent, reflecting a far broader dependence on crude oil as a raw material【page_111】【page_146】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical misstatement that affects the multi-hop reasoning. It incorrectly states that Chevron has a '15% working interest in the Caspian Pipeline Consortium (CPC)' when the original answer and context confirm Chevron holds a 15% interest in *both* TCO and CPC — the LLM conflates the two entities and misattributes the ownership structure. While the FGP start-up timing ('first half of 2025') and ramp-up ('within three months') are accurately cited, the LLM fails to clearly explain that Chevron’s 15% stake in TCO (not CPC) is what provides partial exposure to the production ramp-up; the CPC interest relates to transportation throughput, not production ownership. The comparison to COP is strong: it correctly highlights COP’s broader dependence on crude oil using accurate reserve figures (~3.8 billion barrels of crude-oil-equivalent and over 5.7 billion BOE total), which supports the qualitative point about concentrated exposure. These numbers are factually sound and properly contextualized. However, the reasoning downgrades due to the conflation of TCO and CPC interests — a key multi-hop element in the question. Despite this, the overall narrative about Chevron’s indirect vs. COP’s direct exposure is preserved, and the answer remains contextually relevant and well-supported with document citations. Minor formatting (e.g., '15 %' with space) does not affect accuracy. Thus, quantitative accuracy is high (8), qualitative reasoning is partially flawed (7), but contextual relevance remains strong (9).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 427,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs’ commercial‑real‑estate loan portfolio totals $34.8 bn, and 5 % of that – roughly $1.7 bn – is classified as “hospitality” (hotel‑related) loans【page_118】. MetLife’s real‑estate fund holdings are $3.65 bn, with a $700 m hotel component (about 5 % of its $13.3 bn real‑estate assets)【page_94】. Thus Goldman’s hotel‑related loan exposure is about twice the size of MetLife’s hotel‑focused fund investment, reflecting GS’s credit‑risk exposure through loans versus MetLife’s equity‑style ownership of real‑estate funds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. According to the ground truth, MetLife holds $13.3 billion in total real estate investments, including hotel-focused real estate funds, but the LLM incorrectly states that MetLife’s 'real-estate fund holdings are $3.65 bn' with a '$700 m hotel component'. The original answer does not specify these exact sub-allocations, nor does it state that only $700 million is invested in hotels—this figure is fabricated or misattributed. Similarly, the claim that Goldman Sachs has $1.7 billion in hospitality loans (5% of $34.8 billion) is not supported by the ground truth, which mentions 'significant credit exposure' to hotel-related CRE loans but does not provide a dollar amount or percentage. Thus, both key numerical claims and the comparison that Goldman’s exposure is 'twice the size' of MetLife’s are unsupported and likely incorrect. While the qualitative distinction between Goldman’s lending role and MetLife’s ownership via funds aligns with the original answer, the LLM introduces false precision through unsourced calculations. The reasoning framework—comparing credit exposure vs. equity investment—is contextually relevant and reflects an understanding of strategic differences, but the multi-hop synthesis fails because it builds on invented data. Therefore, while the structure and intent of the answer are sound, the factual foundation is flawed, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 414,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "Boeing’s (BA) pension‑plan assets include private‑equity and real‑asset limited‑partnership (LP) interests that are “not actively traded” and have limited redemption rights, so they are inherently illiquid, but the filing does not spell out a specific lock‑up period or quantify any unfunded amount【page_92】. United Parcel Service’s (UPS) pension fund holds real‑estate LP interests that cannot be redeemed until the partnership ends—generally 10‑ to 15‑year terms—and UPS disclosed roughly $3.3 billion of unfunded commitments that will be funded over the next three‑to‑six years, making its liquidity risk more explicitly tied to a long‑term, quantified funding obligation【page_89】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers are accurate: UPS's $3.3 billion in unfunded commitments is correctly cited, and the 10–15 year partnership terms are accurately reflected for both companies. The time frame for funding UPS's obligations (three-to-six years) is additional detail not in the original answer but does not contradict it and may reflect nuance from the source filing. (2) The LLM correctly identifies both companies' use of limited partnerships in real estate/private assets and the associated liquidity constraints. (3) The multi-hop reasoning is sound—comparing BA's illiquid LP investments with UPS's quantified unfunded pension obligations—though the original answer emphasizes structural similarity more directly, while the LLM highlights that BA's filing lacks specific lock-up or unfunded amount disclosure, which adds nuance. (4) The only minor shortcoming is that the LLM slightly underemphasizes the parallel in 10–15 year terms for BA (implied by context but not explicitly confirmed), whereas the ground truth explicitly states BA's partnerships also span 10–15 years. However, the LLM does not deny this, and the absence is more a matter of emphasis than inaccuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with a small deduction for incomplete symmetry in describing term lengths.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 398,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes versus one vote for Class A, and the Class B holders (founder, CEO and chair) together own a majority of the combined voting power, concentrating control in a single individual and limiting other shareholders’ influence【page_49】. Comcast also has a dual‑class system, but its Class B shares carry 15 votes each and represent only about one‑third of total voting power, with roughly two‑thirds held by widely‑held Class A shares, so while a single Class B holder (Brian Roberts) has significant sway, overall control is less concentrated than at Meta【page_33】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core comparison between META and CMCSA's voting structures, with accurate qualitative insights about control concentration and shareholder influence. Quantitatively, it correctly states that Class B shares at Meta have 10 votes versus 1 at Class A, and that Class B shares at CMCSA have 15 votes each—both aligning with known facts. It also correctly notes that Class A shares at CMCSA hold roughly two-thirds of voting power, which matches the ground truth (66 2/3%). However, the ground truth specifies a key governance detail missing in the LLM response: META’s requirement that a majority of Class B shares must approve change-of-control transactions until they fall below 35% of combined voting power. This anti-takeover provision strengthens control entrenchment and is a critical differentiator in assessing shareholder influence. Additionally, the LLM implies CMCSA’s Class B shares represent 'about one-third' of voting power, which is reasonable but slightly imprecise—the structure is designed so that the single Class B holder (Brian Roberts) maintains durable control due to non-dilutable shares, a nuance not fully conveyed. The reasoning is sound and multi-hop synthesis across companies is appropriate, and the conclusion that control is more concentrated at Meta is valid. Wording differs but meaning is semantically close. Minor omissions in structural details prevent a top score, but core facts and comparisons are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 410,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PEP’s U.S. qualified defined‑benefit plan holds about $1.8 billion of government securities – roughly 15 % of its $11.7 billion U.S. plan assets (page 99) – as part of a 56 % fixed‑income allocation that is blended with equities, real‑estate and high‑quality debt and is aimed at a 7.4 % long‑term expected return (page 98). By contrast, COST’s short‑term portfolio is concentrated in government and agency securities with three‑month‑to‑five‑year maturities, and its stated objective is to preserve principal and earn modest yields, reflecting a more conservative, liquidity‑focused risk‑management approach (page 31).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: PEP's $1.8 billion allocation to government securities (rounded from $1.812 billion) is accurately reported, and the 7.4% long-term return objective matches the original. The mention of a $11.7 billion U.S. plan total and 15% allocation is consistent with the source data (1.8/11.7 ≈ 15%), though not explicitly in the ground truth—this is a reasonable inference. COST’s short-term holdings in government and agency securities with maturities of three months to five years are correctly described. (2) The qualitative reasoning is sound: the contrast between PEP’s diversified, return-oriented strategy and COST’s capital preservation focus is well articulated. The LLM correctly identifies PEP’s broader fixed-income context (56%) and inclusion of equities, real estate, and high-quality debt, which adds useful context beyond the ground truth. (3) Multi-hop synthesis is strong—information about two companies, their distinct investment objectives, time horizons, and risk-return profiles is effectively compared. (4) Minor deduction in qualitative accuracy because the ground truth mentions PEP’s use of derivatives and active management for risk mitigation, which the LLM omits; conversely, the LLM adds contextual detail (e.g., 56% fixed income) not in the original. Overall, the answer is factually correct, contextually relevant, and semantically equivalent, with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 415,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s actual exposure to mortgage‑ and asset‑backed securities is modest – the 2020 fair‑value table shows a $9 million holding under “Mortgage‑ and asset‑backed securities” (Southern Company page 298). By contrast, NextEra Energy’s pension‑plan policy calls for roughly 32 % of the plan’s assets to be allocated to fixed‑income investments overall (NEE target allocation page 101). Thus, Southern’s concrete $9 million mortgage‑backed‑security position is a tiny dollar slice of its fixed‑income mix, whereas NextEra’s framework targets a much larger, 32 % share of the entire portfolio for fixed‑income assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison correctly. (1) Quantitatively, all numbers are correct: Southern Company's $9 million allocation to mortgage- and asset-backed securities matches the ground truth (from Level 2 fixed income of $6,154 million), and NextEra Energy's 32% target allocation to fixed income is accurately cited. The LLM correctly notes that Southern's holding is a 'tiny dollar slice'—which aligns with the ground truth calculation of less than 0.15% (9/6154 ≈ 0.146%)—though it does not explicitly state the percentage. (2) The entities are correct: Southern Company and NextEra Energy (NEE) are properly identified, and the data is attributed to the correct context (fair value table for Southern, pension plan policy for NextEra). (3) The reasoning is sound: the LLM correctly contrasts Southern’s actual, small-dollar allocation with NextEra’s strategic, percentage-based target within fixed income, acknowledging the different nature of the metrics (absolute vs. relative). (4) The only minor omission is that the LLM combines 'mortgage- and asset-backed securities' rather than isolating mortgage-backed securities specifically, and it does not mention the valuation methods (yields on comparable securities vs. commingled arrangements) included in the original answer. However, these are secondary details. The core multi-hop synthesis—comparing actual allocation vs. target framework across two companies—is executed accurately and clearly. Thus, the answer is semantically equivalent in intent and fact, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 431,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla’s Gigafactory partnership with Panasonic is anchored by a 2011 supply agreement (and its 2013 amendment) and a production‑pricing agreement, plus three separate cell‑pricing contracts – a 2019 pricing agreement for Japan‑cells, a 2020 pricing agreement for the Gigafactory 2170 cells, and a 2021 pricing agreement for Japan‑cells (exhibits 10.25, 10.26, 10.32, 10.35‑10.37) 【page_106】【page_107】. GM, on the other hand, secures its battery supply through an equity stake and capital commitments in its Ultium Cells joint‑venture and other VIEs, recording equity earnings from those entities rather than detailed, long‑term pricing contracts, indicating a broader but less contract‑specific integration 【page_76】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the existence of multiple pricing agreements between Tesla and Panasonic, including a 2020 and 2021 pricing agreement, which aligns with the ground truth. However, it incorrectly cites a '2019 pricing agreement for Japan-cells' and a '2011 supply agreement (and 2013 amendment)' as foundational to the Gigafactory partnership, which are not mentioned in the original answer and appear to be factually inaccurate or misattributed in this context. The ground truth specifies the 'Amended and Restated General Terms and Conditions' from June 10, 2020, which the LLM omits entirely. (2) The dates and document references (e.g., 2019, 2020, 2021) are partially correct but misaligned—while a 2020 and 2021 agreement are correctly noted, the 2019 agreement is not in the ground truth, and the 2011/2013 agreements are not part of the Gigafactory-specific arrangements described. The exhibit numbers (10.25, etc.) and page references add specificity but cannot be verified as accurate without source access and may reflect overprecision. (3) The multi-hop reasoning is sound in comparing Tesla’s detailed contractual framework with GM’s more integrated but less contractually transparent model via the Ultium joint venture. The LLM correctly infers that GM’s approach involves equity stakes and VIEs rather than explicit long-term pricing contracts, which is consistent with the original answer’s claim of 'less transparent or structured supplier partnership' in GM’s case. (4) The answer is contextually relevant and captures the core contrast: Tesla has specific pricing agreements while GM relies on joint ventures without equivalent contractual detail. Despite factual inaccuracies in dates and agreements, the overall qualitative comparison remains valid, warranting a score of 7 for correctness—core facts are partially right but with notable errors in specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 517,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron still faces a tax‑audit exposure in Nigeria for years as far back as 2007, with $5.3 billion of unrecognised tax benefits on its balance sheet that could be added to income‑tax expense if the audit results in additional liabilities. Exxon’s Nigeria risk, by contrast, is tied to the contractual life of its production‑sharing contracts – a 30‑year term (10‑year exploration plus a 20‑year production period) that can only be extended subject to the partial‑relinquishment rules in the 2021 Petroleum Industry Act – which could limit or end its production rights. Thus Chevron’s uncertainty is a financial tax‑liability issue, while Exxon’s is an operational risk governed by the PSC’s defined term and extension provisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in precision and completeness. (1) Quantitatively, the LLM correctly reports Chevron's $5.3 billion in unrecognized tax benefits, which aligns with the ground truth value of $5,288 million (rounded appropriately). The audit status—latest finalized for 2007—is accurately reflected. For Exxon, the 30-year PSC structure (10-year exploration + 20-year production) is correctly described, and the reference to the 2021 Petroleum Industry Act’s partial-relinquishment rules for extensions is a valid contextual addition not in the original but factually sound. However, the LLM omits the specific detail that 12% of Exxon’s total proved reserves in 2021 were under PSCs, a minor but relevant completeness gap. (2) The financial figures are correctly interpreted and presented with acceptable formatting ($5.3 billion vs $5,288 million). No calculation errors. (3) The multi-hop reasoning is strong: the model correctly distinguishes Chevron’s financial/tax risk from Exxon’s operational/contractual risk, synthesizing across tax audits and PSC terms. The contrast in risk types—tax liability vs. production rights—is logically and accurately drawn. (4) The answer is fully contextually relevant, directly addressing the comparison requested. The omission of the 12% reserves figure prevents a perfect score, but all other key facts are present and correctly interpreted. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor detail loss.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 441,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reported $470 million of commercial paper on its balance sheet (cash‑equivalents and short‑term investments) as of December 31 2023【page_72】.  By contrast, Duke Energy Ohio disclosed only $25 million of commercial paper in its short‑term obligations (classified as long‑term debt)【page_165】.  Thus, Tesla’s commercial‑paper usage is roughly twenty‑fold greater than that of Duke Energy Ohio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's commercial paper holdings as $470 million and Duke Energy Ohio's as $25 million, both matching the ground truth in amount and date (December 31, 2023). These figures are accurately attributed to their respective companies and contexts—Tesla's as part of short-term investments/cash equivalents, and Duke Energy Ohio's as short-term obligations classified under long-term debt. (2) The calculation comparing Tesla’s holdings to Duke Energy Ohio’s is correct: $470M / $25M = 18.8, which rounds to roughly twenty-fold, making the 'twenty-fold greater' statement a reasonable approximation. No calculation errors. (3) The multi-hop reasoning is sound—information from two different companies (Tesla and Duke Energy Ohio) is correctly synthesized to compare commercial paper usage. The LLM identifies the difference in financial structure (short-term investment vs. short-term obligation) and implies differing liquidity strategies, aligning with the qualitative point in the original answer. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly highlight the broader contrast in business models (technology/auto vs. utility) as in the original answer, which adds contextual depth. However, the core factual and comparative content is preserved. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 392,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan’s climate‑risk framework treats transition risk as a direct source of compliance, reputational and litigation exposure – the Climate Risk Management function sets policies, scenarios and stress‑tests for transition‑risk drivers and escalates any regulatory or legal implications to senior management and the Board, embedding the risk in its overall compliance profile (see JPM pages 78 & 148). Morgan Stanley, on the other hand, notes that it has faced heightened regulatory scrutiny over its climate‑related disclosures, meaning its compliance risk is driven more by external enforcement and reporting expectations than by an integrated internal climate‑risk governance process (see MS pages 78‑79).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan integrates transition risk into its compliance and risk management framework via its Climate Risk Management function, including stress testing and escalation to senior management, which matches the original answer's emphasis on proactive integration. Morgan Stanley’s experience with regulatory scrutiny over climate disclosures is correctly portrayed as externally driven, emphasizing enforcement and reporting expectations, consistent with the original answer’s focus on legal and regulatory scrutiny. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable beyond the absence of errors—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two firms, comparing JPMorgan’s internal governance approach to Morgan Stanley’s external regulatory challenges, capturing the contrast in how transition risk affects compliance risk. The only minor shortcoming is that the LLM answer does not explicitly mention 'reputational damage' or 'carbon taxes' as noted in the original answer for Morgan Stanley, slightly reducing completeness in qualitative detail. (4) Contextual relevance is excellent—the response directly addresses the comparative influence of transition risk on compliance risk and draws a clear, supported distinction between the two firms’ approaches. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 455,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s PSCs give ConocoPhillips a 30‑year contract – a 10‑year exploration window followed by a 20‑year production period that can be extended and that requires partial relinquishment after the first decade – so its deep‑water projects are planned around a long, predictable horizon and the need to surrender acreage if the field is not developed (see page 31). Chevron’s Nigerian deep‑water assets are accounted for under the same regime: OMLs issued under the 1969 Petroleum Act (which cover all deep‑water blocks) have a 20‑year term, are renewable for another 20 years and are subject to a mandatory 50 % relinquishment after ten years, which directly shapes the amount and timing of reserves it can recognize in its Africa reserve balances (see page 106).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core structure of Nigeria's 30-year production-sharing contracts with a 10-year exploration and 20-year production period, correctly noting potential extensions and partial relinquishment, which aligns with the ground truth. It appropriately links this framework to ConocoPhillips' long-term planning in deepwater operations and to Chevron's reserve accounting practices. However, there are key quantitative and factual discrepancies: (1) The LLM incorrectly states that relinquishment occurs after ten years under the 1969 Petroleum Act, while the ground truth ties partial relinquishment to Nigeria's Petroleum Industry Act (not the 1969 Act), which is a more recent regulatory development. (2) The LLM claims a 'mandatory 50% relinquishment'—a specific figure not present in the original answer, which only mentions 'partial relinquishment provisions' without specifying a percentage. This introduces a potentially inaccurate detail. (3) The reference to OMLs (Oil Mining Leases) under the 1969 Act conflicts with the original answer’s focus on PSCs under the newer regulatory regime, suggesting a misalignment in the legal framework applied. While the overall reasoning and synthesis across ConocoPhillips and Chevron are sound and contextually relevant, the introduction of unsupported specifics (50%, 1969 Act) reduces quantitative and qualitative accuracy. The core implications for both companies’ planning and reserve reporting are correctly conveyed, warranting a solid but not high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 417,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing flags the risk that U.S.‑government contracts can be modified, curtailed or terminated – a unique exposure that it discusses in its risk factors (see page 14) – but its 2023 filing makes no reference to applying ASU 2022‑06 to those contracts, implying the guidance is not a material part of its accounting for government‑contract modifications. In contrast, FedEx explicitly cites ASU 2022‑06 (see page 93) as the optional expedient it is using to ease the accounting burden of reference‑rate‑reform‑related contract modifications, monitoring its contracts for impact even though no material effect has yet been observed.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in key aspects but omits critical quantitative and contextual details from the original answer. (1) Quantitative Accuracy: All numeric values in the LLM answer are either absent or implied, but no incorrect numbers are stated. The original answer specifies that 37% of Boeing's revenues are under government contracts and that ASU 2022-06 relief extends through 2024, with both companies reporting no material impact as of May 31, 2024. The LLM answer correctly notes the lack of material impact for both companies and implies correct timing (via FedEx’s 2023 filing), but fails to include the 37% revenue exposure and the May 31, 2024, cutoff date, which are key facts. (2) Completeness: The LLM addresses both Boeing’s and FedEx’s use of ASU 2022-06 and correctly contrasts Boeing’s lack of explicit application with FedEx’s explicit adoption. However, it omits the 37% revenue impact and the shared benefit from the 2024 sunset extension—both central to the original answer’s comparative point. (3) Entity Accuracy: Companies (Boeing, FedEx), accounting standard (ASU 2022-06), and context (reference rate reform, government contract modifications) are correctly identified. Fiscal year context is implied via filings but not explicitly confirmed. (4) Reasoning: The multi-hop logic is sound—Boeing has unique government contract risks but does not apply ASU 2022-06 materially; FedEx uses it explicitly but sees no material effect. This aligns with the original. However, the synthesis is less complete due to missing the shared benefit of the 2024 extension, weakening the comparative insight. (5) Semantic Equivalence: The LLM captures the core contrast but lacks full semantic equivalence due to missing key data points. The omission of the 37% figure and the 2024 sunset context reduces completeness. Overall, the answer is accurate in reasoning and entities but partially incomplete on critical facts, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 537,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported that its net offshore acreage in Angola was ≈ 2.9 million acres at year‑end 2021【page_24】. By contrast, Chevron’s involvement in Angola is limited to a ≈ 25 % equity stake in the Angola LNG joint‑venture, which was cited as a source of higher upstream earnings in 2021 and contributed to the $5.657 billion income from equity affiliates that year【page_42】. Thus, ExxonMobil’s Angola position is measured in millions of acres, whereas Chevron’s exposure is a minority ownership share that nonetheless added to its 2021 upstream earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ExxonMobil's 2.9 million net offshore acres in Angola at year-end 2021 is accurately reported. Chevron's stake in Angola LNG is correctly described as approximately 25%, and the $5.657 billion income from equity affiliates in 2021 is factually consistent with the source. These figures match the knowledge graph's implied data, even if the exact percentage isn't in the original answer—contextually, Chevron's minority stake and earnings contribution are correctly represented. (2) The answer addresses all parts of the multi-hop question: it compares ExxonMobil’s physical acreage to Chevron’s financial stake in Angola LNG and links Chevron’s upstream earnings in 2021 to that asset. (3) Entity accuracy is strong: both companies, the Angola LNG asset, the year 2021, and the financial metric 'income from equity affiliates' are correctly identified. (4) Reasoning is sound: the contrast between ExxonMobil’s operational footprint (acres) and Chevron’s financial exposure (equity stake) is logically drawn and supported by earnings data. The only minor gap is that the original answer does not specify Chevron’s exact stake percentage (25%), which the LLM adds—this is plausible and consistent with public knowledge but not confirmed in the ground truth. However, since the core financial and comparative insights are correct and the added detail doesn’t contradict the truth, this does not significantly detract from accuracy. Overall, the answer is semantically equivalent and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 442,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent about **$6.6 billion** on 46 strategic acquisitions in fiscal 2024 to scale its industry solutions (see Accenture 10‑K, p. 6). Microsoft’s **enterprise and partner services**—which also encompass industry solutions—generated **$7.594 billion** of revenue in fiscal 2024 (Microsoft 10‑K, p. 93). Thus, Accenture’s acquisition outlay was roughly $1 billion less, or about 87 % of Microsoft’s enterprise‑partner services revenue for the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Accenture's $6.6 billion investment in 46 acquisitions and Microsoft's $7.594 billion in enterprise and partner services revenue for fiscal 2024, both of which match the ground truth. The comparison stating Accenture’s outlay was about $1 billion less and approximately 87% of Microsoft’s revenue is accurate: $6.6B / $7.594B ≈ 86.9%, which rounds to 87%. (2) All numeric values are correct and properly cited to the respective 10-K pages. Calculations are sound and semantically equivalent to the original answer. (3) The multi-hop reasoning—linking Accenture’s strategic spending with Microsoft’s revenue generation in a comparable domain (industry solutions)—is logically sound and synthesizes data from two companies appropriately. The conclusion about differing strategies (investment vs. revenue generation) is implied through comparison, though slightly less explicitly stated than in the original answer. (4) The answer is fully contextually relevant, directly addressing the comparison asked. The only minor shortcoming is a slight reduction in qualitative depth—the original answer draws a clearer strategic insight about differing growth approaches, which the LLM implies but does not fully articulate. Hence, qualitative accuracy is high but not perfect. Overall, the response is factually excellent with strong synthesis and precise numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 389,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio was allowed by FERC and the state PUC to pay dividends only after it pledged that its equity (after removing push‑down‑accounting effects) would never drop below 30 % of total capital 【page_147】.  Southern Company’s 50 % stake in the $3 billion SNG pipeline will also need FERC sign‑off 【page_92】, so the company can apply the same discipline – retaining enough earnings, limiting cash‑out distributions and structuring debt so that its equity ratio stays comfortably above any regulator‑mandated floor (e.g., the 30 % benchmark) while financing its half‑share of the project.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Duke Energy Ohio's 30% equity threshold under FERC and PUCO approval is accurately stated, as is Southern Company's 50% cost share in the $3 billion SNG pipeline project requiring FERC approval. The dollar amount ($3 billion), percentage (50%), and equity threshold (30%) are all quantitatively accurate. (2) The reasoning correctly synthesizes the regulatory precedent from Duke Energy and applies it analogously to Southern Company’s situation, suggesting prudent financial discipline—such as earnings retention and debt structuring—to maintain equity ratios above regulatory floors. This reflects sound multi-hop logic connecting dividend policy conditions to capital planning for a new FERC-regulated project. (3) The only minor shortcoming is that the LLM slightly reframes the insight as a recommendation ('can apply the same discipline') rather than explicitly stating that Southern Company may reference Duke’s experience for compliance planning, which is more directly stated in the original. However, this does not distort the meaning and remains semantically equivalent in intent. (4) Contextual relevance is excellent—the response directly addresses how Duke’s experience informs Southern’s financial planning under similar regulatory scrutiny. No irrelevant information is included.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 386,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS treats corporate debt that must be priced without a broker quote as a Level 2 fair‑value item, using “market corroborated pricing, matrix pricing or other models that utilize observable inputs such as yield curves” (UPS 10‑K p. 89). MMM also relies on matrix pricing for such debt, but it combines the matrix yields with a discounted‑cash‑flow model that adds credit‑ and liquidity‑risk adjustments; consequently the corporate‑debt measurements can appear in Level 2 or, when the unobservable adjustments dominate, in Level 3 (MMM 10‑K p. 101).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that UPS categorizes corporate debt instruments under Level 2 and uses matrix pricing or other observable-input models when broker quotes are unavailable, citing observable inputs like yield curves—consistent with UPS's 2022 10-K. (2) For MMM, it accurately states that matrix pricing is used but enhanced with discounted cash flow models incorporating credit and liquidity risk adjustments, which may shift valuations to Level 3 when unobservable inputs dominate—this nuance is correctly drawn from MMM’s disclosures. (3) The multi-hop reasoning is sound: it synthesizes valuation methodologies across two companies, compares their use of matrix pricing, and correctly infers the impact of unobservable inputs on fair value hierarchy classification. (4) The only minor shortcoming is that the LLM does not explicitly state that UPS does *not* mention risk adjustments (a subtle but noted difference in the original answer), though this omission doesn’t distort the overall comparison. All entities (UPS, MMM, Level 2, Level 3, matrix pricing, DCF, credit/liquidity risk) are correct, as are the contextual references to 10-K pages. Number formats and dates are not numerically critical here but are contextually accurate. Semantic equivalence is strong, with slightly more precision in hierarchy implications than the original. Thus, high scores across all dimensions, with a 9 on correctness due to the slight incompleteness regarding UPS’s lack of risk adjustment disclosure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 432,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The $2.8 billion that Vertical Bridge REIT paid in 2024 was not treated as a sale; Verizon recorded $2.0 billion as prepaid rent and the remaining $830 million as a financing obligation, kept the towers on its balance sheet and leased back a portion of the capacity for an initial 10‑year term (with eight five‑year renewal options). By contrast, AT&T’s 2013 Crown Castle deal generated $4.827 billion in cash that was also booked as a financing liability (no prepaid‑rent component); AT&T retained ownership of the towers (except for 627 sold) and sub‑leased space for about 20 years while Crown Castle obtained exclusive lease/operating rights and a purchase option. Both transactions are structured as financing arrangements that preserve AT&T’s operational control of the tower assets, but the Vertical Bridge deal uses a prepaid‑rent split and a shorter lease‑back period, whereas the Crown Castle deal involved a larger cash purchase and a longer lease with purchase options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $2.8 billion total (split into $2.0 billion prepaid rent and $830 million financing obligation), matching the original answer; the $4.827 billion from the 2013 Crown Castle deal is accurately cited. Dates (2024 and 2013) and financial treatments are correct. (2) The answer correctly identifies the financing structures: VZ's dual treatment (prepaid rent + financing obligation) vs. T's (entirely financing obligation), and notes both companies retained ownership and operational control. (3) Multi-hop reasoning is sound—comparing two different transactions across companies (VZ vs. T), years (2024 vs. 2013), and structural elements (accounting treatment, lease terms, retained rights). (4) Minor qualitative discrepancy: the LLM mentions AT&T 'retained ownership of the towers (except for 627 sold)', which is not in the ground truth and introduces a detail (partial sale) not confirmed in the original answer. The original states T retained control and continued depreciating assets, implying full retention on the balance sheet. This addition slightly over-specifies and risks implying a different structure. Also, the original mentions T's interest rate (~3.9%), which the LLM omits. Despite these small gaps, the core comparison on financing structure and operational control is accurate and well-synthesized. Wording differences (e.g., 'lease-back period', 'renewal options') are semantically acceptable and add clarity without distorting facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 430,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck says the IRS is still reviewing its 2017‑18 returns, including the one‑time TCJA transition‑tax payment, and cautions that a disagreement could generate a “significant” tax liability – though no dollar amount is disclosed (MRK 10‑K p. 127). In contrast, Medtronic reports that the Base‑Erosion Anti‑Abuse Tax (the TCJA minimum tax) increased its 2024 effective tax rate by only about 0.3 %, a relatively modest impact on its overall tax expense (MDT 10‑K p. 87).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that MRK faces a potential significant tax liability from the IRS examination of its TCJA transition tax, with no disclosed dollar amount, and that MDT experienced a 0.3% increase in effective tax rate due to BEAT in 2024. These quantitative figures match the ground truth exactly. However, the LLM omits the specific $2.3 billion unrecognized tax benefits figure for MRK as of December 31, 2024, which is a key part of the original answer and provides concrete scale to the potential liability. This omission reduces completeness and affects the overall correctness score. (2) The 0.3% BEAT impact on MDT’s tax rate is accurately reported, and the absence of a disclosed dollar amount for MRK’s exposure is correctly stated. The years referenced (2017–18 for MRK IRS review, 2024 for MDT) are accurate. The only missing numeric data is the $2.3 billion, which is significant but not entirely dispositive to the core comparison. (3) The multi-hop reasoning is sound: the LLM connects the TCJA’s introduction of BEAT to both companies, recognizes that MRK’s exposure stems from the transition tax under TCJA (which includes BEAT considerations), and contrasts the qualitative severity (significant but undefined vs. modest 0.3% impact). It correctly synthesizes information across MRK and MDT 10-Ks and links BEAT as a component of TCJA. The failure to mention the $2.3 billion limits the depth of the comparison but does not invalidate the logical structure. (4) Scores reflect high accuracy in numbers and context, with a moderate deduction in correctness and qualitative accuracy due to the omission of a key financial figure that affects the strength of the comparative assessment. Contextual relevance is perfect—the answer directly addresses the question with appropriate framing and source citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 503,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s deep‑water projects are governed by 30‑year production‑sharing contracts – a 10‑year exploration phase followed by a 20‑year production period, with partial relinquishment and optional extensions【page_31】. ConocoPhillips’ Nigerian activities are therefore organized around these PSCs, so the contract length and relinquishment rules define the scope and duration of its operational footprint in the country【page_151】. Chevron’s African reserve disclosures reflect the same regime: its 42 million‑barrel increase in Africa is attributed to the Sonam field in Nigeria, which is held under a 30‑year PSC【page_105】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major quantitative error: it states that Chevron had a '42 million-barrel increase in Africa' attributed to the Sonam field in Nigeria, while the ground truth states Chevron's total African reserves in 2021 were 106 million barrels. The 42 million figure is not supported by the original answer and appears to be fabricated or misattributed. This is a critical factual error affecting core financial data. (2) Other numerical elements — such as the 30-year PSC structure, 10-year exploration, and 20-year production periods — are correctly reported and align with the ground truth. However, the incorrect reserve figure undermines confidence in the answer’s reliability. (3) The multi-hop reasoning is partially sound: the model correctly links Nigeria’s PSC framework to both ConocoPhillips’ operational footprint and Chevron’s reserve disclosures, showing understanding of how regulatory terms influence corporate strategy. It identifies the correct mechanism (PSC duration, relinquishment) affecting operations and reserves. However, it fails to accurately report Chevron’s actual reserve levels, instead introducing an unsupported incremental increase. (4) Contextually, the answer is highly relevant and well-structured, citing appropriate pages and framing the influence of PSCs on both companies. The qualitative reasoning about contract impacts is strong, but the significant numerical inaccuracy in reserve disclosure severely limits correctness. Thus, the correctness_score is 6 (partially correct with major factual flaw), quantitative_accuracy is 4 (major error in key number), qualitative_accuracy is 7 (solid reasoning despite error), and contextual_relevance is 9 (directly addresses the question’s scope).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 479,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred shares are only allowed to vote on a narrow set of actions—primarily a merger, consolidation, combination or amendment that would affect the preferred holders’ rights—so any restructuring that would change those rights must obtain the affirmative vote of the Series C holders, but otherwise the company can proceed without their input【page_90】. In contrast, Netflix operates under a one‑share‑one‑vote system, giving every shareholder a vote on all corporate matters, which means any restructuring must be approved by a majority of the entire shareholder base【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AT&T’s Series C Preferred Stockholders have voting rights only in specific restructuring scenarios (e.g., mergers, consolidations, or amendments affecting their rights), which aligns with the original answer’s emphasis on limited influence except in high-impact events. It also accurately contrasts this with Netflix’s one-share-one-vote model, where all shareholders have voting power on corporate matters. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between two companies’ stock structures and draws a valid comparison regarding shareholder influence in restructuring decisions. The only minor shortcoming is that the LLM answer does not explicitly mention that AT&T’s preferred shareholders lack voting rights in *all other* corporate decisions (beyond restructuring), which is implied but not stated as clearly as in the original. However, the core reasoning and factual content are intact. (4) Contextual relevance is perfect—the response directly addresses the influence of voting structures on restructuring decisions for both companies. Overall, the answer is highly accurate with only slight room for improved clarity on the breadth of AT&T preferred shareholders’ limitations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 411,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "Pfizer’s Enbrel is shielded by U.S. patents that run until 11 / 22 / 2028 for the fusion‑protein composition, 4 / 24 / 2029 for the DNA‑encoding and manufacturing methods, and 10 / 19 / 2037 for its formulation (Pfizer 10‑K, p. 11). Because AbbVie’s filing explains that biologics can extend protection through patent‑term restoration (up to five years) and a 12‑year BPCIA regulatory exclusivity (plus pediatric extensions) (AbbVie 10‑K, p. 9), Pfizer will need to rely on similar extensions, new indications or reformulations to sustain Enbrel’s cash flow once the 2028‑2037 patents expire and biosimilar competition emerges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all patent expiration dates are correct and match the original answer: fusion protein in 2028, DNA encoding in 2029, and formulation in 2037. The specific dates (e.g., 11/22/2028, 4/24/2029, 10/19/2037) are more precise than the original answer but consistent with the knowledge graph's timeline. (2) The LLM correctly identifies AbbVie’s use of patent-term restoration (up to five years) and references the 12-year BPCIA exclusivity (slightly different from the original’s 14-year mention, but BPCIA baseline is 12 years; pediatric extensions can extend further). This shows strong multi-hop reasoning across Pfizer and AbbVie filings. (3) The reasoning is sound: it infers that Pfizer may need to adopt AbbVie-like strategies (extensions, new indications, reformulations) to protect revenue, which is consistent with the original answer’s conclusion about lifecycle management. (4) Minor difference: original mentions Hatch-Waxman and up to 14 years of exclusivity, while LLM cites BPCIA and pediatric extensions—both valid frameworks, but Hatch-Waxman is more relevant to small molecules; BPCIA is correct for biologics. This nuance slightly affects qualitative accuracy but does not undermine correctness. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 383,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore chemical complex is reported to have an ethylene capacity of **1.9 million metric tons per year** (XOM 10‑K, page 26). Chevron’s filing only notes that it holds a **32.77 % indirect interest in Map Ta Phut Olefins in Thailand, which manufactures ethylene** (CVX 10‑K, page 15), but it does not disclose the joint‑venture’s ethylene output, so a direct capacity comparison cannot be made.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the ethylene production capacity of ExxonMobil's Singapore facility as 1.9 million metric tons per year, matching the ground truth exactly. It also accurately states that Chevron holds a 32.77% indirect stake in the Map Ta Phut Olefins joint venture in Thailand, which manufactures ethylene, consistent with the original answer. The LLM correctly notes that the ethylene capacity attributable to Chevron is not disclosed, making a direct comparison impossible—this aligns with the ground truth's conclusion. All numeric values (1.9 million metric tons, 32.77%) are accurate and properly attributed to the respective 10-K filings. The reasoning is sound: it synthesizes information from two different companies and filings, correctly identifying the limits of available data. The only minor shortcoming is a slight lack of explicit mention that the *joint venture itself* has ethylene capacity (though it's implied), but the core facts and logic are intact. Wording differs slightly from the original answer but maintains semantic equivalence. No calculation errors or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 322,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company recorded a pre‑tax charge of roughly $96 million (about $72 million after tax) tied to the disallowance of capital investments at Nicor Gas in Illinois. By contrast, NextEra Energy’s footprint in Illinois is limited to about 90 miles of transmission lines (and five substations), a modest physical‑asset scale rather than a comparable monetary loss.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that NextEra Energy operates 'about 90 miles of transmission lines' in Illinois, whereas the ground truth specifies that NextEra operates 90 thousand miles of transmission lines across five states (Illinois, Indiana, Kentucky, New Hampshire, and New York), with Illinois being part of that footprint. This is a two-order-of-magnitude error (90 vs 90,000 miles), which drastically misrepresents the scale of infrastructure. (2) The LLM also introduces unverified details not present in the original answer, such as 'five substations' and an after-tax figure of $72 million, which, while plausible, are not supported by the ground truth and introduce speculation. (3) Qualitatively, the reasoning fails to correctly synthesize the multi-hop comparison: the original intent was to contrast Southern Company’s $96M financial loss with the large scale of NextEra’s regional infrastructure (including Illinois), but the LLM incorrectly minimizes NextEra’s footprint, leading to a flawed conclusion about 'modest physical-asset scale.' (4) Contextually, the answer attempts to address the comparison but does so with incorrect data, reducing relevance. While the $96 million pre-tax charge is correctly cited, the misrepresentation of NextEra’s infrastructure renders the core comparison invalid. The answer fails to convey the intended relative scale, which was central to the original answer’s point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 417,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO’s equity‑method portfolio includes a roughly 19 percent ownership stake in Coca‑Cola Europacific Partners plc (CCEP) as of December 31 2021【page_88】. CCEP operates bottling and distribution in Iceland, a market that Costco also serves through its membership‑warehouse business in that country【page_7】【page_63】. Thus KO’s 19 percent stake gives it exposure to the same Iceland market where COST has operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO owned approximately 19% of CCEP as of December 31, 2021, which matches the ground truth exactly. This addresses the first part of the question with full quantitative accuracy. (2) The LLM accurately notes that CCEP operates in Iceland and that COST also operates there through its membership-warehouse business, correctly identifying the shared market exposure. This aligns with the ground truth’s assertion that COST operates in Iceland via wholly owned subsidiaries. (3) The multi-hop reasoning is sound: the model connects KO’s equity stake in CCEP to indirect exposure in Iceland and contrasts it with COST’s direct retail operations, synthesizing information across entities (KO → CCEP → Iceland operations; COST → Iceland operations). (4) The only minor shortcoming is that the LLM does not explicitly clarify that KO’s exposure is indirect (via equity investment in a bottler) while COST’s is direct (via retail warehouses), though this is implied. The original answer makes this distinction more clearly. Despite this, the core facts, numbers, entities, and logic are correct, and the answer is semantically equivalent. Formatting variations (e.g., '19 percent' vs '19%') are acceptable. All citations reference appropriate pages, indicating proper grounding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 368,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy’s registrants are directly exposed to electricity‑price volatility because they buy and sell electricity in bulk power markets and use commodity‑derivative contracts to hedge that risk (see Duke 10‑K p. 179). Southern Company’s exposure is only indirect – its subsidiaries own a stake in PowerSouth, which under a 2021 agreement receives roughly 100 MW of year‑round capacity from Alabama Power, so any price impact is limited to that capacity‑supply arrangement rather than direct market price swings (see Southern 10‑K p. 17).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are accurate: the 100 MW capacity, the 2021 agreement, and the year-round service are correctly reported. The mention of Duke Energy using derivative contracts and Southern Company's indirect exposure via PowerSouth is factually sound. (2) The LLM correctly identifies the key entities: Duke Energy, Southern Company, PowerSouth, and Alabama Power, and accurately references the 2021 agreement. (3) The reasoning is mostly sound: it correctly contrasts Duke Energy’s direct exposure and hedging with Southern Company’s indirect exposure through a capacity arrangement. However, the LLM omits some key qualitative details present in the original answer, such as the role of fuel adjustment clauses, formula-based contracts, and the 10-year coordinated planning and operations agreement that enables shared dispatch and cost-offsetting mechanisms. It also does not mention that the capacity service starts in 2024, which is a specific temporal detail in the ground truth. (4) Despite these omissions, the core comparison is accurate and relevant, and the answer correctly synthesizes information from both 10-Ks. The answer is concise and factually precise, warranting a high correctness score, but not perfect due to missing contextual depth in the multi-hop reasoning about risk mitigation mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 390,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 licensed stores in Taiwan during FY 2022 – the count rose from 523 to 544, a net increase of about 4 % (page 12). In the same year Nike’s Greater China segment produced roughly $6.7 billion of revenue (page 89). Thus, while Starbucks’ Taiwan footprint grew modestly in store numbers, Nike’s contribution from the broader Greater China region (which includes Taiwan) was measured in multi‑billion‑dollar sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Starbucks' net store increase in Taiwan as 21 (from 523 to 544), which aligns with the ground truth total of 544 stores in FY2022. However, it incorrectly states Nike's Greater China revenue as $6.7 billion, whereas the ground truth reports $7.547 billion—a significant numerical discrepancy. (2) The calculation of the ~4% store growth is reasonable (21/523 ≈ 4%), and the store count progression is accurate. But the revenue figure for Nike is off by over $800 million, which undermines quantitative accuracy. This error likely stems from misreading or citing the wrong fiscal figure from the source document (e.g., possibly using an older or adjusted number). (3) The multi-hop reasoning is sound: the model correctly acknowledges that Taiwan is part of Nike’s Greater China segment and draws a logical comparison between Starbucks’ physical expansion in Taiwan and Nike’s regional revenue performance. It also appropriately notes that Taiwan is included in the broader geographic segment, though it doesn’t explicitly state that Nike does not disclose Taiwan-specific revenue, which is a minor omission. (4) The contextual relevance is high because the answer addresses both parts of the comparison and maintains focus on the relationship between the two companies' metrics. However, the major revenue inaccuracy reduces the correctness and quantitative scores significantly, despite otherwise solid reasoning and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 408,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 obliges 3M to pull its supplier‑finance program into the footnotes and accounts‑payable line, disclosing that about $0.3 billion of confirmed invoices remain outstanding and providing a roll‑forward that shows roughly $1.5 billion of invoices confirmed and paid during the year, which makes the liability fully visible. FedEx adopted the same standard and now reports its supplier‑finance exposure (≈ $94 million at year‑end) with a comparable roll‑forward of beginning balance, invoices confirmed, payments and currency adjustments, giving a similar level of transparency, though on a much smaller dollar amount.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly identifies 3M's confirmed invoice obligations as $0.3 billion, it introduces a figure of $1.5 billion in invoices confirmed and paid during the year, which is not present in the original answer and cannot be verified from the provided ground truth. Additionally, the LLM claims FedEx has supplier finance exposure of approximately $94 million at year-end, a specific number absent from the original answer, which only states that FedEx adopted the standard and provided disclosures without specifying the dollar amount. These unverified figures undermine factual accuracy. (2) The original answer does not mention any roll-forward amounts or payments volume for either company, so the $1.5 billion and $94 million figures appear to be hallucinated. The adoption dates are partially correct—3M adopted in 2023 with full reporting in 2024, and FedEx adopted June 1, 2023—but the LLM does not specify this date for FedEx, only implying compliance. (3) The reasoning is qualitatively sound in that it correctly identifies ASU 2022-04’s impact on transparency, balance sheet presentation, and roll-forward requirements, and draws a valid comparison between 3M and FedEx in terms of enhanced disclosure practices. It synthesizes the multi-hop concept that both companies adopted the same standard and now provide greater transparency, which aligns with the ground truth. (4) Despite correct conceptual understanding and contextual relevance, the inclusion of unsupported numerical data significantly reduces quantitative accuracy. The core message about improved visibility and comparable transparency is preserved, but the addition of unverified figures lowers the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 484,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies give a tiny group of insiders outsized voting power – Comcast’s single Class B holder enjoys 15 votes per share, giving him roughly a third of all votes, and Meta’s charter requires that any change‑of‑control transaction obtain separate approval from the Class B holders as long as they hold at least 35 % of the combined voting power. Because that voting power is concentrated, minority Class A shareholders have little ability to affect director elections, mergers or other corporate actions, exposing them to governance risk that key decisions can be controlled or blocked by the dominant Class B owners.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 15-vote-per-share advantage at CMCSA leading to approximately one-third (33⅓%) voting power is accurately represented as 'roughly a third of all votes'; the 35% threshold at META for blocking change-of-control transactions is correctly stated. No calculation errors. (2) The answer addresses both companies and the specific governance mechanisms—disproportionate voting power at CMCSA and supermajority blocking rights at META—linking them to minority shareholder risk. (3) Entity accuracy is strong: CMCSA (Comcast) and META (Meta) are correctly identified, and the distinction between Class A and Class B shares is properly maintained. (4) The reasoning is sound: it correctly synthesizes how concentrated voting power in a small group (e.g., insiders) limits minority shareholders’ influence on key decisions like director elections and mergers, exposing them to governance risks. The only minor shortcoming is that the LLM does not explicitly name Brian L. Roberts as the key holder at CMCSA, though this is not strictly necessary for answering the question about structural risks. Also, the phrase 'separate approval' slightly overstates the mechanism at META—the Class B holders don’t formally approve but can block via voting power, which the ground truth clarifies. However, this does not materially distort the meaning. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 435,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "About 44 % of Visa’s U.S. pension‑plan assets that are classified as Level 2 in 2022 were invested in collective investment funds (US $319 million of the US $733 million Level‑2 total). Capital One’s “other securities” – a $2.8 billion pool of mainly corporate debt and asset‑backed securities – are weighted toward fixed‑income and generate a modest overall yield of roughly 1.6%, reflecting a lower‑yield, income‑focused strategy versus Visa’s more diversified, higher‑return fund exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that 44% of Visa's Level 2 assets were in collective investment funds, calculated as $319M out of $733M. However, the ground truth specifies that $319M in collective funds is part of a total of $960M in *U.S. pension plan assets*, not Level 2 assets. The correct percentage is ~33.2%, not 44%. The LLM incorrectly uses $733M as the Level 2 total, which is not supported by the ground truth—no such figure is mentioned. (2) While the $319M figure for collective investment funds and $2.8B (approximation of $2,834M) for COF's 'other securities' are correct, the denominator used for the percentage calculation is wrong, leading to an incorrect percentage. The yield of 1.6% for COF is close to the true 1.57%, which is acceptable. (3) The qualitative reasoning is partially sound: the LLM correctly identifies that V’s strategy involves diversified collective funds while COF focuses on fixed-income securities with modest yield. The comparison of investment focus (diversified/higher-return vs. income-focused/lower-yield) aligns with the ground truth. However, the reasoning is based on a flawed quantitative foundation. (4) The answer is contextually relevant and addresses both parts of the multi-hop question—allocation percentage and strategic comparison—though the first part is miscalculated. The synthesis across V and COF is appropriate, but the error in the core calculation significantly undermines factual correctness. Hence, correctness score is 5 due to partial accuracy with a major calculation error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 439,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe’s filing does not disclose any material compliance cost tied to Saudi Arabia’s data‑localization law, suggesting the impact is negligible, whereas Microsoft warns that complying with data‑sovereignty and localization rules could require substantial engineering spend and expose it to significant monetary penalties (see Microsoft 10‑K, Item 1A, pages 29‑31). This contrast shows Adobe’s cloud approach is either less dependent on the Saudi market or designed to avoid heavy‑localization requirements, while Microsoft’s globally‑scaled cloud strategy must absorb higher compliance costs to operate in jurisdictions with strict data‑localization regulations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite correct formatting and structure. The Original Answer states that Adobe explicitly acknowledges compliance costs and risks from Saudi Arabia's data localization laws, citing adverse impacts on its business and enterprise customers (ADBE_10k_2024.pdf). However, the LLM incorrectly claims that Adobe's filing 'does not disclose any material compliance cost,' which directly contradicts the ground truth. This is a critical error in factual representation. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning fails because the LLM misrepresents Adobe’s disclosures, leading to an incorrect comparative analysis. While Microsoft’s exposure is accurately described (citing engineering costs and risks in MSFT_10k_2024.pdf), the contrast drawn with Adobe is invalid due to the mischaracterization of Adobe’s position. The conclusion that Adobe’s strategy avoids heavy localization requirements or is less dependent on Saudi Arabia is speculative and unsupported by the source, which actually states Adobe is exposed and vulnerable. (4) Contextual relevance is moderate—the response addresses the right companies, topic, and general strategic implications, but the core factual premise (Adobe’s lack of disclosed costs) is false, undermining the analysis. Correctness and qualitative accuracy are low due to this central inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 420,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy removed its direct FERC‑regulated asset when KO Transmission sold its 90‑mile interstate gas pipeline—an asset that “is subject to the rules and regulations of FERC” (see page 24) and whose facilities were transferred to Columbia Gas Transmission in February 2023 (page 18). By divesting the pipeline, Duke Energy largely eliminates that line‑of‑business’ FERC oversight, whereas Southern Company’s capital‑expenditure program still faces risk from future FERC rule changes, as its construction costs are noted to be “subject to changes in FERC rules and regulations” and to exclude any compliance costs tied to the proposed ELG Supplemental Rule (pages 103‑104).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Duke Energy divested KO Transmission's pipeline facilities in February 2023, which removes its direct FERC regulatory exposure from interstate pipeline operations. The date (February 2023) matches the ground truth, and while the buyer (Columbia Gas Transmission) and pipeline length (90 miles) are additional details not in the original answer, they do not contradict it and appear contextually accurate. (2) There are no numeric inaccuracies—no dollar amounts were misstated, and the timeline is correct. The LLM correctly avoids asserting a sale price, as the original answer notes 'approximately book value' but the LLM omits this rather than misrepresenting it, which is acceptable. (3) The multi-hop reasoning is sound: the LLM correctly infers that divesting a FERC-regulated asset reduces regulatory exposure for Duke Energy and contrasts this with Southern Company’s ongoing risk due to FERC rule changes affecting capital expenditures. It cites Southern Company’s exposure to FERC rule changes and specifically references the ELG Supplemental Rule, which adds precision and supports the claim of regulatory uncertainty. (4) The answer is semantically equivalent to the original: it captures the core contrast—Duke reduced FERC risk via divestiture, while Southern remains exposed to FERC-related cost recovery risks. The only minor shortcoming is that the LLM does not explicitly mention Southern Company’s uncertainty in recovering capital costs, though it implies it by noting expenditures are subject to rule changes. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 466,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports roughly $2.7 billion of unfunded commitments to private‑debt and private‑equity limited‑partnership interests that will be called over the next three‑to‑six years and can only be redeemed at the end of long partnership terms (typically 10‑15 years) – an illiquid, long‑term alternative‑investment exposure【page_93】.  By contrast, Caterpillar’s “other post‑retirement benefit” assets include only about $55 million measured at NAV, a much smaller slice of its plan that is regularly valued and far more liquid than UPS’s commitments【page_102】.  Thus UPS’s exposure is orders of magnitude larger and far less liquid, while Caterpillar’s NAV‑measured allocation is modest and comparatively more liquid.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $2.7 billion unfunded commitments for UPS and $55 million NAV-measured assets for Caterpillar, matching the ground truth exactly in amount and entity. These figures are accurately represented with acceptable formatting (e.g., $2.7 billion = $2.7 billion). (2) Quantitatively, all numbers are correct: UPS’s $2.7B and Caterpillar’s $55M are precisely stated. The LLM adds a detail—'called over the next three-to-six years'—not in the original answer, but this does not contradict the ground truth and may reflect additional context from the source (page 93), so it doesn’t reduce accuracy. (3) The reasoning correctly contrasts UPS’s illiquid, long-term alternative investments with Caterpillar’s more liquid, conservative NAV-measured assets. It captures the core multi-hop comparison: scale ($2.7B vs $55M), liquidity (restricted redemptions vs regular valuation), and investment strategy (long-term growth vs stability). The only minor shortcoming is that the LLM does not explicitly name the types of instruments in Caterpillar’s portfolio (e.g., U.S. corporate bonds, short-term instruments) as in the ground truth, slightly reducing qualitative completeness. (4) Contextual relevance is high—the answer directly addresses the comparison in terms of liquidity and investment strategy as asked. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions in descriptive detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 415,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s 2023 filing shows that the board repurchased only Class A (one‑vote) and Class C (no‑vote) shares – $62.2 billion of those shares were bought back in 2023 – while leaving its high‑voting Class B shares (ten votes per share) untouched【page_81】. Netflix, on the other hand, states that each share of its common stock is entitled to one vote per share, with no dual‑class structure【page_61】. The contrast implies that Alphabet is using repurchases to return capital while preserving and concentrating control in the hands of insiders who hold the super‑voting Class B stock, whereas Netflix follows a uniform, one‑share‑one‑vote governance model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The $62.2 billion repurchase amount in 2023 is correctly stated, matching the original answer. The years and dollar figures are accurate. (2) Entity accuracy: Alphabet and Netflix are correctly identified, with accurate descriptions of their share classes (Class A: one vote, Class C: no vote, Class B: ten votes; Netflix: one vote per share). The fiscal year 2023 is correctly referenced. (3) Reasoning: The multi-hop synthesis is sound—correctly contrasting Alphabet’s selective repurchase strategy (buying back non-voting or low-vote shares while preserving high-vote Class B) with Netflix’s uniform voting structure. The implication about governance strategy—preserving insider control vs. egalitarian voting—is logically derived and matches the original answer’s conclusion. (4) Semantic equivalence: Though phrased differently, the LLM answer conveys the same core information: Alphabet’s capital return strategy is designed to maintain concentrated voting power, while Netflix adheres to a one-share-one-vote model. All parts of the question are addressed with precise, factually correct, and contextually appropriate information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 348,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola disclosed that the Global Intangible Low‑Taxed Income (GILTI) provisions of the Tax Reform Act require it to include foreign subsidiary earnings in its U.S. return and, having elected to expense the tax in the period, the GILTI impact was recorded in its full‑year provision and helped push its effective tax rate to about 21.1% for the year (KO 10‑K p. 107). In contrast, Philip Morris International’s 2021 effective tax rate was 21.8%, and the corporate‑income‑tax reduction enacted in the Philippines (along with the effects of its recent business combinations) partially offset GILTI‑related costs, providing a net tax benefit that kept the rate lower (PMI 10‑K p. 94).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that GILTI 'helped push' Coca-Cola's effective tax rate to 21.1%, implying GILTI increased the rate, but it fails to report the specific $431 million net tax expense or the 4.4 percentage point impact on the effective tax rate as stated in the ground truth. The actual effective tax rate impact (4.4%) is missing, and the 21.1% figure is presented without context or source clarity. For Philip Morris International (PMI), the LLM correctly reports the 2021 effective tax rate (21.8%) but incorrectly frames the Philippine tax reduction as part of a broader offset to GILTI costs and 'recent business combinations' without specifying the 0.1 percentage point decrease due to the tax rate change. The ground truth specifies a discrete 0.1 pp benefit from the Philippines tax reduction in a jurisdiction where PMI completed business combinations; the LLM overgeneralizes and misattributes the cause. (2) Quantitative inaccuracies: The $431 million expense and 4.4% impact for Coca-Cola are entirely omitted. The 0.1 pp decrease for PMI is missing. The LLM mentions 21.1% for Coca-Cola but without attribution to GILTI's directional impact (increase) or magnitude. (3) Multi-hop reasoning is partially sound—linking GILTI to Coca-Cola and Philippine tax changes to PMI—but synthesis is flawed. The answer incorrectly suggests PMI used the Philippine tax cut to offset GILTI costs, which is not supported in the ground truth. The business combinations are mentioned but not correctly tied to the tax benefit context. (4) Scores justified: Correctness is 5 due to partial facts but major omissions and misrepresentations. Quantitative accuracy is low (4) due to missing key numbers and impacts. Qualitative accuracy is moderate (6) as entities and general context are correct. Contextual relevance is high (8) because the answer addresses both companies and relevant tax events, albeit inaccurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 536,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "BAC sold roughly $3.1 billion of mortgage loans to the GSEs in 2023, which trims the pool of loans it continues to service (BAC p. 18). Since MET’s $12.392 billion pass‑through mortgage‑backed securities are directly secured by loans serviced by banks such as BAC, the sale modestly reduces MET’s exposure to BAC‑servicing risk, but the securities remain tied to GSE‑backed loan performance and any GSE‑related credit or policy risk (MET p. 98).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MET's $12.392 billion portfolio of pass-through MBS, matching the ground truth numerically and contextually. These quantitative elements are accurate, earning full marks for quantitative accuracy. 2) However, the reasoning and qualitative analysis diverge significantly from the ground truth. The LLM claims that the sale 'modestly reduces MET’s exposure to BAC-servicing risk' because BAC services fewer loans after the sale. This inference is not supported in the original answer, which instead emphasizes that BAC’s role as a servicer means any servicing issues (e.g., cybersecurity incidents) could negatively impact cash flows and credit risk for MET’s MBS portfolio—regardless of the $3.1B sale. The original does not suggest the sale reduces risk; rather, it highlights ongoing risk due to BAC’s servicing role. 3) The multi-hop reasoning is flawed: the LLM incorrectly infers a risk-reducing effect from the loan sale, while the ground truth focuses on systemic risk exposure through servicing relationships, not loan volume changes. This misrepresents the causal mechanism. 4) Contextually, the answer is relevant and addresses the relationship between BAC’s actions and MET’s portfolio, but the core qualitative claim about reduced risk is unsupported. Thus, while numbers are correct and context is appropriate, the reasoning fails to align with the ground truth, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 417,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "Nike’s embedded derivatives are foreign‑currency forward contracts that are bifurcated from purchase orders and valued with pricing models that require assumptions about future exchange‑rate movements and other factors that cannot be observed in an active market, which places them in Level 3 of the fair‑value hierarchy【page_85】. Lowe’s filings also note that Level 3 measurements use unobservable inputs—i.e., assumptions that are not corroborated by market data—but the discussion is limited to the hierarchy definition rather than detailed modeling, indicating a reliance on non‑market‑based inputs but without the same explicit currency‑index complexity that Nike’s embedded derivatives entail【page_55】.  In both cases the valuations depend on management‑generated assumptions, but Nike’s embedded‑derivative valuations are more intricate because they involve bespoke foreign‑currency forward modeling.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies and omissions compared to the ground truth. Crucially, it fails to mention the $5 million valuation of NKE's embedded derivatives as of May 31, 2022—a key quantitative fact in the original answer. This omission significantly impacts quantitative accuracy. Additionally, the LLM incorrectly characterizes NKE’s embedded derivatives as 'foreign-currency forward contracts bifurcated from purchase orders,' while the ground truth emphasizes that the Level 3 classification stems from 'extrapolation beyond observable limits and policyholder behavior assumptions'—a detail more aligned with insurance-related derivatives (e.g., MET), not NKE. There is no mention of MET in the LLM response, despite the original answer using MET_10k_2022 as an example of Level 3 use involving actuarial inputs. Instead, the LLM fabricates a comparison around 'currency-index complexity' not present in the ground truth. (2) Quantitative accuracy is low because the only numeric fact in the ground truth—$5 million in embedded derivatives—is missing entirely. No other figures are present in either answer, but the omission of this key number constitutes a major factual gap. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that both NKE and LOW involve unobservable inputs in fair value measurements and attempts to contrast their complexity. However, it misattributes the source of NKE’s valuation complexity and fails to accurately represent LOW’s position. The original answer clearly states that LOW reported *no material fair value measurements on a nonrecurring basis* and relies primarily on *observable inputs* like quoted prices or discounted cash flows—information entirely missing from the LLM response. Instead of concluding LOW has *lesser reliance* on unobservable inputs (as per ground truth), the LLM vaguely suggests LOW uses unobservable inputs without qualification, leading to an incorrect comparative assessment. (4) Despite these issues, the LLM answer is contextually relevant and captures the general theme: comparing Level 3 classifications and reliance on non-market-based assumptions. It correctly notes that both companies involve management assumptions and that NKE’s valuations are more complex, which aligns semantically with the conclusion in the original answer, albeit for incorrect reasons. Thus, qualitative accuracy and contextual relevance are moderate to high, but correctness is limited by missing and inaccurate facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 665,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "General Dynamics classifies its fixed‑rate notes as Level 2 assets and values them with market‑based models that use observable inputs such as interest‑rate curves, bond yields and comparable quotes (see GD 10‑K p. 83). Its only Level 3 assets are direct private‑equity investments, which are also valued with unobservable inputs. Lockheed Martin, by contrast, places its $4.951 billion of private‑equity fund holdings in Level 3 and values them using valuation models that rely on unobservable inputs that cannot be corroborated with market data (see LMT 10‑K p. 87‑88). This means GD’s Level 3 valuations are limited to private‑equity and its fixed‑rate notes are priced with observable data, whereas LMT’s large private‑equity portfolio is fully dependent on subjective, unobservable assumptions.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains mostly accurate quantitative information and correctly identifies the $4.951 billion private equity holding by Lockheed Martin (LMT), matching the ground truth's $4,951 million. It also correctly references the use of unobservable inputs for LMT’s private equity funds and cites appropriate 10-K pages. However, there is a critical factual error in the qualitative domain: the LLM incorrectly states that General Dynamics (GD) classifies its fixed-rate notes as Level 2 assets, while the ground truth and actual filings indicate these are Level 3 assets valued using models with observable inputs. This misclassification undermines the core comparison the question hinges on—differences in Level 3 valuation approaches. The LLM further claims GD’s only Level 3 assets are private equity investments, which contradicts the premise of the question and the original answer, which explicitly states GD includes fixed-rate notes in Level 3. While the reasoning structure is sound and the contrast in valuation methodologies is partially captured, the misassignment of asset levels breaks the multi-hop logic required to accurately compare GD’s and LMT’s Level 3 practices. The answer is semantically close and contextually relevant but fails on a key entity classification, leading to a significant drop in qualitative accuracy and overall correctness despite strong performance on numbers and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 391,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder litigation began in September 2019 and a motion to dismiss was filed in January 2020; after a district‑court ruling, the case went through an interlocutory appeal, a Ninth Circuit affirmation, a Supreme‑Court vacatur and remand, and finally a Ninth Circuit opinion on February 10 2025 ordered the complaint dismissed with prejudice, effectively ending the exposure after a six‑year, multi‑stage appellate fight. By contrast, Disney’s antitrust suits (the Biddle and Fendelander actions) were filed in November 2022, Disney moved to dismiss on January 31 2023, received a mixed grant/denial in September 2023, consolidated the cases, and filed a second motion to dismiss the consolidated complaint on December 1 2023, which was partially granted on June 25 2024—leaving portions of the claims alive and the litigation still pending.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key dates and events are correct: Slack's motion to dismiss in January 2020, partial denial in April 2020 (implied by 'district-court ruling' and appeal), Ninth Circuit decision on February 10, 2025, and ultimate dismissal with prejudice. Disney's motions to dismiss on January 31, 2023, partial grant/denial by September 30, 2023, second motion on December 1, 2023, and partial outcome on June 25, 2024 are all correctly stated. (2) Quantitative accuracy is perfect: all dates match exactly or are consistent with the timeline in the original answer. The mention of the Supreme Court vacatur and remand aligns with the appellate history, even if the original answer only notes the reversal by the Ninth Circuit post-remand. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the procedural history of both Slack and Disney litigations, compares their timelines, outcomes, and current statuses, and highlights that Slack’s case is resolved while Disney’s remains ongoing. (4) The only minor omission is that the original answer explicitly notes the class certification deadline of March 27, 2026, for Disney’s cases, which the LLM omits. However, stating that the litigation is 'still pending' captures the essential point. Wording differences (e.g., 'six-year, multi-stage appellate fight' vs. original) are acceptable under semantic equivalence. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 415,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel’s 2022 filing notes that income earned in Hong Kong (together with other low‑tax jurisdictions) generated a 5.9‑percentage‑point reduction in its effective tax rate. Apple’s 2022 segment data shows that the Greater China region – which includes Hong Kong – contributed $74.2 billion in net sales, a far larger dollar‑size impact than Intel’s modest tax‑rate benefit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Intel's 2022 filing reported a 5.9-percentage-point reduction in its effective tax rate due to income earned in Hong Kong and other low-tax jurisdictions, which aligns with known disclosures from Intel’s 10-K (though the ground truth does not specify the exact 5.9-point figure, this is a plausible and accurate detail consistent with public filings). Apple’s $74.2 billion in net sales from the Greater China region in 2022 is exactly matched in both answers, and the inclusion of Hong Kong in Apple’s reporting is correctly acknowledged. (2) All numeric values—$74.2 billion and 5.9 percentage points—are factually accurate and correctly attributed to the right companies and years. The comparison in dollar terms is qualitative but reasonable, as the LLM correctly infers that Apple’s revenue impact dwarfs Intel’s tax benefit in magnitude. (3) The multi-hop reasoning is sound: the model synthesizes Intel’s tax strategy involving Hong Kong with Apple’s revenue from a region that includes Hong Kong, directly addressing the comparative aspect of the question. The only minor shortcoming is that the ground truth emphasizes the statutory tax rate range in Hong Kong (12.5%–24.0%), which the LLM omits; however, this is contextual rather than critical to the core comparison. (4) The answer is semantically equivalent and adds slightly more precise data (the 5.9-point benefit), enhancing rather than distorting accuracy. Scores reflect near-perfect factual alignment, with a small deduction in qualitative accuracy for not noting the statutory rate context, though the core reasoning and synthesis remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 456,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "The 70 % CO₂‑reduction goal in North Carolina’s HB 951 is a central driver of Duke Energy’s 2023 Carolinas Resource Plan – the plan adopts “Portfolio 3,” an all‑of‑the‑above pathway that accelerates coal retirements, extends nuclear life‑time and adds renewables and storage to meet the state‑mandated emissions cuts (DUK 10‑K p.71‑70). In contrast, NextEra Energy’s 10‑K (pages 43‑47) contains no discussion of a comparable state‑level CO₂‑reduction target for its North Carolina assets, indicating that its operational exposure in the state is not directly subject to HB 951’s 70 % requirement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 70% CO₂ reduction target, HB 951 (2021), the 2030 deadline, and Duke Energy's adoption of Portfolio 3 in its 2023 Carolinas Resource Plan are all correctly stated. The mention of coal retirements, nuclear extension, and addition of renewables and storage matches the original answer. (2) The LLM correctly identifies that NextEra Energy is not directly subject to HB 951, citing the absence of discussion around the 70% target in its 10-K (pages 43–47), which supports the conclusion of differentiated regulatory exposure. (3) Multi-hop reasoning is sound: the model connects HB 951 to Duke’s regulatory obligation, links that to its resource plan and portfolio choice, and contrasts it with NextEra’s lack of direct mandate despite operating in the same state. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of Duke Energy Progress and Duke Energy Carolinas as the two entities directly regulated under HB 951, and a small typo in page reference ('p.71-70' likely meant 'p.70-71'). However, the core synthesis and factual content are correct. Wording differences do not affect semantic equivalence. Contextual relevance is perfect—directly addresses both parts of the question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 379,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ applies weighted‑average **actuarial** assumptions – a discount rate (e.g., 5.53% for U.S. plans in 2023) and a health‑care cost‑trend rate (e.g., 7.00% for U.S. plans in 2023) – to project and discount the cash flows of its post‑retirement health‑care plans (MDLZ p. 107). KO, by contrast, uses weighted‑average **market‑based** inputs – risk‑free interest rate, expected life, expected volatility and dividend yield (e.g., 4.18% risk‑free, 20.97% volatility, 2.32% dividend yield for 2023) – in a Black‑Scholes‑Merton model to determine the fair value of stock options (KO p. 108). Thus MDLZ’s assumptions are for measuring benefit obligations, while KO’s are for option‑pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with strong multi-hop reasoning. (1) It correctly distinguishes MDLZ's use of weighted-average actuarial assumptions (discount rate and healthcare cost-trend rate) for postretirement healthcare cost measurement from KO's use of weighted-average market-based inputs in the Black-Scholes-Merton model for stock option valuation. The specific examples (e.g., 5.53%, 7.00% for MDLZ; 4.18%, 20.97%, 2.32% for KO) are consistent with typical disclosures in 10-Ks and align semantically with the ground truth, even though exact dollar amounts ($14M, $12M, -$5M) are omitted. (2) Quantitative accuracy is high: while the LLM does not repeat the dollar-cost time series from the original answer, it provides precise percentage inputs that reflect correct application of the models. The absence of the dollar figures is a minor omission but does not undermine the correctness of the conceptual contrast. (3) Reasoning is sound and synthesizes across two companies and distinct financial models—actuarial valuation vs. option pricing—demonstrating proper multi-hop logic. (4) Contextual relevance is excellent: the answer directly addresses the difference in application context (benefit obligations vs. equity compensation), which is the key point in the ground truth. The use of 'actuarial' vs 'market-based' enhances clarity beyond the original. Only a 9 is given because the LLM omits the specific net periodic cost figures over time ($14M, $12M, benefit of $5M), which were part of the original answer’s quantitative evidence, though the conceptual explanation remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 452,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan mitigates its derivative exposure through ISDA master agreements that give it enforceable set‑off and close‑out netting rights and require collateral posting; under the Orderly Liquidation Authority in Title II of Dodd‑Frank this allows the firm to offset receivables against payables and avoid an automatic stay, preserving liquidity if a counter‑party defaults【page_261】. In contrast, Bank of America’s resolution‑planning obligations under the Orderly Liquidation Authority focus on keeping each subsidiary sufficiently capitalized and liquid and impose inter‑company restrictions that can prevent the parent from drawing on subsidiary funds in a crisis, potentially tightening liquidity during financial distress【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan Chase's use of ISDA Master Agreements with enforceable set-off and close-out netting under Title II of Dodd-Frank is accurately described, including the role of collateral and avoidance of automatic stay during counterparty default. Similarly, Bank of America’s resolution planning obligations under the Orderly Liquidation Authority (OLA) are correctly characterized, particularly the 'single point of entry' strategy implications—though not explicitly named—as reflected in restrictions on intercompany liquidity flows to preserve subsidiary solvency. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory constraints on liquidity risk management for two different banks under overlapping but distinct aspects of the Dodd-Frank Act—derivatives netting for JPMorgan and resolution planning for Bank of America. (4) The LLM conveys the same core information as the original answer with only minor differences in framing: it omits the explicit term 'single point of entry' but accurately describes its operational effect (restricting parent access to subsidiary liquidity). Wording differs slightly but maintains semantic equivalence. No irrelevant or misleading content is present, and the citations (e.g., page references) suggest grounding in source material. The only reason for not scoring a 10 is the slight omission of the formal 'single point of entry' terminology, which is implied but not stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 487,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s utility still carries a coal inventory (≈ $23 million in 2024 for Duke Energy Ohio 【page_124】), showing the state’s ongoing reliance on coal. ExxonMobil’s 2022‑23 EU “coal‑tax” charge of about $1.8 billion (Q4 2022) and $0.2 billion (2023) 【page_115】 highlights the financial penalty it faces for coal‑related earnings, pushing it to accelerate a shift away from coal, whereas Chevron is counter‑balancing Ohio’s coal use by expanding renewable natural‑gas projects – Brightmark RNG facilities now operating in Ohio in 2024 【page_19】 – as a core element of its low‑carbon transition.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in presentation. (1) Quantitatively, the key figures are correct: the $1.8 billion after-tax charge for XOM in 2022 is accurately reported, and Duke Energy Ohio's $23 million coal inventory as of December 31, 2024, is correctly cited (approximated as ≈$23 million). The mention of an additional $0.2 billion charge in 2023 for XOM is not present in the original answer; however, since the original does not contradict this and may reflect additional data, it does not constitute a clear error. (2) The entity identification is accurate: XOM (ExxonMobil), CVX (Chevron), Duke Energy Ohio, and Brightmark RNG Holdings LLC (referred to correctly via project name) are all properly identified with correct activities and timelines. (3) The multi-hop reasoning is sound: the LLM correctly links Ohio’s continued coal use (via Duke Energy) to contrasting corporate strategies—XOM being pushed by EU regulatory penalties, while CVX invests in renewable natural gas (RNG) in the same state. (4) The semantic meaning fully aligns with the original: it captures the regulatory pressure on XOM versus CVX’s proactive low-carbon investments. The only minor shortcoming is slightly less precise phrasing around the EU tax being specifically on 'coal and other energy sectors' and targeting 'surplus profits,' which adds nuance missing in the LLM version. However, the core logic and facts are preserved. Thus, the answer earns a 9 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 431,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "Morgan Stanley’s CLNs are hybrid notes in which the issuer (the SPE) sells credit protection to the note holder.  If a credit event occurs the SPE does not repay the full principal; instead it delivers the collateral securities it holds, so the payout is the market value of that collateral (the note may be partially or fully written‑down)【page_109】【page_129】.  \n\nJPMorgan’s credit‑related notes are funded derivatives: the investor pays the note’s par up‑front, receives periodic coupon‑type payments, and the issuer promises to return par at maturity unless a credit event occurs.  When a credit event happens the issuer pays the investor the shortfall between the note’s par value and the fair‑value (recovery) of the defaulted reference obligation – a cash settlement of the loss rather than a collateral delivery【page_224】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) It correctly identifies that Morgan Stanley's CLNs involve the issuer (SPE) selling credit protection to the note holder—meaning MS, as the structuring party, is effectively the buyer of protection. Upon a credit event, the payout is based on the market value of delivered collateral, leading to potential principal write-down, which matches the original answer’s description of non-full repayment. For JPMorgan, the LLM correctly states that the issuer pays the difference between par and the fair value of the defaulted obligation—i.e., a cash settlement of the loss—consistent with JPM selling credit protection. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly contrasts the two structures by identifying the opposing roles (MS as buyer, JPM as seller of protection) and links these roles to different payout mechanics (collateral delivery vs. cash settlement). (4) The only minor gap is that the LLM does not explicitly state 'MS acts as the buyer of protection while JPM acts as the seller' in summary terms, though this is implied through accurate descriptions of mechanics and protection flows. This slight omission in synthesis clarity prevents a perfect 10, but the answer remains semantically equivalent in substance. Contextual relevance is excellent, directly addressing the comparison of payout mechanics upon credit events.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 441,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both filings state that the subsidiary meets the conditions of General Instruction I.(1)(a) and (b) and therefore uses the reduced‑disclosure format, but they do so in different combined‑filing contexts. Georgia Power Company is listed among several Southern‑Company subsidiaries that “meet the conditions set forth in General Instructions I(1)(a) and (b) of Form 10‑K and is therefore filing this Form 10‑K with the reduced disclosure format specified in General Instructions I(2)(b), (c) and (d).” By contrast, Florida Power & Light Company is noted in the NextEra Energy combined filing that “Florida Power & Light Company meets the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K and is therefore filing this Form with the reduced disclosure format,” without the explicit reference to I(2)(b)‑(d). Thus, while both subsidiaries rely on the same General Instruction criteria, Georgia Power’s reduced‑disclosure statement is part of a multi‑subsidiary Southern‑Company filing that cites the specific sub‑instructions, whereas Florida Power & Light’s statement appears in a combined NextEra filing and references only the general reduced‑disclosure provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both Georgia Power Company and Florida Power & Light Company assert compliance with General Instruction I.(1)(a) and (b) of Form 10-K, thereby qualifying for the reduced disclosure format. The quantitative and entity details (company names, parent companies, filing structure) are correct. The LLM accurately notes that Georgia Power’s filing explicitly references the specific sub-instructions I(2)(b), (c), and (d), while Florida Power & Light’s filing mentions the reduced disclosure format without citing those sub-instructions—this nuance is correctly captured and reflects actual differences in disclosure language. The answer also correctly highlights the different combined-filing contexts: Georgia Power as one of several subsidiaries in a Southern Company consolidated filing, and Florida Power & Light in a two-registrant filing with NextEra Energy, Inc. The only minor omission is that the ground truth specifies NextEra Energy holds all 1,000 shares of FP&L’s common stock—a detail not included in the LLM response—but this does not affect the core correctness regarding disclosure format application. The reasoning is sound, multi-hop synthesis across entities and filings is accurate, and the response is contextually fully relevant. Wording differs but semantic meaning matches. No calculation or date errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1560,
        "completion_tokens": 394,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX treats its U.S. government fixed‑price work as a percentage‑of‑completion contract: under FAR‑mandated performance‑based payments (PBPs) and progress payments, revenue is recorded as costs are incurred – often before the customer’s final bill – creating contract‑asset balances (see RTX 10‑K p. 79‑78). GD, while also subject to the FAR, follows the Cost Accounting Standards to allocate only allowable costs to each contract and recognizes revenue when billings are made; any contract modifications are folded into the existing contract on a cumulative catch‑up or prospective basis rather than accelerating revenue (see GD 10‑K p. 19, 64, 68).  Consequently, RTX’s timing is driven by progress‑based revenue recognition, whereas GD’s timing is driven by cost allocation and billing events, with modifications adjusting the cost‑allocation rather than the revenue‑recognition schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, there are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the original answer, so no numerical inaccuracies exist—this earns a perfect score. (2) The LLM correctly identifies that RTX recognizes revenue under the percentage-of-completion method on fixed-price contracts due to performance-based or progress payments under FAR, leading to revenue in excess of billings (i.e., contract assets), which matches the original answer’s claim about RTX creating contract assets. The citation to RTX’s 10-K (pp. 78–79) supports this. (3) For GD, the LLM accurately states that GD follows Cost Accounting Standards (CAS) under FAR, allocates allowable costs, and recognizes revenue upon billing, with contract modifications handled via cumulative catch-up or prospective adjustments—this reflects GD’s emphasis on compliance, auditability, and cost allocation as in the original answer. The citations to GD’s 10-K (pp. 19, 64, 68) add credibility. (4) The key distinction drawn—RTX’s progress-based revenue recognition vs. GD’s cost-allocation and billing-driven timing—is a valid synthesis across both companies and regulatory responses, capturing the core comparative insight. The only minor shortcoming is that the LLM does not explicitly mention that both companies are subject to FAR-mandated acquisition phases (planning, competition, etc.) or that both must adjust for contract modifications in light of those phases, though it does address modifications in practice. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is strong, and reasoning is sound across the multi-hop comparison of revenue timing, regulatory influence, payment mechanisms, and modification handling.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 502,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s dual‑class structure gives Class B shares ten votes per share versus one vote for each Class A share, concentrating voting power in the hands of the small group that holds Class B stock (see GOOGL 10‑K p. 82).  By contrast, Comcast’s investment in Atairos carries no voting rights – its economic interest is purely financial and it cannot direct Atairos’s activities (see CMCSA 10‑K p. 84‑85).  As a result, Alphabet’s governance can be controlled by a minority of high‑voting shareholders, while Comcast has no governance control over Atairos and is limited to the economic upside and downside of its investment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's Class A shares have 1 vote per share and Class B have 10 votes per share, creating a dual-class structure that concentrates voting power—this matches the original answer. CMCSA has no voting rights in Atairos, which is correctly described as an equity method investment with no governance control. (2) There are no numerical values requiring calculation (e.g., sums, percentages), but the voting ratios (1:10) are accurately reported. Format and citation to 10-K pages (e.g., p. 82, p. 84–85) add precision and align with expected sourcing, though not required for correctness. (3) Multi-hop reasoning is sound: the model correctly contrasts GOOGL’s internal governance structure (dual-class shares) with CMCSA’s external investment relationship (no voting rights in another company), synthesizing information across two companies and their respective filings. (4) The implications for corporate governance are accurately drawn: GOOGL allows minority control via super-voting shares, while CMCSA lacks control over Atairos despite its investment. Wording differs slightly but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 354,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing spells out a concrete concentration risk – McKesson alone accounted for 33 percent of Amgen’s gross product sales in 2021 (see the sales table on page 113) and the company notes that “the substantial majority of our U.S. product sales is made to three pharmaceutical product wholesaler distributors” (page 46). Merck’s 10‑K, by contrast, only flags a generic risk that “reliance on third‑party relationships and outsourcing arrangements could materially adversely affect the Company’s business” (page 31) without quantifying any single distributor’s share of sales. Thus Amgen’s exposure is both quantified and materially larger, whereas Merck’s disclosure is broader and less specific about distribution‑concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that McKesson accounted for 33% of Amgen’s gross product sales in 2021, matching the original answer. It also accurately references Amgen’s disclosure about the 'substantial majority' of U.S. sales going to three wholesalers. (2) The comparison to Merck is factually sound: Merck’s 2022 filing does issue a general warning about third-party relationships without quantifying distributor concentration, which the LLM correctly contrasts with Amgen’s specific, quantified risk. (3) The multi-hop reasoning is strong—linking Amgen’s specific 33% exposure to McKesson, its broader reliance on three distributors, and contrasting this with Merck’s more generic risk disclosure demonstrates proper synthesis across both filings. (4) The only minor shortcoming is that the LLM omits Merck’s additional point about 'unexpected safety or efficacy concerns' mentioned in the ground truth, which slightly weakens the completeness of the industry-wide risk context. However, this does not detract from the core comparison about distribution concentration. Wording differences are acceptable and do not affect semantic equivalence. The answer is contextually precise, directly addressing the comparative risk disclosure question with accurate sourcing and logical contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 380,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips owns a 52.2 % interest in Alba Plant LLC, the joint‑venture that processes natural‑gas from the Alba Unit (extracting condensate and LPG, including output from Chevron) on Bioko Island.  The company’s guarantees for Alba Plant LLC expose it to a maximum potential payment of about **$116 million** over the next three years【page_12】【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ConocoPhillips' 52.2% ownership in Alba Plant LLC and the $116 million maximum potential future payments are accurately reported, matching the original answer and SEC filing data. The format variation ($116 million) is acceptable. (2) The answer correctly identifies the key entities: ConocoPhillips, Alba Plant LLC, the Alba Unit, and Chevron’s role in upstream condensate production (implied via 'including output from Chevron'). (3) The multi-hop reasoning is sound—linking ConocoPhillips’ ownership, the plant’s function in processing gas and extracting condensate/LPG, and the financial exposure via guarantees. The only minor omission is not explicitly mentioning EG LNG’s 56.0% ownership or the downstream monetization through EG LNG’s liquefaction facility, which is part of the full exposure picture but not central to the specific question about Alba Plant LLC. (4) The contextual relevance is excellent—the answer directly addresses ConocoPhillips’ financial exposure from its ownership in Alba Plant LLC and ties in Chevron’s production as a feedstock source. Overall, the answer is factually correct, well-synthesized, and only slightly less comprehensive than the original answer, warranting a high score but not perfect due to the omitted EG LNG context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 383,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics’ Level 2 assets are measured using a market‑approach valuation model that relies on observable inputs such as interest‑rate curves, bond yields and quoted prices for comparable securities (GD 10‑K p. 84). In contrast, Union Pacific reports its real‑estate fund holdings at net‑asset‑value, which is derived from property appraisals and other unobservable inputs and therefore reflects the longer‑term (8‑10‑year) valuation methodology typical for private real‑estate funds (UNP 10‑K p. 57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: General Dynamics uses observable inputs (interest-rate curves, bond yields, comparable securities) for Level 2 assets, consistent with the ground truth. Union Pacific values its real estate funds at NAV using unobservable inputs tied to long-term (8-10 year) appraisals, which aligns with the original answer. (2) Quantitative accuracy is perfect: while no specific dollar amount is mentioned in the LLM answer (e.g., Union Pacific’s $30 million allocation), this omission does not detract from the core comparison being made about valuation methodologies. The absence of the $30M figure is a minor completeness gap but does not affect the correctness of the conceptual contrast. (3) Multi-hop reasoning is sound: the model correctly synthesizes valuation approaches across two companies (General Dynamics and Union Pacific) and links them to appropriate input types (observable vs. unobservable), while correctly contextualizing real estate funds’ long-term valuation cycles. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM cites page numbers and uses precise terminology (e.g., 'net-asset-value', 'unobservable inputs'), enhancing credibility. Only a 9 on correctness due to the missing $30M detail from the original; otherwise, the answer is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 391,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role with Costco is that of a **co‑branded credit‑card partner**, issuing and servicing a consumer card that carries both the Costco and Citibank brands (see the “Citibank, N.A. Co‑Branded Credit Card Agreement” exhibit). In contrast, with Colgate‑Palmolive Citibank is **not a card issuer** but the **administrative agent and arranger** for a corporate five‑year loan facility, handling the loan’s documentation and administration (see the “Five‑Year Credit Agreement” where Citibank is named as Administrative Agent). Thus, the Costco arrangement is a consumer‑marketing partnership, while the Colgate arrangement is a lender‑side loan‑administration function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential distinction between Citibank's roles in the Costco and Colgate arrangements. (1) It correctly identifies the co-branded credit card partnership with Costco and the administrative agent/arranger role with Colgate, aligning with the ground truth. (2) There are no numeric values, dates, or financial figures in the LLM answer, but the absence of such details does not detract from correctness—while the original answer includes dates (October 11, 2023, and November 4, 2022) and the number of amendments (twelve), the LLM answer focuses on the structural and functional differences, which is sufficient for the question asked. The lack of these specific dates and counts is a minor omission but does not affect the core factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that the Costco relationship involves consumer credit and branding, while the Colgate role is about corporate loan administration, drawing from two distinct financial arrangements. (4) The semantic meaning fully matches the ground truth—'consumer-marketing partnership' vs. 'lender-side loan-administration function' is equivalent in meaning to the original's 'retail financial service partnership' vs. 'syndicated corporate credit facility.' Wording differs slightly but meaning is preserved. The LLM cites relevant exhibit names, adding contextual support. Minor deduction from 10 to 9 due to omission of amendment history and dates, which are part of the original answer but not critical to the core comparison. Overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 453,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "Chevron’s 2023 Form 10‑K shows that the QatarEnergy LNG N(3) venture produces an average of **13 thousand barrels of crude oil per day** and that Chevron holds a **30 % working interest** in the project. Multiplying the two gives Chevron’s net daily crude‑oil contribution of **≈3.9 MBD (about 3,900 barrels per day)**.【page_12】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: Chevron holds a 30% working interest in QatarEnergy LNG, which has an average daily net crude oil production of 13 thousand barrels per day (MBD). (2) The calculation is correct: 30% of 13 MBD = 3.9 MBD (or ~3,900 barrels per day), and the answer presents this accurately with appropriate rounding notation (≈3.9 MBD). (3) The multi-hop reasoning is sound—synthesizing ownership percentage and production volume from the same venture to compute net contribution. (4) The entities (Chevron, QatarEnergy LNG), metric (net daily crude oil production), and year (2023) are correctly identified and contextually relevant. Minor wording differences (e.g., 'working interest' vs 'ownership percentage') do not affect factual equivalence, as they are used interchangeably in this context. All aspects of the question are addressed completely and precisely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 272,
        "total_tokens": 1420
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar values its Level 3 non‑U.S. pension assets – which consist of insurance contracts – with internal pricing models that “reflect the assumptions a market participant would use,” i.e., projected cash‑flow and discount‑rate assumptions (Cat 10‑K p. 102). Lockheed Martin, by contrast, values Level 3 fixed‑income investments by first seeking indicative quotes or bid evaluations from vendors or brokers and, when such quotes are unavailable, by applying a discounted‑cash‑flow approach that also uses projected annuity payments and a discount rate (Lockheed Martin 10‑K p. 89). Thus, both rely on unobservable inputs, but Caterpillar’s approach is model‑driven based on management’s market‑participant assumptions, whereas Lockheed Martin’s approach emphasizes external quotes and a DCF method when quotes are lacking.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Caterpillar uses internal pricing models for Level 3 non-U.S. pension assets (insurance contracts) based on management's judgment of market participant assumptions, including projected cash flows and discount rates. Lockheed Martin uses indicative quotes from vendors/brokers first and, when unavailable, applies a discounted cash flow (DCF) approach using projected annuity payments and discount rates for Level 3 fixed income investments. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not applicable in that sense, but all descriptive financial inputs (e.g., 'discount rates', 'projected annuity payments') are correctly reported—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Caterpillar and Lockheed Martin), two asset types (non-U.S. pension assets vs. fixed income investments), and compares their Level 3 valuation methodologies, inputs, and sources. The distinction between Caterpillar’s model-driven, management-based approach and Lockheed Martin’s reliance on external quotes and fallback to DCF is clearly and correctly articulated. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both companies use unobservable inputs—a key point in the original answer—though it is implied by the context of Level 3 assets. This slight omission prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is contextually complete, semantically equivalent, and precisely responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 468,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "Enbrel’s U.S. formulation patents run out on 10 Oct 2037 (see the Pfizer patent table – “Formulations and methods of preparing formulations – 10/19/2037”) and the drug is listed as a core immunology product in Pfizer’s Specialty‑Care portfolio (which includes Xeljanz, Enbrel, Inflectra, etc.). When those patents expire, generic competition could erode Enbrel’s sales and leave the Specialty‑Care segment more dependent on a shrinking set of products, heightening its revenue‑concentration risk. By contrast, Bristol‑Myers Squibb is explicitly building a broad, externally‑sourced pipeline of future assets – as shown by its extensive Phase I‑III investigational compounds table – a strategy that spreads risk across many upcoming products and reduces reliance on any single existing brand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the patent expiration date of October 19, 2037 (cited as 10/19/2037) is correct and matches the knowledge graph data; the mention of Enbrel as a core immunology product in Pfizer’s Specialty Care segment is factually sound. (2) The answer correctly identifies the risk of increased revenue concentration due to potential generic erosion post-2037, which is the central concern in the original answer. (3) The multi-hop reasoning is strong: it connects Enbrel’s patent cliff to Pfizer’s segment-level revenue risk and contrasts this with Bristol Myers Squibb’s external innovation strategy, referencing its broad pipeline of investigational assets as a risk-mitigation approach. (4) The only minor shortcoming is that the LLM does not explicitly state that BMY could enter the post-patent market with new therapies before or around 2037, which is a nuanced but important point in the original answer about shifting competitive dynamics. However, the implication is reasonably covered by noting BMY’s diversified external pipeline. Wording differs but semantic meaning and factual content are substantially equivalent. No calculation errors; all entities (Pfizer, BMS, Enbrel, Specialty Care segment) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 371,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework is built around scenario‑based stress testing and sensitivity analysis: it runs firm‑wide stress tests that model moderate‑to‑severe market moves, uses scenario analysis (e.g., sovereign‑stress events) and quantifies single‑factor shocks such as a 100‑bp parallel yield‑curve shift, a 20 % equity‑price decline or a 10 % FX depreciation (see AIG 10‑K pages 84, 111‑113). In contrast, Capital One’s credit‑loss methodology for its credit‑card portfolio relies on quantitative loss‑forecasting models calibrated to statistical analyses and forward‑looking economic forecasts, supplemented by qualitative management judgments, rather than on formal scenario or sensitivity testing (see COF 10‑K page 135).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual and reasoning errors that undermine its overall accuracy. (1) Quantitatively, the LLM provides specific hypothetical shocks (e.g., 100-bp yield curve shift, 20% equity decline) which are plausible examples but not confirmed in the ground truth; however, the key numeric fact in the original answer — COF's allowance for credit losses (ACL) of $13.0 billion as of December 31, 2024 — is completely omitted. This is a major quantitative omission. (2) On qualitative accuracy, the LLM incorrectly states that Capital One (COF) does *not* use formal scenario or sensitivity testing, directly contradicting the ground truth, which states that COF *does* use scenario-based forecasting models for ACL, incorporating forward-looking economic scenarios and qualitative adjustments. The LLM’s claim that COF relies 'rather than on formal scenario or sensitivity testing' is factually incorrect. (3) The multi-hop reasoning fails because the comparison misrepresents one of the two entities: while AIG's use of scenario and sensitivity analysis for market risk is accurately described, COF's credit loss forecasting is misrepresented as excluding these techniques, when in fact both firms use scenario and sensitivity analysis — just in different risk domains (market vs. credit). (4) Contextual relevance is high because the answer addresses the core question about modeling practices and attempts to contrast the two firms with specific examples and document citations. However, the critical error in portraying COF’s methodology invalidates the comparison. Thus, while the structure and intent are sound, the factual foundation for COF is flawed, leading to a low correctness score despite some accurate details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 480,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm’s filing notes that it is broadly exposed to U.S. export‑control rules – including the Export Administration Regulations – because its advanced‑computing and semiconductor products could be caught by “regulations targeted to advanced computing, semiconductor manufacturing, and emerging technologies such as AI” and its heavy China exposure heightens that risk (QCOM 10‑K p. 36). In contrast, AMD spells out concrete limits on high‑performance FPGA sales: it must file a Notified Advanced Computing (NAC) notice and obtain a license before shipping its Versal VC2602 and VE2602 FPGAs to China (or to customers whose ultimate parent is in a D5 country), and it is barred from shipping other listed Instinct GPUs and Versal VC2802/VE2802 devices without a license (AMD 10‑K p. 33). Thus Qualcomm faces a more general, uncertain EAR exposure, while AMD confronts specific, product‑level export restrictions for its flagship FPGAs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Qualcomm's broad exposure to EAR regulations due to its advanced computing and semiconductor products, referencing the correct risk factors (e.g., AI, advanced computing) and heightened risk from China exposure, consistent with the original answer. It also accurately describes AMD's specific export constraints, including the requirement to file a Notified Advanced Computing (NAC) notification before shipping Versal VC2602 and VE2602 FPGAs to China or to customers with ultimate parents in D5 countries. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses rely on qualitative regulatory disclosures, and all references to product names (VC2602, VE2602) and regulatory mechanisms (NAC) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Qualcomm and AMD), compares their differing levels of EAR exposure (broad vs. specific), and ties the constraints to actual products and geographies. The LLM adds slightly more detail than the original (mentioning Instinct GPUs and VC2802/VE2802), which is consistent with AMD’s 10-K disclosures and does not introduce inaccuracies. (4) The only minor deviation from the original answer is that the LLM implies a license is required for VC2602/VE2602, while the original specifies a 'notification' (NAC) 25 days prior, not necessarily a license. However, in EAR context, NAC is a pre-shipment notification requirement under license exception, so the difference is nuanced and does not materially misrepresent the regulation. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 492,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "Comcast gave up its board seats and “substantially all voting rights” in Hulu, handing operational control to Disney while still holding an economic interest and put/call options on the investment【page_85】. By contrast, Meta’s 10‑K shows it issues multiple share classes – Class A and Class C shares with one vote or no vote and Class B shares that carry ten votes per share – a dual‑class structure that concentrates voting power in insiders and lets the company retain control over corporate decisions despite public ownership【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast between CMCSA's relinquishment of voting rights in Hulu and META's dual-class stock structure. (1) All key facts are correct: CMCSA gave up board seats and substantially all voting rights in Hulu (in 2019, though the year is omitted in the LLM answer, it's not critical here), retained economic interest with put/call options, and Disney made an $8.6 billion payment in 2023 (implied by the arrangement, though not explicitly mentioned in the LLM answer). The LLM correctly identifies the financial guarantee mechanism without specifying the $27.5 billion minimum equity value — a minor omission but not a factual error. (2) Quantitative accuracy is strong: no incorrect numbers are presented, and the absence of dollar figures does not contradict the ground truth; the LLM avoids making up data. (3) Entity accuracy is correct: CMCSA (Comcast), Hulu, Disney, and META are properly identified, and the dual-class structure (Class B with 10 votes, Class A with 1 vote) is accurately described. (4) Reasoning is sound: the LLM correctly contrasts external control transfer (CMCSA to Disney) with internal control retention (META’s stock structure), capturing the strategic distinction. (5) Semantic equivalence is achieved: while the LLM omits the specific $27.5B valuation floor and the 2023 $8.6B payment, it captures the essence of the put/call arrangement and financial motivation. These omissions prevent a perfect 10, but the core multi-hop reasoning — comparing control strategies across companies — is well-executed. Contextual relevance is excellent, directly addressing the question’s focus on control retention strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 460,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ $113.9 billion of broker‑dealer assets (recorded as $113,996 million of “major broker‑dealer subsidiaries” in its GCLA table) are embedded in a liquidity‑risk framework that explicitly obliges those subsidiaries to comply with the SEC’s Regulation Best Interest and to disclose any conflicts of interest to retail customers 【page 106】 【page 108】. Morgan Stanley’s 10‑K instead outlines a broader compliance program that subjects its broker‑dealer and investment‑adviser units to the same Regulation Best Interest duties and internal controls, but it does not tie the obligation to a specific asset size, focusing instead on overall regulatory oversight and best‑interest standards 【page 9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and contextually relevant. (1) Quantitatively, the $113.9 billion in broker-dealer assets is correctly reported, with a precise reference to Goldman Sachs' 'major broker-dealer subsidiaries' listed as $113,996 million ($113.996 billion), which rounds to the stated $113.9 billion—this is factually correct with acceptable formatting variation. No other numerical data (e.g., dates, percentages) are present, and none are incorrect. (2) The answer addresses both parts of the multi-hop question: Goldman Sachs’ approach under Regulation Best Interest in light of its asset size and Morgan Stanley’s compliance framework. It correctly identifies that Goldman ties its compliance obligations to specific subsidiaries and asset disclosures, while Morgan Stanley adopts a broader, firm-wide compliance program not explicitly linked to asset size. (3) Entity accuracy is strong: both firms are correctly named, Regulation Best Interest is accurately referenced, and the regulatory context (SEC) is implied. The citation of specific 10-K pages adds verifiability. (4) Reasoning is sound: the LLM correctly infers that Goldman’s framework is embedded within liquidity risk and disclosure obligations tied to asset size, whereas Morgan Stanley emphasizes overarching internal controls. The original answer notes that Goldman’s larger asset base may require more extensive monitoring—this nuance is partially reflected in the LLM’s focus on structural embedding of compliance, though it does not explicitly compare scale-driven complexity. This minor omission prevents a perfect 10 on qualitative accuracy, but overall, the answer conveys semantically equivalent, factually correct, and well-synthesized information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 471,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on expanding capacity and selling that capacity to third‑party customers through Intel Foundry Services, but Samsung’s push to design and fabricate its own chips means Samsung is less likely to become a foundry client and will compete directly with Intel’s IFS offering (Intel 10‑K p.54‑55). That same vertical‑integration pressure also hurts Qualcomm, whose semiconductor revenue depends on external IC customers—if Samsung and other OEMs build in‑house silicon, Qualcomm’s sales and margins could be eroded (Qualcomm 10‑K p.19‑20, 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required by the question. (1) It correctly identifies Intel's IDM 2.0 strategy as involving capacity expansion to attract foundry customers via Intel Foundry Services, aligning with the ground truth. It accurately notes Samsung's vertical integration—designing and fabricating its own chips—reducing its likelihood of using Intel’s foundry services, which directly impacts Intel’s business model. It also correctly links this to Qualcomm, explaining that if OEMs like Samsung build in-house silicon, Qualcomm’s revenue from external IC sales could be threatened. (2) There are no numeric values, dates, or financial figures in either the ground truth or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The reasoning is sound: the LLM synthesizes implications across three companies (Intel, Samsung, Qualcomm), correctly modeling the competitive dynamics. The only minor shortcoming is that it does not mention the potential broader pricing pressure in the semiconductor market if Intel lowers prices to attract other foundry clients—a nuance in the ground truth that could affect Qualcomm’s cost structure indirectly. This omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing how Samsung’s in-house development affects Intel’s IDM 2.0 and the knock-on effect on Qualcomm. Citations to 10-K pages add credibility, though not required for scoring. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 451,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon turned its tower portfolio into a cash‑generating asset by granting American Tower exclusive lease and operating rights to roughly 11,300 towers for an upfront $5 billion payment, which immediately boosts cash and shifts most of the capital burden of tower ownership to the partner while Verizon retains sub‑lease capacity and limited long‑term control (VZ 10‑K p. 73). Netflix, by contrast, funds the acquisition of exclusive streaming rights and the production of original titles with large upfront licensing and production outlays that strain cash flow, but those investments give it enduring strategic control over a differentiated content library that drives member acquisition and retention (NFLX 10‑K p. 10).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.0 billion upfront payment from American Tower Corporation to VZ in 2015 for exclusive rights to 11,300 towers, which matches the ground truth. It also accurately contrasts this with NFLX's strategy of acquiring exclusive content through large outlays. However, the LLM incorrectly characterizes VZ's arrangement as involving a 'lease and operating rights' transfer that shifts 'most of the capital burden' and results in 'limited long-term control'—this misrepresents the ground truth, which emphasizes that VZ *retained operational control* and continues to depreciate the towers, indicating ongoing asset ownership and control, not diminished control. The LLM's claim of 'limited long-term control' contradicts the original answer’s emphasis on VZ maintaining network usage flexibility and control. (2) Quantitatively, all numbers are correct: $5 billion, 11,300 towers, and proper company names (VZ, NFLX) and context (American Tower Corporation, exclusive content). The citation of VZ 10-K p.73 and NFLX 10-K p.10 adds sourcing, though not required, and does not affect accuracy. (3) The multi-hop reasoning is partially sound—comparing capital impact (upfront cash inflow vs. outflow) is accurate and relevant. However, the strategic control comparison is flawed: VZ’s arrangement preserves strategic control, while the LLM implies it is reduced, which undermines the qualitative accuracy. The contrast with NFLX is stronger: correctly identifying content investments as a cost center that builds long-term control over differentiated content. (4) The answer is contextually relevant and well-structured, addressing both upfront capital impact and long-term strategic control as required. The correctness score is 7 because core financial facts are accurate and the capital impact comparison is strong, but the mischaracterization of VZ's retained control introduces a significant qualitative error that affects strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 538,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The Tax Reform Act’s GILTI rules added $375 million of tax expense, lifting Coca‑Cola’s 2022 effective tax rate by roughly 3 percentage points (KO 10‑K, p. 107). In contrast, the corporate‑income‑tax cut in the Philippines reduced the tax burden on PepsiCo’s Philippine business, partially offsetting other tax pressures and helping sustain low‑single‑digit growth in that market (PEP 10‑K, p. 49; PMI 10‑K, p. 94).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. According to the ground truth, KO's GILTI-related impact was a 1.2% increase in the effective tax rate due to $710 million in pretax charges from equity method investee impairments. However, the LLM claims a $375 million tax expense lifting the rate by ~3 percentage points, which contradicts the ground truth both in magnitude and direction of impact. This represents a major quantitative error. (2) The qualitative description of PEP's situation is partially correct: the corporate tax rate reduction in the Philippines did favorably impact PEP's effective tax rate and supported low-single-digit growth, as stated. However, the LLM incorrectly cites PMI (Philip Morris International) 10-K (p. 94) as a source for PEP's operations, which is a different company and invalidates the sourcing. Only PEP’s 10-K should be cited. (3) The multi-hop reasoning is partially sound—comparing U.S. GILTI effects on KO with local tax changes benefiting PEP—but fails due to incorrect data for KO and improper sourcing for PEP. (4) Contextual relevance is high because the structure and intent align with the question, addressing both companies and contrasting tax effects. However, the correctness score is low due to critical numerical inaccuracies and citation errors that undermine the factual foundation of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 392,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "By regulation Nicor Gas – a 100 %‑owned subsidiary of Southern Company Gas – may distribute dividends only out of its unrestricted retained earnings. At 31 Dec 2021, $1.3 billion of Nicor Gas’s retained earnings were “restricted,” meaning that amount cannot be paid as a dividend or loan to affiliates. Therefore Southern Company’s ability to receive dividends from its subsidiaries is limited to the earnings that remain unrestricted, and the $1.3 billion of restricted retained earnings reduces the dividend pool that can flow up to the parent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: $1.3 billion in restricted retained earnings at Nicor Gas as of December 31, 2021, is factually accurate and matches the context implied in the original answer. The format '$1.3 billion' is acceptable and consistent. (2) The entity relationships are correctly identified: Nicor Gas is a subsidiary of Southern Company Gas, which is part of the Southern Company family, and the regulatory restriction on dividend distributions from restricted retained earnings is accurately described. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: it connects Nicor Gas’s regulated status → restriction on dividend payouts → impact on Southern Company’s dividend inflows → reduced financial flexibility. The only minor omission is that the LLM does not explicitly state that Southern Company relies significantly on subsidiary dividends for income, which is mentioned in the original answer and adds contextual weight. However, the core logic and financial mechanism are correctly conveyed. (4) The answer is semantically equivalent to the original, with slightly more focus on mechanics and less on broader implications, but no factual discrepancies. Thus, the correctness score is 9/10 due to this slight incompleteness in contextual depth, though all key facts and logic are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 393,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Both filings say that the Safety Act’s ever‑more‑stringent standards are driving up compliance spending, but only GM provides a dollar figure. GM notes that meeting the expanding safety standards – and any recall campaigns that may follow – can be “substantial” and records $1.0 billion of compliance‑related costs in 2024 (the amount covers broader regulatory compliance). Tesla, by contrast, merely warns that the increasing regulatory complexity could raise its compliance expenses and does not disclose a specific amount for safety‑related costs. Thus, GM’s compliance outlay is quantified and appears larger, while Tesla’s safety‑related compliance cost is not disclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific dollar amount—$1.0 billion in 2024 for GM’s compliance-related costs—which is not present in the original answer (ground truth). The ground truth does not provide any numerical figures for compliance costs for either Tesla or GM. This is a major factual inaccuracy. Additionally, the claim that GM 'records $1.0 billion of compliance-related costs in 2024' is unsupported by the provided ground truth and appears fabricated or hallucinated. Tesla’s lack of disclosed cost is correctly noted, but this contrast is built on false data. (2) Quantitative accuracy is severely compromised because the only number cited ($1.0 billion) is not in the original answer and cannot be verified from the context given. There is no mention of 2024 or any dollar figures in the ground truth. (3) The multi-hop reasoning is partially sound in that the model correctly identifies that both companies face rising compliance costs due to evolving safety standards and regulatory complexity, and that GM emphasizes global divergence in standards. However, the reasoning fails when it asserts a quantified comparison that the original data does not support. The synthesis incorrectly implies GM has higher or more transparent costs due to a number that was not in the source. (4) While the general theme of increasing compliance burden and regulatory complexity is accurately conveyed (supporting contextual relevance), the inclusion of a false quantitative figure undermines the correctness score. The answer shifts from a qualitative comparison to a misleading quantitative one, which distorts the truth. Thus, despite correct entity identification (Tesla, GM, Autopilot, FSD, National Traffic and Motor Vehicle Safety Act, UN-ECE), the hallucinated data severely limits factual reliability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 494,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics reports that $305 million of other contract costs have been deferred on its balance sheet because they cannot yet be allocated under FAR rules, and the company expects to recover those amounts through its existing backlog and future contracts (GD 10‑K p. 59). Raytheon Technologies, by contrast, warns that its fixed‑price U.S. government contracts place the full burden of any cost overruns on the company, exposing it to potentially unlimited additional expenses that could hurt profitability (RTX 10‑K p. 16). Thus, GD’s risk is a known, recoverable $305 million liability, whereas RTX faces an open‑ended cost‑overrun risk inherent in its fixed‑price contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $305 million deferred cost figure for General Dynamics is correct and matches the original answer. The source citation (GD 10-K p. 59) adds precision and verifies the number's origin. Raytheon’s exposure to cost overruns under fixed-price contracts is correctly described as company-borne with no reimbursement, consistent with the ground truth. (2) The qualitative reasoning correctly contrasts General Dynamics’ deferral model—where costs are deferred but expected to be recovered through backlog and future contracts—with Raytheon’s firm fixed-price (FFP) risk, where overruns are absorbed entirely by the company. This captures the core difference in financial risk profiles. (3) The multi-hop synthesis across two companies and their respective contract risk models is sound: it draws on correct regulatory context (FAR rules) and contract types (fixed-price), and correctly infers that GD’s risk is finite and recoverable, while RTX’s is open-ended. (4) The only minor shortcoming is that the LLM answer refers to the $305 million as a 'liability', whereas the original answer and accounting treatment describe it as a deferred cost asset—this is a subtle but important distinction. Deferred costs are assets, not liabilities, so this mischaracterization slightly affects qualitative accuracy. However, the overall meaning regarding recoverability and risk exposure remains correct. All other elements—context, comparison, risk implications—are semantically equivalent and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 439,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from $10,058 million in 2019 to $13,461 million in 2021, which works out to a compound‑annual growth rate of roughly **15.6 % per year**【page_86】.  By contrast, Apple’s Greater China segment (which includes Taiwan) jumped from $40,308 million in 2020 to $68,366 million in 2021 – a **≈70 % increase** year‑over‑year (i.e., a far higher growth rate than Intel’s Taiwan CAGR)【page_52】【page_25】.  Thus Apple’s Greater China growth far outpaced Intel’s Taiwan revenue growth over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and accurately calculates the CAGR of approximately 15.6%, which matches the ground truth. However, it makes a critical error in the Apple portion by using 2020–2021 data instead of 2019–2021 as required by the question. It states Apple’s Greater China revenue increased from $40,308M in 2020 (incorrect — this was actually the 2019 value in the ground truth) to $68,366M in 2021, leading to an incorrect characterization of the growth as a '≈70% increase' year-over-year. This misrepresents the time period and type of growth (YoY vs CAGR). (2) The correct Apple CAGR from 2019 ($40,308M) to 2021 ($68,366M) is approximately 30.8%, but the LLM fails to compute or report this. Instead, it reports a one-year jump (2020 to 2021), which is not only the wrong comparison window but also mislabeled as supporting the full 2019–2021 period. (3) The multi-hop reasoning is partially sound — the model recognizes that Taiwan is part of Apple’s Greater China segment and attempts to compare the two companies’ regional revenues — but the flawed time frame undermines the validity of the comparison. It concludes Apple grew faster, which is true, but supports it with incorrect reasoning and metrics. (4) The contextual relevance is high because the answer addresses the core comparison and cites relevant data points. However, due to the incorrect use of years and failure to calculate the correct CAGR for Apple over the specified period, the quantitative and qualitative accuracy scores are significantly reduced. The correctness score is 5 because while some key numbers are right, the central comparative analysis is based on a flawed calculation and timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 481,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s $70 billion buy‑back of Class A and Class C shares will shrink the pool of Class A stock, likely lifting its price and making a one‑for‑one conversion of non‑voting Class B shares into Class A more attractive for holders who can convert at any time【page_82】. By contrast, Meta reported a far larger Class A base (≈2.19 billion shares) versus its Class B shares (≈0.34 billion)【page_1】, so converting to an already abundant Class A would have less impact on ownership concentration and be less compelling. Consequently, Alphabet’s repurchase program could incentivize Class B shareholders to convert, whereas Meta’s share structure suggests weaker conversion pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Alphabet's $70 billion share repurchase includes Class A and Class C shares, which reduces the Class A float and may incentivize Class B shareholders to convert. Meta's Class A shares (≈2.19 billion) significantly outnumber Class B shares (≈0.34 billion), which is consistent with the original answer's figures (2,189,898,148 vs. 343,761,117). The rounding to ≈2.19 billion and ≈0.34 billion is acceptable and preserves accuracy. (2) Quantitative accuracy is perfect: dollar amount ($70 billion), share counts, and comparisons are correctly represented with appropriate rounding. No calculation errors. (3) Reasoning is sound: the LLM correctly infers that reduced Class A supply at Alphabet could increase conversion incentives, while Meta’s large Class A float diminishes such pressure. It synthesizes cross-company information logically, demonstrating proper multi-hop reasoning. (4) The only minor shortcoming is a slight omission of the explicit mention that Class B shares have 10x voting rights and that conversion may be motivated by liquidity or timing before price appreciation—details present in the original. However, the core insight about conversion incentives is preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 395,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo states that each RSU “represents our obligation to deliver … one share … when the award **vests at the end of the service period**” and that “RSUs … **accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU … vests and becomes payable**” (PEP 10‑K p. 92). Philip Morris International’s RSUs “generally **vest on the third anniversary of the grant date** (subject to forfeiture) and **do earn dividend equivalents**” (PMI 10‑K p. 110), but the filing does not specify a cash‑out provision; instead the dividend equivalents are embedded in the RSU fair‑value and are reflected in compensation expense (with $160 million of unrecognized cost for non‑vested RSUs as of 12/31/2023) (PMI 10‑K p. 110‑112).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo accrues dividend equivalents that are paid in cash upon vesting, and Philip Morris International (PMI) accrues dividend equivalents on RSUs that vest on the third anniversary of the grant date. The $160 million of unrecognized compensation cost for non-vested RSUs at PMI as of December 31, 2023, is correctly reported. (2) Quantitative accuracy is perfect: the dollar amount ($160 million) and date (12/31/2023) match the original answer exactly, and no calculations were required. (3) The multi-hop reasoning is sound—information is correctly synthesized across both companies’ 10-K filings, and the differences in treatment (cash payout at vesting for PepsiCo vs. dividend equivalents embedded in fair value and compensation expense for PMI) are accurately contrasted. (4) The only minor limitation is that the original answer explicitly notes PMI’s RSUs do not carry voting rights, which the LLM omits; however, this detail is not central to the question about dividend equivalents and financial obligations. The LLM correctly infers from the PMI 10-K that dividend equivalents are reflected in compensation expense and not paid in cash, which represents a nuanced and accurate interpretation. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all information directly addresses vesting conditions and financial obligations related to dividend equivalents in RSUs for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 420,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher values its venture‑capital, partnership and other private‑investment holdings at net‑asset value (NAV) and, when appropriate, by discounted‑cash‑flow, earnings multiples or third‑party appraisals, noting that these methods involve significant judgment and may not reflect net‑realizable value (see DHR 10‑K p. 99). Eli Lilly, by contrast, records acquired intangible assets (e.g., IPR&D) at fair value at the acquisition date, a measurement that also requires management to make material estimates and assumptions (see LLY 10‑K p. 68‑70). Thus, both companies rely on inherently subjective valuation techniques, but Danaher’s are applied to private‑investment portfolios using NAV/DCF, whereas Lilly’s are applied to acquisition‑related intangibles using fair‑value estimation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between DHR and LLY in their use of subjective valuation methods. (1) All factual elements are correct: DHR uses NAV, discounted cash flow, earnings multiples, and third-party appraisals for private investments, with acknowledgment of significant judgment and limitations in reflecting net realizable value. LLY applies fair value estimation to acquired intangibles like IPR&D, requiring material estimates. The LLM correctly identifies the subjective nature of both approaches. (2) Quantitatively, while the LLM answer does not include the specific $3.80 billion charge for LLY in 2023 mentioned in the ground truth, this omission does not undermine the correctness of the overall comparison, as the focus is on methodology rather than specific dollar impacts. No incorrect numbers are presented, so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (DHR and LLY), two types of assets (private investments vs. acquired intangibles), and two valuation contexts, highlighting the shared reliance on judgment and estimation. (4) The answer is contextually relevant and directly addresses the question about comparative subjectivity. The only minor shortcoming is the absence of the $3.80 billion figure and the explicit mention that LLY allows for valuation adjustments within one year post-acquisition—details that would have strengthened completeness. However, the core reasoning and factual accuracy remain strong, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 444,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "Apple’s 2022 Form 10‑K shows that the Greater China segment – which by definition includes Taiwan – generated **$74.2 billion** in net sales. NVIDIA’s 2022 filing does not disclose a separate revenue amount for Taiwan (the provided pages contain no Taiwan‑specific figure), so a direct numeric comparison cannot be made; Apple’s Greater China revenue is therefore far larger than any NVIDIA Taiwan revenue that is publicly reported.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that NVIDIA’s 2022 filing does not disclose revenue from Taiwan. The ground truth confirms that NVIDIA reported $8,544 million in revenue from Taiwan in 2022, which directly contradicts the LLM’s claim that no Taiwan-specific figure is available. This is a major factual error. The Apple revenue figure of $74.2 billion (or $74,200 million) is correctly stated and matches the ground truth. (2) Quantitative accuracy is low because while Apple’s number is correct, NVIDIA’s Taiwan revenue is entirely misrepresented—instead of reporting the correct $8,544 million, the model claims no data is available. This invalidates any quantitative comparison. (3) The reasoning is partially sound in acknowledging that Apple includes Taiwan within its Greater China segment, which is a necessary multi-hop element. However, the model fails the core multi-hop requirement by not comparing NVIDIA’s Taiwan-specific revenue to Apple’s broader regional revenue, instead dismissing the comparison due to a false claim of missing data. (4) Contextual relevance is moderate because the answer addresses the geographic reporting structure and attempts to compare the two companies, but the incorrect denial of NVIDIA’s data severely undermines the response. The answer would have scored higher if it had correctly accessed and compared the disclosed figures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 389,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s filing shows that its Class B shares carry 15 votes each and represent roughly one‑third (≈33 %) of the combined voting power, and all of those shares are beneficially owned by Brian L. Roberts, concentrating control in a single holder (CMCSA_10k_2022, page 38). By contrast, Alphabet’s filing lists about 300.8 million Class A shares outstanding, each with one vote, held by a broad base of investors, indicating a much more dispersed ownership and voting influence (GOOGL_10k_2022, page 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B shares carry 15 votes each and represent approximately 33% of voting power, entirely held by Brian L. Roberts; GOOGL's Class A shares outstanding are reported as ~300.8 million (matching the ground truth 300,754,904, with acceptable rounding); each has one vote and are broadly distributed. (2) Quantitative accuracy is excellent: the 33% voting power, 15 votes per share, and ~300.8 million shares are all correctly reported or acceptably rounded. (3) The multi-hop reasoning is sound—comparing control concentration in CMCSA’s structure versus dispersed ownership in GOOGL—correctly synthesizing data from both 10-K filings. (4) The only minor shortcoming is slightly less explicit contrast in governance dynamics (e.g., no direct mention of 'stark difference' or 'centralized vs distributed control' phrasing), but the implication is clearly conveyed. Wording differences are acceptable under semantic equivalence. No factual errors or calculation issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 311,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s approved equity‑compensation plans show 241 million shares still available versus 25 million shares exercisable – a ratio of roughly **9.6 to 1**【page_77】.  \nJohnson & Johnson’s approved plans show 240.3 million shares available versus 133.8 million exercisable – a ratio of about **1.8 to 1**【page_118】.  \n\nThus UnitedHealth’s “available‑to‑exercisable” ratio is roughly five times higher than Johnson & Johnson’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitative Accuracy: The numbers provided—241 million and 25 million for UnitedHealth Group, and 240.3 million and 133.8 million for Johnson & Johnson—are correctly rounded versions of the exact figures (240,344,013 and 133,794,708). The calculated ratios of 9.6:1 and 1.8:1 are correct (241/25 = 9.64 ≈ 9.6; 240.3/133.8 ≈ 1.795 ≈ 1.8), with only minor rounding differences that do not affect accuracy. (2) Completeness: The answer fully addresses the question by computing and comparing the ratios for both companies under their equity compensation plans approved by security holders. (3) Entity Accuracy: Both companies are correctly identified, and the metrics (shares remaining available, shares issuable upon exercise) are accurate and contextually appropriate. (4) Reasoning: The multi-hop synthesis—pulling data from two different companies and calculating ratios for comparison—is sound. The conclusion that UnitedHealth’s ratio is roughly five times higher is logically valid (9.6 / 1.8 ≈ 5.33). (5) Semantic Equivalence: The LLM conveys the same core information as the ground truth, using slightly different phrasing (e.g., '9.6 to 1' vs '9.64') but preserving factual and comparative meaning. The only minor shortcoming is the lack of explicit mention of the exact raw figures (e.g., 240,344,013), but the rounded values are acceptable and commonly used in reporting. Thus, the answer is factually excellent with negligible simplification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 421,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD warns that its business could be “materially adversely affected” if the third‑party designers, manufacturers or AIB partners that supply its motherboards, graphics cards and other platform components “cease or reduce” production (AMD 10‑K p. 28). In contrast, Intel’s risk is a revenue‑concentration one: Dell alone contributed roughly 21 % of Intel’s net revenue in 2021, meaning a loss of that customer would materially impact earnings (Intel 10‑K p. 87). Thus AMD’s exposure is chiefly supply‑chain‑related, whereas Intel’s exposure is tied to a single large customer’s share of sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's reliance on third-party suppliers for motherboards and related components is accurately described, with proper reference to supply chain risks. Intel's 21% revenue from Dell in 2021 is correctly cited, matching the original answer. (2) Quantitative accuracy is perfect: the 21% figure is correct, and no other numbers are misstated. Format and sourcing (Intel 10-K p. 87, AMD 10-K p. 28) are appropriately included and consistent with factual reporting. (3) Multi-hop reasoning is sound: the model correctly contrasts AMD’s supply-side risk with Intel’s demand-side/customer concentration risk, synthesizing information across two companies and different types of financial exposure. (4) The only minor shortcoming is the omission of the detail about Dell’s share of Intel’s accounts receivable, which adds a layer of financial exposure beyond revenue. While not critical, this nuance was present in the original answer and slightly enhances the risk profile. Otherwise, the reasoning, entity identification (AMD, Intel, Dell), years (2021), and risk categorization are all accurate and well-articulated. Semantic equivalence is strong, and the response is fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 361,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana’s corporate‑tax cuts shave about $34 million off Union Pacific’s deferred tax expense, directly lowering its state‑tax burden and easing its cash‑flow exposure (UNP page 29). Boeing, by contrast, does not benefit from the state‑tax change because its financial risk is tied to the timing and level of U.S. government appropriations and defense spending—factors driven by broader federal legislative dynamics rather than state tax policy (Boeing page 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense is correctly stated, matching the original answer exactly—format variation (‘$34 million’ vs ‘$34 million’) is acceptable. (2) The answer correctly identifies Union Pacific as benefiting directly due to its operations in Louisiana and cites a specific source (UNP page 29), though it omits the detail about the Livonia classification yard, which adds contextual support but is not critical to the core financial impact. (3) For Boeing, the LLM correctly states that it does not benefit from the state tax change and ties its exposure to federal appropriations and defense spending, referencing broader legislative dynamics (Boeing page 10), which matches the original reasoning. It omits some nuance—such as potential impacts on aircraft certifications or future orders—but captures the essential indirect exposure. (4) Multi-hop reasoning is sound: the model distinguishes between direct operational tax benefits (Union Pacific) and indirect federal funding risks (Boeing), synthesizing across entities and policy levels. (5) Semantic equivalence is strong; wording differs but meaning is preserved. The only minor gap is the lack of explicit mention of Louisiana’s legislation enaction or the term ‘deferred tax expense’ being tied to that specific state policy change, but the financial effect and causality are correctly implied. Overall, the answer is factually correct, contextually relevant, and well-reasoned with only slight omissions in descriptive detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 443,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s 10‑K states that “the holders of each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders” (NFLX 10‑K p. 60). In contrast, Meta’s filing shows it has both Class A and Class B shares – 2.19 billion Class A and 344 million Class B shares outstanding – a dual‑class structure that gives the two classes different voting powers (Meta 10‑K p. 1). Charter’s notes similarly disclose that its Class A common stock carries one vote per share, linking voting rights to that specific class (Charter 10‑K p. 95), which highlights the difference between Netflix’s uniform one‑vote‑per‑share model and Meta’s multi‑vote dual‑class arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual elements are correct: Netflix's one-vote-per-share model is properly cited from its 10-K (p. 60), Meta's dual-class structure is accurately described with correct share counts (2.19 billion Class A, 344 million Class B) from its 10-K (p. 1), and Charter's Class A one-vote-per-share disclosure is correctly referenced (p. 95). (2) Quantitative accuracy is perfect—numbers match the source filings and are presented clearly. (3) The multi-hop reasoning is sound: the model correctly contrasts Netflix’s uniform voting with Meta’s and Charter’s tiered structures, synthesizing across three companies. It correctly infers that Meta’s dual-class setup implies differentiated voting rights, even if exact voting powers aren't specified. (4) The only minor shortcoming is that the LLM does not explicitly mention Charter’s Class B stock having variable voting rights tied to A/N’s economic interests—a detail present in the ground truth. While the answer correctly notes Charter’s Class A one-vote-per-share, it omits the nuance of Class B’s variable rights, slightly reducing completeness in qualitative synthesis. However, this does not undermine the core contrast being drawn. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—every part of the answer addresses the question directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 388,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP notes that its exchange‑traded commodity futures “are cash‑settled on a daily basis” (PEP 10‑K p. 107), so the fair value of those contracts is simply the settlement price posted by the exchange each day. MDLZ’s Level 1 financial liabilities – which consist of exchange‑traded commodity futures and listed options – are also measured “based on quoted market prices on commodity exchanges” (MDLZ 10‑K p. 112). Thus, the daily cash‑settlement mechanism provides the observable market price that MDLZ uses for its Level 1 valuation, meaning MDLZ’s methodology directly incorporates the same daily‑updated exchange prices without needing additional valuation adjustments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures that PEP's exchange-traded commodity futures are 'cash-settled on a daily basis' (citing page 107 of PEP's 10-K), which aligns with MDLZ's use of 'quoted market prices on commodity exchanges' for Level 1 financial liabilities (citing page 112 of MDLZ's 10-K). (2) There are no numerical values requiring calculation, but the references to specific disclosures and pages are factually consistent with the knowledge graph. (3) The multi-hop reasoning is sound: it correctly synthesizes the daily cash-settlement mechanism from PEP’s filing and links it to MDLZ’s valuation methodology, showing that observable exchange prices—updated daily due to settlement—are used directly in MDLZ’s Level 1 measurements without adjustments. (4) The answer is contextually precise, directly addressing how the settlement mechanism impacts valuation methodology. All entities (PEP, MDLZ, Level 1 liabilities, exchange-traded commodity futures) are correctly identified and logically connected. Minor wording differences (e.g., 'provides the observable market price' vs. 'directly informs') do not affect factual equivalence. No errors in reasoning, entities, or sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 352,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s Greater China segment (which includes Taiwan) generated $74.2 billion of net sales in fiscal 2022 (Apple Note 11, page 52). AMD’s net sales to customers in Taiwan alone were about $2.1 billion in 2022 (AMD geographic‑sales table, page 78). Thus Apple’s sales in the broader Greater China market were roughly $72 billion higher – more than thirty‑fold the size of AMD’s Taiwan sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's 2022 net sales in Greater China as $74.2 billion (equivalent to $74,200 million in the ground truth) and AMD's 2022 sales in Taiwan as $2.1 billion (close to the exact $2,091 million), with only a minor rounding difference that is acceptable under format variation. (2) Calculations are accurate: the difference of approximately $72.1 billion is correctly stated as roughly $72 billion higher, and the claim that Apple's sales were more than thirty-fold AMD’s is valid (74.2 / 2.1 ≈ 35.3x). (3) Multi-hop reasoning is sound—information from two companies, two geographic scopes (Greater China vs. Taiwan alone), and correct fiscal year (2022) are synthesized appropriately. (4) The answer conveys the same core insight as the original: Apple’s regional sales dwarf AMD’s Taiwan-specific sales. The only minor shortcoming is slightly less precise phrasing around AMD’s exact figure ($2.1B vs $2,091M), but this does not affect factual correctness. All entities, metrics, and years are accurate. Thus, the answer is highly correct with negligible rounding, earning a 9/10 for overall correctness and qualitative accuracy, while maintaining perfect quantitative and contextual scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 347,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy’s remediation liabilities are recorded as expenses (e.g., $73 million of environmental‑remediation reserves for Duke Energy in 2024) and are only recovered if a regulator deems recovery probable – otherwise the costs are expensed as incurred【page_163】. By contrast, Southern Company Gas’s natural‑gas distribution utilities have explicit regulatory riders that permit recovery of environmental‑remediation costs, allowing those expenses to be recouped through rates rather than being fully charged to earnings【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that Duke Energy typically expenses remediation costs as incurred unless recovery is probable, and provides a specific dollar amount ($73 million in 2024) for environmental-remediation reserves, which is consistent with the type of detail expected, though the exact figure is not in the original answer. Since the original answer does not specify a number, the inclusion of $73 million from a plausible source (page_163) adds precision without contradicting the ground truth. (2) The contrast with Southern Company Gas is accurately portrayed: the LLM correctly identifies that its natural gas utilities have explicit regulatory riders allowing cost recovery, citing page_22 as support. This reflects the core distinction in recovery mechanisms. (3) Multi-hop reasoning is sound—LLM synthesizes Duke's expense treatment with Southern's recovery mechanism, correctly inferring that Southern has reduced financial exposure due to regulatory approval pathways. (4) Minor deduction in quantitative accuracy only because the $73 million figure, while plausible and cited, is not confirmed in the original answer and could be specific to a subset of liabilities; however, it does not misrepresent the overall pattern. Wording differs but semantic equivalence is strong. No issues with entity accuracy (Duke Energy, Southern Company Gas, correct fiscal context). Contextual relevance is perfect—directly addresses the comparative exposure and recovery mechanisms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 424,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s fair‑value hierarchy places its Level 2 measurements on pricing models that are fed with observable market inputs—including reported trades and broker‑dealer quotes—so the company’s valuations are anchored to current market data (LOW 10‑K p. 54). By contrast, General Motors estimates its product‑warranty reserves with internal actuarial/valuation models that rely on historical claim frequency, average cost per claim and other experience‑based assumptions, also using industry‑standard modeling techniques (GM 10‑K p. 55‑56). Thus, both firms depend on standard valuation models, but Lowe’s inputs are market‑observable quotes, whereas GM’s inputs are historical and actuarial data for liability estimation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LOW uses broker/dealer quotes and observable market inputs (e.g., reported trades) for Level 2 fair value measurements, which aligns with market-driven, observable data (as per LOW’s 10-K, p. 54). GM uses internal actuarial/valuation models based on historical claim frequency, average cost per claim, and experience-based assumptions for warranty reserves (GM 10-K, pp. 55–56). These inputs match the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes how two different companies use valuation models in distinct contexts—LOW for asset valuation with market-observable inputs (Level 2), GM for liability estimation with management judgment and historical data. The comparison highlights the role of industry-standard models while distinguishing input types and purposes. (4) The only minor shortcoming is that the LLM answer does not explicitly state that GM’s approach involves 'forward-looking assumptions' or 'more management judgment'—a nuance present in the original answer that strengthens the contrast. However, the implication is present through phrases like 'experience-based assumptions' and 'liability estimation.' Wording differences are acceptable under semantic equivalence, and the core contrast is preserved. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 459,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "Both Capital One and Citigroup would have to compute risk‑weighted assets under the new Expanded Risk‑Based Approach and under the existing standardized approach and then apply the lower of the two resulting CET1, Tier 1 and total‑capital ratios as the binding measure.  The rule takes effect on July 1 2025 with a three‑year transition, so the additional capital needed will be phased in; Citigroup’s filing states the change would “materially increase” its required regulatory capital, and Capital One’s filing indicates the same lower‑ratio requirement will likely raise its capital needs as the expanded approach is phased in.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both banks must calculate risk-based capital under the Expanded Risk-Based Approach and the existing standardized approach, using the lower of the two ratios; the effective date is July 1, 2025, with a three-year transition period; Citigroup expects a 'material increase' in required capital; Capital One anticipates higher capital needs as the expanded approach is phased in. (2) Quantitative accuracy is perfect: the July 1, 2025 effective date and three-year transition are correctly stated; no numerical calculations are required beyond these dates, which are accurately presented. (3) Multi-hop reasoning is sound—information is synthesized correctly across both banks and the regulatory framework, correctly identifying that both must comply with the lower ratio and that the transition is phased. (4) The only minor omission is that the original answer specifies that all capital buffer requirements still apply regardless of which approach yields the lower ratio, further constraining capital flexibility—a nuance not mentioned in the LLM response. However, this does not undermine the core correctness. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 389,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips does have condensate exposure – it owns 52.2 % of Alba Plant LLC, the joint‑venture that extracts condensate (and LPG) from the Alba Unit’s natural‑gas stream and records its share of the revenue 【page_12】.  By contrast, Chevron’s 2024 10‑K shows zero condensate production (the “Condensate” column is blank/‑ for all regions, indicating no condensate output or reserves) 【page_109】.  So ConocoPhillips retains a non‑zero condensate exposure through Alba Plant, while Chevron reports no direct condensate production in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 52.2% ownership stake in Alba Plant LLC is accurately reported, and the statement that Chevron reports zero condensate production in its 2024 10-K is consistent with the original answer. The reference to 'blank/-' columns on page 109 supports the conclusion of no condensate output or reserves. (2) The answer correctly identifies both entities—ConocoPhillips and Chevron—and the relevant time period (2024), satisfying entity accuracy. (3) The multi-hop reasoning is sound: it connects ConocoPhillips’ indirect exposure via equity ownership in a joint venture (Alba Plant LLC) to condensate extraction, while contrasting it with Chevron’s lack of direct production or reserves. The use of 'Equity in earnings of affiliates' is implied through the mention of revenue share, though not explicitly named—this is a minor omission but does not detract significantly from correctness. (4) The semantic meaning fully matches the original: ConocoPhillips has indirect exposure; Chevron has none in 2024. The only reason for not scoring a perfect 10 is the slight lack of specificity around how COP's share is accounted for (i.e., not explicitly stating it appears in 'Equity in earnings of affiliates'), which is present in the ground truth but only implied here. Otherwise, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 401,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO already treats contract modifications by first determining whether the added goods or services are distinct and then allocating the price on a standalone‑selling‑price basis, accounting for the change either as a new contract, prospectively or on a cumulative‑catch‑up basis (see AVGO 10‑K p. 63). Because that policy aligns with the optional expedients in ASU 2020‑04, the reference‑rate‑reform update did not materially alter AVGO’s revenue‑recognition timing. Oracle likewise completed its adoption of ASU 2020‑04 in Q1 2024 and disclosed that the guidance – which eases the accounting for contracts affected by reference‑rate reform – had no material impact on its consolidated financial statements or notes (see ORCL 10‑K p. 72).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AVGO's treatment of contract modifications using standalone selling prices and prospective/cumulative catch-up accounting aligns with ASU 2020-04, and Oracle adopted the standard in Q1 of fiscal 2024 with no material impact. The statement that both companies experienced no material effect on financial statements matches the original answer. (2) Quantitatively, all dates and fiscal periods are accurate—ORCL's adoption in Q1 2024 is correctly stated (fiscal 2024 aligns with calendar 2023 reporting), and the March 12, 2020–December 31, 2024 effective period for ASU 2020-04 is implied by context even if not explicitly repeated. No numerical errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes AVGO’s existing accounting policy with the optional expedients in ASU 2020-04 to conclude no material change, and separately confirms ORCL’s adoption and impact. The connection to reference rate reform (e.g., LIBOR transition) is appropriately contextualized. (4) Minor deduction in qualitative accuracy because the LLM does not explicitly mention that ASU 2020-04 applies to modifications due to reference rate reform (though it is implied), nor does it specify that AVGO’s bundled arrangements use standalone selling prices—this detail is present in the original. However, the omission does not distort the conclusion. Wording differences are semantically equivalent and acceptable. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 437,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s dual‑class structure gives its ten‑vote Class B shares (held by Zuckerberg and other insiders) a controlling majority of the combined voting power, so Class A shareholders have little ability to affect corporate decisions and the Class A stock is viewed as less attractive 【page_49】【page_50】. In contrast, Comcast’s Class B shares carry 15 votes per share (about one‑third of total voting power) but are convertible share‑for‑share into Class A, giving holders a mechanism to align their voting rights while still preserving a fixed, non‑dilutable super‑voting block 【page_91】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Meta's Class B shares have superior voting rights (10 votes per share implied by 'controlling majority' and context), Zuckerberg and insiders hold them, and Class A shares are less attractive due to limited influence. CMCSA’s Class B shares have 15 votes per share and represent about one-third of total voting power, which aligns with the ground truth's 33⅓% non-dilutable block. The convertibility of CMCSA Class B to Class A on a share-for-share basis is correctly stated. (2) Quantitative accuracy is perfect: 15 votes per share, one-third (≈33⅓%) voting power, and the structural comparison are all factually correct. (3) Multi-hop reasoning is sound—LLM correctly contrasts Meta’s entrenched control (via disproportionate voting) with CMCSA’s convertible structure that preserves a fixed super-voting block. The only minor omission is that the ground truth specifies Meta requires a majority of Class B shares to approve change-of-control transactions until their voting power drops below 35%, which adds a conditional governance detail not mentioned in the LLM response. However, this does not undermine the overall correctness. (4) The answer is contextually relevant, directly addressing governance control and shareholder influence for both companies. Wording differs but semantic meaning matches. Thus, a high score is warranted, with a small deduction in qualitative accuracy for the omitted procedural detail on Meta’s class-vote requirement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 431,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PepsiCo discloses that its commodity‑price hedges include exchange‑traded futures, but because those futures are cash‑settled daily they are omitted from the fair‑value hierarchy table and are not reported as Level 1 assets. Costco, by contrast, states that it held no Level 1 (or Level 3) financial assets measured at fair value on a recurring basis, meaning it has no exchange‑traded commodity futures at all. Thus, PepsiCo uses such futures but excludes them from Level 1 reporting, while Costco simply has none.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PEP uses exchange-traded commodity futures that are cash-settled daily and thus excluded from the fair value hierarchy table, aligning with the original answer's statement about omission from the fair value table as of December 25, 2021. It also accurately notes that COST reported no Level 1 or Level 3 financial assets measured at fair value on a recurring basis as of August 28, 2022. While the LLM does not explicitly name MDLZ as the source defining Level 1 assets, this detail is contextually secondary to the main comparison between PEP and COST. (2) There are no numeric values, dates, or financial amounts in the LLM answer that conflict with the ground truth; all qualitative timelines and disclosures are correctly attributed. (3) The multi-hop reasoning is sound: the model correctly synthesizes the treatment of cash-settled futures (excluded from fair value tables despite being Level 1 instruments) and contrasts PEP’s active use of such instruments with COST’s absence of any Level 1 assets. (4) The LLM simplifies the explanation by stating that Costco 'has none' of these futures, which is a reasonable inference given the absence of Level 1 assets and the typical inclusion of exchange-traded futures in Level 1. The only minor shortcoming is the omission of the explicit reference to MDLZ’s disclosure defining Level 1 assets, which slightly weakens the sourcing chain but does not affect the factual correctness of the conclusion. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 449,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs had $1,634 million of securities loaned that mature in 31‑90 days (GS 10‑K, p. 187). Morgan Stanley’s 10‑K shows total securities‑loaned balances of $9,499 million (U.S.) + $6,853 million (non‑U.S.) = $16,352 million (MS 10‑K, p. 148). Thus, Goldman’s short‑term loaned‑securities exposure is roughly one‑tenth of Morgan Stanley’s overall loaned‑securities book, indicating a comparatively lower short‑term securities‑lending risk for Goldman Sachs.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Goldman Sachs has $1,634 million in securities loaned with maturities of 31-90 days, which the LLM correctly reports. However, the LLM incorrectly states that Morgan Stanley's total securities loaned amount to $16,352 million ($9,499M U.S. + $6,853M non-U.S.), which directly contradicts the ground truth value of $281 million total securities loaned. This is a critical quantitative error. (2) The calculation of Morgan Stanley’s total securities loaned is factually wrong — the cited sum does not match the ground truth, and no such numbers appear in the correct context. The ground truth explicitly states Morgan Stanley’s total as $281 million, not over $16 billion. (3) The multi-hop reasoning fails because the LLM uses incorrect data for Morgan Stanley, leading to a completely reversed conclusion: instead of Goldman Sachs having significantly higher short-term exposure, the LLM claims Goldman has only one-tenth of Morgan Stanley’s exposure, which is false. (4) Due to the severe inaccuracy in core financial data and the resulting incorrect comparison and conclusion, the correctness score is very low. Quantitative accuracy is poor due to the massive discrepancy in Morgan Stanley’s reported value. Qualitative reasoning is flawed because the logic, while internally consistent, is based on false premises. Contextual relevance is moderate because the answer addresses the right topic and structure but with wrong data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 419,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided ownership of Alabama Power’s Plant Miller Units 1 and 2 represents **8.16 %** of its total owned generating capacity【page_17】. In comparison, Duke Energy reported **approximately 22,344 GWh** of electricity generation for 2021【page_187】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and Duke Energy's 2021 generation of 22,344 GWh, matching the ground truth exactly. These numbers are cited with correct formatting and units. (2) All quantitative values are accurate: 8.16% and 22,344 GWh are correct and properly attributed. No calculations were required beyond accurate reporting. (3) The multi-hop reasoning is sound—information about PowerSouth’s ownership stake and Duke Energy’s system-wide generation comes from different contexts, and the LLM correctly synthesizes them for comparison. However, the LLM slightly misrepresents the 8.16% figure as being 'of its total owned generating capacity' rather than clarifying it is an 8.16% interest in Plant Miller Units 1 and 2 (which contributes to its overall capacity). This is a minor qualitative nuance but does not distort the core fact. (4) The answer is contextually complete and relevant, directly addressing both parts of the question with precise data and appropriate comparison. The only reason for not scoring a 10 is the slight imprecision in framing the 8.16%—though still factually defensible, it omits the nuance that this is a percentage of the Plant Miller units, not of PowerSouth’s total capacity directly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 367,
        "total_tokens": 1564
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "NIKE’s $11.6 billion cash‑equivalents and short‑term investment portfolio is directly exposed to interest‑rate risk – its fixed‑income holdings (investment‑grade securities) have a weighted‑average maturity of roughly 65 days, so changes in rates affect the portfolio’s value (NKE 10‑K, p. 50). McDonald’s interest‑rate sensitivity is more indirect: the company’s derivatives are valued with Level 2 pricing models that use observable market inputs such as interest‑rate yield curves, so fluctuations in those curves affect the fair‑value of those instruments (MCD 10‑K, p. 46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: NIKE's $11.6 billion portfolio of short-term fixed-income investments is accurately stated, and the reference to investment-grade securities exposed to interest rate risk is consistent. The mention of McDonald’s use of Level 2 pricing models relying on observable market inputs like interest rate yield curves matches the original. (2) Quantitative accuracy is perfect: the $11.6 billion figure is correct, and while the weighted-average maturity of 65 days is an additional detail not in the ground truth, it does not contradict it and appears to be correctly sourced from the cited 10-K page. No calculations were required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (NIKE and McDonald’s), identifying that both use observable market data in valuation models but face interest rate risk through different instruments—NIKE via direct fixed-income holdings, McDonald’s via derivative valuations. (4) The only minor shortcoming is that the LLM answer omits the explicit comparison of the nature and magnitude of risk differing by instrument type, which is included in the original. However, this concept is implicitly conveyed through the contrast in exposure mechanisms. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparison of interest rate risk exposure and valuation methodologies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 415,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s charter gives every share of its common stock one vote, so voting power is directly proportional to each shareholder’s economic stake (see Netflix 10‑K p. 60). Alphabet, by contrast, has a multi‑class system in which Class A shares also carry one vote but Class B shares carry ten votes and Class C shares carry none, concentrating control in the hands of insiders who hold Class B stock (see Alphabet 10‑K p. 82). As a result, Netflix’s governance is more egalitarian and responsive to all shareholders, whereas Alphabet’s structure allows a relatively small group of high‑voting shareholders to dominate corporate decisions despite holding a smaller economic interest.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Netflix's one-vote-per-share policy and contrasts it with Alphabet's multi-class structure, accurately describing Class A (1 vote), Class B (10 votes), and mentioning Class C (no votes), which aligns with the structural details in the original answer. (2) All quantitative elements are correct: the voting ratios (1:10) are accurate, and there are no numerical errors or miscalculations. The reference to specific 10-K pages (60 for Netflix, 82 for Alphabet) adds verifiable context and matches typical disclosures. (3) The multi-hop reasoning is sound—comparing governance implications across two companies with different voting structures—and correctly infers that Alphabet’s structure concentrates control among insiders (e.g., founders or early investors holding Class B shares), while Netflix’s structure ensures voting power aligns with economic ownership. (4) The answer fully addresses the question’s focus on how voting rights influence shareholder governance dynamics, providing a clear, nuanced comparison. Minor additions (e.g., mention of Class C shares and page numbers) enhance completeness without introducing error. All criteria—factual accuracy, reasoning, entity identification, and relevance—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 373,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "AbbVie notes that the IRA will let HHS set a ceiling price for Imbruvica under Medicare Part D beginning in 2026, which “could…accelerate revenue erosion prior to expiration of intellectual‑property protections” and will force the company to re‑tool pricing, rebate and launch strategies for that high‑spending, single‑source drug 【page_19】. Johnson & Johnson’s XARELTO is also on the CMS “selected‑drug” list, so it will face a Medicare‑set price, but J&J’s larger, more diversified portfolio and lower reliance on any one Medicare‑driven product give it more leeway to absorb the discount and adjust its overall revenue mix rather than suffer a sharp, product‑specific hit 【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Imbruvica (AbbVie) and XARELTO (Johnson & Johnson) are both selected for IRA price-setting starting in 2026, which matches the original answer’s timeline. There are no numeric values (e.g., dollar amounts, percentages) in either answer, so no discrepancies exist. (2) The LLM correctly identifies that AbbVie expects accelerated revenue erosion before patent expiry and must adjust pricing and launch strategies—this directly reflects the original answer’s point about strategic evaluation and revenue risk. (3) The LLM accurately contrasts AbbVie’s product-specific vulnerability with J&J’s more diversified portfolio and greater ability to absorb pricing impacts, which is consistent with the ground truth’s emphasis on differing exposure and strategic responses. (4) One minor omission: the LLM does not mention J&J’s litigation challenging the IRA’s constitutionality, a key element of J&J’s aggressive revenue protection strategy noted in the original answer. This slightly weakens the qualitative accuracy but does not undermine the core correctness. Otherwise, the reasoning is sound, entities are correctly identified, and the synthesis across companies and strategies is appropriate. The answer is fully contextually relevant and conveys semantically equivalent information with only slight differences in emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 393,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Citi’s compliance‑risk governance is anchored by the Independent Compliance Risk Management (ICRM) function, which is led by the Group Chief Compliance Officer (CCO) reporting to the Chief Legal Officer and with matrix reporting to the CRO, and by the Group Business Risk and Control Committee (GBRCC) that provides board‑level oversight of compliance and operational risk.  Because ICRM and the GBRCC sit in the second‑line of defense and have direct access to the Board’s Risk Management Committee and the Group Risk Management Committee, they are required to identify, measure, monitor and escalate any compliance issues that could arise from transition‑climate risks—such as the credit‑or‑liquidity amplifications described by Morgan Stanley—so that those climate‑related credit and liquidity exposures are incorporated into Citi’s risk‑appetite limits, controls and remediation actions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in structure and context, with no numeric inaccuracies (quantitative accuracy is 10). It correctly identifies Citi's governance mechanisms—specifically the Independent Compliance Risk Management (ICRM) function, the Group Chief Compliance Officer (CCO), and the Group Business Risk and Control Committee (GBRCC)—as second-line-of-defense bodies with board-level oversight and escalation responsibilities. It also correctly links transition climate risks to potential credit and liquidity risk amplifications, referencing Morgan Stanley's disclosures as a source of that risk characterization. However, the original answer emphasizes the Board and Executive Management Team’s overarching accountability, Internal Audit’s role in providing independent assurance (reporting to the Citi Audit Committee Chair), and the alignment of compliance controls with evolving regulatory expectations on climate disclosures. These key governance elements are missing in the LLM response, which instead focuses on ICRM and GBRCC without mentioning Internal Audit or the Board’s direct role in ERM oversight. While the LLM captures the logical connection between transition risks and financial exposures, it omits the specific assurance mechanism (Internal Audit) and underrepresents the Board’s central role, weakening the completeness of the multi-hop synthesis. The answer remains contextually relevant and semantically aligned in intent, but lacks full completeness in governance structure coverage, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 426,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "Qualcomm’s licensing revenue is heavily weighted toward a few Chinese OEMs—about 30% of its royalties—so any U.S.–China trade restrictions, export‑license revocations, sanctions or payment‑collection problems with those OEMs can sharply cut its cash flow (see QCOM risk factors on Chinese OEM concentration, trade‑policy actions and the loss of Huawei business). Texas Instruments, by contrast, is expanding its own 300 mm wafer‑fab footprint (RFAB2, LFAB1, SM2, etc.) to source the bulk of its wafers, assembly and test internally, which gives it lower cost, greater control and reduced exposure to external supplier disruptions, albeit with the usual capital‑intensive investment risk (see TI discussion of internal capacity expansion and supply‑chain control).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated. No other numerical values (e.g., dates, dollar amounts) are present in either answer, so no discrepancies exist. Format variations (e.g., '300 mm' vs '300mm') are acceptable and do not affect accuracy. (2) The answer addresses all parts of the multi-hop question: it contrasts QCOM's reliance on Chinese OEMs for licensing revenue with TXN's internal 300mm wafer fab expansion, and correctly identifies the differing supply chain risks—geopolitical and contractual for QCOM, capital investment risk for TXN. (3) Entity accuracy is strong: QCOM and TXN (TI) are correctly identified, and the facilities mentioned—RFAB2, LFAB1—are accurate; SM2 is a minor discrepancy (ground truth says SM1), which slightly affects qualitative accuracy but does not change the overall correctness, as these are examples of internal fab investments. (4) The reasoning is sound and synthesizes the core contrast: QCOM’s exposure to external geopolitical and payment risks vs. TXN’s strategy of vertical integration to reduce external dependency. The mention of Huawei and trade restrictions adds relevant context not in the original but is factually plausible and enhances, rather than detracts from, the answer. Only a perfect match would score 10; the SM2 vs SM1 inconsistency prevents full qualitative accuracy, but the overall meaning and risk comparison remain correct. Thus, the answer is semantically equivalent and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 437,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says it has elected to apply the ASU 2020‑04 amendments to any debt‑modification transactions and, because its current LIBOR‑referenced debt and hedging contracts are being rewritten to incorporate an alternative rate, it does not expect a material impact on its interest‑rate derivatives, although the final outcome of the transition cannot yet be determined【page_194†L1-L9】【page_195†L1-L4】.  \n\nDuke Energy likewise notes that its variable‑rate debt and LIBOR‑indexed interest‑rate swaps are being reviewed, that it is evaluating the optional expedients and alternative‑index provisions under ASU 2020‑04, and while contract amendments or terminations may be required, it does not expect a material effect on its financial statements and the ultimate result remains uncertain【page_137†L1-L9】.  \n\nThus, both firms are still assessing the reform, anticipate no material impact, and acknowledge uncertainty, but Southern Company emphasizes its election to apply the guidance to debt modifications and hedges, whereas Duke Energy focuses on the need to possibly amend or terminate LIBOR‑linked contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: both Southern Company and Duke Energy are evaluating ASU 2020-04 in the context of LIBOR transition, with Southern applying the amendments to debt modifications and hedges and not expecting a material impact, while Duke is assessing optional expedients for contract amendments or terminations and also expects no material impact. Both acknowledge uncertainty, which matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective assessments of the same accounting standard, highlighting both similarities (ongoing evaluation, no expected material impact, uncertainty) and differences (Southern’s election to apply guidance vs. Duke’s focus on contract amendments). The only minor gap is that the original answer specifically references 'Note 14' for Southern and notes Duke’s assessment may extend beyond 2023, which the LLM omits—this prevents a perfect 10 but does not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing the comparative assessment of ASU 2020-04 as applied to interest rate derivatives and LIBOR-indexed contracts. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to minor omissions in contextual detail, but all key facts and reasoning are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 440,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s filing notes that it “holds cash equivalents and/or marketable securities in foreign currencies such as British Pounds … and Euros” – meaning its balance‑sheet is directly exposed to the translation impact of those currencies (AMZN p. 9). Nike, by contrast, does not rely on currency‑denominated cash balances but instead “hedges a portion of the remaining exposures using derivative instruments such as forward contracts and **options**” to offset foreign‑exchange risk (Nike p. 48). Thus Amazon’s risk comes from un‑hedged GBP/EUR assets, while Nike actively manages similar risks through option‑based hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, exposing it to translation risk, citing the specific risk factor from its filing (p. 9). It accurately contrasts this with NKE’s use of derivative instruments, specifically mentioning 'options' (highlighted), which matches the original answer’s emphasis on option contracts for hedging. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the citation of page numbers (p. 9 for AMZN, p. 48 for NKE) is consistent with typical 10-K referencing and does not contradict the knowledge graph, earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMZN and NKE), compares their foreign exchange risk management strategies, and draws a valid contrast—AMZN’s exposure due to unhedged assets vs. NKE’s active hedging using options. The only minor shortcoming is that the LLM answer does not explicitly state that AMZN does *not* use derivatives (only that it doesn’t mention them), whereas the original answer makes this absence clearer. This slight omission in nuance prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison of exposure and risk management approaches as asked. Overall, the LLM conveys semantically equivalent information with high fidelity, minor wording differences notwithstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 444,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta’s dual‑class system gives one vote to each Class A share and ten votes to each Class B share. With 2.19 billion Class A shares and 344 million Class B shares outstanding, the Class B stock commands roughly 60 % of the total voting power, the balance belonging to Class A【page_1】. Google’s structure is analogous—Class A shares have one vote, Class B shares have ten votes (Class C has none)【page_82】—so its Class B holders also hold a controlling voting stake, the exact proportion varying with the relative share counts. This illustrates the dynamic relationship where voting power shifts according to the number of shares outstanding in each class.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, at META, Class A holds 66 2/3% of voting power and Class B holds 33 1/3%, with each Class B share having 15 votes—not 10 as stated by the LLM. The LLM incorrectly claims Class B has 10 votes and calculates ~60% voting power for Class B based on share counts (2.19B Class A, 344M Class B), but this data is not in the original answer and contradicts the ground truth distribution. The actual META structure gives Class A majority voting power (66.7%), not Class B. (2) For GOOGL, the LLM correctly states Class A has 1 vote and Class B has 10 votes, aligning with the original answer, though it adds unsupported detail about Class C having no votes (not in ground truth). However, the original does not provide percentage distributions for GOOGL, so the LLM’s comparison based on shifting proportions due to share counts introduces speculation. (3) Multi-hop reasoning is partially sound—comparing voting structures across companies—but fails on core facts: it reverses the actual voting power distribution at META and uses incorrect vote multiples. The synthesis is flawed because it builds on wrong data. (4) Despite correct framing and contextual relevance in discussing dual-class structures and dynamic voting power, the answer scores low on correctness due to major quantitative errors. The 60% voting power claim for META Class B is unsupported and factually wrong given the ground truth. Minor flexibility is allowed for wording, but vote counts and percentages are materially incorrect. Thus, correctness is severely impacted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 448,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s equity‑method stake in Southern Company Gas (SNG) represents roughly half of a $3 billion pipeline – about $1.2‑$1.3 billion – and the project cannot move forward until the Federal Energy Regulatory Commission (FERC) and other regulators grant approval, making the capital outlay contingent on that regulatory clearance【page_92】. In contrast, Duke Energy Ohio’s FERC involvement was limited to approving dividend payments, with the commission (and the PUCO) imposing a covenant that the subsidiary’s equity must remain at least 30 % of total capital, which restricts cash distributions but does not tie to a new capital‑intensive investment【page_147】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's investment is stated as $1.2–$1.3 billion, which aligns with the ground truth $1,245 million (≈$1.25B), and SNG's $3 billion pipeline project with 50% ownership is accurately reflected. The 30% equity requirement for Duke Energy Ohio (DUK) is correctly reported. (2) The regulatory bodies—FERC and PUCO—are correctly identified for DUK’s dividend restrictions, and FERC’s role in SNG’s project approval is accurately described. (3) The multi-hop reasoning is sound: the model correctly synthesizes that SNG faces regulatory constraints on project execution (timing and approval), while DUK’s constraint relates to capital structure and dividend policy, not project development. (4) The only minor shortcoming is that the LLM does not explicitly state Southern Company Gas owns 50% of the project (though this is implied by 'half of a $3 billion pipeline'), nor does it mention the potential 2029 delay, which is present in the original. However, the contingent nature of the capital outlay captures the timing risk. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 361,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s 2021‑22 buy‑back program included an Accelerated Share Repurchase with a third‑party financial institution – the company paid $3 billion in November 2021 for an initial 10.3 million shares and received a further 1.6 million shares in January 2022 – a direct cash‑to‑shareholder transaction that reduces the outstanding share count. By contrast, Home Depot does not repurchase shares for this purpose; instead it distributes value through dividend equivalents attached to its restricted‑stock, performance‑share and RSU awards, which accrue on unvested shares and are paid as additional shares when the awards vest, providing an indirect, compensation‑linked form of shareholder value.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor discrepancies in quantitative details. (1) Quantitatively, the LLM states that Lowe's paid $3 billion in November 2021 for an initial 10.3 million shares and received an additional 1.6 million shares in January 2022, totaling 11.9 million shares — this aligns with the ground truth's total of 11.9 million shares from a $3.0 billion ASR. While the exact timing (December vs. November 2021 authorization) and phasing of share delivery are slightly different, these details are close and plausibly derived from similar filings; the total dollar amount and total shares match exactly. However, the original answer emphasizes the $13.0 billion additional authorization bringing the total to $28.0 billion since 2020, which the LLM omits — a minor but notable completeness gap. (2) The qualitative reasoning is sound: the LLM correctly identifies Lowe's use of financial institutions for ASR as a direct share count reduction mechanism and contrasts it with Home Depot’s use of dividend equivalents on unvested equity awards, accurately describing them as accruing and being paid in additional shares upon vesting. (3) Multi-hop synthesis is strong — the model correctly links Lowe's ASR activity with financial intermediaries to shareholder value distribution and contrasts it with Home Depot’s compensation-linked dividend equivalents, capturing the fundamental difference in mechanisms: direct capital return vs. indirect, equity-based compensation alignment. (4) Contextual relevance is excellent — the response directly addresses the comparison of shareholder value distribution mechanisms between the two firms over the 2021–2022 period. The omission of the broader $28B repurchase authorization context slightly reduces quantitative completeness, but the core facts and synthesis remain accurate and insightful.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 516,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both Caterpillar and Honeywell have incorporated the new ASU 2022‑04 requirement, which obliges a buyer that uses supplier‑finance programs to present a yearly roll‑forward of the confirmed obligations beginning in 2024. Caterpillar’s Note 19 now shows a roll‑forward from a $803 million opening balance to a $830 million closing balance for 2024 (with $5,140 million of invoices confirmed and $5,113 million paid) (pages 111‑112), and Honeywell’s filing (page 60) notes the adoption and provides a similar roll‑forward in its Note 19 (beginning $1,112 million, $3,098 million confirmed, $3,060 million paid, ending $1,150 million for 2024) (pages 61‑62).  The ASU does not change the measurement of the obligations, only the required disclosure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that both Caterpillar and Honeywell adopted ASU 2022-04 and that the rollforward requirement became effective in 2024, aligning with the ground truth. It accurately notes that the standard enhances disclosures without changing measurement. However, there are significant quantitative inaccuracies: the LLM states Caterpillar’s opening balance was $803 million and provides a detailed rollforward ($5,140M confirmed, $5,113M paid), but the ground truth only confirms the ending balance of $830 million without specifying the full rollforward. Similarly, the LLM attributes a $1,112M opening and $1,150M ending balance to Honeywell with detailed activity, but the original answer does not provide any specific numbers for Honeywell—only that it adopted the rollforward requirement. These detailed figures appear to be fabricated or misattributed, which severely impacts quantitative accuracy. While the qualitative reasoning—understanding the multi-hop requirement across both companies and the 2024 effective date—is sound and contextually relevant, the inclusion of unsupported numerical details reduces factual correctness. The answer goes beyond the ground truth with unverified data, though the core conclusion about enhanced transparency and adoption is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 361,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s balance sheet shows $49,549 million (≈ $49.5 billion) of credit‑card loans due within one year 【page_86】. Visa, by contrast, says it sees “more than $20 trillion of opportunity globally … to convert cash, check, ACH, domestic schemes and other electronic payments into cards and digital credentials” 【page_8】—so the $49.5 billion of existing short‑term credit‑card debt is only about 0.25 % of the $20 trillion growth pool Visa is targeting through credit‑card issuance.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Company C's $49,549 million in credit card loans due within 1 year and accurately converts this to approximately $49.5 billion. It also correctly cites Visa's $20 trillion opportunity figure. The calculation of 0.25% ($49.5 billion / $20 trillion) is mathematically accurate and factually sound. (2) All numeric values match the ground truth: $49,549 million is correctly represented, and $20 trillion is accurately referenced. The percentage calculation (≈0.25%) is correct. (3) However, the LLM answer focuses narrowly on a quantitative comparison and misses the qualitative alignment emphasized in the original answer—specifically, that Company C’s short-term credit exposure reflects broader industry trends that align with Visa’s strategic growth initiatives through partnerships and increased transaction velocity. The multi-hop synthesis between Company C’s balance sheet item and Visa’s strategic vision is partially correct but underdeveloped. (4) While the numbers and context are largely accurate and relevant, the failure to fully synthesize the strategic implication—that Company C’s loan portfolio exemplifies the kind of activity Visa aims to scale—reduces the qualitative accuracy. The answer is factually correct but lacks depth in connecting financial data to strategic intent as required by the multi-hop nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 385,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution revenues are insulated from weather‑driven consumption swings by regulatory “weather‑ and revenue‑normalization” mechanisms and weather‑derivative contracts that limit exposure to typical weather changes (SO 10‑K p.86). NextEra Energy’s electricity demand, however, is directly affected by severe weather—both raising load and causing outages—and the company relies on hedging, trading and operational actions such as winterizing and load‑shedding, which it notes may not fully protect against extreme‑weather impacts (NEE 10‑K pp.26‑28).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) Quantitatively, there are no numeric values in the LLM answer that contradict the original; while the 6.2% net income decrease for Southern Company Gas in 2023 is omitted, the LLM does not include any incorrect numbers, and the absence of this figure does not introduce inaccuracy. The LLM correctly references risk mitigation strategies without fabricating statistics. (2) The entity identification is correct: Southern Company Gas (referred to accurately as Southern Company) and NextEra Energy (with correct ticker NEE) are properly distinguished. The years and regulatory mechanisms (weather normalization, weather derivatives, hedging, operational actions) are correctly attributed. (3) The multi-hop reasoning is sound: the model compares weather impacts on gas distribution (consumption-driven, mitigated by normalization) versus electricity demand (operationally disruptive, with partial mitigation), synthesizing across both companies’ risk exposures and strategies. (4) The LLM captures the qualitative contrast: Southern’s structured, revenue-stabilizing mechanisms vs. NEE’s exposure to severe, unpredictable events with incomplete protection. The only minor omission is the specific 2023 financial impact (6.2% net income decline), which adds context but does not alter the correctness of the overall comparison. Wording differences (e.g., 'revenue-normalization' vs. 'weather normalization') are acceptable and semantically aligned. The answer is fully relevant and focused on the comparative risk exposure and mitigation strategies as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 457,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s earnings are driven almost entirely by its franchise network – about 41,432 of its 43,477 system‑wide restaurants (≈95 %) are owned by conventional franchisees, developmental licensees or foreign affiliates, and the Company’s revenue comes mainly from franchise royalties, rent and related fees rather than from directly operated stores (see page 45‑46). In contrast, General Motors uses non‑consolidated joint‑venture affiliates to produce trucks, crossovers and other vehicles, but sales to those affiliates are a tiny slice of total revenue (automotive sales to affiliates were only $90 million in 2024 versus roughly $172 billion of total net sales, and the affiliates are accounted for using the equity method) and the affiliates operate as separate, equity‑owned production partners rather than core revenue generators (see pages 77‑78, 103‑104).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies McDonald's franchise-based revenue model, emphasizing royalties, rent, and fees from affiliates, and contrasts it with GM's use of nonconsolidated joint ventures for vehicle production. The core distinction—recurring royalty income vs. transactional affiliate sales—is accurately conveyed. (2) Quantitatively, the LLM provides specific figures: ~95% of McDonald's restaurants are franchised (41,432 of 43,477), and GM's automotive sales to affiliates were $90 million in 2024 versus ~$172 billion in total net sales. These numbers are plausible and consistent with typical SEC filing disclosures; while the original answer doesn’t include these exact figures, they do not contradict it and add precision. The $90M vs $172B comparison effectively underscores that affiliate sales are a negligible portion of GM’s revenue, reinforcing the qualitative point. (3) The multi-hop reasoning is sound: the model synthesizes operational structure (franchise vs. joint-venture manufacturing), revenue type (recurring vs. transactional), and financial contribution across two different companies and business models. It correctly notes that GM accounts for these affiliates under the equity method, implying they are not consolidated, which supports the structural distinction. (4) The answer is contextually excellent—directly addressing revenue contribution and operational structure as asked. The only minor limitation is that it doesn’t explicitly mention 'crossovers' in the context of GM’s affiliate production beyond the initial reference, though it does group them with trucks and other vehicles. Overall, the answer exceeds the ground truth in specificity and remains factually and logically consistent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 486,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "CMCSA’s Class B shares lock in a fixed 33⅓ % of the company’s voting power that is expressly non‑dilutable, and they may only be converted share‑for‑share into Class A stock under specific restrictions (CMCSA 10‑K p. 91). In contrast, Alphabet’s Class B shares carry ten votes each but can be converted at the holder’s option at any time and automatically convert to Class A upon any sale or transfer, so the voting power can shift through voluntary or transfer‑triggered conversion (Alphabet 10‑K p. 82).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a non-dilutable 33⅓% voting power and are convertible share-for-share into Class A with restrictions; GOOGL's Class B shares have 10 votes per share, can be voluntarily converted, and automatically convert to Class A upon sale or transfer. (2) Quantitative elements—33⅓% voting power and 10 votes per share—are correctly stated. No calculations are required, and all numbers match the original. (3) The multi-hop reasoning is sound: the answer correctly contrasts CMCSA’s structural voting protection (immune to issuance dilution) with GOOGL’s conversion-upon-transfer policy, which exposes its Class B shares to loss of voting control. (4) The answer fully addresses the comparative aspect of the question, including conversion mechanisms and implications for voting dilution, with appropriate contextual citations to the 10-Ks. Wording differs slightly but meaning is preserved. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 308,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "American Express treats its Level 3 debt securities – which have no active market – by using the carrying amount as a “reasonable proxy” for fair value, adjusting only if its internal credit model indicates that cash‑flows may not be fully received【page_146】. Because Level 3 pricing relies on unobservable, model‑driven inputs rather than observable market prices, a sudden loss of market liquidity can cause the proxy value to diverge from the price that could actually be realized, exposing AmEx to valuation risk in illiquid conditions【page_145】. Morgan Stanley warns that market‑liquidity shocks and sharp asset devaluations make it difficult to value and monetize positions, which can impair its ability to hedge or unwind exposures and thus weaken its market‑risk management during such periods【page_13】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying AXP's (American Express's) use of internal credit models and carrying amounts as a proxy for fair value for Level 3 securities, which are sensitive in illiquid markets. It accurately captures the risk that model-driven, unobservable inputs can lead to valuation divergence when liquidity dries up, aligning with the ground truth's emphasis on valuation risk under scarce observable data. The reference to Morgan Stanley (MS) correctly reflects MS_10k_2024.pdf's warning about liquidity shocks impairing valuation, monetization, hedging, and risk management—directly addressing the second part of the question. However, the LLM omits specific examples mentioned in the original answer: (1) the debt securities from Community Development Financial Institutions, and (2) the embedded derivative in GBT JerseyCo Limited valued via Monte Carlo simulations. These are key multi-hop details that demonstrate the specific valuation techniques and instruments involved, and their absence represents a minor but notable gap in completeness. There are no numerical inaccuracies—no specific numbers (e.g., dollar amounts, percentages) are cited in either answer, so quantitative accuracy is unaffected. The reasoning is sound and synthesizes across AXP and MS filings appropriately, showing how AXP's methodology creates exposure that can propagate into broader market risk management challenges for MS. Wording differs but meaning is semantically equivalent. Thus, while the core facts and logic are correct, the missing specific instruments and valuation methods prevent a perfect score on qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 464,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron values its Level 2 derivatives with internal discounted‑cash‑flow models that are anchored to observable market inputs—such as quoted interest‑rate curves, foreign‑exchange rates, stock prices and volatility—so the fair‑value estimate is largely market‑driven with only modest management tweaking【page_119】. Exxon, by contrast, valued the upstream assets acquired from Pioneer using discounted‑cash‑flow models that depend heavily on management‑derived assumptions about future production, commodity‑price forecasts (based on third‑party expert averages), drilling and operating costs and risk‑adjusted discount rates, making the valuation far more judgment‑intensive【page_71】【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly contrasts Chevron's use of observable market inputs (interest-rate curves, FX rates, stock prices, volatility) for Level 2 derivatives with Exxon's use of management-intensive discounted cash flow models for valuing upstream assets from Pioneer. The characterization of Chevron's approach as 'largely market-driven with only modest management tweaking' aligns with the original answer's emphasis on minimal adjustments and reliance on third-party quotes and pricing services. Similarly, the LLM correctly identifies that Exxon's DCF model relied on management-derived assumptions—production forecasts, commodity prices based on third-party expert averages, costs, and risk-adjusted discount rates—highlighting the higher subjectivity, consistent with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; all references are qualitative and correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes valuation approaches across two companies (Chevron and Exxon), two asset types (Level 2 derivatives vs. upstream acquisition), and two methodologies (market-anchored models vs. judgment-heavy DCFs), correctly attributing sources of inputs and degree of management judgment. (4) The only minor deviation is that the original answer explicitly mentions 'third-party broker quotes, industry pricing services, and exchanges' for Chevron, while the LLM focuses on 'internal models anchored to observable inputs'—a slightly different framing but semantically consistent given that Level 2 valuations often use internal models calibrated to observable data. This nuance does not undermine factual correctness. Overall, the answer is factually sound, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 514,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy’s renewable projects are held in VIEs that are backed by corporate guarantees for debt service and O&M, and the PPAs it negotiates are a key input to those VIE financing structures; the company also uses tax‑equity partnerships to monetize the federal investment‑tax credits attached to the assets (DUK 10‑K Commercial Renewables discussion of PPAs and tax‑equity arrangements). Southern Power’s solar investments, on the other hand, are accounted for as long‑term operating‑lease PPAs (up to 25 years) and the associated ITCs are largely transferred to tax‑equity partners, with the retained credits shown as expected future benefits and occasional lease‑related losses (SO 10‑K Tax Credits and PPAs as operating leases).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with strong semantic equivalence. (1) All factual elements are correct: Duke Energy uses VIEs with corporate guarantees and negotiates PPAs that are critical to financing, and it leverages tax-equity partnerships to monetize federal tax credits. Southern Power structures its solar investments as long-term operating leases (up to 25 years), consistent with the original answer, and transfers ITCs to tax-equity partners, retaining future benefit expectations. (2) Quantitative accuracy is perfect: while no specific dollar amounts or dates are repeated in the LLM answer (e.g., $1.2 billion unutilized credits as of December 31, 2021), the omission does not constitute an error—these specifics were present in the ground truth but not strictly required for correctness if the broader mechanism (use and transfer of ITCs via tax equity) is accurately described. The LLM correctly references the use of tax credits and their treatment without misstating any numbers. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Duke Energy and Southern Power, contrasting their financial structures (VIEs vs. operating leases) and tax credit utilization strategies, drawing on appropriate SEC filing disclosures (citing DUK and SO 10-Ks). (4) The answer is contextually relevant and fully addresses the comparative question on financial structure and tax credit use in relation to PPAs. The only minor shortcoming is the absence of the specific $1.2 billion figure and date, which would have strengthened completeness, but since the qualitative mechanism of tax credit utilization is correctly explained, this does not undermine the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 512,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s dual‑class structure concentrates control – holders of Class A common stock elect three‑quarters of the Board of Directors (Nike 10‑K p.27). In Home Depot, restricted‑stock awards give each recipient voting rights on the shares underlying the award (including unvested shares) but do not allocate a fixed block of board seats, so the voting influence is dispersed among many employees rather than concentrated (Home Depot 10‑K p.67).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that Nike's Class A Common Stock elects three-quarters of the Board of Directors, matching the original answer. It also accurately describes Home Depot's practice of granting voting rights on restricted stock awards at grant date, including unvested shares. No numerical errors are present. (2) The answer addresses all key aspects of the question: it contrasts NKE’s centralized governance via a dual-class structure with HD’s broader distribution of voting rights through restricted stock awards. (3) Entity accuracy is correct—NKE and HD are properly identified, and the governance mechanisms (Class A stock, restricted stock awards) are accurately attributed. (4) The reasoning is sound: it correctly infers that NKE concentrates voting power while HD disperses it, even though HD does not allocate fixed board seats. The only minor omission is that the LLM does not explicitly mention that neither company allows Class B/C shareholders to vote on most matters, which is included in the ground truth and adds a small nuance to the comparison. However, this does not detract significantly from the overall correctness. The answer is semantically equivalent in substance and conveys the core contrast in governance influence accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 375,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix does not disclose a dollar‑amount for its foreign‑exchange exposure; instead it uses forward contracts that are designated as cash‑flow hedges of forecasted revenue transactions, with gains or losses initially recorded in AOCI and re‑classified to revenue when the underlying sales occur, thereby dampening the impact of currency movements. Disney, on the other hand, quantifies its currency‑sensitive exposure with a VAR model that estimates a one‑day potential loss of about $45 million (average $48 million, up to $57 million) for its currency‑sensitive financial instruments. Thus, Netflix’s exposure is managed through hedges without a disclosed risk figure, whereas Disney’s exposure is explicitly measured and reported as a VAR amount in the tens of millions of dollars.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Netflix does not disclose a dollar amount for its foreign-exchange exposure, but the ground truth states Netflix had a $293 million loss in 2023 from foreign currency transactions, which is a disclosed exposure figure. The LLM incorrectly reports Disney's VAR estimate as around $45 million (average $48 million, up to $57 million), while the ground truth states Disney's VAR for maximum one-day loss was $255 million in 2024 (down from $284 million in 2023). These numbers are drastically different and materially misrepresent the scale of risk. (2) Quantitative accuracy is very low: the $293M Netflix loss and $255M/$284M Disney VAR figures are entirely missing or replaced with incorrect values. The LLM's cited VAR range of $45M–$57M contradicts the ground truth by over 80%. (3) While the LLM correctly identifies that Netflix uses forward contracts to hedge forecasted revenue transactions and that Disney uses a VAR model, it fails to capture the key multi-hop insight: Disney's VAR model explicitly excludes forecasted transactions, whereas Netflix hedges them. This critical comparative point is missing, undermining the reasoning. (4) Contextual relevance is moderate because the answer addresses FX risk management and hedging instruments, but the incorrect numbers and missing comparative analysis severely limit its usefulness. The conclusion that Netflix lacks a disclosed risk figure is false given the $293M loss data. Overall, major factual and quantitative errors lead to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 438,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "MDLZ’s VAR model builds the expected‑return distribution from market moves observed in the **quarter immediately before the measurement date** and then uses **the four most recent quarters** to compute average VAR figures. PM’s VAR does the same – it derives the distribution from **interest‑rate and forward‑currency movements primarily over the preceding quarter** and uses **the four preceding quarters** for its average, high and low VAR calculations. Because both firms use a one‑day, 95 %‑confidence horizon but base the distribution on recent quarterly data, each assessment is focused on short‑term (daily) risk while anchoring the estimate in the most recent market behavior.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: both MDLZ and PM use the preceding quarter for year-end VAR distributions and four quarters for average VAR calculations. The LLM correctly identifies that both companies use recent quarterly data, with no incorrect numbers or time periods. (2) The answer accurately reflects that MDLZ uses the prior quarter for return distribution and four quarters for averages, and PM uses the same approach for average, high, and low VAR—this matches the original answer. (3) The reasoning is sound: the LLM correctly synthesizes that both firms anchor in recent market behavior with a short-term (daily) risk horizon. However, it slightly underemphasizes the nuance in the original answer that MDLZ 'explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon'—this comparative implication is downplayed in favor of emphasizing similarity. (4) Despite this minor omission in interpretive depth, the LLM captures the core multi-hop comparison and maintains semantic equivalence. The contextual relevance is excellent, directly addressing time periods and risk horizon implications. Minor deduction only for not fully highlighting MDLZ’s potentially extended horizon as a differentiating point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 378,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "Disney’s $0.6 billion goodwill impairment in fiscal 2024 was the result of management’s quantitative fair‑value test, and the auditor treated the related assumptions—future revenues, operating expenses, margins, terminal growth rates and discount rates—as a critical audit matter, testing the controls, underlying data and the reasonableness of those assumptions with specialist expertise. Netflix’s auditor took a similar approach to significant assumptions, but focused on the content‑amortization model, testing controls over the method and the historical and forecasted viewing‑hour assumptions, comparing them to actual trends and performing sensitivity analyses. In short, both audits centered on evaluating and testing management’s key estimates, but Disney’s pertained to goodwill valuation while Netflix’s pertained to content amortization estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge and fiscal 2024 are correctly stated. No calculations are required, and all numeric references are accurate. (2) The LLM correctly identifies that Disney's goodwill impairment was based on significant assumptions including future revenues, operating margins, terminal growth rates, and discount rates, and that the auditor (PricewaterhouseCoopers LLP, though not explicitly named here) treated these as a critical audit matter, evaluating controls, data, and reasonableness using specialists—consistent with the original. Similarly, for NFLX, the focus on content amortization assumptions like forecasted and historical viewing hours, comparison to actual trends, and use of sensitivity analyses is correctly captured. (3) The multi-hop reasoning is sound: the answer synthesizes audit approaches across two companies (DIS and NFLX), correctly contrasting the specific estimates (goodwill vs. content amortization) while highlighting commonalities in auditor methodology (use of specialists, sensitivity analysis, benchmarking to actuals). (4) Minor deduction in qualitative accuracy because the LLM does not explicitly name the auditor (PwC) for both companies, though this is implied by context. Otherwise, the answer is semantically equivalent, complete, and highly relevant, addressing both the nature of the impairment and the comparative audit approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 410,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck HIV‑injectable collaboration is structured around a modest cost‑share—Gilead funds about 60 % of development and commercialization costs and Merck 40 %—and the parties split product revenue 50/50 until sales exceed $3.5 billion (injectable) or $2 billion (oral), at which point Gilead’s share rises to 65 %; the filing notes no upfront fees or large milestone payments. In contrast, the Arcellx partnership uses a 50/50 cost‑share but required a $313 million upfront payment plus a $299 million equity investment, and it includes performance‑based development and regulatory milestones of up to $1.5 billion (with $68 million paid in 2024) plus additional commercial milestones and royalties, making it far more capital‑intensive and milestone‑driven than the Merck arrangement.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $313 million upfront payment, $299 million equity investment, and $68 million in milestones paid in 2024 for the Arcellx collaboration, which aligns with the ground truth. However, it introduces revenue-sharing terms (50/50 split with thresholds at $3.5B and $2B, and Gilead’s increase to 65%) and a 50/50 cost-share with Arcellx that are not present in the original answer or supported by the knowledge graph. The ground truth states Gilead and Merck share costs at 60/40 (Gilead/Merck), but says nothing about revenue splits or sales thresholds, nor does it mention any cost-sharing structure with Arcellx—only that Gilead made upfront and milestone payments. These additions are factually unsupported and represent significant quantitative inaccuracies. (2) While the dollar amounts and dates for the Arcellx deal are accurate, the inclusion of unverified percentages and thresholds (e.g., 50/50 revenue split, $3.5B trigger, 65% uplift, 50/50 cost-share with Arcellx) undermines quantitative accuracy. The original answer emphasizes that the Merck deal has no material expenses through 2024 and focuses on cost-sharing without upfront payments, which the LLM captures in spirit but distorts with fabricated details. (3) The multi-hop reasoning is sound in comparing the nature of the two agreements—highlighting that Arcellx involves significant upfront and milestone payments while Merck does not—but the synthesis is weakened by inventing structural terms not in the source. The core contrast (cost-sharing vs. capital-intensive milestone-driven deal) is valid and well-reasoned. (4) Contextual relevance is high because the answer directly addresses the comparison of financial commitment and milestone payments between the two collaborations. Despite the factual overreach, the central conclusion—that the Arcellx deal is more financially committed and milestone-driven—is consistent with the ground truth. The score is reduced due to unsupported numerical claims, even though key facts are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 554,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla has entered into multi‑year pricing agreements with Panasonic that lock in the price of its Gigafactory 2170 cells (the 2020 Pricing Agreement) and of Japan‑sourced cells (the 2019 and 2021 Pricing Agreements), giving the company a stable, predictable cost base for those batteries (TSLA 10‑K p. 107). In contrast, GM’s 10‑K does not disclose comparable long‑term battery pricing contracts and instead notes exposure to battery‑procurement cost fluctuations, meaning its battery costs are more subject to market volatility and less predictable (GM 10‑K p. 76‑80).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced cells, and contrasts them with GM's lack of disclosed long-term contracts. The core conclusion about Tesla having greater cost predictability and GM facing more volatility is consistent with the ground truth. However, there are minor inaccuracies in dates: the LLM states '2019 and 2021 Pricing Agreements' for Japan-sourced cells, while the ground truth specifies execution on December 29, 2020. This discrepancy affects quantitative accuracy. Additionally, the Tesla 10-K page cited (p. 107) is not verified against the ground truth, which does not include page numbers, but this is a lesser concern. (2) The ground truth specifies the Gigafactory agreement was executed June 9, 2020, and Japan-sourced on December 29, 2020—both in 2020. The LLM incorrectly splits Japan-sourced agreements into 2019 and 2021, introducing factual error in timing. No calculations are involved, so numerical accuracy is not an issue beyond dates. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Tesla and GM filings, comparing contractual stability and cost predictability. It infers from absence of disclosures in GM’s 10-K (pp. 76–80) that GM lacks long-term visibility, which aligns with the ground truth referencing p. 78. (4) Despite the date inaccuracies, the overall qualitative assessment and contextual relevance are strong. The answer addresses all parts of the question, draws a valid comparison, and supports it with appropriate sourcing. The correctness score is reduced to 8 due to the incorrect dating of agreements, but the core factual and inferential content remains largely accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 481,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola actively hedges its currency exposure – it designates foreign‑currency senior notes as net‑investment hedges (a non‑derivative instrument) and also uses forward contracts and fair‑value hedges – which limited the impact of a 10% adverse FX move to about $38 million of pretax earnings in 2024 (versus a $516 million hit without hedges). Procter & Gamble, despite operating in the same markets, simply reports the size of the exposure – foreign‑exchange fluctuations reduced net earnings by roughly $589 million in 2024 – and its filing does not describe a comparable non‑derivative hedging strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its quantitative claims. The ground truth does not mention specific figures such as a 10% adverse FX move costing $38 million or $516 million without hedges for Coca-Cola, nor does it state that FX fluctuations reduced Procter & Gamble's net earnings by $589 million in 2024. These numbers are not present in the original answer and appear to be fabricated or hallucinated. There is also no mention of forward contracts or fair-value hedges in the ground truth for Coca-Cola — only non-derivative instruments like foreign currency-denominated debt are cited. (2) The quantitative accuracy is low because all cited dollar amounts and hypothetical scenarios (e.g., 10% FX move) are unsupported by the original answer. While the format variation allowance applies to number presentation, it does not excuse introducing entirely unverified figures. (3) Qualitatively, the reasoning is partially sound: the LLM correctly contrasts Coca-Cola’s structured use of non-derivative hedges with P&G’s reported exposure and lack of comparable non-derivative strategy. It captures the core idea that Coca-Cola has a more formal hedging framework while P&G acknowledges material FX impact. This reflects multi-hop synthesis across both companies’ disclosures. (4) Contextual relevance is high because the response directly addresses the comparison between Coca-Cola’s hedging practices and P&G’s FX exposure in shared international markets like the UK and Germany. Despite incorrect numbers, the overall direction and intent of the comparison align with the original answer. However, the inclusion of fabricated metrics severely undermines factual correctness, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 476,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen explicitly notes that Maryland is one of the four states whose Prescription‑Drug Affordability Boards (PDABs) have the authority to set “upper‑payment limits” on certain drugs, creating a direct regulatory exposure that could force Amgen to cap the price it receives for products sold in‑state 【page_18†L1-L5】.  Amgen’s own discussion of pricing strategy – “pricing our medicines to reflect the value they provide” and developing “more affordable therapeutic choices” – is therefore tied to the risk that a Maryland PDAB could limit those prices 【page_18†L13-L19】.  \n\nBy contrast, the Gilead excerpts provided do not contain any Maryland‑specific PDAB or state‑price‑cap language; Gilead’s disclosed risks are framed in broader terms (e.g., manufacturing disruptions, general pricing pressures) without a distinct Maryland affordability‑board component 【page_17†L1-L8】.  Consequently, Amgen’s exposure in Maryland is a targeted regulatory pricing risk, whereas Gilead’s operational risk in the state is more generic and not linked to a PDAB‑style price‑limit mechanism.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Amgen's exposure to Maryland's PDAB laws and accurately characterizes it as a regulatory pricing risk tied to upper payment limits, supported by specific references to Amgen's 10-K (page 18). It correctly notes that Amgen links its pricing strategy to value and affordability, which is directly relevant to PDAB oversight. However, the LLM answer fails to mention Gilead's CAR T-cell therapy manufacturing facility in Maryland—a key operational risk vector explicitly stated in the ground truth. While the LLM correctly observes that Gilead’s filings do not reference Maryland-specific PDAB risks, it omits the critical multi-hop element that Gilead faces *manufacturing and logistical risks* due to its physical presence and complex production processes in the state. This omission weakens the comparative analysis, which is central to the question. The reasoning is sound where information is present, and all entities (Amgen, Gilead, PDAB) are correctly identified. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is contextually relevant, but the lack of synthesis around Gilead’s operational footprint reduces completeness and qualitative accuracy. Semantic equivalence is partially achieved, but the absence of Gilead’s manufacturing exposure limits full alignment with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 378,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s separate accounts are policy‑holder‑directed funds that are legally segregated and each carries its own investment objective, with the investment risk borne by the policyholder and no explicit sub‑advisor structure or manager‑level diversification described (AIG p.195). By contrast, MET’s ERISA plan assets are placed in insurance separate accounts that are overseen by external investment managers who have discretionary authority, and the assets are deliberately spread across multiple asset classes and managers to limit concentration risk, providing an additional layer of risk mitigation through sub‑advisory discretion (MET p.304).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts and reasoning. (1) It accurately captures that AIG's separate accounts are legally segregated, policyholder-directed, and carry investment risk borne by policyholders, with no mention of sub-advisory discretion—consistent with the original answer. It correctly contrasts this with MET's use of external investment managers with discretionary authority managing ERISA plan assets through separate accounts. The emphasis on diversification across asset classes and managers for risk mitigation is correctly noted for MET. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AIG and MET, comparing their use of separate accounts and risk management approaches. However, the LLM omits some details from the original answer, such as the specific asset classes used by both firms (e.g., derivatives, real estate, private equity for MET), and does not mention that both restrict derivatives to risk mitigation and duration management. It also does not include MET’s explicit goal of maximizing funded status and minimizing volatility. These omissions reduce completeness but do not invalidate the core correctness. (4) The answer remains contextually relevant and semantically aligned with the ground truth, with only minor gaps in detail. Wording differences are acceptable and do not affect meaning. The citation of page numbers (p.195, p.304) suggests source fidelity, though not required for correctness. Overall, the answer is factually accurate and logically structured, meriting a high score with minor deductions for incompleteness in asset class detail and risk strategy nuances.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 495,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock carries essentially no voting power except on a narrow set of defined matters, so Class B holders cannot affect director elections or merger votes and the company’s anti‑takeover provisions (which give Class A shareholders three‑quarters of board votes) remain dominant 【page_27】. In contrast, Home Depot’s restricted‑stock awards give recipients voting rights at the grant date, allowing those award‑holders to vote on board composition and other shareholder matters—including takeover proposals—thereby expanding the group of investors who can influence corporate‑governance decisions 【page_67】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that NKE's Class B stockholders have no voting rights except on limited matters and cannot influence director elections or merger votes, while HD's restricted stock recipients receive voting rights immediately upon grant. The structural impact on corporate governance—particularly board composition and takeover defenses—is accurately contrasted. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance implications from two different companies' stock structures (NKE and HD), drawing a valid comparison about investor influence. The mention of anti-takeover provisions giving Class A shareholders dominance aligns with the knowledge graph, even if slightly more detailed than the original answer. (4) The answer is fully contextually relevant, directly addressing how voting rights structures affect investor influence on governance. The only minor shortcoming is that the LLM does not explicitly name 'Class A Common Stockholders' as the controlling party at NKE, instead referring to them indirectly via voting power concentration, which slightly reduces qualitative precision. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 411,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "META’s Class B common stock is entitled to one vote per share on any matter submitted to a shareholder vote, and the company’s charter gives no special voting rights or extra restrictions to those shares (Meta 10‑K, Item 5, p. 61). Netflix’s voting‑rights policy likewise provides one vote per share of its common stock, but it expressly limits voting to matters actually brought before shareholders and states that holders have no special voting privileges (Netflix 10‑K, Item 5, pp. 59‑61). Thus, both firms use a one‑vote‑per‑share model, but Netflix’s framework emphasizes the limitation to matters presented for a vote, whereas META’s Class B shares enjoy the same voting power as Class A without additional constraints.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim about META's Class B voting rights. According to the ground truth, META restricts Class B common stockholders' voting rights to specific matters such as amendments affecting Class B or C stock, decisions to exit the core payments business, or certain mergers—meaning they do not have general voting rights on all matters. In contrast, the LLM claims that 'META’s Class B common stock is entitled to one vote per share on any matter submitted to a shareholder vote' and that there are 'no special voting rights or extra restrictions,' which directly contradicts the ground truth. This error fundamentally undermines the comparison with NFLX, which correctly provides one vote per share on all matters brought before shareholders. While the LLM accurately describes NFLX's voting framework and correctly notes the one-vote-per-share structure for both companies, it fails to identify the critical limitation on META Class B voting rights. There are no numerical values in dispute, so quantitative accuracy is high. However, the qualitative reasoning is flawed due to incorrect synthesis of META’s voting structure, leading to a misleading comparison. The answer is contextually relevant but based on incorrect information, hence the low correctness and qualitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 370,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both companies rely on a parametric delta‑gamma approximation under normal‑market assumptions (95 % confidence, one‑day holding period). PM uses the technique in its VAR to estimate the maximum probable daily loss in the **fair‑value** of interest‑rate‑ and foreign‑currency‑sensitive instruments (page 81), whereas MDLZ applies the same method in its VAR model to estimate the **potential one‑day loss in pre‑tax earnings** from interest‑rate, currency and commodity‑price movements (page 64).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: both companies use the parametric delta-gamma approximation under normal market conditions, apply a 95% confidence interval, and use a one-day holding period—these match the original answer exactly. (2) The LLM correctly identifies that PM estimates risk in terms of fair value of interest-rate and foreign-currency-sensitive instruments, while MDLZ focuses on potential one-day loss in pre-tax earnings from currency and commodity instruments—this distinction is present in the ground truth and accurately reflected. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use the same technique and similar observation windows (prior quarter), though the LLM does not explicitly mention that both use movements over the preceding quarter for year-end VAR calculations, which is a minor omission. (4) The answer is contextually relevant and directly addresses the comparison asked in the question. The only reason for not scoring a 10 is the lack of explicit mention of the observation period (prior quarter) used by both companies, which is part of the original answer and relevant to methodological similarity. However, this does not undermine the core correctness. Semantic equivalence is maintained, and entity accuracy (PM, MDLZ, VAR, pre-tax earnings, fair value) is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 396,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s Advanced‑Approach capital calculations embed a 2.5 % capital‑conservation buffer in its CET1 regulatory minimum (CET1 = 4.5 % + 2.5 % G‑SIB surcharge + 2.5 % CCB)【page_146】. American Express, which applies the Standardized Approach, must satisfy a 5.4 % stress‑capital buffer (plus a 3.0 % G‑SIB surcharge), resulting in an overall capital‑buffer requirement of roughly 8.4 % of risk‑weighted assets【page_134】. Thus AXP’s required buffer is more than double BAC’s CCB and forms a larger portion of its total Basel III buffer.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Bank of America applies a 2.5% Capital Conservation Buffer (CCB) under the Advanced Approach, it incorrectly breaks down BAC's CET1 requirement as '4.5% + 2.5% G-SIB surcharge + 2.5% CCB', which is not supported by the ground truth and misrepresents the composition of regulatory capital. The original answer does not provide such a breakdown, nor does it mention a 4.5% base or G-SIB surcharge. Similarly, for American Express, the LLM claims a '5.4% stress-capital buffer' and a '3.0% G-SIB surcharge', resulting in an '8.4% overall buffer', but the ground truth does not specify these exact numbers or calculations. These quantitative details are fabricated or inferred beyond what the original answer supports. (2) The quantitative accuracy is low because the specific percentages (5.4%, 3.0%, 8.4%) and the comparative claim that 'AXP’s required buffer is more than double BAC’s CCB' are not present in or inferable from the ground truth. The original answer makes no numerical comparison between the size of the buffers—only that different buffers are used. (3) The multi-hop reasoning is partially sound in that the model identifies the correct institutions (BAC and AXP) and associates them with the correct buffer types (CCB for BAC, SCB for AXP) and regulatory approaches (Advanced vs Standardized). However, it goes beyond the source by introducing unsourced numerical values and a comparative analysis not grounded in the original answer, undermining the qualitative accuracy. (4) Contextual relevance is high because the response addresses the core contrast in buffer mechanisms under Basel III for the two firms. Despite incorrect numbers, it attempts a relevant comparison. However, the correctness score is low due to the invention of specific percentages and calculations not present in the ground truth, which fundamentally misrepresents the factual basis of the answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 536,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "Lockheed Martin values a subset of its Level‑3 fixed‑income holdings using a discounted‑cash‑flow model, where the discount rate applied to projected annuity payments is identified as a “significant input” to the valuation (LMT p. 89). Honeywell, by contrast, uses a discounted‑cash‑flow approach to estimate the fair value of goodwill and indefinite‑life intangibles and explicitly states that the discount‑rate assumption is material and that sensitivity analyses are performed because changes in that rate could materially affect impairment outcomes (HON p. 45). Thus, while both companies treat the discount rate as a key driver, Honeywell emphasizes its material impact and quantifies its sensitivity, whereas Lockheed Martin merely notes its importance without providing a detailed sensitivity analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for valuing certain Level 3 fixed income investments, with the discount rate as a significant input (citing LMT p. 89), and that HON applies DCF to goodwill and intangible asset impairment testing, where the discount rate is a material assumption subject to sensitivity analysis (citing HON p. 45). All entities (LMT, HON), contexts (fixed income vs. intangible assets), and methodologies (DCF with discount rate sensitivity) are accurately represented. The LLM adds value by noting that HON explicitly quantifies the impact of discount rate changes and performs sensitivity analyses, while LMT acknowledges the importance of the rate but does not detail such analyses—this nuance is consistent with the original answer’s implication about sensitivity treatment and is plausibly inferred from the source references. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers are involved beyond page citations, which are correctly attributed). The reasoning is sound and synthesizes information across two companies and use cases appropriately. The only minor limitation is that the original answer also mentions 'projected annuity payments' for LMT and 'terminal value assumptions' for HON, which the LLM omits—these are contextual details that enhance completeness but do not alter the core correctness. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 462,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "Comcast’s Class B stock carries 15 votes per share and, in aggregate, accounts for roughly one‑third (33 ⅓ %) of the company’s voting power, a share that is expressly non‑dilutable【page_91】. Because Comcast’s buy‑back program has been limited to Class A shares (which have only one vote), each repurchase reduces the number of low‑vote shares and consequently increases the relative voting influence of the high‑vote Class B holders. Alphabet’s dual‑class structure gives its Class B shares ten votes each, but those shares can be converted into one‑vote Class A shares—diluting Class B voting power—and Alphabet’s repurchases have been confined to Class A and Class C shares, leaving its Class B voting power essentially unchanged【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B shares have 15 votes per share and maintain a fixed 33 1/3% voting power, which is non-dilutable; repurchases are limited to Class A shares, increasing the relative voting power of Class B holders. Alphabet’s Class B shares have 10 votes each and convert to Class A with dilution, and repurchases are limited to Class A and C shares. (2) Quantitatively, all percentages and vote ratios are accurate (33 1/3%, 15 votes, 1 vote, 10 votes). The dollar amount of $62.0 billion in repurchases from the ground truth is not mentioned in the LLM answer, which is a minor omission, but no incorrect numbers are presented. (3) The multi-hop reasoning is sound: the answer correctly contrasts CMCSA’s fixed voting power structure with Alphabet’s dilutive conversion mechanism and explains how share repurchases affect voting control differently in each structure. (4) The answer is contextually relevant and directly addresses the influence of repurchases on voting control under both companies’ dual-class systems. The only minor shortcoming is the absence of the $62.0 billion repurchase figure for Alphabet in 2024, which was present in the original answer and would have strengthened completeness. However, this does not impair the core correctness of the reasoning or conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 385,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s “Food & beverage” category – which includes all beverage sales – generated $23.8 billion of its $106.6 billion net sales in 2024, or roughly **22 % of total sales**【page_49】.  PepsiCo reports that **beverages account for 23 % of net revenue in its APAC division**【page_73】.  Thus, Target’s overall beverage mix is slightly lower but essentially comparable to PepsiCo’s beverage contribution in the APAC market.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM claims Target's 'Food & beverage' category generated $23.8 billion of $106.6 billion in net sales (22%) in 2024, but this data is not present in the original answer or supported by the context provided. The ground truth states that TGT does not break out beverage sales separately from its grocery segment, so any precise percentage or dollar figure for beverage sales is unsupported. This is a critical error. While PEP's 23% beverage contribution in APAC is correctly cited, the LLM fabricates comparable data for TGT. (2) Completeness: The question asks for a comparison of TGT's beverage sales mix to PEP's beverage revenue contribution in APAC, given both companies' exposure. The original answer clarifies that TGT does not disclose beverage-specific sales, especially in APAC, making a direct comparison impossible. The LLM incorrectly implies such a comparison is valid by asserting a global beverage mix for TGT and comparing it to PEP's APAC-specific figure, which is misleading. (3) Entity Accuracy: The companies (TGT, PEP), metric (beverage revenue contribution), and region (APAC) are correctly identified. However, the LLM misattributes a granular sales mix disclosure to TGT that does not exist in the provided truth. (4) Reasoning: The multi-hop reasoning fails because it compares a global beverage mix for TGT (which isn't disclosed) to a regional (APAC) beverage contribution for PEP, creating a false equivalence. The original answer emphasizes that PEP provides specific regional beverage data while TGT does not — a key distinction the LLM overlooks. (5) Semantic Equivalence: The LLM's conclusion that the mixes are 'slightly lower but essentially comparable' is not supported by the ground truth, which states TGT does not break out beverage sales at all. Thus, while the PEP data is accurate, the TGT data is fabricated, leading to an incorrect synthesis. The answer is partially relevant but fundamentally flawed in its core claim.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 556,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "The Medicare price‑setting provision of the IRA, which will begin for Otezla on Jan 1 2027, could lower the drug’s reimbursement and therefore shrink the cash‑flows that underpin Amgen’s $5.2 billion developed‑product‑technology rights intangible asset, creating a risk that the asset may need to be impaired【page_137】.  Because Otezla is also marketed by Bristol‑Myers Squibb under a licensing agreement (the product table lists BMS as a competitor‑marked product for Otezla)【page_15】, any Medicare price cuts would reduce both Amgen’s and BMS’s revenue share, further increasing the likelihood that the intangible‑asset valuation will be adversely affected【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IRA's Medicare price negotiation starts January 1, 2027 (correct date), applies to Otezla, and poses a risk to Amgen’s $5.2 billion intangible asset valuation (correct dollar amount and asset type). The mention of Bristol-Myers Squibb (BMY) marketing Otezla under a licensing agreement is accurately reflected, with correct entity names and relationship. (2) Quantitative elements—$5.2 billion and Jan 1, 2027—are factually correct and match the original answer; no calculations were required. (3) The multi-hop reasoning is sound: the model correctly links the IRA price negotiation to reduced reimbursement, lower cash flows, potential impairment of the intangible asset, and further amplifies the risk due to BMS’s role in marketing Otezla, which affects revenue sharing. The use of document citations (e.g., page references) supports traceability. (4) The only minor shortcoming is that the LLM does not explicitly quote Amgen’s own statement about future changes in estimates potentially impacting recoverability—a key point in the original answer—making the response slightly less complete in terms of direct corporate disclosure. However, the semantic meaning and risk implication are effectively conveyed. Wording differs but meaning is equivalent. Thus, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only a slight omission in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 416,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s filing shows that its FPGA families (Virtex, Kintex, Artix, Spartan, etc.) are included in its data‑center portfolio and are sold directly to hyperscale cloud operators as part of its server‑CPU, GPU, DPU and FPGA product mix. By contrast, Intel’s Altera business provides programmable‑semiconductor FPGAs for a broader range of embedded, communications and cloud‑enterprise applications, and Intel has chosen to run Altera as a standalone business to monetize it (and eventually spin it off), rather than integrating it into its core product lines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that AMD offers FPGAs (naming specific families like Virtex, Kintex, etc.) as part of its data center portfolio and sells them directly to hyperscale cloud operators, integrating them with CPUs, GPUs, and DPUs—this matches the original answer's emphasis on AMD's direct role in hyperscale data centers, including for AI workloads. The LLM also accurately states that Intel operates Altera as a standalone business to monetize it (with potential spin-off or IPO), and that Altera serves embedded, communications, and cloud-enterprise markets—consistent with the original answer. The only minor omission is that the LLM does not explicitly mention AMD's Adaptive SOCs or Intel's pursuit of an IPO as a specific monetization path, though 'spin it off' is semantically close. There are no numeric values in the question or answers, so quantitative accuracy is not applicable but assumed perfect. The reasoning is sound, showing a clear multi-hop synthesis between AMD’s integration strategy and Intel’s structural decision with Altera. The answer is contextually fully relevant and conveys the competitive yet distinct positioning of both companies. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight incompleteness on AMD's Adaptive SOCs and Intel's IPO plans, but remains highly accurate overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 393,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s Class B common stock carries 15 votes per share and provides roughly one‑third (33.3 %) of the company’s total voting power, yet all of those votes are held by a single insider – Brian L. Roberts – with only three record holders of the Class B shares【page_38†L13-L21】【page_38†L23-L27】. In contrast, Alphabet’s Class A common stock is widely held, with about 300.8 million shares outstanding (each with one vote) and no comparable concentration of ownership, reflecting a far more dispersed shareholder base【page_2†L31-L34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively: The 33.3% voting power for CMCSA Class B stock is correctly stated (matches 33⅓% in original). The detail that Brian L. Roberts beneficially owns all shares and there are only 3 record holders is accurately reflected. For GOOGL, the LLM rounds 300,754,904 shares to 'about 300.8 million', which is acceptable and common in financial reporting. The original specifies a market value of ~$1,451.1B as of June 30, 2021, which the LLM omits, but this is a minor omission that does not affect the core comparison. (2) Calculations: No explicit calculations required; percentages and comparisons are sound. (3) Multi-hop reasoning: The LLM correctly synthesizes across two companies (CMCSA and GOOGL), compares voting power concentration vs. dispersion, and ties it to ownership structure—answering the comparative question. It correctly notes CMCSA’s Class B has concentrated control (15 votes/share implied but not critical to the voting power %) while GOOGL’s Class A is widely held. (4) Semantic equivalence: The LLM captures the essential contrast—concentrated insider control at CMCSA vs. broad, dispersed ownership at GOOGL—despite slightly different phrasing. The only minor shortcoming is the omission of the GOOGL market value figure, but this is not central to the ownership structure comparison. All entities (CMCSA, GOOGL, Class A/B stock, Brian L. Roberts) and timeframes (implied 2021/2022) are correct. Overall, the answer is factually sound, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 438,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The Keytruda patent‑license agreement cuts Merck’s royalty on global Keytruda sales from 6.5 % through 2023 to 2.5 % from 2024‑2026, which will slash BMS’s share of Merck’s Keytruda royalties by roughly two‑thirds (BMS 10‑K p. 90). While that reduction lowers BMS’s direct royalty income and thus its revenue reliance on Merck, BMS remains financially linked to Merck through joint development of combination regimens—e.g., the V940‑Keytruda Phase 3 program where Merck and Moderna share development costs and any profits equally (p. 90)—and the Reblozyl co‑promotion deal that generates additional royalty and milestone payments (p. 90).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the royalty drop from 6.5% to 2.5% starting in 2024 is accurately stated, and the reference to a roughly two-thirds reduction in BMS's royalty income is a valid approximation (a (6.5 - 2.5)/6.5 ≈ 61.5% decrease, so 'two-thirds' is a reasonable rounding for emphasis). The time frame '2024–2026' is not in the original answer but does not contradict it and may reflect additional context from the 10-K. (2) The entities—Bristol-Myers Squibb, Merck, Moderna, Keytruda, V940 (mRNA-4157), Ono (implied in original but not mentioned here), and Reblozyl—are correctly identified. The mention of the Reblozyl co-promotion deal adds context not in the original answer but is factually relevant and enhances completeness without introducing error. (3) Multi-hop reasoning is sound: the answer correctly links the reduced royalty rate to lower direct income for BMS, acknowledges the continued financial linkage via combination therapies (specifically the V940-Keytruda trial with equal cost/profit sharing), and contextualizes BMS’s ongoing dependency. (4) The only minor shortcoming is that the original emphasizes BMS’s growing reliance on Keytruda royalties (noted increase in 2023), which the LLM answer omits—this slightly weakens the qualitative assessment. However, the core multi-hop logic—reduced royalties diminish upside from new combinations—is effectively conveyed. Wording differs but semantic meaning matches. Overall, the answer is factually correct, well-contextualized, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 443,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "CAT’s adoption of ASU 2022‑06 adds optional expedients that reduce the operational and financial impact of contract modifications that replace a reference rate (e.g., LIBOR) and, as CAT notes, did not have a material effect on its consolidated statements. BA’s 2023 risk disclosure, however, centers on U.S.‑government‑initiated contract modifications, curtailments or terminations—issues that the reference‑rate reform guidance does not address—so the ASU does not mitigate the material risk BA identified, although it may ease accounting for any rate‑related changes that arise.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains some correct elements but fundamentally misrepresents the relationship between ASU 2022-06 and BA's disclosed risk, leading to a significant reasoning error. (1) Quantitatively, the answer does not contradict any numbers in the ground truth—it correctly references ASU 2022-06 and implies its relevance to reference rate reform (e.g., LIBOR), and while it omits BA's 37% revenue figure from U.S. government contracts, it does not state incorrect numbers. Thus, quantitative accuracy is high by absence of error, though incomplete. (2) However, the core reasoning is flawed: the LLM claims ASU 2022-06 'does not mitigate the material risk BA identified' because BA’s risk relates to government-initiated modifications, which it claims are outside the scope of reference rate reform. This contradicts the ground truth, which correctly explains that ASU 2022-06 *does* help BA manage the accounting impact of contract modifications due to reference rate changes—even in government contracts—by allowing simplified treatment. The fact that U.S. government contracts can be modified without notice *increases* the relevance of such expedients, rather than negating it. (3) The multi-hop synthesis fails: the model incorrectly treats 'contract modifications' in BA’s risk disclosure as unrelated to reference rate reform, when the ground truth explicitly links them in the context of LIBOR transition. (4) The LLM also mischaracterizes CAT’s adoption as having 'no material effect'—while technically true per CAT’s filing—it uses this to downplay the ASU’s broader utility, missing that the standard’s value lies in preventing material impacts through simplified accounting. Overall, the answer is partially factually accurate but fails the central logical connection required by the question, warranting a low correctness score despite acceptable formatting and no numerical errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 511,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 Crown Castle transaction was a $4.8 billion cash deal in which AT&T kept the 9,048 towers on its balance sheet, continued to depreciate them and recorded the entire cash receipt as a financing obligation (interest‑bearing at roughly 3.9 % and a $269 million payment in 2024)【page_90†L13-L20】【page_91†L1-L4】. Verizon’s 2024 Vertical Bridge REIT deal was smaller – $2.8 billion – and likewise left the towers on Verizon’s books with ongoing depreciation, but the cash was split into $2.0 billion of prepaid rent and an $830 million financing obligation for the towers Verizon still occupies【page_73†L9-L16】. Thus, both companies treated the tower assets as retained and depreciated them, and both structured the cash proceeds as financing liabilities, though Verizon’s arrangement is lower‑valued and partially accounted as prepaid rent.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the $4.8 billion (rounded from $4.827B) and $2.8 billion figures are correct; the $830 million financing obligation for Verizon is exact. The interest rate (~3.9%) and the mention of a $269 million payment in 2024 (likely a future obligation) are consistent with the financing structure, though the latter detail isn't in the original answer but doesn't contradict it. The split of Verizon’s proceeds into $2.0 billion prepaid rent and $830 million financing obligation correctly sums to $2.8 billion and aligns with the original. (2) The answer addresses all parts of the question: asset treatment (towers remain on balance sheet, depreciation continues), financing obligations (structured as liabilities), and comparison between the two deals. (3) Entities are correct: AT&T (implied in LLM answer despite question mentioning Verizon—note: correction needed), Crown Castle (2013), Vertical Bridge REIT (2024). However, the LLM incorrectly attributes the 2013 deal to AT&T in the response while the question asks about Verizon’s 2024 deal vs. a 2013 deal—yet the original answer clarifies it was AT&T’s 2013 deal, not Verizon’s. The LLM correctly identifies this, so no error. (4) Multi-hop reasoning is sound: it synthesizes asset treatment, financing structure, and accounting treatment across two different transactions. The only minor issue is the rounding of $4.827B to $4.8B without clarification, but this is acceptable per format flexibility. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 449,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s New Zealand business is part of its Asia Pacific, Australia and New Zealand segment, which “makes, markets, distributes and sells” its beverage brands through its own bottling and distribution facilities in the country【page_5】.  Coca‑Cola’s presence in New Zealand is indirect – the Company holds roughly a 19 % equity stake in Coca‑Cola Europacific Partners (CCEP), the independent bottler that “bottles and distributes” Coca‑Cola products there【page_7】【page_88】.  Thus, PepsiCo operates directly in the market, whereas Coca‑Cola’s influence is financial through its minority investment in the bottler.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP operates directly in New Zealand through its APAC segment (specifically mentioned as 'Asia Pacific, Australia and New Zealand'), and KO holds a ~19% stake in CCEP, which bottles and distributes Coca-Cola products there. The 19% figure matches the ground truth. (2) Quantitative accuracy is perfect—no calculations required, and the percentage (19%) is correctly reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes that PEP has direct operational control (via its own facilities) while KO’s influence is indirect through equity in CCEP, a key distinction emphasized in the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention that KO's stake allows for 'influence' or 'indirect control' beyond financial interest—though 'financial through its minority investment' implies this. It also omits the explicit contrast in business models (direct operation vs. equity influence) framed as 'distinct models' in the original, but the semantic meaning is effectively conveyed. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 359,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG values its mortgage‑backed securities (both RMBS and CMBS) primarily with internal, discounted‑cash‑flow models that incorporate market‑derived inputs such as single‑name CDS spreads, issuance spreads and other observable data, and management reviews those model outputs for reasonableness (see AIG 5‑FAIR VALUE pages 112‑113). In contrast, Schwab relies on independent pricing services that base CMBS and other fixed‑income prices on observable trades, broker‑dealer quotes and benchmark yields, and it generally accepts those quoted prices unless they appear materially inconsistent (see Schwab page 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core differences between AIG's and SCHW's fair value determination methods for mortgage-backed securities. (1) It correctly states that AIG uses internal discounted-cash-flow models incorporating market-derived inputs like CDS spreads and issuance spreads, with management review—consistent with the ground truth's mention of internal models using interest rates, creditworthiness, and comparable loan pricing. (2) It accurately describes SCHW’s reliance on independent pricing services using broker/dealer quotes, observable trades, and benchmark yields, aligning with the original answer’s emphasis on external pricing sources and observable market data. (3) The LLM references specific document sections (AIG pages 112–113, SCHW page 81), adding verifiability, though these were not required. (4) The only minor omission is that the original answer includes GILD’s evidence to contextualize industry practice—showing that both approaches are complementary within broader market norms. This synthesis across three firms (AIG, SCHW, GILD) is a multi-hop element slightly underdeveloped in the LLM response, but the core comparison between AIG and SCHW is thoroughly and correctly addressed. (5) No numerical inaccuracies exist; there are no explicit numbers in the query or answer, so quantitative accuracy is scored as 10 based on correct use of qualitative financial concepts. (6) Wording differs but maintains semantic equivalence: e.g., 'discounted-cash-flow models' vs 'internal valuation models' are consistent. Overall, the LLM captures the essential contrast and methodology accurately, meriting a 9/10 for correctness due to the partial omission of the broader industry context provided by GILD.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 475,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO’s Level 2 securities are measured using “significant other observable inputs” – for example yield curves, benchmark rates and other market‑derived data – which places them in the Level 2 fair‑value hierarchy (see AVGO 10‑K p. 76‑78). By contrast, Adobe values its fixed‑income securities with a matrix‑pricing approach that combines market‑approach and discounted‑cash‑flow models and also relies on observable inputs such as benchmark yields, issuer spreads and U.S. Treasury or swap curves (see ADBE 10‑K p. 71). Both companies therefore depend on observable market inputs, but AVGO’s methodology is described generically as a Level 2 valuation, whereas Adobe explicitly uses a matrix‑pricing model to incorporate those inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that AVGO uses observable inputs like yield curves and benchmark rates for Level 2 securities, placing them in the Level 2 hierarchy, and references the appropriate section of AVGO's 10-K. It accurately states that ADBE uses matrix pricing with observable inputs such as benchmark yields, issuer spreads, and U.S. Treasury or swap curves, citing the correct document location. There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities (AVGO, ADBE, Level 2 securities, matrix pricing, observable inputs) are correctly identified. The reasoning correctly synthesizes the multi-hop comparison: both companies rely on similar observable market inputs, though ADBE explicitly uses matrix pricing while AVGO’s description is more general. The only minor shortcoming is that the LLM does not explicitly note that matrix pricing itself is a Level 2 technique, which the original answer clarifies, but this does not undermine the overall correctness. Semantic equivalence is strong, and the response is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 324,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "Coca‑Cola HBC accounts for roughly 13 % of Coca‑Cola’s non‑U.S. unit‑case volume. It coordinates distribution of Coca‑Cola trademark beverages in 28 countries, the list of which includes the Czech Republic【page_7】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant factual inaccuracies. The percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC is stated as 13%, whereas the ground truth is 17%. Similarly, the number of countries where distribution is coordinated is reported as 28, but the correct number is 30. Both key quantitative figures are incorrect. (2) Numeric verification: '13%' vs. '17%' and '28 countries' vs. '30 countries' — these are clear discrepancies that affect the factual correctness of the response. While the mention of the Czech Republic aligns with the ground truth, the core metrics are inaccurate. (3) Multi-hop reasoning: The model correctly identifies that Coca-Cola HBC manages a portion of non-U.S. volume and coordinates distribution across multiple countries, including the Czech Republic, indicating some level of proper entity and relationship recognition. However, it fails to retrieve or synthesize the correct values from the knowledge base, undermining the reasoning outcome. (4) The contextual relevance is high because the answer addresses both parts of the question and references appropriate entities and context (e.g., non-U.S. volume, distribution coordination, Czech Republic). However, due to major quantitative errors, the correctness and accuracy scores are low. Minor formatting like 'unit-case' vs. 'unit case' is acceptable and does not impact scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1118,
        "completion_tokens": 398,
        "total_tokens": 1517
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50% equity interest in the Hardy Storage underground facility— a FERC‑regulated, interstate gas‑storage asset in West Virginia— reflects a strategy of investing in stable, rate‑based infrastructure that supports its regulated gas‑utility business and limits market risk. In contrast, NextEra Energy’s 31.9% stake in a 303‑mile pipeline under construction in West Virginia and Virginia is a growth‑oriented, higher‑risk investment that hinges on securing regulatory approvals and resolving legal challenges before it can deliver returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia are accurately reported. These figures match the original answer exactly, satisfying quantitative accuracy. (2) The answer correctly identifies both companies, assets, and their geographic scope, confirming entity accuracy. (3) The reasoning correctly contrasts Duke’s low-risk, regulated infrastructure strategy with NextEra’s higher-risk, growth-oriented approach dependent on regulatory approvals and facing legal challenges—this reflects sound multi-hop synthesis across strategic positioning, asset type, and regulatory context. (4) While the LLM omits a few contextual details present in the original (e.g., naming Pine Needle as another Duke asset, or explicitly stating that Hardy supports reliable supply), the core strategic contrast is fully preserved and semantically equivalent. The omission of minor supporting details prevents a perfect 10 but does not undermine the factual or inferential correctness. Contextual relevance is strong as the response directly addresses the divergent strategies in light of regulatory and market challenges.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 361,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Both Meta and Alphabet use a 10‑to‑1 voting structure, giving each Class B share ten votes and each Class A share one vote (Meta’s 10‑K Note 11 【page_2】; Alphabet’s 10‑K Note 11 【page_82】). With 2.19 bn Class A and 0.344 bn Class B shares, Meta’s Class B shares—though only about 14 % of total shares—command roughly 60 % of voting power (2.19 bn × 1 + 0.344 bn × 10 ≈ 5.6 bn votes) 【page_1】; Alphabet’s identical 10:1 ratio, together with $62 bn of 2024 repurchases of low‑voting Class A and C shares 【page_82】, further concentrates control in the relatively few Class B holders, implying a comparable or even higher ownership concentration than Meta’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies despite addressing all parts of the question and demonstrating relevant contextual understanding. (1) The claim that Meta uses a 10-to-1 voting structure is incorrect: the original answer (ground truth) explicitly states that Meta does not disclose the exact voting ratio between Class A and Class B shares in its filings, whereas the LLM confidently asserts a 10:1 ratio, citing a non-existent disclosure. This is a major factual error. (2) The calculation of Meta's voting power (60%) is based on the false assumption of a 10:1 ratio and is therefore invalid. While the share counts are approximately correct (2.19 bn and 0.344 bn vs. 2,189,898,148 and 343,761,117), the derived voting power (5.6 bn votes) and percentage (60%) are speculative and unsupported by the source. (3) The LLM correctly identifies GOOGL’s 10:1 voting ratio and $62.0 billion in 2024 share repurchases, aligning with the ground truth. (4) The reasoning incorrectly equates Meta’s structure with GOOGL’s by assuming parity in voting ratios, undermining the key distinction highlighted in the original answer: GOOGL’s structure is explicitly defined, while Meta’s is not. This misrepresents the core comparison. (5) Despite incorrect facts, the answer is contextually relevant and attempts multi-hop synthesis (ownership concentration, repurchases, voting power calculations). However, the foundational error in Meta’s voting ratio severely compromises both quantitative and qualitative accuracy. Minor formatting of numbers (e.g., 2.19 bn) is acceptable. Final score reflects partial correctness on numbers and structure but major failure in factual fidelity to disclosed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 463,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The TRAF reform gave Johnson & Johnson a net $0.4 billion tax benefit in 2020, which cut its annual effective tax rate by roughly 2.6 percentage points. Merck’s Swiss tax‑holiday, which started in 2021, shows up as a $1.4 billion foreign‑earnings differential that reduced its effective tax rate by about 10.4 percentage points that year—far larger than the TRAF‑related benefit to J&J.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that JNJ's effective tax rate decreased by 1.9% due to TRAF in 2020, but the LLM claims a 2.6 percentage point reduction, which is incorrect. Additionally, the LLM introduces a $0.4 billion tax benefit for JNJ, which is not mentioned in the original answer and cannot be verified. For MRK, the original answer notes that the tax holiday began in 2021 and contributes to lower tax rates through favorable provisions, but does not quantify the impact. The LLM, however, asserts a $1.4 billion foreign-earnings differential and a 10.4 percentage point reduction in MRK's effective tax rate—specific figures absent from the ground truth and thus unsupported. (2) The dates (2020 for JNJ, 2021 for MRK) are correctly identified, but all numerical values (dollar amounts, percentage impacts) are either fabricated or misstated. Calculations cannot be verified due to lack of source data, but the magnitudes differ significantly from the ground truth. (3) The multi-hop reasoning is partially sound in that the model attempts to compare two companies' Swiss tax incentives across different years, identifying different mechanisms (TRAF reform vs. tax holiday). However, it fails to accurately represent the nature of JNJ's benefit (adjustment of tax basis leading to deductions) and MRK's phased benefit starting in 2021. The synthesis is undermined by invented metrics. (4) While the LLM addresses both parts of the question and maintains focus on Swiss tax impacts affecting effective tax rates, the introduction of false quantitative claims severely undermines factual correctness. The qualitative structure and intent align with the question, but the answer is misleading due to unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 487,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "MCD’s foreign‑currency asset hedging is done by using foreign‑currency debt and derivative contracts to offset the risk on royalties, intercompany financing and long‑term investments in foreign subsidiaries, but the filing does not disclose a specific notional amount for those hedges (see MCD 10‑K p. 22). Nike, by contrast, manages its transactional FX exposure with forward and option contracts—recorded as cash‑flow hedges—covering $9.9 billion of net notional amount in 2024 (up from $8.3 billion in 2023) plus $3.4 billion of cross‑currency swaps, with the explicit objective of reducing earnings and cash‑flow volatility from product‑cost, sales and monetary‑asset/liability transactions (see NKE 10‑K p. 50).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the reversal of notional amounts between MCD and NKE. According to the ground truth, MCD has $9.9 billion in notional amounts of foreign exchange cash flow hedges as of September 28, 2024, while the LLM incorrectly attributes this $9.9 billion figure to NKE. Additionally, the LLM claims NKE had $9.9 billion in net notional amount in 2024 and $3.4 billion in cross-currency swaps, but this data is not present in the original answer and contradicts it—no mention of cross-currency swaps or specific year-over-year changes for NKE exists in the ground truth. The original answer does not provide a notional amount for NKE at all, nor does it mention $8.3 billion in 2023 or any increase. Conversely, the LLM states MCD’s filing 'does not disclose a specific notional amount,' which directly contradicts the ground truth stating MCD had $9.9 billion in notional hedges. This major quantitative error undermines the correctness of the response. Qualitatively, the LLM correctly identifies that both companies use options and derivatives for FX risk management and that NKE focuses on transactional exposures like product costs and sales, aiming to stabilize USD inventory costs. It also correctly notes MCD uses derivatives to hedge foreign currency assets, though it adds unverified details like 'foreign-currency debt' and 'royalties' not mentioned in the ground truth. The reasoning partially supports a comparison but is based on incorrect data attribution, failing the multi-hop synthesis requirement—correctly linking MCD’s asset-based hedging with its $9.9B notional and contrasting it with NKE’s transactional focus. Contextually, the answer is well-structured and relevant to the question’s intent, discussing objectives, instruments, and notional amounts as requested, but the core numerical misassignment leads to an incorrect conclusion. Thus, while the framework is sound, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 533,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The PW800’s exclusive integration on the G500 gives the aircraft higher thrust, lower fuel burn, reduced emissions and greater range and speed—making it faster, more fuel‑efficient and higher‑performing than the older models. Those propulsion benefits underpin General Dynamics’ claim that the clean‑sheet G500 (and G600) replace the G450/G550 with a next‑generation jet that offers superior cabin volume, efficiency, range and flight‑control technology (GD 10‑K page 4 & page 5; RTX 10‑K page 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the PW800 engine's exclusive use on the G500, its performance benefits (fuel efficiency, range, speed, emissions), and how these support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550. The mention of 'clean-sheet design' and advanced technology aligns with the original answer. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the LLM correctly links RTX’s PW800 engine (from RTX 10-K) to the G500 aircraft (from GD 10-K), synthesizing across entities and documents to explain strategic positioning. (4) The only minor omission is that the original answer specifies the PW800 also powers the G400 and G600, which the LLM mentions only parenthetically ('G500 and G600')—but this does not detract from the main point. Wording differs slightly (e.g., 'superior cabin volume, efficiency, range and flight-control technology' adds detail not in the original), but this enhances rather than distorts. Overall, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 360,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes and, as of year‑end 2023, Class B shareholders control roughly 80 % of the total voting power, with the articles of incorporation providing a non‑dilutable floor that keeps Class B voting power above about 50 % (META 10‑K p. 56). Comcast’s structure gives each Class B share fifteen votes but only about 33 ⅓ % of the combined voting power, while Class A holds the remaining 66 ⅔ %; that one‑third share is also generally non‑dilutable under its articles of incorporation (CMCSA 10‑K p. 33).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses all key aspects of the question with strong factual and qualitative accuracy. (1) Quantitatively, the LLM correctly states that CMCSA's Class B has 15 votes per share and holds 33 1/3% of voting power, while Class A holds 66 2/3%—matching the ground truth exactly. It also correctly identifies that CMCSA’s Class B voting power is non-dilutable under its articles of incorporation. For META, the LLM claims Class B holds 'roughly 80%' of voting power and is protected by a non-dilutable floor above 50%, citing the 10-K page 56. While the non-dilutable floor is accurately represented as a structural protection, the exact percentage (80%) is not explicitly confirmed in the ground truth, which instead emphasizes the concentration of ownership (only 23 stockholders of record) without specifying a precise voting percentage. This introduces a minor discrepancy, though such a figure may be inferred from public filings; thus, it does not constitute a major error. (2) The calculation of voting power distribution is logically consistent and aligns with known disclosures, though the absence of direct confirmation of the '80%' figure in the ground truth limits full quantitative precision. (3) Qualitatively, the reasoning is sound: the LLM correctly synthesizes information across both companies, compares voting power, share classes, vote multiples (10 vs 15), and non-dilution mechanisms. It correctly identifies that CMCSA’s non-dilution preserves a fixed one-third voting share, while META’s structure ensures Class B remains above 50%, showing proper multi-hop comparison. (4) Contextual relevance is excellent—the response directly answers the comparative question about dual-class structures, non-dilutable provisions, and voting percentages. The only reason for not scoring 9–10 on correctness is the introduction of a specific '80%' figure not present in the ground truth, which, while plausible, lacks corroboration in the provided reference. Overall, the answer demonstrates strong understanding and accurate synthesis with only minor factual uncertainty.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 565,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMS warns that Revlimid’s European exclusivity is already being eroded by patent settlements that will allow generic lenalidomide to launch in the United Kingdom on January 18 2022 and in other EU countries on February 18 2022, exposing the product to immediate generic competition (BMY 10‑K p. 36). In contrast, Eli Lilly’s risk discussion emphasizes its reliance on regulatory data‑protection—particularly orphan‑drug exclusivity—to extend market protection, noting that any loss or shortening of that data protection would undermine its commercial exclusivity (LLY 10‑K p. 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY (BMS) faces generic entry for Revlimid in the UK on January 18, 2022, and in other European countries on February 18, 2022, due to patent settlements—this matches the original answer exactly. The reference to BMY 10-K p. 36 supports the claim. (2) Quantitative accuracy is perfect: dates are correct and match the ground truth; no calculations are required, but temporal precision is maintained. (3) The contrast with LLY is well-reasoned: the LLM correctly identifies that Eli Lilly relies on regulatory data protection, particularly orphan drug exclusivity (7 years, though not explicitly stated in the LLM answer, the concept is accurately conveyed), and that loss of such protection would impact exclusivity. The citation to LLY 10-K p. 9 adds credibility. (4) Multi-hop reasoning is sound—synthesizing BMY’s patent-based vulnerability with LLY’s regulatory-based protection demonstrates understanding of differing IP strategies. The only minor shortcoming is that the LLM does not explicitly state that orphan drug exclusivity lasts seven years or that it operates independently of patents, which is included in the ground truth and would strengthen completeness. However, the core contrast in exclusivity mechanisms is clearly and correctly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparative risk posed by different IP frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 421,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "Morgan Stanley notes that a portion of its Wealth‑Management and Investment‑Management revenues comes from management fees on client holdings that are heavily weighted toward fixed‑income assets, so those revenues are “sensitive to changes in related markets” such as fixed‑income price movements, although the impact may not track market moves one‑for‑one【page_62】. By contrast, PayPal’s exposure to market risk is more direct: its derivatives and available‑for‑sale debt securities are measured at fair value using pricing models that incorporate interest‑rate yield curves and other observable market inputs, so fluctuations in those markets generate recognized gains or losses on the balance sheet【page_93】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between MS and PYPL's exposure to market risk through pricing models and fixed income markets. (1) All factual elements are correct: MS's asset management revenues are tied to fees on client assets with sensitivity to fixed income markets, though not perfectly correlated; PYPL uses fair value pricing models for derivatives and debt securities with observable inputs, leading to direct recognition of gains/losses. The LLM correctly identifies that MS’s exposure is indirect (via fees) while PYPL’s is direct (via balance sheet impacts). (2) There are no numeric values in the original or LLM answer requiring verification—both describe qualitative risk exposures—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (MS and PYPL), linking their respective use of pricing models and market risk exposure. It correctly contrasts MS’s fee-based sensitivity with PYPL’s fair value accounting treatment, though it omits the specific mention that PYPL elected the fair value option for foreign currency-denominated debt, which strengthens the direct exposure point. This is a minor omission, not a factual error. (4) The answer is contextually relevant, directly addressing the comparison asked in the question. Wording differs from the original but maintains semantic equivalence. The score is 9 instead of 10 due to the slight underdevelopment of PYPL’s fair value election detail, which is part of the full ground truth reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 432,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is embedding generative‑AI directly into its data‑layer service—MySQL HeatWave now “combines transactions, real‑time analytics, machine learning **and generative AI** in one managed cloud service” (ORCL 12) and is offered through OCI, Exadata Cloud@Customer and other on‑premise options (ORCL 10)—so enterprise customers can run AI models where their data lives. Qualcomm, by expanding its **AI Engine and Hexagon NPU** for “high‑performance AI inference at very low power” (QCOM 7) and targeting “consumer IoT products … that adopt on‑device AI capabilities” such as AI‑focused PCs and Snapdragon‑powered devices (QCOM 8), is positioning low‑power, on‑device AI as a core differentiator for consumer‑grade IoT experiences. Together, the two firms are pushing AI processing to the edge of the workload: Oracle for enterprise data workloads, Qualcomm for consumer IoT devices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service (via OCI, Exadata, etc.), enabling enterprise AI workloads where data resides. Qualcomm is advancing on-device AI through its AI Engine and Hexagon NPU for low-power, high-performance inference in consumer IoT devices like smartphones and PCs. (2) Quantitative accuracy is perfect—no numeric claims were made in the LLM answer that contradict or misrepresent the ground truth. While the original answer includes specific projections (19% of smartphones in 2024 and 46% in 2027 being generative AI-capable), the LLM answer does not attempt to reproduce these numbers, which is acceptable since they were not explicitly cited in the provided document excerpts (ORCL 10, ORCL 12, QCOM 7, QCOM 8). Thus, omission does not constitute an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes Oracle’s enterprise-focused, cloud-native AI integration with Qualcomm’s consumer-oriented, edge-processing strategy, drawing a clear contrast in market focus (enterprise vs. consumer) and deployment model (cloud-managed vs. on-device). (4) Semantic equivalence is strong—though wording differs, the core strategic distinction is preserved and accurately conveyed. The only minor shortcoming is the lack of specific IoT market projection numbers from Qualcomm, which were present in the ground truth and would have strengthened completeness. However, since the LLM response is based on cited excerpts that may not contain those stats, this omission is understandable. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 480,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe warns that the EU AI Act will likely force “costly changes” to how it builds, deploys and monetizes its AI models, raising its compliance, governance and R&D expenses and squeezing margins (see Adobe 10‑K Risk Factors p. 23‑24). Because Salesforce’s growth strategy now hinges on Agentforce—an AI‑driven “digital‑labor” layer that powers its sales‑ and service‑platforms (see Salesforce 10‑K p. 6‑7)—Adobe’s added regulatory costs could slow its AI rollout, limit pricing flexibility and reduce investment capacity, leaving it at a relative disadvantage to Salesforce’s more‑integrated, AI‑centric offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Adobe anticipates costly changes due to the EU AI Act, including increased compliance, governance, and R&D expenses, which could slow AI innovation and reduce investment capacity. Salesforce’s reliance on Agentforce as a core growth driver is accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—both correctly note the EU AI Act’s phased implementation through 2030 is not explicitly mentioned in the LLM answer, but this detail is present in the original and only partially reflected here. However, the absence of specific dates does not detract significantly from correctness since the focus is on the competitive dynamic, not timelines. (3) Multi-hop reasoning is sound: the model correctly synthesizes Adobe’s regulatory cost risks with Salesforce’s AI-dependent strategy, concluding that Adobe may be at a relative disadvantage. The logic that increased compliance costs could limit pricing flexibility and investment, benefiting Salesforce, is a valid inference supported by the original. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM cites specific 10-K page references (e.g., p. 23–24 for Adobe, p. 6–7 for Salesforce), adding precision not in the original, which enhances credibility. The only minor omission is the explicit mention that both companies face similar regulatory pressures (per GS_10k_2024), but the focus on Adobe’s vulnerability relative to Salesforce’s integrated AI platform still captures the core competitive implication. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 502,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "Home Depot’s deferred‑share awards give each non‑employee director one share of common stock at the end of service and also accrue dividend equivalents that are paid out as **additional shares** when the underlying share is delivered (HD 10‑K p. 68). In contrast, Lowe’s Accelerated Share Repurchase agreements are a corporate buy‑back tool in which the company pays cash up‑front, receives an initial block of shares, and then **receives further shares (or cash)** from the financing institution at settlement, altering the company’s overall share count rather than directly compensating individual directors (LOW 10‑K p. 61‑62). Thus, HD’s structure distributes stock‑based value directly to directors, while LOW’s structure distributes value indirectly by adjusting the pool of shares held by the company and its shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that HD issues additional shares as dividend equivalents to non-employee directors upon payout of deferred shares, tied to accrued dividends, which matches the original answer. It also accurately describes LOW's ASR agreements as involving receipt of additional shares (or cash) from financial institutions at settlement, not as compensation. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of page numbers (HD p.68, LOW pp.61-62), which are correctly cited. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (HD and LOW), two distinct financial instruments (deferred shares with dividend equivalents vs. ASR agreements), and two stakeholder contexts (direct compensation to directors vs. capital return to shareholders). (4) The only minor shortcoming is that the LLM does not explicitly state that LOW's additional shares are tied to 'repurchase efficiency and final notional value calculations'—a nuance present in the ground truth—but it does convey the essential contrast in purpose and mechanism. Overall, the answer captures the core distinction in stock-based value distribution: HD compensates individuals directly; LOW adjusts overall share count as part of buybacks. Wording differs but semantic meaning and factual content are equivalent. Hence, high scores across all dimensions with a 9 on correctness due to slight omission of LOW's valuation trigger detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 445,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T notes that its adoption of ASU 2020‑04 – the reference‑rate‑reform expedient for contract modifications – “does not materially impact our financial statements” (page 53), indicating that the change is not expected to alter the timing of revenue recognition or the measurement of performance obligations. In contrast, Verizon explicitly discloses that contract modifications can change the timing and scope of its contracts, thereby affecting when revenue will be recognized and the amount of unsatisfied performance obligations (page 67). Thus, AT&T expects little or no effect, while Verizon acknowledges a direct impact on revenue‑recognition timing and performance‑obligation balances.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the qualitative distinction between AT&T and Verizon regarding the impact of contract modifications on revenue recognition and performance obligations. It accurately states that AT&T's adoption of ASU 2020-04 did not materially impact its financial statements and that Verizon acknowledges changes in timing and scope of performance obligations due to contract modifications. However, it omits all quantitative disclosures from Verizon—specifically the $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—which are central to the original answer and critical for a complete comparison. (2) The quantitative accuracy is low because the LLM fails to report any of the dollar amounts disclosed by Verizon, which are key financial metrics directly tied to the impact on revenue recognition timing. These numbers were explicitly stated in the ground truth and are essential for assessing the magnitude of Verizon’s exposure. Their absence represents a significant factual omission. (3) The multi-hop reasoning is sound: the model correctly identifies that ASU 2020-04 relates to reference rate reform and that AT&T and Verizon differ in how they treat contract modifications. It draws a valid contrast in impact—minimal for AT&T versus material for Verizon—even without the numbers. The logic and synthesis across entities are coherent and contextually appropriate. (4) The contextual relevance is high because the answer addresses the core of the question—comparing the impact on revenue recognition timing and performance obligations. The qualitative accuracy is strong due to correct entity identification (AT&T, Verizon, ASU 2020-04), proper interpretation of disclosures, and accurate citation of page numbers (though not required, this adds credibility). However, the lack of quantitative data prevents a full, factually complete response, warranting a correctness score of 7 rather than higher.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 536,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s pension note spells out that “state and local municipal bonds … are classified as Level 2 investments” and that they are valued using a bid‑evaluation process with observable market data (UNP 10‑K p. 57). Lockheed Martin’s pension table shows Level 2 exposure only to corporate, U.S. government and agency debt and contains no municipal‑bond line item (LMT 10‑K p. 87), indicating it does not rely on Level 2 methods for that asset class. Both companies are complying with ASC 820 by disclosing the fair‑value hierarchy, but UNP’s filing reveals a direct reliance on Level 2 valuation for municipal bonds, whereas LMT’s pension plan shows no such reliance.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims Lockheed Martin's pension plan does not rely on Level 2 valuation for municipal bonds because there is no explicit 'municipal-bond line item' in its disclosures. However, the ground truth states that LMT does use Level 2 methodologies for fixed income securities, including when indicative quotes from pricing vendors are corroborated—this would encompass municipal bonds even if not explicitly itemized. The LLM incorrectly infers absence of Level 2 use from lack of granular line-item disclosure, which contradicts the original answer’s assertion that both companies apply Level 2 methods. Union Pacific’s disclosure is accurately represented. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not heavily applicable; however, the citation of page numbers (p. 57, p. 87) appears consistent with typical 10-K structures and does not contradict known facts—thus, no numeric inaccuracies are present. (3) The multi-hop reasoning fails: the model should have synthesized that both companies use Level 2 for similar asset classes under ASC 820, with differences in disclosure specificity, not presence/absence of methodology. Instead, it draws an incorrect conclusion based on reporting format. This undermines the qualitative accuracy. (4) Contextual relevance is moderate—the response addresses pension disclosures, valuation levels, and ASC 820 compliance, so it stays on topic, but the erroneous conclusion about LMT’s methodology significantly reduces its correctness. The implication about ASC 820 adherence is partially valid (both disclose hierarchy), but the contrast drawn is factually unsupported. Thus, correctness score is low due to major factual misinterpretation despite proper framing and citation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 506,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO’s Argentine sales are funneled through Coca‑Cola FEMSA, whose bottling and distribution footprint in Argentina is limited to the federal capital of Buenos Aires and its surrounding area (as listed among FEMSA’s five largest bottlers) 【page_7】. By contrast, Mondelēz’s own Argentine operations are directly subject to the country’s hyper‑inflationary environment—MDLZ applied highly‑inflationary accounting in 2018, recorded a $13 million remeasurement loss in 2021 and contributed only 1.4 % of net revenue—exposing it to currency‑ and inflation‑driven earnings volatility 【page_88】. Thus KO’s risk is tied to a bottling partner’s limited geographic coverage, whereas MDLZ bears direct macro‑economic and inflationary risk in Argentina.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Coca-Cola FEMSA's distribution footprint in Argentina is accurately described as limited to Buenos Aires and surrounding areas; MDLZ’s $13 million remeasurement loss in 2021, Argentina’s contribution of $401 million (1.4%) to MDLZ’s net revenues, and the classification of Argentina as a highly inflationary economy since 2018 are all correctly stated. The dollar amount for KO’s net sales to equity method investees ($14.471 billion) is missing, but this does not detract from the core comparison. (2) Quantitative accuracy is excellent: the $13 million loss, 1.4%, and 2018/2021 timeframes match the original answer exactly. Format variations (e.g., $13 million vs $13M) are acceptable and correctly interpreted. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across KO’s distribution reliance via Coca-Cola FEMSA and MDLZ’s direct financial exposure due to inflation and currency volatility. The distinction between indirect (KO) and direct (MDLZ) exposure is clearly and logically articulated. (4) Semantic equivalence is strong—while the LLM does not explicitly mention the $14.471 billion in net sales to equity investees, it captures the essential contrast in exposure mechanisms. The use of 'hyper-inflationary' instead of 'highly inflationary' is a minor wording difference but does not distort meaning. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 427,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B common stock carries ten votes per share and can be converted at the holder’s option into one‑vote Class A shares, concentrating voting power with insiders and letting the company steer equity policy through control rather than massive buy‑backs 【page_82】. Alphabet’s dual‑class system (Class A = 1 vote, Class C = 0 votes, insider‑held Class B = 10 votes) instead relies on a $62 billion share‑repurchase program in 2024 that retires Class A and Class C shares, shrinking the public float and increasing the relative voting weight of its Class B shares while returning cash to shareholders 【page_82】. This contrast shows Meta leans on voting‑power concentration, whereas Alphabet uses large buy‑backs within its dual‑class framework to enhance control and shareholder returns.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B stock has 10 votes per share vs. 1 for Class A, and can be converted into Class A shares; Alphabet’s structure includes Class A (1 vote), Class B (10 votes, held by insiders), and Class C (no votes). The $62 billion 2024 share repurchase by Alphabet targeting Class A and Class C shares is accurately reported. (2) Quantitative accuracy is perfect: the $62 billion figure is correctly cited, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the answer synthesizes information across both companies’ dual-class structures and equity strategies, correctly contrasting Meta’s reliance on voting concentration with Alphabet’s use of large-scale buybacks to enhance insider control and shareholder value. The insight that retiring non-insider shares increases the relative voting weight of Class B shares is a valid and nuanced addition supported by the structure. (4) Semantic equivalence is strong—while the LLM adds slight interpretive depth (e.g., 'shrinking public float'), it does not distort meaning and enhances clarity. The only minor difference from the original answer is that the LLM emphasizes strategic contrast more than the original’s focus on shared flexibility, but this is a valid interpretive lens rather than an error. No factual inaccuracies or omissions affect the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 403,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s COVID‑19 antiviral Veklury fell from $2.184 billion in 2023 to $1.799 billion in 2024 – a decline of roughly $385 million (about 18 %) – because the spread of vaccines and other COVID‑19 treatments has reduced demand. Amgen, by contrast, flags that alternative therapies and generics (e.g., biosimilars to ENBREL, generic Otezla, etc.) are eroding pricing and market share across its therapeutic lines, but its filing only describes the effect qualitatively, not as a specific revenue drop. Thus Gilead’s impact is quantified as a sizable sales contraction, whereas Amgen’s impact is expressed as a broader competitive pressure without a precise dollar figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Veklury sales declined from $2.184 billion in 2023 to $1.799 billion in 2024, a difference of $385 million (17.6%, rounded to ~18%), which matches the ground truth. The formatting ($2.184 billion vs $2,184 million) is equivalent. (2) The LLM correctly identifies that GILD’s decline is directly quantified and tied to alternative treatments and reduced demand, while AMGN’s impact is described qualitatively—this is consistent with the original answer, which notes Amgen faces payer-driven shifts due to alternatives for ENBREL, Otezla, Repatha, and Aimovig, but does not report a specific revenue drop. (3) Multi-hop reasoning is sound: the model synthesizes data from both GILD and AMGN filings, compares the nature of competitive impact (direct revenue decline vs. systemic market pressure), and correctly infers that Amgen does not provide a dollar figure. (4) The only minor shortcoming is that the LLM attributes reduced demand to 'vaccines and other treatments,' while the ground truth emphasizes 'availability and uptake of alternative treatments'—vaccines are not explicitly mentioned in the original. This slight over-specification does not undermine the core accuracy. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 381,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % Senior Notes require interest to be paid twice a year – on February 15 and August 15 – and the entire principal is due when the notes mature in fiscal 2022 (2022 $312 million principal)【page_66】. Qualcomm’s notes (aggregate fair value ≈ $14.0 billion) pay interest semi‑annually on the fixed‑rate portion and quarterly on the floating‑rate portion, and the principal is spread over many years (e.g., $1.4 billion in FY 2023, $914 million in FY 2024, $1.4 billion in FY 2025, $2.0 billion in FY 2027 and the balance after FY 2027)【page_79】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and amounts are correct: AMD's $312 million 7.50% Senior Notes with semi-annual interest payments on February 15 and August 15 are accurately reported, as is the fiscal 2022 maturity. For QCOM, the $14.0 billion aggregate fair value is correctly noted, along with the distinction between semi-annual payments for fixed-rate notes and quarterly for floating-rate notes. The principal payment schedule ($1.4B in FY2023, $914M in FY2024, etc.) matches the ground truth, including the absence of FY2026 principal. (2) The answer correctly notes that AMD has a single principal repayment in FY2022, while QCOM spreads principal over multiple years, which addresses the comparison aspect of the question. (3) The multi-hop reasoning is sound: the model synthesizes payment frequency and fiscal obligations across two companies and different note structures. (4) The only minor shortcoming is that the original answer explicitly mentions 'no principal due in fiscal 2026', which the LLM implies by skipping that year in the list but does not state outright. This omission is minor and does not affect factual correctness. Wording differences are semantically equivalent. All entities (AMD, QCOM, note types, fiscal years) are correctly identified. The answer is fully relevant and responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 390,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "The U.S. patents covering Prolia and XGEVA run out in February 2025, opening the products to generic and biosimilar competition and stripping Merck of a key protected revenue stream—an especially serious hit given the company’s reliance on strong patent rights to fend off generics (MRK_10k_2024.pdf p. 10; p. 33).  At the same time, Amgen is already confronting biosimilar entrants that are eroding its biologics in overseas markets, heightening industry‑wide pricing pressure and making the loss of Merck’s bone‑health exclusivity a further competitive disadvantage (AMGN_10k_2024.pdf pp. 9‑13).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly attributes Prolia and XGEVA to Merck, when in fact these are Amgen products. The original answer correctly identifies that the patent expiration affects Amgen, not Merck. This misattribution fundamentally undermines the reasoning. (2) Quantitatively, the date 'February 2025' is correctly stated and matches the ground truth; no other numerical values (e.g., dollar amounts, percentages) are present, so quantitative accuracy is fully preserved. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the relationship between Amgen's patent loss and Merck's competitive position. Instead, it wrongly suggests Merck loses exclusivity on Prolia/XGEVA, reversing the roles. While it correctly references Merck’s reliance on patent protection and Amgen’s exposure to biosimilars, the causal logic is inverted. (4) Contextual relevance is moderate—the answer discusses relevant themes (patent expiration, biosimilar competition, pricing pressure) and cites appropriate documents, but the core error in entity attribution severely limits its usefulness. The answer would be strong if the companies were correctly assigned, but as written, it misleads on a key fact. Thus, correctness and qualitative accuracy are low despite correct dates and document references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 378,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom does not break out a separate AI‑specific line‑item for VMware Cloud Foundation; the AI capability is folded into the overall VMware contribution of $12.4 billion of net revenue for fiscal 2024 (see AVGO page 67). The VCF product is described as “enables advanced AI and machine learning workloads at enterprise scale” (AVGO page 8), which dovetails with Cisco’s stated strategy of delivering the networking and compute infrastructure that powers AI training and inference workloads (Cisco page 4). In other words, Broadcom embeds AI functionality within its VCF platform, while Cisco focuses on the underlying infrastructure needed to run those AI workloads—both companies are aligning around AI as a growth driver.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details. The ground truth states that $1,380 million of $2,900 million in VMware Cloud Foundation (VCF) revenue in fiscal 2024 was tied to AI workloads. However, the LLM incorrectly claims that Broadcom does not break out AI-specific revenue and instead cites the total VMware segment revenue as $12.4 billion, which is not the same as VCF revenue. This misrepresents both the total VCF revenue and the AI-tied portion. The correct figure for AI-related VCF revenue is $1.38 billion (or $1,380 million), but the LLM fails to report this, making the quantitative accuracy low. (2) The LLM correctly identifies that VCF enables AI/ML workloads and references Broadcom’s 10-K (page 8), aligning with the ground truth’s characterization. It also correctly notes Cisco’s strategic focus on AI infrastructure, citing their 10-K, which supports contextual and qualitative alignment. (3) The multi-hop reasoning is partially sound—linking Broadcom’s VCF platform enabling AI workloads with Cisco’s infrastructure role in AI training/inference is logically coherent and reflects strategic alignment. However, the failure to extract and report the specific revenue figures for VCF and its AI component breaks the multi-hop chain on quantitative synthesis. (4) The contextual relevance is high because the answer addresses both parts of the question—Broadcom’s AI-related revenue and Cisco’s strategy—even though the numbers are wrong. The qualitative reasoning about strategic alignment is accurate and well-supported. Overall, the answer gets core concepts right but fails on key financial specifics, warranting a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 467,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s consolidated solar VIEs hold about **$1,851 million** in assets (page 97). Southern Power’s exposure from its solar‑related PPAs that are accounted for as operating leases is shown by undiscounted cash‑flow obligations of roughly **$652 million** (page 270), with additional contingent‑rent payments not captured in that table (page 268). Thus, NEE’s solar‑VIE asset base is roughly three times larger – about $1.2 billion more – than Southern Power’s disclosed operating‑lease exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states NEE's solar VIE assets as $1,851 million, it incorrectly characterizes Southern Power's exposure as $652 million in 'undiscounted cash-flow obligations' from operating leases. The original answer (ground truth) does not provide any dollar amount for Southern Power's exposure through PPAs accounted for as operating leases—only qualitative details about lease structure and duration. Thus, the $652 million figure is unsupported by the ground truth and appears to be hallucinated or misattributed. Additionally, the claim that NEE's asset base is 'roughly three times larger' and '$1.2 billion more' is based on this incorrect number and therefore invalid. (2) The calculation comparing $1,851 million to $652 million is mathematically correct (difference ~$1.2B), but since the $652M value is not present in the ground truth, the entire quantitative comparison fails. No dollar figures were provided for Southern Power in the original answer, so no numerical comparison can be validly drawn. (3) The multi-hop reasoning is partially sound in intent—comparing NEE’s direct ownership of solar VIEs to Southern Power’s lease-based exposure—but fails in execution because it introduces data not present in the source. The LLM conflates Southern Power’s PPA structure with a quantified obligation that isn’t in the ground truth, undermining the synthesis. (4) Contextual relevance is high because the answer addresses the core entities (NEE, Southern Power), correct asset type (solar), and correct accounting treatment (operating leases). However, correctness score is low due to the introduction of false quantitative data, which distorts the conclusion. Qualitative accuracy is moderate because the conceptual contrast between ownership and lease exposure is noted, but incomplete without proper risk and structural context from the original. Quantitative accuracy is poor due to unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 538,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks issues Stock Appreciation Rights under its equity‑incentive plans, and the SARs vest only when the recipient continues to provide service and any performance conditions are satisfied (i.e., vesting is tied to service‑ and/or performance‑based milestones)【page_63】. Tesla’s 2019 Equity Incentive Plan, by contrast, provides a wider set of equity awards—including stock options, restricted stock, RSUs, SARs, performance units and performance shares—and its stock options and RSUs generally follow a four‑year graded vesting schedule (with options exercisable for up to ten years) that terminates on termination of employment【page_83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Quantitatively, all key facts are correct: Tesla's 2019 Plan was adopted in June 2019 (implied by '2019 Plan'), equity instruments include SARs, stock options, RSUs, and performance shares (LLM adds 'restricted stock' and 'performance units', which are semantically consistent with 'performance shares' and do not contradict), and Tesla's vesting is over four years with a 10-year exercisability window—exact matches to the ground truth. (2) The LLM correctly identifies that Starbucks uses SARs and ties vesting to service and performance conditions, consistent with the original answer's mention of performance-based RSUs tied to EPS and ROIC. While the original answer notes that Starbucks has not broadly used stock options recently, the LLM does not contradict this—it simply doesn't mention it, which is a minor omission. (3) Multi-hop reasoning is sound: the model correctly contrasts Starbucks' SAR-focused approach with Tesla's broader array of equity instruments and accurately compares vesting timelines. (4) Semantic equivalence is maintained: the LLM uses slightly different phrasing (e.g., 'graded vesting schedule') but conveys the same meaning. The only minor gap is that the original specifies Starbucks' use of fair value expensing and performance metrics, which the LLM omits, but the core of the comparison—equity instruments and vesting—is fully addressed. Thus, the answer earns a 9/10 for correctness due to high factual accuracy with a small completeness gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 431,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s Class B common stock carries ten votes per share, giving its holders (including the founder) a ten‑fold voting power versus Class A and allowing a relatively small group of large shareholders to dominate board elections and other governance decisions (Meta 10‑K, Note 11, p. 82). In contrast, Alphabet’s Class A common stock is entitled to one vote per share, so voting influence is proportional to the percentage of total shares owned, limiting any single large shareholder’s ability to control corporate governance (Alphabet 10‑K, Class A shares, p. 80).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that Meta's Class B common stock has ten votes per share; in reality, according to the ground truth, Meta's Class B shares have *no voting rights* except in limited circumstances (e.g., exiting the core payments business or specific charter amendments). This is a direct reversal of the actual voting structure. (2) The answer misattributes influence at Meta, claiming Class B holders have dominant voting power, when in fact it is Meta's *Class A* shares (held by the public) that have one vote per share, and *Class B* shares (held by insiders like the founder) that historically had *super-voting rights* (not zero). However, the ground truth provided states the opposite: that Class B has *no* voting rights except in defined matters—this contradicts publicly known facts and suggests the ground truth may reflect a hypothetical or future state (e.g., post-restructuring), but the LLM answer fails to align with *that* stated truth. (3) For GOOGL, the LLM correctly notes that Class A shares have one vote per share, which aligns with the original answer. However, it incorrectly infers that this limits large shareholders’ control—while technically true relative to super-voting structures, this point misframes the comparison: the original answer emphasizes that GOOGL Class A shareholders *can* influence decisions, unlike Meta Class B holders. (4) Multi-hop reasoning is flawed: the LLM fails to correctly contrast Meta’s restricted-vote Class B with GOOGL’s standard-vote Class A, instead inverting Meta’s structure. (5) Quantitative accuracy is low due to the 'ten votes per share' claim, which is unsupported and contradicts the ground truth. (6) Despite incorrect facts, the answer attempts the right comparison framework (voting rights → governance influence), so contextual relevance is moderate. Overall, major factual and reasoning errors result in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 537,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC’s filing quantifies its foreign‑exchange activity: it reports $2.2 trillion of swap assets and $4.3 trillion of spot/forward assets (plus smaller option balances) against roughly $110 billion of foreign‑exchange liabilities, leaving a modest net foreign‑exchange asset after netting and showing the portion that is designated as qualifying cash‑flow or fair‑value hedges. JPM’s filing, on the other hand, discusses foreign‑currency derivatives only in qualitative terms—fair‑value, cash‑flow and net‑investment hedges for foreign‑currency‑denominated assets, liabilities and forecasted transactions—and notes that many are not hedge‑accounted, without providing a comparable asset‑liability breakdown.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies. The ground truth does not provide specific dollar amounts such as $2.2 trillion in swap assets, $4.3 trillion in spot/forward assets, or $110 billion in liabilities for BAC—these figures are fabricated or hallucinated. There is no mention in the original answer of numerical breakdowns of derivative positions or netting results, nor any reference to hedge designation details like 'qualifying cash-flow or fair-value hedges' with specific values. Thus, the quantitative accuracy is very low. On the qualitative side, the LLM correctly identifies that BAC includes foreign currency derivatives under risk management activities (implied by the gross presentation before netting), and that JPM uses them to manage FX risk related to non-USD assets, liabilities, and forecasts—this aligns with the original answer’s emphasis on JPM’s qualitative disclosures about offsetting gains/losses and balance sheet presentation. The LLM also correctly contrasts BAC’s more quantitative disclosure approach with JPM’s primarily qualitative discussion, which shows sound reasoning in comparative analysis. However, the original answer does not support the claim that JPM 'does not provide a comparable asset-liability breakdown' because it doesn’t state that BAC provides one—only that BAC presents derivatives gross before netting. Therefore, the inference that BAC gives a detailed asset-liability split is an overinterpretation. Despite this, the LLM captures the core contrast in disclosure style (quantitative vs. qualitative), maintaining contextual relevance. The hallucination of precise financial figures severely undermines factual correctness, warranting a low overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 472,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s downside comes from lower industrial production that cuts electricity and natural‑gas use, which directly reduces sales and cash flow even though fuel‑ and gas‑related costs are recoverable under regulated rate‑of‑return provisions (DUK p. 27). Southern Company’s risk is that the large environmental‑compliance costs it must incur – costs it expects to recover through retail and wholesale rates – may not be fully recoverable and can also dampen demand from commercial‑ and industrial‑customer segments, creating both cost‑recovery and demand‑side pressure (SO p. 26 & 89). Thus, Duke’s exposure is primarily demand‑driven, while Southern’s is a blend of cost‑recovery uncertainty and potential demand loss, even though both rely on regulated rate‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies Duke Energy's risk as demand-driven due to industrial customers reducing production during economic downturns, leading to lower electricity and natural gas usage and reduced sales and cash flow—consistent with the original answer. It also accurately characterizes Southern Company's risk as stemming from large environmental compliance costs that, despite expected recovery through regulated rates, may not be fully recoverable and could suppress demand from commercial and industrial customers. (2) There are no numeric values, dates, or dollar amounts in either answer that conflict; both mention future cost impacts without specific figures, and the LLM correctly references expected recovery through rate mechanisms without inventing numbers. Format and citations (e.g., DUK p.27, SO p.26 & 89) are consistent with source documentation and do not affect factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks across two companies, distinguishes between demand-side volatility (Duke) and cost-recovery plus demand risks (Southern), and acknowledges both rely on regulated rate recovery mechanisms—though with different structures (implied by tariff names in original, described generally in LLM). The only minor shortcoming is that the LLM does not name Southern’s specific mechanisms (ECO Plan, CNP Compliance, ECCR), which slightly reduces qualitative precision but does not impair the core comparison. (4) The answer is contextually excellent—directly addressing the comparison of risk exposures, the role of regulated recovery, and the differing nature of the threats to industrial customer segments. Overall, the LLM captures the semantic essence and factual core with high fidelity, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 530,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s governance is anchored by a single holder of its Class B common stock—Brian L. Roberts—who owns all 9.44 million Class B shares, each carrying 15 votes and representing about one‑third of the combined voting power, giving him decisive control over board elections and corporate decisions【page_31】. Alphabet’s dual‑class system, by contrast, gives each publicly traded Class A share one vote and each non‑public Class B share ten votes, allowing founders and insiders to retain control despite holding a smaller economic stake, with Class B shares convertible to Class A at the holder’s option【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information in the ground truth with only minor omissions. (1) Quantitatively, all numbers are correct: Brian Roberts owns all Class B shares (9.44 million implied but not critical), each with 15 votes, representing approximately one-third (33 1/3%) of voting power—this aligns with the ground truth. GOOGL’s Class A (1 vote) and Class B (10 votes) structure is accurately described. (2) The LLM correctly notes that GOOGL’s Class B shares are convertible upon sale or transfer, though it phrases it as 'convertible at the holder’s option,' which slightly understates the automatic nature of conversion in most cases—this is a minor wording issue, not a factual error. (3) The multi-hop reasoning is sound: the model correctly contrasts CMCSA’s non-dilutable, high-vote-per-share, single-holder structure with GOOGL’s broader insider-held but transfer-restricted Class B shares, capturing the key governance implication—more entrenched control at CMCSA vs. more fluid control at GOOGL. (4) The only missing nuance is the explicit mention that CMCSA’s Class B voting power is 'non-dilutable under the company's articles of incorporation,' which strengthens the governance entrenchment point. However, the phrase 'giving him decisive control' effectively captures the outcome. Semantic equivalence is maintained, and all entities (CMCSA, GOOGL, Brian Roberts, share classes) are correct. The answer is fully relevant and addresses both parts of the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 417,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "Coca‑Cola’s exposure to Taiwan is indirect – its bottling partner Swire Beverages “has bottling and distribution operations … in … Hong Kong, Taiwan …” (KO 10‑K p. 7) – but the filing does not disclose any specific volume or revenue growth for that market. By contrast, PepsiCo reports that Taiwan “experienced low‑single‑digit growth” in its beverage business (PEP 10‑K p. 48), indicating modest but positive direct growth in 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast in exposure between KO and PEP in Taiwan in 2022. It correctly identifies KO's indirect exposure through Swire Beverages operating in Taiwan and notes the absence of specific volume or revenue growth data for Taiwan from KO's filings. It accurately cites PEP's 'low-single-digit growth' in beverages in Taiwan in 2022, aligning with the ground truth. However, the LLM omits a key quantitative detail present in the original answer: that Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021. While this does not pertain directly to Taiwan alone, it is a critical piece of context for understanding the scale of KO’s indirect exposure through this partner. The answer correctly synthesizes multi-hop information—KO’s relationship with Swire and Swire’s operations in Taiwan, plus PEP’s direct reporting on Taiwan—but misses the 17% volume figure, which slightly weakens completeness. The reasoning is sound, entities and years are accurate, and the wording aligns semantically with the ground truth. The citation of page numbers from 10-Ks adds precision. Quantitative accuracy is high but not perfect due to the missing 17% figure. Overall, the answer is factually strong and contextually relevant, meriting a high score with minor deduction for incompleteness on a supporting metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 379,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The 10‑K notes that Trulicity “will lose significant patent and remaining data protections in the next few years” and that loss of exclusivity “typically results in the entry of one or more generic competitors, leading to a rapid and severe decline in revenues” – reflected already in a 26 % drop in Trulicity sales from 2023 to 2024 (page 49). Merck’s filing stresses that its strategy depends on “strong patent protection” to preserve market exclusivity and that a loss of such protection would “have a material adverse effect on the sales of any such products” (pages 31‑33). Thus, as Trulicity’s patents expire, Eli Lilly can expect a similar erosion of revenue, underscoring the same risk Merck warns would undermine competitive positioning when patent protection lapses.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer is largely correct in its reasoning and synthesis, accurately reflecting the risks associated with Trulicity's patent expiration and drawing a valid comparison to Merck's reliance on patent protection. The core message — that loss of exclusivity leads to generic competition and steep revenue decline — is consistent with the ground truth. However, there is a discrepancy in the quantitative claim: the LLM states a '26% drop in Trulicity sales from 2023 to 2024', while the original answer cites a '32% decrease in Trulicity's U.S. revenue' in 2024. This difference, though minor in magnitude, is significant because it misrepresents a key data point from the source. It is possible the LLM misread or misquoted the 10-K figure, or referred to a different metric (e.g., global vs. U.S. sales). (2) The citation of page 49 and pages 31–33 adds credibility, but without access to the exact filings, the evaluation relies on consistency with the ground truth. The 26% vs. 32% difference lowers confidence in quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly links LLY’s Trulicity patent risk to MRK’s strategic emphasis on patent protection, inferring that LLY faces a similar vulnerability. This demonstrates strong qualitative synthesis across companies and filings. (4) Contextual relevance is excellent — the answer directly addresses the question’s focus on revenue trajectory and competitive positioning in light of patent expiration. The wording differs from the original but maintains semantic equivalence in argument structure and conclusion. The correctness score is 8 due to the factual inaccuracy in the percentage drop, which prevents a 9 or 10 despite otherwise strong performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 472,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s exposure is primarily operational – it runs roughly 200 FedEx Office stores that are leased inside hotels and convention centers (all stores are leased on five‑ to ten‑year terms) and therefore its risk is tied to the health of those venues and the ability to renegotiate or relocate leases if hotel traffic falls【page_44】. UPS, on the other hand, carries a much larger financial‑valuation risk: its defined‑benefit pension and post‑retirement plans hold about $10.1 billion of assets in real‑estate, private‑debt and hedge‑fund investments, which are illiquid and subject to NAV‑based valuation swings that can affect pension funding status and earnings during a real‑estate market downturn【page_61】. Thus FedEx’s risk is limited to lease‑related operating costs and foot‑traffic, whereas UPS faces broader balance‑sheet‑level exposure to real‑estate market volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 200 leased retail locations and $10.1 billion in pension assets invested in real estate, private debt, and hedge funds are accurately reported, with correct timeframes (five- to ten-year leases) and context (as of December 31, 2024, implied by source data). Format variations (e.g., $10.1 billion vs $10.1B) are acceptable and semantically equivalent. (2) The answer is complete, addressing both FedEx’s operational reliance on hotel-located stores and UPS’s financial exposure via pension investments, and correctly contrasting the nature of risks—operational vs. financial. (3) Entity accuracy is strong: FedEx, UPS, FedEx Office stores, lease terms, pension and postretirement plans, and investment categories (real estate, private debt, hedge funds) are all correctly identified. (4) The reasoning is sound and reflects multi-hop synthesis: it distinguishes direct operational exposure (FedEx’s lease dependency on hotel foot traffic and tenant stability) from indirect financial exposure (UPS’s asset-level risk through fund valuations affecting pension liabilities). The conclusion that FedEx faces operating cost and traffic risks while UPS faces balance-sheet-level volatility is logically consistent with the ground truth. The only minor shortcoming is that the LLM does not explicitly mention that UPS’s exposure could affect long-term liability projections—though it does reference pension funding status and earnings impact, which captures the core financial consequence. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1610,
        "completion_tokens": 486,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B shares carry ten votes per share, giving their holders a disproportionately strong say in board elections and other strategic matters (see GOOGL 10‑K, p. 82). In contrast, Comcast’s investment in Atairos provides it no voting power – the firm only has economic rights and limited consent rights, while all voting rights (and thus control over Atairos’s strategy) reside with the management companies led by its former CFO (see CMCSA 10‑K, p. 83‑85). Consequently, GOOGL’s Class B stock confers direct control, whereas Comcast’s Atairos stake does not.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key facts are correct: GOOGL's Class B shares have 10 votes per share (vs. 1 for Class A), and CMCSA has no voting rights in Atairos—both match the original answer. The page references (GOOGL 10-K p.82; CMCSA 10-K p.83-85) add precision and are consistent with expected disclosure locations. (2) The answer correctly contrasts direct control via voting rights (GOOGL) with lack of voting power and reliance on consent rights (CMCSA), accurately reflecting the difference in influence over strategic decisions. (3) Multi-hop reasoning is sound: it synthesizes information across two companies (GOOGL and CMCSA), two distinct structures (share classes vs. VIE investment), and correctly infers the implications for control. (4) Minor deduction in qualitative accuracy because the original answer explicitly mentions that CMCSA retains 'certain consent rights' and that it lacks power to direct activities that most significantly impact economic performance—nuances slightly underemphasized in the LLM version, though 'limited consent rights' captures the essence. Overall, the LLM answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor omissions in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 369,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper financing is modest – only about $25 million of paper is reported for the Ohio subsidiary (see the “Commercial paper (a)” line in the short‑term obligations table) and it is classified as long‑term debt because the utility has back‑stop credit facilities and an average maturity of just 15‑23 days (footnote (d) on pages 165‑166). PepsiCo, by contrast, relies on a far larger commercial‑paper program – roughly $2.3 billion of 5.5 % paper is listed under short‑term debt (page 100) and the proceeds are used for general corporate purposes, with repayment funded by senior‑note issuances (page 101). Thus, Duke Energy Ohio uses a small, highly liquid, back‑stop‑supported paper facility, while PepsiCo’s short‑term strategy centers on a sizable, interest‑bearing commercial‑paper borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's $25 million in commercial paper (as of December 31, 2023) and PepsiCo's $2,286 million (rounded to $2.3 billion) in commercial paper obligations in 2023 are accurately reported. The format variation ($2.3 billion vs $2,286 million) is acceptable. (2) The broader context of PepsiCo’s total short-term debt of $6,510 million is not explicitly mentioned in the LLM answer, which is a minor omission affecting completeness but not the core comparison. (3) Entity accuracy is strong: both companies are correctly identified, with correct fiscal year (2023) and proper attribution of commercial paper usage. (4) The reasoning is sound and adds value by explaining that Duke Energy Ohio classifies its commercial paper as long-term due to back-stop credit facilities and short average maturity (15–23 days), a nuance supported by the source. Similarly, the LLM correctly notes PepsiCo’s use of commercial paper for general corporate purposes and repayment via senior-note issuances. (5) The semantic meaning matches the original answer: both highlight the stark contrast in scale and strategic use of commercial paper. The LLM enhances the answer with additional context (classification, maturity, funding mechanism), which improves qualitative accuracy. Only a perfect score is withheld because the total short-term debt figure for PepsiCo ($6,510 million) is omitted, slightly reducing completeness in the multi-hop synthesis. However, the core comparison remains fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 439,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy’s filing notes that its gas‑utility segment expects the number of commercial customers in the Carolinas, Ohio and Kentucky to rise (see DUK 10‑K p. 17).  Southern Company, however, relies on state‑approved, cost‑based rates to recoup the sizable environmental‑compliance and ARO costs it incurs (see SO 10‑K p. 26‑89).  If new environmental rules curb industrial activity and commercial gas demand falls, regulators may be less willing to approve or may limit the amount of compliance‑cost recovery, and a smaller demand base would shrink the revenue pool from which those costs can be recovered—potentially forcing Southern to absorb more of the expense or delay compliance investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Duke Energy expects growth in commercial gas customers in the Carolinas, Ohio, and Kentucky (cited from DUK 10-K p.17), and Southern Company relies on regulated rate recovery for environmental and ARO costs (SO 10-K pp.26-89). There are no numeric values requiring calculation, so quantitative accuracy is fully preserved. (2) The LLM correctly identifies the risk that declining commercial demand—due to environmental regulations impacting industrial operations—could undermine rate recovery by shrinking the revenue base and reducing regulator willingness to approve cost recovery. This matches the core reasoning in the original answer. (3) Multi-hop reasoning is sound: the model connects Duke's regional customer growth expectations with Southern's regulatory recovery model and then evaluates how external regulatory pressure on industrial users could disrupt that model. The only minor omission is not explicitly stating that Southern Company also faces direct infrastructure upgrade costs (implied via 'compliance and ARO costs'), and slightly less emphasis on the feedback loop where reduced demand undermines the very mechanism (rate recovery) needed to fund compliance. However, the key causal chain is intact. (4) Wording differs but semantic meaning is equivalent. The LLM uses precise citations and slightly more regulatory-technical language (e.g., 'ARO costs', 'cost-based rates'), enhancing clarity without distorting meaning. No incorrect entities, years, or metrics are introduced. Thus, the answer earns a 9 for correctness and qualitative accuracy due to near-perfect synthesis and factual alignment, with only minimal contextual nuance missing from the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 489,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts continues to control all of the 9.44 million Class B shares, which carry 15 votes each and account for 33 ⅓ % of Comcast’s total voting power (see page 33). Because the company’s 2023 buy‑back program repurchased only Class A shares – about 262 million of them (page 33) – the pool of one‑vote shares shrank while the Class B voting bloc was unchanged, leaving Roberts’ voting stake at its statutory 33 ⅓ % (and effectively increasing its weight relative to the remaining shareholders).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Mr. Roberts owns all Class B shares, which carry 15 votes each and represent 33 1/3% of voting power. It notes that only Class A shares were repurchased in 2023 (262 million), reducing the pool of low-vote shares. (2) The numbers cited—9.44 million Class B shares, 262 million Class A repurchases—are consistent with typical disclosures (e.g., 10-K page 33), and while the ground truth does not specify share counts, these figures are plausible and do not contradict it. The percentage (33 1/3%) is correct. (3) The reasoning is sound: repurchasing only Class A shares dilutes the relative voting power of the remaining public shareholders while preserving Roberts’ 33 1/3% bloc, thereby increasing its relative influence—this is correctly interpreted as strengthening his control. (4) The LLM slightly misses the explicit statement that Roberts’ control is enhanced *because* of the dilution of the broader shareholder base, though it implies it by noting the unchanged voting bloc amid a shrinking Class A pool. Wording like 'effectively increasing its weight' captures the economic reality. No factual errors; minor lack of explicit emphasis on equity dilution for public shareholders keeps it from a perfect 10. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 387,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are “contingent‑value” awards whose ultimate payout is driven by a payout‑simulation model that ties the number of shares earned to the company’s stock‑holder return relative to a comparator group (and to stand‑alone financial targets). Because the simulation uses assumed correlations and volatilities, the actual share payout can vary widely with market performance, making the payout less predictable 【page_126】.  \n\nIn contrast, BMS’s exposure to its financial agreements is managed through explicit counter‑party‑credit‑risk controls—limits on exposure to any one counterparty, use of high‑credit‑quality counterparties, and hedging via foreign‑exchange forwards, options and cross‑currency swaps—so that even a counter‑party failure would not be material and the risk‑management outcome is far more predictable 【page_97】【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer specifies Amgen's performance units were valued at $121 million in 2023, this figure is not mentioned in the LLM response. However, no incorrect numbers are provided, and the absence of the dollar amount does not introduce inaccuracy—just a minor omission. All other financial mechanisms are described correctly. (2) The LLM correctly identifies Amgen’s payout simulation model based on stockholder returns relative to a comparator group, using correlations and volatilities, which matches the contractual structure in the ground truth. It accurately characterizes the variability and reduced predictability of payouts due to market dependence. (3) For Bristol-Myers Squibb, the LLM correctly details counterparty credit risk mitigation strategies: exposure limits, high credit quality requirements, and use of conventional instruments like forwards, options, and swaps. It correctly concludes that these enhance predictability and minimize material risk from counterparty failure. (4) The comparison between Amgen’s performance-linked payout predictability and BMY’s risk-control focus is logically sound and semantically equivalent to the original answer. The multi-hop reasoning—synthesizing Amgen’s incentive design with BMY’s risk management—is well executed. (5) The inclusion of citation markers like 【page_126】 and 【page_97】【page_99】 suggests grounding in source material, though not required for scoring. The only reason for not scoring a perfect 10 is the omission of the $121 million valuation for Amgen’s performance units, which was present in the original answer and adds quantitative specificity. However, since the question emphasizes structural and predictability comparison rather than exact figures, this does not severely impact correctness. Overall, the answer is factually sound, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 534,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative risk is largely confined to the contracts themselves – its OTC‑bilateral trades are covered by ISDA Master Agreements that, under the Orderly‑Liquidation Authority (Title II of Dodd‑Frank), let the company net‑set‑off receivables against payables and apply collateral without the automatic stay of bankruptcy, thereby limiting loss exposure【page_261】. By contrast, Bank of America’s Dodd‑Frank‑required resolution plan creates a much broader liquidity‑and‑capital risk: if the FDIC and Fed deem a “single‑point‑of‑entry” resolution necessary, the agency could invoke the orderly‑liquidation authority, restrict the parent’s ability to draw on subsidiaries, impose stricter capital or leverage limits and potentially force a bridge holding company, exposing the firm to significant funding constraints and greater losses for security holders【page_13】【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: MetLife's use of ISDA Master Agreements allowing close-out netting and collateral application under the Orderly Liquidation Authority (OLA) is accurately described, as is Bank of America's 'single point of entry' resolution plan under Dodd-Frank. The regulatory frameworks (OLA, FDIC/Fed oversight) are correctly identified for both firms. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different firms, regulatory mechanisms (OLA vs. resolution planning), and risk types (derivative exposure vs. parent-level resolution risks). It distinguishes MetLife’s transaction-level risk mitigation from BAC’s structural resolution risks, which aligns with the original answer. (4) The LLM adds slightly more detail on potential consequences for Bank of America (e.g., funding constraints, capital limits), which is consistent with typical resolution planning but not explicitly in the ground truth; however, this does not introduce error. The only reason for not scoring a 10 is that the original answer more explicitly links both firms to altered treatment of financial obligations during insolvency, a unifying theme slightly downplayed in the LLM version. Overall, the answer is highly accurate, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 442,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike generated about **$7.5 billion** in revenue from its Greater China segment (which includes Taiwan) in fiscal 2022【page_88】.  Starbucks reported **544 licensed stores** operating in Taiwan at the end of fiscal 2022【page_12】.  The contrast – billions of dollars of sales versus a few‑hundred physical locations – suggests Nike’s economic footprint across Greater China is far larger, while Starbucks’ presence in Taiwan is measured by a modest but significant store network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Nike's $7.5 billion revenue from the Greater China region in fiscal 2022, which matches the ground truth of $7,547 million (rounded appropriately). It also accurately states that Starbucks operated 544 stores in Taiwan as of the end of fiscal 2022, aligning with the original answer's figure and timeframe (October 2, 2022). These numbers are presented with acceptable formatting variations ($7.5 billion ≈ $7,547 million) and are fully accurate.\n\n2) Quantitatively, all figures are correct: Nike’s revenue and Starbucks’ store count match the ground truth. The fiscal year alignment (2022) is consistent across both entities. No calculations were required beyond interpretation, and the LLM correctly reframed the revenue figure in rounded billions without loss of essential precision.\n\n3) The reasoning is sound and captures the multi-hop nature of the question—comparing Nike’s regional revenue (Greater China, including Taiwan) to Starbucks’ localized operational footprint (stores in Taiwan only). The LLM correctly identifies that these metrics represent different dimensions of market presence: economic scale (Nike) vs. physical footprint (Starbucks). It slightly simplifies the scope clarification by not explicitly noting that Nike’s revenue includes mainland China and Hong Kong, but it does mention the Greater China segment includes Taiwan, which preserves key context.\n\n4) The answer is contextually relevant and directly addresses both parts of the question: the quantitative comparison and the implication about relative market presence. The conclusion—that Nike has a larger economic footprint while Starbucks has a modest but significant store network—is logically derived and semantically equivalent to the original answer’s interpretation. The only minor shortcoming is a slightly less nuanced explanation of the geographic mismatch (Nike’s broader region vs. Starbucks’ Taiwan-specific data), but this does not undermine the overall correctness. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 548,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The American Tower deal brought Verizon a larger cash inflow ($5 billion) but, aside from the sub‑lease of capacity, Verizon did not record any separate prepaid‑rent or financing liability – the towers simply remain on its property‑plant‑equipment balance and are depreciated (see page 73). In the Vertical Bridge transaction Verizon received a smaller upfront amount ($2.8 billion) but it recognized $2.0 billion of prepaid rent and an $830 million financing obligation for the portion of towers it continues to occupy, while also keeping those towers on PP&E and depreciating them (see page 73).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.0 billion from American Tower in 2015 and $2.8 billion from Vertical Bridge in 2024 are correctly stated, along with the $2.0 billion prepaid rent and $830 million financing obligation in the Vertical Bridge deal. The absence of such breakdowns in the American Tower transaction is also accurately noted. (2) Quantitative accuracy is perfect—dollar amounts, references to balance sheet treatment (PP&E), and depreciation responsibilities match the original. Format variations (e.g., $5 billion vs $5.0 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both transactions involve retained ownership, continued depreciation, and subleasing, while distinguishing the additional accounting treatment (prepaid rent and financing obligation) only present in the Vertical Bridge deal. (4) The only minor shortcoming is that the LLM does not explicitly state that both deals involve exclusive rights transactions or that the towers remain on the balance sheet due to retained ownership—though it implies this by mentioning continued depreciation and PP&E inclusion. This slight omission in explanatory depth prevents a perfect 10 on qualitative accuracy, but the core reasoning and factual content are robust. Contextual relevance is excellent, directly addressing the comparison in obligations and asset treatment as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 413,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital is derived from an AMA/LDA model that explicitly folds fraud risk into its one‑year, 99.9 %‑confidence capital charge, but the filing does not disclose a dollar amount for that component. By contrast, Citi quantifies the fraud‑related, emerging‑market risk in Russia – if it loses control of AO Citibank it would book a $1.6 billion CTA loss plus a $0.9 billion inter‑company liability loss, roughly $2.5 billion – providing a concrete exposure figure rather than a model‑based estimate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $1.6 billion CTA loss and $0.9 billion intercompany liability loss are accurately reported, and their sum (~$2.5 billion) is correctly implied. These match the original answer exactly, with acceptable formatting (e.g., $1.6 billion = $1.6B). (2) The LLM correctly identifies JPMorgan’s use of the Advanced Measurement Approach (AMA), specifically noting it uses a loss distribution approach (LDA) model with a 99.9% confidence level for a one-year horizon, which is consistent with Basel III AMA requirements. It correctly states that fraud risk is included but no dollar amount is disclosed—this matches the ground truth. (3) For Citigroup, the answer accurately highlights the specific fraud-related risk scenario in Russia involving loss of control of AO Citibank and the resulting financial impacts, correctly naming CTA and intercompany liabilities as the mechanisms. (4) The multi-hop reasoning is sound: it contrasts JPMorgan’s model-based, non-quantified capital estimation with Citigroup’s concrete, scenario-based quantification of losses, capturing the core comparative insight. (5) Minor deduction in qualitative accuracy (9/10) because the LLM does not explicitly mention 'external losses, scenario analysis, and business environment metrics' as part of JPMorgan’s AMA framework—details present in the original—though the reference to AMA/LDA implies such components. Otherwise, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 436,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "A prolonged conflict that disrupts Taiwan would jeopardize Qualcomm’s chipset supply because the company “depends on…consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” and a conflict could “severely limit or prevent us from receiving chipset supply from Taiwan” (QCOM 10‑K p.35). Intel’s risk is more revenue‑focused – it generated $6.867 billion of 2023 revenue from Taiwan (Intel 10‑K p.88) and, as a fab‑owner, can shift production to other sites, so the conflict would mainly curtail sales in the region rather than halt its own chip supply.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners and the risk to its chipset supply is accurately quoted from its 10-K (p.35), and Intel's $6.867 billion in 2023 revenue from Taiwan is correctly cited from its 10-K (p.88). (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) matches the original answer exactly, and no calculations were required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (Qualcomm and Intel), distinguishes between supply chain dependency (Qualcomm) and revenue exposure (Intel), and draws a valid contrast based on their respective business models—fabless vs. fab-owning. (4) Contextual relevance is high: the answer directly addresses the question by comparing the differential impact of a geopolitical conflict on each company’s operations and supply chain, using precise evidence from filings. Minor wording differences (e.g., 'curtail sales' vs. 'market demand and revenue generation') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 333,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests on a **regular, quarterly basis** by applying **discounted‑cash‑flow models together with earnings and market multiples**, and it updates the values for any changes in the operating results, financial condition, or prospects of the underlying portfolio companies (RTX 10‑K p. 102). By contrast, Boeing’s Level 3 assets that are measured **only on a non‑recurring basis** (e.g., when an impairment is recognized) are valued using an **income approach (discounted‑cash‑flow) or a market approach**, relying on significant unobservable inputs that are disclosed for each asset class (Boeing 10‑K p. 124). Thus, RTX’s methodology is a periodic, multiples‑adjusted valuation, whereas Boeing’s is an ad‑hoc, impairment‑driven valuation using disclosed unobservable inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of methodology and key distinctions. (1) It accurately states that RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, adjusting for changes in portfolio company performance—this matches the original answer and is supported by RTX’s 10-K (p. 102). (2) For Boeing, it correctly identifies that Level 3 assets are measured on a nonrecurring basis, typically during impairment, using an income approach (discounted cash flows) and market approach with unobservable inputs, citing Boeing’s 10-K (p. 124). However, the LLM omits specific details about Boeing’s use of third-party aircraft valuation publications and the application to operating lease equipment and finance leases, which are key differentiators in the original answer. It also does not mention median collateral values or adjustments based on unique aircraft attributes or expected net sales prices, which weakens the completeness of the comparison. (3) The multi-hop reasoning is sound—correctly contrasting RTX’s periodic, performance-adjusted valuation with Boeing’s ad-hoc, impairment-triggered approach—but lacks full synthesis of Boeing’s specific data sources and asset types. (4) No numerical inaccuracies are present; all qualitative claims are correctly attributed. The answer is contextually relevant and well-structured. The score is reduced slightly due to missing specific details about Boeing’s methodology that are central to the original answer’s precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 434,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix discloses that it enters into forward contracts to hedge the foreign‑exchange risk on forecast‑revenue and on firm‑commitment transactions tied to foreign‑currency‑denominated content licences and production (see Netflix 10‑K p. 48), but the filing only reports the net annual foreign‑currency transaction results (e.g., a $293 million loss in 2023) and gives no specific one‑day loss figure. In contrast, Disney’s 10‑K provides a quantitative VAR analysis that estimates the maximum potential one‑day loss on its currency‑sensitive financial instruments at $45 million for fiscal 2023 (up to $57 million at the high end) and a combined‑portfolio one‑day loss of $284 million (see Disney 10‑K p. 60). Thus, Netflix’s approach is described qualitatively as a hedge, whereas Disney quantifies its exposure with a concrete one‑day loss estimate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. First, it reports Disney's one-day VAR loss as $45 million (up to $57 million) for currency-sensitive instruments and a combined-portfolio loss of $284 million, which contradicts the ground truth stating Disney's total one-day loss exposure is $255 million as of September 28, 2024. These figures do not align with the disclosed $255 million figure in the original answer, and no breakdown by risk category matching the LLM's numbers is supported by the ground truth. Additionally, the LLM cites fiscal 2023 Disney data, while the ground truth references a specific date in 2024, introducing a temporal mismatch. The mention of a $293 million foreign exchange loss for Netflix in 2023 is not present in the ground truth and appears to be fabricated or misattributed, further reducing quantitative accuracy. On qualitative grounds, the LLM correctly identifies that Netflix uses forward contracts to hedge foreign exchange risk on firm commitments and does not disclose a VAR metric, while Disney does provide a VAR estimate—this reasoning and entity mapping (Netflix vs. Disney, forward contracts vs. VAR model) is sound and contextually relevant. The answer appropriately contrasts qualitative disclosure (Netflix) with quantitative risk modeling (Disney), fulfilling the comparative aspect of the question. However, due to the incorrect numerical values and unsupported specifics, the overall correctness is significantly compromised despite structurally appropriate reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 429,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "AMD’s 2021 tax provision was helped by the Philippines corporate‑income‑tax cut – the reduction, enacted in Q1 2021, partially offset higher repatriation costs and GILTI‑related charges and kept the company’s effective tax rate only 0.1 percentage‑point above 2020 at 21.8% (see page 94). In contrast, Texas Instruments’ exposure in the Philippines is reflected in capital spending – its property, plant and equipment at the two Philippine sites rose to $370 million at year‑end 2021 (from $333 million in 2020) (see page 33), creating future depreciation tax shields rather than an immediate reduction in its income‑tax provision.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD’s effective tax rate increased by 0.1 percentage point to 21.8% in 2021, with the Philippines tax cut partially offsetting GILTI-related charges; Texas Instruments had $370 million in PPE in the Philippines as of year-end 2021 (up from $333 million in 2020), indicating significant operational investment. These numbers match the original answer and are presented with correct context. (2) Quantitative accuracy is perfect: dollar amounts ($370M), percentages (21.8%, 0.1 pp increase), and timeframes (Q1 2021 enactment, year-end 2021) are all correct. The LLM even adds a minor detail ($333M in 2020) not in the original answer but consistent with it, enhancing completeness. (3) Reasoning is sound: the LLM correctly distinguishes between AMD’s tax provision impact (immediate benefit via lower effective tax rate) and TI’s operational exposure (long-term benefit via capital investment and future depreciation shields), demonstrating proper multi-hop synthesis across tax policy, corporate financials, and strategic implications. (4) The only reason for not scoring a 10 is a slight difference in emphasis: the original answer explicitly frames TI’s investment as benefiting from the lower tax rate, while the LLM focuses on depreciation shields as a different mechanism. This is a nuanced but not incorrect interpretation—both are valid under international tax principles. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 429,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM treats its affiliates as joint‑venture and variable‑interest entities that supply parts, build vehicles and provide financing – it records equity‑method earnings (e.g., automotive China JVs, Ultium Cells) and VIE‑related assets but does not fully consolidate them because they are integral to the company’s manufacturing and supply‑chain model【page_77】【page_75】【page_79】. In contrast, McDonald’s affiliates are franchisees, developmental licensees and foreign affiliates; the firm reports them using the equity method (e.g., China and Japan) and does not consolidate them, reflecting a franchise model where the core business is the brand and royalty/rent fees rather than direct restaurant operation【page_45】【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies GM's affiliate relationships as joint ventures and variable-interest entities focused on vehicle production, parts supply, and financing—particularly in China—with accurate references to nonconsolidated, equity-method accounting (e.g., automotive China JVs, Ultium Cells), which matches the production-focused model in the ground truth. Similarly, it accurately characterizes McDonald's affiliate model as franchise-based, emphasizing brand licensing, royalty/rent fees, and non-consolidation of franchisees and foreign affiliates (e.g., China and Japan), reflecting its asset-light, service-oriented business model. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages; however, the absence of incorrect numbers supports a full score. (3) The multi-hop reasoning is sound: the model synthesizes information across two distinct companies (GM and McDonald’s), correctly contrasting their use of affiliates based on business model differences—manufacturing vs. franchising. It draws appropriate inferences from accounting treatment (equity method, non-consolidation) to operational models. (4) The only minor shortcoming is that the LLM answer omits specific brand names under which GM’s affiliates operate (Baojun, Buick, Cadillac, Chevrolet, Wuling), which were present in the original answer and add contextual richness. However, this omission does not undermine the core factual accuracy or the qualitative comparison. Overall, the answer is semantically equivalent, contextually precise, and well-supported by document references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 475,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62 billion buy‑back of Class A (and Class C) shares in 2024 cut the number of one‑vote Class A shares outstanding (5,855 million in 2024)【page_84】. Because each Class B share still carries ten votes and only converts to a single‑vote Class A share when it is sold or transferred【page_82】, the shrinkage of the low‑voting Class A pool means the same number of Class B shares now represents a larger share of total voting rights, thereby increasing the relative voting power of the remaining Class B shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Alphabet's $62 billion share repurchase in 2024 of Class A and Class C shares, matching the original answer. The mention of 5,855 million Class A shares outstanding in 2024 is an additional detail not in the ground truth but does not contradict it and appears contextually plausible. (2) The quantitative elements are accurate: the $62 billion figure is correct, and while the 5,855 million share count is specific to the LLM's source citation (page_84), it does not introduce an error and supports the reasoning. No calculations are required beyond relative comparisons, which are handled correctly. (3) The reasoning is sound and captures the multi-hop logic: repurchases reduce Class A shares, Class B shares retain 10 votes until converted (upon sale/transfer), and thus the relative voting power of Class B shares increases as the pool of voting shares shrinks. This correctly synthesizes the impact of buybacks and conversion rules on voting control. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., explicit share count), and fully addresses all parts of the question. The only minor point preventing a perfect 10 is the introduction of a specific share count not present in the ground truth, which, while not incorrect, is unverified and not essential. Overall, the response is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 410,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "Both Colgate‑Palmolive and Coca‑Cola adopted ASU 2020‑01 on January 1 2021, which clarifies that equity securities are measured at fair value (or, when the measurement‑alternative is elected, at cost less impairment) and that the accounting for those securities is separate from equity‑method investments and from any related derivative contracts. Each company noted that the clarification merely confirms existing practice and therefore had no material impact on their consolidated financial statements (Colgate‑Palmolive – page 81; Coca‑Cola – page 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the adoption date of January 1, 2021, is correct for both companies, and the statement that the impact was not material is consistent with the original answer. No numerical calculations were required, but the dates and references to financial statement impact are factually correct. (2) The answer correctly identifies both companies and the relevant accounting standard, ASU 2020-01, and accurately describes its scope regarding equity securities, equity method investments, and derivative contracts. (3) The reasoning is sound: it captures the multi-hop aspect by noting that both companies adopted the same standard, applied the clarifications, and concluded no material impact due to alignment with existing practice. It also implicitly reflects the synthesis across both firms’ disclosures. (4) While the LLM answer is slightly less detailed than the original (e.g., it does not explicitly mention the calculation of net unrealized gains/losses or the specific guidance on observable transactions), it conveys the essential meaning and correctly emphasizes the separation of accounting treatments and the lack of material impact. The inclusion of page references (81 for both) adds precision and supports credibility. The minor omission of some granular detail prevents a perfect 10, but the core facts, entities, dates, and reasoning are correct and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 404,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ Standardized‑Approach CET1 requirement includes a 6.2 % Stress Capital Buffer (SCB) as of Dec 2024【page_208】, whereas Citibank’s required CET1 ratio (through Citigroup) incorporates a 4.1 % SCB【page_35】. The larger SCB at Goldman Sachs shows a more conservative, stress‑focused capital stance, while Citibank’s smaller SCB reflects a less aggressive buffer but still meets the regulatory capital adequacy standards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Goldman Sachs has a 6.2% SCB, which is correct and matches the original answer. However, the LLM incorrectly states that Citibank has a 4.1% SCB, while the ground truth explicitly states that Citibank’s CET1 requirement of 7.0% is composed of the 4.5% minimum CET1 and a 2.5% Capital Conservation Buffer, with no mention of an SCB. This is a critical error, as the absence of an SCB for Citibank under the Standardized Approach is a key differentiator. (2) The quantitative accuracy is low because the 4.1% SCB for Citibank is factually wrong and not supported by the ground truth. Additionally, the ground truth does not attribute any SCB to Citibank under the Standardized Rules, making the comparison of SCB sizes invalid. (3) The reasoning is partially sound in interpreting that a higher SCB implies a more stress-focused capital stance, but the multi-hop synthesis fails because it assumes both banks are subject to SCB under the same rules, which is incorrect. The model fails to recognize that SCB applies differently—Goldman Sachs under stress-based requirements, while Citibank’s 7.0% is a fixed sum of minimum and conservation buffers without SCB. (4) Contextual relevance is moderate because the answer addresses the regulatory capital adequacy theme and compares the two banks, but the core factual error undermines the conclusion. The model misrepresents Citibank’s regulatory framework, leading to an incorrect interpretation of their respective capital approaches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 434,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana footprint is mainly physical – the company owns about 90 miles of rate‑regulated transmission lines and five substations in the state (see the “Other” row in the transmission table on page 16). By contrast, Duke Energy Indiana finances its Indiana activities through tax‑exempt debt, carrying roughly $285 million of tax‑exempt bonds classified as long‑term debt (and a total of about $352 million of tax‑exempt bonds maturing 2027‑2046) as of December 31 2023 (see the tax‑exempt‑bond balances on pages 163 and 165). This highlights NextEra’s focus on building infrastructure, while Duke relies on tax‑exempt bond financing to fund its Indiana operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly reports NextEra Energy's 90 miles of transmission lines and 5 substations in Indiana. It also accurately states Duke Energy Indiana's $285 million in tax-exempt bonds classified as long-term debt as of December 31, 2023. However, the LLM adds a detail not present in the original answer—'a total of about $352 million of tax-exempt bonds maturing 2027–2046'—which, while potentially true, is not part of the ground truth and slightly exceeds the provided information. This does not contradict the original but introduces unverified detail. (2) The core financial figure of $285 million matches exactly, and the date (December 31, 2023) is correct. (3) Entity accuracy is strong: both companies (NextEra Energy and Duke Energy Indiana) and the relevant financial instruments (tax-exempt bonds, transmission infrastructure) are correctly identified. (4) The reasoning is sound: the LLM correctly contrasts NextEra’s physical infrastructure focus with Duke’s financing strategy, demonstrating proper multi-hop synthesis across operational and financial domains. (5) The answer is contextually relevant and directly addresses the comparison asked. The only minor deviation is the inclusion of the $352 million figure, which, while plausible, is not in the original and slightly affects quantitative precision. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a small over-specification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 426,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store revenue is tied to a large ecosystem of third‑party developers and content owners, so the company is exposed to the risk that changes such as the EU‑mandated alternative‑payment‑processing rules or short‑term licensing agreements can shrink the commission it retains or cause providers to pull or price‑up their content, directly affecting its earnings (AAPL 13). Microsoft, by largely creating its own content, does not face that commission‑loss risk; instead its primary exposure is reputational—public scrutiny of its own content, AI and data‑privacy choices can damage the Microsoft brand and therefore its business (MSFT 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: Apple's reliance on third-party developers and commission-based App Store model, risks from EU alternative payment rules (referencing DMA implicitly), and potential developer backlash are accurately described. Microsoft's in-house content production and associated reputational risks, including from AI and data privacy, are also correctly identified. (2) There are no numeric values, dates, or percentages in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly contrasts Apple’s ecosystem-dependent revenue risk with Microsoft’s brand-reputation risk, synthesizing distinct strategies and their implications across companies and regulatory environments. The citation of 'AAPL 13' and 'MSFT 32' suggests grounding in source documents, though not required for scoring. (4) Minor deduction in qualitative accuracy due to slightly narrower framing—ground truth explicitly mentions 'brand reputation tied to content decisions' and 'backlash from public scrutiny,' while LLM broadens to AI and data privacy, which, while plausible, slightly shifts focus. However, this does not undermine the core correctness. Contextual relevance is perfect—the answer directly addresses all parts of the complex, multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 402,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company warns that a release of radioactive material – such as tritium – at its nuclear units could generate damages that “could exceed the amount of decommissioning trusts or external insurance coverage” and therefore create liability beyond its current coverage 【page_29】. In contrast, NEE’s filing notes that the market value of its nuclear de‑commissioning funds could fall short of the amounts needed to retire its plants, “may materially adversely affect … liquidity, financial condition and results of operations” 【page_32】 (and that de‑commissioning costs could exceed the funds available 【page_31】). Thus, both companies face nuclear‑health‑related financial exposure, but Southern’s risk is tied to an acute tritium‑leak incident that could surpass insurance, whereas NEE’s risk is a longer‑term shortfall in the funds set aside for de‑commissioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company's risk of tritium leakage leading to liabilities exceeding decommissioning trusts or insurance is accurately cited, as is NEE's disclosure about decommissioning fund shortfalls potentially affecting liquidity and financial condition. The LLM correctly identifies that both companies face nuclear-related financial risks, with Southern's being incident-driven (acute) and NEE's being structural/long-term. (2) There are no numeric values in the original or LLM answer beyond percentages in the ground truth (26%, 28% in 2021), which the LLM omits. However, these percentages are not critical to the core comparison about liability types and financial exposure, and their absence does not impair the answer’s correctness. No calculations are required. (3) Multi-hop reasoning is sound: the LLM synthesizes risk disclosures from two different companies (Southern and NEE), correctly distinguishing the nature of their exposures while highlighting the parallel financial implications. (4) Semantic equivalence is strong—while the LLM adds slight interpretive framing (e.g., 'acute' vs 'long-term'), it remains factually consistent with the original. The only minor shortcoming is the omission of the specific generation percentages from the ground truth, but since the question does not explicitly ask for them and they serve contextual rather than decisive roles, this does not significantly detract from correctness. Hence, a score of 9 is warranted, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 448,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The Q1‑2021 cut to the Philippines corporate income‑tax rate only modestly affected Altria’s tax picture – it was a small offset to other tax‑rate drivers, leaving the company’s 2021 effective tax rate essentially unchanged (the rate rose just 0.1 percentage point)【page_94】. For Coca‑Cola, the lower Philippine tax rate improves the after‑tax return on the assets that make up roughly 10 % of its consolidated property, plant and equipment【page_124】, reinforcing its willingness to continue capital spending in the country as reflected in its segment‑level capital‑expenditure allocations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the 0.1 percentage point increase in Altria's effective tax rate and the 10% of Coca-Cola's consolidated PPE in the Philippines are accurately reported, matching the original answer. The time frame (Q1 2021 tax reform) is correctly referenced. (2) The LLM correctly identifies that the tax reduction contributed to a 0.1 pp increase in Altria’s effective tax rate—note that while phrased as a 'small offset' that left the rate 'essentially unchanged,' this does not contradict the ground truth, which states the rate increased to 21.8% due to the reform; the slight rise is consistent with both answers. (3) For Coca-Cola, the LLM correctly links the tax cut to improved after-tax returns on its Philippine PPE (10% of total), and notes sustained capital investment, aligning with the original answer’s claim of 'maintained significant capital investment.' The reference to 'segment-level capital-expenditure allocations' adds context not in the original but is plausible and relevant. (4) Multi-hop reasoning is sound: the model synthesizes tax policy change with company-specific financial impacts for both MO and KO. The only minor shortcoming is slightly less clarity on the direction of Altria’s tax benefit (the 0.1 pp increase in effective rate may seem counterintuitive, but the ground truth confirms it was favorable due to deferred tax adjustments); the LLM could have clarified this better. However, the numbers and synthesis are factually correct. Wording differs but meaning is semantically equivalent. All entities (Altria/MO, Coca-Cola/KO, Philippines, PPE, effective tax rate) are accurate. No irrelevant content. Thus, high scores across all dimensions with a 9 on correctness due to slight ambiguity in explaining Altria’s tax benefit.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 509,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung is listed by NVIDIA as one of the “foundries … to produce our semiconductor wafers” (NVDA 10‑K p. 9) and also appears in NVIDIA’s competitive set as a “supplier of hardware and software for SoC products … Samsung” (NVDA 10‑K p. 9).  Qualcomm likewise notes that “certain of our largest customers (for example, Samsung) develop their own integrated‑circuit products … and compete with us” (QCOM 10‑K p. 19).  Because Samsung must balance wafer capacity for its own SoC lines and for external customers such as NVIDIA, it could give priority to its own products, leaving less capacity for Qualcomm; under Qualcomm’s purchase agreements, any shortfall or under‑utilization can trigger incremental fees, loss of prepaid amounts, or the need to find alternative capacity for the $12.8 billion of multi‑year commitments (QCOM 10‑K p. 82).  Consequently, Samsung’s dual role creates a supply‑risk that could increase Qualcomm’s costs or force it to re‑source capacity, jeopardizing the fulfillment of those commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Samsung is a foundry for NVIDIA (citing NVDA 10-K p.9), competes with Qualcomm in SoCs (citing QCOM 10-K p.19), and Qualcomm has $12.8 billion in multi-year capacity commitments (explicitly stated and cited to QCOM 10-K p.82). The dollar amount is correctly reported with no calculation errors. (2) Quantitative accuracy is perfect: the $12.8 billion figure is accurately referenced and contextualized within the risk framework. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across NVIDIA’s and Qualcomm’s 10-Ks to identify Samsung’s dual role as supplier and competitor, and infers the plausible risk to Qualcomm’s capacity access. It goes further by specifying contractual consequences (fees, loss of prepayments, need to re-source), which are consistent with the type of risks implied in the ground truth. (4) The only minor shortcoming is that the original answer emphasizes Samsung potentially prioritizing its own product lines over *external* manufacturing demand broadly (including both Qualcomm and NVIDIA), while the LLM focuses the risk more narrowly on Qualcomm. However, this does not undermine the correctness of the core argument. Wording differs but semantic meaning and factual content are equivalent. Citations enhance credibility and precision. No irrelevant or incorrect information is present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 399,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s 10‑K shows that about **$665 million** of its receivables are from other governments and commercial customers – including ULA launch customers – and are expected to be collected in 2025, giving a near‑term cash source to support its 50 % ownership of United Launch Alliance【page_76】.  Boeing, which holds the other 50 % stake in ULA, reported **$125 million** of equity‑method income from the joint venture in 2024, indicating that the venture is generating earnings for its owners【page_42】.  Together, the commercial receivables and Boeing’s earnings reinforce ULA’s liquidity and profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $665 million in commercial receivables from Lockheed Martin's 10-K as of December 31, 2024 (implied by context), and correctly states Boeing's $125 million equity income from ULA in 2024. These figures match the ground truth exactly and are properly attributed. 2) Quantitative accuracy is perfect: both dollar amounts are correct, and no calculations are required beyond accurate reporting. Format variations (e.g., $665 million vs $665M) are acceptable and handled appropriately. 3) The multi-hop reasoning is largely sound: it connects Lockheed’s receivables (including those tied to ULA launch customers) to its ownership in ULA, and links Boeing’s equity income to ULA’s profitability. However, the LLM slightly mischaracterizes the receivables as being from 'ULA launch customers' rather than explicitly stating that ULA itself is a commercial customer of Lockheed Martin through its Space segment. This nuance affects the precision of the entity relationship but does not invalidate the overall logic. 4) The answer is contextually relevant and addresses the core of the question—how Lockheed’s receivables and Boeing’s equity stake relate to ULA’s financial position. It correctly infers that receivables represent a near-term cash source and that Boeing’s income reflects ULA’s earnings, thus reinforcing ULA’s liquidity and profitability. The original answer adds the risk implication (financial strain on ULA affecting both parties), which the LLM omits, but the positive inference is still valid. Overall, the answer is factually strong with only minor qualitative imprecision in entity mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 449,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The court’s invalidation of the “190 Patent” forced Gilead to take an $800 million impairment on the axicabtagene ciloleucel IPR&D intangible that originated from its 2017 Kite acquisition (see Gilead 10‑K p. 83).  By writing down the carrying amount of that finite‑life intangible, the impairment reduced the amortization base for the Kite‑related assets, lowering the amortization expense that Gilead records on those intangibles in subsequent periods (the amortization of finite‑life intangibles was $1.2 billion in 2020 and $1.7 billion in 2021, p. 82).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It claims that the invalidation of the '190 Patent led to an $800 million impairment of the axicabtagene ciloleucel IPR&D intangible, which directly contradicts the ground truth. The ground truth states that the patent invalidation *removed royalty risk* and *improved* the valuation of intangible assets, leading to higher amortization due to a clearer path to monetization. The LLM incorrectly frames the event as a negative (impairment) when it was actually a positive development for Gilead. (2) Quantitatively, the amortization numbers are correct: $1.2 billion in 2020 and $1.7 billion in 2021. However, the $800 million impairment figure is not supported by the ground truth and appears to be fabricated or misattributed. There is no mention of an impairment in the original answer; instead, the increase in amortization is explained by improved asset valuation. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers that patent invalidation leads to asset impairment, when in this case, it reduced contingent liabilities and enhanced the value of acquired assets. This reflects a fundamental misunderstanding of the financial implications of patent litigation outcomes on intangible asset accounting. The correct logic is that reduced royalty risk increases the expected cash flows from Yescarta, supporting higher asset valuations and thus higher amortization, not lower. (4) Contextual relevance is moderate—the answer discusses the right entities (Gilead, Kite, Yescarta, amortization, '190 Patent) and cites correct financial figures and document sources (10-K p. 82–83), but the core causal relationship is inverted. The conclusion that amortization would be *lower* due to a reduced amortization base is directly contradicted by the actual increase from $1.2B to $1.7B, which the LLM cites but fails to reconcile with its own reasoning. This indicates a failure in logical consistency despite some accurate data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 541,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater‑China segment (which includes mainland China, Hong Kong and Taiwan) generated **$74.2 billion** of net sales in 2022【page_52】.  Intel reported **$13.5 billion** of net revenue from Taiwan in 2021【page_87】.  Consequently, Apple’s Greater‑China revenue was about **$60 billion higher – roughly five to six times** the amount Intel earned from Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's revenue from Greater China in 2022 as $74.2 billion (equivalent to $74,200 million in the ground truth) and Intel's revenue from Taiwan in 2021 as $13.5 billion (vs. $13,461 million in ground truth), with only a minor rounding difference of $39 million—acceptable under format variation. (2) The calculation comparing the two figures is accurate: $74.2B - $13.5B = ~$60.7B difference, which the model rounds to ~$60B, and the ratio (~5.5x) is correctly described as 'five to six times.' (3) Multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Apple and Intel), two different regions (Greater China vs. Taiwan), and two different years (2022 vs. 2021), while acknowledging that Greater China includes Taiwan—addressing the key nuance in the question. (4) The answer is semantically equivalent to the ground truth, with slightly more precise comparative analysis. The only minor deduction is for rounding Intel’s revenue from $13,461M to $13.5B (though standard), which slightly affects quantitative precision. All entities, metrics, and years are correct. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 336,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS values its over‑the‑counter foreign‑currency and interest‑rate derivatives at the Level 2 fair‑value tier, using pricing models that depend on market‑observable inputs such as yield curves, interest‑rate levels and credit spreads (see UPS p. 89, 137). Boeing’s fixed‑income investments are likewise measured with observable market data—benchmark yields, swap curves, base (credit) spreads and broker quotes—through market‑approach or income‑approach valuations (see Boeing p. 102). Thus, both companies rely heavily on observable market inputs, but UPS emphasizes yield‑curve inputs for its derivative valuations, while Boeing’s fixed‑income valuations draw on a broader set of market rates and credit‑spread information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: both UPS and Boeing use Level 2 fair value measurements relying on observable market data; UPS uses yield curves, interest rates, and credit spreads for derivative valuation; Boeing uses benchmark yields, swap curves, credit spreads, and broker quotes for fixed income investments. The mention of specific page references (e.g., UPS p. 89, 137; Boeing p. 102) adds precision and matches typical disclosure locations, though exact page numbers are not part of the ground truth and are acceptable as contextual support. (2) There are no numerical values requiring calculation, so quantitative accuracy is fully satisfied as all referenced inputs (yield curves, credit spreads, etc.) are correctly attributed. (3) The multi-hop reasoning is sound—correctly comparing two companies’ valuation practices across different instruments (derivatives vs. fixed income) while identifying common reliance on observable inputs and subtle differences in emphasis (UPS on yield curves, Boeing on broader credit and rate data). (4) The LLM slightly expands on the original by specifying 'benchmark yields' and 'broker quotes' for Boeing, which are consistent with but not explicitly stated in the ground truth; this is acceptable as semantic elaboration, not error. The conclusion that both rely heavily on observable inputs, with nuanced focus areas, matches the original’s intent. No major omissions or inaccuracies—only a minor difference in specificity, not correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 460,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "META uses discounted‑cash‑flow (DCF) models to determine the fair value of impaired lease‑right‑of‑use assets and lease‑hold improvements.  The models rely on Level 3 (unobservable) inputs – management’s assumptions about expected downtime before subleasing, projected sublease cash flows over the remaining lease term, and a risk‑adjusted discount rate that reflects the uncertainty of receiving those cash flows【page_98】.  \n\nDIS, on the other hand, applies internal DCF models to value its Level 2 derivatives, but the models are driven by observable market inputs such as current interest rates, yield curves and foreign‑exchange rates (with only a modest credit‑risk adjustment)【page_119】.  \n\nThus, META’s impairment testing depends on internal, assumption‑heavy Level 3 inputs, whereas DIS’s derivative valuation uses observable Level 2 inputs tied to market rates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies that META uses DCF models with Level 3 (unobservable) inputs for impairment testing of lease-related assets, citing specific assumptions such as expected downtime, projected sublease cash flows, and risk-adjusted discount rates. (2) It accurately states that DIS applies internal DCF models to value Level 2 derivatives using observable market inputs like interest rates, yield curves, and foreign exchange rates, with only a modest credit-risk adjustment. (3) The multi-hop reasoning is sound: the answer correctly contrasts the two companies' use of DCF models by emphasizing the difference in input observability (Level 3 vs. Level 2) and links this to their respective financial reporting contexts—impairment testing vs. derivative valuation. (4) All entities (META, DIS, Level 2/3 inputs, DCF models) are correctly identified and appropriately contextualized. There are no numerical inaccuracies, and while no explicit numbers are present, the qualitative descriptors align precisely with the ground truth. The answer is complete, contextually relevant, and demonstrates strong synthesis across the two companies' disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 349,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The 2022 filing notes that a global semiconductor shortage has left IQOS device supply “tight” in the second half of 2021 and, despite some easing, the company still lacks full visibility for 2022 (​page 28​).  Because Altria’s agreement gives PM USA the exclusive right to commercialize PMI’s heated‑tobacco products in the United States only “subject to FDA authorization” (​page 36​) and an ITC import ban has already prevented any IQOS sales in the U.S. (​page 29​), the device‑supply constraint means that even if FDA approval is obtained, PM USA cannot launch the products until sufficient devices are available.  At the same time, PM USA is a 100 % Altria subsidiary that unconditionally guarantees Altria’s debt obligations (​page 51​); thus a delayed U.S. rollout caused by the supply shortage could pressure PM USA’s cash‑flow capacity to meet those guarantees, but it does not alter its guarantor status.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the global semiconductor shortage affecting IQOS supply in the second half of 2021 is accurately cited from PM's 2022 filing, the ITC import ban halting U.S. sales is correctly referenced, and PM USA’s role as an exclusive commercialization partner subject to FDA authorization is properly described. The answer correctly notes that PM USA is a 100% Altria subsidiary and an unconditional guarantor of Altria’s debt obligations. (2) Quantitative accuracy is perfect: no specific numbers (e.g., dollar amounts, percentages) are misstated, and all time references (e.g., 2021, 2022) match the context of the original answer. The mention of page numbers (28, 36, 29, 51) suggests precise sourcing, though not required for correctness. (3) Multi-hop reasoning is sound: the model correctly links the semiconductor shortage → supply constraints → delayed U.S. rollout potential even with FDA approval → impact on PM USA’s commercialization ability → financial pressure due to debt guarantee obligations. The causal chain is logically structured and synthesizes information across operational, regulatory, and financial domains. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the November 29, 2021, cessation date of IQOS sales or the specific reference to fraudulent conveyance risk under insolvency considerations, which are part of the original answer’s financial risk analysis. While the general financial pressure on PM USA is noted, this omission slightly reduces completeness in the qualitative dimension. However, the core financial implication—pressure on cash flow affecting guarantee capacity—is preserved. Overall, the answer is semantically equivalent and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 503,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMS (BMY) flags biosimilar entry as a source of “very substantial and rapid declines” in product revenues once market exclusivity ends and notes that lower‑priced generics or biosimilars for its biologics could cut volumes and prices, but the risk is spread across its portfolio rather than tied to a single blockbuster (see BMS risk‑factor discussion of loss of exclusivity and generic/biosimilar pressure, pages 27‑28). AbbVie, by contrast, is far more exposed to one product: Humira alone generated about 27 % of its 2023 net revenues and is already facing direct biosimilar competition worldwide (see AbbVie 10‑K, page 81 and competition section, page 8), making its revenue outlook far more vulnerable to that specific biosimilar challenge.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Humira accounted for 27% of AbbVie's 2023 net revenues, which matches the original answer; BMY faces portfolio-wide biosimilar risk while ABBV has concentrated risk on Humira. (2) Quantitative accuracy is perfect: the 27% figure is correctly cited and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound—LLM correctly synthesizes risk exposure across two companies, drawing from different parts of their 10-Ks (e.g., BMY’s risk factors on pages 27–28 and ABBV’s Humira exposure on page 81 and competition section on page 8), demonstrating proper cross-document inference. (4) The answer fully addresses the comparative aspect of the question: it contrasts BMY’s diversified risk with ABBV’s single-product vulnerability, mirroring the original answer’s core insight. Wording differs but meaning is preserved, and additional context (e.g., 'very substantial and rapid declines') enhances accuracy without introducing error. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 321,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards “earn dividend equivalents” that remain part of the award and are delivered as additional shares when the RSU vests – generally on the third anniversary of the grant 【page_110】. PepsiCo’s RSUs and PSUs also accrue dividend equivalents, but those are paid out in cash (without interest) at the moment the award vests and becomes payable 【page_92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences in dividend equivalent treatment between PM and PEP. (1) It correctly states that PM's dividend equivalents accrue and are paid as additional shares upon vesting, typically on the third anniversary, aligning with the ground truth's mention of a three-year vesting period and settlement in shares. (2) For PEP, it accurately notes that dividend equivalents are paid in cash (without interest) at vesting, matching the original answer. (3) The LLM cites correct page references (110 for PM, 92 for PEP), indicating proper sourcing. (4) The only minor omission is that the ground truth includes additional vesting triggers for PM such as death, disability, or reaching age 58, and clarifies that PEP does not have age-based triggers—this contextual nuance is missing in the LLM response, slightly weakening the completeness of the comparison. However, the key structural difference—PM settling dividend equivalents in shares at vesting vs. PEP paying cash at vesting—is clearly and correctly conveyed. All entities (PM, PEP, RSUs, PSUs), payout structures, and timing are accurately represented. No numerical inaccuracies; dates and terms are correct. Multi-hop reasoning is sound, synthesizing across two companies' policies. Thus, the answer is factually correct and contextually relevant, meriting a high score with a small deduction for incomplete detail on vesting triggers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 397,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s run‑off insurance unit carries about **$1.41 billion of limited‑partnership real‑estate fund interests that are not redeemable and can only be sold with general‑partner approval, so the exposure is highly illiquid and is measured at NAV** (GE 10‑K, p. 51). In contrast, Boeing’s pension plan allocates roughly **7 % of its assets to global private real‑estate and real‑asset investments held through LPs or other fund structures, many also measured at NAV, but these holdings are part of a broader, diversified portfolio that is actively managed for liquidity risk** (BA 10‑K, pp. 99‑101).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: GE's $1.41 billion (equivalent to $1,410 million) investment is accurately reported, and Boeing's ~7% allocation to private real estate and real assets is consistent with its 10-K disclosures. The use of NAV measurement and limited partnership structures is correctly attributed to both companies. (2) The answer addresses all parts of the multi-hop question: it compares GE’s illiquid real estate fund investments through run-off insurance operations to BA’s broader real estate strategy, focusing on liquidity risk and fund structure. (3) Entity accuracy is strong—GE and BA (Boeing) are correctly identified, and the context of run-off insurance (GE) and pension plan investments (BA) is accurate. (4) Reasoning is sound: the LLM correctly infers that both use LP/fund structures with NAV measurement and limited liquidity, but contrasts GE’s concentrated, non-redeemable exposure with BA’s diversified, actively managed portfolio. The only minor shortcoming is that the original answer emphasizes BA’s integration of real estate within a broader asset allocation (including private equity and hedge funds), which the LLM mentions only implicitly via 'broader, diversified portfolio.' This slight omission in elaborating the full breadth of BA’s strategy prevents a perfect 10, but the core facts, synthesis, and semantics are correct. Wording differences are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 416,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "Bank of America does not provide a disclosed notional amount for equity‑market derivatives; its equity‑market exposure is shown only through a VaR measure of roughly $9 million at year‑end (about $18 million on an average basis)【page_77】. MetLife, by contrast, reports equity‑market derivative contracts with a notional of $23.6 billion and a sensitivity that would generate a $522 million loss if equity prices fell 10%【page_129】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies MET's notional value ($23.6 billion vs. ground truth $23,595 million — equivalent within rounding) and sensitivity to a 10% decrease in equity prices ($522 million — exact match). However, it introduces a significant factual error regarding BAC: the claim that BAC has a VaR measure of $9 million (or $18 million on average) for equity-market derivatives is not supported by the original answer or typical BAC disclosures in this context. The ground truth states that BAC does not specify exact notional amounts and emphasizes qualitative risk management via hedging tools, with no mention of VaR figures for equity derivatives. This quantitative addition misrepresents the available data and undermines factual accuracy. While the comparison structure and entity identification (BAC vs. MET) are sound, and the MET numbers are accurately reported, the incorrect attribution of VaR numbers to BAC constitutes a major error in the multi-hop synthesis. The reasoning is otherwise logical and relevant, contrasting disclosed quantitative exposure (MET) with qualitative disclosure (BAC), but the inclusion of unsupported figures reduces correctness. Semantic equivalence fails on the BAC point due to fabricated metrics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 349,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 10‑K shows a dedicated “Greater China” segment that generated $74.2 billion in net sales and is supported by a regional operations center in Singapore (which serves Greater China, Japan, India and APAC) plus datacenters across Asia 【page_25】, indicating a broad, multi‑channel footprint in the region. AMD’s 10‑K reports that sales to Taiwan were $2.1 billion in the most recent year, representing roughly 13 % of its total external‑customer revenue of $16.4 billion 【page_78】, showing a relatively high concentration in a single market. Thus, Microsoft pursues a diversified, large‑scale regional strategy in Greater China, whereas AMD’s 2022 strategy relies more heavily on a key market (Taiwan) for a sizable share of its revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's operational footprint in Greater China and AMD's revenue concentration in Taiwan, aligning with the core of the ground truth. However, there are quantitative inaccuracies: Microsoft does not report a 'Greater China' segment with $74.2 billion in net sales in its 10-K — this figure likely conflates overall international revenue or misattributes segment data. Microsoft’s actual 10-K does not break out standalone 'Greater China' sales at this level, making the $74.2 billion figure incorrect. AMD’s $2.1 billion in sales to Taiwan is approximately correct (ground truth: $2,091 million), and 13% of total revenue (~$16.4B) is accurate, so AMD’s numbers are acceptable with rounding. (2) The calculation for AMD’s percentage is sound: $2.091B / $16.4B ≈ 12.75%, which rounds to 13%, so this is quantitatively accurate. Microsoft’s claimed $74.2B in Greater China sales cannot be verified and is inconsistent with public filings — Microsoft does not disclose revenue at that granularity, and global revenue in 2022 was around $198B, making $74.2B for one region implausible. (3) The multi-hop reasoning is strong: the model correctly contrasts Microsoft’s regional hub strategy (Singapore supporting Greater China) with AMD’s concentrated revenue exposure to Taiwan. It infers strategic differences — diversified regional access vs. key market dependency — which matches the ground truth’s conclusion. (4) Despite the incorrect Microsoft revenue figure, the qualitative reasoning and strategic interpretation remain sound, and AMD’s data is accurate. The answer is contextually relevant and addresses both parts of the question. The correctness score is reduced due to the significant overstatement of Microsoft’s regional revenue, but not severely penalized because the strategic comparison still holds based on operational structure and AMD’s accurate data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 519,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "Meta’s dual‑class system gives its Class B shares ten votes each and concentrates control in Mark Zuckerberg and other insiders, so that even though Class A holders own most of the equity they have only one vote per share and are effectively unable to sway shareholder‑approved matters (Meta 10‑K pp. 49‑50). In contrast, Netflix has a single‑class common stock where every share carries one vote, giving all investors an equal say on corporate‑governance votes (Netflix 10‑K p. 61).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) It correctly identifies META's dual-class structure, specifying that Class B shares have ten votes per share (as stated in Meta's 10-K, pp. 49–50), which gives insiders like Mark Zuckerberg disproportionate control, while Class A shares have one vote each, limiting influence despite economic ownership. This quantitative detail (10:1 voting ratio) is not in the original answer but is factually correct and adds precision. (2) It accurately contrasts this with NFLX’s single-class structure where each share has one vote, citing Netflix’s 10-K, p. 61, which matches the ground truth’s claim of a one-share-one-vote policy. (3) The multi-hop reasoning—comparing governance models across two companies using their respective 10-Ks—is sound and correctly synthesizes information. (4) The only minor shortcoming is that the LLM answer omits explicit mention of 'board composition' and 'change-of-control transactions' as specific governance matters affected, which are included in the original answer for context. However, the phrase 'unable to sway shareholder-approved matters' broadly covers these. The omission is not a factual error but a slight reduction in completeness. All entities (Meta, Netflix, Class A/B shares), metrics (voting rights), and sources (10-K pages) are correct. Wording differs but semantic meaning is equivalent. Quantitative accuracy is perfect, including the 10:1 vote ratio. Contextual relevance is high as it directly addresses investor influence over corporate governance. Thus, correctness is 9/10 due to minor contextual omission, but all critical facts and reasoning are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 459,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson makes clear that once a compound patent (or other patent) on a drug expires, the product’s market‑exclusivity ends and sales can fall sharply as generics or biosimilars enter – the company warns that “the impact of patent expirations…typically followed by the introduction of competing generic, biosimilar or other products and resulting revenue and market‑share losses” (JNJ 10‑K p. 4) and that “the FDA cannot approve an ANDA until after the innovator’s listed patents expire” (JNJ 10‑K p. 7). By contrast, Eli Lilly relies on regulatory exclusivity extensions—such as five‑year data‑package protection, seven‑year orphan‑drug exclusivity and six‑month pediatric exclusivity that can be added to patent terms—to keep competitors out and preserve a U.S. competitive advantage even after patents run out (LLY 10‑K p. 10; product table showing data‑protection and orphan exclusivity dates, p. 13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that JNJ faces loss of market exclusivity and revenue declines post-patent expiration due to generic/biosimilar entry, citing direct language from JNJ's 10-K about 'revenue and market-share losses' and FDA approval timelines (ANDA). It also accurately notes JNJ's concern about aggressive patent challenges, though this specific point is slightly less emphasized in the LLM version compared to the original. (2) Quantitatively, the LLM correctly references the types and durations of regulatory exclusivity used by LLY—five-year data exclusivity, seven-year orphan drug exclusivity, and six-month pediatric exclusivity—without introducing any incorrect numbers or dates. These match the types of regulatory protections implied in the ground truth (e.g., orphan and pediatric exclusivity). (3) The multi-hop reasoning is sound: it contrasts JNJ’s vulnerability to patent expiration with LLY’s strategic use of regulatory exclusivity extensions beyond patent terms, citing both companies’ 10-Ks appropriately. It even references a product table in LLY’s filing (p.13), adding contextual support. (4) The only minor shortcoming is that the original answer references BMY’s 10-K as a source for the general principle that regulatory exclusivity can extend beyond patent terms, which the LLM omits. However, the LLM still correctly conveys the concept using LLY’s own disclosures, so this does not undermine the core accuracy. Wording differs but semantic meaning is equivalent. Overall, the answer is factually correct, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 451,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s 2021 interest expense fell to $34 million from $47 million in 2020 – a $13 million reduction that the company attributes to “lower debt balances as a result of conversions by holders of our 2.125 % Convertible Senior Notes due 2026”【AMD_10k_2022, p.48】.  By contrast, after Microsoft’s acquisition of Nuance, only $1 million of Nuance’s convertible senior notes remained outstanding – the $986 million issued in 2015‑2017 was almost entirely redeemed, leaving a negligible liability on Microsoft’s balance sheet【MSFT_10k_2022, p.78】.  \n\nThis contrast implies that AMD is using convertible‑debt conversions to actively cut interest costs and deleverage its capital structure, whereas Microsoft has effectively removed Nuance’s legacy convertible debt, reflecting a strategy of cleaning up and simplifying the acquired company’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: AMD's interest expense decreased from $47 million in 2020 to $34 million in 2021, a $13 million reduction, due to conversions of its 2.125% Convertible Senior Notes due 2026. Nuance issued $986 million in convertible notes, with $985 million redeemed by June 30, 2022, leaving $1 million outstanding post-acquisition by Microsoft. These figures match the ground truth exactly. (2) Quantitative accuracy is perfect: all dollar amounts, timeframes, and the implied calculation of the $13 million reduction are correct. The note about $986 million issued and $1 million remaining aligns with the redemption of $985 million, which is accurate. (3) The multi-hop reasoning is sound—information is correctly synthesized across AMD’s and Nuance’s filings (via Microsoft’s 10-K), and the comparison between AMD’s conversion-driven deleveraging and Microsoft’s post-acquisition redemption strategy is logically drawn. (4) The only minor shortcoming is that the LLM does not explicitly name Nuance’s redemption timeline (by June 30, 2022) or specify that the remaining liability sits in Microsoft’s Intelligent Cloud segment, which adds slight contextual depth. However, the core implications about capital structure strategies—AMD proactively reducing debt via conversions vs. Microsoft cleaning up Nuance’s balance sheet—are accurately interpreted and semantically equivalent to the ground truth. Thus, the answer is highly accurate with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 419,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "American Tower’s March 2015 deal gave it exclusive rights to about 11,300 Verizon towers for an upfront $5.0 billion – roughly $170 million more than Crown Castle’s December 2013 transaction, in which it paid $4.827 billion for exclusive rights to roughly 9,000 AT&T towers (and bought 627 towers outright).  In both transactions the tower owners (Verizon and AT&T) retained legal title, kept the towers on their Property‑Plant‑and‑Equipment balances and continued to depreciate them, while the cash received was recorded as a financing obligation rather than a sale‑lease‑back.【page_73】【page_90】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: American Tower paid $5.0 billion in March 2015 for exclusive rights to 11,300 Verizon towers; Crown Castle paid $4.827 billion in December 2013 for exclusive rights to ~9,000 AT&T towers and purchase of 627 towers. The $170 million difference ($5.0B - $4.827B = $173M) is approximately correct and reasonably rounded. (2) Quantitative accuracy is excellent—dollar amounts, tower counts, and dates match or are acceptably approximated (e.g., 'roughly 9,000' vs 9,048 is reasonable). (3) Entity accuracy is strong: correct companies (American Tower, Crown Castle, Verizon, AT&T), correct years (2015 vs 2013), and correct transaction structures. (4) Multi-hop reasoning is sound: the model correctly synthesizes that both deals involved exclusive rights, retained ownership, continued depreciation, and financing obligation treatment rather than sale-leaseback accounting. (5) The only minor omission is that the original answer specifies Verizon's leaseback term (minimum 10 years) and AT&T's estimated original sublease term (20 years), which the LLM answer leaves out. This contextual detail about lease durations adds nuance to the comparison but does not undermine the core correctness. The LLM correctly identifies the key accounting treatment (retained on PPE, depreciation continued, financing obligation). Wording differences (e.g., 'legal title' vs 'ownership') are semantically equivalent. Overall, the answer is factually correct, well-reasoned, and contextually appropriate—just missing a small but relevant detail on lease terms, warranting a 9 instead of 10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 464,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power’s wind projects are financed through tax‑equity partnerships that pass essentially all of the Production Tax Credits to the tax partner, while the projects are tied to long‑term PPAs (operating‑lease‑type contracts) that can run as long as 25 years, giving Southern Power a stable, lease‑like revenue stream (see pages 97 & 268‑269). Duke Energy likewise uses tax‑equity arrangements for its renewable VIEs to capture federal tax credits, but the PPAs are embedded in the VIE structure and are backed by corporate guarantees rather than a separate, long‑term lease contract, so the credit monetization is achieved through the VIE financing framework rather than a distinct 25‑year PPA (see pages 202‑204).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Southern Power's use of tax equity partnerships with long-term PPAs up to 25 years, the transfer of PTCs to tax partners, and the lease-like revenue structure are all consistent with the original answer. Duke Energy’s use of tax equity for renewable VIEs, PPA integration within VIEs, and reliance on corporate guarantees instead of standalone long-term contracts are also correctly represented. No specific numbers (e.g., dollar amounts, percentages) are misstated. (2) The answer correctly identifies both companies, their respective structures (tax equity, VIEs), and the role of PPAs in monetizing tax credits. (3) The multi-hop reasoning is sound: it synthesizes information across Southern Power’s PPA structure and tax equity model with Duke’s VIE-based approach, highlighting the contrast in how each monetizes tax credits—Southern via long-term lease-type PPAs aligned with the 10-year PTC window, Duke via VIE financing frameworks with embedded PPAs and guarantees. (4) The only minor shortcoming is that the LLM does not explicitly mention the HLBV consolidation method used by Southern Power or clarify that Duke’s VIEs involve third-party tax equity investors financing eligible assets—details present in the original. However, this omission does not undermine the core accuracy or comparative insight. The answer remains semantically equivalent in substance and correctly captures the key distinction: Southern Power relies on long-term PPAs as a direct monetization mechanism tied to the PTC period, while Duke embeds PPAs within a broader VIE financing model. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 479,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "Comcast’s charter gives each Class B share ten votes versus one vote for a Class A share, and the two classes otherwise share identical economic rights; Class B holders can convert their shares to Class A at any time, so a relatively small group of super‑voting shareholders can dominate board elections and other major actions while still being subject to Delaware‑law amendment safeguards (see CMCSA Note 11, page 82). Alphabet’s dual‑class system separates voting power from the publicly traded shares – Class A carries one vote, Class C carries none, and the 10‑vote Class B shares are held only by insiders – concentrating control of strategic decisions (e.g., mergers, charter changes) in the hands of founders and limiting ordinary shareholders’ influence (see GOOGL Note 11, page 82).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) It incorrectly states that CMCSA's Class B shares have ten votes and Class A shares have one vote, which is the opposite of the ground truth: CMCSA's Class B common stock has *no voting rights*, not super-voting rights. This is a critical error that completely inverts the governance structure of CMCSA. (2) The answer correctly describes GOOGL's dual-class system: Class B shares have 10 votes and are held by insiders, Class A has 1 vote, and Class C has none. This part is factually accurate and aligns with the original answer. (3) The reference to 'CMCSA Note 11, page 82' and 'GOOGL Note 11, page 82' appears fabricated or misapplied, as such specific citations were not part of the verified knowledge graph data, and cannot be confirmed. (4) The reasoning is partially sound for GOOGL but fundamentally flawed for CMCSA due to the inversion of voting rights, leading to an incorrect comparison of corporate governance models. The conclusion that a small group of super-voting shareholders dominates at CMCSA is false—CMCSA does not have a super-voting class; rather, it restricts voting rights in Class B entirely. (5) While the answer addresses the question's intent regarding shareholder influence and governance, the core factual inaccuracy regarding CMCSA's voting structure severely limits its validity. The semantic meaning diverges significantly from the ground truth, especially on the key point of which class has voting power. Thus, despite correct description of GOOGL, the misrepresentation of CMCSA results in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 446,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes while Class A and Class C shares carry only one vote (or none for Class C)【page_81】. In 2023 the company bought back $62.2 billion of low‑vote Class A and Class C stock, shrinking the pool of one‑vote shares and thereby raising the percentage of total voting power held by the high‑vote Class B holders【page_81】. Netflix, by contrast, has a single‑class structure where every share gets one vote【page_61】, so any repurchases would dilute all shareholders equally and cannot concentrate control the way Alphabet’s structure does.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $62.2 billion share repurchase amount for GOOGL in 2023 is correctly stated, and the distinction between voting rights (10 votes for Class B, 1 vote for Class A, and 0 for Class C) is factually correct. The format variation ($62.2 billion vs $62.2B) is acceptable. (2) The answer correctly explains that repurchasing low-vote Class A and C shares reduces the total voting pool of one-vote shares, thereby increasing the relative voting power concentration among Class B shareholders—this is a correct interpretation of the control-dilution effect in dual-class structures. (3) The comparison to NFLX’s one-share-one-vote structure is accurate and highlights how repurchases under a single-class system do not disproportionately shift control, which addresses the multi-hop reasoning requirement linking capital allocation (repurchases) to governance (control dynamics). (4) Minor deduction in qualitative accuracy because the original answer notes that Class C shares have no voting rights, while the LLM mentions Class C as having 'one vote or none'—this introduces slight ambiguity, though the overall reasoning remains sound. Otherwise, all entities (GOOGL, NFLX, 2023, share repurchases, share classes) are correctly identified and synthesized. The answer is contextually excellent, directly addressing the impact of voting structure differences on control dynamics in light of repurchase activity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 412,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMY retained royalty rights on the Byetta (Amylin) product when it divested its diabetes business, and those royalties generated roughly $1.9 billion of pretax income in 2021 – a “significant percentage” of the company’s pretax earnings and operating cash flow【page_48】. Thus, even though the Byetta trademark is now owned by Eli Lilly, the retained royalty stream remains a material source of BMY’s profitability【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.9 billion pretax income figure from 2021 is correctly reported, matching the original answer and sourced from BMY's 2022 10-K. The year (2021) and metric (pretax income) are accurate. (2) The answer correctly identifies the key entities: BMY (Bristol Myers Squibb), Byetta, Amylin, and Eli Lilly (LLY) as the current trademark holder. (3) The multi-hop reasoning is sound: it connects BMY’s divestiture of the diabetes business, retention of royalty rights, continued financial benefit despite LLY owning the trademark, and the materiality of the royalty stream to BMY’s profitability. (4) The only minor omission is that the original answer notes a forward-looking risk — that a decline in these royalties could adversely affect BMY’s future performance — which the LLM answer does not explicitly mention. However, the LLM’s emphasis on the royalty being a 'material source' and a 'significant percentage' of earnings captures the financial significance effectively. Wording differs slightly (e.g., 'significant percentage' is added detail not in the original but supported by context), but semantic equivalence is maintained. No factual errors; minor omission does not detract significantly from correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 364,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab must hold a total risk‑based capital ratio of 10.5%, which reflects both a 2.5% stress‑capital buffer on its holding company and a 2.5% capital‑conservation buffer on its bank subsidiary【page_122】. JPMorgan Chase’s bank subsidiary also has a 10.5% minimum total risk‑based capital ratio, but this includes only the 2.5% capital‑conservation buffer (no stress buffer)【page_291】. Thus, the numeric requirement is the same, but Schwab’s structure requires an extra stress‑buffer allocation that JPMorgan Chase does not need.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Schwab and JPMorgan Chase have a 10.5% minimum total risk-based capital ratio requirement, with Schwab subject to both a 2.5% stress capital buffer and a 2.5% capital conservation buffer, while JPMorgan Chase only applies the 2.5% capital conservation buffer. This matches the ground truth in all key factual aspects. (2) Quantitative accuracy is perfect: percentages (10.5%, 2.5%, 2.5%) are correctly reported, and the synthesis of the components (base minimum + buffers) aligns with regulatory logic. The numeric requirement being the same despite different buffer structures is accurately conveyed. (3) The multi-hop reasoning is sound—information about two different companies, their respective buffers, and how these affect capital requirements is correctly synthesized. The only minor shortcoming is that the LLM attributes the stress capital buffer to the holding company and conservation buffer to the bank subsidiary, which adds detail not in the original answer; while plausible and potentially accurate based on regulatory structure, this level of entity-specific assignment (holding vs. bank subsidiary) was not in the ground truth and slightly extends beyond it. (4) Despite this minor addition, the core facts, comparisons, and implications are correct and relevant. The answer is semantically equivalent to the original, with excellent contextual relevance and precise numerical accuracy, warranting a high score with only a slight deduction in qualitative accuracy due to the unverified structural attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 436,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "Both companies have built‑in fallback language that will automatically switch the benchmark when USD LIBOR ends. Lockheed Martin’s $14.4 billion credit facility already contains alternative‑rate provisions and, because the change will be treated under ASU 2020‑04, the required contract modifications can be accounted for with little or no impact on its results, financial position or cash flows (LMT p. 85). General Electric’s floating‑rate debt and its LIBOR‑linked preferred stock are likewise subject to New York‑law fallback language that will replace LIBOR with SOFR + a spread, and the transition will be accounted for under the same ASU 2020‑04 relief, limiting any material accounting effect (GE p. 37).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both LMT and GE have fallback provisions for LIBOR transition, LMT’s $14.4 billion credit facility is accurately cited (though not in the original answer, it is consistent and plausible, and does not contradict), and both companies apply ASU 2020-04 for accounting relief. The mention of SOFR + spread for GE under New York law matches the original. (2) Quantitative accuracy is excellent—no incorrect numbers or calculations; the $14.4 billion figure is specific and format-appropriate. While the original answer doesn’t include this dollar amount, its inclusion in the LLM answer adds precision without introducing error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the impact on LMT’s credit facility and derivatives, and GE’s floating-rate debt and preferred stock, linking both to ASU 2020-04. The reasoning across entities and instruments is logical and complete. (4) Semantic equivalence is strong—wording differs but meaning is preserved, and the LLM enhances the answer with document page references (LMT p. 85, GE p. 37), suggesting grounding in source material. The only minor gap is that the original emphasizes LMT’s derivatives, which the LLM omits, but mentions 'contract modifications' which may encompass them. This small omission prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 406,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "Comcast’s 2023 balance sheet shows that it issued 9,444,375 shares of a new Class B common stock (authorized 75 million, all issued and outstanding) that carries ten votes per share, creating a high‑voting class that concentrates voting power with the holders of those shares【page_69】. Alphabet’s dual‑class system also gives Class B shares ten votes, but they may be converted at any time and automatically convert to Class A shares when sold or transferred, so voting power cannot be transferred to new owners【page_81】. Thus, Comcast’s Class B shares remain a distinct, high‑voting class, whereas Alphabet’s Class B shares effectively become ordinary voting shares upon any transfer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA issued 9,444,375 Class B shares in 2023, and the LLM correctly identifies this figure. The voting structure (10 votes per share for both CMCSA and GOOGL Class B) is accurately stated. (2) The comparison between CMCSA and GOOGL's dual-class systems is sound: both have Class B shares with 10 votes, and GOOGL's automatic conversion upon sale/transfer is correctly described. The LLM accurately notes that CMCSA’s Class B shares remain a distinct high-voting class, unlike GOOGL’s, which convert upon transfer. (3) The multi-hop reasoning is strong—synthesizing information across two companies and their share structures. However, the LLM omits a minor but relevant point from the original answer: GOOGL’s $62.2 billion share repurchase in 2023 and the absence of a similar buyback program at CMCSA. This contextual financial activity is part of the strategic comparison and was not addressed, slightly reducing completeness. (4) Despite this omission, the core facts, entities, dates, and reasoning are correct. Wording differs but semantic meaning matches. The answer is contextually relevant and well-structured. Hence, a score of 9 is justified—excellent accuracy with a minor gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 367,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDLZ’s multi‑employer pension commitments are funded by contributions made as incurred (e.g., $4 million in 2021, $5 million in 2020) and a withdrawal liability that must be paid on a pro‑rata monthly basis over 19 years, so the expense is recognized when contributions are paid and the liability is amortized over the long‑term payment schedule【page_120】【page_106】. By contrast, Walmart’s equity awards vest much more quickly—RSUs generally vest 25 % per year over four years and other restricted‑stock awards over one to three years—and the fair‑value cost is spread ratably over the vesting period, leaving unrecognized compensation balances with a weighted‑average remaining expense horizon of roughly 1.2‑1.5 years【page_66】【page_67】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core contrast between MDLZ's long-term multiemployer pension obligations and WMT's shorter equity vesting schedules, correctly identifying key structural differences in cost recognition and duration. However, there are significant quantitative inaccuracies: the ground truth states MDLZ had a $526 million withdrawal liability and $11 million in 2021 contributions, while the LLM reports $4 million in 2021 and $5 million in 2020—these figures are incorrect and materially understate the amounts. 2) The 19-year amortization period for MDLZ’s withdrawal liability is accurately reported. For WMT, the 25% annual vesting over four years is correct, and the 1.2–1.5 year remaining expense horizon aligns with the concept of unrecognized compensation cost, though the ground truth does not specify this exact range—this appears to be an inference from the source material. The 3.8% dividend discount mentioned in the original is omitted. 3) The reasoning is sound: the model correctly synthesizes that MDLZ’s obligations arise from collective bargaining with long-term liabilities and interest accruals, while WMT uses internally designed equity plans with ratable expense recognition. This reflects proper multi-hop understanding across pension vs. equity compensation frameworks. 4) Despite missing some specifics (e.g., dividend discounting) and containing incorrect contribution amounts, the LLM conveys a largely accurate qualitative comparison. The error in financial figures reduces confidence in data fidelity, but the structural and accounting treatment comparison remains valid. Hence, a score of 7 is warranted: core facts and logic are correct, but with notable numerical inaccuracies affecting precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 472,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Under the Advanced Approach, Bank of America must hold a buffer of 2.5 % (capital‑conservation) + 2.5 % (G‑SIB surcharge) + 0 % (CCyB) = 5.0 % above the regulatory minimum【page_146】. Morgan Stanley’s buffer is 2.5 % (capital‑conservation) + 3.0 % (G‑SIB surcharge) + 0 % (CCyB) = 5.5 %【page_54】【page_134】. Thus BAC’s combined buffer is 0.5 percentage point lower than MS’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative components. While it correctly identifies the 2.5% Capital Conservation Buffer and 0% Countercyclical Capital Buffer (CCyB) for both BAC and MS, it incorrectly states MS's G-SIB surcharge as 3.0% (citing pages 54 and 134), whereas the ground truth confirms both BAC and MS have a 2.5% G-SIB surcharge. This leads to an incorrect total buffer of 5.5% for MS instead of 5.0%. The conclusion that BAC’s buffer is 0.5 percentage points lower is therefore false—both institutions have identical 5.0% total buffer requirements. (2) Calculations themselves are mathematically correct (2.5% + 2.5% = 5.0%; 2.5% + 3.0% = 5.5%), but the inputs are factually wrong for MS. The G-SIB surcharge discrepancy is critical and not a minor variation. (3) The reasoning structure is sound—multi-hop synthesis is attempted by combining buffers across institutions and comparing totals—but it fails due to incorrect data retrieval for MS’s G-SIB surcharge. The model cites specific pages, suggesting access to source data, but the information extracted is inconsistent with the ground truth. (4) Correctness and quantitative accuracy are low due to the core error in G-SIB percentage, which alters the comparison. Qualitative accuracy is slightly higher because the framework of buffer composition is correctly understood. Contextual relevance is high—the answer addresses the right concepts, institutions, and regulatory framework.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 413,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes are highly rate‑sensitive – a 50‑basis‑point shift in market rates would change their fair value by about $1.7 billion (≈ $3.4 billion per 100 bp) and the company does not hedge this exposure (aside from occasional treasury rate‑lock contracts). In contrast, Oracle uses cross‑currency and interest‑rate swaps that convert its fixed‑rate Euro debt to a floating‑rate USD exposure (effective rate ≈ 8.76 %) and lock floating borrowings into a fixed 4.74 % rate, thereby neutralizing much of the fair‑value impact—an approach mirrored by Cisco’s $0.5 billion swap that swaps fixed‑rate senior notes into floating‑rate, offsetting the same type of interest‑rate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets several key facts correct: AVGO's $56.3 billion fixed-rate notes and the $1.7 billion fair value impact from a 50 bps shift are accurate. ORCL's effective interest rate of 4.74% is correctly cited. CSCO's $0.5 billion swap is also correctly mentioned. However, a critical error occurs in stating ORCL's effective rate as '≈8.76%' — this number does not appear in the ground truth and contradicts the stated 4.74% effective rate after swaps. The ground truth clarifies that ORCL uses swaps to convert floating-rate debt to fixed, achieving a 4.74% effective rate on a 3.07% base, not 8.76%. The 8.76% figure appears to be a misinterpretation or conflation with another metric, possibly from a different context or miscalculation. (2) Quantitative accuracy is partially compromised: while $56.3B, $1.7B, 50 bps, $0.5B, and 4.74% are correct, the erroneous 8.76% undermines trust in the financial data synthesis. The approximation of $3.4 billion per 100 bps is a reasonable extrapolation from $1.7B/50bps and is acceptable. (3) Multi-hop reasoning is generally sound: the model correctly identifies that ORCL uses swaps to manage interest rate exposure and that CSCO’s swap converts fixed to floating, aligning with AVGO’s unhedged risk. However, it mischaracterizes ORCL’s swap outcome by suggesting it results in an 8.76% rate, which contradicts the ground truth that swaps help ORCL lock in a lower effective rate (4.74%) by converting floating to fixed. This misrepresents the direction and purpose of ORCL’s hedging. (4) Contextual relevance is high — the answer addresses all three companies and the role of swaps in interest rate management. The structure and intent align well with the question, but the factual error in ORCL’s effective rate significantly reduces overall correctness. The model captures the hedging concept but distorts a key financial outcome.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 514,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s capital structure gives its Class B shares outsized voting power – each Class B share carries ten votes, so the 343.8 million Class B shares (about 13‑14 % of the total 2.53 billion shares outstanding on Jan. 24 2025) control a much larger slice of the company’s voting rights【page_1】.  Alphabet, by contrast, is actively buying back both its voting Class A shares and its non‑voting Class C shares (it repurchased 73 million Class A and 306 million Class C shares in 2024 and still has $44.7 billion of authorization for further Class A/C buy‑backs)【page_82】, which reduces the number of shares in each class but leaves the per‑share voting rights unchanged.  Thus, Meta concentrates voting power in a small, high‑vote class, whereas Google’s repurchase program trims the overall share pool across voting and non‑voting classes without shifting the voting weight per share.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta's Class B shares have 'ten votes' per share, while the ground truth specifies 15 votes per share. Second, it claims that Class B shares represent '13–14% of total shares outstanding' and that there are 343.8 million Class B shares, but the ground truth does not provide these specific numbers, and more importantly, emphasizes that Class B holds 33 1/3% of combined voting power due to super-voting rights — a key structural point that is misrepresented. The LLM incorrectly implies that voting power concentration stems from disproportionate control relative to economic ownership, but misstates both the vote ratio and the voting power percentage. (2) For GOOGL, the LLM correctly notes repurchases of both Class A and Class C shares and cites $44.7 billion in remaining authorization, but the ground truth specifies $62.0 billion repurchased in 2024 — a major quantitative omission. The LLM mentions share counts repurchased (73M Class A, 306M Class C), which are not in the ground truth and appear fabricated or misattributed. (3) The multi-hop reasoning is partially sound: the model correctly contrasts Meta’s concentration of voting power with Google’s buybacks across share classes. However, it fails to mention that GOOGL’s Class B shares (not Class A) have 10 votes per share, and that Class A and C have 1 and 0 votes respectively — a critical error in entity mapping. It also omits that Meta’s Class B is non-dilutable and held by a single individual, a core part of the governance structure. (4) Despite these errors, the answer captures the high-level contrast in strategies — concentrated voting vs. broad repurchases — and remains contextually relevant. Hence, correctness is partially accurate but undermined by key factual and numerical errors, especially in vote counts and repurchase amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 515,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm’s outlook that 46 percent of smartphones will be generative‑AI capable by 2027 (up from 19 percent in 2024) drives a strategic push to deepen its AI‑engine, Hexagon NPU and AI‑stack capabilities and to pair them with 5G/5G‑Advanced connectivity so that on‑device AI experiences can be delivered at scale (page 7). By contrast, Salesforce is channeling its resources into software‑centric generative and agentic AI—exemplified by the Agentforce layer that adds autonomous AI agents across its CRM suite—focusing on cloud‑based AI functionality rather than hardware‑driven connectivity (page 41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Qualcomm's projection that 46% of smartphones will be generative AI-capable by 2027, up from 19% in 2024, matching the ground truth exactly. These percentages and years are accurate, satisfying quantitative accuracy. (2) The LLM correctly attributes Qualcomm’s strategic focus to on-device AI through hardware advancements such as the Hexagon NPU and AI stack, paired with 5G/5G-Advanced connectivity—this aligns with the ground truth’s emphasis on edge computing and device-level AI enabled by hardware innovation. (3) For Salesforce, the LLM accurately notes its investment in generative and agentic AI via the Agentforce platform across CRM products, emphasizing cloud-based AI functionality, which matches the original answer’s description. (4) The comparison between Qualcomm’s hardware-driven, edge-focused AI strategy and Salesforce’s software- and cloud-centric approach is logically sound and semantically equivalent to the ground truth. The only minor omission is that the LLM answer does not explicitly mention the lack of a direct business relationship or dependency between the two companies, which is included in the original answer. However, this does not detract significantly from the overall correctness, as the question primarily asks about strategic focus and influence. (5) All entities—Qualcomm, Salesforce, Agentforce, 5G/5G-Advanced, generative and agentic AI—are correctly identified and contextualized. (6) The reasoning is multi-hop: it connects market projections to strategic R&D focus for Qualcomm, contrasts it with Salesforce’s product-level AI integration, and differentiates their technological domains (hardware vs. software). This synthesis is accurate and relevant. (7) Contextual relevance is high, as the response directly addresses both parts of the comparative question. The inclusion of page references (e.g., page 7, page 41) suggests source grounding, though they are not evaluated for correctness here. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth due to the missing note on no direct business link.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 579,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe is embedding generative‑AI services such as Sensei, Firefly and the new “Generative Fill/Expand” features directly into Creative Cloud and Document Cloud to make the UI more intuitive, personalized and capable of on‑the‑fly content creation (e.g., AI‑powered Liquid Mode for PDFs). Qualcomm forecasts that by 2027 roughly half of smartphones and at least 50 % of PCs will be generative‑AI‑capable, with on‑device AI engines (Hexagon NPU, AI Engine) delivering low‑latency, privacy‑first processing that powers richer, more interactive user interfaces. Thus Adobe’s AI‑driven user‑experience upgrades align with Qualcomm’s projection that edge devices will have the on‑device AI compute needed to run those features efficiently and enhance UI experiences.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the alignment between Adobe's AI-driven UX enhancements and Qualcomm's projections for generative AI-capable edge devices. It accurately references Adobe's integration of AI tools (Sensei, Firefly, Generative Fill/Expand, Liquid Mode) into Creative Cloud and Document Cloud to improve UI intuitiveness and personalization, which aligns with the ground truth's emphasis on user interface competitiveness. The answer also correctly identifies Qualcomm's focus on on-device AI processing (via Hexagon NPU and AI Engine) enabling low-latency, private, and responsive experiences. (2) However, there is a quantitative discrepancy: the LLM states that 'roughly half of smartphones and at least 50% of PCs' will be generative AI-capable by 2027, while the ground truth specifies 46% of smartphones (up from 19% in 2024) — a precise figure the LLM approximates as 'half.' While 'roughly half' is a reasonable approximation of 46%, the addition of 'at least 50% of PCs' introduces new information not present in the original answer and potentially overstates the projection. This affects quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes Adobe’s UX strategy with Qualcomm’s edge AI roadmap, drawing a logical connection between on-device processing capabilities and the performance needs of AI-powered creative tools. It correctly infers that Qualcomm’s edge AI advancements support Adobe’s strategic goals. (4) Despite the minor overgeneralization of the 46% smartphone projection and the unverified addition about PCs, the answer is contextually excellent, addressing all aspects of the question with strong qualitative accuracy and relevance. The core alignment between the two companies’ strategies is correctly and clearly articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 494,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSU awards accrue dividend equivalents that are credited as stock units and, for directors, may be paid together with the award on the first business day of April after the one‑year anniversary of the grant (directors may elect this treatment) – employee RSUs generally vest on the third anniversary of the grant and also earn dividend equivalents (see LMT 10‑K p. 110 & p. 100). Honeywell’s RSU awards simply vest over three‑to‑six years and are settled in common stock at vesting, with no separate dividend‑equivalent credit or payment schedule disclosed (see HON 10‑K p. 92).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Lockheed Martin credits dividend equivalents as stock units and notes the specific April payment timing for non-employee directors tied to the one-year anniversary of the grant, which matches the original answer. It also correctly states that employee RSUs generally vest on the third anniversary, consistent with disclosed vesting terms. For Honeywell, it accurately reports that RSUs vest over three to six years and are settled in common stock at vesting, with no separate dividend equivalent payment schedule disclosed. (2) All quantitative elements—timeframes (one-year, three-to-six years, third anniversary), payment timing (first business day of April), and settlement form (common stock)—are factually correct and match the original answer. No calculations are required, and all dates and periods are accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ 10-K disclosures, contrasting Lockheed Martin’s structured, delayed payment for directors and dividend equivalent crediting under the DMICP with Honeywell’s lack of disclosed dividend equivalent treatment and its focus on long-term vesting. The mention of the DMICP is implied through the crediting mechanism, though not explicitly named in the LLM answer, which is a minor omission. (4) The answer is contextually precise, directly addressing the differences in dividend equivalent treatment and payment structures. The only minor gap is the lack of explicit mention of Honeywell’s performance-based vesting (a qualitative nuance), but the core factual contrast on dividend equivalents is well-supported. Overall, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 497,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments says that in 2021 it sourced roughly 40 percent of its assembly‑and‑test work from subcontractors (TI 10‑K p. 9). By contrast, NVIDIA’s filing (NVDA 10‑K pp. 23‑27) makes clear that it has no owned fabs and outsources essentially all wafer fabrication (primarily to TSMC and Samsung) and the subsequent assembly‑test steps to third‑party manufacturers, meaning its exposure to external capacity is far higher than TI’s 40 percent share. Both companies face the same type of supply‑chain risk that AMD highlighted in its own 10‑K (AMD 10‑K pp. 21‑25)—limited supplier options can lead to capacity constraints, yield problems, price spikes or delivery delays that could materially affect results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: Texas Instruments' 40% reliance on subcontractors for assembly and test is accurately cited from its 10-K (p. 9), and NVIDIA’s complete outsourcing of fabrication and assembly-test steps is correctly described, with no owned fabs, relying on TSMC and Samsung. These facts match the knowledge graph. (2) The answer is complete, addressing all parts of the multi-hop question: TXN's subcontractor reliance, NVDA's third-party exposure, comparison between the two, and risks illustrated by AMD’s experience. It correctly notes that NVIDIA's external dependency is far greater than TXN’s 40%, which is a key differentiator not explicitly in the original answer but logically sound and supported by context. (3) Entity accuracy is strong: correct tickers (TXN, NVDA, AMD), correct reference to 10-K filings with page numbers, and accurate identification of third-party manufacturers (TSMC, Samsung, GF, ATMP implied via AMD). (4) Reasoning is sound: the LLM correctly infers that while both companies face similar types of supply chain risks (capacity constraints, delivery delays, etc.), NVIDIA's exposure is structurally higher due to full outsourcing, especially of fabrication—a nuance that enhances the original answer. The reference to AMD’s 10-K reinforcing limited supplier options and associated risks is consistent with the ground truth. (5) Semantic equivalence is high: though the LLM emphasizes NVIDIA’s greater exposure more strongly than the original, this is a valid interpretation supported by the data. The only minor gap is that the original mentions financial penalties for unmet purchase targets (specific to AMD’s joint ventures), which the LLM omits, but it does capture the broader risk category. Overall, the answer is factually excellent, well-sourced, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 520,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "The Clean Energy Connection program calls for ten new solar facilities with an estimated total cost of about **$1 billion** over the next three years【page_153】. Southern Power finances comparable solar (and wind) projects through PPAs that are recorded as **operating leases with terms that can extend up to 25 years**【page_268】, indicating both companies are using long‑term lease‑type structures to fund renewable‑energy assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities over three years, matching the ground truth. It also accurately states that Southern Power uses PPAs treated as operating leases with terms up to 25 years. All key facts are present and factually correct. (2) Quantitative accuracy is perfect: '$1 billion' is correctly reported, and 'up to 25 years' matches the original. No calculations are required, and all numbers are presented accurately. (3) The multi-hop reasoning is sound—linking Duke's direct investment in solar facilities to Southern Power's use of PPAs as operating leases to support renewable projects. The LLM correctly infers that both companies are investing in long-term renewable infrastructure, though it slightly oversimplifies by describing Duke's approach as a 'lease-type structure,' which is not accurate—Duke is making direct investments included in base rates, not using leases. This minor mischaracterization prevents a perfect qualitative score. (4) Contextual relevance is excellent: the answer directly addresses both parts of the question, cites appropriate sources, and maintains focus on the comparison between the two companies' investment strategies in renewable energy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 358,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock gives each share one vote (“The holders of each share of common stock shall be entitled to one vote per share” – NFLX 10‑K p. 60). Alphabet’s capital structure is dual‑class: Class A shares have one vote, Class C shares have no voting rights (“Class C capital stock has no voting rights” – Alphabet 10‑K p. 82). Because Alphabet can preserve voting control through its voting Class A shares, it directs the bulk of its 2024 $62 billion repurchase program to the non‑voting Class C shares (306 million shares for $50.2 billion) and only a smaller portion to Class A shares (73 million shares for $11.9 billion) – a strategic split that would not be needed for Netflix, where all shares carry equal voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Netflix's one-vote-per-share structure and Alphabet's differentiated voting rights: Class A (1 vote), Class C (no votes), citing specific 10-K page references. (2) Quantitatively, it provides precise figures for Alphabet's 2024 repurchase: $50.2 billion for 306 million Class C shares and $11.9 billion for 73 million Class A shares, summing to $62.1 billion (a $0.1 billion rounding difference from $62.0 billion is negligible and likely due to reporting precision; this does not constitute a material error). (3) The reasoning is sound: it correctly infers that because Class C shares have no voting rights, Alphabet can repurchase them aggressively without diluting control, preserving voting power in Class A (and implicitly Class B) shares. This strategic logic directly addresses the influence of voting structure on repurchase allocation. (4) The answer goes beyond the original by adding specific share counts and dollar splits, enhancing completeness. The only minor shortcoming is not explicitly mentioning Class B shares (10 votes per share), though the reasoning about preserving control through voting shares still holds. Overall, the answer demonstrates strong multi-hop synthesis across Netflix and Alphabet’s structures and correctly links governance design to capital allocation strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 387,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "BAC’s preferred‑stock provisions give holders a “stress‑trigger” vote: if dividends on any non‑B, F or G series fall into arrears for three semi‑annual (or six quarterly) periods, the holders of those series and any equally‑ranked preferred series may elect two additional directors, and the rights cease once dividends are caught up. Visa’s Class C common shareholders, by contrast, have only narrowly‑defined voting rights—limited to a few specific actions such as a core‑payments exit, certain mergers or charter amendments—and cannot elect directors or otherwise influence board composition, even during periods of financial stress. This makes BAC’s preferred investors a much more potent governance voice when the firm is under strain, whereas Visa’s Class C holders remain largely sidelined.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors if dividends are in arrears for three semi-annual or six quarterly periods, and these rights terminate after two semi-annual or four quarterly periods of payment—this matches the original answer. The LLM correctly notes that this applies to non-B, F, G series, which is a detail consistent with BAC's charter. (2) Quantitative elements (3 semi-annual, 6 quarterly, 2 directors, etc.) are all accurate and match the ground truth. Format variations (e.g., 'semi-annual' vs 'semi‑annual') are acceptable. (3) The contrast with Visa’s Class C common stockholders is well-reasoned: they have limited voting rights only on specific matters like exiting the core payments business or certain restructurings, and cannot influence board composition. The LLM correctly emphasizes that their rights are not tied to financial performance, unlike BAC’s mechanism. (4) The multi-hop reasoning—comparing contingent voting rights triggered by financial stress (BAC) vs. structurally limited rights not tied to performance (V)—is sound and directly addresses the corporate governance comparison during financial stress. (5) Minor deduction in qualitative accuracy because the LLM omits the explicit mention that Class C voting rights do not extend to amendments solely affecting preferred stock, a small but relevant nuance in governance scope. However, this does not undermine the overall correctness. The answer is contextually excellent, directly addressing governance dynamics under financial stress.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 459,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing business – which earns royalties on a wide range of characters, including the high‑margin Star Wars brand (DIS 10‑K p. 22) – supplies a steady cash stream that the company can redeploy to fund Disney+ content creation (DIS 10‑K p. 13).  That extra financing lets Disney invest in new and localized Disney+ series for European audiences, bolstering its competitive position against Comcast’s Europe‑focused Sky Glass and XClass TV smart‑TV platforms (CMCSA 10‑K p. 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in depth of detail. (1) All entities are correct: Disney, Star Wars, Disney+, CMCSA (Comcast), Sky Glass, XClass TV, and their competitive context in European markets are accurately identified. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no numbers were introduced or misstated. (3) The multi-hop reasoning is sound: the LLM correctly links Star Wars licensing revenue (from DIS 10-K) to funding Disney+ content development, specifically in Europe, and contrasts Disney’s strategy with CMCSA’s integrated hardware-content platforms (citing CMCSA 10-K). (4) The answer captures the core causal chain: licensing → content investment → competitive positioning. The only minor shortcoming is that it does not explicitly mention that Star Wars programming is a 'core content tile' on Disney+, which is a small but relevant detail from the original about subscriber acquisition. However, the implication is present through the reference to investing in localized series. The use of citations (e.g., DIS 10-K p.22) adds precision and aligns with source-based reasoning. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 363,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express estimates that a parallel 200‑basis‑point rise in market rates would cut its annual net‑interest income by about **$560 million** (Table 23, page 81), because its interest‑rate‑sensitive assets and liabilities are assumed to reprice in tandem, with the effect moderated only by any applicable caps or floors on those rates. Morgan Stanley, by contrast, routinely **purchases interest‑rate caps (and swaps)** in its residential‑mortgage securitizations (page 128) to limit the cash‑flow impact of rising rates on the assets it retains, thereby managing the same repricing‑risk exposure that AXP measures. In short, AXP quantifies the earnings hit from repricing risk, while MS uses caps to hedge that risk in its securitization strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $560 million figure for AXP's net interest income impact from a 200 basis point increase is correctly stated and matches the source data. While the original answer does not specify the exact dollar amount, the LLM provides a precise number from Table 23, page 81, which enhances detail without contradicting the ground truth. The mention of MS purchasing interest rate caps (and swaps) is consistent with the original answer’s claim about MS using caps in securitization. (2) The reasoning correctly identifies repricing risk as a common thread: AXP measures its sensitivity to rate changes in net interest income, while MS uses caps to hedge similar risks in retained assets from securitizations. This reflects sound multi-hop synthesis across two firms and contexts. (3) Entity accuracy is strong—AXP and MS are correctly identified, and the financial instruments (caps, swaps) and contexts (net interest income, securitization) are accurate. (4) The LLM adds value by specifying the $560M impact and mentioning swaps, which are not contradicted by the ground truth but slightly extend it. However, the original answer emphasizes that AXP's modeling already includes the effect of caps/floors in its repricing assumptions, a nuance slightly underemphasized in the LLM response. Still, the core logic and factual content are correct, with only minor omission of that detail. Hence, a 9/10 for correctness—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 418,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDL Z says that a weaker U.S. dollar “benefits our consolidated earnings and net assets” (MDLZ 10‑K p. 65). Coca‑Cola, by contrast, notes that a weaker dollar versus the euro and British pound generated a “favorable impact” for its Europe, Middle East & Africa segment, but that benefit only partially offset a larger adverse currency effect that reduced consolidated net operating revenues by about 5% (and produced a ‑16% currency‑related hit to the EMEA segment) (Coca‑Cola 10‑K p. 49). Thus MDL Z’s weaker‑dollar effect is described as a net positive to earnings, while Coca‑Cola’s weaker‑dollar effect is a limited, segment‑specific offset to an overall negative currency impact.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a significant factual inaccuracy in the quantitative details: it claims Coca-Cola experienced a 'larger adverse currency effect' that reduced consolidated net operating revenues by about 5% and a -16% hit to the EMEA segment, which contradicts the ground truth. The original answer does not mention any negative overall currency impact or specific percentages for Coca-Cola's currency effects. These figures are not present in the provided ground truth and represent an overreach or misinterpretation not supported by the given information. While the LLM correctly identifies that both companies cite the euro and British pound as key currencies and that a weaker dollar benefits MDLZ and Coca-Cola's EMEA segment, it introduces unsupported quantitative claims that distort the comparison. The reasoning is partially sound in noting that MDLZ sees a net positive while Coca-Cola's benefit is more limited, but this contrast is exaggerated based on fabricated metrics. The entities (MDLZ, KO, EMEA) and general direction of impact are correct, and the answer addresses the multi-hop aspect by comparing two companies' disclosures. However, the introduction of unverified percentages undermines factual accuracy. Semantic equivalence fails on the quantitative dimension, though the qualitative direction of effects is reasonably conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 376,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Mastercard’s Class B shares are only seven in number, each carrying 15 votes, so they supply 105 votes out of roughly 1,012 total votes (≈10 % of voting power) given the 907–927 Class A shares outstanding (see MA page 68). Visa’s Class B shares are far more numerous—125 shares in 2024 (245 in 2023)—and with the same 15‑vote weighting they generate 1,875 votes (3,675 votes in 2023) out of a total of 3,608 votes (5,269 votes), representing about 52 % (2024) and 70 % (2023) of voting power (see V page 58). Thus, voting power is much more concentrated in Visa’s hands than in Mastercard’s.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core comparison between MA and V dual-class structures and concludes that voting power is more concentrated at V than MA, which aligns with the ground truth. However, there are quantitative discrepancies. For MA, the LLM states 907–927 Class A shares; while 907 is correct (per ground truth), the upper bound of 927 is unexplained and introduces ambiguity. The total vote calculation for MA is approximately correct: 7 Class B shares × 15 votes = 105 votes; 907 Class A shares × 1 vote = 907 votes; total votes ≈ 1,012; Class B voting share ≈ 105 / 1,012 ≈ 10.4%, which matches the ground truth. The LLM rounds this to '≈10%', which is acceptable. (2) For V, the LLM states 125 Class B shares in 2024 (matching ground truth) and correctly applies 15 votes per share (1,875 votes). However, it claims 1,733 Class A shares (from ground truth) but calculates total votes as 3,608 — this is incorrect: 1,733 + 1,875 = 3,608 only if Class A votes are counted as 1,733 (correct), but the LLM does not explicitly state this. The resulting 52% (1,875 / 3,608 ≈ 51.96%) is mathematically accurate given those inputs, but the ground truth reports 68.5%, indicating a conflict in underlying data. Upon inspection, the ground truth must assume a different total number of Class A shares or different vote weights. The LLM cites V page 58 and reports 245 Class B shares in 2023 generating 3,675 votes (245 × 15), and total votes as 5,269, leading to ~70% — this internal calculation is correct, but the 2023 data is not requested in the question, which focuses on current (2024) structure. The inclusion of 2023 data adds context but distracts from the main comparison. (3) Multi-hop reasoning is sound: the model synthesizes share counts, vote weights, and ownership percentages across two companies and performs comparative analysis. It correctly infers that fewer Class B shares with high vote weight lead to less concentration at MA vs V. (4) The main issue is the discrepancy in V's voting power percentage: LLM reports 52% for 2024, while ground truth says 68.5%. This suggests either different underlying share counts or an error in assumptions. Since the LLM uses 125 Class B shares and presumably 1,733 Class A shares, the math yields ~52%, so unless Class A shares are misstated, the 68.5% cannot be replicated. This indicates a potential data conflict or miscalculation in the ground truth or LLM's source. Given that the LLM’s calculations are internally consistent and based on plausible inputs, the score is reduced slightly for quantitative accuracy. Overall, the answer is factually coherent, well-reasoned, and contextually appropriate, but contains minor data inconsistencies affecting precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 726,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NextEra Energy (NEE) and Southern Company flag essentially the same nuclear‑decommissioning risk – that the cost to retire their reactors could outstrip the money they have set aside. NEE states that a decline in the market value of its decommissioning funds (and any external insurance) could leave required funding higher than the amounts available, which would materially hurt its liquidity and financial condition. Southern Company likewise notes uncertainty about maintaining adequate capital reserves for decommissioning and warns that damages or decommissioning costs could exceed the balances in its decommissioning trusts (and statutory insurance), also creating a material‑adverse exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: both NEE (including FPL) and Southern Company (via subsidiaries Alabama Power and Georgia Power) acknowledge the risk that decommissioning costs could exceed available reserves, potentially leading to material financial impacts. The LLM correctly identifies that funding shortfalls could arise from market declines affecting decommissioning trust funds and that insurance may be insufficient—key points in the original. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes risks across two companies and their respective subsidiaries, correctly aligning the nature of exposure (trust fund performance, insurance limits, material adverse impact). The only minor omission is the explicit mention of 'long-term planning uncertainties' in cost estimation noted in the original, which slightly reduces qualitative completeness. (4) The answer is fully contextually relevant, directly addressing the comparison of financial risks related to decommissioning cost exposure. Wording differs but semantic meaning matches. No factual errors—minor lack of nuance in elaborating on estimation uncertainties prevents a perfect 10 on qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 388,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS values the $9.9 billion of pension‑plan real‑estate fund holdings at net‑asset value (NAV), using the fund managers’ audited and unaudited reports and adjusting for activity up to year‑end 2023 (see UPS 10‑K p. 58). General Dynamics, by contrast, classifies its private‑equity and real‑estate fund holdings as Level 3 assets and values them at NAV based on internal valuation models that rely on unobservable inputs, periodic appraisals and discounted‑cash‑flow techniques (see GD 10‑K p. 83‑84 & 88). Both companies therefore depend on model‑driven NAV estimates, but GD’s approach is explicitly a Level 3 fair‑value measurement using unobservable inputs, whereas UPS’s NAV valuation is a practical expedient for pension‑plan assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $9.9 billion valuation for UPS is correctly stated, and no other numerical values are in dispute. The fiscal year 2023 reference is consistent with typical reporting timelines and does not contradict the original answer. (2) The LLM correctly identifies that UPS uses NAV as a practical expedient based on fund managers’ audited and unaudited reports, with adjustments for interim activity—matching the ground truth. It also accurately notes that General Dynamics (GD) uses internal valuation models with unobservable inputs, periodic appraisals, and discounted cash flow techniques for its Level 3 assets. (3) The multi-hop reasoning is sound: the answer synthesizes information across two companies (UPS and GD), their respective asset types (pension plan real estate funds vs. Level 3 private equity), and valuation methodologies. The key distinction—that UPS uses NAV as a practical expedient while GD classifies its NAV-based valuations as Level 3 due to unobservable inputs—is correctly drawn and reflects a nuanced understanding of fair value hierarchy treatment. (4) Minor deduction in qualitative accuracy because the original answer emphasizes that GD’s Level 3 assets are *direct* private equity investments valued with unobservable inputs, while the LLM generalizes to 'private-equity and real-estate fund holdings' without clarifying that these are direct investments (not fund-of-funds). This slightly blurs the distinction in investment structure. However, the core comparison on valuation approach remains correct. Wording differences are acceptable under semantic equivalence, and the LLM adds helpful detail (e.g., DCF techniques, page references) without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 484,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "PepsiCo’s AMESA (Africa‑Middle‑East) division generates about 30 % of its beverage revenue (PEP 10‑K p. 73), so a disruption in that region would cut off a sizable share of the PepsiCo drinks that Target stocks. Because Target records vendor‑supplied merchandise only when it is sold and does not carry it in inventory (TGT 10‑K p. 49), a supply shortfall would shrink on‑hand inventory for those SKUs, likely raising turnover (or creating stock‑outs) while postponing the cash outflow until any replacement units are actually sold, thereby shifting cash‑flow timing later.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that PepsiCo's Africa and Middle East region accounts for 30% of beverage revenue, citing the correct source (PEP 10-K p.73), and accurately references Target's vendor payment model (TGT 10-K p.49). These quantitative and entity details are correct. (2) All numbers and percentages match the ground truth: 30% exposure is accurately reported, and no calculations are required beyond this figure. (3) However, the reasoning contains a critical error: the LLM claims a supply disruption would 'raise inventory turnover' due to lower on-hand inventory, which contradicts standard inventory dynamics. In reality, inventory turnover = COGS / average inventory; a supply disruption reduces inventory availability and leads to stockouts, which reduce sales and thus COGS, likely decreasing turnover—not increasing it. The ground truth correctly states that turnover would decrease. Additionally, the LLM incorrectly suggests that cash outflow is 'postponed'—but since Target only pays after sale, no payable is triggered until sale occurs, so there is no delay in outflow timing relative to the model; rather, revenue and associated cash inflow are delayed. (4) While the answer is factually accurate on numbers and sources (quantitative accuracy = 10), the flawed logic in interpreting inventory turnover and cash flow impact reduces qualitative accuracy. The answer addresses the right companies and mechanisms and is contextually relevant, but the incorrect inference about turnover direction and cash flow timing undermines the core analytical conclusion, warranting a correctness score of 5—partially correct but with significant conceptual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 461,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "LLY’s 2022 filing (see LLY pages 27‑31) contains no discussion of specific price‑adjustments, discounts or rebate programs for its insulin biologics in response to payer‑driven pressure, indicating that it has not disclosed any product‑specific concessions. By contrast, Amgen’s 2022 filing (see AMGN page 41) details a proactive response to payer restrictions on Repatha – the company cut the net price, expanded payer discounts and rebates, and introduced a lower‑list‑price NDC after utilization‑management criteria limited access. This shows Amgen taking concrete pricing‑reduction actions, whereas LLY’s filing does not describe comparable measures for its insulin products.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and contextually relevant, correctly identifying that Amgen (AMGN) took concrete pricing actions in response to payer restrictions on Repatha, including reducing net and list prices, expanding discounts and rebates, and introducing a lower-priced NDC—consistent with the original answer's mention of discontinuing higher-priced NDCs in 2019 and partnering with payers. The reference to AMGN's 2022 filing (page 41) aligns with the type of evidence expected. On the LLY side, the LLM correctly observes no disclosed price adjustments or rebate programs for insulin in its 2022 filing, which supports the original answer’s emphasis on LLY facing pricing scrutiny without detailing active mitigation strategies. The LLM answer is slightly less comprehensive than the ground truth in that it does not explicitly mention AMGN’s direct partnerships with payers to align on health outcomes or the broader regulatory and legislative uncertainty LLY emphasizes (e.g., Alzheimer’s Monoclonal Antibody NCD or government price negotiation). However, the core contrast—AMGN taking active pricing actions while LLY has not disclosed similar measures—is accurately conveyed. All entities (LLY, AMGN, Repatha, insulin) and years (2022 filing) are correct. No numerical inaccuracies are present, and the reasoning across payer strategies is sound, though slightly less detailed in synthesis than the original. Thus, the answer earns high marks for quantitative accuracy and contextual relevance, with a minor deduction in qualitative accuracy and overall correctness for incomplete multi-hop synthesis of strategic differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 448,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Both firms satisfy the buffer requirement without using a counter‑cyclical buffer, which the Federal Reserve has kept at 0 %【page_146】【page_122】. Bank of America does so by adding a capital‑conservation (or stress) buffer, a 3 % G‑SIB surcharge and a supervisory capital buffer (SCB of about 5.4‑5.8 %), lifting its CET1 ratio to roughly 12‑13 % versus a ~9.5 % regulatory minimum that already includes the zero CCyB【page_146】. Charles Schwab, by contrast, relies on a 2.5 % stress‑capital buffer for the holding company and a 2.5 % capital‑conservation buffer for its banking subsidiary (plus a 3 % SLR and a 2 % leverage buffer), resulting in CET1 ratios of 24.5 % (holding company) and 37.9 % (bank) well above the 7 % minimum inclusive of buffers【page_122】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general context correctly—that both BAC and SCHW meet capital buffer requirements under a zero Countercyclical Capital Buffer (CCyB) environment and that they employ different buffer strategies. However, there are significant quantitative inaccuracies that reduce correctness. According to the ground truth, BAC applies a 2.5% Stress Capital Buffer (SCB) under the Standardized approach as of December 31, 2023, and also faces a 2.5% G-SIB surcharge. The LLM incorrectly states a 3% G-SIB surcharge and an SCB of 5.4–5.8%, which does not align with the original answer. Additionally, the LLM cites a 'supervisory capital buffer' of 5.4–5.8% leading to a CET1 of 12–13%, but the ground truth does not specify these exact figures or ranges, making this an unsupported extrapolation. For SCHW, the original answer states that its subsidiary CSB maintains a 2.5% Capital Conservation Buffer, and SCHW structures capital around minimum ratios of 7.0%, 8.5%, and 10.5% for CET1, Tier 1, and Total Risk-Based Capital, inclusive of buffers. The LLM incorrectly attributes a 2.5% stress-capital buffer to the holding company and adds a 3% SLR and 2% leverage buffer not mentioned in the ground truth. It also reports implausibly high CET1 ratios of 24.5% and 37.9%, which are not in the original answer and appear exaggerated. While the LLM correctly identifies that both benefit from the 0% CCyB and that BAC has a G-SIB surcharge while SCHW does not, the numerical misstatements and unsupported details (e.g., specific SCB ranges, CET1 levels, additional buffers) undermine factual accuracy. The reasoning structure is sound in comparing the two firms’ approaches, and the answer is contextually relevant, but the quantitative errors are material, especially in a regulatory capital context where precision is critical. Thus, the correctness score is moderate due to partial factual alignment but significant numerical deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 523,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar projects are owned (or co‑owned) by Southern Power and are sold under long‑term PPAs that are accounted for as operating leases (terms up to 25 years) and are funded through tax‑equity partnerships; the company reported about $1.2 billion of unused federal investment‑tax credits and production‑tax credits that it expects to fully utilize by 2024 (see pages 96‑97, 268‑270). By contrast, Duke Energy’s renewable assets are largely held in non‑consolidated VIEs that rely on PPAs and tax‑equity structures to guarantee debt service and O&M costs, but the filing does not provide a specific timeline for using those tax credits, indicating a more indirect financing model without a defined utilization horizon (see pages 203‑204).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Southern Company's $1.2 billion in unutilized federal ITCs and PTCs as of December 31, 2021, and expected full utilization by 2024 are accurately reported. The mention of up to 25-year PPA terms and tax equity financing is consistent. (2) The LLM correctly identifies Southern Company’s use of tax equity partnerships where tax benefits are largely captured by the tax partner, and that its solar facilities are accounted for as operating leases under long-term PPAs. (3) For Duke Energy, the LLM accurately notes its use of VIEs, tax equity structures, and PPAs to finance renewables, and correctly highlights that Duke is the primary beneficiary due to control over siting, PPA negotiation, and operations—though it slightly underemphasizes this point by not explicitly stating Duke’s primary beneficiary status, instead focusing on the lack of a defined tax credit timeline. (4) The LLM correctly contrasts Southern’s defined tax credit utilization timeline (by 2024) with Duke’s lack of a disclosed timeline, which reflects a more indirect model—this is a valid inference from the ground truth. (5) The answer synthesizes multi-hop information across both companies’ financing strategies, tax credit use, and PPA structures. The only minor shortcoming is that the LLM does not explicitly state that Duke is the primary beneficiary of the VIEs, which is a key qualitative distinction in control and economic benefit. However, the overall reasoning, entity accuracy, and contextual relevance are strong, and the answer directly addresses the comparative question on financing strategies and tax credit timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 472,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s charter requires that any Class B share sold or transferred automatically become a Class A share (​page 81​), which over time can dilute the founder’s voting bloc as those shares move out of the high‑voting class. In contrast, Comcast’s articles lock in a non‑dilutable 33 % voting power for its Class B stock that cannot be eroded by new issuances (​page 91​). Because Meta’s dual‑class structure concentrates voting control with its founder and lacks either a conversion‑driven dilution mechanism or a protected‑voting‑block safeguard (​page 49​), investors may view Meta’s governance as more entrenched and less investor‑friendly than the models used by Google and Comcast.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares convert to Class A upon transfer (per page 81 reference), Comcast's Class B shares have non-dilutable 33 1/3% voting power (correctly cited as 33%, acceptable rounding), and Meta lacks mechanisms to dilute or protect voting power, preserving founder control. (2) Quantitative accuracy is perfect: the 33% figure matches the 33 1/3% in the original (minor rounding is semantically acceptable), and no incorrect numbers or calculations are present. (3) Multi-hop reasoning is sound—LLM correctly contrasts Google’s dilutive mechanism, Comcast’s protected block, and Meta’s entrenched control, synthesizing across three companies to assess investor sentiment implications. (4) The answer captures the core concern about Meta’s governance being seen as less investor-friendly, though it does not explicitly mention investor sentiment toward Meta’s Class A stock being negatively affected (a minor omission from the original). However, the implication is clearly conveyed through 'more entrenched and less investor-friendly,' maintaining semantic equivalence. Wording differs but meaning is preserved. No irrelevant content; fully contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 357,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s Cordavis launch is intended to increase the supply of lower‑priced biosimilars, which should shift utilization away from higher‑priced brand drugs (CVS page 12). UnitedHealth’s rebates are accrued each month as they are earned based on product utilization and contract terms and are recorded as a reduction to product revenue when prescriptions are dispensed (UNH page 50; UNH page 48). Therefore, a greater share of biosimilars could shrink the rebate base and lead manufacturers to offer smaller rebate percentages—reducing the overall $12.5 billion receivable—while the monthly accrual process will cause the rebate‑related revenue adjustments to be recognized in the periods the biosimilars are actually used, potentially accelerating or shifting the timing of revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: CVS's Cordavis initiative aims to increase biosimilar availability (correctly cited from CVS page 12), and UnitedHealth has $12.5 billion in rebates receivable, which are accrued monthly based on utilization and contract terms (accurately referencing UNH pages 48 and 50). The dollar amount ($12.5 billion) is correctly stated, and no other numerical values require calculation. (2) Quantitative accuracy is perfect—no errors in numbers or dates; the $12.5 billion figure matches the ground truth and is properly contextualized. (3) The multi-hop reasoning is sound: the model correctly links CVS’s biosimilar expansion to potential shifts in drug utilization, which in turn affects the rebate base for UNH. It logically infers that lower-priced biosimilars could reduce both the size of rebates (due to lower list prices and potentially lower rebate percentages) and the total receivable, while correctly noting that revenue recognition timing follows utilization via monthly accruals. (4) The answer is semantically equivalent to the original, though slightly more concise. One minor point preventing a perfect 10 is the lack of explicit mention that changes in utilization may affect the *predictability* or *payment cycles* of rebates—mentioned in the ground truth—as this adds nuance to timing impacts. However, the core reasoning on timing (monthly accruals tied to actual use) is correct and relevant. Overall, the response is factually precise, contextually appropriate, and demonstrates strong synthesis across entities and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 450,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Regulation Best Interest forces Goldman Sachs’s broker‑dealer units to add new policies, disclosures and monitoring to prove they are acting in retail customers’ best‑interest, which the firm says could raise its compliance expenses and expose it to additional litigation (GS 10‑K p.20; p.61). Morgan Stanley, by contrast, already runs a large wealth‑management franchise and notes that some rivals enjoy “less stringent” consumer‑protection regimes, giving them a cost edge in expanding retail clients (MS 10‑K p.23; p.25). Thus, the RBI‑driven cost increase may erode Goldman Sachs’s cost competitiveness and make it harder to grow its retail base as aggressively as Morgan Stanley unless it can offset the higher compliance burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs faces increased compliance costs due to Regulation Best Interest (RBI), including new policies, disclosures, and monitoring, with potential litigation risk—consistent with MET_10k_2024.pdf and GS 10-K references. Morgan Stanley’s established wealth management franchise and competitive environment, including rivals under less stringent regimes, are accurately cited from MS 10-K. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; references to page numbers (e.g., p.20, p.61, p.23, p.25) are correctly attributed and plausible within 10-K structures. (3) Multi-hop reasoning is sound: the model correctly synthesizes that RBI increases compliance costs for Goldman Sachs, which is expanding in retail, while Morgan Stanley, with an existing retail infrastructure, has a competitive advantage in cost efficiency. The conclusion that this may erode Goldman’s cost competitiveness and slow retail growth relative to Morgan Stanley is logically derived and semantically equivalent to the original. (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of state-level extensions enabling private litigation (implied in 'additional litigation'), but the core regulatory and competitive dynamics are fully captured. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses compliance costs and competitive positioning as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 442,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s dual‑class structure gives its sole Class B holder, Brian L. Roberts, all 9.44 million Class B shares, each carrying 15 votes, which together represent roughly one‑third (33 %) of the company’s total voting power while the remaining 66 % is held by the many Class A shareholders【page_31】. Alphabet’s Class B shares also have super‑voting rights—10 votes per share—but the filing notes that they are held by insiders and can be converted to Class A, concentrating control with a lower per‑share voting multiplier than Comcast’s 15‑vote shares【page_82】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that CMCSA's Class B shares carry 15 votes per share and are held entirely by Brian L. Roberts, representing approximately 33% of voting power, while Class A holds about 66%, which aligns with the ground truth (66 2/3% and 33 1/3%). The use of 'roughly one-third (33%)' and '66%' is acceptably close to the exact fractions, especially given common rounding in reporting. However, the LLM introduces a specific number—'9.44 million Class B shares'—that is not present in the original answer or implied by the ground truth, making this an unsupported addition. (2) The comparison to GOOGL is mostly accurate: Class B shares have 10 votes per share, are held by insiders, and can be converted to Class A upon sale, which matches the ground truth. However, the LLM claims Alphabet's structure results in 'concentrated control with a lower per-share voting multiplier', which is reasonable but slightly overreaches by implying a direct comparison of control concentration without data on actual ownership percentages or total voting power distribution for GOOGL—information not provided in either the original or LLM answer. (3) Multi-hop reasoning is sound: the model correctly synthesizes voting rights, ownership concentration, and convertibility across two companies from different filings. It contrasts CMCSA’s non-dilutable, fixed control with GOOGL’s potentially dilutable structure due to conversion rules, which is a valid inference. (4) The answer is contextually excellent, directly addressing the question about concentrated control and structural differences. The minor issues—introduction of an unsupported share count and slight overstatement of comparative control—are not critical but prevent a top score. Thus, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 491,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "PM notes that Turkey’s market “up by 8.2%…partially offset by a higher estimated prevalence of illicit trade,” which dampened its cigarette‑volume growth (PM 10‑K p. 55). In contrast, P&G flags Turkey as one of the countries with “significant exchange‑rate fluctuations” that create translation and transaction exposure and hurt net sales and earnings (PG 10‑K p. 23). Together they illustrate that the same market poses two different operational risks: PMI faces product‑level loss to illegal sales, while P&G is vulnerable to macro‑economic currency swings that can erode profitability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the 8.2% market growth in Turkey is correctly cited from PM's 10-K, and there are no calculations required beyond accurate reporting of this figure. The reference to 'significant exchange-rate fluctuations' for PG matches the substance of the original answer's 'foreign exchange exposure' due to Turkey's volatility. (2) The LLM correctly identifies both companies (PM and PG, though PM is referred to as PMI once, which is a minor inconsistency but not factually incorrect as PMI is Philip Morris International), and accurately attributes the risks: illicit trade for PM affecting volume, and FX volatility for PG impacting earnings and sales. (3) The multi-hop reasoning is sound—synthesizing risks across two different companies in the same market, distinguishing operational (illicit trade) vs. financial (currency) risks. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor shortcoming is the brief use of 'PMI' instead of 'PM', though this does not impair understanding or factual accuracy. Wording is concise and semantically equivalent to the original. No factual errors or omissions affect the core conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 356,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan tackles transition risk through a dedicated Climate Risk Management function that has built a Firmwide Climate Risk Framework – setting policies, standards and scenario‑analysis tools to identify, measure, monitor and control transition‑related exposures across its three‑line model and reporting to the Board’s risk committees【page_148】. By contrast, Bank of America’s climate‑related reputational risk stems from the need to meet its $1.5 trillion sustainable‑finance goal; the firm mitigates this by proactively monitoring reputational exposures, embedding climate risk in its overall risk governance and having processes to remediate issues when its climate commitments are perceived as unmet【page_83】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: JPMorgan's Firmwide Climate Risk Framework and Bank of America's $1.5 trillion sustainable finance goal (including the $1 trillion low-carbon component, though not explicitly broken down in the LLM answer, is not contradicted) are accurately referenced. No calculations are required, and the dollar amounts match exactly. (2) The LLM correctly identifies both entities—JPMorgan and Bank of America—and their respective climate risk approaches, satisfying entity accuracy. (3) The reasoning is sound and reflects multi-hop synthesis: it contrasts JPMorgan’s structured, scenario-based transition risk management with BAC’s reputational risk focus tied to public commitments. The LLM captures JPMorgan’s use of scenario analysis and governance reporting and BAC’s emphasis on monitoring and remediation of reputational risks. (4) While the original answer includes slightly more detail about BAC’s $1 trillion low-carbon allocation and JPMorgan’s data strategy, the LLM answer conveys semantically equivalent information with only minor omissions. Wording differs but meaning is preserved. The inclusion of specific page references adds credibility. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 387,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft records revenue from hardware‑software bundles as a single performance obligation and recognizes the revenue at the point in time ownership is transferred to the reseller or end‑customer (i.e., immediately on sale). Cisco’s financing of hardware purchases is reflected in loan receivables that carry average terms of one to three years, so cash collection is spread over that period after the sale. As of July 29 2023, Cisco’s total allowance for credit losses on its financing receivables (loan + lease) was $72 million.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the $72 million credit loss allowance as of July 29, 2023, is correctly reported, and the one to three-year average term for Cisco's loan receivables is accurately stated. (2) The answer is complete, addressing all parts of the multi-hop question: Microsoft's revenue recognition timing for hardware-software bundles as a single performance obligation (point-in-time at transfer of ownership), Cisco's average loan receivable terms for financing hardware (1–3 years), and the specific credit loss allowance figure as of the given date. (3) Entity accuracy is perfect: Microsoft and Cisco are correctly identified, along with relevant financial metrics (revenue recognition, loan receivables, credit loss allowance). (4) The reasoning is sound and synthesizes information across two companies and domains (revenue accounting and financing terms), correctly contrasting Microsoft's immediate revenue recognition with Cisco's extended cash collection period due to financing terms. (5) The semantic meaning is equivalent to the original answer, with slightly rephrased but factually identical content. No errors in logic, calculation, or fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 355,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "A delay in FAA certification of the G700 would keep FedEx from adding the new, fuel‑efficient jet to its fleet as scheduled – the company’s inventories were already being built up “in anticipation of its certification” (GD 10‑K p. 71). Because FedEx’s CORSIA costs are driven by the fuel‑efficiency of its aircraft, a prolonged reliance on older, less‑efficient planes that could be deemed non‑compliant under ICAO’s January 1 2028 production‑cutoff would force FedEx to purchase more carbon offsets, sustainable‑aviation fuel or allowances, thereby raising its compliance expenses (FedEx 10‑K p. 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FAA certification delays for the G700 could prevent timely fleet modernization, increasing FedEx's reliance on less fuel-efficient aircraft, thereby raising CORSIA compliance costs due to greater need for offsets, sustainable aviation fuel (SAF), or allowances. The reference to ICAO’s 2028 production cutoff is correctly interpreted. (2) Quantitative accuracy is strong: the 2028 cutoff date is correctly cited, and while no explicit numbers (e.g., dollar amounts) are present, the temporal markers (2028) and regulatory framework (CORSIA, ETS) are accurately represented. The mention of FedEx’s 2023 10-K context is implied through correct citation of risk factors. (3) Multi-hop reasoning is sound: the model correctly links Gulfstream’s G700 certification (from Gulfstream’s 10-K) to FedEx’s fleet planning and emissions compliance strategy (from FedEx’s 10-K), recognizing the dependency between certification timing and fleet efficiency. It also correctly infers that delayed access to fuel-efficient aircraft increases compliance costs under CORSIA. (4) The only minor shortcoming is the omission of the detail about free allowances being phased out by 2026 (mentioned in the original answer), which adds nuance to the cost increase trajectory. However, this does not undermine the core correctness. Wording differences (e.g., 'inventories being built up' vs 'inventory ramp-up') are semantically equivalent. Citations to page numbers (p. 71, p. 18) suggest accurate sourcing. Overall, the answer is factually correct, contextually relevant, and demonstrates strong cross-document synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 462,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "CMCSA’s charter gives each Class A share one vote and each Class B share fifteen votes, so Class A holders control roughly two‑thirds (≈66 ⅔ %) of the total voting power and Class B about one‑third (≈33 ⅓ %)【page_33】. Alphabet (GOOGL) also grants one vote to each Class A share, but its Class B shares carry ten votes per share, creating a super‑voting tier for Class B (the filing does not state the exact voting‑power split)【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA Class B shares have 15 votes per share, Class A has 1 vote per share (implied by the 66 2/3% vs. 33 1/3% split and the 15:1 structure), and GOOGL Class A has 1 vote, Class B has 10 votes per share. The percentages (≈66 ⅔% and ≈33 ⅓%) match the ground truth exactly. (2) The answer correctly notes that GOOGL does not disclose the exact voting power split, which aligns with the original answer. (3) The multi-hop reasoning is sound: the model correctly compares the per-share voting ratios (15:1 at CMCSA vs. 10:1 at GOOGL) and implies that CMCSA gives more relative weight to Class B shares, though it could have made this comparison more explicit (minor omission). (4) Entity accuracy is perfect: CMCSA and GOOGL are correctly identified, and the stock classes are accurately described. (5) The answer is contextually relevant and directly addresses the question about voting power distribution and per-share voting ratios. The only reason for not scoring a 10 is the slightly less explicit comparison of the 15:1 vs. 10:1 ratios in terms of 'significantly more voting weight'—the implication is there, but the original answer makes the contrast more explicit. Overall, this is a semantically equivalent, factually correct, and well-reasoned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 385,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and, together, represent about one‑third (33 ⅓ %) of the company’s total voting power, with the remaining two‑thirds held by Class A shareholders【page_33】. Alphabet’s dual‑class structure gives each Class B share ten votes, concentrating voting control in the founders/insiders and providing them a majority of the voting power (the filing notes the 10‑vote per‑share structure)【page_81】. Consequently, while both companies grant extra votes to Class B, Comcast’s high‑voting shares account for a smaller slice of overall voting power than Alphabet’s, where the Class B class dominates voting control.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of quantitative accuracy: it correctly states that CMCSA's Class B shares have 15 votes per share and represent 33 1/3% of voting power, while GOOGL's Class B shares have 10 votes per share. These numbers match the ground truth. However, the LLM incorrectly implies that GOOGL’s Class B shareholders hold a majority of the voting power, which is not stated in the original answer and cannot be confirmed from the provided context. The original answer emphasizes that GOOGL’s structure allows conversion to single-vote Class A shares, highlighting fluidity and control concentration among insiders, but does not specify the percentage of total voting power held by Class B. The LLM’s claim that Alphabet’s Class B 'dominates voting control' goes beyond the information in the ground truth and introduces an unsupported comparative conclusion. This affects qualitative accuracy, as the reasoning behind the comparison is partially flawed. The answer is contextually relevant and addresses the core comparison of voting power distribution and per-share voting rights. While it captures the higher per-share voting power at CMCSA (15 vs 10), it misrepresents the relative influence by suggesting GOOGL’s Class B has greater overall control, whereas the ground truth notes CMCSA’s Class B has fixed minority control (33 1/3%) versus GOOGL’s more fluid structure. Thus, the multi-hop synthesis is partially sound but contains a key misinterpretation in the comparative influence assessment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 417,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s oral S1P‑modulator Zeposia was cleared by the U.S. FDA in May 2021 for ulcerative colitis, whereas Merck’s HIF‑2α inhibitor Welireg received its first FDA approval in August 2021 for von Hippel‑Lindau disease 【page_94】. Zeposia’s launch expanded BMS’s 2021 immunology portfolio by adding a new UC therapy, while Welireg’s approval grew Merck’s oncology portfolio and generated a $50 million milestone payment in 2021 【page_101】【page_52】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's Zeposia was approved in May 2021 for ulcerative colitis, and MRK's Welireg was approved in August 2021 for von Hippel-Lindau disease. The $50 million milestone payment to former Peloton shareholders is correctly reported. (2) Quantitative accuracy is perfect: dates (May 2021, August 2021) and dollar amount ($50 million) match the original answer exactly. (3) Multi-hop reasoning is sound—LLM correctly compares two distinct FDA approvals across companies, indications, and therapeutic areas (immunology vs. oncology), and links each to portfolio impact. (4) Minor wording difference: LLM refers to 'BMS' instead of 'BMY'—while BMS is commonly used for Bristol Myers Squibb, the question uses 'BMY' (its ticker), but this does not affect factual accuracy. The LLM also omits the mention of the True North trial, which is a minor omission but not critical to the core question about timelines and portfolio impacts. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 313,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "EMR’s equity awards vest on a fixed “cliff” schedule – restricted‑stock awards become owned after a service period that can range from three to ten years (restricted‑stock units vest after three years) and expense is recognized ratably over that period (EMR 10‑K p. 72). UPS’s multi‑employer pension plans, by contrast, impose vesting requirements that are set in the collective‑bargaining agreements for each plan (the plans specify eligibility, participation and vesting periods, but the exact length is not disclosed) and the benefits are paid from the pooled plan trust rather than directly by UPS (UPS 10‑K p. 110). Thus EMR’s vesting is a company‑controlled equity‑compensation timeline, while UPS’s vesting is part of a defined‑benefit scheme whose funding risk and benefit delivery are shared among all participating employers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and timeframes are correct: EMR's cliff vesting periods of 3–10 years for restricted stock and 3 years for RSUs are accurately reported, with expense recognition over the service period. The absence of specific vesting durations for UPS’s plans is correctly noted, as the original answer also states they are defined by collective bargaining agreements without fixed public durations. (2) The answer correctly identifies the entities (EMR and UPS), their respective compensation and pension structures, and cites correct 10-K page references (p.72 for EMR, p.110 for UPS), indicating proper sourcing. (3) Multi-hop reasoning is sound: the model successfully contrasts EMR’s company-controlled, equity-based vesting with UPS’s multiemployer defined-benefit plan structure, highlighting differences in funding risk (pooled trust vs. direct expense) and benefit delivery mechanisms. (4) The only minor shortcoming is that the LLM does not explicitly mention 'withdrawal liability' or 'surcharge contributions' in critical status plans—key risk elements in UPS’s exposure per the ground truth—making the qualitative accuracy slightly less complete. However, the core contrast in risk sharing and funding mechanisms is clearly conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the original, with only a slight omission in risk detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 409,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Netflix warns that a breach of the personal data it holds – such as member names, billing details and viewing habits – could trigger regulatory investigations, legal claims and “regulatory fines or penalties,” but its filing notes only that the costs could be material and that it carries no specific data‑breach insurance. Comcast, however, is expressly subject to the Communications Act and FCC rules that impose concrete privacy duties (e.g., protection of customer proprietary network information, breach‑notification and data‑handling requirements), and the 10‑K states that non‑compliance can lead to administrative enforcement actions, civil or criminal fines and operational restrictions on its cable, broadband and voice services. Thus, Comcast’s obligations under the Act carry more defined financial penalties and operational constraints than Netflix’s broader, less‑specific privacy‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX faces potential regulatory fines and material costs from data breaches involving personal information (e.g., billing and viewing data), with no insurance coverage noted. CMCSA is explicitly subject to the Communications Act and FCC rules, which impose specific privacy obligations (e.g., protection of customer proprietary network information, breach notification), and non-compliance can lead to administrative, civil, or criminal penalties and operational constraints on its services. (2) There are no numeric values requiring calculation in the question or answer, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial and operational risk descriptions are factually consistent with the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face regulatory scrutiny under the Communications Act, but CMCSA has more defined obligations and enforceable constraints, while NFLX’s exposure is framed as risk of penalties without the same regulatory structure or insurance mitigation. (4) The only minor shortcoming is that the LLM slightly underemphasizes that NFLX’s exposure is *also* tied to reputational damage (mentioned in the original), though it does mention regulatory investigations and legal claims. Otherwise, the answer captures the core contrast in regulatory frameworks and risk mitigation (insurance vs. compliance infrastructure). Wording differs but semantic meaning and factual content are equivalent. Thus, the answer is excellent with only a slight omission in completeness, warranting a 9/10 on correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 470,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "PM introduced Platform 5 nicotine pouches in Sweden in January 2022 as a brand‑new, stand‑alone product built on its recent AG Snus acquisition; the rollout is a market‑specific launch that relies on its own manufacturing capability and a retail‑, trial‑ and digital‑focused commercialization strategy. In contrast, CCEP’s presence in Sweden is that of Coca‑Cola’s independent bottler – it entered the market through a longstanding bottler’s agreement that obligates it to purchase Coca‑Cola concentrates/syrups and to produce and distribute the Company’s trademark beverages, making its role dependent on Coca‑Cola’s product supply rather than a direct product launch.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PM launched Platform 5 in Sweden in January 2022 under the Shiro brand following the AG Snus acquisition, which is accurately described as a direct market entry. CCEP’s role as a bottler for KO in Sweden is correctly characterized, including its dependency on KO for concentrates. (2) Quantitative accuracy is perfect: the LLM correctly avoids introducing any incorrect numbers and does not misstate the 41% figure from the original (though it omits it, this does not make it incorrect). The date January 2022 is correctly cited. (3) Multi-hop reasoning is sound: the model successfully contrasts PM’s direct innovation and acquisition-based entry with CCEP’s third-party distribution model dependent on KO, synthesizing information across two companies and business models. (4) The only minor shortcoming is the omission of the specific statistic that CCEP and four other major bottlers accounted for 41% of KO’s global unit case volume in 2021, which adds contextual depth to CCEP’s significance. However, this omission does not detract from the core comparison on market entry and product dependency. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 385,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "The 8% drop in UnitedHealthcare’s Medicare Part D enrollment (3,050 k in 2024 vs 3,315 k in 2023, an 8% decline) reduces the member pool that underpins CVS’s Medicare Advantage contracts【page_31】. At the same time, the IRA now obliges drug makers to provide larger manufacturer discounts and shifts catastrophic‑phase reinsurance costs onto Part D sponsors, raising per‑member drug‑cost liabilities【page_17】【page_16】. Because CVS locks in Medicare Advantage premiums in advance and cannot recover cost overruns (its premiums are set on forecasts made months before the contract year)【page_40】, the combination of lower enrollment and higher drug‑cost obligations amplifies CVS’s financial exposure under its Medicare Advantage contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the 8% decline from 3,315,000 to 3,050,000 is accurately represented (3,315,000 × 0.92 ≈ 3,050,000), and the use of '3,050k' and '3,315k' is an acceptable format variation. (2) The answer correctly identifies the IRA's manufacturer discount requirements and the shift in reinsurance responsibility to Part D sponsors, which increases per-member liabilities—this matches the original answer’s emphasis on financial risk due to reduced federal reinsurance and increased manufacturer obligations. (3) The LLM synthesizes multi-hop elements well: it connects UNH's enrollment decline to reduced member pools affecting CVS, links IRA structural changes to increased cost exposure, and explains how CVS’s advance premium setting (from page 40) limits its ability to adjust for cost overruns—this is a strong inference supported by the context. (4) The only minor gap is that the LLM does not mention Amgen’s rebate accrual experience, which the original answer uses as a supporting example of manufacturer discount impacts. While this adds depth in the original, its omission does not undermine the core reasoning about CVS’s exposure. The LLM focuses more tightly on the enrollment–cost–premium mismatch dynamic, which is central to the question. Overall, the reasoning is sound, entities (UNH, CVS, IRA, Medicare Part D) are correct, and the answer is contextually precise and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 412,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas distribution utilities are regulated by state public‑service commissions that permit “cost‑recovery” riders, allowing remediation expenses to be passed through to customers as a recoverable rate component (see Southern Company Gas discussion of cost‑recovery mechanisms on page 22). Duke Energy, however, records its remediation exposure as direct liabilities – $73 million of environmental‑remediation reserves (plus $396 million of asbestos reserves) – and can be held strictly liable for cleanup under federal, state and local laws, relying on insurance and indemnities rather than a systematic cost‑recovery mechanism (see remediation reserves on page 163 and asbestos reserves on page 164).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that Southern Company uses cost recovery mechanisms via state regulatory approval to pass environmental remediation costs to customers, citing a specific reference (page 22). It contrasts this with Duke Energy's approach of recording direct liabilities for remediation, relying on insurance and indemnities rather than guaranteed cost recovery. (2) The quantitative data is mostly accurate: the LLM specifies $73 million in environmental remediation reserves and $396 million in asbestos reserves for Duke Energy, which are plausible figures consistent with typical SEC filing disclosures (though the original answer uses a placeholder $X million). The numbers are treated as concrete, but given the context of real filings, this specificity is acceptable and likely reflects actual reported values. There are no calculation errors. (3) The multi-hop reasoning is sound—correctly synthesizing differences in regulatory frameworks (Southern’s cost recovery riders vs. Duke’s liability exposure) and financial treatment (capitalized/recovered vs. expensed). (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., mentioning asbestos reserves), and fully addresses the comparative aspect of the question. The only minor limitation is the lack of explicit mention that Duke’s costs are expensed unless recovery is probable, but the implication is clear from the absence of a recovery mechanism. Overall, the response is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 440,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "Caterpillar reports 40,873,176 securities remaining available for future issuance under equity‑compensation plans approved by security holders (page 127) and Johnson & Johnson reports 111,042,139 such securities (page 121), giving a combined total of 151,915,315 securities.  3M’s equity‑compensation plans approved by security holders have 21,316 (thousand) ≈ 21,316,000 securities remaining available (page 116).  Thus, the Caterpillar‑J&J total is roughly 130 million securities – about seven times larger – than 3M’s available pool.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Caterpillar's available securities (40,873,176) and Johnson & Johnson's (111,042,139), and accurately calculates their combined total as 151,915,315, which matches the ground truth. However, it incorrectly reports 3M's available securities as approximately 21,316,000 (from 21,316 thousand), while the ground truth states 39,563,000. This is a significant factual error affecting the comparison. (2) The calculation of the sum (40,873,176 + 111,042,139 = 151,915,315) is correct. However, the use of 21,316,000 for 3M is incorrect — either due to misreading the source (e.g., confusing a different line item or year) or incorrect conversion. The comparison stating the Caterpillar-J&J total is 'about seven times larger' than 3M's is therefore flawed; the correct ratio is ~3.84 (151.9M / 39.6M), not 7x. (3) The multi-hop reasoning is structurally sound — the model identifies the correct metric across three companies and attempts synthesis and comparison. However, the incorrect value for 3M undermines the validity of the conclusion. (4) Scores reflect that core calculations for the two-company sum are accurate and entities are correctly identified, but a major error in a key number (3M's securities) reduces correctness and quantitative accuracy. Contextual relevance is perfect — the answer addresses all parts of the question with appropriate structure and sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 394,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s diabetes franchise will keep U.S. market exclusivity only until May 2026 (Januvia and Janumet) and, under the Inflation‑Reduction Act, a government‑set price will apply to Januvia on 1 Jan 2026 and to Janumet on 1 Jan 2027, sharply limiting any revenue after the patent cliff【page_58】. Pfizer, instead, leans on statutory U.S. regulatory exclusivity—five years for new chemical drugs (seven for orphan indications) and twelve years for biologics, with possible pediatric extensions—providing a longer, predictable protection that is not tied to IRA price caps【page_7】【page_11】. Thus, Merck’s post‑2025 earnings are vulnerable to a near‑term exclusivity loss and price controls, whereas Pfizer’s revenue protection rests on broader regulatory exclusivity periods that extend well beyond 2025.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in content and captures the core contrast between Merck and Pfizer's exclusivity strategies. However, there are minor inaccuracies in the dates related to IRA pricing implementation. The original answer states that IRA-mandated price-setting applies to Januvia in 2026 and Janumet/Janumet XR in 2027, which aligns with the knowledge graph. The LLM answer incorrectly specifies '1 Jan 2026' and '1 Jan 2027' as exact dates, which are not present in the ground truth and may be over-precise. While the years are correct, the exact start dates (January 1) are not confirmed in the original and could misrepresent the timing. Additionally, the LLM omits mention of Janumet XR’s July 2026 exclusivity expiration, a detail included in the original and relevant to completeness.\n\n2) Quantitative accuracy is mostly sound: May 2026 for Januvia and Janumet exclusivity loss is correct. The IRA pricing years (2026 for Januvia, 2027 for Janumet) are directionally accurate, but the assignment of January 1 as the specific start date introduces unwarranted precision not supported by the ground truth. This minor error affects quantitative accuracy but not the overall conclusion.\n\n3) The multi-hop reasoning is strong: the LLM correctly synthesizes Merck’s patent-based exclusivity timeline with IRA pricing implications and contrasts it with Pfizer’s reliance on regulatory exclusivity (e.g., 5-, 7-, 12-year terms). The conclusion about divergent post-2025 revenue protection strategies is logically sound and well-supported.\n\n4) Contextual relevance is excellent—the response directly addresses all parts of the question: Merck’s exclusivity and pricing constraints, Pfizer’s alternative strategy, and the implication for post-2025 revenue protection. The omission of Janumet XR’s July 2026 date is a minor completeness gap, but the overall synthesis is accurate and insightful. Hence, high scores for qualitative and contextual accuracy, with a slight deduction in quantitative accuracy due to date precision and missing detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 552,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLN holdings are “credit‑linked” notes in which the firm has sold credit protection to the issuer, so a credit‑event on the reference entity can leave the principal unpaid. To curb the counter‑party risk of those hybrid instruments, MS posts collateral, relies on net‑ting of derivative positions and uses bilateral downgrade agreements that trigger additional collateral or termination payments if a counter‑party’s rating falls. Bank of America, on the other hand, uses CDS and other credit‑derivatives to buy (and occasionally sell) protection on its commercial loan exposures; it manages counter‑party risk chiefly through clearing‑house membership, net‑ting and loss‑sharing arrangements rather than the extensive collateral‑posting and downgrade‑agreement framework that MS employs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and conceptual contrast between MS and BAC. (1) It correctly identifies that MS invests in CLNs where it has effectively sold credit protection, exposing it to credit event risk if the reference entity defaults, while BAC uses credit derivatives (like CDS) to purchase protection as part of credit risk mitigation—this matches the original answer’s central thesis. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, the absence of fabricated or incorrect figures supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use credit derivatives but with opposing risk profiles (MS assuming risk by selling protection, BAC reducing risk by buying protection). The LLM adds operational details about risk management—such as MS using collateral posting, netting, and downgrade triggers, and BAC using clearinghouses and loss-sharing—that are plausible and contextually relevant, though not explicitly stated in the ground truth. These additions do not contradict the original but go beyond it; since they are reasonable industry practices and do not introduce inaccuracies, they don’t warrant a major penalty. (4) The only minor shortcoming is that the original emphasizes BAC records fair value changes in other income, which the LLM omits. This is a secondary detail, so the completeness loss is small. Overall, the answer captures the key contrast and manages entities (MS, BAC, CLNs, credit derivatives) accurately, with strong contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 454,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement moves a defined set of PFAS‑related and other post‑spin‑off obligations to Solventum, and Solventum also agrees to indemnify and defend 3M for those matters, so the transferred liabilities are removed from 3M’s balance sheet and only the liabilities the company retained (e.g., its environmental reserve) are recognized. In RTX’s case, a portion of its third‑party financial guarantees are “subject to indemnification for our benefit,” but the guarantees remain on RTX’s books; the company accrues the most‑likely cost and records the maximum‑potential payment as a liability, reflecting retained risk rather than a transfer of liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of core facts and structure. (1) It accurately captures that 3M transferred liabilities (specifically mentioning PFAS-related and post-spin-off obligations) to Solventum, with Solventum assuming indemnification and defense responsibilities, resulting in removal from 3M’s balance sheet—consistent with the ground truth’s emphasis on liability transfer in the spin-off. It also correctly states that RTX retains financial guarantees on its books despite some being subject to indemnification, reflecting retained exposure. (2) There are no numeric values in either answer, so quantitative accuracy is not applicable; however, the absence of fabricated or incorrect figures supports a score of 10. (3) The reasoning is sound in comparing the structural difference: 3M transferred liability via spin-off (derecognized), while RTX retains liability on its books (recognized), which reflects accurate multi-hop synthesis across two companies and accounting treatments. However, the LLM omits specific litigation examples mentioned in the ground truth (Bair Hugger and Federal False Claims Act/Qui Tam Litigation) and does not reference ASC 450 or ASC 610-30, which are key for full qualitative completeness. Also, the LLM focuses on PFAS (which may be accurate but not specified in the original answer) rather than the litigations cited in the ground truth, introducing a potential factual deviation. (4) Despite these omissions, the answer remains contextually precise, directly addressing the comparison of indemnification structures, liability transfer, and recognition of losses. The core distinction—transfer vs. retention of liability—is correctly identified and explained, justifying a high correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 486,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD reported $1.84 billion of sales to customers in Taiwan for fiscal 2023 (about 8 % of its total $22.68 billion revenue)【page_71】. By contrast, NVIDIA warns that its key chip‑supply comes from foundries located in Taiwan and that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan,” creating a material supply‑chain risk【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: $1.84 billion in sales to Taiwan for AMD in 2023 (equivalent to $1,841 million), and the total revenue of $22.68 billion are accurate. The 8% calculation (1.84 / 22.68 ≈ 8.11%) is approximately correct and reasonably rounded. (2) The entity identification is correct—AMD and NVIDIA are properly attributed with their respective fiscal years (2023 implied), and the risk context is tied to Taiwan and geopolitical tensions with China. (3) The multi-hop reasoning is sound: the model correctly contrasts AMD’s revenue exposure (market demand side) with NVIDIA’s supply chain dependency (production side) in Taiwan, synthesizing information from both companies’ filings. (4) The only minor shortcoming is that the LLM adds a percentage breakdown (8%) not present in the original answer, which, while accurate, slightly extends beyond the provided ground truth. However, this does not detract from correctness. The citation of page numbers (e.g., 【page_71】, 【page_35】) suggests proper sourcing, though not required. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full semantic equivalence to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 360,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s repowered wind assets are covered by long‑term power‑sales agreements with a weighted‑average remaining term of about 15 years, which locks in price and output for a decade‑plus and therefore yields a very stable, predictable revenue stream (NEER page 13). Southern Power, by contrast, sells most of its renewable output under PPAs whose specific durations and pricing are not disclosed, so its cash‑flows depend more on variable generation, market prices and unknown contract terms, making long‑term revenue less certain (Southern Power page 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER is correctly stated, matching the original answer. No other numerical values are involved, so there are no calculation errors. (2) The answer addresses both parts of the multi-hop question: NEER's long-term contracts enhancing revenue predictability and Southern Power's lack of disclosed contract terms limiting visibility. It correctly identifies NEER and Southern Power as the entities and ties the information to revenue predictability. (3) The reasoning is sound: the LLM correctly infers that long-term, disclosed contracts (NEER) provide greater revenue stability compared to undisclosed terms (Southern Power), which introduces uncertainty. The synthesis across both companies is logical and supported by the source material. (4) Semantic equivalence is strong—while the LLM adds minor details like 'page 13' and 'page 81' (which may be accurate but not in the ground truth), the core message about NEER’s structural advantage in transparency and revenue predictability versus Southern Power’s opacity is preserved. The only minor shortcoming is that the original emphasizes investor confidence and financial planning implications, which the LLM omits, slightly reducing qualitative completeness. However, this does not undermine the factual correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 422,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX applies FAR‑guided revenue‑recognition rules to its U.S. government fixed‑price work by using performance‑based and progress payments and recognizing revenue over time on a percentage‑of‑completion basis, which often creates contract‑asset balances when billings lag performance (page 79‑78). By contrast, Honeywell’s filing stresses that, under the same FAR regime, its government contracts carry the risk that the government can terminate them for convenience or for cause and can impose audit‑driven price adjustments or refunds, exposing the company to contract‑termination risk rather than a specific revenue‑recognition method (page 35).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies RTX's revenue recognition practices under FAR for fixed-price contracts, noting the use of performance-based and progress payments and the creation of contract assets when billings lag performance—consistent with the original answer's explanation of revenue in excess of billings due to 80-90% cost coverage. While the exact percentage (80-90%) is omitted in the LLM answer, this is a minor detail and does not undermine the factual correctness, especially since the core mechanism (billings lagging performance leading to contract assets) is accurately described. (2) Quantitatively, no specific numbers (e.g., dollar amounts, exact percentages) are misstated; the absence of the 80-90% range is a slight omission but not an inaccuracy. (3) The multi-hop reasoning is sound: the LLM correctly contrasts RTX’s FAR-compliant revenue recognition approach with Honeywell’s exposure to termination risk under the same FAR framework, citing the government’s right to terminate for convenience or cause and potential audit-driven adjustments. This directly mirrors the original answer’s comparison. (4) The LLM cites page numbers (79-78, 35), suggesting grounding in source documents, and uses semantically equivalent terms (e.g., 'contract-asset balances' = 'contract assets'). The only minor gap is the lack of explicit mention that both companies are subject to the same FAR cost and payment structures, but the implication is present through context. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 443,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries **no voting rights** – the only distinction from its Class A and B shares is the lack of a vote, while dividend, liquidation and other economic rights remain identical (Alphabet 10‑K Note 11, p. 82). In contrast, Comcast **relinquished its board seats and virtually all voting rights in Hulu**, ceding operational control to Disney; that surrender produced a **$8.6 billion cash payment (plus a tax gain)** and left the Hulu investment on Comcast’s books at a modest historical‑cost balance (Comcast 10‑K, Hulu and Collateralized Obligation, p. 85).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between Alphabet's structural use of non-voting shares and Comcast's strategic relinquishment of voting rights in Hulu. (1) Key facts are accurate: Alphabet’s Class C shares have no voting rights (citing correct 10-K note), and Comcast gave up control of Hulu to Disney, receiving $8.6 billion in cash. The answer correctly identifies the financial outcome and cites relevant disclosures. (2) Quantitative accuracy: The $8.6 billion payment from Disney matches the ground truth. However, the LLM omits the $9.2 billion minimum equity value of the put option and the $557 million adjustment for prior capital calls, which slightly reduces completeness. It also omits Alphabet’s $44.7 billion remaining share repurchase authorization in 2024, a key financial detail. The reference to a 'tax gain' is not in the original answer and may be an inference beyond the provided truth. (3) Reasoning is sound: The model correctly synthesizes governance implications—Alphabet retains control via dual-class structure while optimizing capital, whereas Comcast traded control for liquidity. The comparison of mechanisms (structural vs. transactional) is logically presented. (4) Contextual relevance is high—the answer directly addresses governance control and financial outcomes as asked. Minor omissions in financial figures prevent a top score, but the core multi-hop reasoning across companies and governance structures is accurate and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 413,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "Both Eli Lilly and Thermo Fisher rely heavily on external manufacturers, and each warns that quality‑assurance lapses or supply‑chain disruptions can cause production delays, product shortages and the need to ration limited inventory (LLY 10‑K p. 45; TMO 10‑K p. 23‑24). Because Thermo Fisher’s $26.9 billion of multi‑year performance obligations are largely tied to contract‑manufacturing over three‑to‑five‑year periods (TMO 10‑K p. 49), any failure in third‑party quality or delivery could jeopardize its ability to meet those long‑term commitments just as Lilly’s intermittent incretin‑product delays could erode its capacity to satisfy growing demand and contractual obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: LLY's supply constraints for incretin products like Mounjaro and Zepbound due to third-party manufacturing dependencies and quality risks are accurately described, as are TMO's $26.92 billion in performance obligations (rounded to $26.9 billion, which is acceptable). The 3-5 year duration of contract manufacturing agreements is correctly noted. (2) Quantitative accuracy is excellent—$26.9 billion is a valid rounding of $26.92 billion, and no other numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks in third-party manufacturing affecting both companies—LLY facing patient demand shortages and inventory rationing, TMO risking delays in fulfilling long-term contracts. It appropriately cites page numbers from the 10-Ks for both companies, indicating proper sourcing. (4) The only minor shortcoming is that the LLM does not explicitly mention AMD’s 10-K reference (which supports the broader industry risk), but this is a secondary detail in the ground truth and does not undermine the core argument. The answer captures the shared vulnerability and its implications on fulfillment of commitments with strong qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 362,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "The cumulative other‑than‑temporary impairment recorded on NextEra Energy Resources’ XPLR equity‑method investment totals roughly **$2.0 billion** – the $1.2 billion impairment recognized in 2023 plus the $0.8 billion impairment recorded in 2024【page_92†L1-L9】.  Prior to the 2024 write‑down, the investment carried a balance of about **$2.6 billion**【page_92†L13-L16】, so the total impairments represent roughly three‑quarters of the pre‑impairment carrying amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the cumulative impairment charge of $2.0 billion is correctly calculated as the sum of the $1.2 billion impairment in 2023 and the $0.8 billion impairment in 2024. The pre-2024 impairment carrying value of $2.6 billion is correctly stated, and the post-impairment value of $1.8 billion is implied by the $0.8 billion write-down. (2) Quantitative accuracy is perfect: $1.2B + $0.8B = $2.0B, and $2.6B - $0.8B = $1.8B, matching the ground truth. The statement that impairments represent 'roughly three-quarters' of the pre-impairment value is a reasonable approximation (77%, close to 75%). (3) Multi-hop reasoning is sound: the model correctly synthesizes data from two different impairment events across years (2023 and 2024) and links them to the carrying value before the 2024 impairment. (4) Entities (NextEra Energy Resources, XPLR, equity-method investment) and time periods (2023, 2024) are correctly identified. The answer addresses both parts of the question: total cumulative impairment and comparison to pre-2024 carrying value. Minor wording differences (e.g., 'other-than-temporary impairment', 'write-down') do not affect factual accuracy. All citations reference the correct document sections.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 369,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE notes that it adopted ASU 2022‑04 on 1 Jan 2023 (with roll‑forward reporting from 1 Jan 2024) and that the change “did not have a material impact” on its consolidated statements, but it does not disclose a specific confirmed‑invoice balance – the obligations are simply described as part of its supply‑chain finance evaluation and remain included in accounts payable. By contrast, 3M (MMM) provides the detailed figures required by the same standard – it reports roughly $0.3 billion of confirmed invoices outstanding at year‑end (2023 and 2024) and a $1.5 billion roll‑forward of invoices confirmed and paid, and it likewise presents those amounts within accounts payable on the balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GE adopted ASU 2022-04 on January 1, 2023, with prospective roll-forward disclosures starting January 1, 2024, and that MMM discloses $0.3 billion in confirmed invoice balances for 2023 and 2024—this aligns with the ground truth. However, the LLM introduces a $1.5 billion roll-forward figure for MMM that is not present in the original answer or supported by the provided ground truth, which only mentions the $0.3 billion outstanding balance. This is a factual overstatement and a significant quantitative error. (2) The dates and adoption timelines are accurate. The $0.3 billion figure for MMM is correctly stated for both years. But the $1.5 billion roll-forward amount lacks verification from the ground truth, which does not include any roll-forward totals. This reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly contrasts GE’s qualitative, non-quantitative disclosures with MMM’s specific numerical disclosures, and both companies’ inclusion of supplier finance obligations in accounts payable is accurately noted. The synthesis across companies and standards is logically sound and addresses the comparative transparency aspect of the question. (4) Despite the incorrect $1.5 billion figure, the core comparison—GE’s lack of specific confirmed invoice disclosure vs. MMM’s clear quantification—is valid and well-reasoned. The answer remains contextually relevant and mostly accurate, but the unsupported number prevents a higher score. Hence, correctness is 8 (minor but notable factual error), quantitative accuracy is 7 (one key number incorrect), qualitative accuracy is 9 (strong reasoning), and contextual relevance is 10 (fully on-topic and responsive).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 480,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria records its 75 % stake in Cronos using the equity method, so it must recognize Cronos’s earnings and the carrying value of the investment on its own statements.  Because Cronos’s cannabis business is subject to U.S. FDA (and related) regulations, a compliance failure could depress Cronos’s profitability, force an impairment charge to Altria’s investment and reduce the earnings Altria reports from the stake (Altria Note 1 – equity‑method accounting; Risks relating to Cronos – FDA compliance) 【page_60】【page_16】.  \n\nWalmart’s pharmacy operations, by contrast, are directly regulated by the FDA (and DEA); any violation would lead to product recalls, fines, loss of pharmacy licenses or other penalties that would affect Walmart’s own results rather than flowing through an equity‑method investment (Walmart health‑care regulatory discussion and FDA enforcement powers) 【page_24】【page_25】【page_26】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the claim that Altria holds a 75% stake in Cronos is correct and consistent with the knowledge graph; no other numerical values (dates, dollar amounts) are present in either answer, so no discrepancies exist. Format and precision are appropriate. (2) The answer fully addresses both parts of the multi-hop question: it explains how Altria’s equity-method accounting ties its financials to Cronos’s FDA compliance risks, and contrasts this with Walmart’s direct regulatory exposure via pharmacy operations. The use of specific citations (e.g., 'Altria Note 1', 'Walmart health-care regulatory discussion') supports factual grounding. (3) Entity accuracy is strong: both companies, their respective business units (Cronos, Walmart pharmacies), and regulatory bodies (FDA, DEA) are correctly identified. The distinction between equity-method impact (impairment charges, reduced earnings) versus direct operational penalties (fines, license loss) is logically sound and reflects proper multi-hop reasoning across investment structure and regulatory exposure. (4) The only minor shortcoming is that the original answer emphasizes the *similarity* in regulatory risk profile despite different business models, which the LLM downplays in favor of contrast. While the LLM correctly highlights structural differences, it slightly underrepresents the parallel nature of FDA-related financial exposure noted in the ground truth. However, this does not undermine factual correctness. Overall, the response is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 451,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "Lilly’s 2021 filing notes that roughly 15‑20 percent of its U.S. sales are shipped through Cardinal Health, making Cardinal a key distributor for Lilly’s products (LLY 10‑K p. 7).  CVS, however, is the primary beneficiary of the Red Oak joint venture and consolidates Red Oak in its Retail/LTC segment, receiving fixed quarterly payments from Cardinal (CVS 10‑K p. 138).  Thus, Cardinal’s dual role means CVS’s exposure to Red Oak is limited to the payments it receives from Cardinal and the VIE’s own results; any change in Lilly’s distribution volumes could affect Cardinal’s cash flow, but CVS’s consolidated financial risk remains tied to Cardinal’s ability to meet its Red Oak payment obligations, not directly to Lilly’s sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 15-20% U.S. sales shipped through Cardinal Health is accurately cited from LLY's 10-K, and the structure of fixed quarterly payments from Cardinal to CVS via Red Oak Sourcing is correctly represented. While the $183 million annual payment mentioned in the original answer (as of 2021) is not explicitly stated in the LLM response, this omission does not introduce inaccuracy—only a slight reduction in specificity. (2) The entity identification is correct: LLY (Eli Lilly), Cardinal Health, CVS, and Red Oak Sourcing are properly named and linked, with accurate references to their respective roles (distributor, joint venture partner, primary beneficiary). (3) The reasoning is sound and captures the multi-hop logic: LLY’s reliance on Cardinal affects Cardinal’s financial health; since Cardinal has payment obligations to Red Oak, any strain could indirectly impact CVS’s consolidated financial exposure through its consolidation of Red Oak. The LLM correctly emphasizes that CVS’s risk is not direct exposure to LLY’s sales but rather mediated through Cardinal’s ability to fulfill its contractual payments. (4) The answer is contextually relevant and directly addresses the question’s core: how LLY’s distribution dependency impacts CVS’s financial exposure via Cardinal’s dual role. The only minor shortcoming is the lack of the specific $183M figure, which would have strengthened quantitative completeness. However, the conceptual and factual accuracy remains high, warranting a 9/10 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 443,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial‑paper program is a short‑term, unsecured financing vehicle that it taps for general corporate purposes, with only a few hundred million dollars of paper outstanding and senior notes that sit at the same seniority level as that paper. Cisco, by contrast, carries a much larger commercial‑paper balance (about $10.9 billion) and in February 2024 issued $13.5 billion of senior fixed‑rate notes that are expressly pari‑passu with its commercial‑paper obligations, meaning its senior debt is integrated with and ranks equally to its short‑term paper. Thus Oracle’s use of commercial paper is modest and primarily for short‑term needs, whereas Cisco’s debt structure ties a sizable senior‑note issuance directly to its commercial‑paper program.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several key inaccuracies, particularly in quantitative details. First, it incorrectly states that Cisco has a 'much larger commercial-paper balance (about $10.9 billion)', which is not supported by the ground truth and contradicts the original answer — the ground truth does not specify Cisco's commercial paper balance at all, only its $13.5 billion senior note issuance. This is a major factual error. Second, while the LLM correctly notes that Cisco issued $13.5 billion in senior fixed-rate notes in February 2024 and that these are pari passu with commercial paper, it omits the critical detail that Cisco's notes are redeemable with a makewhole premium, which is a key feature mentioned in the original. Additionally, the LLM implies Oracle has 'senior notes' that sit at the same level as its commercial paper, but the ground truth does not state this for Oracle — only for Cisco — creating a misleading comparison. The ground truth emphasizes that Oracle's commercial paper is unsecured and issued under private placement, with only $401 million outstanding as of May 31, 2024, maturing through August 2024 — details the LLM omits or downplays. While the LLM captures the high-level contrast (Oracle uses commercial paper modestly for short-term needs; Cisco integrates large senior notes pari passu with CP), it fails in precise multi-hop synthesis: it invents a number ($10.9B CP balance for Cisco) and misattributes structural features. The reasoning is partially sound in framing the comparison but flawed due to incorrect inputs. Semantic equivalence is partially achieved in the overall narrative but undermined by significant factual deviations. Contextual relevance is strong — the answer addresses the right concepts and structure — but accuracy is compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 486,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment treats wind as a core pillar of its 3,554 MW renewable portfolio, operating 23 wind facilities across 22 states. Southern Company’s wind focus is illustrated by the Skookumchuck project—a single 136 MW wind facility in Washington that is secured by a 20‑year power‑purchase agreement, reflecting a targeted, long‑term commitment to that specific asset.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it claims Duke Energy operates 23 wind facilities with a total renewable portfolio of 3,554 MW, and that wind is a 'core pillar' of this portfolio. However, the ground truth states that Duke Energy does not disclose specific capacity figures for wind in its Commercial Renewables segment, making these numbers unsupported and incorrect. There is no mention in the original answer of 3,554 MW or 23 facilities, so these figures are fabricated or misattributed. (2) The Skookumchuck project details (136 MW, 20-year PPA, Washington location) are correctly stated, which supports partial credit for Southern Company's portion. (3) Qualitatively, the reasoning is partially sound in contrasting Duke’s broader renewable strategy with Southern’s targeted project, but the characterization of Duke’s wind involvement as a 'core pillar' contradicts the original answer’s emphasis on lack of specific disclosure and a diversified (non-wind-specific) portfolio. (4) Contextually, the answer addresses the comparison between Duke and Southern regarding wind strategy and includes relevant elements like PPA term and capacity for Skookumchuck, so it remains focused on the question. However, the incorrect numerical claims about Duke Energy severely compromise factual accuracy. The model fails the multi-hop requirement by not accurately synthesizing the absence of specific wind data for Duke versus the concrete data for Southern. Thus, while the structure and intent of the answer are relevant, the factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 443,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley must hold a 5.5% buffer – 2.5% capital‑conservation buffer + 3.0% G‑SIB surcharge + a Counter‑Cyclical Capital Buffer that the Federal Reserve has set at 0%. Charles Schwab’s banking subsidiaries instead carry a 2.5% stress‑capital buffer (CSC) and a 2.5% capital‑conservation buffer (CSB), also with a CCyB of 0%; Schwab’s requirement therefore lacks the G‑SIB surcharge that is part of MS’s buffer.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core comparison between Morgan Stanley (MS) and Schwab (SCHW) regarding capital buffer requirements and correctly notes that the Countercyclical Capital Buffer (CCyB) is zero for both. It correctly identifies that MS is subject to a G-SIB surcharge while SCHW is not, and both have a 2.5% Capital Conservation Buffer. However, there are key quantitative inaccuracies: the LLM states MS has a '5.5% buffer' composed of 2.5% + 3.0% G-SIB + 0% CCyB, but the original answer does not specify the exact G-SIB surcharge percentage (3.0%) or total buffer (5.5%)—this level of precision is not supported by the ground truth. The G-SIB surcharge varies over time and by firm, and the knowledge graph does not confirm it was exactly 3.0% for MS at this time. Additionally, the LLM introduces the term 'stress-capital buffer (CSC)' for Schwab, which is not mentioned in the original answer; the ground truth only references a 2.5% Capital Conservation Buffer for SCHW. This misrepresents the regulatory framework applicable to Schwab. While the reasoning correctly synthesizes the multi-hop elements (different buffer structures, CCyB alignment, G-SIB distinction), the introduction of unsupported specific percentages and incorrect terminology reduces quantitative and qualitative accuracy. The answer remains contextually relevant and conveys the essential contrast in regulatory treatment, particularly the absence of G-SIB surcharge for SCHW.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 402,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivatives with internal discounted‑cash‑flow models that use observable market inputs—such as interest‑rate curves, yield curves and foreign‑exchange rates—to determine fair value (see Disney 10‑K p. 119). Meta, by contrast, applies discounted‑cash‑flow models (an income‑approach using Level 3 inputs) to estimate the fair value of operating‑lease right‑of‑use assets and leasehold improvements for impairment testing, incorporating projected sublease cash flows, expected downtime and risk‑adjusted discount rates, which produced a $383 million impairment charge in fiscal 2024 (see Meta 10‑K p. 98). Thus Disney’s DCF use is for routine fair‑value measurement of derivatives with observable inputs, whereas Meta’s DCF use is for impairment assessment of lease assets with unobservable, management‑driven assumptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: Disney uses discounted cash flow (DCF) models with observable inputs (interest rates, foreign exchange rates) for Level 2 derivatives, while Meta uses DCF models with Level 3 inputs (projected sublease income, downtime, risk-adjusted discount rates) for impairment testing of operating lease assets. The $383 million impairment charge by Meta in fiscal 2024 is correctly attributed and matches the original answer. (2) Quantitative accuracy is perfect: the dollar amount ($383 million) and fiscal year (2024) are correct, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Disney and Meta), two distinct accounting contexts (derivative valuation vs. asset impairment), and two fair value hierarchy levels (Level 2 vs. Level 3), drawing a precise comparative conclusion. (4) Semantic equivalence is strong: while the LLM adds slightly more detail (e.g., 'risk-adjusted discount rates', 'yield curves', page references), all additions are consistent with the original and enhance clarity without introducing error. The core comparison—Disney’s routine, observable-input DCF use vs. Meta’s non-recurring, unobservable-input DCF use—is accurately conveyed. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 391,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco market (partly offset by a higher prevalence of illicit trade) translated into a measurable gain for Philip Morris International: its Middle‑East & Africa regional market share rose 1.1 percentage points to 23.1 % and its Turkey shipment volume jumped 17.2 % as adult‑smoker up‑trading boosted Marlboro and Parliament sales (PM 10‑K pages 56‑57). Altria (MO) does not link illicit trade to a specific market‑share change; instead its 10‑K flags illicit trade as a broad risk that can erode sales, tax revenues and trigger stricter regulation across its tobacco operating companies (MO 10‑K pages 40‑42). Thus PM’s market‑share dynamics are directly enhanced by Turkey’s volume growth, whereas MO’s exposure to illicit trade remains a general, non‑quantified threat to its overall tobacco business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claims. It states that PM's Middle-East & Africa regional market share rose to 23.1% (up 1.1 points), but the ground truth focuses on PM's market share in Turkey specifically, which increased from 41.3% to 44.8%—a 3.5 percentage point gain. The LLM incorrectly shifts the geographic scope from Turkey to a broader region. Additionally, while it correctly notes a shipment volume increase, it cites a 17.2% rise without directly referencing the actual shipment numbers (47.5B to 55.7B units, which is a ~17.3% increase—this one calculation is approximately correct). However, the 8.2% market growth mentioned in the question is not verified or connected to the shipment data in the answer. (2) The LLM invents a '1.1 percentage point' increase in regional share not present in the original answer and misattributes the market share context. The original answer specifies Turkey market share (41.3% → 44.8%), not a regional figure. The reference to 'adult-smoker up-trading boosting Marlboro and Parliament sales' is not in the ground truth and introduces unsupported detail. (3) The reasoning for MO is partially sound: it correctly identifies that MO treats illicit trade as a broad risk rather than linking it to a specific market share change. However, it fails to mirror the original answer’s parallel structure—both PM and MO are affected by illicit trade, but PM benefits from volume growth despite it, while MO emphasizes systemic risks. The LLM does capture this contrast at a high level but lacks precision. (4) Contextual relevance is strong—the answer addresses both companies, the impact of illicit trade, and market dynamics. However, due to major quantitative and entity errors (wrong market share numbers, incorrect geographic aggregation), the correctness score is low. The answer appears plausible but misrepresents key facts from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 525,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The IRA‑driven redesign of Medicare Part D shifts a larger share of drug‑benefit risk from the government to plan sponsors, so CVS now bears greater liability for Part D claims and must comply with new CMS‑negotiation and price‑control rules. At the same time, the redesign forces manufacturers to shoulder more of the cost of benefits, meaning AbbVie’s Imbruvica will be subject to a government‑set price beginning in 2026 and to mandatory manufacturer discounts (10%/20% under the new coverage‑gap structure), compelling AbbVie to curb price increases and reshape its pricing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop relationship between the Inflation Reduction Act's (IRA) Medicare Part D redesign and its dual impact on CVS and AbbVie. (1) It correctly identifies that financial risk is shifting to plan sponsors like CVS, increasing their liability—consistent with the ground truth’s point about negative profitability impacts. It also correctly states that AbbVie’s Imbruvica will face government-set pricing starting in 2026. (2) Quantitatively, the LLM introduces specific discount rates (10%/20%) under the new coverage-gap structure, which are plausible under the IRA but not explicitly confirmed in the ground truth; however, these figures are contextually accurate and align with known IRA provisions, so they do not constitute a factual error. The 2026 date matches exactly. (3) The reasoning is sound: it synthesizes the impact across two distinct entities (CVS as insurer, AbbVie as manufacturer) under the same regulatory change, demonstrating correct multi-hop logic. (4) While the original answer emphasizes capped reimbursement below current prices and revenue impact, the LLM focuses more on mandatory discounts and curbing price increases—slightly different emphasis but semantically aligned. The LLM omits explicit mention of administrative complexity for CVS and the statutory ceiling detail for AbbVie, which are minor omissions but do not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually complete, warranting a high score with only slight deduction for minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 437,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values its impaired customer‑financing assets with a market‑approach that “calculates a median collateral value from a consistent group of **third‑party aircraft value publications** and applies aircraft‑condition adjustments” – inputs the company classifies as Level 3 because they are **significant unobservable** (see BA 10‑K p.124). RTX, by contrast, values its private‑equity limited‑partnership interests **quarterly using discounted‑cash‑flow models, earnings multiples and market multiples**, with adjustments for the portfolio companies’ results and prospects – a process that also relies on **significant unobservable inputs** but is based on internal valuation models rather than external publications (see RTX 10‑K p.102). Thus both companies depend on Level 3 inputs, but Boeing leans on external third‑party market data, while RTX uses internally‑generated DCF and multiple assumptions updated each quarter.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Boeing uses a median from third-party aircraft value publications with adjustments, classifying inputs as Level 3 due to significant unobservable elements; RTX uses quarterly discounted cash flows, earnings multiples, and market multiples with internal models and adjustments based on portfolio company performance. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the qualitative financial methodologies are described precisely and match the original answer. Format variations (e.g., 'Level 3' vs 'Level 3') are stylistic and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes Boeing's external-market-data approach with RTX's internal-model-driven process, both involving Level 3 inputs but differing in source and methodology. (4) The comparison is well-articulated—Boeing relies more on consistent third-party data while RTX applies forward-looking financial modeling—exactly mirroring the original answer’s conclusion. All entities (Boeing, RTX, impaired customer financing assets, private equity limited partnerships) are correctly identified and contrasted. The inclusion of 10-K page references (p.124, p.102) adds contextual support without altering factual accuracy. No errors in reasoning, completeness, or factual content.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 399,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes versus one vote for Class A; with 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding (≈13.6 % of total equity) the B‑shares command roughly 60 % of the voting power (page 1). Alphabet also has a 10‑to‑1 voting split (page 82) and has been repurchasing large amounts of low‑vote stock—78 million Class A and 450 million Class C shares in 2023 and 73 million Class A and 306 million Class C shares in 2024 (page 82)—which reduces the pool of one‑vote and non‑voting shares and thereby concentrates voting power even more in the hands of the non‑public Class B holders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both the voting structure and share repurchase data. It incorrectly states that Meta's Class B shares have 10 votes and Class A have 1 vote, when in fact the opposite is true: at META, Class A has full voting rights and Class B has no voting rights except in limited circumstances. This fundamental error completely inverts the ownership and control structure. The LLM also misrepresents GOOGL's share repurchases: it cites 78 million Class A and 450 million Class C shares repurchased in 2023 and 73 million Class A and 306 million Class C in 2024, but the ground truth states a $62.0 billion repurchase of Class A and Class C shares in 2024, with no mention of 2023 activity. The dollar amount and year are both incorrect. (2) The share counts for META (2.19B Class A and 343.8M Class B) are accurate, but the derived claim that Class B holds ~60% of voting power is false due to the incorrect voting rights assignment. The calculation is based on a wrong premise. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the relationship between share class structures and control concentration. It incorrectly assumes GOOGL's repurchases of Class A and C shares (which are low or non-voting) would concentrate power in Class B hands—which is logically sound—but uses incorrect data and timeframes. (4) Despite these major errors, the answer is contextually relevant, addressing both companies, their dual-class structures, and the impact of repurchases on control concentration. However, due to the inversion of Meta’s voting structure and incorrect financial data for GOOGL, the correctness score is low. Quantitative accuracy is severely compromised, qualitative reasoning is based on false premises, though the general direction of logic (repurchases reduce non-voting shares, increasing relative control) is valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 517,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PEP said its convenient‑foods unit volume in the APAC division rose 19% in 2022, driven by double‑digit growth in China (excluding the acquisition) and Thailand, while Taiwan posted only low‑single‑digit growth【page_48】. By contrast, Procter & Gamble’s Greater China segment – which explicitly includes Taiwan【page_40】 – is described as a market where the company “is well‑positioned, often holding a leadership or significant market‑share position”【page_18】, emphasizing market dominance rather than a specific growth rate. Thus, PEP is reporting strong volume expansion in the region, whereas PG highlights its leading market position across the same geography, including Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports PEP's 19% convenient foods unit volume growth in APAC in 2022 and specifies that Taiwan contributed low-single-digit growth, which aligns with the ground truth. It accurately contrasts this with PG's market position in Greater China, explicitly noting that Taiwan is included in PG's regional reporting. The characterization of PG's position as one of leadership or significant market share is consistent with the original answer. (2) All quantitative elements are correct: the 19% growth, the time frame (2022), and the low-single-digit growth in Taiwan are all factually accurate and properly attributed. No calculations are required, and all numbers match the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across PEP’s and PG’s respective regional structures and performance metrics, drawing a valid comparison between PEP’s growth narrative and PG’s market leadership in overlapping geographies. The only minor limitation is that the LLM references 'China (excluding the acquisition)' and 'double-digit growth in China and Thailand'—details not present in the ground truth—which adds some extraneous information but does not contradict or distort the core facts. (4) The answer is semantically equivalent to the original, with slightly more detail from the source document (e.g., page references and additional drivers), but the core comparison and factual content are preserved. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to minor over-specification without error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 445,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III finalization raised the well‑capitalized CET1 floor to 6.5 percent (with a 5 percent leverage floor) for insured depository institutions【page_11】. Bank of America’s banking subsidiary reports a CET1 of 13.5 % (standardized) / 16.8 % (advanced) and a regulatory minimum of 7.0 %—well above the new 6.5 % bar【page_146】, while Capital One’s bank (CONA) posts a CET1 of 13.1 % (both approaches) with a well‑capitalized threshold of 6.5 % (minimum 4.5 %)【page_193】. Thus both banks meet the higher PCA‑framework requirements, but the updated thresholds increase the baseline CET1 each must maintain to be classified as well‑capitalized.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the updated PCA framework threshold under Basel III, stating that the well-capitalized CET1 floor is 6.5%, which aligns with the ground truth. It also correctly notes that both BAC and COF (via its subsidiary CONA) exceed these thresholds, which is contextually accurate and relevant. However, there are key quantitative inaccuracies: the LLM claims BAC's regulatory minimum CET1 is 7.0%, while the ground truth states it is 4.5% under Basel III (with 6.5% required to be well-capitalized). This misrepresents the regulatory minimum, which is a critical component of the multi-hop comparison. Additionally, the LLM introduces 'standardized' and 'advanced' CET1 ratios (13.5% and 16.8%) for BAC and 13.1% for CONA, which, while possibly accurate, are not present in the ground truth and distract from the core regulatory thresholds the question focuses on. The ground truth emphasizes that both banks must meet a 6.5% CET1 to be well-capitalized under PCA, above their 4.5% minimum—this structural point is partially conveyed but obscured by extraneous data. The LLM does synthesize information across entities (BAC and COF) and correctly concludes that both meet the higher PCA thresholds, showing sound qualitative reasoning. However, the incorrect regulatory minimum for BAC undermines quantitative accuracy. The mention of a 5% leverage floor is not addressed in the ground truth and may be misleading. Overall, the answer captures the main idea—that updated thresholds raise the bar for well-capitalized status—but with notable factual deviations in key regulatory numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 439,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s amortization of content is based on estimates of historical and forecasted viewing‑hour consumption, and the company runs sensitivity analyses to see how changes in those viewing‑pattern assumptions would affect the amount of amortization recorded【page_40】. In contrast, AT&T’s sensitivity work centers on the discount rates used to measure its defined‑benefit pension and post‑retirement obligations and on the key assumptions (terminal growth rates, long‑term EBITDA margins and weighted‑average cost of capital) in its goodwill‑impairment tests, which can materially change the measured pension liabilities and goodwill values【page_44】. Both firms treat the assumptions as material, but Netflix’s focus is on content‑usage timing, while AT&T’s focus is on pension valuation and goodwill impairment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's sensitivity analyses focus on viewing-hour consumption affecting content amortization timing, and T's (AT&T's) analyses involve pension discount rates and goodwill impairment assumptions like terminal growth rates, EBITDA margins, and WACC. The entities (Netflix, AT&T), financial concepts (amortization, pension liabilities, goodwill impairment), and key assumptions are correctly identified. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not compromised—no figures were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies perform sensitivity analyses but on fundamentally different types of assumptions—consumption-based for NFLX vs. long-term financial valuation for T. The comparison is logically structured and mirrors the original answer’s intent. (4) Minor wording differences exist (e.g., 'AT&T' instead of 'T', slightly different phrasing of assumptions), but these do not affect meaning—semantic equivalence is maintained. The use of 'materially change the measured pension liabilities and goodwill values' adds slight interpretive detail but remains consistent with the original. No critical information is omitted. One point deducted from qualitative accuracy due to slightly less precise framing of 'corporate bond credit quality' and 'timing of benefit payments' in T's pension assumptions, which are present in the original but not reflected in the LLM answer, representing a minor omission in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 454,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe lists Taiwan as one of its individual local field‑office locations, showing a dedicated on‑the‑ground presence there【page_15】. In contrast, Apple does not treat Taiwan as a separate market; it folds Taiwan into its “Greater China” segment (which also includes mainland China and Hong Kong) and reports that segment generated $74.2 billion in net sales in 2022【page_40】【page_52】. Thus Adobe’s Taiwan footprint is a single, localized office, while Apple’s approach is a broader regional strategy that aggregates Taiwan with the rest of Greater China.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key information is correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022. (2) Quantitative accuracy is perfect: the $74.2 billion figure is correctly cited with proper context and year. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information about two companies' geographic strategies from different parts of the filings, contrasting Adobe’s localized presence with Apple’s consolidated regional reporting. (4) Entity accuracy is strong: both companies, the 'Greater China' segment, and Taiwan are correctly identified. The answer fully addresses the comparative aspect of the question, explaining operational and strategic differences with precise, relevant details. Minor wording differences (e.g., 'on-the-ground presence' vs 'direct local engagement') do not affect meaning and are semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 294,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin discloses that its credit facility and certain derivative contracts are currently tied to LIBOR, but the agreements contain fallback language and the company has adopted the ISDA 2020 IBOR‑fallback protocol, so it expects the transition under ASU 2020‑04 to have no material impact on results (Lockheed Martin 2022 10‑K p. 85). 3M, by contrast, does not highlight specific LIBOR‑linked instruments; it says it will apply the optional expedients of ASU 2020‑04 to any contracts that are modified and, after reviewing its arrangements, concluded that the reform will not be material to its consolidated results (3M 2022 10‑K p. 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Lockheed Martin has LIBOR-based credit facilities and derivatives, has adopted the ISDA 2020 IBOR Fallbacks Protocol, and expects no material impact by the end of 2022. 3M reviewed its arrangements and concluded ASU 2020-04 would not have a material impact. Both companies reference ASU 2020-04 for easing the transition from LIBOR. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—dates (implied 2022 transition) and references (ASU 2020-04) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two companies, their exposure to LIBOR, use of ASU 2020-04, and materiality assessments. The only minor difference is that the LLM frames 3M as not highlighting specific LIBOR-linked instruments, while the ground truth does not emphasize this contrast—however, this is a nuance in emphasis, not a factual error. (4) The answer is contextually fully relevant, directly addressing the comparison of exposure and preparedness under ASU 2020-04. The conclusion of parallel preparedness is implied in both answers. The LLM slightly under-synthesizes the 'parallel' nature of preparedness due to differing financial structures, but the core message remains equivalent. Hence, correctness is 9/10—excellent but not perfect in full synthesis depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 412,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s voting power is split roughly two‑thirds to one‑third: holders of Class A common stock collectively control about 66 % of the total voting power, while the single holder of all Class B shares controls the remaining ≈33 % (the “33 /3%” figure)【page_31】. Because each Class B share carries fifteen votes, the modest 9.44 million Class B shares (versus roughly 3.8 billion Class A shares) translate into a disproportionately large voting bloc, giving the sole Class B owner (Brian L. Roberts) decisive influence over corporate decisions despite the far larger number of Class A shares outstanding【page_31】【page_67】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: the 66% and 33% split (approximating 66⅔% and 33⅓%) is accurately represented, and the 15 votes per Class B share is correctly stated. The share counts (9.44 million Class B vs ~3.8 billion Class A) are precise and support the explanation of disproportionate voting power. Minor rounding of 66⅔% to 'about 66%' and 33⅓% to '≈33%' is acceptable and common in reporting. (2) The answer correctly identifies Brian L. Roberts as the sole holder of Class B shares, which is consistent with the knowledge graph's implication of concentrated control, though this detail wasn't in the original answer—it is contextually valid and enhances completeness. (3) The reasoning is sound: it explains how 15 votes per share leads to disproportionate control despite minority share count, fulfilling the multi-hop requirement (linking share structure → voting rights → control implications). (4) The answer is semantically equivalent to the original, adding contextual detail (share counts, named individual) without introducing errors. The only minor shortcoming is the slight simplification of fractional percentages, but this does not affect correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 387,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "Comcast’s sensitivity tests are applied to macro‑economic market risks – it runs a “hypothetical 10 % shift in foreign‑exchange rates” (page 61) and uses market‑valuation and sensitivity analyses for its interest‑rate exposure (page 60) to see how those moves would affect net income and interest expense. Netflix, by contrast, performs sensitivity analyses on the assumptions underlying its content‑amortization model – testing how changes in projected viewing patterns would alter amortization amounts (page 40) – which reflects its primary risk of content‑valuation and subscriber‑behavior fluctuations. Both disclosures are reviewed by the same independent accounting firm (Netflix audit report on page 39; Comcast’s report of the independent registered public accounting firm on page 61), but the analyses focus on different risk categories that stem from each company’s distinct business model.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that CMCSA (Comcast) uses sensitivity analyses for interest rate and foreign exchange risk, referencing market-valuation methods and a 10% hypothetical shift in FX rates, which reflects its exposure to macroeconomic risks tied to derivatives and financing. The mention of interest expense impact is implied through context, though the specific $56 million reduction in interest expense in 2023 from interest rate swaps—present in the original answer—is omitted. This is a minor gap in quantitative completeness but does not distort the overall accuracy. For NFLX (Netflix), the LLM correctly states that sensitivity analyses are applied to content amortization assumptions, particularly projected viewing patterns, which directly ties to its content valuation risk. The entity identification (CMCSA as Comcast, NFLX as Netflix) and auditor consistency are accurately conveyed, with references to audit reports on specific pages supporting the claim that both are audited by the same firm. The reasoning is sound and reflects multi-hop synthesis: linking business models to risk exposures, identifying how each company applies sensitivity analysis differently, and acknowledging consistent audit oversight. The only minor shortcoming is the absence of the exact $56 million figure and the specific year (2023), which were present in the ground truth and would have strengthened quantitative precision. However, the LLM compensates with specific page references and accurate qualitative descriptions. Wording differs but semantic equivalence is maintained. All key facts are correct, calculations are not required beyond what’s implied, and the logic is coherent and relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 483,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s Enbrel enjoys a U.S. formulation‑patent that does not expire until October 19 2037, giving it more than a decade of patent‑based protection beyond the typical biologic exclusivity period. By contrast, AbbVie’s biologics rely on statutory regulatory exclusivities—generally 12 years of BPCIA protection (with possible orphan or pediatric extensions) that end far sooner than Enbrel’s 2037 patent horizon, leaving AbbVie’s products more exposed to biosimilar entry earlier. Thus, Enbrel’s later patent expiry bolsters Pfizer’s competitive position relative to AbbVie’s shorter‑term regulatory exclusivity strategy. (​Pfizer 10‑K p. 11; AbbVie 10‑K p. 9)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the expiration date of Enbrel's U.S. formulation patent is correctly stated as October 19, 2037, which matches the knowledge graph's reference to 2037; the 12-year BPCIA exclusivity period is also correctly cited. (2) The answer correctly contrasts Pfizer’s long-term patent-based protection with AbbVie’s reliance on regulatory exclusivity, accurately noting that AbbVie’s exclusivity periods typically end earlier, increasing exposure to biosimilars sooner. (3) The multi-hop reasoning is sound: it synthesizes Pfizer’s patent timeline with AbbVie’s regulatory strategy and draws a valid competitive comparison. (4) Minor deduction in qualitative accuracy because the LLM omits mention of AbbVie’s potential use of *both* patent and regulatory strategies (e.g., pediatric extensions) as a layered approach, which the original answer highlights. The LLM implies AbbVie relies only on regulatory exclusivity, slightly oversimplifying its strategy. However, the core facts, dates, and competitive implications are correct and well-supported, with proper citation to 10-Ks. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 346,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "A shift to 0.1‑percentage‑point increments would make the G‑SIB surcharge far less steep, so each step would add only a modest amount to JPMorgan Chase’s required capital (MS 10‑K p. 60). Because the Parent’s eligible long‑term debt is the first loss‑absorbing layer in a single‑point‑of‑entry bankruptcy (JPM 10‑K p. 15), a smaller surcharge increment would reduce the amount of eligible LTD that must be held, thereby lowering the extra capital buffer the firm would need to meet the surcharge in a resolution scenario.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies in reasoning and implications. (1) Quantitatively, the shift from 0.5- to 0.1-percentage-point increments is correctly described as a change in granularity, and the reference to JPMorgan's single point of entry (SPE) resolution strategy and eligible long-term debt (LTD) as a loss-absorbing layer aligns with the ground truth. However, the LLM incorrectly implies that smaller increments would 'reduce the amount of eligible LTD that must be held'—this is unsupported. The increment size does not inherently reduce capital or LTD requirements; it only allows for more precise calibration of surcharges based on G-SIB scores. (2) The LLM mischaracterizes the impact: a finer increment does not make the surcharge 'less steep' in a way that lowers capital; rather, it could result in a slightly higher, lower, or unchanged surcharge depending on JPM's exact G-SIB score. The original answer correctly notes the direction of change (increase or decrease) depends on the score, while the LLM assumes a reduction, which is speculative and incorrect. (3) The multi-hop reasoning fails in synthesis: while the model connects G-SIB surcharge changes to capital requirements and references the SPE structure correctly, it incorrectly links the increment change directly to reduced LTD holdings, conflating regulatory capital with loss-absorbing debt capacity. Eligible LTD is held to absorb losses in resolution, not directly to meet G-SIB surcharge requirements, which are capital-based (CET1). (4) Contextual relevance is high—the answer addresses the resolution scenario, references correct documents (JPM 10-K), and engages with the right concepts—but the flawed logic undermines factual correctness. Thus, the answer is partially accurate but contains critical reasoning errors that affect the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 509,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin values its Level 3 fixed‑income holdings with a discounted‑cash‑flow model that hinges on “projected annuity payments and the discount rate applied to those payments” (LMT 10‑K p. 88), but the filing does not describe a formal sensitivity analysis of those inputs. Honeywell, however, also uses a discounted‑cash‑flow approach for goodwill and indefinite‑life intangible‑asset impairment testing (HON 10‑K p. 47) and explicitly performs sensitivity analyses on the key assumptions—including the projected cash‑flow forecasts and the discount rate—stating that changes in those assumptions could materially affect the fair‑value measurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, citing the correct page (p. 88) from the LMT 10-K. It also accurately states that HON uses DCF for goodwill and indefinite-lived intangible asset testing, citing p. 47 of the HON 10-K. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or answers, so quantitative accuracy is not compromised—no errors in calculations or figures. (3) The multi-hop reasoning is sound: the model correctly compares two companies (LMT and HON), two different applications of DCF (investments vs. goodwill/intangibles), and contrasts their sensitivity analyses. The LLM adds value by noting that while both use DCF, only HON explicitly performs and discloses sensitivity analyses—this nuance is supported by the filings and enhances the answer beyond the ground truth. (4) The only reason for not scoring a perfect 10 is minor incompleteness: the ground truth mentions HON’s use of strategic plans, terminal value, growth rates, and sales volumes in sensitivity analysis, which the LLM summarizes more narrowly as 'projected cash-flow forecasts and discount rate.' While not incorrect, this omits some detail on the specific drivers HON evaluates. However, the core comparison on sensitivity to assumptions is preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with added precision from document citations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 444,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T measures its defined‑benefit pension and post‑retirement obligations using discount rates that are built from a yield curve of high‑quality corporate bonds whose credit quality is matched to the timing of expected benefit payments – the auditor’s critical‑audit‑matter work focused on evaluating the bond‑selection and credit‑quality assumptions (see AT&T pages 44‑43). Netflix amortizes its content on the basis of estimated future viewing hours, using historical and forecasted viewing patterns, and the auditor tested the reasonableness of those viewing‑pattern assumptions and the underlying data (see Netflix page 40). Both companies therefore rely on significant, judgment‑heavy estimates that are subject to detailed auditor scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, no specific dollar amounts or percentages are misstated; the LLM does not include the $67,854 million figure from the original answer but this omission does not introduce inaccuracy—only slight incompleteness. All other financial concepts (discount rates, viewing patterns, amortization methods) are correctly described. (2) The LLM correctly identifies both companies (AT&T and Netflix), their respective significant assumptions (corporate bond credit quality for discount rates; forecasted viewing patterns for content amortization), and the fact that both are subject to auditor evaluation. It even references specific pages from the filings (AT&T pp. 44–43, Netflix p. 40), enhancing credibility. (3) The multi-hop reasoning is sound: it draws a valid parallel between two different companies using judgment-heavy estimates in distinct domains (pensions vs. content), both subject to auditor scrutiny—a key point in the original answer. (4) The only minor shortcoming is the absence of the explicit $67,854 million goodwill and postretirement liabilities figure, which adds quantitative grounding in the original. However, the LLM captures the conceptual equivalence and auditor processes (sensitivity analysis, reasonableness testing) accurately. Wording differs but semantic meaning aligns closely. Thus, the answer earns a 9/10 for correctness—excellent, but slightly less complete than the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 417,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Altria (MO) only adopted ASU 2023‑07 when it prepared its 2024 annual statements – i.e., for the year ended December 31 2024, applying the guidance retrospectively and adding expanded segment footnote disclosures, with interim segment reporting to begin in the first quarter of 2025【page_62†L19-L23】【page_63†L1-L4】. Philip Morris International (PM) implemented the update earlier, revising its segment structure in January 2024 by folding the former Swedish Match segment into its four existing geographic segments (Europe; SSEA/CIS/MEA; EA/AU/PMI DF; and Americas) while leaving the Wellness & Healthcare segment unchanged【page_86†L9-L15】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all dates and timelines are correct: MO adopted ASU 2023-07 for the year ended December 31, 2024, with interim reporting starting Q1 2025; PM implemented changes in January 2024. These match the original answer. (2) The qualitative details are also correct: MO added expanded footnote disclosures in its 2024 annual report (referencing Note 17 implicitly via context), with interim disclosures beginning in 2025. PM restructured its segments by integrating the former Swedish Match segment into its four geographic segments starting January 2024, while keeping Wellness & Healthcare unchanged. (3) The multi-hop reasoning is sound—correctly contrasting adoption timelines and segment reporting changes between MO and PM. (4) Minor deduction in qualitative accuracy because the LLM mentions MO applied the standard 'retrospectively'—which is plausible but not explicitly stated in the ground truth—and does not explicitly name 'Note 17' as the location of disclosures, though this is implied. Overall, the answer is semantically equivalent, factually correct, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 334,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "BMY says that the HHS has placed Pomalyst in the IRA’s price‑negotiation list, with government‑set pricing to begin in 2027; this could accelerate revenue erosion before the drug’s U.S. exclusivity expires and therefore weigh on BMY’s outlook, although the company has not quantified the impact (BMY 10‑K p. 43). Pfizer, by contrast, already forecasts a roughly $1 billion net revenue hit in 2025 from the IRA’s Medicare Part D redesign and warns that additional products may be selected for future negotiations, indicating a more immediate and quantified exposure (Pfizer 10‑K pp. 16‑18). Both firms rely heavily on Medicare Part D sales, but BMY’s risk is product‑specific and later‑dated, whereas Pfizer’s is broader and already reflected in its near‑term guidance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Pomalyst is included in the IRA price negotiation program with government-set pricing starting in 2027 (BMY 10-K p.43), which may lead to revenue erosion before exclusivity expires. PFE forecasts a $1 billion net revenue impact in 2025 due to IRA Medicare Part D redesign (Pfizer 10-K pp.16-18), and faces potential future price negotiations on other products. These numbers, dates, and sources match the original answer. (2) Quantitative accuracy is perfect: $1 billion, 2025, and 2027 are all correctly cited with appropriate context. (3) Multi-hop reasoning is sound—LLM correctly synthesizes across BMY and PFE disclosures, compares timing (later vs. immediate), scope (product-specific vs. broad), and financial impact (unquantified vs. quantified). (4) The only minor limitation is that the LLM does not explicitly name Ibrance and Xtandi as PFE products selected for 2027 negotiations, though it references 'additional products may be selected,' which slightly reduces qualitative completeness. However, the core comparison of BMY’s Pomalyst-specific risk versus PFE’s broader exposure is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is full—directly addresses IRA impact, Medicare Part D reliance, and exclusivity timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 383,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine operations generated $401 million in 2021, or roughly 1.4 % of its total net revenues [page_89]. By contrast, Coca‑Cola’s exposure to Argentina is through Arca Continental – one of its five largest independent bottlers (together they represent about 41 % of Coca‑Cola’s worldwide unit‑case volume) – whose territory includes northern Argentina [page_7]. Therefore, MDLZ’s Argentine business is a modest, low‑percentage revenue slice, whereas KO’s reliance on Arca Continental is part of a much larger bottling partnership that contributes a significant share of its overall sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies MDLZ's $401 million in net revenues from Argentina in 2021 and accurately characterizes it as a modest portion of total revenue (1.4%), which aligns with the ground truth. It also correctly states that Arca Continental is one of KO's five largest independent bottlers and operates in northern Argentina. However, the LLM omits the key financial impact of Argentina's inflationary status on MDLZ, specifically the $13 million remeasurement loss in 2021, which is a significant element of MDLZ's exposure. (2) Quantitatively, all numbers are accurate: $401 million, 1.4%, 41% of worldwide unit-case volume from top bottlers including Arca Continental. The 1.4% figure is a valid inference if derived from MDLZ's total net revenues (~$28.6 billion in 2021), though not explicitly stated in the ground truth. The 41% figure is correctly attributed to the collective contribution of KO’s top bottlers, though the ground truth does not specify this exact percentage—this is a minor addition from the LLM’s source [page_7], but does not contradict known facts. (3) The multi-hop reasoning is sound: the LLM correctly contrasts MDLZ’s direct operational exposure with KO’s indirect exposure via a key bottler. It synthesizes information across MDLZ’s direct revenues and KO’s bottler structure. However, it misses the contractual exclusivity (Arca must source concentrates exclusively from KO), which strengthens KO’s strategic control and is part of the ground truth. (4) The answer is contextually relevant and directly addresses the comparison of exposure. The omission of the remeasurement loss and contractual exclusivity prevents a top score, but core facts and synthesis are correct, warranting a high but not perfect correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 483,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY notes that the FDA’s Fast Track designation is a key tool for speeding regulatory review and getting new therapies to patients more quickly (BMY 10‑K p. 18). Because PR006 already carries Fast Track status, LLY can expect an accelerated path to approval, which directly supports the CVR provision that pays $4.00 per share if a product is approved in a major market by Dec 31 2024 (with the payment value eroding month‑for‑month thereafter) (LLY 10‑K p. 70). Thus, the Fast Track process that BMY values underscores the strategic benefit of LLY’s acquisition—enhancing the likelihood of timely approval and securing the full CVR payout.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PR006 has Fast Track Designation, the CVR pays $4.00 per share (approximately $160 million total) upon first regulatory approval by December 31, 2024, with a month-for-month erosion thereafter. The LLM correctly identifies the relevance of BMY's emphasis on Fast Track to LLY's strategic position. (2) Quantitative accuracy is perfect: the $4.00 per share and Dec 31, 2024 deadline match the original; the mention of payment erosion, while slightly more detailed than the original, is consistent with the timeline constraint and adds nuance without inaccuracy. (3) Multi-hop reasoning is sound: the model correctly links BMY’s regulatory strategy, PR006’s Fast Track status, the CVR terms from the LLY 10-K, and the strategic value of timely approval. (4) The only minor gap is that the LLM does not explicitly mention that the acquisition occurred in 2021 or that the Fast Track was for frontotemporal dementia with GRN mutations—details present in the original—making the answer slightly less complete but not factually deficient. Overall, the answer captures the core strategic implication accurately and concisely, with excellent use of cited sources.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 352,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "V added 139 Class A shares in 2024 (1,733 versus 1,594 in 2023) – an ≈9 % rise that reflects new issuances and a net shift from its 245 Class B shares in 2023 to just 125 Class B shares in 2024【page_58】. In contrast, Mastercard’s Class B stock can be converted one‑for‑one into Class A, but only 7 Class B shares were outstanding at year‑end 2024, so the conversion mechanism has a negligible impact on its shareholder composition【page_92】【page_93】. Thus, V’s capital structure is actively expanding its voting‑eligible Class A base, whereas MA’s structure remains essentially unchanged, with conversion potential limited by a tiny Class B pool.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding V's Class B share numbers. The ground truth does not mention V having 245 Class B shares in 2023 or 125 in 2024; these numbers are entirely fabricated and not supported by the original answer or implied context. The only verified fact is V’s increase in Class A shares from 1,594 to 1,733 (a correct difference of 139 shares, ≈9% increase). However, the claim that this reflects conversion from Class B is unsupported in the original answer, which makes no mention of V having a Class B-to-A conversion mechanism or any Class B shares at all. (2) The calculation of the 139-share increase and ≈9% rise is quantitatively accurate based on the given numbers (1,733 - 1,594 = 139; 139 / 1,594 ≈ 8.72%, which rounds to ≈9%). However, the additional quantitative claims about Class B shares (245 → 125) are incorrect and unsupported, severely undermining quantitative accuracy. (3) The reasoning is partially sound in contrasting V’s expansion with MA’s stagnant Class B pool, but it incorrectly attributes V’s growth to Class B conversions, introducing a false mechanism not present in the original answer. The original emphasizes V’s 'organic growth or issuance' and does not reference any Class B shares or conversion, making the LLM’s multi-hop inference invalid. MA’s part is accurate: only 7 Class B shares outstanding in 2024, minimal conversion impact, one-for-one conversion rule—all align with the ground truth. (4) Contextual relevance is high because the answer addresses the comparative shareholder structure evolution and focuses on the right companies and timeframes. However, the correctness score is low due to major factual and reasoning errors in the V portion, especially the invention of Class B share data and conversion dynamics not present in the ground truth. The answer creates a false parallel between V and MA’s mechanisms, undermining its overall validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 532,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe notes that Saudi Arabia’s data‑localisation rules – which require personal and other data to be collected, stored and processed inside the kingdom – are a regulatory risk for its international operations【ADBE_10k_2024.pdf page 28】.  Under U.S. export‑control regulations, NVIDIA’s high‑performance GPUs such as the H100 and L40S are subject to a licensing requirement for shipments to Country‑Group D5, which includes Saudi Arabia【NVDA_10k_2024.pdf page 27】.  The localisation mandate therefore adds an extra layer of compliance and may make it harder or slower for NVIDIA to obtain the needed export license, potentially limiting or delaying the deployment of those chips in Saudi Arabia.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and factually accurate, with strong alignment to the ground truth. (1) It correctly identifies Adobe's mention of Saudi data localization requirements as a risk (from ADBE_10k_2024.pdf p.28) and NVIDIA's export control constraints under U.S. regulations for H100 and L40S chips (from NVDA_10k_2024.pdf p.27). The entities (Adobe, NVIDIA, H100, L40S, Saudi Arabia), regulatory frameworks (data localization, U.S. export controls), and document sources are accurate. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable but assumed correct. (3) The reasoning is sound: the answer connects data localization (requiring in-country processing) with export restrictions (requiring licenses for high-performance GPUs), concluding that this combination may delay or limit deployment. However, it incorrectly states that Saudi Arabia is in Country Group D5, while the ground truth specifies Country Group D4. This is a significant but not critical error, as the core logic about licensing requirements remains valid. (4) The answer is contextually relevant and addresses the multi-hop nature of the question—linking Adobe’s risk disclosure to NVIDIA’s export challenges. The omission of the revenue impact and market access reduction mentioned in the original answer is a minor completeness gap. Overall, the answer is semantically close and factually strong, warranting a high score but docked slightly for the Country Group misclassification and slightly less comprehensive synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 436,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing points out that it has elected to use the optional expedients in ASU 2020‑04 and the deadline‑deferral in ASU 2022‑06, but so far the transition away from LIBOR has had no material effect on its contracts and the company is simply monitoring for any future application. GE’s filing, by contrast, only references the original ASU 2020‑04, says it evaluated the LIBOR impact under that guidance and found it immaterial, and makes no mention of the ASU 2022‑06 extension or ongoing monitoring. This shows FedEx taking a forward‑looking, optional‑relief stance, while GE provides a retrospective, immaterial‑impact assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FedEx applied ASU 2020-04 and the extension in ASU 2022-06, reports no material effect, and continues monitoring; GE references ASU 2020-04, concludes immaterial impact, and does not mention ASU 2022-06 or ongoing monitoring. These points match the original answer. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—only qualitative disclosures—so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies, compares their application of the same accounting standards, and infers differing approaches (FedEx’s forward-looking monitoring vs. GE’s retrospective assessment). The only minor shortcoming is that the LLM slightly overemphasizes GE’s lack of mention of ASU 2022-06 as evidence of not applying it, whereas the original answer allows for the possibility that GE may still be under the extension but simply did not disclose ongoing monitoring. However, this is a reasonable interpretation given the absence of disclosure. (4) The answer is contextually relevant, directly addressing the differing applications of accounting relief under the two ASUs. Overall, the response captures the core contrast accurately and with appropriate nuance, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 396,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple warns that a large share of its hardware is assembled by outsourcing partners in Taiwan, and that manufacturing or logistics in that region can be disrupted by geopolitical tensions—potentially delaying shipments, raising costs and reducing its control over product quality (Apple 10‑K pp. 11 & 9). NVIDIA likewise depends on Taiwanese foundries for its semiconductor wafers and says a military or political conflict involving Taiwan could cut off that chip supply, creating material shortages, higher component costs and a severe adverse impact on its business (NVIDIA 10‑K pp. 35 & 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Apple relies on outsourcing partners in Taiwan for hardware assembly, and geopolitical tensions could disrupt manufacturing, logistics, product quality, and shipment timelines. NVIDIA depends on Taiwanese foundries for semiconductor wafers, and a conflict could cut off supply, leading to shortages and increased costs. These points match the original answer's core claims. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks to both Apple and NVIDIA by referencing their respective dependencies on Taiwanese manufacturing and foundry partners, drawing logical conclusions about supply chain disruptions. It appropriately cites page numbers from the 10-K filings (e.g., Apple pp. 11 & 9; NVIDIA pp. 35 & 17), indicating accurate sourcing. (4) The LLM adds slightly more detail than the original (e.g., mention of reduced control over quality, higher component costs), but these are reasonable inferences consistent with the risks described in 10-Ks and do not contradict the ground truth. The answer fully addresses the question’s focus on supply chain impacts due to geopolitical tensions. Only a minor deduction in qualitative accuracy due to slightly expanded risk factors not explicitly stated in the ground truth, but still contextually valid. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 445,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s filing notes that a “significant portion” of the $24,156 million developed‑technology intangible asset acquired in the VMware deal is tied to VMware Cloud Foundation, but it does not disclose a specific percentage 【page_51】. By contrast, Oracle’s net developed‑technology balance of $1,276 million represents roughly 18‑19 % of its total net intangible assets of $6,890 million (≈ 1,276 ÷ 6,890 ≈ 18.5 %) as of May 31 2024 【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that a 'significant portion' of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is tied to VMware Cloud Foundation, but no exact percentage is disclosed—this matches the ground truth. It accurately reports Oracle's net developed technology value ($1,276 million), total intangible assets ($6,890 million), and calculates the percentage as approximately 18.5%, which aligns with the ground truth's 18.4% (minor rounding difference is negligible and acceptable). (2) All numeric values are correct: $24,156 million, $1,276 million, $6,890 million, and the calculated percentage (1,276 ÷ 6,890 = 0.185 = 18.5%) are precise and properly formatted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies (Broadcom and Oracle), two different acquisitions (VMware and Oracle’s internal asset breakdown), and compares the relative importance of developed technology within each firm’s intangible asset base. (4) The answer is semantically equivalent to the ground truth, with only slight rewording (e.g., '18-19%' vs 'approximately 18.4%'). The only minor shortcoming is that the ground truth explicitly draws a comparative strategic conclusion about differing valuations, which the LLM implies but does not fully articulate, slightly reducing qualitative accuracy. Otherwise, the response is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 415,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "Comcast’s Class B shares concentrate voting power – they account for roughly one‑third (33 ⅓ %) of the company’s total voting rights, each share carries 15 votes and is owned entirely by Brian L. Roberts (the only three record holders) 【page_38†L9-L15】【page_38†L23-L27】.  By contrast, Alphabet’s non‑affiliate market value was about $1.45 trillion as of June 30 2021, and the firm has 44.6 million Class B shares outstanding that, like its dual‑class structure, give insiders disproportionate voting influence despite the massive market value held by non‑affiliates 【page_2†L9-L13】【page_2†L15-L18】.  Thus, Comcast’s Class B voting power is a fixed 33 ⅓ % of total votes, while Alphabet’s ownership is measured by a huge non‑affiliate market value but still relies on its super‑voting Class B shares to maintain insider control.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several correct elements but also significant factual inaccuracies. It correctly identifies that CMCSA's Class B shares carry 15 votes per share and represent 33⅓% of voting power, and that this structure concentrates control. It also correctly references GOOGL's non-affiliate market value of approximately $1.45 trillion (aligned with $1,451.1 billion in the ground truth). However, it incorrectly states that GOOGL had 44.6 million Class B shares outstanding — the original answer does not mention this number at all, and the cited figure in the LLM response (from 'page_2') contradicts the ground truth, which specifies 300,754,904 Class A shares outstanding, not Class B. This is a major quantitative error. Additionally, the LLM incorrectly names Brian L. Roberts as the sole holder of CMCSA’s Class B shares and claims there are only three record holders total — while the ground truth confirms three record holders, it does not name them, so attributing ownership specifically to Roberts exceeds the provided information.\n\n2) Quantitative verification: The $1.45 trillion non-affiliate market value is acceptably close to $1,451.1 billion (rounding is reasonable). The 33⅓% voting power and 15 votes per share for CMCSA are accurate. However, the 44.6 million Class B shares figure for GOOGL is unsupported by the ground truth and appears to be a misreading or hallucination. The correct figure from the original answer is 300,754,904 Class A shares outstanding — a critical distinction.\n\n3) Multi-hop reasoning: The LLM attempts to compare control mechanisms — correctly noting that CMCSA has a fixed, concentrated voting structure while GOOGL maintains insider control via super-voting shares despite large non-affiliate market value. This synthesis is logically sound and addresses the comparative aspect of the question. However, the reasoning is undermined by the incorrect share count, which affects the validity of the structural comparison.\n\n4) Justification: The correctness score is 6 due to partial accuracy — key facts about voting power and market value are right, but major errors in share counts and ownership attribution reduce reliability. Quantitative accuracy is low (5) due to the incorrect GOOGL share number. Qualitative accuracy is higher (7) because the conceptual comparison and reasoning are strong. Contextual relevance is high (9) as the response directly addresses the comparative structure and control mechanisms as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 659,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 balance sheet shows it had 4.65 billion Class A shares issued versus only 9.44 million Class B shares issued (≈0.2 % of total)【page_67】. Meta’s 2024 filing reports 2.19 billion Class A shares and 343.8 million Class B shares outstanding (about 14 % of total)【page_1】. Thus, Comcast’s equity is overwhelmingly concentrated in the low‑voting Class A class with a negligible high‑voting Class B component, whereas Meta’s dual‑class structure places a substantial share of voting power in its high‑voting Class B class, creating a far more concentrated voting‑rights structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core quantitative data from both CMCSA and META filings. The numbers are accurately represented in rounded form: 4.65 billion Class A shares (vs. 4,651,093,045) and 9.44 million Class B shares (vs. 9,444,375) for CMCSA; 2.19 billion Class A (vs. 2,189,898,148) and 343.8 million Class B (vs. 343,761,117) for META — all within acceptable rounding. The percentage calculation for Class B shares at ~14% (343.8M / (2.19B + 343.8M) ≈ 13.6%) is correctly approximated. (2) All calculations and numeric representations are factually accurate with appropriate rounding; no calculation errors. (3) The reasoning correctly infers that CMCSA’s equity structure is dominated by Class A shares, implying more diffuse voting power, while META has a significant proportion of high-voting Class B shares, leading to concentrated control — this aligns with the ground truth. The LLM omits the explicit detail about Class B shares carrying 10 votes and automatic conversion upon transfer, which was present in the original answer and adds depth to the voting rights explanation. However, the core inference about voting concentration is still sound based on share distribution. (4) The answer is contextually fully relevant, directly addressing the comparative equity structure concentration. The omission of the vote ratio and conversion rule slightly reduces qualitative completeness but does not undermine the central conclusion. Hence, high scores across all dimensions with a minor deduction in qualitative accuracy for missing key structural details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 437,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health risk is tied to its heavy reliance on Medicare/Medicare‑Advantage payments – a change in Medicare reimbursement rates or program rules could directly cut the segment’s revenue (see CVS 10‑K p. 47). By contrast, AbbVie is exposed to a much broader, product‑wide risk: the IRA gives HHS authority to set price caps for single‑source drugs and biologics under Medicare Part B and D, which could substantially lower prices and reimbursements for many of AbbVie’s products (see AbbVie 10‑K p. 19 & 37).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both CVS's Oak Street Health and AbbVie's exposure to Medicare-related risks under the IRA, with no incorrect numbers, dates, or entities. It correctly identifies that Oak Street Health is exposed to changes in Medicare reimbursement rates and program rules, and that AbbVie faces risk from IRA-mandated price caps on drugs in Medicare Part B and D. The citation of specific 10-K pages (p. 47 for CVS, pp. 19 & 37 for AbbVie) adds verifiability and aligns with the type of sourcing expected, though the ground truth does not require page numbers. However, the LLM omits a key detail present in the original answer: that AbbVie’s drug Imbruvica has already been selected for price-setting under the IRA, with prices taking effect in 2026. This is a significant omission because it provides concrete, company-specific evidence of exposure, making the original answer more precise and complete. While the LLM captures the general mechanism of risk for both companies and correctly frames their differing exposure pathways (reimbursement risk vs. mandated pricing), it fails to synthesize this specific multi-hop fact—linking Imbruvica’s selection to AbbVie’s direct IRA exposure—which weakens the qualitative accuracy slightly. There are no quantitative inaccuracies; no numbers are misstated. The reasoning is sound and contextually relevant, clearly contrasting the two companies’ risk profiles within the evolving Medicare framework. Thus, the answer is largely correct but lacks a critical detail that would make it fully equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 439,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft reports that operating systems are a component of its product revenue, underscoring that OS is a core, revenue‑generating product for the company (see Microsoft 10‑K p. 62).  AMD explicitly states that its x86‑based microprocessors and graphics products “depend … on Microsoft designing and developing its operating systems to run on or support” those products, so AMD’s ability to sell and innovate is directly tied to Microsoft’s continued OS support (see AMD 10‑K p. 28).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the core dependency relationship between AMD and Microsoft as described in the ground truth. It accurately cites Microsoft's inclusion of operating systems in product revenue (referencing p. 62 of Microsoft's 10-K) and AMD's explicit reliance on Microsoft's OS support for its x86-based microprocessors and graphics products (citing p. 28 of AMD's 10-K). There are no numeric values, dates, or financial figures in the question or answers that require quantitative verification, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is 9 because the LLM captures the essential multi-hop reasoning—Microsoft’s OS support impacts AMD’s market success—but omits the downstream effects mentioned in the original answer, such as independent software vendors avoiding optimization for AMD and reduced customer demand, which are important for full completeness. However, the central dependency is clearly articulated with proper sourcing, and the reasoning is logically sound. Contextual relevance is 10, as the response directly addresses the influence of Microsoft's OS revenue on AMD's dependency, using appropriate evidence from both companies’ filings. Minor deduction in correctness score due to partial omission of downstream business impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 365,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference solution is built on a high‑density networking fabric – its Silicon One‑based routers, Nexus/Catalyst switches and high‑performance optics – that delivers the bandwidth, low‑latency and unified management needed to scale AI workloads and is marketed as a foundation for multicloud data‑center architectures. Broadcom, by contrast, delivers AI/ML capability through VMware Cloud Foundation, an integrated private‑cloud stack that bundles compute, networking, storage and management with native Kubernetes, giving customers a single, license‑portable platform to run enterprise‑scale AI/ML workloads across on‑premises and public clouds. Thus Cisco focuses on the underlying high‑speed network infrastructure, while Broadcom provides a software‑defined, Kubernetes‑enabled multicloud environment that abstracts and orchestrates those AI workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Cisco's role in providing high-density routers (Silicon One), switches (Nexus/Catalyst), and high-performance optics for AI networking is accurately described, as is Broadcom's delivery of AI/ML capabilities via VMware Cloud Foundation (VCF) with native Kubernetes support. The distinction between Cisco’s hardware-centric network infrastructure and Broadcom’s software-defined, Kubernetes-enabled platform is clearly and correctly articulated. (2) There are no numeric values, dates, or financial figures in either the question or answers that require verification; thus, quantitative accuracy is not applicable but no errors are present. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Cisco and Broadcom), their respective technologies (Cisco networking vs. VCF), and how each enables multicloud architectures and Kubernetes integration for AI workloads. The only minor omission is that the original answer notes Broadcom values VCF using the multi-period excess earnings method—a detail absent in the LLM response. While this is a factual gap, it does not pertain directly to the functional comparison asked in the question, so it does not significantly detract from correctness. (4) The LLM answer demonstrates strong contextual relevance and semantic equivalence, clearly addressing all parts of the question: comparison of infrastructure approaches, support for enterprise-scale AI/ML, multicloud enablement, and Kubernetes integration. Wording differs but meaning matches. Thus, a correctness score of 9 is warranted due to near-complete accuracy with one minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 472,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal values its derivatives with pricing models that use contract terms plus observable market data (e.g., currency rates, yield curves, option volatilities) and classifies them as Level 2; the filing notes that it had no assets or liabilities requiring Level 3 measurement with significant unobservable inputs【page_93】. Morgan Stanley, on the other hand, reports Level 3 fair‑value measurements that rely on material unobservable assumptions—such as pre‑payment rates, credit‑spread and discount‑rate inputs for mortgage‑backed securities and other instruments—showing a much higher dependence on judgment‑driven inputs【page_99】【page_100】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that PayPal uses Level 2 inputs for derivatives valuation, relying on observable market data such as currency rates, yield curves, and option volatilities, and explicitly confirms no Level 3 assets or liabilities as of the reporting date (implied December 31, 2024, consistent with the filing context). Morgan Stanley’s use of Level 3 measurements with significant unobservable inputs—such as pre-payment rates, credit spreads, and discount rates—is accurately described, particularly for instruments like mortgage-backed securities. (2) There are no numerical values requiring calculation, but the classification levels (Level 2 vs Level 3) and their implications are correctly interpreted. The absence of Level 3 for PayPal and presence for Morgan Stanley is correctly contrasted. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (PayPal and Morgan Stanley), compares their fair value measurement approaches, and correctly infers that Morgan Stanley has greater reliance on unobservable, judgment-driven inputs compared to PayPal, which avoids Level 3 entirely. (4) The answer is fully contextually relevant, directly addressing the comparison of pricing models and reliance on unobservable inputs. Minor wording differences (e.g., 'judgment-driven inputs' vs 'internally derived assumptions') do not affect factual equivalence. All key elements from the original answer are preserved and accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 429,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "Meta’s 343.8 million Class B shares (as of Jan. 24 2025) carry only limited voting rights on a narrow set of corporate actions, so even if all Class B holders acted together they would control a relatively small and constrained voting bloc and could not readily drive broad governance changes【page_1】. In contrast, Comcast’s 3.78 billion outstanding Class A shares are the primary voting class, giving shareholders a much larger and unrestricted voting power to influence board elections, charter amendments and other governance matters【page_67】. Consequently, shareholder‑driven governance changes are far more feasible at Comcast than at Meta.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the numbers are correctly represented with acceptable rounding: 343,761,117 shares is accurately rounded to 343.8 million, and 3,778,302,017 is correctly rounded to 3.78 billion. The date 'Jan. 24 2025' is not in the original answer but may reflect a forward-looking filing date; since the original does not specify a date, this does not constitute a factual error. (2) The answer correctly identifies that META's Class B shares have limited voting rights on only specific corporate actions, restricting their influence on governance, while CMCSA's Class A shares carry full voting rights. (3) The multi-hop reasoning is sound: it compares ownership structures across two companies, links share class rights to governance influence, and correctly concludes that shareholder-driven changes are more feasible at CMCSA than META due to voting power distribution. (4) Minor deduction in qualitative accuracy due to slightly less specificity about the exact types of corporate actions (e.g., 'exiting core payments business') mentioned in the original, but the essence of 'narrow set of corporate actions' preserves semantic equivalence. Overall, the answer is factually correct, contextually appropriate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 369,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "KO’s non‑U.S. unit case volume is 71 percent attributable to sparkling soft drinks【page_7】. By contrast, Philip Morris International has a direct operational footprint in Portugal – it operates one of its largest manufacturing facilities there【page_19】, underscoring its presence in a key CCEP market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly states that 71% of KO's non-U.S. unit case volume is attributable to sparkling soft drinks, which matches the ground truth. It also accurately notes that Philip Morris International (PM) has a major manufacturing facility in Portugal, one of CCEP's key markets, highlighting PM's direct operational presence. The quantitative accuracy is perfect—71% is correctly cited. The qualitative accuracy is high, as the model correctly synthesizes information across KO, CCEP, and PM, linking Portugal as a shared strategic market. The only minor omission is that the original answer specifies PM's Portugal facility produces 'over 30 billion units (cigarettes and heated tobacco units combined)', a detail absent in the LLM response. While this adds context, it does not undermine the core correctness of the comparison. The reasoning is sound, and the answer is semantically equivalent in addressing both parts of the multi-hop question. Contextual relevance is excellent, directly addressing the comparative operational footprint question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 301,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s loan‑receivable portfolio – which explicitly includes financing for hardware, software **and technical‑support services** – shows a credit‑loss allowance that fell from $103 million in 2022 to $53 million in 2023 (see page 84). That roughly 50 percent reduction signals Cisco now expects far fewer defaults on these loans, freeing up reserve capital and increasing the net amount of financing it can extend. Consequently, Cisco should have greater capacity and lower cost to fund technical‑support services through its loan‑receivable program (see page 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth. The percentage decrease is accurately described as 'roughly 50 percent,' which aligns with the exact 48.5% drop (calculated as (103-53)/103 ≈ 48.5%). This meets quantitative accuracy standards, including correct dollar amounts, years, and logical approximation of the percentage. (2) The entity accuracy is correct—Cisco is the subject, the time frame is accurate (2022 to 2023), and the financial metric (credit loss allowance on loan receivables) is properly identified. The inclusion of technical support services in the loan receivables portfolio is explicitly noted, as stated in the original answer. (3) The reasoning is sound and reflects multi-hop synthesis: the model connects the reduced allowance to improved expected credit performance, links this to freed-up capital, and infers increased capacity to finance technical support services—consistent with the ground truth’s conclusion about expanded financing options and reduced risk. The mention of 'lower cost to fund' and 'greater capacity' mirrors the original’s implication of enhanced financing ability. (4) The only minor shortcoming is that the LLM does not explicitly state that the reduced allowance may reflect increased confidence in customer creditworthiness, which is a nuance in the original answer. However, the implication is present through 'expects far fewer defaults.' The answer is semantically equivalent and contextually fully relevant, with appropriate use of supporting document pages (84 and 82) indicating source grounding. Thus, the answer is highly accurate with only slight room for deeper qualitative elaboration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 482,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares can vote only on a narrow set of “defined matters” – essentially any merger, consolidation or similar transaction that would treat the preferred holders differently from Class A common shareholders【page_90】. In contrast, every share of Netflix’s common stock carries one vote on all shareholder‑subject matters, giving holders a universal right to influence the company’s governance decisions【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AT&T’s Series B Preferred Stockholders have voting rights only on specific merger-related matters (referred to as 'defined matters'), while Netflix common stockholders have one vote per share on all matters. The core comparison on corporate governance influence is preserved. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—only qualitative and conceptual accuracy matter here, and these are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two different companies (AT&T and Netflix) and contrasts limited vs. universal voting rights. The citation of page numbers (90 and 61) suggests grounding in source documents, though not required for correctness. (4) Minor difference: the LLM uses 'defined matters' and specifies transactions that treat preferred holders differently, which adds slight nuance not in the original answer but does not contradict it—this is acceptable under semantic equivalence. The original answer emphasizes 'single class' voting, which the LLM omits, but this is a minor detail that doesn’t affect the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 400,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal treats BNPL and cryptocurrency as clear risk factors – it warns that rapid‑changing payment‑technology trends, regulatory scrutiny of its BNPL products and the custody, insurance and compliance risks of its crypto offerings could erode usage of its services and increase costs (PayPal 10‑K risk‑factor and regulatory sections, pp. 18‑20). Visa, by contrast, classifies BNPL firms and crypto platforms as “alternative‑payments providers” that can be both partners and competitors, and it actively pursues fintech‑fast‑track programs, strategic investments and open‑banking collaborations to work with them while protecting its network (Visa 10‑K, “Alternative Payments Providers” discussion, p. 16). Thus, PayPal’s view is exposure‑focused, whereas Visa’s strategy is to partner with and compete against these emerging players.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies PayPal's exposure to technological disruption from BNPL and cryptocurrency, citing specific risk factors such as regulatory scrutiny, custody, insurance, and compliance risks—consistent with PayPal’s 10-K disclosures. It accurately contrasts this with Visa’s strategic positioning, noting Visa’s dual role as both partner and competitor to alternative payment providers, supported by initiatives like fintech fast-track programs and open-banking collaborations—details corroborated by Visa’s 10-K. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the citation of page numbers (pp. 18–20, p. 16) adds precision and matches the expected sourcing, which is acceptable and enhances credibility. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (PayPal and Visa), their respective risk disclosures and strategic narratives, and correctly infers the contrast in strategic posture—exposure-focused vs. adaptive partnership/competition. (4) The semantic meaning fully captures the original answer’s intent: PayPal faces higher vulnerability and must react defensively, while Visa proactively engages with emerging trends to maintain dominance. The only minor shortcoming is a slightly less explicit mention of Visa’s 'global network and security advantages' as a lever, though the reference to protecting its network implies it. Thus, the answer is factually complete, contextually precise, and logically well-structured, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 489,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s 2023 proxy statement notes that “the holders of each share of common stock shall be entitled to one vote per share”【page_61】. Alphabet’s 2023 filing states that “each share of Class A common stock is entitled to one vote per share”【page_81】. Therefore, both Netflix’s common stock and Alphabet’s Class A shares carry the same voting power – one vote for each share owned.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Netflix's common stock and Alphabet's Class A Common Stock both provide one vote per share, citing the correct voting rights from each company's 2023 filing. (2) There are no numerical values requiring calculation, but the key quantitative fact—'one vote per share'—is correctly reported for both companies, with no discrepancies in numbers or dates. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two separate companies (Netflix and Alphabet) and compares their voting structures, noting equivalence in voting power for the specified share classes. (4) The answer is contextually relevant, directly addressing the comparison asked in the question and correctly identifying that while Alphabet has multiple share classes, the Class A shares specifically carry one vote, just like Netflix's common stock. Minor wording differences (e.g., 'proxy statement' vs '10-K') do not affect factual accuracy, as both refer to the same regulatory filing context. All entities (Netflix, Alphabet, Class A Common Stock, voting rights) are correctly identified and analyzed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 339,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both PMI and Mondelēz use a parametric delta‑gamma VAR model that assumes normal market conditions, a 95 % confidence interval and a one‑day holding period. PMI’s model is limited to interest‑rate and foreign‑currency exposures and produces larger fair‑value VAR numbers (e.g., ≈ $297 m for interest‑rate risk and ≈ $77 m for currency risk at 12/31/23), with the inter‑relationships derived from interest‑rate and forward‑currency moves over the prior quarter. Mondelēz applies the same technique but expands the risk set to include commodity‑price risk (valuing options on a non‑linear basis) and reports both fair‑value and pre‑tax‑earnings impacts, resulting in smaller VAR estimates (≈ $119 m interest‑rate, ≈ $14 m currency and ≈ $21 m commodity fair‑value impact at 12/31/23).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth does not provide any specific VAR figures for PM or MDLZ, especially not the precise numbers cited (e.g., $297M, $77M, $119M, etc.), nor does it mention a date of '12/31/23'. The original answer explicitly states that PM does not disclose a specific VAR figure, making the LLM's attribution of exact dollar amounts to PM factually incorrect. Similarly, while MDLZ discloses VAR amounts at year-end, the ground truth does not specify the values cited in the LLM answer. (2) The quantitative accuracy is very low because all dollar amounts and the specific date (12/31/23) are fabricated or hallucinated. There is no support in the ground truth for any numerical VAR estimates. (3) The qualitative accuracy is partially correct: the LLM correctly identifies that both companies use the parametric delta-gamma method under normal conditions, with a 95% confidence level and one-day horizon. It also correctly notes that MDLZ includes commodity risk and accounts for non-linear option valuation, while PM focuses on interest rate and currency risks. The mention of using prior quarter data for interrelationships aligns with the ground truth. However, the claim that MDLZ reports 'pre-tax earnings impacts' is not supported. (4) Contextual relevance is high because the LLM addresses the core comparison between PM and MDLZ regarding VAR methodology, risk factors, and assumptions. Despite hallucinating numbers, it attempts the correct multi-hop synthesis. The correctness score is low due to the severe quantitative inaccuracies, which undermine trust in the response, even though some qualitative elements are directionally accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 479,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the Market Risk Rule because its trading‑book assets exceed the rule’s trigger of ≥10 % of total assets (or $1 bn) and therefore must adjust its capital ratios using its internal risk‑management VaR, which is calculated on a one‑day, 95 %‑confidence basis and back‑tested daily (COF p. 86; p. 146‑147). JPMorgan, on the other hand, meets Basel III capital requirements that rely on a regulatory VaR applied to all “covered” positions; this VaR uses a ten‑business‑day holding period and an approximate 99 % confidence level and is not tied to a specific trading‑asset threshold (JPM p. 145).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key factual inaccuracy regarding Capital One's VaR methodology. The ground truth states that COF is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with no mention of using an internal VaR model at a 95% confidence level or one-day holding period. The LLM incorrectly asserts that COF uses an internal risk-management VaR (one-day, 95% confidence), which is not supported by the original answer and misrepresents COF's compliance approach. This is a significant quantitative and methodological error. However, the description of JPMorgan Chase's regulatory VaR (99% confidence, ten-business-day holding period, applied to covered positions) is accurate and aligns with the ground truth. The threshold condition for the Market Risk Rule (trading assets ≥$1B or 10% of total assets) is correctly stated. The answer addresses the comparison of regulatory frameworks and trading asset thresholds, fulfilling much of the multi-hop requirement. While the core structural comparison between COF’s rule-based compliance and JPM’s internal modeling is implied, the erroneous attribution of a specific VaR model to COF undermines full factual accuracy. Wording and synthesis are otherwise clear and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 360,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco reports a $50 million allowance for credit losses on its loan receivables – which include financing for hardware, software and technical‑support services – as of July 27 2024【page_82】. Salesforce, by contrast, flags a qualitative risk that it depends on third‑party developers and technology partners to deliver support, integrations and data services, noting that any failure by those providers could harm its business but does not quantify a comparable credit‑loss allowance【page_21】. Thus, Cisco quantifies its service‑delivery risk with a $50 million allowance, whereas Salesforce’s exposure to third‑party support risk is described only in narrative terms.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported credit loss allowance amount and date. The ground truth states Cisco's allowance was $53 million as of July 29, 2023, while the LLM reports $50 million as of July 27, 2024—both the amount and fiscal date are incorrect. This undermines quantitative accuracy. (2) The LLM correctly identifies that Cisco includes financing for technical support services in its loan receivables and that it quantifies credit risk, which aligns with the original answer. However, the misstatement of the dollar amount and reporting date constitutes a material discrepancy, especially since the question hinges on comparing specific risk exposures. (3) The qualitative assessment of Salesforce is mostly accurate: the company relies on third-party providers, and failure by those parties could harm its business, with no quantified credit loss allowance. The LLM correctly contrasts Cisco’s quantified financial risk with Salesforce’s narrative risk disclosure. However, the LLM slightly mischaracterizes Salesforce’s third-party reliance as including 'developers and technology partners' rather than specifically 'technical support providers,' which dilutes precision. (4) The reasoning correctly synthesizes a multi-hop comparison between Cisco’s direct credit risk and Salesforce’s indirect service delivery risk, showing sound logic despite factual inaccuracies. Contextual relevance is high as the answer addresses both companies’ risk profiles in relation to service delivery. The core structure and intent of the comparison are valid, but the incorrect numbers reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 453,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s 10‑K makes clear that its dual‑class structure gives the founder’s ten‑vote Class B shares control of the company, so even though Zuckerberg owns a small percentage of the total equity he can dictate outcomes of any shareholder vote.  This “controlled‑company” status is expressly noted as a factor that could make the widely‑held Class A stock less attractive and depress investor confidence (Meta 10‑K pp. 48‑50).  Comcast, on the other hand, merely reports a small amount of Class B common stock on its balance sheet (≈9.4 million shares) with no conversion mechanism or voting‑control provisions that affect governance, so its Class A shares are not subject to the same governance‑risk drag (Comcast 10‑K pp. 69‑70).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the figure of approximately 9.4 million Class B shares for CMCSA (Comcast) matches the ground truth value of 9,444,375 shares as of 2023; the minor rounding to '≈9.4 million' is acceptable. No other numerical data (e.g., voting rights, ownership percentages) are misstated. (2) The answer correctly identifies that META’s dual-class structure grants disproportionate control to Class B shareholders (e.g., Zuckerberg) with 10 votes per share and highlights the 'controlled company' designation as a risk factor explicitly mentioned in Meta’s 10-K (pp. 48–50), which may reduce investor confidence in Class A stock—this is consistent with the original answer. (3) For CMCSA, the LLM correctly notes the presence of Class B shares but emphasizes the absence of governance-linked conversion mechanisms or voting control provisions, accurately contrasting it with META. The citation of Comcast’s 10-K (pp. 69–70) adds contextual support. (4) The multi-hop reasoning—comparing governance structures across two companies, synthesizing implications for investor sentiment, and differentiating based on conversion mechanisms and control rights—is sound and logically presented. (5) While the LLM omits the specific 35% voting power threshold and the requirement for Class B approval on change of control (mentioned in the ground truth), this is a minor omission that does not undermine the core factual accuracy or comparative insight. Wording differs but semantic equivalence is preserved. All entities (Meta, CMCSA/Comcast, Class A/B shares) and years (implied 2023 via 10-K references) are correct. The answer is fully relevant and focused on the governance-risk contrast as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 480,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its residential‑mortgage‑backed securities with a discounted‑cash‑flow model that explicitly incorporates unobservable assumptions – a constant pre‑payment rate, loss‑severity, default rate and the yield used to discount cash flows (see AIG 10‑K p. 120). Morgan Stanley also applies discounted‑cash‑flow techniques for fair‑value measurement of Level 3 assets, but its filing describes the approach only in general terms, noting that Level 3 valuations “incorporate significant unobservable inputs” without listing the specific assumptions (see MS 10‑K p. 42). Thus, both firms rely on unobservable inputs in DCF models, but AIG spells out the exact inputs for RMBS, whereas MS refers to the reliance more broadly as part of its Level 3 fair‑value methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AIG uses discounted cash flow (DCF) models for RMBS valuation with unobservable inputs, and mentions specific inputs like constant prepayment rate, loss severity, default rate, and discount yield. While the original answer provides ranges for prepayment rate (4.10%–9.26%) and loss severity (40.81%–76.72%), the LLM does not include these exact numbers but correctly characterizes the use of such inputs—this is a minor omission, not an error. (2) For Morgan Stanley (MS), the LLM accurately states that DCF is used for Level 3 assets and that unobservable inputs are significant, though described more generally. It correctly notes MS’s Level 3 assets were 0.9% of total assets as of December 31, 2024, in the original answer, but the LLM omits this specific percentage. This is a partial gap in quantitative completeness, but the qualitative point about MS using significant unobservable inputs is preserved. (3) The multi-hop reasoning is sound: the model compares AIG’s detailed disclosure of specific unobservable inputs for RMBS to MS’s broader, less specific use of DCF in Level 3 valuations, correctly highlighting the contrast in transparency and specificity. (4) The LLM answer is semantically equivalent in intent and meaning, with only minor omissions of precise numerical values. Wording differences are acceptable and do not affect factual correctness. The answer is fully contextually relevant, directly addressing the comparison of DCF model reliance on unobservable inputs between AIG and MS.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 440,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables that finance its hardware fell from $53 million in FY 2023 to $50 million in FY 2024 – a $3 million reduction (see Cisco 10‑K p. 82/84). Microsoft, by contrast, treats hardware that cannot operate without its operating system as a single performance‑obligation bundle and records the revenue at the point of transfer to the reseller or end‑customer (see Microsoft 10‑K p. 62). Thus Cisco’s exposure is primarily credit‑risk related to financing hardware sales, while Microsoft’s exposure is tied to the timing and delivery of integrated hardware‑software bundles rather than to credit losses.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. It states that Cisco's allowance decreased from $53 million in FY 2023 to $50 million in FY 2024, but the ground truth reports a decrease from $103 million in FY 2022 to $53 million in FY 2023. The LLM uses incorrect years and values, misrepresenting the trend and magnitude of change. There is no mention of FY 2024 in the original answer, making this a fabrication based on the provided truth. (2) The calculation of a '$3 million reduction' is based on incorrect data and does not align with the ground truth, which shows a $50 million reduction ($103M to $53M). (3) While the qualitative description of Microsoft's revenue recognition is largely accurate—correctly identifying that hardware interdependent with software is treated as a single performance obligation and recognized at point of sale—the comparison in financial exposure is only partially correct. The LLM correctly identifies Cisco's exposure as credit-risk-related and Microsoft's as tied to delivery/timing, but misses the deeper insight from the original answer about Cisco’s multi-year financing risk versus Microsoft’s post-sale performance dependency. (4) Contextually, the answer addresses the right concepts and companies, and attempts the multi-hop comparison between Cisco’s credit loss allowance and Microsoft’s revenue recognition. However, due to the critical error in financial figures and time periods, the core factual foundation is flawed. The reasoning is sound where facts are correct, but built on incorrect data. Hence, correctness is significantly compromised despite appropriate framing and relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 457,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG reported a $75 million loss from embedded derivatives in 2024 (AIG 10‑K, p. 144). Morgan Stanley’s credit‑risk exposure to CDOs that contain similar hybrid instruments is limited to the $62 million of debt‑ and equity‑interest holdings shown for CDOs (MS 10‑K, p. 128). Thus, AIG’s loss is larger—about $13 million higher—than the credit‑risk amount Morgan Stanley carries in those CDOs.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors. (1) Quantitatively, while AIG's $75 million loss in 2024 is correctly stated, the claim that Morgan Stanley's (MS) credit risk exposure is limited to $62 million in CDO holdings misrepresents the nature of the exposure. The $62 million refers to MS's holdings in CDOs, not its full credit risk exposure from selling credit protection via hybrid instruments like CLNs and CDOs. The original answer emphasizes that MS faces potential principal loss if a credit event occurs—similar to AIG’s realized loss—rather than having a fixed $62 million exposure. Thus, comparing $75M vs $62M as direct measures of loss or risk is misleading. (2) The calculation claiming AIG’s loss is '$13 million higher' is mathematically correct ($75M - $62M = $13M), but it's conceptually invalid because it compares a realized loss (AIG) to a holdings figure (MS), not equivalent metrics. (3) Qualitatively, the LLM fails to capture the multi-hop reasoning required: both firms are exposed through structured credit products involving embedded derivatives and sold credit protection, creating similar risk profiles. Instead, the LLM incorrectly reduces MS’s exposure to asset holdings, missing the parallel in risk mechanism—i.e., principal non-repayment upon credit events. (4) Contextually, the answer addresses both firms and structured products, so it remains relevant, but the core analysis is flawed. The original answer correctly identifies the structural similarity in risk, while the LLM incorrectly frames the comparison as a simple numerical difference in exposure amounts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 442,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s foreign‑exchange cash‑flow hedges for forecasted transactions are set up with option (and forward) contracts that “generally not to exceed four years” 【page_121】. Google’s cash‑flow hedges also use forward and option contracts (including collars) but “have maturities of 24 months or less” 【page_70】. Thus Disney’s hedge horizon can be up to about twice as long as Google’s, which is limited to two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Disney's hedge duration is 'generally not to exceed four years' and Google's is '24 months or less' — both match the original answer exactly. The comparison stating Disney’s horizon can be up to twice as long is logically sound and semantically equivalent. Dollar amounts ($9.9B for Disney, $731M for Google) are not repeated in the LLM answer, but the question did not explicitly ask for hedge values, only the duration comparison and use of option contracts. Thus, omission of dollar figures does not constitute a critical error. (2) The use of option contracts by both companies is correctly identified, satisfying the second part of the question. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from two companies (Disney and Google), compares their hedge durations, and draws a valid conclusion about relative hedge horizon lengths. (4) Minor deduction in qualitative accuracy due to lack of mention of the specific financial values (though not strictly required), and slightly less completeness than the original answer. However, the core of the question — comparing durations and confirming use of options — is fully addressed with precise, correctly attributed information. Contextual relevance is perfect as the response directly answers the comparative duration and instrument usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 395,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "Qualcomm says the OECD‑mandated 15 % global minimum tax that will begin to apply in fiscal 2025 “is not expected to materially impact our consolidated financial statements” because most of its earnings are already taxed at rates above the floor and it benefits from sizable R&D credits【page_43】. Intel, however, notes that a portion of its profit is generated in jurisdictions with rates below the 15 % threshold, so the Pillar Two rules could increase its effective tax rate – although the company also does not expect a material impact – reflecting Intel’s broader exposure to low‑tax locations compared with Qualcomm’s more US‑centric, higher‑taxed income mix【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that QCOM expects minimal (non-material) impact from the Global Minimum Tax starting in fiscal year 2025 due to its earnings being taxed above the 15% threshold and benefiting from R&D credits, which matches the original answer's claim of 'minimal impact' and no material operations in low-tax jurisdictions. (2) For INTC, the LLM correctly identifies that a portion of its profits are in jurisdictions below 15%, leading to potential increases in its effective tax rate under Pillar Two, though it also does not expect a material impact—this is consistent with the original answer noting INTC is still evaluating impacts due to its broader international footprint. (3) The multi-hop reasoning is sound: the model correctly contrasts QCOM’s US-centric, higher-taxed income with INTC’s broader exposure to low-tax jurisdictions, explaining the differing levels of exposure. (4) Minor point: the original answer emphasizes INTC faces 'more immediate uncertainty' due to ongoing legislative adoptions (e.g., EU in 2024), which the LLM answer does not explicitly mention, slightly reducing completeness. However, the core facts, entities (QCOM, INTC, Pillar Two, 15%, fiscal 2025), and comparative reasoning are correct. All numbers (15%, fiscal 2025) are accurate. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 393,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes versus one vote for Class A, and the Class B shares can be converted into Class A shares at the holder’s option; as conversions occur, the remaining Class B holders retain a larger share of the total voting power, allowing the founder (who holds the bulk of Class B) to preserve a majority‑control position as long as he keeps a modest percentage of those shares 【page_81】. Comcast’s structure, by contrast, grants each Class B share fifteen votes but caps the aggregate voting power of all Class B shares at a non‑dilutable one‑third of the total voting power, fixing the founder’s influence at roughly 33 % regardless of new issuances 【page_91】. Thus, Alphabet’s conversion mechanism can amplify founder control to a majority, while Comcast’s non‑dilutable Class B rights provide a stable but minority block of voting power.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general contrast between Alphabet's and Comcast's dual-class structures and correctly identifies the core governance implications. However, there are significant quantitative inaccuracies that undermine factual correctness. First, the LLM incorrectly states that Comcast's Class B shares have 'fifteen votes' per share — the ground truth does not specify a per-share vote count, but rather that Class B holds a fixed 33⅓% of total voting power, which is non-dilutable. There is no evidence in the ground truth that this results from a 15:1 voting ratio, making this a factual error. Second, the LLM claims Alphabet's Class B shares 'can be converted into Class A shares at the holder’s option,' but the ground truth states that conversion happens automatically upon sale or transfer — a key distinction in control dynamics that the LLM misrepresents. The ground truth emphasizes that Alphabet’s control is 'dynamic' and can diminish with transfers, while the LLM suggests conversions enhance remaining founders' control, which mischaracterizes the mechanism. While the LLM correctly notes Alphabet’s 10:1 voting ratio and Comcast’s one-third non-dilutable control, the reasoning around how these structures affect founder control contains partial truths and some flawed logic. The conclusion that Alphabet’s structure can 'amplify' control is misleading — it doesn’t amplify beyond the 10:1 ratio, but rather maintains concentrated control as long as shares aren’t transferred. In contrast, Comcast’s fixed 33⅓% is accurately portrayed as stable. Despite these issues, the answer is contextually relevant and attempts correct multi-hop reasoning by comparing governance outcomes. Semantic equivalence is partially achieved, but key factual and mechanistic errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 490,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution agreement obligates PMI to indemnify Altria (and PM USA) for any tobacco‑product claims that stem from products PMI makes or contracts to make, so Altria carries essentially no recorded liability – the fair‑value of the indemnity is deemed insignificant【page_108】. In contrast, PMI retains the litigation risk on its own books: it booked a $194 million pre‑tax charge for the RBH judgment and continues to bear exposure to the Canadian cases that remain stayed under the CCAA deconsolidation of RBH【page_114】【page_113】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error in the quantitative claim that PMI booked a $194 million pre-tax charge for the RBH judgment. This figure does not appear in the ground truth and is not supported by the original answer, which only mentions reclassifications from accumulated other comprehensive losses related to RBH deconsolidation, not a specific charge. This undermines the quantitative accuracy. The entity relationships are partially correct: PMI does indemnify Altria and PM USA for liabilities related to PMI-manufactured products, and Altria has not recorded a liability due to the indemnification. However, the LLM incorrectly shifts focus to PMI bearing litigation risk and a specific charge, whereas the original answer emphasizes that PM (not PMI) retains obligations tied to RBH deconsolidation, involving reclassifications, not new litigation charges. The reasoning misattributes financial impacts to PMI instead of PM, breaking the multi-hop logic between Altria, PM USA, PM, and RBH. While the indemnification structure is correctly described in part, the synthesis of how this limits Altria’s exposure compared to PM’s retained obligations is flawed. The answer is contextually relevant and addresses the core question about financial exposure but fails in key factual and structural details. Semantic equivalence is partially achieved but undermined by the incorrect $194M charge and misassignment of liability to PMI.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 399,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan‑receivable allowance fell from $103 million in 2022 to $53 million in 2023 (page 84), and loan receivables are used to finance the sale of hardware, software and “technical support and advanced services” (page 82). The lower allowance signals better credit quality and frees up capital that can be used to sustain or expand its financing of technical‑support services at a lower cost. Adobe, by contrast, does not rely on loan financing; its technical‑support offerings are funded directly through subscription entitlements and annual maintenance‑fee contracts embedded in its SaaS and perpetual‑license revenue (page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, with no calculation errors. (2) The entity identification is correct—Cisco and Adobe are properly distinguished, and the relevant financial years (2022 and 2023) are correctly referenced. (3) The reasoning is sound: the LLM correctly infers that a lower allowance suggests improved credit quality and reduced risk, which can free up capital and lower financing costs for technical support services. It also accurately notes that Cisco uses loan receivables to finance technical support, citing the relevant product categories. (4) The comparison with Adobe is semantically equivalent to the original: Adobe funds technical support through subscription entitlements and maintenance fees, not loan receivables, and this is correctly highlighted. The only minor shortcoming is that the LLM does not explicitly mention the 1- to 3-year terms of Adobe’s maintenance programs, a small omission in completeness. However, the core funding mechanism is correctly described. The inclusion of page references (e.g., page 84, 82, 17) suggests fidelity to source material, though not required. Overall, the answer demonstrates strong multi-hop reasoning across companies and financial mechanisms, with excellent contextual relevance and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 408,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. is named as the administrative (or “agent”) for both facilities, but Boeing’s 2019 Five‑Year Credit Agreement also appoints JPMorgan Chase Bank, N.A. as syndication agent and lists both banks as joint lead arrangers, and the agreement was amended on August 25 2022 (Amendment No. 1) 【page_126†L1-L4】【page_126†L5-L7】. In contrast, Caterpillar’s 2022 5‑Year Credit Facility only identifies Citibank, N.A. as the agent and provides no syndication‑agent designation or amendment timeline in the disclosed exhibits 【page_128†L1-L4】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Citibank, N.A. as the administrative agent in both Caterpillar's 2022 and Boeing's 2019 credit agreements and accurately notes the August 25, 2022 date for Boeing's Amendment No. 1. However, it incorrectly states that Caterpillar's facility has 'no amendment timeline in the disclosed exhibits,' which contradicts the ground truth stating that Amendment No. 1 to Caterpillar's 5-Year Facility was dated August 31, 2023—within one year of the original agreement. This omission of a key factual date significantly undermines the quantitative and qualitative accuracy. Additionally, while the LLM correctly identifies JPMorgan Chase Bank, N.A.'s role in Boeing's syndication structure, it fails to mention MUFG Bank, Ltd.'s involvement in Caterpillar's syndication, instead claiming only Citibank is listed as agent with no syndication-agent designation—this misrepresents the structure. The ground truth confirms that Caterpillar’s syndication involved Citibank and MUFG Bank, Ltd. in agent roles, though without a dual lead arranger setup. Thus, the LLM omits a key entity and mischaracterizes the syndication structure. While the comparison framework is relevant and partially accurate, the missing amendment date for Caterpillar and incomplete syndication details result in partial correctness. Semantic equivalence is partially achieved but critical multi-hop elements (comparing amendment timelines and full syndication structures) are flawed due to omissions. Quantitative accuracy is moderate due to one correct date and one missing date; qualitative accuracy suffers from incomplete reasoning and entity representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 451,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "A prolonged conflict over Taiwan could cripple the wafer supply both firms depend on – NVIDIA states that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan,” which would have a material adverse impact on its business (NVDA 10‑K p. 35). Qualcomm, which is fabless and sources its chips from foundries largely located in Taiwan (and Korea), likewise flags that “geopolitical conflicts” pose a risk to its ability to obtain critical components, threatening the reliability of its supply chain (QCOM 10‑K p. 36).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the core risk to both NVIDIA and Qualcomm due to their reliance on Taiwanese foundries, citing each company's own risk disclosures from their 10-K filings. (2) There are no numerical values in the question or answers that require verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable but not deficient—no numbers are misstated. (3) The multi-hop reasoning is sound: the model connects the geopolitical risk involving Taiwan to both companies’ supply chain dependencies, synthesizing information from two separate firms and their respective disclosures. It correctly notes that both are fabless and depend on external foundries, particularly in Taiwan. (4) The LLM enhances the original answer by including specific page references (p. 35 for NVDA, p. 36 for QCOM) and direct quotes, improving sourcing without introducing error. Wording differs slightly but preserves and accurately conveys the meaning of the original answer. All entities (NVIDIA, Qualcomm, Taiwan, China, foundry partners) are correctly identified and contextually applied. The answer fully addresses the question about supply chain reliability and shared regional dependency.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 366,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing says that for some U.S. government contracts it may receive indemnification from the government, but its insurance “may not cover all claims or liabilities” and it could still be forced to bear substantial costs, especially for liabilities that fall outside U.S. SAFETY‑Act protection (see Boeing 10‑K p. 20). In contrast, 3M’s spin‑off agreement transferred PFAS‑related, Bair‑Hugger and Federal False‑Claims Act liabilities to Solventum, with Solventum expressly agreeing to “indemnify and defend the Company” for those actions, thereby removing those exposures from 3M’s balance sheet (see 3M 10‑K p. 85).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and context. (1) It accurately identifies Boeing's indemnification risk exposure related to U.S. government contracts and notes the limitations of insurance coverage, particularly outside SAFETY-Act protection, citing the correct page (p. 20) of Boeing’s 10-K. It also correctly states that 3M transferred specific liabilities—PFAS-related, Bair Hugger, and Federal False Claims Act—to Solventum in the spin-off, with Solventum assuming the obligation to indemnify and defend, citing 3M’s 10-K p. 85. (2) There are no numeric values, dates, or financial figures in the question or ground truth that require verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly contrasts Boeing’s ongoing risk exposure (not indemnified in full by the government) with 3M’s transferred liabilities post-spin-off. However, the LLM omits Boeing’s specific mention of pension cost allocations under CAS (Cost Accounting Standards), which is a key part of the original answer and central to Boeing’s indemnification risk. This is a minor but notable omission affecting qualitative accuracy. (4) The answer remains contextually relevant and semantically equivalent in intent and substance, though slightly less precise in capturing the full scope of Boeing’s exposure. The reference to SAFETY-Act is relevant but not directly tied to indemnification under government contracts as described in the ground truth. Overall, the answer is factually strong but misses a key technical detail in the multi-hop comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 450,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "CMCSA’s Class B stock is owned entirely by Brian L. Roberts and carries 15 votes per share, giving him roughly one‑third (33 ⅓ %) of the combined voting power and making that control essentially non‑dilutable (CMCSA p.33). META’s dual‑class structure works the same way: its Class B shares (10 votes per share) are held by Mark Zuckerberg and other insiders, who therefore control a majority of the voting power and render META a “controlled company,” limiting Class A shareholders’ ability to influence directors and other corporate matters (META p.49‑50). Thus, the concentration of voting power in a single holder in CMCSA illustrates the governance risk for META’s Class A stock – a small group can dominate decision‑making, reduce board independence and curb ordinary shareholders’ influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B stock is entirely owned by Brian L. Roberts, carries 15 votes per share, and represents 33⅓% of combined voting power. META's Class B shares carry 10 votes per share (not 15, correctly stated), and insiders like Mark Zuckerberg hold majority voting control, making META a 'controlled company'—this matches the original answer’s emphasis on outsized control. (2) Quantitative accuracy is perfect: percentages, vote ratios, and ownership structures are correctly reported without calculation errors. (3) The multi-hop reasoning is sound—LLM correctly draws a parallel between CMCSA’s concentrated voting structure and META’s dual-class system to highlight governance risks for Class A shareholders, even though the companies are unrelated. It synthesizes the implication that concentrated control limits influence of public shareholders, which is the core of the question. (4) Minor deduction in qualitative accuracy because the original answer includes the specific threshold (Class B must fall below 35% of voting power before control changes), which the LLM omits. However, the essence of the governance risk—dominance by insiders, reduced board independence, limited shareholder influence—is fully conveyed. Contextual relevance is perfect: the response directly addresses how CMCSA’s structure illustrates the risks in META’s governance model.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 403,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s bottling system relies on Arca Continental, which “has bottling and distribution operations in … northern Argentina” (KO 10‑K p. 7). Procter & Gamble explicitly flags Argentina as a market where it “has significant foreign‑exchange exposure” and faces translation‑ and transaction‑related impacts from peso volatility (PG 10‑K pp. 22‑23). Thus, both companies’ activities in the same region are tied to Argentine peso movements—Coca‑Cola’s distribution partner’s performance and pricing can be affected by the same currency risk that PG reports on its earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Coca-Cola's reliance on Arca Continental for distribution in northern Argentina and cites the correct source (KO 10-K p.7), and accurately notes Procter & Gamble's foreign exchange exposure in Argentina with reference to its 10-K (pp.22-23). (2) There are no numerical figures requiring calculation in this question, but the qualitative data (e.g., 'significant foreign-exchange exposure', 'peso volatility') are correctly reported and contextually precise. (3) The multi-hop reasoning is sound: it connects Coca-Cola’s indirect exposure via Arca Continental’s operations to P&G’s direct exposure through Argentine peso volatility, correctly synthesizing risks across two companies operating in the same country. (4) While the original answer includes the additional detail that Coca-Cola’s global unit case volume through bottlers includes a 17% share (with Arca contributing to that), this quantitative point is not essential to the core intersection of risk exposure in Argentina. The LLM captures the key conceptual overlap—shared vulnerability to Argentina’s currency and economic conditions—through different but logically equivalent reasoning. Wording differs but semantic meaning and factual content are substantially equivalent. Minor deduction in qualitative accuracy only for not referencing the broader context of Coca-Cola’s global bottler volume, which adds depth but does not alter the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 414,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Lilly warns that the loss of Alimta’s patent “will cause a rapid and severe decline in revenue for the product” because, as a non‑biologic small‑molecule drug, generic competitors can enter quickly under the Hatch‑Waxman framework (LLY p. 25). Amgen’s biologics, however, are shielded by the BPCIA’s 12‑year data‑exclusivity and a separate biosimilar approval pathway, so its patent‑related risk is tied to slower, uncertain biosimilar challenges and possible regulatory changes rather than an immediate revenue collapse (AMGN p. 45‑46). Thus, Alimta’s expiry threatens a sharp drop in Lilly’s oncology sales, whereas Amgen’s biologic exposure is more gradual and contingent on biosimilar‑specific regulatory dynamics.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies the rapid and severe revenue decline for Eli Lilly's Alimta due to generic competition post-patent expiry, contrasting it with Amgen's more gradual biosimilar exposure. The explanation of regulatory frameworks—Hatch-Waxman for small molecules and BPCIA for biologics—is accurate, including the 12-year data exclusivity for biologics. (2) There are no numerical values (e.g., years, percentages, dollar amounts) in the original or LLM answer that conflict; the mention of '12-year data-exclusivity' aligns with BPCIA standards and is correctly attributed. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Lilly and Amgen), two drug types (small molecule vs. biologic), and two regulatory pathways (Hatch-Waxman vs. BPCIA), correctly drawing a comparative conclusion about the speed and severity of revenue impact. (4) The LLM cites specific page references (LLY p.25; AMGN pp.45–46), indicating proper sourcing from the filings, and uses terminology ('umbrella exclusivity' implied via 'uncertain biosimilar challenges') consistent with the regulatory complexities mentioned in the original. Wording differs but meaning is preserved. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 374,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel says that because it has no material operations in jurisdictions whose statutory rates fall below the 15 % Pillar‑Two floor, the OECD’s Pillar‑Two model rules are not expected to materially raise its global tax cost, and its non‑U.S. tax benefit—driven by a higher proportion of income taxed abroad—should remain largely intact【page_44】. Microsoft, however, notes that a significant share of its operating income is earned outside the United States and that changes in international tax law, including the global minimum‑tax regime, could increase its effective tax rate and erode its foreign tax advantages, making its exposure to the minimum‑tax rules greater than Intel’s【page_31】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual reversal: it states that Intel has no material operations in jurisdictions below the 15% Pillar Two floor and thus will not face a material tax increase, which contradicts the ground truth that Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions and that it is actively evaluating the impact of Pillar Two—implying potential exposure. Conversely, the LLM claims Microsoft expects increased exposure and erosion of tax advantages, while the ground truth states Microsoft does not expect a material increase in tax costs due to limited operations in low-rate jurisdictions. This inversion of both companies' positions severely undermines factual correctness. (2) Quantitatively, the 15% Pillar Two floor is correctly cited, and no other numbers (dates, dollar amounts) are present, so numerical accuracy is acceptable. (3) The multi-hop reasoning is structurally sound—comparing two companies' exposure to Pillar Two based on international tax strategies—but the synthesis is based on incorrect attributions, leading to a flawed conclusion. (4) Contextual relevance is fair, as the answer addresses the right topic and cites relevant concepts (non-US income, tax benefits, Pillar Two), but the misrepresentation of each company's stance reduces its validity. The answer appears well-sourced with page references but conveys the opposite of the ground truth, likely due to hallucination or misattribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 416,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "KO’s 2024 transfer of $523 million of surplus international pension assets out of the pension trusts and into the Company’s general assets shrinks the pool of plan assets that include “real‑estate and other commingled funds” – which the footnote identifies as investments in limited partnerships and private‑credit funds – thus reducing KO’s exposure to limited‑partnership holdings【page_43】. By contrast, PepsiCo’s pension plan still reports “real‑estate and other commingled funds measured at net asset value” that contain limited‑partnership investments and its investment strategy explicitly includes limited‑partnership vehicles, indicating PEP maintains its exposure to such partnerships【page_99】【page_101】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $523 million transfer by KO in 2024 is accurately cited, and the characterization of PEP's ongoing use of limited partnerships is consistent with the original. Number format ($523 million) matches, and no calculations were required. (2) The answer correctly identifies both companies (KO and PEP), the correct year (2024), and the relevant financial action (transfer of surplus pension assets). (3) The reasoning is sound: it explains that removing assets from pension trusts reduces exposure to investment vehicles like limited partnerships, which are embedded in 'real-estate and other commingled funds'—a detail supported by KO’s filing. It contrasts this with PEP’s continued inclusion of such funds, citing their 10-K language about net asset value reporting and investment strategy. (4) The only minor shortcoming is that the LLM does not explicitly name NEE as a reference point for pension strategy (as in the ground truth), but this is not essential to answering the KO vs PEP comparison. The core multi-hop synthesis—KO reducing exposure via asset transfer vs PEP maintaining it—is correctly executed. Wording differs slightly but maintains semantic equivalence. No factual errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 369,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion rise in income from continuing operations in 2021 was “primarily attributable to … higher revenues” that the company can sustain while its products remain protected by patents and other exclusivity rights (see page 36). Patents are described as “a key determinant of market exclusivity” and, for biologics, U.S. law provides a 12‑year data‑protection period that prevents biosimilar approval until that time (see pages 9‑10); Eli Lilly therefore leans on this 12‑year biologic data protection to keep revenue flowing after its patents expire. Both firms’ financial performance therefore hinges on the ability of patent and regulatory exclusivity mechanisms to preserve sales once a product’s patent term ends.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020, which matches the ground truth in both amount and direction. This satisfies quantitative accuracy. However, the LLM misattributes the primary cause of the increase to 'higher revenues' based on page 36, while the ground truth clarifies it was 'partly due to lower asset impairment charges and higher net gains on equity securities'—not primarily revenue growth. This is a significant qualitative inaccuracy in reasoning. (2) All numbers and timeframes are correct: $17.3 billion, 12-year U.S. biologic data protection period. No calculation errors. (3) The multi-hop reasoning partially succeeds: it connects PFE’s financial performance to patent rights and correctly links LLY’s reliance on 12-year data protection under U.S. law. However, it fails to clearly distinguish that PFE’s 2021 gain was not mainly driven by product exclusivity or sales from patented drugs, weakening the causal link implied. The synthesis overstates the role of patent-driven revenues for PFE in this specific increase. (4) Despite the reasoning flaw, the answer remains contextually relevant by addressing the relationship between financial performance and exclusivity mechanisms, and correctly explaining LLY’s use of data protection. The core entities (PFE, LLY, 2021 vs 2020, 12-year protection) are accurate. Thus, correctness is reduced to 7 due to incorrect causal attribution, though numbers and conceptual framework are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 427,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 filing shows that Hulu pays ESPN (and other Entertainment linear‑network businesses) a fee for the right to carry ESPN’s channels on Hulu Live; this inter‑segment fee is listed under “Eliminations” and is removed from total consolidated revenue. The $8.6 billion Comcast received in November 2023 was a one‑time purchase of its remaining Hulu equity (plus a 50 % share of future tax benefits) and is unrelated to the ongoing ESPN‑Hulu revenue‑sharing arrangement.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct factual elements but fails in multi-hop reasoning, leading to a significant conceptual error. (1) Quantitatively, the $8.6 billion figure and November 2023 timing are accurate, and the mention of inter-segment fees being eliminated in consolidation aligns with Disney's reporting practices. The format and numbers are consistent with the ground truth. (2) However, the key error lies in stating that the $8.6 billion payment is 'unrelated' to the ESPN-Hulu revenue-sharing arrangement. This contradicts the ground truth, which correctly identifies that the ongoing revenue streams—such as ESPN’s licensing fees—contribute to Hulu’s valuation and thus underpinned the economic value of Comcast’s stake. The put option exercise and resulting $8.6 billion payment were based on Hulu’s equity value, which is influenced by its content cost structure and revenue model, including payments to Disney entities like ESPN. (3) The LLM fails the multi-hop synthesis: it correctly identifies two facts (ESPN receives fees from Hulu; Comcast was paid $8.6B for its stake) but incorrectly concludes they are unrelated, when the ground truth establishes a causal financial link—ESPN’s revenue share contributes to Hulu’s operating costs and content value, which affects overall platform valuation. (4) Therefore, while entities, numbers, and surface-level context are accurate, the reasoning is flawed, resulting in a partially correct answer that misses the core relationship the question asks about. This justifies a low correctness score despite strong quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 437,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "Coca‑Cola applies its financial assumptions (discount rate, risk‑free rate, expected volatility, dividend yield and expected term) to equity‑based compensation – stock options, performance‑share units and restricted stock – and records the resulting expense on a straight‑line basis over the awards’ vesting periods (generally 2‑4 years) or, for unvested awards, over a weighted‑average 1.7‑year horizon (KO 10‑K, pp. 94‑97).  \nMondelez, by contrast, uses assumptions such as discount rates, health‑care cost‑trend rates, ultimate trend rates and the year the trend is reached to value its post‑retirement pension and health‑care obligations, recognizing the cost as service and interest expense each year and projecting payments out to the ultimate‑trend years of 2031 (U.S.) and 2040 (non‑U.S.) (MDLZ 10‑K, pp. 106‑107).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that KO applies financial assumptions to equity-based compensation (stock options, PSUs, restricted stock) and expenses them over vesting periods (2–4 years), which matches the ground truth’s mention of a typical four-year vesting period and straight-line expensing. The LLM adds more granularity (e.g., weighted-average 1.7-year horizon for unvested awards), which is consistent with KO’s 10-K disclosures but not contradicted by the ground truth. (2) For MDLZ, the LLM accurately states that assumptions are used for postretirement pension and healthcare obligations, with annual recognition of service and interest costs, and includes specific forward-looking trend years (2031 U.S., 2040 non-U.S.), which are correct per MDLZ’s 10-K. These dates are not in the ground truth but are factually accurate and enhance completeness. (3) The multi-hop reasoning is sound: the LLM correctly contrasts KO’s use of assumptions for equity awards with fixed vesting periods versus MDLZ’s use for long-term actuarial liabilities recalculated annually. (4) Minor difference: the ground truth specifies KO uses Black-Scholes-Merton model; the LLM doesn’t name the model but correctly lists the inputs (volatility, expected term, etc.), implying its use. This omission is minor given the focus on assumptions and instruments. All entities (KO, MDLZ), instruments, and timeframes are correct. Quantitative accuracy is high—no errors in numbers or dates. Contextual relevance is perfect. Thus, the answer earns a 9 for correctness due to slight over-specification (e.g., 1.7-year horizon) not in the ground truth, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 467,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Enbrel’s core U.S. patents on the fusion‑protein composition and its manufacturing methods expire in Nov 2028 and Apr 2029, with a formulation patent lasting until Oct 2037 (AbbVie 10‑K, p. 11). When those dates lapse, generic competition could erode the drug’s sales that contribute to Pfizer’s international (ROW) revenue (Pfizer 10‑K, p. 9), but AbbVie’s practice of seeking patent‑term restoration under the Hatch‑Waxman Act and securing additional regulatory exclusivities can extend the effective protection beyond the listed expirations, thereby delaying any revenue decline for Pfizer abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the expiration dates for Enbrel's patents are correctly cited: fusion-protein composition (Nov 2028), manufacturing methods (Apr 2029), and formulation (Oct 2037), which matches the broader timeline in the original answer (2028–2037). While the original answer does not specify exact months, the LLM adds precision from the 10-K, which is acceptable and enhances accuracy. (2) The LLM correctly identifies AbbVie’s use of patent-term restoration under the Hatch-Waxman Act and regulatory exclusivity to extend protection—key elements of the strategy mentioned in the ground truth. (3) Entity accuracy is strong: AbbVie (patent holder) and Pfizer (ex-U.S./Canada marketer) are correctly attributed, and the reference to international (ROW) revenue reflects the correct commercial arrangement. (4) Multi-hop reasoning is sound: the model connects patent expirations → biosimilar risk → impact on Pfizer’s international revenue → AbbVie’s legal strategy to delay competition. The only minor shortcoming is that the original answer emphasizes the *international* extension of exclusivity due to U.S.-influenced strategies, while the LLM focuses on the U.S. patents and implies international impact without elaborating on cross-jurisdictional dynamics. However, the core logic and facts are correct, and the conclusion about delayed revenue decline is valid. Thus, the answer earns a 9 for correctness—excellent but not perfect in fully explicating the international extension mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 430,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity stress tests explicitly model “early contract‑holder and policy‑holder withdrawal” scenarios and, if those scenarios generate cash shortfalls, the company’s contingency plan calls on “global funding sources including commercial paper and various credit and committed facilities” (MET 10‑K p. 123). Capital One’s Liquidity Framework, by contrast, stresses maintaining a “sizable liquidity reserve comprised of cash, high‑quality unencumbered securities and committed collateralized credit lines” and accesses “secured and unsecured debt markets” as part of a diversified funding mix, rather than relying heavily on commercial‑paper funding (COF 10‑K p. 96). Thus MetLife’s approach makes commercial‑paper markets a key back‑stop under stress, whereas Capital One’s approach leans on diversified sources and large reserves to meet liquidity needs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: MET's stress testing includes early policyholder withdrawal scenarios and triggers reliance on global funding sources like commercial paper and credit facilities, as cited from MET’s 10-K (p. 123). COF’s framework emphasizes diversified funding and a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines, per COF 10-K (p. 96). These details match the original answer’s substance. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MET and COF), compares their liquidity strategies, and links MET’s policyholder withdrawal risk to its reliance on commercial paper, while contrasting COF’s reserve-based, diversified approach. The reference to AIG in the original answer is extraneous and not required for correctness—the LLM answer remains complete without it. (4) Semantic equivalence is strong: though the LLM uses slightly different phrasing (e.g., 'contract-holder' vs 'policy-holder', 'contingency plan' vs 'adjusts asset mix'), the meaning is consistent with the ground truth. The only minor gap is that the LLM does not mention MET’s use of rolling 12-month forecasts or asset maturity adjustments, which are part of its proactive liquidity management. However, this omission does not undermine the core comparison on stress testing and funding source reliance. Overall, the answer is contextually relevant, factually correct, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 475,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose a roll‑forward of the confirmed obligations. GE adopted the standard on 1 Jan 2023 and, as the ASU specifies, began providing the roll‑forward prospectively in 2024 (see GE 10‑K p. 57‑57). Caterpillar already presents a roll‑forward of its supplier‑finance obligations in Note 19 (beginning‑of‑period balance, invoices confirmed, invoices paid and end‑of‑period balance – see CAT 10‑K p. 111‑112). Thus, for 2024 the two companies now disclose comparable supplier‑finance data, but because GE’s roll‑forward was only required starting in 2024, its prior‑year disclosures lack this detail, limiting period‑to‑period comparability with Caterpillar’s historical disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ASU 2022-04 mandates roll-forward disclosures for supplier finance obligations and that GE adopted the standard on January 1, 2023, with prospective application of the roll-forward requirement starting in 2024. It accurately references Caterpillar's (CAT) existing roll-forward disclosure in its 2024 10-K (Note 19, pages 111-112), including the structure of the roll-forward (beginning balance, invoices confirmed, paid, ending balance). While the original answer mentions CAT’s year-end 2024 obligation of $830 million, the LLM answer omits this specific number but still correctly conveys that CAT provides a full roll-forward, which supports comparability. This omission is minor and does not affect the core conclusion. (2) All dates and adoption timelines are accurate: GE’s adoption date (Jan 1, 2023) and implementation of roll-forward in 2024 align with the ground truth. Page references in the LLM answer contain a minor error (citing GE 10-K p.57-57 instead of p.47 as in ground truth), but this does not impact factual correctness. No calculations are required, and all entities (ASU 2022-04, GE, CAT, supplier finance obligations) are correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes information across GE’s and CAT’s 10-Ks and correctly infers that the adoption of ASU 2022-04 enhances comparability in 2024 due to standardized roll-forward disclosures, while noting that GE’s prior-year data lacks this detail, which limits historical comparability. This adds analytical depth beyond the original answer. (4) The LLM answer is semantically equivalent in substance, with slightly more emphasis on the limitation in period-to-period comparability. The omission of the $830 million figure prevents a perfect score, but the overall factual accuracy, reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 511,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ classifies exchange‑traded commodity futures as Level 1 assets and values them at fair value using the quoted market price on the commodity exchange. PepsiCo, however, treats exchange‑traded commodity futures as cash‑settled each day, so they are not recorded as assets or liabilities in its fair‑value tables and are excluded from the Level 1 measurement. This means MDLZ relies on a market‑price valuation, while PEP’s daily settlement removes the need to report them as separate fair‑value items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued using quoted market prices, while PEP excludes them from fair value hierarchy tables due to daily cash settlement. All entities (MDLZ, PEP, Level 1, exchange-traded commodity futures) are correctly identified. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a problematic sense—no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly contrasts MDLZ’s valuation methodology with PEP’s exclusion based on settlement practices, synthesizing accounting treatments across two companies. (4) The only minor shortcoming is a slight simplification in phrasing—'removes the need to report them as separate fair-value items' is slightly less precise than the original answer’s emphasis on balance sheet reporting and operational distinctions—but the semantic meaning remains intact. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 337,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "CMCSA’s capital structure has two classes: Class A shares carry one vote each, while each Class B share carries 15 votes, giving the single Class B holder roughly one‑third of the total voting power (CMCSA 10‑K, page_31). Meta also uses a dual‑class system, issuing Class A shares with one vote per share and Class B shares with ten votes per share, concentrating voting control with its founders (Meta 10‑K, page_1). Thus both companies grant disproportionate voting power to a small class of shares, but the vote‑weighting differs (15‑to‑1 at Comcast versus 10‑to‑1 at Meta).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that both CMCSA and META have dual-class share structures with disproportionate voting rights, and it accurately states that CMCSA's Class B shares have 15 votes per share and hold about one-third of voting power. However, it incorrectly claims that META's Class B shares have 10 votes per share, which is not supported by the ground truth; the original answer explicitly states that the exact vote ratio per share for META is not disclosed. This is a significant quantitative error. Additionally, the LLM answer omits key information from the ground truth: CMCSA’s Class A holds 66 2/3% and Class B 33 1/3% of voting power, and META had 343,761,117 Class B shares outstanding as of January 24, 2025—details that are relevant for a full comparison. While the reasoning framework is sound—comparing vote ratios and control concentration—the use of an incorrect vote ratio for META undermines the accuracy. The answer is contextually relevant and captures the structural similarity between the two companies, but the false specificity on META’s 10-to-1 ratio reduces factual reliability. Semantic equivalence is partially achieved but fails on critical numeric points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 336,
        "total_tokens": 1595
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "AIG treats its CLO holdings as **Level 3 fixed‑maturity securities AFS** and evaluates credit loss under the CECL model – it projects cash‑flows using historic performance, delinquency, default, loss‑severity and pre‑payment assumptions and, when a fair‑value decline is credit‑related, records an allowance for credit losses; any fair‑value shortfall that is not credit‑related is shown as **unrealized appreciation/depreciation in OCI** (Note 11, p. 128‑129).  \n\nMetLife also places CLOs in its **structured‑product portfolio** and uses an allowance‑for‑credit‑losses approach (including a “purchased‑credit‑deteriorated” method that adds the allowance to the purchase price) with the same inputs (delinquency, default, loss severity, pre‑payment, structural features) (Note 10, p. 130‑131), but **unrealized gains or losses on those securities are recognized directly in earnings** via the “unrealized net gains (losses) recognized in earnings” line of its Net Investment Gains table (p. 225).  \n\nThus, while both firms use similar credit‑loss modeling for CLOs, AIG records non‑credit unrealized losses in OCI, whereas MetLife records all unrealized CLO losses in net investment income.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in its qualitative characterization of MetLife's credit loss evaluation methodology and unrealized loss recognition, despite correctly identifying some structural elements. (1) The claim that MetLife uses 'the same inputs (delinquency, default, loss severity, pre-payment, structural features)' and an allowance-for-credit-losses approach with a 'purchased-credit-deteriorated method' for CLOs is not supported by the ground truth, which states that MetLife does not disclose detailed cash flow modeling and emphasizes its passive investor status with exposure limited to carrying amounts. This contradicts the implication of active modeling similar to AIG. (2) The assertion that MetLife recognizes all unrealized CLO losses in earnings via 'unrealized net gains (losses) recognized in earnings' is incorrect; the ground truth makes no such claim and instead highlights MetLife’s focus on structural protection and limited involvement, without specifying recognition in earnings. AIG’s split between credit (allowance) and non-credit (OCI) components is accurately described. (3) The LLM incorrectly implies methodological similarity in credit loss modeling, while the ground truth emphasizes a key difference: AIG uses detailed CECL-based cash flow projections, whereas MetLife does not appear to disclose such modeling. (4) Quantitative accuracy is high in terms of correct referencing of accounting frameworks (CECL, AFS, OCI) and portfolio classification, but the cited page numbers and note references (e.g., Note 10, p.130-131) cannot be verified and may be fabricated, slightly reducing confidence. (5) Multi-hop reasoning is partially sound—linking CLO holdings to accounting treatment—but fails in comparative synthesis by overstating similarities. Overall, while the answer reflects plausible financial reporting language, it misrepresents MetLife’s approach, leading to a significant drop in correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 534,
        "total_tokens": 2068
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The IRA’s redesign of Medicare Part D pushes a greater share of drug‑cost risk onto manufacturers and health‑plan sponsors, creating new volatility in the cost base that CVS must model; consequently CVS says it may be less able to accurately anticipate, detect and price for medical‑cost trends. For Bristol‑Myers Squibb, the redesign adds mandatory discounts and inflation‑penalty rebates to Part D, so its gross‑to‑net U.S. rebate accruals for the program become larger and far more judgment‑intensive, requiring extensive assumptions and audit scrutiny.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the IRA shifts more drug-cost risk to manufacturers (like BMY) and health-plan sponsors (impacting CVS), increasing rebate obligations and forecasting uncertainty. The mention of mandatory discounts, inflation-penalty rebates, and judgment-intensive accruals aligns with the increased gross-to-net rebate accruals for BMY starting in 2025. For CVS, the answer correctly identifies heightened difficulty in forecasting medical cost trends due to new cost-sharing dynamics. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer beyond '2025' in the original, which the LLM does not explicitly mention but implies through context. Since the LLM answer does not state or imply an incorrect date, and the 2025 effective date is not central to the qualitative mechanism described, this omission does not materially affect correctness. (3) Multi-hop reasoning is sound: the model correctly links IRA provisions → manufacturer liability (BMY rebate accruals) and → health plan cost uncertainty (CVS forecasting challenges), synthesizing impacts across two companies and financial reporting domains. (4) Semantic equivalence is strong; the LLM uses slightly different phrasing (e.g., 'judgment-intensive', 'audit scrutiny') but accurately reflects the increased complexity and uncertainty in financial reporting and forecasting. One minor point preventing a perfect 10 is the absence of explicit reference to the 'catastrophic phase' cost shift, a specific mechanism in the IRA redesign, though the overall effect is correctly described. Thus, the answer is excellent in contextual relevance, quantitative accuracy (no incorrect numbers), and qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 492,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase’s GSIB status forces it to hold a Stress Capital Buffer of roughly 5.4 % of CET1, which together with a 3 % GSIB surcharge (and a zero CCyB) creates an 8.4 % total regulatory buffer that must sit above the minimum risk‑based ratios; any breach of that buffer triggers the firm’s dividend‑ and share‑repurchase restrictions (see pages 134 & 22). Charles Schwab’s banking subsidiary, by contrast, is only required to keep a 2.5 % Capital‑Conservation Buffer (no GSIB surcharge), so the capital that must be retained is smaller and the distribution limits are correspondingly less stringent, although a shortfall would still impose limits (see page 122).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core conceptual distinction between JPMorgan Chase's dynamic Stress Capital Buffer (SCB) and Charles Schwab's static Capital Conservation Buffer (CCB), correctly identifying that JPMorgan faces more complex and variable capital constraints due to its GSIB status, stress testing, and additional surcharges. The qualitative reasoning is sound: it correctly notes that breaches trigger distribution limits for both, and that Schwab’s requirements are less stringent. However, the quantitative accuracy is problematic. The LLM states JPMorgan’s SCB is 'roughly 5.4%' and the GSIB surcharge is '3%', resulting in an '8.4% total regulatory buffer'. The ground truth does not specify exact percentages (especially not 5.4% or 3%), nor does it confirm a zero CCyB. These precise figures are not supported by the original answer and appear to be fabricated or over-specified. While the general structure of multiple buffers (SCB + GSIB + CCyB) is correct, inserting specific unverified percentages reduces factual accuracy. Additionally, the original answer emphasizes the *dynamic vs. static* nature of the buffers as the key differentiator, which the LLM downplays in favor of quantitative comparison. The mention of 'pages 134 & 22' and 'page 122' suggests source references not present in the ground truth, raising concerns about hallucination. Despite these issues, the LLM correctly identifies the entities (JPMorgan Chase, Charles Schwab Bank), regulatory mechanisms (SCB, CCB, GSIB surcharge), and their implications for capital distributions. The answer is contextually relevant and synthesizes multi-hop concepts (regulatory buffers → capital constraints → distribution limits), but the unsupported numbers prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 476,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics treats the state‑and‑local income taxes that are tied to its FAR‑regulated U.S. government contracts as ordinary operating costs – they are recorded in earnings and are **not** part of the company’s income‑tax provision (see GD 10‑K p. 66). Raytheon Technologies, by contrast, records state income taxes in its income‑tax expense, but because its contracts are subject to the FAR’s cost‑allowability rules, those taxes are normally **recoverable** through contract pricing and are allocated to contracts as SG&A when paid (see RTX 10‑K p. 78‑79). Thus GD bears the tax expense directly with no separate provision, while RTX incurs a tax expense that it can offset by recovering the taxes from the government under FAR‑governed pricing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes on U.S. government contracts from its tax provision and instead treats them as operating expenses, citing FAR regulations and referencing the correct page (p. 66) in GD's 10-K. Raytheon Technologies is accurately described as recording these taxes in income tax expense but recovering them through FAR-allowable cost mechanisms, with reference to pages 78–79 of RTX’s 10-K. (2) There are no numerical figures in this question, so quantitative accuracy is not applicable in terms of calculations or dollar amounts; however, the textual references to document pages are correct and support the claims, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, their differing accounting treatments, and the role of FAR in cost allowability and pricing—correctly concluding that GD bears the expense directly while RTX recovers it. The only minor shortcoming is a slight simplification in framing RTX's 'recovery' mechanism without fully elaborating on performance-based or progress payment structures mentioned in the original, but this does not undermine the core accuracy. (4) The answer is contextually precise, directly addressing the comparative financial exposure question and leveraging regulatory and contractual frameworks appropriately. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to near-perfect factual alignment and reasoning, with only negligible depth differences from the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 448,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "META’s dual‑class system gives each Class B share ten votes while each Class A share carries one vote, and the $0.50‑per‑share cash dividend announced in February 2024 is paid on an equal‑per‑share basis to both classes (META 10‑K p.56‑57). Alphabet’s structure is similar in that Class B shares also have ten votes per share, but the charter requires them to convert automatically to one‑vote Class A shares on any sale or transfer, so voting power stays with insiders and public shareholders hold only one‑vote Class A (and non‑voting Class C) stock (GOOGL 10‑K p.81).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the number of votes per Class B share for META: it states 'ten votes' whereas the ground truth specifies '15 votes'. This is a major quantitative inaccuracy. All other numbers—$0.50 per share dividend, February 2024 initiation, 10 votes for GOOGL Class B—are correct. (2) The dividend amount and timing are accurate and correctly attributed to both classes receiving equal treatment post-2024, which aligns with the ground truth. However, the omission of META’s Class B having a non-dilutable 33 1/3% aggregate voting power—a key structural feature—is a significant omission that affects completeness and understanding of founder control mechanics. (3) The reasoning around GOOGL’s automatic conversion upon transfer is correctly understood and contrasted with META’s voluntary conversion (subject to restrictions), showing sound multi-hop synthesis between the two companies’ structures. The LLM correctly identifies that GOOGL’s mechanism ensures voting power remains with insiders, which reflects good qualitative reasoning. (4) Contextual relevance is high as the response directly addresses the comparison of dual-class structures and dividend policies. However, due to the incorrect vote count for META Class B shares and missing non-dilutable voting power percentage, the correctness score is reduced to 6. Quantitative accuracy is penalized heavily (score 5) due to the vote count error, while qualitative accuracy (7) reflects otherwise solid reasoning and entity identification. Contextual relevance is strong (9) as all core aspects of the question are addressed, albeit with inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 455,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both companies set their VaR at the 95 % confidence level, meaning the loss figure they report is the amount that would be exceeded only 5 % of the time over a one‑day horizon under normal market conditions. Using a parametric delta‑gamma approximation, they translate first‑ and second‑order sensitivities of interest‑rate, currency and commodity movements into a return distribution, and then compute the one‑day loss that corresponds to the 95 % confidence bound – for Philip Morris this yields a fair‑value VaR for its interest‑rate‑ and foreign‑currency‑sensitive derivatives, and for Mondelez it yields a pre‑tax‑earnings VaR for its currency and commodity exposures. (PM 10‑K p. 77; MDLZ 10‑K p. 66)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key elements are correct: both companies use a 95% confidence interval for one-day VaR under normal market conditions, and the parametric delta-gamma approximation is correctly identified. The confidence level, time horizon, and modeling technique are all accurately represented. (2) The LLM correctly identifies that Philip Morris applies the model to interest-rate- and foreign-currency-sensitive derivatives (fair-value VaR), while Mondelez applies it to currency and commodity exposures (pre-tax earnings VaR), which matches the original answer’s emphasis on differing scopes (PM excludes anticipated transactions; MDLZ includes commodities and notes non-linearity of options). (3) The multi-hop reasoning is sound—synthesizing shared methodology (parametric delta-gamma, 95% confidence) across two firms while distinguishing their application contexts. (4) The only minor omission is that the LLM does not explicitly state the limitation of the model during market stress or the exclusion of anticipated transactions by PM, which is present in the original answer. However, the core technical and comparative insights are preserved with high fidelity. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness—excellent but not fully complete on contextual caveats.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 388,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO‑related embedded derivatives are confined to VIEs with a **maximum loss exposure of about $62 million in 2024** (MS p. 128) and are largely non‑recourse, with the firm’s overall net derivative liabilities that have credit‑contingent features limited to **$22.4 billion and backed by posted collateral** (MS p. 107). By contrast, Bank of America’s structured liabilities are recorded as **fair‑value long‑term debt of roughly $283 billion** (BAC p. 165) and contain embedded derivatives whose **market‑making gains and losses** (BAC p. 164) directly reflect credit‑event risk, making the exposure materially larger and more directly tied to its trading activities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific quantitative figures not present in the original answer (ground truth), such as Morgan Stanley's $62 million exposure and $22.4 billion derivative liabilities, and Bank of America's $283 billion fair-value long-term debt. These numbers, while possibly accurate in context, are not part of the provided ground truth and cannot be verified against it. Since the original answer does not include any numerical data, the inclusion of such specifics creates a mismatch in factual alignment, undermining quantitative accuracy. The LLM also cites page numbers (e.g., MS p. 128, BAC p. 165), which are not referenced or verifiable in the ground truth, suggesting potential hallucination or external sourcing. Qualitatively, the LLM captures the general idea that both firms have embedded derivatives tied to credit events and market-making, and that Morgan Stanley’s risk is linked to reference entities in CDOs while Bank of America’s is tied to structured liabilities and hedging—this aligns with the original answer’s reasoning. However, the LLM overemphasizes collateral and non-recourse structures not mentioned in the ground truth, and frames the comparison around scale of exposure ($62M vs $283B), which shifts focus from the original’s emphasis on risk mechanism and hedging dynamics. The multi-hop synthesis is partially sound—linking CDOs to credit event risk and structured liabilities to market-making—but the reasoning is skewed by unsupported numbers. Contextually, the answer remains relevant to the question about comparative risk exposure in market-making contexts, but the added precision is misleading without grounding. Thus, while the conceptual framework is partially correct, the introduction of unverified quantitative data significantly reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 490,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce says the OECD Pillar‑Two 15 % global minimum tax “is not expected to materially increase our global tax costs” because it has no material operations in jurisdictions with rates below the floor, so its effective tax rate should remain essentially unchanged【page_75】. Microsoft, by contrast, notes that Pillar Two will begin to apply to its worldwide earnings in fiscal 2025 and could raise its tax expense, but it does not yet quantify a material impact and stresses that the final rules and timing of adoption remain uncertain【page_47】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces a significant factual discrepancy regarding Salesforce's position. The original answer states that Salesforce acknowledges the *potential* for a material impact due to OECD Pillar Two, reflecting uncertainty. However, the LLM answer claims Salesforce 'is not expected to materially increase our global tax costs' and that its effective tax rate will 'remain essentially unchanged,' which contradicts the cautious, uncertain tone of the ground truth and overstates confidence. This misrepresents Salesforce’s actual disclosure. For Microsoft, the LLM correctly notes Pillar Two applies starting fiscal 2025 and that no material impact is currently estimated, aligning with the original answer. (2) Quantitatively, the LLM omits Microsoft’s actual effective tax rates (19%, down to 18% in fiscal 2024) mentioned in the original answer, which are relevant for comparison. While it correctly identifies fiscal 2025 as the start date for Microsoft, it fails to include these key metrics, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound—comparing Salesforce and Microsoft’s exposure to Pillar Two—but the synthesis is flawed because it incorrectly contrasts Salesforce’s alleged lack of exposure with Microsoft’s, whereas the original answer emphasizes uncertainty for both, with Microsoft having a clearer timeline but still no material expected impact. (4) Contextual relevance is high because the answer addresses the core issue—Pillar Two’s impact on tax rates for both companies—and references jurisdictional adoption uncertainty. However, the incorrect characterization of Salesforce’s position and omission of key quantitative data reduce correctness, qualitative, and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 492,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit agreement names **JPMorgan Chase Bank, N.A. as the sole syndication agent**, with **Citibank, N.A. serving as administrative agent and, together with JPMorgan, as joint lead arranger and book‑manager**【page_125】.  \nHoneywell’s credit facilities (both the 364‑day and the amended five‑year agreements) list **JPMorgan Chase Bank, N.A. as one of two syndication agents – the other being Wells Fargo Bank, N.A. – while Bank of America, N.A. acts as the administrative (and swing‑line) agent**【page_125】.  \n\nThus, Boeing relies on a single‑agent syndication structure with Citibank as the key partner, whereas Honeywell uses a co‑syndication structure with JPMorgan and Wells Fargo, and its primary banking partner is Bank of America.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All entities are correctly identified: Boeing's agreement correctly names JPMorgan Chase Bank, N.A. as syndication agent and Citibank, N.A. as administrative agent and joint lead arranger/book manager. Honeywell's agreement accurately lists JPMorgan and Wells Fargo as co-syndication agents and Bank of America, N.A. as administrative and swing line agent. (2) No numeric values (dates, amounts) are incorrect—though the LLM omits the exact dates (October 30, 2019, and March 20, 2023), these were not critical to the comparison asked. The focus was on syndication structure and key partners, which are correctly detailed. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective credit agreements, identifying both the common role of JPMorgan and the structural differences (sole vs. co-syndication agents, different lead banks). (4) The only minor shortcoming is the claim that JPMorgan is the 'sole syndication agent' for Boeing—while technically accurate, the original answer notes both JPMorgan and Citibank serve as joint lead arrangers and book managers, implying a shared leadership role beyond syndication. The LLM slightly underrepresents Citibank’s co-equal role in arrangement, but does not misstate facts. Wording differences (e.g., 'single-agent syndication' vs 'co-syndication') are semantically valid. Overall, the answer is factually correct, well-structured, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 425,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Both banks’ Advanced‑Approach buffer is simply the 2.5 % capital‑conservation buffer plus the 2.5 % G‑SIB surcharge, because the counter‑cyclical capital buffer is set at zero (see Bank of America’s note that “the countercyclical capital buffer was zero” and the same statement for Morgan Stanley【page_146】,【page_135】). Consequently, each firm must hold a total capital‑buffer of 5.0 % of risk‑weighted assets under the Advanced Approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the absence of the Countercyclical Capital Buffer (CCyB) results in a total CET1 capital buffer of 5.0% for both Bank of America and Morgan Stanley under the Advanced Approaches framework, composed of a 2.5% Capital Conservation Buffer and a 2.5% G-SIB surcharge. This matches the ground truth in both structure and numerical accuracy. (2) Quantitatively, all percentages are correct: 2.5% + 2.5% = 5.0%, and the CCyB is correctly stated as zero, consistent with the original answer. The LLM supports its claim with specific document references (page_146 for Bank of America, page_135 for Morgan Stanley), which strengthens factual grounding. (3) The multi-hop reasoning is sound: the model correctly synthesizes the regulatory components (G-SIB surcharge, Capital Conservation Buffer, and CCyB) across both banks and applies the absence of CCyB to reduce total buffer requirements. However, the original answer notes that Morgan Stanley’s G-SIB surcharge is 'not quantified in the provided data but assumed to be included,' while the LLM assumes it is exactly 2.5% like Bank of America. This is a minor gap in qualification, though not factually incorrect given the context. (4) The answer is contextually precise, directly addressing the impact of CCyB absence on total buffer requirements. The only reason for not scoring a perfect 10 is the lack of explicit acknowledgment that Morgan Stanley’s G-SIB surcharge value was not explicitly confirmed in the data, though the overall synthesis and conclusion remain valid and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 445,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s effective tax rate for fiscal 2022 was **13.5%** (shown in the percentage‑of‑revenue table in NVIDIA’s 2022 Form 10‑K, page 50). Apple’s Greater China segment reported operating income of $31,153 million on net sales of $74,200 million, giving an **operating‑income margin of about 42%** (31,153 ÷ 74,200, Apple 10‑K, page 52). Thus Apple’s Greater China operating margin was roughly three times higher than NVIDIA’s effective tax rate.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in NVIDIA's effective tax rate. The ground truth states it was 1.9% in fiscal year 2022, but the LLM claims 13.5%, which is incorrect. This number appears to be a misreading of NVIDIA’s 10-K, as the actual effective tax rate reported by NVIDIA in its 2022 10-K (page 50) is indeed approximately 1.9%, not 13.5%. The 13.5% figure may refer to a different line item or be a misinterpretation of the percentage-of-revenue table. Apple’s operating income ($31,153 million) and net sales ($74,200 million) in Greater China are correctly cited, and the calculated margin of ~42% is accurate (31,153 ÷ 74,200 ≈ 0.4199 or 42%). (2) Calculations: Apple’s margin calculation is correct. However, the comparison that Apple’s margin is 'roughly three times higher' than NVIDIA’s tax rate is based on the incorrect tax rate (13.5% vs actual 1.9%), making the comparison invalid. If using correct values (42% vs 1.9%), the margin is over 20 times higher. (3) Multi-hop reasoning: The model correctly identifies the need to compare two distinct financial metrics from two different companies in the same fiscal year and pulls data from both 10-Ks. It synthesizes the information logically but fails at the first hop due to incorrect extraction from NVIDIA’s filing. (4) Justification: Correctness score is 5 due to one major quantitative error undermining the core answer, though Apple’s data and reasoning structure are sound. Quantitative accuracy is low (4) due to the wrong tax rate. Qualitative accuracy is moderate (6) because the logic and structure are good, but entity/metric extraction failed. Contextual relevance is high (9) as the response directly addresses the question’s intent and format.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 477,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s (BA) Level 2 valuations are built on a wide range of market‑observable data – the company cites reported trades, broker quotes, benchmark yields and base spreads, and for over‑the‑counter derivatives adds swap‑curve rates, cash‑flow analyses, rating‑agency data and inter‑dealer broker rates (plus quoted prices for comparable short‑term instruments). United Parcel Service (UPS) relies on a narrower set of observables for its Level 2 assets, stating that its OTC interest‑rate and foreign‑currency derivatives are valued using pricing models that depend mainly on yield curves, foreign‑currency exchange rates and forward‑price information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Boeing (BA) uses pricing models for Level 2 assets emphasizing inputs like benchmark yields, swap curves, inter-dealer broker rates, cash-flow analyses, and rating-agency data—primarily for fixed income and OTC derivatives. UPS is accurately described as relying on yield curves, foreign currency exchange rates, and forward prices for its OTC derivatives. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in observable inputs emphasized by two companies (BA vs. UPS) for Level 2 assets based on their 2024 filings. The only minor shortcoming is that the LLM slightly overgeneralizes BA’s inputs as applying broadly to Level 2 assets, while the ground truth specifies they are primarily for fixed income investments. However, the inclusion of OTC derivatives in the LLM answer aligns with the broader context. (4) The answer is contextually relevant, directly addressing how the two companies differ in their use of observable inputs in pricing models for Level 2 assets. Wording differs but semantic meaning is equivalent. One point deducted from qualitative and overall scores due to slight imprecision in asset categorization emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 400,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s capital structure gives Class A shares one vote each while each Class B share carries ten votes – a ten‑fold voting advantage for the B‑share holders【page_81†L1-L4】. Netflix, by contrast, has a single class of common stock in which every share gets one vote 【page_61†L1-L3】. Alphabet’s 2023 $62.2 billion share‑repurchase program bought back Class A (and Class C) shares, but it does not alter the ten‑to‑one voting imbalance between its two common‑stock classes【page_81†L5-L9】, whereas Netflix’s uniform voting rights remain unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the 1:10 voting ratio between GOOGL's Class A and Class B shares and accurately contrasts this with NFLX's uniform one-vote-per-share structure. The $62.2 billion share repurchase amount for 2023 is correctly stated, and the focus on Class A and Class C buybacks is factually accurate. Quantitative accuracy is perfect—no errors in numbers or dates. The reasoning correctly notes that the repurchase does not alter the voting ratio, which is true. However, the LLM omits a key point present in the original answer: that retiring Class A and C shares indirectly preserves Class B control by reducing the pool of shares that could dilute voting power upon transfer (since Class B shares convert to Class A when sold). This is a significant nuance in the multi-hop logic connecting the repurchase to long-term voting control. While the LLM captures the surface-level impact, it misses this deeper structural consequence, slightly weakening the qualitative accuracy. The answer remains highly relevant and factually sound, warranting a high score but not full marks due to the incomplete synthesis of the repurchase's strategic effect on voting balance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 332,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "Accenture (ACN) records its U.S. government debt securities as Level 2 assets, valuing them with observable inputs other than quoted market prices. Broadcom (AVGO) places the same securities in Level 1, measured at quoted market prices (e.g., $961 million of U.S. government debt shown in Level 1 for 2023)【page_78】. Because the two firms use different fair‑value hierarchies, the valuation basis and reliability differ, making a direct comparison of their U.S. government‑debt holdings less meaningful.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the core issue—ACN classifies U.S. government debt securities as Level 2 while AVGO classifies them as Level 1, affecting comparability. This aligns with the ground truth. However, the LLM introduces a specific number for AVGO—$961 million of U.S. government debt in Level 1 for 2023—which is not present in the original answer and cannot be verified from the provided ground truth. The original answer mentions ACN’s $9,765 million in Level 2 securities, but the LLM omits this figure entirely, a significant omission in quantitative terms. (2) Quantitative accuracy is compromised: while the $961 million figure may be factually correct in AVGO’s filings, it is not part of the ground truth provided, and the absence of ACN’s $9,765 million weakens the response. The original answer hinges on the contrast between ACN’s classification and the general market practice (supported by UPS evidence), not on AVGO’s specific dollar amount. (3) The multi-hop reasoning is sound—LLM connects ACN’s valuation approach, AVGO’s contrasting method, and the implication for comparability. It correctly references fair value hierarchy differences and their impact on transparency. However, it fails to incorporate the UPS evidence that U.S. government securities are typically Level 1, which is a key support point in the original answer. (4) Despite missing key numbers and external evidence, the LLM captures the essential qualitative contrast and its implications, earning strong marks for reasoning and relevance. The omission of ACN’s $9,765 million and introduction of an unverified AVGO figure reduce quantitative accuracy, but the core logic and intent are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 465,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive said it began applying the supplier‑finance‑program disclosure requirements of ASU 2022‑04 on January 1 2023 and will provide the required roll‑forward detail starting January 1 2024 【page_84】. Target already reports the required information for its most recent fiscal year, showing a confirmed vendor‑obligation balance of $3.398 billion at year‑end (and $3.666 billion for the next year) 【page_54】. Thus, Colgate‑Palmolive’s adoption was earlier but the amount outstanding is not disclosed in the excerpt, whereas Target’s implementation is current and includes a disclosed year‑end balance of about $3.4 billion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding Target's disclosed amounts. The ground truth states that Target does *not* quantify the exact confirmed obligations in the provided excerpt, yet the LLM claims Target reported a confirmed balance of $3.398 billion at year-end and $3.666 billion for the next year — this data is not supported by the original answer and appears fabricated or misattributed. This is a major quantitative error. (2) The adoption timeline for Colgate-Palmolive is correctly stated: adoption began January 1, 2023, with roll-forward disclosures effective January 1, 2024 — this matches the ground truth and earns partial credit. However, the claim about Target’s implementation being 'current' and including a disclosed balance is incorrect; the original answer explicitly says 'exact confirmed amounts are not quantified in the provided excerpt.' (3) The multi-hop reasoning is partially sound — the model attempts to compare adoption timelines and disclosure practices between two companies — but fails at synthesis because it invents numerical data for Target that is not present in the source. This undermines the core of the comparison. (4) Contextual relevance is high because the structure and intent of the response align with the question — comparing adoption timelines and disclosure details — but correctness is severely compromised by the false quantification. Thus, while the reasoning framework is appropriate, factual accuracy, especially on numbers, is poor, warranting a low correctness score despite some accurate elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 442,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock flags that its dependence on Microsoft Azure for the Aladdin platform creates “operational and execution risks” and even a “prolonged global failure of cloud services” could lead to “reputational harm” (BlackRock 10‑K p. 28). Mastercard, by contrast, treats operational‑resilience and information‑security risks as a distinct risk category that is overseen by its enterprise‑risk governance and monitoring processes, linking those controls directly to its “Brand, Reputational Impact” risk management framework (Mastercard 10‑K pp. 24‑25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies BlackRock's reliance on Microsoft Azure for Aladdin as a source of operational and execution risks, including reputational harm from cloud service failures, citing the correct risk disclosure from BlackRock's 10-K (p. 28). It also accurately characterizes Mastercard's approach by linking operational resilience and information security to its 'Brand, Reputational Impact' risk framework, with accurate reference to pages 24–25 of its 10-K. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a problematic sense; the model does not introduce any incorrect figures. (3) The multi-hop reasoning is sound: it synthesizes risk disclosures from two different companies, compares their approaches to operational and reputational risk, and correctly infers that BlackRock's external dependency contrasts with Mastercard's integrated resilience strategy. The only minor shortcoming is that the LLM does not explicitly mention BlackRock’s risk stemming from 'regulatory oversight' or 'third-party control' nuances noted in the ground truth, nor does it define operational risk as broadly (e.g., internal processes, systems, external events). However, the core contrast—external dependency vs. internal resilience integration—is clearly and correctly conveyed. (4) The answer is contextually relevant, directly addressing the comparison asked in the question. Wording differs slightly from the original answer but maintains semantic equivalence. Thus, the correctness score is 9 due to minor omissions in depth, not errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 464,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "In 2021, Cardinal Health accounted for about 20 percent of Bristol‑Myers Squibb’s gross sales to the three largest U.S. pharmaceutical wholesalers, making it one of BMY’s top customers. At CVS, Cardinal is a 50 percent owner of Red Oak Sourcing, LLC, providing sourcing and supply‑chain expertise and jointly negotiating generic‑drug supply contracts for both CVS and Cardinal through the venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, the 20% figure for Cardinal Health's contribution to BMY's revenue in 2021 is correctly stated (though phrased as 'gross sales to the three largest U.S. pharmaceutical wholesalers'—a slight contextual nuance but not factually incorrect). (2) The ownership structure of Red Oak Sourcing, LLC (50% each by CVS and Cardinal) and its role in jointly negotiating generic drug supply contracts is accurately reported. (3) The multi-hop reasoning—linking Cardinal as both a major BMY customer and a strategic partner in CVS’s sourcing via Red Oak—is logically sound and synthesizes across entities correctly. (4) The only minor omission is that the original answer notes Red Oak does not involve inventory ownership, which adds a layer of operational detail absent in the LLM response. However, this does not undermine the core accuracy. Wording differences are semantically equivalent, and all key facts are present. Thus, the answer earns a 9/10 for correctness due to high factual fidelity with only a small loss in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 321,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "Meta’s Class B stock can only vote on a narrow set of matters (e.g., mergers, charter amendments) and each share’s vote is multiplied by the applicable conversion rate, giving each Class B share multiple votes 【META_10k_2023.pdf p.57】. By contrast, Netflix’s common stock gives every holder one vote on every shareholder matter 【NFLX_10k_2023.pdf p.61】. Thus, Meta’s Class B shareholders have greater voting power per share—but only in those limited voting scenarios—while Netflix shareholders have a uniform one‑vote‑per‑share right.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Meta’s Class B shares have restricted voting rights applicable only in specific scenarios (e.g., mergers, charter amendments), with each share’s vote multiplied by the conversion rate, while Netflix common stockholders have one vote per share on all matters. This aligns with the original answer. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts, dates), so quantitative accuracy is not compromised; the references to document pages are consistent with source verification. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different 10-K filings (META and NFLX) and contrasts their voting structures accurately. (4) The only minor shortcoming is that the LLM answer states Meta Class B shareholders have 'greater voting power per share'—which, while likely true due to the multiplier, is an inference not explicitly confirmed in the ground truth (the original answer says 'variable influence' without asserting 'greater'). This slight overstatement prevents a perfect 10, but does not undermine the overall correctness. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 360,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter lets Class B shares be converted at any time and automatically converts them to Class A shares on any sale or transfer (GOOGL 10‑K p. 81), effectively stripping the voting premium whenever the shares change hands. In contrast, Meta’s certificate of incorporation preserves a voting moat by requiring a separate majority vote of Class B holders for any change‑of‑control transaction until Class B voting power falls below a set threshold (Meta 10‑K p. 50). Mastercard’s rule that Class B holders must sell or otherwise transfer the Class A shares they receive upon conversion (Mastercard 10‑K p. 99) adds a mandatory post‑conversion disposition that limits the buildup of voting‑class stock, illustrating how such covenants can temper dual‑class power in governance assessments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer; META requires separate Class B approval for change-of-control transactions until Class B falls below a threshold; Mastercard mandates post-conversion sale or transfer of Class A shares. The descriptions of each company’s governance mechanism are factually sound. (2) There are no numeric values (percentages, dollar amounts, dates) in the original or LLM answer beyond the 35% threshold mentioned in the ground truth, which the LLM omits explicitly stating. This is the only minor factual omission—while the LLM correctly describes Meta’s requirement for Class B approval, it does not specify the '35% of combined voting power' threshold, which is a quantitatively relevant detail from the original. However, the concept is still accurately conveyed in qualitative terms. (3) Multi-hop reasoning is strong: the LLM synthesizes across three companies (GOOGL, META, Mastercard), correctly contrasts their dual-class governance approaches, and draws a logical inference about how these mechanisms affect control entrenchment versus dilution. The use of terms like 'voting moat' and 'mandatory post-conversion disposition' reflects nuanced understanding. (4) Semantic equivalence is high—though the LLM uses more metaphorical language ('voting moat', 'stripping the voting premium'), the underlying meaning matches the original. Contextual relevance is excellent, directly addressing all parts of the complex, multi-faceted question. The omission of the 35% threshold prevents a perfect score, but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 479,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck’s filings note that, under the FDA Modernization Act and the EU SPC system, its products can earn an additional six‑month pediatric exclusivity (U.S.) or SPC‑linked pediatric extension (EU) that can be stacked with patent‑term restoration (see MRK p. 16‑18). In contrast, Amgen warns that its biologics face regulatory‑exclusivity risk because recent policy moves could shrink the 12‑year data‑protection period for biologics and may eliminate “umbrella” extensions, exposing its products to earlier biosimilar competition (see AMGN p. 44‑46).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the six-month pediatric exclusivity in the U.S. (and EU SPC extension) for MRK matches the ground truth, and AMGN's risk from potential reduction in the 12-year biologic data protection period is correctly stated. The mention of 'umbrella' exclusivity being at risk is consistent with the original answer's reference to 'umbrella exclusivity' under FDA consideration. (2) The answer correctly identifies both companies (MRK and AMGN), relevant regulatory frameworks (FDA Modernization Act, EU SPC), and the nature of the risks and benefits each faces. (3) Multi-hop reasoning is sound: it contrasts MRK’s proactive use of existing exclusivity mechanisms with AMGN’s exposure to policy changes, synthesizing information across both companies and regulatory environments. (4) The only minor shortcoming is that the LLM answer does not explicitly name a product like EPOGEN or link MRK’s exclusivity to a high-risk adult COVID-19 treatment as in the original, slightly reducing qualitative completeness. However, the core comparison and strategic implications are accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparative question on exclusivity opportunities vs. risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 379,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s capital structure consists of a publicly‑traded Class A common stock and a very small, non‑traded block of Class B common stock (≈7 million shares versus ≈926 million Class A shares, with no public market for Class B) 【page_2】, which concentrates voting power in the hands of the few Class B holders (the filing does not detail per‑share voting rights but the tiny number of Class B shares implies a concentrated control block) 【page_1】.  \n\nVisa, by contrast, has a large public Class A pool (≈622 million shares) and multiple non‑voting or limited‑voting classes (B‑1, B‑2 and C) that only vote on specified matters and, when they do, their votes are multiplied by conversion rates (≈1.56‑1.79 for B‑1, ≈1.54‑1.79 for B‑2, 4.0 for C) 【page_87】【page_90】; these classes are subject to transfer restrictions and conversion‑rate adjustments tied to litigation escrow, providing a more complex, adjustable mechanism for concentrating control 【page_89】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the voting power distribution in MA and V. The ground truth states that MA's Class B shares have 15 votes per share and are held entirely by Mr. Brian L. Roberts, giving him 33⅓% of voting power, while Class A holds 66⅔%. The LLM does not mention the 15 votes per share, misrepresents the ownership (does not identify Mr. Roberts), and incorrectly implies that the concentration of control is due to the small number of Class B shares rather than the explicit super-voting rights. For V, the ground truth explains that Class B shares' convertibility and transferability are tied to U.S. covered litigation, with conversion rates adjustable based on litigation outcomes or follow-on offerings. The LLM incorrectly describes multiple voting classes (B-1, B-2, C) with vote multipliers, which is not supported by the original answer; instead, the original focuses on transfer restrictions and conditional conversion mechanisms, not vote multiplication during specified matters. The LLM introduces vote multipliers (e.g., 1.56–1.79, 4.0) that are not present in the ground truth. (2) Quantitative accuracy is low: the LLM provides share counts (e.g., 7M Class B vs 926M Class A for MA; 622M Class A for V), which are not in the original answer and appear to be fabricated or misattributed. The original answer does not include any share counts or vote multipliers. The 33⅓% and 66⅔% voting split in MA is omitted entirely. (3) Multi-hop reasoning is partially sound—the model attempts to contrast MA and V’s structures and identifies that V has more complex, adjustable control mechanisms versus MA’s static allocation. However, it fails to correctly synthesize the actual mechanisms: litigation-linked conversion and exchange programs for V, and super-voting Class B shares for MA. Instead, it invents vote-weighting schemes and omits key structural details. (4) Contextual relevance is high because the response addresses the core question about dual-class structures, voting power, and control concentration. However, due to major factual and quantitative errors, the correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 588,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX says that its FAR‑regulated fixed‑price contracts normally create **contract assets** because revenue is recognized before the government bills are paid, leaving the company with cash‑flow exposure and the possibility of audit‑related liabilities under the FAR and CAS (see RTX p. 79). The LMT excerpts (pages 107‑111) do not disclose a comparable amount of revenue recognized in excess of billings, but LMT likewise notes that its U.S. government contracts are subject to FAR‑based audits and could give rise to liabilities, without quantifying the exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately identifies RTX's financial exposure through contract assets due to revenue recognized in excess of billings under FAR-regulated fixed-price contracts, citing the correct mechanism (performance-based payments leading to timing differences in revenue recognition and billing). It also correctly notes the associated cash-flow exposure and audit risks under FAR and CAS, referencing the correct page (p. 79), which supports contextual accuracy. (2) For LMT, the LLM correctly observes that while there is no explicit disclosure of revenue in excess of billings, LMT faces potential liabilities from government audits under FAR, citing relevant pages (107–111). This matches the ground truth’s emphasis on LMT’s compliance and enforcement risks. (3) The multi-hop reasoning is sound: the model correctly contrasts RTX’s balance sheet exposure (contract assets) with LMT’s lack of comparable quantitative disclosure and shifts focus to audit-related liabilities, capturing the qualitative difference in risk profiles. (4) Minor omission: the LLM does not explicitly mention LMT’s risk of debarment or suspension, nor the 'dependence on U.S. government contracts' as a material risk factor, which is a key part of the original answer’s qualitative comparison. While the audit risk is noted, the absence of this operational consequence slightly weakens the completeness of the risk profile comparison. However, no numerical inaccuracies exist—there are no specific dollar amounts in the original, and the LLM does not fabricate any. Wording differences are within acceptable semantic equivalence. Thus, the answer is factually accurate and contextually relevant, with only a slight gap in qualitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 486,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "The META filing only notes that it has a listed Class A share and an unlisted Class B share (see META page 57) but does not disclose the voting rights attached to each class, so the voting‑power split cannot be determined from the excerpts provided. In contrast, Alphabet’s 10‑K explicitly states that each Class A share carries one vote, each Class B share carries ten votes (and Class C carries none) (see GOOGL page 81). Thus, while GOOGL’s structure gives Class B ten‑times the voting power of Class A, META’s voting‑power distribution is not disclosed in the supplied pages.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It falsely claims that META's voting rights are not disclosed in the provided excerpts, but the original answer (ground truth) clearly states that Class B shares have 15 votes per share and hold 33 1/3% of total voting power, while Class A holds 66 2/3%—indicating this information *is* available in the source data. The LLM fails to report these specific percentages and vote ratios for META, which are central to the question. (2) Quantitatively, the LLM omits all correct numbers for META (15 votes per Class B share, 33 1/3% and 66 2/3% splits) and only correctly reports GOOGL’s 10 votes for Class B and 1 vote for Class A. This partial numeric accuracy is outweighed by the absence of key META figures. (3) Reasoning is flawed: the LLM concludes that META’s structure is undisclosed when it should have compared the two companies’ dual-class systems, especially the higher per-share voting power in META (15:1) versus GOOGL (10:1). The multi-hop synthesis—comparing both companies’ voting power distribution and concentration mechanisms—is missing. (4) While the response is relevant to the topic and correctly interprets GOOGL’s structure, its failure to acknowledge disclosed META voting data severely undermines factual correctness. The answer incorrectly asserts lack of disclosure rather than making the comparison the question demands.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 391,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "The loss of Opdivo’s 12‑year regulatory data‑protection removes the FDA barrier that blocks biosimilar approval, and under the Biologics Price Competition and Innovation Act a biosimilar applicant can file a Paragraph IV certification as early as four years after launch, prompting a surge of patent‑infringement suits (see J&J’s discussion of data protection and Paragraph IV challenges)【page_8】【page_9】. Because Stelara depends on comparable data‑protection and patent exclusivity, its upcoming patent cliffs will likely trigger the same wave of Paragraph IV ANDA filings and raise J&J’s litigation exposure【page_4】【page_6】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the mechanism by which expiration of regulatory data protection leads to Paragraph IV ANDA filings and increased litigation risk, drawing a valid parallel between BMY's Opdivo and JNJ's Stelara. It accurately references the 4-year trigger for Paragraph IV certifications under the BPCIA framework, aligning with the ground truth's mention of Paragraph IV filings after four years of a five-year exclusivity period. However, it incorrectly states that Opdivo has a '12-year regulatory data protection' period, which is not supported by the original answer or typical for small-molecule drugs like Opdivo (which is an oncology biologic but approved under an NDA, not a BLA with 12-year biosimilar exclusivity). The original answer does not specify the length of BMY’s data protection, only referencing the general five-year regulatory data protection period. This introduces a factual inaccuracy in quantitative accuracy. Additionally, while the LLM cites 'J&J’s discussion of data protection and Paragraph IV challenges' with page references, the original answer attributes the litigation risk discussion to JNJ’s 2022 10-K and cites Stelara’s $8B+ revenue—specific financial data absent in the LLM response. The omission of Stelara’s financial magnitude reduces completeness, though the core reasoning about precedent and litigation exposure remains sound. The multi-hop logic—linking BMY’s experience to JNJ’s risk via regulatory and patent pathways—is well-executed and contextually relevant. Thus, the answer is qualitatively strong and relevant but penalized for incorrect exclusivity duration and missing key quantitative detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 453,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "Meta’s charter ties change‑of‑control approval to a voting‑power threshold – a majority of the Class B shareholders must approve any such transaction while Class B shares represent at least 35 % of the combined voting power (Meta 10‑K, p. 50). Alphabet’s dual‑class system gives each Class B share ten votes, but those shares automatically convert to one‑vote Class A shares on any sale or transfer, so voting control is retained only while the shares remain Class B (Alphabet 10‑K, p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Meta's requirement for Class B majority approval for change-of-control transactions while Class B holds at least 35% of voting power is accurately stated, and the citation to the 10-K (p. 50) supports this. Alphabet's Class B shares carrying 10 votes and converting automatically to Class A upon transfer is also correctly described, with proper reference to its 10-K (p. 81). (2) Quantitative accuracy is perfect: the 35% threshold and 10-to-1 vote ratio are correctly reported, with no calculation errors. (3) Multi-hop reasoning is sound—information from two different companies (Meta and Alphabet) and their respective dual-class structures is correctly synthesized and contrasted. The LLM captures the key distinction: Meta’s control mechanism is threshold-based and non-automatic, while Alphabet’s is transfer-triggered and automatic. (4) The only minor shortcoming is that the LLM answer does not explicitly state the comparative conclusion about Meta’s structure providing 'more enduring governance insulation' or the rationale about 'limiting long-term entrenchment' in GOOGL’s case, which are present in the original answer. However, the factual basis for that conclusion is fully supported by the LLM response, so the omission is one of synthesis wording, not substance. Thus, the answer is semantically equivalent and highly accurate, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 420,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS said it “did not elect to apply the practical expedients provided under Topic 848” when it moved its debt to SOFR, so the full GAAP impact of the reference‑rate change is being reflected 【page_74】. By contrast, 3M’s filing notes that the ASU 2020‑04 relief “can generally be applied through December 31, 2024” and that its interest‑rate swaps – originally based on LIBOR and now amended to reference SOFR – were subject to that reform, indicating the company likely used the optional expedients to simplify accounting for those hedging relationships 【page_74】【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not elect to apply the practical expedients under ASU 2020-04 (referred to as Topic 848, which is correct—ASU 2020-04 amends ASC 848), and that it reflected the full GAAP impact. This matches the original answer. (2) For MMM (3M), the LLM correctly notes the extended relief availability through December 31, 2024, as provided by ASU 2022-06, and infers that 3M likely used the expedients based on its disclosure about LIBOR-to-SOFR amendments in interest-rate swaps. While the LLM does not include the specific $152 million reclassification figure from AOCI mentioned in the ground truth, this is a minor omission that does not undermine the core reasoning or conclusion. (3) The multi-hop reasoning is sound: the model correctly synthesizes UPS’s explicit non-election with 3M’s likely use of relief based on disclosures and the extended deadline. (4) All entities (UPS, 3M/MMM, ASU 2020-04, ASU 2022-06), years (2023, 2024), and accounting concepts are accurate. The only reason for not scoring a 10 is the omission of the specific quantitative evidence ($152M) that strengthens the inference about MMM’s hedging activity, which was present in the original answer. However, the conclusion remains logically supported and semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 382,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "Because exchange‑traded commodity futures are cash‑settled each day, their market price is directly observable and the contracts are re‑measured to market daily. Mondelez therefore classifies those futures as Level 1 financial assets and values them at the quoted exchange price (MDLZ p.112). PepsiCo notes the same daily‑settlement feature and, while it omits the contracts from its fair‑value table, it likewise treats them as Level 1 instruments measured at market prices (PEP p.107).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that exchange-traded commodity futures are daily cash-settled, which makes their market prices directly observable, leading MDLZ to classify them as Level 1 assets valued at quoted exchange prices. This matches the original answer's explanation of MDLZ's valuation methodology. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the LLM correctly uses PEP’s disclosure (daily settlement leading to omission from balance sheet and Level 1 classification) to support MDLZ’s treatment of similar instruments, demonstrating proper cross-company synthesis. The only minor shortcoming is that the LLM does not explicitly state that the daily cash settlement results in these instruments not being included in the year-end balance sheet table (a point emphasized in the original answer), though it does mention PEP omits them from the fair-value table, which is semantically close. (4) All entities—MDLZ, PEP, Level 1 financial assets, exchange-traded commodity futures—are correctly identified and contextually applied. The answer is fully relevant to the question, clearly explaining how daily cash settlement impacts valuation methodology through observable pricing and classification. Overall, the answer is factually correct, well-reasoned, and only slightly less complete than the ground truth in contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 435,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s dual‑class structure gives each Class A share one vote and each Class B share fifteen votes, so the single Class B holder (Brian L. Roberts) controls roughly one‑third of the total voting power (≈33 % versus ≈67 % for Class A)【page_31】. Alphabet (Google) also uses a dual‑class system, but its Class B shares carry ten votes each while Class A shares carry one vote, concentrating voting control with insiders; the filing does not break out the exact voting‑power split, but the vote multiplier is lower (10‑to‑1) than Comcast’s (15‑to‑1)【page_82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B shares carry 15 votes (vs. Class A's 1 vote), and the voting power split is accurately described as approximately 67% for Class A and 33% for Class B, matching the ground truth of 66 2/3% and 33 1/3%. GOOGL's Class B shares carry 10 votes per share, Class A has 1 vote, and Class C has no voting rights—this is correctly noted in substance, though the LLM omits explicit mention of Class C having no voting rights, which is a minor omission. (2) The comparison of vote multipliers (15-to-1 for CMCSA vs. 10-to-1 for GOOGL) is correctly highlighted, supporting the conclusion that CMCSA gives more per-share voting weight to its superior class. (3) The reasoning is sound: the LLM correctly infers that despite the lower multiplier, GOOGL still concentrates control with insiders, and it accurately contrasts the degree of voting power concentration. (4) The answer is contextually relevant, directly addressing the comparison of voting power distribution between CMCSA and GOOGL. The only minor shortcoming is the lack of explicit mention that GOOGL’s Class C shares have zero voting rights, which slightly affects completeness but does not undermine the core accuracy. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 397,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "Bank of America reported that its market‑making and similar activities generated a net gain of roughly **$4.2 billion in 2024** that is attributed to the embedded derivatives in the structured liabilities it makes a market in【page_164】. Morgan Stanley, by contrast, only describes its participation in **credit‑linked notes (CLNs) as a hybrid instrument that transfers assets to an SPE and enters a credit‑derivative protection contract, exposing the firm to the same credit‑event risk as the note’s investors**; the filing does not disclose a specific gain or loss amount for those CLN positions【page_129】. Thus, while both firms face credit‑event risk in structured notes, BAC quantifies a sizable $4.2 bn gain from the embedded‑derivative component, whereas MS’s CLN exposure is presented qualitatively without a comparable monetary figure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces a specific quantitative figure—$4.2 billion in net gains for BAC in 2024—which is not present in the original answer (ground truth). The ground truth does not provide any numerical value for BAC’s gains, only stating that gains (losses) are typically offset by hedging activities. This makes the $4.2 billion figure factually unsupported and incorrect in context. Additionally, the year 2024 is mentioned, but the ground truth does not specify any fiscal year, so this is a fabrication. (2) The LLM claims MS structures CLNs via SPEs and derivative contracts but notes no monetary figure is disclosed, which aligns with the ground truth’s qualitative description. However, the original answer emphasizes MS *retains risk* through selling credit protection, while the LLM only states MS has exposure 'similar to investors,' which understates MS’s active risk retention. (3) The multi-hop reasoning is partially sound—both firms are correctly linked to structured notes with embedded derivatives and credit-event risk—but the synthesis is flawed because the LLM incorrectly implies BAC reports a standalone gain from embedded derivatives, whereas the ground truth stresses these gains are *offset by hedges*, meaning no net gain is implied. The LLM misses this key hedging dynamic entirely. (4) Contextual relevance is high because the response addresses both firms, embedded derivatives, CLNs, and credit-event risk. However, the introduction of false quantitative data and misrepresentation of BAC’s hedging behavior significantly reduce factual accuracy. The qualitative accuracy is moderate due to correct entity identification but flawed reasoning. Quantitative accuracy is low due to invented numbers and dates.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 477,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce flags the OECD’s Pillar Two model rules – a new global minimum‑tax regime – as a material “global tax development” (see CRM 10‑K p. 28). Intel notes that a large share of its earnings is taxed outside the United States and that it is actively assessing how the 15 % Pillar Two floor will affect those jurisdictions (see INTC 10‑K p. 44). If the rules are adopted, the minimum‑tax floor would erode the advantage of low‑tax jurisdictions and could push Intel’s overall effective tax rate higher than the recent declines driven by non‑US income.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Salesforce identifies Pillar Two as a material global tax development; Intel has significant non-US income and is evaluating Pillar Two; the global minimum tax rate is 15%; implementation began in 2024 in several jurisdictions including EU Member States. The LLM correctly notes that low-tax jurisdictions may lose their advantage, potentially increasing Intel's effective tax rate. (2) Quantitative accuracy is perfect: the 15% minimum tax rate is correctly cited, and no incorrect numbers or dates are present. The LLM omits the specific mention of '2024' but refers generally to adoption, which is acceptable given the focus on ongoing evaluation. (3) Multi-hop reasoning is sound: the model correctly links Salesforce’s identification of Pillar Two as a risk to multinational firms with Intel’s geographic income exposure and its potential tax rate impact. It synthesizes cross-company, cross-document insights logically. (4) The answer is contextually relevant and directly addresses how Pillar Two could affect Intel’s effective tax rate given its non-US exposure. The only minor shortcoming is the lack of explicit mention of '2024' and 'EU Member States enacting legislation', which are in the original answer and add specificity, but the overall meaning and implication remain intact. Thus, the answer is factually complete and semantically equivalent, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 417,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX’s FAR‑regulated fixed‑price contracts are accounted for on a percentage‑of‑completion basis, so revenue is recognized as work is performed—often before the customer has paid the full amount—resulting in contract‑asset balances on the balance sheet (see RTX p. 79‑78). Boeing, by contrast, notes that its U.S. government contracts can be terminated for convenience or default, exposing it to sudden loss of future cash receipts and even liability for termination costs (see BA p. 7 & 21). Thus RTX’s cash inflows tend to lag but follow a relatively predictable schedule tied to performance milestones, whereas Boeing’s cash flows are more volatile because termination risk can abruptly curtail or reverse expected payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, no specific numbers (percentages, dollar amounts, dates) are misstated; the mention of 80-90% in the original answer is implied in the LLM's description of interim payments and revenue recognition before full payment, though not explicitly repeated. However, this omission does not constitute a factual error, as the core concept of partial payment coverage is preserved. (2) The LLM correctly identifies RTX’s revenue recognition method (percentage-of-completion) leading to contract assets, consistent with FAR regulations and resulting in cash inflows lagging revenue—this matches the original answer’s claim about retained payments and timing mismatches. (3) For Boeing, the LLM accurately notes exposure to termination for convenience or default, which can lead to loss of future payments or liabilities—directly reflecting the original answer’s point about allowable costs and re-procurement risks. (4) The synthesis across both companies is sound: RTX faces predictable but lagged cash flows due to billing timing, while BA has more volatile cash flows due to termination risk—this contrast in cash flow predictability is correctly drawn. (5) The LLM cites specific page references (RTX p. 79-78, BA p. 7 & 21), suggesting grounding in source material, though these are not evaluable for correctness here. Minor deduction in qualitative accuracy only because the original answer explicitly mentions performance-based or progress payments covering 80-90% of costs, which strengthens the explanation of cash flow timing—this detail is omitted but not contradicted. Overall, the LLM captures all key entities, reasoning steps, and implications with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 477,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "MMM’s 2024 filing shows that $119 million of its floating‑rate notes carry a 2025 put provision and are classified as the current portion of long‑term debt (page 69). GE, on the other hand, discloses $315 million of fixed‑ and floating‑rate notes that contain 2025 put options (page 55), so GE’s exposure to potentially callable debt in the near term is about $196 million greater than 3M’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All numeric values are correct: $119 million for MMM and $315 million for GE, both tied to 2025 put provisions. The difference of $196 million ($315M - $119M) is accurately calculated. (2) The entity names (MMM/3M and GE) and years (2025) are correct, and the financial instruments (floating/fixed rate notes with put options) are properly identified. (3) The multi-hop reasoning is sound—information from both companies is correctly synthesized to compare near-term debt exposure. (4) The answer correctly notes that both companies classify these obligations as current due to the put options, indicating awareness of the accounting implications. The only minor shortcoming is that it does not explicitly state that GE’s exposure is 'more than 2.5 times larger' (315/119 ≈ 2.65), which was part of the original insight. However, providing the $196 million difference is a valid alternative comparison. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only a slight omission in comparative framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 328,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PEP values its exchange‑traded commodity futures by using the contracts’ daily cash‑settlement price – the market price that settles each day – and therefore does not list them in its derivative‑valuation tables【page_107】. MDLZ, by contrast, classifies exchange‑traded commodity futures as Level 1 financial assets and measures their fair value directly from quoted market prices on the exchanges【page_95】. Both companies rely on observable, daily market pricing, but MDLZ explicitly places the instruments in the Level 1 hierarchy, whereas PEP emphasizes the daily cash‑settlement mechanism rather than a Level 1 classification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP excludes exchange-traded commodity futures from its fair value tables due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. Both rely on daily market pricing, but differ in classification approach. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound—correctly contrasting PEP’s and MDLZ’s treatments by synthesizing their respective valuation methodologies and disclosure practices. The LLM correctly identifies that both use observable daily pricing but differ in reporting and classification logic. (4) The only minor shortcoming is that the LLM does not explicitly state that PEP's exclusion is *because* of the daily cash settlement mechanism in the same causal phrasing as the ground truth, though it strongly implies it. This slight omission in emphasis prevents a perfect 10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 337,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s 2022 net sales for the Greater China segment (which includes mainland China, Hong Kong and Taiwan) were **$74.2 billion**【page_25】. Intel’s most recent disclosed revenue for Taiwan (the “Taiwan” line in its regional breakdown) was **$13.5 billion**【page_87】. Thus Apple’s Greater China revenue was roughly **$60 billion more – about five‑times larger** than Intel’s Taiwan revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's 2022 revenue from the Greater China region as $74.2 billion (equivalent to $74,200 million in the ground truth), and Intel's 2022 revenue from Taiwan as $13.5 billion (very close to the ground truth $13,461 million). The slight rounding from $13.461 billion to $13.5 billion is acceptable and common in financial reporting. (2) Calculations are accurate: the difference is approximately $60.7 billion, which the model rounds to 'roughly $60 billion more'—this is reasonable. The 'five-times larger' comparison is also approximately correct (74.2 / 13.5 ≈ 5.5), so the characterization is sound. (3) Multi-hop reasoning is correct: the model synthesizes data from two different companies (Apple and Intel), two different geographic scopes (Greater China vs. Taiwan only), and correctly contrasts aggregated regional exposure with country-specific operations. (4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing and effective use of comparison. The only minor deduction is for rounding Intel's revenue up slightly more than necessary, though this does not affect the overall correctness. All entities (Apple, Intel, Greater China, Taiwan, 2022) and metrics (net sales/revenue) are accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 369,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "MMM’s net property, plant & equipment related to finance leases was $106 million in 2021 and $119 million in 2020, for a combined total of about $225 million (see MMM 10‑K page 133).  GD reported $234 million of revenue from South America in 2021 (see GD 10‑K page 80).  Consequently, MMM’s combined net PP&E investment in the Americas is slightly lower than GD’s South‑America revenue contribution.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly reports MMM's net property, plant, and equipment (PP&E) as $106 million in 2021 and $119 million in 2020, totaling $225 million, but these figures refer only to finance lease-related PP&E, not the total net PP&E for the Americas. The ground truth states that MMM's total net PP&E for the Americas in 2021 was $5,864 million, which the LLM completely misses. The GD revenue figure of $234 million from South America in 2021 is correct and properly cited. (2) The calculation of a 'combined' PP&E ($106M + $119M) is irrelevant because the question asks for MMM's net PP&E investment in the Americas, not a sum across years or a subset related to finance leases. The comparison drawn — that MMM’s investment is 'slightly lower' than GD’s revenue — is therefore false; in reality, MMM’s $5,864M is vastly larger than GD’s $234M. (3) The multi-hop reasoning fails because the LLM does not synthesize the correct metric from MMM’s filing. It misidentifies the relevant PP&E figure, leading to flawed cross-company comparison. The geographic scope (Americas including South America) is acknowledged in the original answer but not meaningfully addressed in the LLM response. (4) Due to major quantitative and qualitative inaccuracies, especially the use of an incorrect and much smaller PP&E figure, the correctness score is low. The contextual relevance is moderate because the answer attempts the right comparison with correct GD data and mentions the relevant companies and region, but the core financial data is wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 437,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor performed sensitivity analyses on the key assumptions underlying the content‑amortization model—such as historical and forecasted viewing patterns—to see how changes in those inputs would alter the amortization expense. By contrast, Comcast uses sensitivity analyses as a risk‑management tool to gauge how shifts in interest rates would affect the cost and volatility of its fixed‑ and variable‑rate debt and related interest expense. Thus, both firms employ sensitivity testing, but Netflix’s is audit‑focused on accounting estimates, whereas Comcast’s is used to monitor and manage market‑interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses on viewing pattern assumptions to evaluate content amortization, which affects financial reporting; CMCSA (Comcast) uses sensitivity analyses to assess interest rate risk on its debt portfolio. The distinction between audit-focused accounting estimates (NFLX) and financial risk management (CMCSA) is correctly identified. (2) Quantitative accuracy is perfect—while the LLM answer does not mention the $56 million reduction in interest expense from derivatives in 2023, this detail is present in the ground truth but not included in the LLM response. This is a minor omission, not an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two distinct uses of sensitivity analysis (accounting vs. risk management), and two financial contexts (amortization assumptions vs. interest rate exposure). (4) Semantic equivalence is strong—wording differs but meaning aligns closely with the original. The only reason for not scoring a 10 is the omission of the specific $56 million derivative impact, which is a relevant quantitative detail in the ground truth. However, since the question focuses on the *use* of sensitivity analyses rather than required inclusion of all peripheral financial figures, the omission does not undermine the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 404,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo explicitly uses exchange‑traded commodity futures – cash‑settled daily contracts that are priced on active exchanges – as part of its commodity‑price hedging program (see PEP page 107 and the discussion of swaps and futures on page 105). Costco, however, discloses that it held **no** Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis (see COST page 51). Thus, while both firms apply the same fair‑value hierarchy, PepsiCo actively employs Level 1 exchange‑traded futures for risk management, whereas Costco reports the absence of any Level 1 financial liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PEP uses exchange-traded commodity futures (Level 1 instruments) for risk management, specifically in commodity-price hedging, and these are cash-settled daily. COST discloses no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis. The fair value hierarchy framework is correctly acknowledged as common to both. (2) There are no numeric values, dates, or calculations in the LLM answer that conflict with the ground truth; while the ground truth includes specific dates (December 25, 2021, and August 28, 2022), the LLM omits them but does not misstate—this is a minor omission, not an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, identifying PEP’s active use of Level 1 derivatives versus COST’s absence of such instruments, and draws a valid contrast in risk management strategies under the same reporting framework. (4) Semantic equivalence is strong: the LLM captures the core contrast and key details (e.g., exchange-traded, cash-settled, Level 1 classification, no Level 1 liabilities at COST). The only minor shortcoming is the lack of specific fiscal dates present in the ground truth, which slightly reduces completeness but does not affect factual correctness. Hence, a score of 9 is justified—excellent accuracy with negligible omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 403,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s patent table shows that Enbrel’s U.S. composition and method patents expire in Nov 2028 and Apr 2029, with its formulation patent lasting until Oct 2037 (Amgen 10‑K, p. 11). Because Merck flags exposure to biosimilar competition and pricing pressure as a key risk (Merck 10‑K, Competition & Pricing sections, pp. 32‑33), the 2028‑29 expirations will likely intensify that pressure and erode Merck’s competitive stance in the rheumatoid‑arthritis market. Pfizer, which markets Enbrel outside the U.S. (Pfizer 10‑K, Specialty‑Care list, p. 10) and operates a global manufacturing network (International Operations, p. 10), must align its international production to preserve supply and pricing advantage while preparing for eventual biosimilar entry once the U.S. patents lapse.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key dates are correct: Nov 2028 (composition), Apr 2029 (DNA encoding), and Oct 2037 (formulations), matching the original answer exactly. These are correctly attributed to Amgen's 2024 10-K, and the staggered expiration timeline is accurately represented. (2) The LLM correctly identifies Merck’s exposure to biosimilar competition and pricing pressures, citing relevant sections of its 10-K, and logically infers that patent expirations in 2028–2029 will intensify these pressures, which is consistent with the original answer. (3) For Pfizer, the LLM correctly notes that it markets Enbrel outside the U.S. and has a global manufacturing network, aligning with the international production strategy mentioned in the ground truth. It also correctly implies that international markets will face biosimilar competition earlier than the U.S., though it could have more explicitly stated that Pfizer produces Enbrel internationally (not just markets it), which is a minor omission. (4) The reasoning is sound and multi-hop: it synthesizes patent expiration data from Amgen, competitive risks from Merck, and production strategy from Pfizer, drawing logical conclusions about competitive positioning and strategic implications. The only minor shortcoming is slightly less detail on Pfizer’s production alignment with biosimilar preparedness compared to the original answer’s explicit mention of 'accelerating exposure to generic competition outside the U.S.' However, the core facts, dates, entities, and logic are correct, and the answer remains semantically equivalent in intent and substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 455,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR says its private‑equity fund holdings measured at NAV have roughly **$90 million** of unfunded commitments 【page_64】. UPS, also measuring its alternative‑investment interests at NAV, reports **about $2.7 billion** of unfunded commitments to private‑equity and other limited partnerships 【page_93】. Thus EMR’s unfunded commitment is tiny – roughly 30 times smaller (about 3 % of UPS’s amount).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the LLM correctly reports EMR's $90 million and UPS's $2.7 billion unfunded commitments. The use of 'million' for EMR's $90 is a minor formatting assumption not contradicted by the original answer (which states $90), but given standard financial reporting, $90 likely means $90 million — so this is a reasonable and common interpretation. The comparison stating EMR’s amount is 'about 3% of UPS’s' and 'roughly 30 times smaller' is mathematically sound: $90M / $2.7B = 0.033 or 3.3%, which rounds to about 3%, and 2.7B / 90M = 30. (2) Completeness: The answer addresses both companies, their unfunded commitments, the fact that both measure investments at NAV, and provides a meaningful scale comparison — fulfilling the multi-hop requirement. (3) Entity accuracy: EMR and UPS are correctly identified, and the context of NAV measurement is accurately noted. The only minor issue is the implicit assumption that $90 means $90 million; while plausible and likely correct, the original answer states '$90' without units, so adding 'million' introduces a small assumption. However, given that UPS’s figure is in billions and EMR’s is 30x smaller, the magnitude implies millions, so this is not a significant error. (4) Reasoning and synthesis are strong: the model correctly compares the two figures and contextualizes the difference in scale. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a negligible assumption on unit scaling.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 438,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment generated $4.845 billion of net revenue in 2024, of which 23 % was beverage revenue【page_72】.  Mondelēz reported total beverage sales of $1.096 billion for 2024【page_121】—about the same size as PepsiCo’s APAC beverage contribution (≈$1.11 billion).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in key numbers. While it correctly states that 23% of PepsiCo's APAC segment revenue came from beverages, it incorrectly reports PepsiCo's APAC revenue as $4.845 billion, leading to a calculated beverage revenue of approximately $1.11 billion. However, the ground truth states that PepsiCo's APAC revenue was only $10 million in 2024, making beverage revenue $2.3 million (23% of $10M). This is a two-order-of-magnitude error. Additionally, while the LLM correctly cites Mondelēz's total beverage revenue as $1.096 billion (or $1,096 million), it incorrectly concludes this is 'about the same size' as PepsiCo’s APAC beverage revenue, when in fact Mondelēz’s beverage revenue is over 475 times larger. (2) Number verification: 23% is correct; PepsiCo APAC revenue should be $10M (not $4.845B); beverage portion should be $2.3M (not ~$1.11B); Mondelēz beverage revenue is correctly cited at $1.096B. (3) Multi-hop reasoning fails: the model does not correctly synthesize the comparison—despite having one correct percentage and one correct external figure, the miscalculation of the base revenue invalidates the comparison. The conclusion drawn is therefore factually wrong. (4) Scores reflect severe quantitative inaccuracy (2/10), poor qualitative reasoning due to flawed synthesis (3/10), partial contextual relevance as it addresses the right companies and metric types (6/10), and low overall correctness (3/10) due to critical errors in core financial figures and the resulting misleading comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 430,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $623 million of delinquent loans at December 31 2023 (the “Total Delinquent Loans” line in its Table 3.8 of loan‑modification performance)【page_161】. MetLife’s residential mortgage loan portfolio is built, in part, from reperforming loans that have been performing for at least 12 months after a modification【page_240】. Thus, the $623 million of delinquent loans at Capital One represents a potential supply of loans that, once cured and re‑performing, can be purchased by MetLife—so a larger delinquent‑loan balance at Capital One expands the pool of reperforming loans available for MetLife’s residential‑mortgage acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key factual elements: Capital One's $623 million in delinquent loans as of December 31, 2023, and MetLife's strategy of purchasing reperforming loans that have been performing for at least 12 months after modification. All numbers and dates are accurate and match the ground truth. (2) Quantitative accuracy is perfect: $623 million is correctly cited, and the date (December 31, 2023) is exact. No calculations are required, but the reference to the source table (Table 3.8) and page numbers adds precision. (3) The multi-hop reasoning is sound: the LLM correctly links Capital One’s delinquent loans to the future pool of reperforming loans that MetLife may purchase. It accurately describes the causal relationship—higher delinquencies today can lead to more reperforming loans tomorrow, which MetLife targets. The only minor shortcoming is that the original answer specifies delinquency must last at least 12 months before reperformance, a nuance slightly underemphasized in the LLM answer, though implied via 'once cured and re-performing'. (4) The answer is contextually fully relevant, directly addressing how Capital One's delinquency volume affects MetLife's acquisition opportunities. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate with only a slight gap in elaborating the 12-month delinquency criterion explicitly, warranting a 9/10 on qualitative accuracy and 9 overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 409,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s pension plan holds only about $30 million of real‑estate limited‑partnership interests (valued at NAV) and has roughly $5 million of future contribution commitments to such partnerships (UNP 10‑K p. 58‑56). By contrast, UPS reports unfunded commitments of roughly $3.3 billion to private‑equity, private‑debt and real‑estate limited partnerships, also measured at NAV (UPS 10‑K p. 89). Thus UPS’s NAV‑based exposure to these illiquid structures is orders of magnitude larger than UNP’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that UNP's pension plan holds interests in limited partnerships investing in privately-held companies (not specifically quantified at $30 million for real estate), while the LLM claims UNP holds only $30 million in real-estate limited-partnership interests and $5 million in future commitments—specific figures not present in the original answer and unsupported by the provided context. The $3.3 billion unfunded commitment by UPS is correctly cited and aligns with the ground truth. However, the LLM introduces precise numbers for UNP that are either fabricated or misattributed, severely undermining quantitative accuracy. (2) The calculation or comparison that UPS’s exposure is 'orders of magnitude larger' is based on incorrect inputs and thus invalid. While the direction of the comparison (UPS > UNP) may be plausible, the magnitude claim cannot be verified due to erroneous data. (3) The multi-hop reasoning is partially sound—both companies use NAV-based valuations for illiquid assets, and the LLM correctly identifies this and contrasts exposure levels. However, it fails to mention key qualitative aspects from the original answer, such as UPS’s limited redemption provisions and the 10–15 year partnership terms, which are central to the liquidity and valuation challenges. The LLM also narrows UNP’s investments specifically to real estate, while the original answer describes a broader focus on privately-held companies, potentially misrepresenting the nature of the exposure. (4) Despite these issues, the answer remains contextually relevant by addressing the core comparison of NAV-based exposures and illiquidity. The structure and intent follow the question, but the introduction of false quantitative details drastically reduces overall correctness. Hence, correctness is scored low (4), quantitative accuracy very low (3), qualitative reasoning moderate (5) due to correct use of NAV concept and partial synthesis, and contextual relevance high (8) as the response stays on topic and attempts the required comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 572,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s 7 nm‑and‑below chips are built by external foundries (primarily TSMC), so the company has limited control over wafer yields, process quality and capacity; any manufacturing inefficiency or quality problem at the supplier could impair product quality or cause supply shortfalls (AMD 10‑K pp. 23‑26). In contrast, Cisco’s contract manufacturers use automated test equipment, burn‑in, comprehensive inspection, statistical process controls and ISO 9001‑certified procedures, giving Cisco a structured, audited quality‑control system that reduces its exposure to such risks (Cisco 10‑K p. 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies AMD's reliance on third-party foundries (specifically TSMC) for 7 nm and smaller nodes, noting limited control over yields, quality, and capacity—directly aligning with the original answer's emphasis on risks in manufacturing yields, delivery schedules, and quality assurance. It also accurately contrasts this with Cisco’s use of automated test equipment, burn-in, inspection, statistical process controls, and ISO 9001-certified processes—matching the original's description of Cisco’s internal quality control systems. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, all referenced document locations (e.g., AMD 10-K pp. 23–26, Cisco 10-K p. 9) are consistent with the expected sourcing and do not contain inaccuracies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMD and Cisco), compares their supply chain and quality control strategies, and draws a valid contrast in exposure to quality risks. The only minor shortcoming is that the LLM answer does not explicitly state that Cisco integrates quality control 'directly into its manufacturing procedures' or that this reduces variability—nuances present in the original—but the mention of audited, structured systems implies this. (4) The answer is contextually fully relevant, directly addressing the comparative quality control risk exposure as requested. Thus, the correctness score is 9 due to slight omission of nuance, but all key facts and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 466,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos is an equity‑method investment in a VIE that gives it **no voting rights** and therefore no ability to direct Atairos’ operations, but it obligates Comcast to **absorb about 99 % of any losses and to receive roughly 86 % of any residual returns**, with a remaining unfunded capital commitment of $1.4 billion that caps its financial exposure【page_84】【page_85】.  \n\nAlphabet’s Class C capital stock likewise carries **no voting rights**, yet the shares retain the same dividend, liquidation and residual‑value rights as the voting classes, so shareholders bear only the normal equity risk while governance is concentrated in the higher‑voting Class B (and Class A) shares【page_82】.  \n\nThus, both companies separate voting from economic rights, but Comcast’s non‑voting position is tied to a VIE structure that concentrates loss‑absorption and upside exposure on the investor, whereas Alphabet’s non‑voting shares simply forgo governance while preserving full economic participation.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Comcast has no voting rights in Atairos, which is a VIE, and that it does not consolidate it—aligning with the ground truth. It accurately notes the $1.4 billion unfunded capital commitment as of December 31, 2024. However, the LLM introduces specific quantitative loss and return allocations—'99% of losses' and '86% of residual returns'—which are not present in the original answer and cannot be verified from the provided ground truth, representing an overprecision or potential hallucination. These percentages may exist in the source document but were not part of the verified knowledge graph answer, so their inclusion introduces unverified data. (2) The Alphabet portion correctly states that Class C shares carry no voting rights but have equivalent economic rights, and correctly contrasts governance concentration in Class A/B shares. However, the LLM omits the key fact from the original answer that Alphabet actively manages governance and share structure through large-scale repurchases—$62.0 billion in 2024—which is a critical element of how Alphabet maintains control. This omission weakens the completeness of the comparison. (3) The multi-hop reasoning is strong: the model correctly synthesizes the distinction between governance and economic exposure across two different corporate structures (VIE vs dual-class stock). The conceptual contrast—Comcast lacks control despite financial exposure, while Alphabet retains control via share structure—is well articulated and semantically aligned with the ground truth. (4) The contextual relevance is excellent, directly addressing the core comparison. The qualitative accuracy is high due to sound logic and correct entity mapping, but quantitative accuracy is reduced due to unverified percentages and missing the $62.0B repurchase figure. Correctness score is 8 because the core facts are accurate and the reasoning is solid, but there are notable omissions and additions that affect full fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 544,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC lists Austria among the countries where it operates its own bottling and distribution network, meaning the company has a dedicated production‑to‑retail footprint there. Philip Morris, by contrast, notes that it holds at least a 15 % market‑share in Austria, indicating a sizable but non‑exclusive presence that relies on its distribution and sales channels rather than owning bottling facilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 15% market share for Philip Morris in Austria is correctly reported, matching the original answer. No other numerical figures (e.g., Coca-Cola HBC’s 41% contribution to global volume via top bottlers) were included in the LLM response, but this omission does not introduce inaccuracy—only a slight reduction in completeness. (2) The entity identification is correct: Coca-Cola HBC and Philip Morris are accurately named, and their respective operational roles (bottling/distribution vs. tobacco market presence) are correctly attributed. (3) The reasoning is sound: the LLM correctly infers that Coca-Cola HBC has a dedicated physical footprint (production-to-retail) in Austria, while Philip Morris maintains a strong but non-exclusive presence through distribution channels, consistent with the original answer’s mention of 'exclusive zonified and direct distribution strategies.' (4) The answer is contextually relevant and directly compares the two companies’ operational footprints in Austria as requested. The only minor shortcoming is the omission of the detail about Coca-Cola HBC contributing to 41% of Coca-Cola’s global unit case volume through the top five bottlers, which adds contextual depth but is not central to the Austria-specific comparison. This does not impair the core factual correctness. Overall, the answer is semantically equivalent in substance, with precise quantitative reporting and strong multi-hop synthesis between corporate operations and market disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 434,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "Bank of America reported that its commercial‑real‑estate credit quality worsened in 2023, with the office‑property segment driving higher non‑performing loans and reservable‑criticized exposure (see BAC 10‑K p. 65). MetLife’s IBNR calculations for Protection Life and Protection Health use the Bornhuetter‑Ferguson method— which blends prior loss‑ratio expectations with emerging claim experience— and the company “updates the assumptions … annually to reflect emerging trends in claim experience” (see MET 10‑K p. 196). Thus, the heightened credit‑risk signal from BAC’s office‑loan deterioration feeds into MetLife’s need to give greater weight to recent experience and to revise its unpaid‑claims assumptions each year for those products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that BAC experienced a deterioration in commercial real estate credit quality in 2023, specifically in office properties, citing rising non-performing loans and criticized exposure (consistent with BAC’s 10-K). (2) It accurately states that MET uses the Bornhuetter-Ferguson method for estimating unpaid claims (IBNR) for Protection Life and Health products and updates assumptions annually to reflect emerging trends in claim experience, citing MET’s 10-K. (3) The multi-hop reasoning is sound: BAC’s credit deterioration signals broader macroeconomic stress, which could influence MET’s actuarial assumptions via updated loss ratios—especially for long-duration or experience-rated contracts. The only minor omission is not explicitly mentioning that MET’s expected loss ratios are sensitive to economic shifts or that adverse claim experience may be passed to sponsors, which slightly weakens the explanation of *how* the macroeconomic signal affects claims assumptions. However, the core logic—that BAC’s data serves as an early indicator influencing MET’s annual updates—is preserved. (4) All entities (BAC, MET, Protection Life and Health, Bornhuetter-Ferguson method), years (2023), and financial concepts are correct. Number formats and citations are appropriately handled. The answer is semantically equivalent to the original, with only slight compression of causal detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 407,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s equity is a single‑class structure – every share of its common stock is entitled to one vote per share, giving all shareholders equal voting power (see NFLX 10‑K, p. 60). Meta, however, operates a multi‑class system: its publicly traded Class A shares also carry one vote each, but a separate Class B series carries ten votes per share (and Class C is non‑voting), so control is concentrated in the higher‑voted Class B shares, making the influence of Class A shareholders far weaker than the uniform voting rights enjoyed by Netflix investors (see Meta 10‑K, p. 82; p. 1).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Netflix has a single-class structure with one vote per share, while Meta has a multi-class structure where Class A shares have one vote, Class B shares have ten votes, and Class C shares are non-voting—this aligns perfectly with the original answer. (2) All quantitative elements are correct: 'one vote per share' for Netflix and Meta Class A, 'ten votes per share' for Meta Class B—no calculations are required, but the comparison of voting power is accurately represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between the two companies, contrasting Netflix’s uniform voting rights with Meta’s control concentration via Class B shares. (4) The answer is fully relevant, directly addressing the comparison of voting rights structures and the influence of Class A stock in both firms. Minor additions (e.g., mention of Class C) enhance completeness without introducing error. Citations to 10-K pages further support accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 310,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PepsiCo notes that its exchange‑traded commodity futures are cash‑settled each day and therefore are **not presented in the fair‑value hierarchy table** (they are omitted from the Level 1 liability line) 【page_107】. In contrast, Mondelez classifies exchange‑traded commodity futures as **Level 1 financial liabilities (and assets)**, valuing them at quoted market prices on the exchanges and reporting a Level 1 liability amount (e.g., $46 million) in its fair‑value table 【page_112】. Thus, while both firms cash‑settle the contracts, PepsiCo excludes them from Level 1 reporting, whereas Mondelez includes them as Level 1 liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PEP excludes exchange-traded commodity futures from its fair value hierarchy table due to daily cash settlement, citing page 107, and that MDLZ includes them in Level 1 financial liabilities based on quoted market prices, citing page 112. The $46 million figure for MDLZ is consistent with the type of detail expected, though the original answer does not specify an amount—this addition does not contradict but enhances the response. (2) There are no numerical inaccuracies; the dollar amount is plausibly presented and format is appropriate. (3) The multi-hop reasoning is sound: the model correctly synthesizes treatment differences between two companies regarding the same instrument type, despite both using cash settlement. It captures the key distinction—PEP omits due to settlement timing, MDLZ reports at fair value as of balance date. (4) The only minor shortcoming is that the original answer emphasizes both treat them as Level 1 conceptually, but PEP excludes from reporting, while the LLM slightly implies PEP does not treat them as Level 1 at all—though this is nuanced. Still, the core factual and conceptual content is preserved. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 367,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "The Merck‑Gilead agreement splits development and commercialization costs 60 % to Gilead and 40 % to Merck, with revenues shared equally until each product exceeds $2 billion (oral) or $3.5 billion (injectable) in sales, after which Gilead’s share rises to 65 % (Gilead 10‑K p. 74). Pfizer’s 10‑K instead describes internal cost‑reduction programs—enterprise‑wide cost realignment and manufacturing optimization—aimed at lowering its own expense base rather than sharing risk with a partner (Pfizer 10‑K p. 30). Thus, Merck and Gilead mitigate their financial exposure to long‑acting HIV therapies through a defined cost‑share and tiered revenue split, whereas Pfizer’s exposure remains fully on its balance sheet but may be softened by overall cost‑saving initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the 60/40 cost split (Gilead/Merck), equal revenue sharing until thresholds of $2.0 billion (oral) and $3.5 billion (injectable), and Gilead's increased revenue share post-threshold (though the exact post-threshold percentage of 65% is mentioned in the LLM answer but not in the original, it is plausible and not contradicted). (2) Quantitative accuracy is excellent: all dollar amounts and percentages match or are consistent with the original. The LLM correctly interprets the tiered revenue structure and cost-sharing model. (3) Multi-hop reasoning is sound—correctly contrasting Merck-Gilead's risk-sharing partnership with Pfizer's internal cost-reduction initiatives (enterprise-wide realignment and manufacturing optimization) drawn from Pfizer’s 10-K. (4) The answer addresses all parts of the question: compares cost-sharing arrangements, describes Pfizer’s initiatives, and discusses implications for financial exposure. The only minor gap is that the original emphasizes the risk of Pfizer’s initiatives disrupting pipeline delivery (including HIV R&D), which the LLM implies but does not explicitly state. However, the core implication—Pfizer bears full financial exposure vs. shared risk—is clearly conveyed. Semantic equivalence is maintained with precise, slightly more detailed wording in the LLM response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 392,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx says that, although it is monitoring contracts that reference LIBOR, the ASU 2022‑06 changes have had no material effect on its results or cash flows and its exposure to LIBOR‑related hedging adjustments is essentially negligible. UPS, by contrast, has already transitioned its affected debt and other contracts to the Secured Overnight Financing Rate and continues to assess its hedging relationships, but likewise reports no material impact. Both companies can rely on the ASU 2022‑06 optional expedients through the extended sunset date of December 31 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states the extended sunset date of ASU 2022-06 as December 31, 2024, which matches the ground truth and is a key quantitative element. It also accurately notes that FDX has had no material effect from ASU 2022-06 and is monitoring LIBOR-related contracts. However, the LLM incorrectly claims that UPS has already transitioned its affected debt to SOFR and reports no material impact, which contradicts the ground truth stating that UPS may be actively leveraging the extended relief in its hedging relationships—implying ongoing use of LIBOR-related hedges and potential benefit from the extension. This misrepresents UPS’s position and undermines the comparative analysis. (2) All dates and technical terms (ASU 2022-06, LIBOR, hedging relationships) are correctly used, and there are no numerical inaccuracies. (3) The multi-hop reasoning is partially sound—linking ASU 2022-06’s extension to both companies’ hedging activities—but fails in synthesizing the correct contrast: FDX has negligible exposure, while UPS is likely still using the relief for active hedging. Instead, the LLM suggests both have minimal impact, missing the nuance that UPS could be actively benefiting from the extension. (4) The answer is contextually relevant and well-structured, but the qualitative inaccuracy regarding UPS’s hedging strategy significantly reduces correctness. While the factual components are well-presented, the core comparative insight is flawed, warranting a moderate score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 418,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "Meta’s dual‑class structure gives its ten‑vote Class B shares to the CEO and a small group of insiders, concentrating voting power and “limit[ing] or preclude[ing]” ordinary shareholders’ ability to influence corporate matters (Meta 10‑K pp. 49‑50). Alphabet’s Class B shares also carry ten votes per share, but they can be converted at any time and automatically convert to one‑vote Class A shares upon sale or transfer, which erodes the voting‑power differential as shares change hands and thus provides comparatively greater protection for other investors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core differences between META's and GOOGL's dual-class structures with high precision. (1) All key facts are correct: both companies have 10-vote Class B shares, GOOGL's Class B shares convert to Class A upon sale or transfer, and this conversion mechanism limits long-term insider control. The statement that Meta’s structure limits shareholder influence aligns with the ground truth regarding reduced governance protections. (2) Quantitative accuracy is perfect: the 10-to-1 voting ratio for Class B shares in both companies is correctly stated, and no erroneous numbers or calculations are present. Format and phrasing (e.g., 'ten votes per share') match the ground truth semantically. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ structures and draws a valid comparative conclusion that GOOGL’s conversion feature provides greater eventual balance and investor protection. The only minor omission is that the ground truth specifies Meta’s Class B voting power persists unless it drops below 35% of total voting power, which adds a precise threshold not mentioned in the LLM response. This detail is important but not central to the main comparison. (4) Contextual relevance is excellent—the response directly addresses the comparative impact on investor protections and voting power differential as asked. Overall, the answer is semantically equivalent to the ground truth with only a slight lack of completeness regarding Meta’s 35% threshold, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 436,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO ( Coca‑Cola) uses option (and forward) contracts as **designated cash‑flow hedges** for forecasted foreign‑currency transactions; the fair‑value changes on those options are first recorded in other‑comprehensive income and later re‑classified into earnings when the underlying transaction occurs, thereby smoothing earnings volatility (see KO 10‑K pp. 81 & 121). MDLZ, by contrast, reports the after‑tax gains and losses on its forecasted‑transaction hedges as **economic hedges** that are recognized directly in the income statement (e.g., $106 m in cost‑of‑sales for 2024 and $17 m in interest expense), indicating the hedges are not designated for hedge accounting and affect earnings immediately (see MDLZ 10‑K pp. 96‑97).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: MDLZ's $106 million gain through cost of sales and $17 million through interest and other expense in 2024 are accurately reported, matching the original answer. No calculations were required, but the figures are cited correctly. (2) The LLM correctly identifies KO’s use of option contracts as designated cash flow hedges, with gains/losses initially recorded in AOCI (referred to as other comprehensive income) and reclassified into earnings upon transaction occurrence—this matches the original answer’s description of deferred recognition to reduce earnings volatility. (3) For MDLZ, the LLM correctly observes that gains and losses are recognized directly in the income statement, specifying the line items and amounts, which reflects the original answer’s emphasis on granular disclosure of realized impacts. The inference that MDLZ’s hedges are likely treated as economic (undesignated) hedges—due to immediate earnings impact—is a reasonable interpretation supported by accounting standards and adds analytical value, even if not explicitly stated in the ground truth. (4) The only minor shortcoming is that the original answer contrasts KO’s structured hedging *strategy* with MDLZ’s *disclosure practices*, while the LLM focuses more on accounting treatment differences. However, this distinction is subtle and the core multi-hop synthesis—comparing KO’s deferral approach with MDLZ’s immediate recognition and disclosed amounts—is sound and factually correct. Wording differs slightly but semantic equivalence is maintained. No entity, metric, or year errors. Citations to 10-K pages add credibility but are not required for scoring. Overall, this is a strong, factually accurate response with excellent reasoning and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 504,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s pension tables list its fixed‑income funds in the “not subject to leveling” column (e.g., $739 million of domestic fixed‑income funds) – they are measured using a NAV practical‑expedient and are not placed in the Level 1‑3 fair‑value hierarchy, so the company does not rely on quoted market prices for those assets. Bristol‑Myers Squibb, on the other hand, classifies its fixed‑income funds as Level 2 (e.g., $785 million in 2023), meaning they are valued using observable inputs such as bond yields and prices for similar securities, indicating a greater reliance on observable market data for pension‑asset valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that TMO (Thermo Fisher) reports fixed income funds as 'not subject to leveling,' using the NAV practical expedient, which places them outside the Level 1–3 fair value hierarchy—consistent with the original answer’s claim of being valued outside the standard hierarchy. BMY (Bristol-Myers Squibb) is correctly noted to classify its fixed income funds under Level 2, indicating use of observable inputs. (2) The dollar amounts cited—$739 million for TMO and $785 million for BMY—are factually correct per the knowledge graph and appropriately contextualized, though the original answer does not include these specific figures; their inclusion adds precision without introducing error. Format variations are acceptable. (3) The multi-hop reasoning is sound: the model correctly contrasts TMO’s exclusion from the hierarchy (NAV-based, less reliance on market prices) with BMY’s Level 2 classification (reliance on observable market data like yields and prices for similar securities), drawing the correct inference about differing reliance on market data. (4) Semantic equivalence is strong—while the LLM adds specific dollar figures and mentions the NAV practical expedient (which enriches but does not contradict the ground truth), the core meaning and analytical contrast are preserved. The only minor point preventing a perfect 10 is that the original answer emphasizes the structural implications of BMY’s methodology more explicitly, which the LLM implies but doesn’t fully elaborate. Overall, the response is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 455,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Lockheed Martin notes that its cost‑plus‑fixed‑fee contracts are governed by FAR clauses that give the government ownership of work‑in‑process and a right to terminate for convenience, so the company treats the contract as a single performance obligation and records revenue **over time** as costs are incurred (percentage‑of‑completion)【page_77】. Boeing’s filing, by contrast, says that under FAR a contract terminated for convenience entitles it to payment for **work completed**, implying revenue is recognized when the performance obligation is satisfied or the bill is earned rather than continuously【page_7】. Thus, FAR causes Lockheed to recognize U.S.‑government revenue continuously throughout performance, while Boeing’s revenue may be recognized later, at the point of completion or billing, creating a timing difference.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers or miscalculations, it is scored as 10 by default. The contextual relevance is high because the response addresses the core topic—FAR's impact on revenue recognition timing for LMT and BA (Boeing). However, the qualitative accuracy is low due to significant misrepresentation of Boeing’s revenue recognition policy. The original answer (ground truth) states that both LMT and BA have comparable revenue recognition patterns under FAR, with both recognizing revenue progressively due to termination for convenience clauses that entitle them to payment for costs incurred plus profit. The LLM incorrectly interprets Boeing’s disclosure to mean that revenue is recognized only upon completion or billing, suggesting a point-in-time model, which contradicts the ground truth that BA also recognizes revenue over time. This misinterpretation breaks the multi-hop reasoning: while LMT's treatment is accurately described, BA's is not, leading to an erroneous conclusion about a timing difference. The ground truth emphasizes that both companies have similar patterns under FAR, with only potential minor differences due to contract specifics—whereas the LLM invents a structural divergence. Thus, despite correct entity identification and relevant context, the reasoning and factual synthesis are flawed, warranting a correctness score of 4 for partial accuracy on LMT but major error on BA.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 423,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s senior‑note indentures name U.S. Bank National Association solely as the trustee – the filing does not show a separate issuing entity. In Abbott’s case, the notes are issued by Abbott Ireland Financing DAC, with U.S. Bank National Association again acting as trustee, and the series was launched with the September 2018 indenture and followed by supplemental issuances in November 2019 and June 2020. Thus, both companies rely on the same trustee, but Abbott uses a distinct Irish issuer and provides a clear, multi‑year note‑issuance timeline.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between AbbVie and Abbott Laboratories regarding the use of U.S. Bank National Association as trustee and the issuance of notes through different structures, which maintains contextual relevance. However, there are significant quantitative inaccuracies: the LLM states a June 2020 supplemental issuance for Abbott, but the ground truth specifies the November 19, 2019 Second Supplemental Indenture, with no mention of June 2020. Additionally, the LLM omits the May 14, 2020 agreements for AbbVie (Supplemental Indentures No. 8 and 9), instead implying a simpler structure. The LLM incorrectly claims that AbbVie’s filings do not show a separate issuing entity and that U.S. Bank acts solely as trustee, whereas the ground truth indicates AbbVie uses Elavon Financial Services DAC as a paying agent via Agency Agreements, which is a key structural difference. The answer also fails to mention specific notes issued by Abbott Ireland Financing DAC (e.g., 1.500% Note due 2026, 0.100% Note due 2024), which are important for completeness. While the high-level reasoning about Abbott using a distinct Irish issuer is correct, the LLM misses the multi-hop nuance that Abbott Ireland Financing DAC is the issuer with Abbott Laboratories as guarantor, and underplays AbbVie’s use of Elavon. Thus, while the qualitative understanding of trustee roles and issuance timelines is partially sound, the answer lacks precision in dates, omits key entities and roles, and contains factual errors in the timeline description, reducing its overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 432,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVDA’s supply chain is tightly tied to its foundry partners—especially TSMC—to fabricate its newest GPUs and CPUs on the most advanced 7 nm‑and‑smaller nodes, so any capacity or yield shortfall at TSMC would directly curtail NVDA’s flagship products (NVDA 10‑K p. 18). By contrast, AMD also uses TSMC for its leading‑edge chips but sources the majority of its microprocessor and GPU volume on larger‑node wafers (≥ 7 nm) from GlobalFoundries and other foundries, making its competitive IC production less concentrated on TSMC’s most advanced capacity (AMD 10‑K p. 23‑24). Thus NVDA’s risk is more focused on advanced‑node fab availability, whereas AMD’s exposure is spread across both advanced and larger‑node fabs.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy that undermines its qualitative accuracy. (1) Quantitatively, there are no numeric errors—the answer does not introduce incorrect numbers, dates, or financial figures, so quantitative accuracy is high. (2) However, the key claim that AMD sources 'the majority of its microprocessor and GPU volume on larger-node wafers (≥ 7 nm) from GlobalFoundries and other foundries' is incorrect and contradicts the ground truth. AMD’s 10-K filings indicate a strategic shift to TSMC for advanced nodes (7nm, 6nm, 5nm), and GlobalFoundries no longer manufactures leading-edge AMD products; AMD does not produce the majority of its volume on larger nodes from alternative foundries. Instead, like NVDA, AMD relies heavily on TSMC for advanced process nodes. (3) The multi-hop reasoning is flawed: while the model attempts to contrast NVDA and AMD’s foundry strategies, it incorrectly infers a structural difference in TSMC dependency. In reality, both companies are highly dependent on TSMC for 7nm and smaller nodes, creating a shared supply chain risk, as stated in the ground truth. The LLM answer wrongly suggests AMD has diversified away from TSMC for competitive IC production, which is not supported by current disclosures. (4) Despite this, the answer is contextually relevant and correctly identifies TSMC as a critical supplier for both firms and the risks of advanced-node concentration. The contrast drawn is logical in structure but based on incorrect underlying facts, leading to a correctness score of 5—partially correct but with a major error in entity and strategic relationship accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 454,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "The WTO panel decision shows that Thailand’s customs‑valuation and tax rules for imported cigarettes remain unsettled and may be revised, creating ongoing regulatory uncertainty 【page_68】. Because Colgate‑Palmolive operates a major overseas manufacturing and warehousing facility in Thailand 【page_25】, any changes to customs valuation or tax treatment could increase the cost of importing raw materials or exporting finished products and expose the company to heightened compliance scrutiny, potential penalties or delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the unresolved WTO panel decision and its implications for Thailand's customs and tax practices, noting the regulatory uncertainty. The mention of Colgate-Palmolive's manufacturing and warehousing presence in Thailand aligns with the original answer. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the model connects the Philip Morris/WTO customs dispute to the broader regulatory environment in Thailand and correctly infers that Colgate-Palmolive, as a manufacturer in the same jurisdiction, could face increased costs or compliance risks due to inconsistent customs enforcement. The only minor omission is not explicitly stating that Thailand has not complied due to the inoperability of the WTO Appellate Body, which slightly weakens the causal chain but does not undermine the core logic. (4) The answer is highly contextually relevant, directly addressing how unresolved customs issues in Thailand could impact Colgate-Palmolive’s operational costs and regulatory exposure. Wording differs but meaning is preserved. Thus, correctness is high—9/10—with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 378,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UNH reported that its stand‑alone Medicare Part D membership fell from 3.315 million in 2023 to 3.050 million in 2024 – a drop of 265 thousand enrollees (‑8 %)【page_31】.  The filing links that decline to the IRA‑driven redesign of Medicare Part D, which imposes new discount and out‑of‑pocket‑cap rules that are already curbing enrollment and revenue for insurers.  Pfizer’s 10‑K notes that the same IRA redesign will force manufacturers to provide larger discounts and price‑setting under Medicare Part D, creating an estimated $1 billion revenue hit in 2025【page_17】.  In short, the IRA’s Part D changes are shrinking UNH’s enrollment while simultaneously eroding Pfizer’s future sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 265,000 decline in UNH's Medicare Part D enrollment (from 3.315 million to 3.050 million), which matches the ground truth's implied numeric drop (though ground truth states $265,000, this appears to be a typo—context confirms it should be 265,000 enrollees, not dollars). The LLM correctly interprets this as an 8% decline and cites the correct years (2023 to 2024). It accurately references Pfizer’s projected $1 billion revenue loss in 2025 due to IRA changes. All numeric values, percentages, and timeframes are correct and properly contextualized. (2) The calculation of the enrollment drop (3.315M - 3.050M = 265,000) is accurate. The 8% decline is approximately correct (265,000 / 3.315M ≈ 8.0%). The $1 billion revenue loss for Pfizer in 2025 is correctly stated. The only discrepancy is the ground truth’s '$265,000'—this is likely a transcription error in the original answer, as a decline in enrollment would be measured in people, not dollars. The LLM correctly interprets it as 265,000 enrollees. (3) The multi-hop reasoning is sound: the LLM connects UNH’s enrollment decline to the IRA’s Part D redesign, links the same IRA provisions to Pfizer’s revenue loss, and synthesizes information from both companies’ filings. It correctly identifies the causal chain: IRA changes → increased costs for insurers and manufacturers → reduced enrollment (UNH) and projected revenue loss (Pfizer). The reasoning is slightly more direct than the ground truth but semantically equivalent. (4) The LLM answer is contextually excellent, directly addressing the relationship between the enrollment decline and the IRA’s impact on both UNH and Pfizer. The qualitative accuracy is high, though it could have mentioned the $2,000 out-of-pocket cap and manufacturer discount structure (10%/20%) for full parity with the ground truth. However, the core logic and synthesis are intact. Thus, correctness is 9/10 due to minor omission of specific IRA mechanics, but quantitative accuracy is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 550,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reports $4,863 million of private‑equity fund assets measured at NAV (see LMT page 88), whereas FedEx applies the NAV practical expedient only to a small slice of its equity‑security portfolio—$37 million in 2024 (see FedEx page 117). Thus, Lockheed’s NAV‑valued holdings are roughly $4.8 billion larger, reflecting a far more extensive reliance on the NAV approach than FedEx.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states Lockheed Martin's $4,863 million investment in private equity funds valued using the NAV practical expedient, it incorrectly claims FedEx applies the NAV expedient to only $37 million of equity securities. The original answer (ground truth) does not provide any specific dollar amount for FedEx’s NAV-based investments—only qualitative information about its accounting policy and immaterial impairments. This $37 million figure is unsupported by the provided ground truth and appears to be hallucinated or derived from external data not in the context. (2) The calculation comparing $4.863 billion to $37 million (implying a $4.8 billion difference) is therefore invalid due to the fabricated FedEx number. No such quantitative comparison can be made based on the original answer. (3) The multi-hop reasoning is partially sound in intent—comparing how two companies apply the NAV practical expedient—but fails because it introduces data not present in the ground truth. The original answer emphasizes qualitative differences in application: Lockheed Martin uses NAV for private equity with unobservable inputs and long-term commitments, while FedEx applies the measurement alternative with adjustments only for observable price changes and impairments, which it deems immaterial. The LLM misses this nuance and replaces it with a false quantitative contrast. (4) Despite the incorrect numbers, the answer remains contextually relevant by addressing the core question about comparative use of the NAV expedient and citing appropriate document locations. However, the hallucinated figure severely undermines factual correctness, warranting a low quantitative accuracy score and a moderate overall correctness score due to partial alignment with the conceptual comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 505,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "Comcast’s Class B shares carry ten‑to‑fifteen votes each and represent a fixed one‑third of the company’s total voting power; they may be converted at the holder’s option (or automatically on transfer) into one‑vote Class A shares, which reduces the holder’s voting influence while the aggregate 33 % voting power of Class B remains non‑dilutable【page_82】【page_91】. Alphabet’s dual‑class structure separates voting rights into Class A (1 vote), Class B (10 votes held by insiders) and non‑voting Class C shares, and the 2024 $62 billion repurchase of Class A and Class C shares simply shrinks the pool of low‑vote and non‑voting shares—effectively increasing the relative weight of the insider‑controlled Class B votes rather than converting or diluting them【page_80】【page_82】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies GOOGL's $62.0 billion 2024 share repurchase targeting Class A and Class C shares and notes that this increases the relative voting weight of Class B shares, which aligns with the ground truth. It also correctly states that CMCSA's Class B stock holds a fixed 33% (one-third) of voting power that is non-dilutable. However, it inaccurately claims CMCSA Class B shares carry 'ten-to-fifteen votes each,' which is false—CMCSA Class B shares do not have a per-share vote count but instead collectively hold one-third of total voting power regardless of share count. This is a significant qualitative error. (2) Quantitatively, the $62 billion figure and 33% voting power are correct, and the year 2024 is accurate. The format variation ($62 billion vs $62.0 billion) is acceptable. No calculation errors are present. (3) The multi-hop reasoning is mostly sound: the model correctly contrasts CMCSA’s fixed voting power structure with GOOGL’s repurchase-driven concentration of voting power. However, the incorrect attribution of per-share voting multiples to CMCSA undermines the reasoning, as it misrepresents the mechanism (fixed aggregate power vs. per-share super-voting). (4) Scores reflect that core facts (repurchase amount, year, structural differences in voting concentration) are correct and the answer is highly relevant, but a key factual error about CMCSA’s voting mechanism prevents a higher score. Semantic equivalence is partially achieved, but not fully due to the erroneous voting rights description.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 430,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s 50 % ownership of Red Oak Sourcing is a joint‑venture that merely negotiates generic‑drug supply contracts for CVS and Cardinal and does not represent a material, disclosed portion of CVS’s consolidated revenue【page_18】. In contrast, Cardinal Health is one of Eli Lilly’s three largest U.S. distributors, contributing about 15 %–20 % of Lilly’s consolidated revenue, indicating a far larger revenue reliance on that partner【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 50% ownership of Red Oak Sourcing by CVS and the 15%–20% contribution of Cardinal Health to LLY’s consolidated revenue are accurately reported. Format variations (e.g., 15–20% vs 15 %–20 %) are acceptable. (2) The answer correctly identifies the entities: CVS, Red Oak Sourcing, Cardinal Health, and Eli Lilly (LLY), with proper roles. (3) Multi-hop reasoning is sound: it contrasts CVS’s non-material, operational role in Red Oak (a sourcing JV that does not generate direct revenue) with LLY’s significant revenue dependence on Cardinal Health as a top distributor. (4) While the LLM omits the explicit mention that Red Oak serves both CVS and Cardinal or that there are three major distributors (McKesson, AmerisourceBergen), these omissions are minor and do not detract from the core comparison about revenue exposure. The key insight—that LLY has far greater revenue reliance on Cardinal than CVS does—is correctly conveyed. Semantic equivalence is maintained. One point deducted from qualitative accuracy for slight incompleteness in contextual detail, but correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 339,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "Honeywell’s common stock provides one vote per share (see HON 10‑K, Note 18, page 96). The UPS 10‑K pages provided (e.g., the balance‑sheet summary on page 69) list Class B common stock but do not state how many votes each share carries, so the voting‑right difference cannot be calculated from the documents supplied.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that UPS's Class B voting rights are not disclosed in the provided documents. The ground truth states that UPS's Class B common stock has 10 votes per share, which should have been extractable from the UPS 10-K (e.g., in governance or stock structure sections). The LLM incorrectly concludes that the difference cannot be calculated due to missing data, when in fact the necessary information was available in the source filings. (2) Quantitatively, the LLM fails to report the correct voting rights: it correctly identifies Honeywell’s 1 vote per share (from Note 18, page 96), but omits UPS’s 10 votes per share, leading to a complete failure in calculating the 9-vote difference. This results in a major quantitative error. (3) The multi-hop reasoning is flawed: the question requires comparing voting rights across two companies (UPS and Honeywell) using their respective 10-Ks. The LLM acknowledges Honeywell's data but incorrectly claims insufficient data from UPS, failing to synthesize the two data points. This breaks the multi-hop logic chain. (4) Contextual relevance is moderate because the LLM attempts to reference specific document locations and understands the structure of the question, but its conclusion is incorrect due to failure in data extraction. Correctness and quantitative accuracy are very low due to missing core facts and miscalculating the difference as 'unknown' instead of 9 votes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 408,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s 3.625 % notes were issued with a 2024 maturity, so when those notes were repaid the related $1.4 billion of interest‑rate swap contracts were terminated at the end of 2024 【page_149】.  By contrast, AbbVie’s interest‑rate swap contracts were employed as hedge instruments in 2024 but were not tied to a 2024 note maturity – the only cash‑flow‑designated swaps AbbVie mentions had previously matured in November 2022, and its 2024 swaps were primarily fair‑value hedges that remained in effect rather than being terminated by a note’s maturity 【page_81】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It incorrectly states that AbbVie employed interest rate swap contracts as hedge instruments in 2024, claiming they were 'primarily fair-value hedges that remained in effect.' However, the original answer clearly states that ABBV had $0 in active interest rate swap contracts designated as cash flow hedges in 2024, and there is no mention of fair value hedges being active. This misrepresents ABBV's actual hedging activity. (2) Quantitatively, the AMGN portion is correct: the 3.625% 2024 Notes matured in 2024 and triggered the termination of $1.4 billion in swaps — this matches the ground truth. However, the ABBV data is wrong: the LLM claims swaps were active in 2024, while the ground truth states ABBV had no cash flow hedges in 2024 and only $6 million in 2022, which the LLM does not contradict directly but fails to accurately reference. The mention of a November 2022 maturity for ABBV’s previous swaps is plausible but not confirmed in the ground truth, which only notes a drop from $6M in 2022 to $0 in 2024 without specifying a date. (3) The multi-hop reasoning is partially sound — the model attempts to compare AMGN’s maturity-triggered swap termination with ABBV’s use of swaps — but it draws an incorrect contrast by asserting ABBV had active 2024 swaps. This undermines the synthesis. The model also conflates hedge types (cash flow vs. fair value), which is not supported by the original answer and introduces unsupported complexity. (4) The contextual relevance is high because the structure and intent align with the question, and it references appropriate documents. However, due to the critical error in ABBV’s 2024 hedge status, the qualitative and correctness scores are significantly reduced. The answer is partially correct on AMGN but mostly incorrect on ABBV, leading to a correctness score of 4.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 521,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "After adopting ASU 2022‑02, Capital One replaced its troubled‑debt‑restructuring (TDR) disclosures with financial‑difficulty‑modification (FDM) reporting that breaks out each modification type—interest‑rate cuts ($687 m), term extensions ($970 m), principal reductions ($21 m), combined rate‑and‑term changes ($711 m) and other ($460 m)—and shows the weighted‑average interest‑rate reductions (e.g., 19.3% for domestic cards) and payment‑delay durations for each loan segment. JPMorgan’s pre‑ASU TDR disclosures, by contrast, aggregated concessions (e.g., 54 % of loans received rate cuts, 67 term extensions in 2022) and summarized overall financial effects such as a drop in weighted‑average rate from 4.75 % to 3.35 % and an extension of the average term from 22 to 38 years, without the granular segment‑level detail that Capital One now provides.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details, despite addressing the right conceptual framework. (1) Quantitative Accuracy: The dollar amounts cited for Capital One's FDMs ($687M, $970M, etc.) are not present in the ground truth and are likely fabricated; the ground truth only mentions JPMorgan reporting $136M in FDMs for 2023. The interest rate reductions (e.g., 19.3% for domestic cards) and payment-delay durations are not supported by the original answer. For JPMorgan’s pre-ASU TDRs, the LLM claims a drop from 4.75% to 3.35%, but the ground truth states a reduction from 7.21% to 4.44% post-adoption in 2023—not pre-ASU. Also, the claim that the average term extended from 22 to 38 years contradicts the ground truth, which states extensions by 20 years (not to 38). (2) Completeness: The answer attempts to cover both companies and the shift from TDRs to FDMs, but misattributes granular disclosures to Capital One without evidence in the ground truth, which does not specify Capital One’s segment-level data. The original answer emphasizes that modification types remained the same across frameworks, which the LLM omits. (3) Entity Accuracy: Companies (Capital One, JPMorgan) and standards (ASU 2022-02, TDR, FDM) are correctly identified, and the general timeline (pre- vs post-adoption) is appropriate. (4) Reasoning: The multi-hop synthesis is partially sound—comparing disclosure granularity between pre-TDR and post-FDM reporting—but based on incorrect data. The conclusion about increased granularity is speculative and not directly supported in the ground truth, which focuses on standardized reporting rather than enhanced detail. (5) Semantic Equivalence: The overall structure mirrors the question’s intent, but the factual foundation is flawed. While the shift in reporting framework is acknowledged, the specific financial effects are misrepresented. Due to major numerical errors and unsupported claims, the correctness score is low despite relevant context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 544,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s swaps are structured so that the dollar‑weighted average maturity (about two years) “generally matches the duration of the activities that are at risk,” effectively aligning swap maturities with the specific debt exposure they are intended to hedge (GD 10‑K p. 82). UPS, by contrast, uses an “economic‑hedge” approach that matches the overall maturity profile of its interest‑rate swaps to the aggregate schedule of its debt rather than on a one‑to‑one basis (UPS 10‑K p. 136). This shows GD prioritizes precise cash‑flow matching to eliminate mismatches, while UPS focuses on managing the net economic impact of interest‑rate changes across its entire debt portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies GD's two-year dollar-weighted average maturity and its alignment with the duration of at-risk activities, citing the correct document (GD 10-K p. 82), which matches the ground truth. It also accurately references UPS's economic hedge approach and cites UPS 10-K p. 136. However, there is a key misrepresentation in the qualitative interpretation: the LLM claims UPS matches the 'overall maturity profile' of swaps to its debt 'aggregate schedule,' implying some form of maturity alignment, whereas the ground truth states UPS does *not* specify maturity alignment and instead emphasizes using offsetting positions to terminate swaps and eliminate market valuation effects. This mischaracterizes UPS’s strategy as more structurally aligned than it is, missing the emphasis on dynamic offsetting transactions over duration matching. While the core facts about GD are correct and the contrast is partially valid, the reasoning misrepresents UPS’s approach, leading to an inaccurate inference about its risk management priority. The LLM suggests UPS manages 'net economic impact' through maturity profiling, but the ground truth reveals it does so through termination via offsetting positions—highlighting a different mechanism (transactional agility vs. structural alignment). Thus, while numbers and sources are accurate (quantitative accuracy = 10), the qualitative synthesis is partially flawed, reducing the correctness score to 7. Contextual relevance remains high as the response directly addresses the comparative risk management question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 431,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 buy‑backs were limited to its voting Class A shares (1 vote each) and non‑voting Class C shares, cutting the number of voting shares outstanding while leaving the 10‑vote Class B shares untouched; this shrinks the denominator of total votes and therefore raises the relative voting power of the undiluted Class B shares【page_81】. In contrast, Comcast’s charter expressly fixes its single‑shareholder Class B stock at a non‑dilutable one‑third (33 ⅓ %) of the combined voting power, so repurchases of Class A shares do not change that voting‑power percentage【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet's 2023 repurchase of Class A and Class C shares (though the $62.2B figure is omitted, this does not appear in the LLM answer and is not referenced in the provided pages cited), the 10-vote structure of Class B shares, and the fact that repurchases of voting Class A and non-voting Class C shares increase the relative voting power of Class B shares by reducing the total voting denominator. (2) Quantitative accuracy is strong: while the $62.2B figure from the original answer is missing, the LLM does not make any numerical claims that contradict it, and the percentages and vote weights (1, 10, and 15 votes per share) are correctly implied or stated. The 33 1/3% non-dilutable voting power at Comcast is accurately described. (3) Reasoning is sound: the LLM correctly explains the mechanism—reducing the number of voting shares outstanding increases the relative influence of the unchanged Class B shares. It also correctly contrasts Alphabet’s structural outcome (increased relative voting power due to repurchases) with Comcast’s legally fixed voting percentage, which is contractually insulated from share count changes. (4) The only minor shortcoming is the omission of the explicit comparison that both companies use dual-class structures for long-term control, and that Alphabet’s repurchases 'amplified' concentration—this contextual synthesis is slightly less developed than in the original, but the core multi-hop reasoning (impact of buybacks on voting power + cross-company structural comparison) is fully present. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both parts of the question with precise, document-supported logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 491,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Rule 10b5‑1 plan at Disney authorizes the sale of up to **372,412 shares** of Disney common stock and is slated to **terminate on December 17 2024** (subject to early termination)【DIS, p.61】. Peggy Alford’s Rule 10b5‑1 plan at Meta authorizes the sale of **up to $1.2 million worth of Class A shares** and will **terminate on November 15 2025** (subject to early termination)【META, p.124】. Both plans rely on the same regulatory framework, but Iger’s is share‑count specific and ends about a year earlier, whereas Alford’s is value‑based and runs for roughly a year longer.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412) for Robert Iger at DIS and the $1.2 million value for Peggy Alford at META are correctly reported. Termination dates (December 17, 2024, for Iger; November 15, 2025, for Alford) are accurate. (2) Completeness: The answer addresses all parts of the question—structure (share count vs. value-based), number of shares/dollar amount, termination dates, and the shared regulatory framework under Rule 10b5-1. (3) Entity accuracy: Companies (DIS/META), individuals (Iger/Alford), stock types (Class A common stock), and regulatory rule (10b5-1) are correctly identified. (4) Reasoning: The multi-hop comparison is sound—correctly contrasts Iger’s fixed-share plan tied to expiring options (implied from context) with Alford’s value-based plan and notes the difference in duration. The observation that Alford’s plan runs about a year longer is accurate (difference of ~11 months). (5) Semantic equivalence: Though slightly rephrased, all key information is preserved and correctly synthesized from the two sources. Minor additions like 'subject to early termination' are contextually appropriate and do not detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 351,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards all have roughly three‑year vesting periods – stock options vest ratably over three years, time‑vested RSUs vest at the end of a three‑year restriction period, and performance‑based RSUs vest after a three‑year performance cycle【page_96】. Philip Morris International’s RSU awards likewise vest on the third anniversary of the grant date, i.e., a three‑year schedule【page_110】. As a result, Colgate‑Palmolive spreads the compensation expense for its unvested awards over weighted‑average periods of about 1.4–1.6 years, while PMI amortizes RSU expense over the three‑year restriction period but expects to recognize its $160 million of unvested RSU cost over a weighted‑average of roughly 17 months (≈1.4 years), meaning both companies expense the awards before the full vesting period, with similar timing【page_97】【page_98】【page_110】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both CL and PM have three-year vesting timelines for equity awards, with CL using stock options that vest ratably over three years and PM using RSUs that vest on the third anniversary. It also correctly states that PM had $160 million in unrecognized compensation costs expected to be recognized over a weighted-average period of 17 months (~1.4 years), aligning with the ground truth. However, the LLM incorrectly attributes time-vested and performance-based RSUs to Colgate-Palmolive (CL), which is not supported by the original answer — the ground truth only mentions stock options for CL, not RSUs. This is a significant qualitative error in entity/metric attribution. (2) Quantitatively, all numbers are accurate: $160 million, 17 months (~1.4 years), and the comparison to CL’s 1.4–1.6-year expense recognition period are correctly reported. The conversion of 17 months to ~1.4 years is acceptable. (3) The multi-hop reasoning is mostly sound — the model correctly compares vesting schedules and links them to compensation expense recognition patterns. However, it introduces RSUs for CL without evidence, which undermines the synthesis. The conclusion that both companies expense awards before full vesting is reasonable given the weighted-average recognition periods, though PM’s acceleration due to triggering events (death, disability, age 58) is omitted, weakening the explanation of *why* PM recognizes expenses earlier. (4) Scores reflect high factual accuracy in numbers and relevance to the question, but docked for introducing unsupported equity types for CL and missing key nuance in PM’s early vesting triggers, affecting qualitative accuracy and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 474,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Both companies say that bans on characterising flavours and moves toward plain‑ or standardized packaging strip away the visual and sensory cues that underpin their brands. Philip Morris notes that the EU Tobacco Products Directive’s flavour ban, mandatory health‑warning coverage and plain‑packaging rules – and similar proposals elsewhere – force reformulation and limit branding, which can erode brand equity and curb premium‑price positioning in its key international markets (PM 10‑K pp. 41‑42, 16). Altria likewise warns that U.S. and foreign restrictions on flavour, branding, packaging and advertising diminish its ability to differentiate products, reinforce down‑trading to lower‑priced tiers and limit price‑increase flexibility for its premium and mid‑price brands (MO 10‑K pp. 15‑42).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the impact of flavor bans and standardized packaging on brand equity and pricing power for both PM and MO. It accurately references regulatory actions such as the EU Tobacco Products Directive and cites correct document sources (PM 10-K pp. 41-42, MO 10-K pp. 15-42), though exact page numbers are not part of the ground truth and may vary by filing year—this is acceptable as long as the reference is plausible. There are no numeric values in the original or LLM answer, so quantitative accuracy is scored as 10 by default. The LLM captures the key qualitative mechanisms: erosion of brand equity due to loss of sensory and visual differentiation, constraints on premium pricing, and reduced marketing flexibility. However, it omits specific examples mentioned in the ground truth, such as PM’s exposure to menthol bans in Turkey and Brazil, the 8% illicit trade in the EU, and MO’s state-level restrictions in six U.S. states plus D.C., including California’s delayed menthol ban and proposed nicotine caps in Massachusetts. These omissions reduce completeness and slightly weaken multi-hop synthesis, particularly around jurisdiction-specific risks. Still, the reasoning is sound, logically connecting regulatory restrictions to brand and pricing outcomes. The answer is highly relevant to the question and conveys semantically equivalent information, albeit with less granular detail. Thus, correctness and qualitative accuracy are slightly reduced due to missing specifics, but overall the response is strong and factually aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 440,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG quantifies its RMBS exposure by recording an allowance for credit losses (e.g., a $48 million allowance on its mortgage‑backed securities) and by making prospective yield adjustments that incorporate expected credit losses and updated pre‑payment expectations 【page 170】; Bank of America, by contrast, reflects RMBS valuation risk in Level‑3 fair‑value models that depend on unobservable inputs such as pre‑payment speed (average 12 % CPR) and default rate (average 1 % CDR), so changes in those assumptions can materially swing the fair value of its holdings 【page 159‑161】.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core accounting and risk treatment differences between AIG and BAC regarding RMBS. AIG's approach—using allowance for credit losses and prospective yield adjustments based on expected cash flows, credit losses, and prepayment expectations—is accurately described and aligns with the ground truth. BAC's reliance on Level-3 fair-value models with sensitivity to unobservable inputs like prepayment speed (CPR) and default rate (CDR) is also correctly characterized. The mention of specific figures—$48 million allowance, 12% CPR, 1% CDR—adds precision. However, the ground truth does not specify these exact numbers (e.g., $48M, 12% CPR, 1% CDR), so while plausible and contextually consistent, their inclusion introduces unverifiable quantitative claims not present in the original answer, slightly reducing quantitative accuracy. (2) The numbers are internally consistent and format-appropriate, but since the ground truth does not include specific dollar amounts or percentages, their addition—while potentially accurate—cannot be confirmed and risks overprecision. (3) The multi-hop reasoning is sound: the model correctly synthesizes AIG’s accounting treatment (amortized cost, yield recalculations, credit loss allowances) with BAC’s valuation risks (fair value sensitivity to prepayment and default assumptions), drawing a valid contrast in risk focus—AIG on cash flow and credit loss adjustments, BAC on model-driven valuation volatility. (4) The answer is semantically equivalent to the ground truth in qualitative terms, with excellent contextual relevance and strong reasoning. The minor deduction in quantitative accuracy is due to unsupported specific figures, but overall correctness remains high as the conceptual and comparative framework is fully accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 495,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom treats its cyber‑security developed technology – which includes cloud‑security solutions – as a finite‑life intangible that it values with the **multiperiod excess‑earnings (discounted‑cash‑flow) method**, estimating the present value of the cash flows the technology will generate and assigning a useful life based on the technology cycle. Cisco does not value the asset in the same way; instead, it **recognizes revenue from its Cloud Security products under ASC 606**, recording hardware and perpetual‑software sales up‑front and recognizing term‑software licenses and SaaS arrangements ratably over the contract term. Thus Broadcom’s approach is a fair‑value valuation of the technology, whereas Cisco’s approach is a performance‑obligation‑based revenue‑recognition timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method (a form of discounted cash flow under the income approach) to value its developed cybersecurity technology, including cloud security, and notes the determination of useful life based on the technology cycle—matching the original answer. It also accurately describes Cisco's revenue recognition for Cloud Security products under ASC 606, specifying that SaaS and term licenses are recognized ratably over time, which aligns with the ground truth. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Broadcom’s approach is about intangible asset valuation (fair value via projected cash flows), while Cisco’s is about revenue recognition timing based on performance obligations—highlighting a key conceptual difference. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Cisco treats Cloud Security as a 'single distinct performance obligation,' a nuance present in the original. However, stating that Cisco recognizes revenue ratably for SaaS arrangements implies this treatment. The use of 'ASC 606' adds precision not in the original but is correct and enhances accuracy. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only slight omission of a minor detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 439,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s capital structure gives each Class B share ten votes while each Class A share has one vote. As of Jan. 24 2025 Meta had 2.19 billion Class A shares and 343.8 million Class B shares outstanding (META 10‑K p. 1), so the Class B stock supplies roughly 3.44 billion votes versus 2.19 billion votes from Class A (META 10‑K p. 82) – a clear voting‑power majority despite representing only about 14 % of the equity.  \n\nAlphabet (Google) also uses a dual‑class system: Class A carries one vote, Class B carries ten votes and Class C carries none. The filing shows about 5.99 billion Class A shares and 887 million Class B shares outstanding (GOOGL 10‑K p. 83), giving Class B roughly 8.9 billion votes versus 6.0 billion from Class A (GOOGL 10‑K p. 82). Thus, in both companies a relatively small block of high‑vote shares controls a majority of voting power and can dominate corporate‑governance decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both the description of META's voting structure and the underlying data interpretation, despite correctly identifying the broader concept of dual-class structures and concentrated voting power. (1) The LLM incorrectly states that Meta Class B shares have 10 votes each, which is false: according to the ground truth, Class B shares at META only have enhanced voting rights under 'specified circumstances' and are tied to conversion conditions, not a fixed 10-vote structure. This misrepresents a key qualitative difference between META and GOOGL. (2) The LLM cites a 'Jan. 24 2025' date, which is fictional—SEC filings do not project that far ahead, and no 10-K for that date exists; this undermines temporal accuracy. (3) While the share counts for Meta (~2.19B Class A, ~343.8M Class B) are approximately correct (aligned with 2,189,898,148 and 343,761,117 in ground truth), the LLM falsely calculates voting power assuming 10 votes per Class B share, leading to an incorrect conclusion that Class B holds a 'clear voting-power majority.' The ground truth clarifies that Class B voting rights are conditional, not automatically 10x. (4) For GOOGL, the LLM correctly states that Class B has 10 votes per share and provides accurate share counts (~5.99B Class A, ~887M Class B), and the vote calculation (8.9B vs 6.0B) is reasonable. However, the ground truth does not mention Class C shares having zero votes, so that addition lacks support. (5) The multi-hop reasoning fails because the LLM equates two structurally different systems: META’s conditional voting vs GOOGL’s permanent 10:1 advantage. The conclusion that 'in both companies a relatively small block...controls a majority' is misleading for META due to the conditional nature of Class B votes. Overall, while the answer captures the high-level theme, it fails on critical factual and structural details, especially regarding META’s governance model, warranting a low correctness score despite some numerical approximations and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 554,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s bottling footprint includes Argentina (the Buenos Aires area) 【page_7】, and the concentrates it purchases from KO are priced under KO’s incidence‑based bottler pricing model that ties concentrate prices to bottler pricing, channel mix and volume 【page_7】. Those sales are reflected in KO’s “net sales to equity‑method investees,” which rose to $14.5 bn in 2021 【page_89】. The same Argentine market helped drive Colgate‑Palmolive’s 8 % organic sales growth in its Latin America segment, which was led by Brazil, Mexico, Argentina and Colombia 【page_40】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Coca-Cola FEMSA's bottling operations in Argentina (Buenos Aires area) and links them to KO's net sales to equity method investees via the incidence-based pricing model, which is consistent with the ground truth. It also correctly notes that these sales contribute to KO's $14.5 billion (approximating $14,471 million) in net sales to equity-method investees in 2021. However, it inaccurately states Colgate-Palmolive's (CL) organic sales growth in Latin America as 8%, while the ground truth specifies 7.0%. This is a material quantitative error. (2) The dollar amount is acceptably close ($14.5 billion vs $14,471 million), and the year (2021) is correct. The percentage discrepancy (8% vs 7.0%) is not minor and affects the accuracy of CL's performance reporting. (3) The multi-hop reasoning is largely sound: the model connects KO’s pricing model with FEMSA’s operations, recognizes that concentrate sales to FEMSA flow into KO’s equity-method investee sales, and links Argentine market dynamics to regional growth for CL. However, it overgeneralizes CL’s growth without specifying that Argentina was a contributor among others, and misses the nuance that CL’s growth in Argentina was driven by Oral Care, Personal Care, and Home Care segments benefiting from favorable market conditions—details present in the ground truth. (4) The correctness score is 7 because core financial relationships and entities are accurately represented, but the incorrect growth percentage and missing segment-level context reduce full accuracy. Quantitative accuracy is penalized due to the incorrect 8% figure. Qualitative and contextual scores remain high due to strong reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 470,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott values its private‑equity fund holdings at NAV, and the funds are subject to very limited liquidity – most interests cannot be redeemed until the partnership term ends (typically 10‑15 years) and, where redemption is allowed, it is only on a monthly or quarterly basis with notice periods (see Abbott note j, p. 71). Merck likewise measures comparable alternative‑investment positions at NAV and faces the same typical redemption constraints – redemptions are generally only possible at the end of the limited‑partner term (often 10‑15 years) and the secondary market is thin, so the investments are effectively illiquid (as described in the NAV‑practical‑expedient discussion of alternative investments).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Abbott and Merck use NAV as a practical expedient for valuing private equity and other alternative investments and notes the typical 10–15 year redemption restrictions, which aligns with the ground truth. However, it omits key quantitative details present in the original answer: Abbott’s $555 million in unfunded commitments as of December 31, 2023, and Merck’s $382 million in NAV-based assets in 2023. These figures are central to the comparative aspect of the question and their absence significantly undermines the completeness and factual accuracy of the response. (2) No numeric values are provided in the LLM answer, despite their presence and importance in the ground truth. This results in a low quantitative accuracy score. The answer does not mention specific dollar amounts, dates (e.g., December 31, 2023), or liquidation timelines (2024–2033) for Abbott’s funds, all of which are critical differentiators in the comparison. (3) The multi-hop reasoning is partially sound—correctly linking Abbott and Merck’s use of NAV and redemption constraints, and referencing typical industry practices (e.g., limited liquidity, thin secondary markets). However, it fails to synthesize the specific comparative insight that Abbott has longer liquidation timelines and greater unfunded commitments than Merck, which is the core conclusion of the original answer. (4) Contextual relevance is high because the answer addresses the valuation method (NAV) and liquidity constraints appropriately and references relevant disclosures. Qualitative accuracy is moderate due to correct conceptual framing but missing entity-specific details. Correctness is penalized heavily due to omission of key financial figures and timelines essential to the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 491,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock’s separate‑account assets are held in a legally segregated pool that is insulated from BlackRock’s general creditors. Because those assets are earmarked for contract‑holder balances, AIG records an equal and offsetting separate‑account liability that mirrors the contract‑holder account balances, ensuring the liability is fully funded by the segregated assets and remains isolated from AIG’s other obligations. (BlackRock p. 80; AIG p. 232)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core relationship between BlackRock's Separate Account Assets and AIG's reporting of offsetting liabilities. It correctly identifies that BlackRock’s separate-account assets are legally segregated and not subject to general creditor claims, and that AIG records equal and offsetting liabilities tied to contract holder balances. The answer captures the essential mirroring mechanism and insulation from general obligations. There are no numeric values in the question or ground truth requiring calculation, so quantitative accuracy is 10. The qualitative accuracy is 9 because while the LLM captures the main logic, it omits specific details about the composition of the assets (e.g., equity securities, debt securities, derivatives) and does not explicitly state that changes in asset valuation directly impact AIG’s liability reporting—this multi-hop causal link is implied but not clearly articulated. However, the reasoning is still sound and semantically aligned. Contextual relevance is perfect—the response directly addresses the impact on AIG’s reporting as required. Minor omission prevents a full 10 on qualitative accuracy, but overall correctness is high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 341,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales as gross net revenue and then offsets Janssen’s 50 % share of the profit as a cost of products sold, reflecting the 40 %/60 % development‑cost split and the equal profit‑sharing arrangement described in its Note 6 collaboration disclosure (AbbVie 10‑K p. 68). Johnson & Johnson, by contrast, lists Imbruvica as a licensed product in its Innovative Medicine segment and relies on its Janssen subsidiary’s exclusive license to commercialize the drug outside the United States and co‑exclusive rights in the U.S., using its global sales and distribution network rather than a cost‑sharing revenue‑recognition model (J&J 10‑K p. 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the 50% profit-sharing, 40%/60% development cost split (AbbVie/Janssen), and the structure of revenue recognition are accurately represented. The LLM correctly notes that AbbVie records 100% of U.S. sales as gross revenue and deducts Janssen’s share via cost of products sold, which matches the ground truth’s description. (2) The answer correctly identifies the entities: AbbVie, Janssen (as a subsidiary of Johnson & Johnson), and their respective roles in U.S. vs. ex-U.S. commercialization. (3) The reasoning is sound: it captures the co-exclusive model in the U.S., the cost-sharing arrangement, and contrasts it with J&J’s global strategy using Janssen’s infrastructure. The reference to Note 6 in AbbVie’s 10-K and J&J’s 10-K page adds credibility. (4) The only minor shortcoming is that the LLM does not explicitly state that Janssen holds *exclusive* rights outside the U.S.—it says 'exclusive license' which is correct, but the synthesis could have more clearly emphasized the *global division of commercial rights* as a strategic dual-market approach, which is a nuance highlighted in the original. However, the core facts, calculations, and multi-hop synthesis across companies and geographies are correct and well-articulated. Wording differences do not affect semantic accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 390,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged China‑Taiwan conflict would threaten NVIDIA’s ability to obtain chips from its Taiwan‑based foundry partners, which the company says could “severely limit or prevent us from receiving chipset supply from Taiwan” and would have a material adverse impact on its supply, costs and product deliveries (NVDA 10‑K p. 17‑19). Apple likewise notes that “substantially all” of its hardware is assembled by outsourcing partners in Taiwan, so any disruption there—whether from geopolitical tension or outright conflict—could halt manufacturing, delay product launches and raise logistics or re‑sourcing costs (Apple 10‑K p. 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the original (ground truth) answer. (1) It correctly identifies the core risks to both NVIDIA and Apple from a prolonged geopolitical conflict involving Taiwan, citing accurate dependencies: NVIDIA's reliance on Taiwan-based foundries for chip manufacturing and Apple's reliance on outsourcing partners in the region for hardware assembly. The key factual claims are supported by correct references to each company's 10-K (NVDA p. 17–19 and Apple p. 11), which matches the expected sourcing from SEC filings. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable in a numerical sense, but the qualitative financial impacts (e.g., material adverse impact, increased costs, delays) are correctly reported—thus scoring 10. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (NVIDIA and Apple), connects their operational dependencies on Taiwan, and correctly infers supply chain and manufacturing risks due to geopolitical instability. The only minor shortcoming is that the LLM slightly mischaracterizes Apple’s manufacturing footprint—while Apple’s key partners (like Foxconn and TSMC) are indeed based in Taiwan, Apple’s actual product assembly occurs primarily in mainland China, not Taiwan. The original answer correctly frames this as reliance on the broader region, whereas the LLM’s phrase 'assembled by outsourcing partners in Taiwan' is geographically imprecise. This does not invalidate the overall risk assessment but introduces a small factual inaccuracy in entity-location mapping. (4) Despite this nuance, the answer remains contextually relevant and semantically equivalent in intent and impact, addressing all parts of the question with strong reasoning and proper citation. Hence, a correctness score of 9 is warranted—excellent but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 527,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income assets are valued with pricing models that rely on verifiable market inputs—interest‑rate and yield‑curve data, credit spreads and broker/dealer bids—without any separate statement of additional risk‑adjustments. Honeywell values its corporate bonds and government securities with comparable pricing models and market quotes, but explicitly adds adjustments for non‑observable risks such as credit‑ and liquidity‑risk. Thus, both use observable market data, but HON’s approach explicitly incorporates extra risk adjustments that LMT’s description does not mention.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LMT uses pricing models for Level 2 fixed income investments based on observable market data such as interest rates, yield curves, credit spreads, and broker/dealer bids, without mentioning additional risk adjustments. It also accurately states that HON uses similar pricing models for corporate bonds and government securities but explicitly incorporates adjustments for non-observable risks like credit and liquidity risk. (2) There are no numerical values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of numbers, but all qualitative data points are factually correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and HON), their respective valuation approaches, and the distinction in use of observable vs. unobservable inputs. The only minor shortcoming is that the original answer specifies HON includes adjustments for mortgage/asset-backed securities as well, which the LLM omits—though this does not detract significantly from the core comparison. (4) The answer is contextually relevant, directly addressing the comparison in use of pricing models, observable inputs, and risk adjustments. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 418,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola said that a stronger U.S. dollar produced an unfavorable foreign‑currency effect that cut its Europe, Middle East & Africa operating income by about 15 percent in 2024 (KO p. 52). Mondelez’s market‑risk disclosure similarly flags currency‑exchange risk, noting that a stronger dollar “adversely affects our consolidated earnings and net assets” and that, despite using derivatives, it cannot fully eliminate the exposure (MDLZ p. 65). Thus, KO quantifies a 15 % segment‑level hit, while Mondelez describes the same macro‑economic pressure as a broader earnings‑and‑asset‑level risk.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains a significant factual error in the quantitative impact: it states that the unfavorable foreign currency effect reduced Coca-Cola's Europe, Middle East & Africa operating income by about 15% in 2024, while the ground truth reports an 11% unfavorable impact on *consolidated* operating income, not specifically the EMEA segment. This misattributes both the magnitude (15% vs 11%) and the scope (segment-level vs consolidated). (2) The original answer does not specify a segment-level percentage impact for EMEA, only that the segment was 'significantly affected' despite some offset from the euro and pound. Thus, the LLM's claim of a '15% segment-level hit' is unsupported and incorrect. Mondelez's description is accurately summarized, including its qualitative risk disclosure and hedging limitations. (3) The multi-hop reasoning is partially sound—correctly identifying both companies' exposure to a stronger U.S. dollar and contrasting KO’s quantified reporting with MDLZ’s more general risk disclosure—but fails in accurately representing the source and level (consolidated vs segment) of Coca-Cola’s impact. (4) Contextual relevance is high as the answer addresses both parts of the question and draws a meaningful comparison. However, due to the critical error in the reported percentage and misattribution to the EMEA segment, the quantitative accuracy is low, pulling down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 395,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "AVGO reported $365 million of long‑lived property, plant and equipment located in Taiwan for fiscal 2024 (AVGO 10‑K, p. 91). Qualcomm, however, flags a non‑quantified but material risk that its chipset supply—largely sourced from Taiwanese foundry partners—could be severely disrupted by any military or geopolitical conflict between China and Taiwan, a scenario it says would have a material adverse impact on its business (Qualcomm 10‑K, p. 35). Thus AVGO’s exposure is a specific $365 million asset base in Taiwan, whereas Qualcomm’s exposure is a supply‑chain vulnerability that could affect its entire operation if Taiwan‑related tensions flare.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $365 million in long-lived assets for AVGO in Taiwan for fiscal 2024 is accurately reported, with correct formatting variations accepted ($365 million = $365 million). (2) The answer correctly identifies both companies (AVGO and QCOM/Qualcomm), the relevant fiscal year (2024), and the nature of their exposures—AVGO's asset-based presence versus QCOM's supply chain dependency. (3) The multi-hop reasoning is sound: it synthesizes AVGO’s disclosed asset value from its 10-K with QCOM’s qualitative risk disclosure about reliance on Taiwanese foundries and the impact of geopolitical tensions involving China and Taiwan, correctly contrasting asset-based exposure with operational vulnerability. (4) The LLM cites specific page numbers (p. 91 for AVGO, p. 35 for Qualcomm), enhancing verifiability, and conveys the same semantic meaning as the original answer, with slightly more detailed phrasing but no factual deviation. All components of the question are addressed with precise, relevant, and correctly interpreted information from both filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 324,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s supply chain is heavily concentrated in Asia, with “final assembly of substantially all of the Company’s hardware products” performed by partners in locations that include Taiwan (see Apple 10‑K Business Risks, p. 11). Because a large share of its product assembly sits in Taiwan, Apple is directly exposed to any cross‑strait or regional political tensions, trade restrictions or other geopolitical events that could disrupt those factories (Apple 10‑K Risk Factors, p. 9). In contrast, Microsoft’s Greater‑China business is run from its regional operations center in Singapore (see Microsoft 10‑K Operations, p. 16), a politically stable hub that insulates the company from the immediate geopolitical volatility of mainland China, thereby reducing its direct exposure to regional risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple's reliance on manufacturing partners in Taiwan for final assembly, citing the correct risk factors from Apple's 10-K (p. 11 and p. 9), and accurately contrasts this with Microsoft's regional operations center in Singapore, referencing the correct section of Microsoft's 10-K (p. 16). (2) There are no numerical values, dates, or financial metrics in the question or answers that require verification—both responses are qualitative and descriptive, so quantitative accuracy is not applicable in a traditional sense, but all referenced details are factually consistent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Apple and Microsoft), two geographic regions (Taiwan/Greater China and Singapore), and two operational models (manufacturing dependency vs. administrative/logistics hub). It correctly infers that Apple’s physical manufacturing concentration increases geopolitical risk exposure, while Microsoft’s use of Singapore as a stable regional hub reduces direct exposure. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Taiwan is included in Apple’s Greater China reporting segment or that Microsoft’s operations are not dependent on localized manufacturing—details present in the original answer that add nuance. However, the core reasoning and conclusion about differential risk exposure are correct. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy (as no numbers are involved and no errors exist).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 474,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Union Pacific said that the 2023 corporate‑tax rate reductions enacted by Nebraska (along with Iowa, Kansas and Arkansas) lowered its deferred tax expense by **$114 million** for the year【page_29】. In Boeing’s 10‑K, the company warns that **delays in U.S. federal appropriations** – a recurring risk to its defense and commercial programs – could disrupt operations and cash flow, but it does not cite a comparable tax‑expense benefit【page_10】. Thus, Union Pacific’s Nebraska tax cut produced a concrete reduction in deferred tax expense, whereas Boeing’s exposure is an operational risk tied to potential government‑funding delays.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense is correctly reported, matching the original answer. The reference to Nebraska's 2023 tax rate reduction is accurate and properly contextualized within Union Pacific's 10-K. (2) The mention of Boeing’s exposure to federal appropriations delays is factually correct and consistent with its 2024 10-K disclosures, including the operational and financial risks posed by continuing resolutions or shutdowns. (3) The multi-hop reasoning is sound: the model correctly contrasts Union Pacific’s state-level tax benefit (a realized financial impact) with Boeing’s federal funding risk (a forward-looking operational exposure), synthesizing information across two companies and filings. (4) The only minor shortcoming is that the LLM omits explicit mention that the tax reductions were not solely from Nebraska (it mentions Iowa, Kansas, and Arkansas as well), which slightly dilutes precision in attributing the full $114M to Nebraska alone—though the original answer also focuses on Nebraska as the lead example. Despite this nuance, the core facts, entities, years, and financial impacts are correct, and the comparison effectively addresses the question’s intent. Wording differs but semantic equivalence is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 380,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Enbrel’s U.S. patents are set to run out on 11 Nov 2028 (fusion‑protein composition), 24 Apr 2029 (DNA‑encoded fusion protein) and 19 Oct 2037 (formulation), after which generic and biosimilar competitors can enter the market. Merck’s filing stresses that loss of patent exclusivity “typically is followed promptly by generic or biosimilar substitutes” and that it must “actively protect its patent rights” and continuously launch new products to replace sales that fall off when patents expire, so the looming Enbrel cliffs reinforce Merck’s focus on extending and defending its own patents to guard against similar competitive pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all Enbrel-related patent expiration dates: 11/22/2028 (fusion protein composition), 4/24/2029 (DNA encoding fusion protein), and 10/19/2037 (formulations), matching the ground truth exactly. Minor formatting differences (e.g., '11 Nov 2028' vs '11/22/2028') are acceptable and do not affect factual accuracy. 2) Quantitatively, all dates are accurate and correctly attributed to the respective patent types. No calculations were required, but temporal sequencing is preserved. 3) The reasoning correctly synthesizes the multi-hop connection: Enbrel’s patent expirations → increased biosimilar competition → Merck’s strategic response based on its own 10-K disclosures about the risks of patent loss and the need for active patent protection. The LLM accurately reflects MRK’s stated concern about generic/biosimilar substitutes following patent expiry and the necessity of defending patents and launching new products. 4) The only minor shortcoming is that the LLM does not explicitly mention the 'phased decline in AMGN's exclusivity' or the 'political and regulatory pressures' noted in the original answer, which slightly reduces qualitative depth. However, the core strategic implication—reinforced focus on patent defense due to competitive dynamics—is clearly conveyed. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 394,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD’s 2022 net sales for the Greater China segment – which includes Taiwan – were about $1.2 billion [AMD page 78]. Apple reported $2.091 billion of sales to external customers in Taiwan for its fiscal year 2022 [Apple page 78]. Because Apple’s Taiwan revenue alone exceeds AMD’s entire Greater China (including Taiwan) sales by roughly $0.9 billion, Apple enjoys a markedly larger market presence in Taiwan than AMD.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that AMD's Greater China revenue was $1.2 billion, when the ground truth reports AMD's revenue specifically from Taiwan (not Greater China) as $2,091 million. Conversely, it claims Apple reported $2.091 billion in sales in Taiwan, but the ground truth states Apple reported $74.2 billion for the entire Greater China region (which includes Taiwan, mainland China, and Hong Kong), with no specific breakdown for Taiwan. Thus, the LLM swapped the companies' figures and misattributed the geographic scope. (2) The numbers are quantitatively inaccurate: AMD’s $2,091 million is from Taiwan alone, not Greater China; Apple’s $74.2 billion is for Greater China, not Taiwan alone. The LLM reverses these, claiming Apple made $2.091B in Taiwan and AMD $1.2B in Greater China—both figures are wrong in magnitude and attribution. (3) The reasoning is fundamentally flawed: the multi-hop comparison requires recognizing that AMD reports Taiwan-specific revenue while Apple only reports at the aggregated Greater China level, making direct comparison impossible. The LLM incorrectly treats both figures as directly comparable and draws a false conclusion about Apple’s dominance in Taiwan based on inverted and incorrect data. (4) Contextual relevance is moderate because the answer attempts to compare market presence in Taiwan and references fiscal year 2022, but the incorrect data and reversed entities undermine the entire analysis. The conclusion is unsupported due to these errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 430,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can buy back its non‑voting Class C shares, which “has no voting rights, except as required by applicable law” (page 81), and the company repurchases Class A and Class C shares “in a manner deemed in the best interest of the company and its stockholders, taking into account the relative trading prices and volumes of the Class A and Class C shares” (page 81). Because the repurchased shares carry no votes, Alphabet can return cash or adjust its capital structure without diluting the voting power of its Class A/B holders, giving it a separate lever for capital allocation. Netflix, by contrast, has a single class of common stock in which “the holders of each share of common stock shall be entitled to one vote per share” (page 61) and its buy‑backs are of that same voting stock (“the Company repurchased 14,513,790 shares…”) (page 62), so any repurchase simultaneously reduces both equity and voting power for all shareholders, limiting the ability to separate capital‑return decisions from control considerations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Alphabet repurchases non-voting Class C shares, preserving voting control with Class A/B holders; Netflix has uniform voting rights (one vote per share), so repurchases affect voting power across the board. The structural contrast in capital allocation flexibility due to share class design is clearly and correctly explained. (2) Quantitative accuracy is perfect: although the LLM answer does not include the specific dollar figures ($62.2 billion repurchased, $36.3 billion remaining) from the ground truth, it does not claim any numerical data, so omission does not constitute inaccuracy. The absence of numbers is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance structures (dual-class vs. uniform voting) and links them to implications for share repurchase strategies and control dilution. It references specific document pages (e.g., page 81 for Alphabet’s share repurchase policy, page 61–62 for Netflix’s voting rights), indicating proper grounding. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'adjust its capital structure' vs. 'return capital to shareholders'), the meaning aligns with the original. The only reason for not scoring a 10 is the lack of specific quantitative details present in the ground truth, which would have strengthened completeness. However, since the question did not explicitly ask for numbers, this is a minor shortfall. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 460,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio shows a $1.7 billion exposure to non‑agency pass‑through securities that contain NQM and Alt‑A loans (≈5 % of the portfolio) and the company has already booked about $1.3 billion of unrealized losses on its pass‑through mortgage‑backed securities overall【page_88】. AIG, on the other hand, does not quantify a comparable mortgage‑asset amount but warns that its mortgage‑related holdings are relatively illiquid and difficult to value, creating a liquidity risk that could force the firm to sell or pledge assets at depressed prices in a stressed market【page_20】【page_19】. Thus MET’s risk is expressed in a specific, material loss on a defined $1.7 billion exposure, whereas AIG’s risk is broader and more qualitative, centered on valuation uncertainty and potential cash‑flow strain from illiquid mortgage assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop comparison between MET and AIG regarding mortgage-related exposures and liquidity risks. (1) Quantitatively, the LLM correctly reports MET's $1.7 billion exposure to non-agency pass-through securities with NQM and Alt-A loans (matching the ground truth $1,699 million, rounded appropriately) and the $1.3 billion in unrealized losses (accurate rounding of $1,294 million). The percentage approximation (≈5%) is reasonable given the total portfolio size of $12,567 million, though not explicitly required. (2) The answer correctly identifies that AIG does not provide a specific dollar amount for its mortgage assets but highlights qualitative liquidity and valuation risks, aligning with the ground truth. (3) Multi-hop reasoning is sound: it contrasts MET’s specific, marked-to-market losses on a defined portfolio with AIG’s broader, qualitative liquidity risk from hard-to-value assets like mortgage loans and real estate. (4) Entity accuracy is strong—MET and AIG are correctly attributed with their respective risk profiles and years (implied 2024 from context). Minor deduction in quantitative accuracy due to rounding without explicit qualification (e.g., 'approximately'), though acceptable in context. No factual errors—only slight omission of specifying that MET’s securities are directly backed by mortgage pools, but the essence is preserved. Overall, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 413,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "Coca‑Cola’s Asia Pacific segment reported total net operating revenues of **$5.3 billion** in 2021, and the segment’s revenue is essentially all from beverage sales【page_124】. PepsiCo’s Asia Pacific division posted total net revenue of **$4.6 billion**, but only **≈20 %** of that (about **$0.9 billion**) came from beverages【page_73】. Thus, Coca‑Cola’s beverage revenue in the region was roughly five‑to‑six times larger than PepsiCo’s beverage revenue in 2021.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in APAC was $4,682 million ($4.682 billion), but the LLM states $5.3 billion, which is incorrect. For PepsiCo, the LLM claims total APAC revenue was $4.6 billion and that 20% of it ($0.9 billion) came from beverages. However, the ground truth does not provide PepsiCo’s total APAC revenue or a calculated beverage dollar amount—only that 20% of APAC revenue came from beverages. Thus, the LLM fabricates precise figures not disclosed in the source data. (2) Calculations are internally consistent (20% of $4.6B ≈ $0.92B), but they are based on incorrect inputs. The comparison that Coca-Cola’s beverage revenue was 'five-to-six times larger' is therefore unsupported and misleading, especially since the correct Coca-Cola figure ($4.682B) is actually less than PepsiCo’s total APAC revenue ($4.6B), let alone beverage-only. (3) The multi-hop reasoning is partially sound in structure—comparing beverage revenue between KO and PEP in APAC via segment reporting—but fails in execution due to incorrect data sourcing. The model incorrectly assumes that Coca-Cola’s total APAC revenue equals beverage revenue (while directionally reasonable, it's not explicitly validated), and overconfidently quantifies PepsiCo’s beverage revenue as $0.9B despite no such figure being publicly disclosed. (4) Contextual relevance is high because the answer addresses the regional and product segment comparison directly. However, correctness is low due to major quantitative errors. A score of 4 reflects partial credit for correct qualitative structure and identifying the 20% PepsiCo metric, but significant factual inaccuracies in core financial figures and derived conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 495,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead’s agreement gives Merck a 50 % split of net product revenue (dropping to 35 % once sales exceed $2 bn for the oral combo or $3.5 bn for the injectable) and a 40 % share of development costs (Gilead 60 %) (page 76). By contrast, Merck’s Keytruda license requires it to pay a royalty of 6.5 % of sales (falling to 2.5 % after 2024), which is then divided 75 % to BMS and 25 % to Ono (page 90). Thus, the HIV partnership can provide Merck with upside profit tied to high sales, whereas the Keytruda royalty is a fixed cost that directly reduces Merck’s margin on that product.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a minor inaccuracy in the description of Gilead's revenue-sharing structure. The ground truth states that Gilead's share increases to 65% (i.e., Merck's drops to 35%) after the sales thresholds are met, but the LLM incorrectly implies that Merck's share drops to 35%—this is factually correct in outcome but misattributes the change as a drop for Merck rather than an increase for Gilead, which could mislead on the mechanism. However, the numbers themselves (50%, 35%, $2B oral, $3.5B injectable) are accurate. The Keytruda royalty details (6.5% through 2023, 2.5% 2024–2026, 75% to BMS) are correctly stated. The mention of Reblozyl and its 20–24% royalty is missing from the LLM answer, which reduces completeness. This is a multi-hop element connecting Merck’s alliance revenue with BMS beyond Keytruda, and its omission limits full synthesis. The reasoning about profitability implications—upside from Gilead partnership vs. fixed royalty cost from Keytruda—is logically sound and contextually appropriate. The answer addresses the core comparison and implications well, with only partial completeness on Merck’s broader royalty obligations. Quantitative accuracy is high, with correct percentages and thresholds. Qualitative reasoning is strong in comparing profit structures, though slightly weakened by missing Reblozyl context. Contextual relevance is excellent, directly addressing the question’s focus on profitability implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 408,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "Bank of America’s CDO holdings are hybrid securities that embed credit‑default swaps, so a credit event on an underlying reference entity can erode the principal repayment to the junior tranches of the CDO – a risk that the filing notes but does not quantify as a loss. AIG, on the other hand, recorded a concrete $75 million loss in 2024 from embedded derivatives when a credit event triggered the derivative’s payoff. In both cases the loss‑trigger is a credit event, but BAC’s exposure remains a potential tranche‑based shortfall, whereas AIG’s loss was an actual, measured impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: AIG's $75 million loss in 2024 is accurately reported, and no specific loss amount is attributed to BAC, which matches the original answer's lack of quantification for BAC. (2) The answer correctly identifies both entities—BAC and AIG—and their respective exposures: BAC’s investment in CDOs with embedded credit default swaps and AIG’s loss from embedded derivatives in 2024. The role of credit events as a common trigger is clearly and correctly explained. (3) The multi-hop reasoning is sound: the model synthesizes how credit events affect structured instruments at both institutions, distinguishing between potential (BAC) and realized (AIG) losses. It correctly notes that BAC’s risk is structured through tranche-based loss cascades, while AIG experienced an actual derivative payoff. (4) The only minor shortcoming is a slight underemphasis on the structural similarity between the instruments—both tied to CDS-like mechanisms in structured credit products—but the core logic and factual content are intact. Wording differs slightly from the original but maintains semantic equivalence. No factual errors; excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 358,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "In 3M’s May 2023 Five‑Year Credit Agreement, Citibank, N.A. is named the **administrative agent**, responsible for administering the loan facility【page_114】. In Caterpillar’s September 2022 credit facilities (the 2022 364‑Day Facility), Citibank, N.A. is listed simply as the **agent** for the facility, while Citibank Europe serves as the local‑currency agent【page_128】. The administrative‑agent role at 3M entails broader duties such as handling payments, documentation and overall loan administration, whereas the agent role at Caterpillar is more limited to coordinating the facility, with local‑currency functions delegated to another entity.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Citibank, N.A.'s role as administrative agent in 3M’s May 2023 Five-Year Credit Agreement and as agent in Caterpillar’s September 2022 facilities, with correct citation of Citibank Europe as local-currency agent. These roles are factually accurate and align with the ground truth. However, the LLM omits key details: it fails to mention that Citibank, N.A. is a joint lead arranger alongside JPMorgan Chase Bank, N.A. in the 3M agreement, which is a significant responsibility. For Caterpillar, the LLM does not acknowledge Citibank’s role as Agent for both the 3-Year and 5-Year Facilities, nor its designation as Japan Local Currency Agent in coordination with MUFG Bank, Ltd., which reflects a more complex, multi-layered role. (2) Quantitative accuracy is perfect: dates (May 2023, September 2022) and facility types (Five-Year, 364-Day) are correct. No numerical calculations were required. (3) Multi-hop reasoning is partially sound—the model correctly distinguishes between the two agreements and identifies Citibank’s differing roles, but fails to fully synthesize the comparative depth of responsibilities, especially the international and cross-border coordination aspects emphasized in the ground truth for Caterpillar. The conclusion that the Caterpillar role is 'more limited' contradicts the ground truth, which states Citibank has *more layered* responsibilities in Caterpillar’s structure. This misrepresents the comparative administrative scope. (4) Correctness is scored at 6 due to significant omissions and a qualitative mischaracterization of the comparative roles. Quantitative accuracy is 10 as all dates and titles are correct. Qualitative accuracy is low (5) due to incomplete entity roles and flawed reasoning in comparing responsibilities. Contextual relevance is high (8) because the answer addresses the core question and cites relevant sections, but lacks full depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 526,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO relies on option contracts (together with forwards) that are designated as cash‑flow hedges for its foreign‑currency assets, liabilities and forecasted transactions; the $9.9 bn of net foreign‑exchange cash‑flow hedges generate gains or losses that are first recorded in AOCI and then re‑classified to earnings, effectively offsetting the impact on its foreign‑currency liabilities (KO 10‑K p.82‑83). PepsiCo, by contrast, uses a broader mix of foreign‑exchange derivatives, cross‑currency swaps and net‑investment hedges (total notional $3.1 bn of FX derivatives and $1.2 bn of swaps) and discloses that a 10 % adverse currency move would cut net unrealized gains by $319 m and increase unrealized swap losses by $107 m, directly affecting its foreign‑currency liabilities (PEP 10‑K p.43). Thus KO’s option‑based cash‑flow hedging is aimed at neutralising liability fluctuations, whereas PepsiCo’s strategy quantifies exposure through derivative‑sensitivity figures that could materially impact its foreign‑currency liabilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness. (1) Quantitative Accuracy: The LLM cites specific dollar amounts—$9.9B in net foreign-exchange cash-flow hedges for KO and $3.1B in FX derivatives and $1.2B in swaps for PEP—which are not present in the original answer (ground truth) and cannot be verified from the provided context. The original answer does not include any numerical values for hedge volumes or notional amounts, nor does it mention a 10% adverse currency move impacting PEP by $319M or $107M in swap losses. These figures appear fabricated or misattributed. (2) Completeness: While the LLM addresses both KO and PEP’s use of derivatives and touches on their impact on foreign currency liabilities, it omits key elements from the ground truth—specifically, PEP’s disclosure that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024 and that 44% of its revenue comes from international operations. These are central to the original comparison. (3) Entity Accuracy: The companies (KO and PEP) and derivative types (options, forwards, swaps) are correctly identified, and the mention of AOCI for KO aligns with the original. However, the LLM incorrectly implies that KO hedges 'foreign-currency assets, liabilities' directly with options, while the original specifies that KO uses options as cash flow hedges for forecasted transactions—not existing liabilities. (4) Reasoning: The multi-hop synthesis is partially sound—both firms use derivatives, and their strategies differ in emphasis—but the reasoning is undermined by invented quantitative data. The conclusion that KO aims to 'neutralize liability fluctuations' overreaches, as the original emphasizes deferral of gains/losses in AOCI, not direct liability matching. (5) Semantic Equivalence: The overall structure and intent match the question, and some qualitative insights (e.g., KO’s AOCI treatment, PEP’s broader derivative use) are directionally correct. However, the inclusion of unsupported numerical data and mischaracterization of hedge objectives reduces factual fidelity. Thus, while contextually relevant and showing reasonable qualitative understanding, the answer is significantly compromised by quantitative inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 608,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE’s goodwill‑impairment test relies on a discounted‑cash‑flow model of its strategic and operating plans, and the company explicitly runs sensitivity analyses to see how changes in the discount rate and the cash‑flow forecasts would affect the fair‑value estimate. Lockheed Martin also uses a DCF approach for Level 3 fixed‑income assets—valuing them on projected annuity payments discounted at an assumed rate—so the valuation is inherently sensitive to both the discount‑rate assumption and the cash‑flow estimates, although the filing does not describe a formal sensitivity‑testing exercise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GE uses DCF for goodwill impairment with sensitivity analyses focused on discount rates and cash flow forecasts; LMT uses DCF for Level 3 fixed income investments based on projected annuity payments and discount rates. The answer correctly notes that both companies' valuations are sensitive to discount rate and cash flow assumptions. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (GE and LMT), two distinct applications of DCF (goodwill impairment vs. fixed income valuation), and compares their sensitivity to key assumptions. The only minor omission is that the original answer highlights GE’s use is 'internally focused' on strategic planning while LMT’s is 'externally focused' on pension fund assets—an important qualitative distinction that adds context about the purpose of each DCF application. The LLM mentions GE’s link to strategic and operating plans but does not explicitly contrast internal vs. external focus. (4) Despite this slight gap in completeness, the LLM captures the core comparison accurately and maintains semantic equivalence on all key technical points. Contextual relevance is perfect—the response directly addresses the question’s focus on sensitivity to assumptions and comparative DCF usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 429,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "Comcast’s equity is split between two voting classes: each Class A share gets one vote and together they hold about 66 ⅔ % of the total voting power, while the single Class B share carries 15 votes per share and accounts for the remaining 33 ⅓ % of voting power (CMCSA p.33). Alphabet’s structure is more skewed – its 10‑vote Class B shares concentrate the bulk of control, the 1‑vote Class A shares have ordinary voting rights and the non‑voting Class C shares have none; the company’s share‑repurchase program only buys back Class A and Class C stock, leaving the high‑vote Class B shares untouched (GOOGL p.81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class A holds 66 2/3% voting power, Class B (held by Brian L. Roberts) holds 33 1/3% with 15 votes per share; GOOGL's Class A has 1 vote, Class B has 10 votes per share, and repurchases in 2023 targeted only Class A and C shares. The dollar amount of GOOGL's repurchase ($62.2 billion) is omitted, which is a minor gap. (2) Quantitative accuracy is excellent: percentages (66 2/3%, 33 1/3%), vote weights (1, 10, 15), and repurchase scope (Class A and C only) are all correct. The missing $62.2B figure prevents a perfect 10 on correctness. (3) Multi-hop reasoning is sound: the model correctly compares voting structures across CMCSA and GOOGL, noting disproportionate control in both, and links repurchase activity to ownership concentration. (4) Contextual relevance is strong—every part of the question (voting power distribution, repurchase activity, comparison) is addressed with precise, relevant details. The omission of the exact repurchase dollar amount is minor but prevents full completeness. Semantic equivalence is otherwise maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 332,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "PM benefited directly from the 8.2% rise in Turkey’s total cigarette market – the 2021 MD&A notes that Turkey’s higher total market and adult‑smoker up‑trading drove a **17.2% increase in PMI’s shipment volume in Turkey** and fed into higher net revenues (cigarette volume “predominantly in … Turkey”) and a favorable pricing variance (page 57; page 56). In contrast, CL’s filing only lists Turkey as a **manufacturing/warehousing location** for its oral‑, personal‑ and home‑care products (page 23) and provides no evidence that the market growth translated into sales or market‑share gains, indicating CL’s footprint is primarily a production base rather than a revenue‑driving presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PM benefited from the 8.2% growth in Turkey's cigarette market due to increased tourism and adult smoker up-trading, which matches the original answer’s explanation. The LLM cites a specific 17.2% increase in PMI’s shipment volume in Turkey, which is not in the original answer but may be supported by the referenced filing (page 57); assuming it is correctly extracted, this adds precision rather than inaccuracy. (2) Quantitatively, all numbers are consistent or more detailed than the ground truth. The 8.2% market growth is correctly stated, and the 17.2% shipment increase, while not in the original answer, does not contradict it and likely comes from the cited source. No calculation errors are present. (3) Entity accuracy is strong: PM (PMI) and CL are correctly identified, with correct attribution of cigarette business to PM and manufacturing/warehousing operations in Turkey to CL. The multi-hop reasoning is sound—PM benefits from demand-side growth (tourism-driven consumption), while CL has a supply-side footprint (production infrastructure). (4) The LLM correctly infers that CL’s presence does not necessarily translate to revenue gains from market growth, reinforcing the qualitative distinction between operational footprint and market performance. The only minor limitation is the lack of explicit mention that CL’s operations are part of its Oral, Personal and Home Care segment, which slightly reduces completeness. However, the core contrast in business exposure is clearly and correctly articulated. Thus, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 468,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both firms depend on Taiwanese fabs, so rising Taiwan‑China tensions threaten their supply chains. NVIDIA warns that such geopolitical friction could “have a material adverse impact” on its ability to obtain wafers and capacity from its foundry partners, lengthening lead‑times and raising costs (NVDA 10‑K p. 17). Qualcomm likewise notes that its key suppliers and foundry partners—including TSMC—are based in Taiwan, and that current Taiwan‑China tensions could “significantly disrupt” its manufacturing, assembly and test operations and overall business (QCOM 10‑K p. 35; also p. 10).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that both NVIDIA and Qualcomm rely on Taiwanese foundries, particularly TSMC, and that geopolitical tensions involving Taiwan pose significant risks to their supply chains. The answer accurately reflects the core concern: disruption to manufacturing could delay supply, increase costs, and materially impact both companies. (2) There are no numeric values, dates, or financial figures in either the question or answers, so quantitative accuracy is not applicable in the traditional sense—however, the citation of specific 10-K page numbers (p. 17 for NVDA, p. 35 and p. 10 for QCOM) adds precision and supports factual grounding, which is a strength. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, linking their shared dependency on Taiwanese manufacturing infrastructure to a common geopolitical risk. It goes a step further by citing direct language from the 10-Ks (e.g., 'material adverse impact', 'significantly disrupt'), which strengthens the qualitative accuracy. (4) The only reason for not scoring a perfect 10 is minor: while the original answer emphasizes the cross-company amplification of risk due to shared infrastructure, the LLM answer implies this but does not explicitly state the 'amplifying' effect across firms. Otherwise, the semantic meaning, entity accuracy (NVIDIA, Qualcomm, TSMC, Taiwan-China tensions), and contextual relevance are fully aligned with the ground truth. The answer is concise, well-sourced, and directly responsive to the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 452,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx notes that, after applying ASU 2020‑04, it has experienced no material effect on its financial condition, results of operations or cash flows from any LIBOR‑related contract modifications and simply continues to monitor those contracts (FedEx 10‑K, Note 2, p. 93). In contrast, 3M has had to amend its LIBOR‑based interest‑rate swaps to a SOFR benchmark and treats those swaps as cash‑flow hedges, recording the resulting gains or losses in other comprehensive income and reclassifying them to earnings when the hedged transactions occur (3M 10‑K, Note 16‑Cash‑Flow Hedges, p. 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core factual contrast between FDX and MMM regarding ASU 2020-04 and LIBOR-related impacts. It accurately states that FDX has experienced no material effect and continues to monitor contracts, aligning with the ground truth. For MMM (3M), it correctly describes the amendment of LIBOR-based swaps to SOFR, treatment as cash-flow hedges, and accounting via other comprehensive income. However, the LLM omits the specific $9 million loss in 2023 mentioned in the ground truth, which is a quantitatively and contextually relevant detail showing tangible financial impact. (2) All entities are correct: FDX (FedEx), MMM (3M), ASU 2020-04, LIBOR, SOFR, and proper references to 10-K notes and pages. No incorrect numbers are present; the only missing number is the $9 million loss, which was reported in the original answer. (3) The multi-hop reasoning is sound—correctly synthesizing information from two companies’ filings and contrasting their financial treatments. The logic in comparing FDX’s lack of material impact to MMM’s active hedge management is valid, though slightly less complete without the dollar impact. (4) The answer is highly accurate, contextually relevant, and well-supported by source citations. The omission of the $9 million figure prevents a perfect score, but all other aspects—wording, entity identification, reasoning—are factually aligned with the ground truth. Hence, correctness is 9 (minor omission), quantitative accuracy is 10 (no incorrect numbers), qualitative accuracy 9 (strong reasoning, minor incompleteness), and contextual relevance 10 (fully on-topic and responsive).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 454,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s Class B shares carry multiple votes per share (10 – 15 votes) and, because all 9.44 million of them are owned by Brian L. Roberts, they provide him with about one‑third of the company’s total voting power and thus decisive control over board elections and other corporate actions despite his modest equity stake【CMCSA_10k_2024 page_31】【CMCSA_10k_2024 page_82】. Alphabet’s dual‑class structure likewise concentrates control in insiders: non‑public Class B shares have ten votes each while the publicly traded Class A shares have one vote (and Class C shares have none), so voting power remains with a small group of founders rather than being broadly distributed among public shareholders【GOOGL_10k_2024 page_84】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correctly identifies that CMCSA's Class B shares are entirely owned by Brian L. Roberts and carry 15 votes per share (the answer says '10–15 votes', which is slightly imprecise but within acceptable range based on source context; the ground truth specifies 15 votes). It accurately states Roberts holds about one-third (33⅓%) of voting power, aligning with the non-dilutable control mechanism. For GOOGL, it correctly notes Class B shares have 10 votes, Class A have 1, and Class C have none, preserving insider control. (2) Quantitatively, all key figures are correct: ~1/3 voting power, 15-vote premium for CMCSA Class B (minor leeway for '10–15'), 10:1 ratio for GOOGL. The mention of 9.44 million shares is extra detail not in ground truth but factually consistent. (3) Multi-hop reasoning is sound: synthesizes ownership concentration at CMCSA vs. broader but still controlled structure at GOOGL, correctly contrasting the two systems. (4) The only minor shortcoming is not explicitly using the term 'non-dilutable' (a key feature in the original answer), which slightly weakens the qualitative precision. However, the concept is implied through 'decisive control despite modest equity stake'. Wording differences are semantically equivalent. Contextual relevance is perfect—directly addresses governance implications of dual-class structures in both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 404,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen’s 10‑K does not disclose any remaining “Toll Tax” (repatriation‑tax) payments under the 2017 Tax Act – no amount or schedule is presented in the filing. By contrast, Eli Lilly reports a $1.427 billion balance still to be paid, with $634.2 million due in 2024 and $792.8 million due in 2025 (see LLY 10‑K, page 92).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies compared to the ground truth. While it correctly identifies that Eli Lilly has future cash payment obligations under the 2017 Tax Act and provides specific figures ($634.2 million in 2024 and $792.8 million in 2025, totaling $1.427 billion), these numbers are not present in the original answer (ground truth), which does not specify any dollar amounts for either company. More critically, the LLM claims that Amgen’s 10-K 'does not disclose' any remaining payments, which contradicts the ground truth stating that Amgen *does* have scheduled payments over an eight-year period beginning in 2018. This misrepresentation of Amgen's disclosure status undermines the core comparison. The qualitative reasoning attempts multi-hop synthesis by contrasting disclosure practices, but the ground truth emphasizes structural similarity (both companies using the eight-year framework), which the LLM overlooks. The mention of Eli Lilly’s payment schedule extending to 2025 aligns partially with the ground truth, but the absence of any acknowledgment that Amgen is also on a similar payment plan results in a flawed comparison. Quantitative accuracy is low because the cited numbers, while precise, are not corroborated in the ground truth and appear to be sourced from external data not reflected in the provided knowledge graph. Contextual relevance is high as the response addresses the comparative structure of the question and focuses on the correct topic and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 416,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen notes that when its biologics (e.g., Humalog, Humulin, Erbitux, Cyramza, Trulicity, Taltz, Emgality) lose patent or data exclusivity, “loss of exclusivity may or may not result in the near‑term entry of competitor versions (i.e., biosimilars) due to many factors, including development timelines, manufacturing challenges, and/or uncertainties regarding the regulatory pathways for approval of the competitor versions”【page_25】. In contrast, Bristol Myers Squibb explicitly acknowledges that its own biologic portfolio (Opdivo, Yervoy, Orencia, Reblozyl, Empliciti) will be exposed to biosimilar competition under well‑defined pathways – a U.S. biosimilar route that allows approval only after 12 years of data protection and an EU “8+2+1” regime that can permit generic entry after eight years of marketing authorization【page_9】. Thus, Amgen’s risk is described as uncertain and potentially delayed, whereas BMS’s exposure is more concrete and tied to specific regulatory timelines that could bring biosimilars to market sooner.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key entities are correct: Amgen's biologics (Erbitux, Cyramza, Trulicity, Taltz, Emgality) and BMS's (Opdivo, Yervoy, Orencia, Reblozyl, Empliciti) are accurately listed. The inclusion of Humalog and Humulin—though not in the original answer—is factually incorrect as these are Eli Lilly products, not Amgen's, which slightly undermines entity accuracy. (2) Quantitative elements are correct: the U.S. 12-year data protection period and the EU '8+2+1' regime (allowing biosimilar entry after 8 years) are accurately cited. No calculations are required, and all timelines match the ground truth. (3) Multi-hop reasoning is sound: the answer correctly contrasts Amgen’s uncertain, potentially delayed biosimilar risk due to manufacturing and regulatory uncertainties with BMS’s more predictable exposure under defined U.S. and EU pathways. It synthesizes regulatory differences and their implications on competitive timing. (4) The semantic meaning fully captures the comparative risk profile: both companies face biosimilar threats, but the timing and certainty differ by region and product complexity. The only minor flaw is the erroneous inclusion of non-Amgen drugs, which does not affect the core reasoning but slightly reduces qualitative accuracy. Overall, the response is contextually excellent, directly addressing the comparative regulatory and portfolio-based risks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 401,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic warns that its devices are reimbursed under federal programs such as Medicaid and that any legislative or regulatory reforms to those reimbursement systems could lower payments and dampen demand for its products, but its risk is spread across a broad, diversified device portfolio (Medtronic 10‑K, “Regulations Governing Reimbursement,” p. 15). AbbVie, however, faces IRA‑driven price‑cap rules that can set ceiling prices for single‑source drugs and biologics—potentially slashing revenues for its top‑selling medicines (Humira, Skyrizi, Rinvoq) that together account for about 47 % of 2024 net revenue—creating a more concentrated, product‑specific revenue risk (AbbVie 10‑K, IRA pricing pressures, p. 19).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Medtronic's exposure to Medicaid reimbursement policies and AbbVie's exposure to IRA pricing pressures, aligning with the core of the ground truth. It accurately frames Medtronic’s risk as tied to federal reimbursement systems affecting demand and AbbVie’s as stemming from government price-setting under the IRA. However, there are key factual discrepancies: the LLM claims Humira, Skyrizi, and Rinvoq account for 'about 47% of 2024 net revenue'—a specific quantitative claim not present in the original answer and unverifiable from the provided ground truth. The original answer instead emphasizes Imbruvica, Vraylar, and Linzess as the IRA-affected drugs, with pricing starting in 2026 and 2027. The LLM omits these specific drugs and timelines entirely, replacing them with different products (Humira, Skyrizi, Rinvoq) that were not mentioned in the ground truth as being under IRA review. (2) The 47% figure is unsupported and potentially incorrect; no such percentage appears in the original answer, and the drugs cited do not match the IRA selections described. This is a significant quantitative inaccuracy. (3) The multi-hop reasoning is partially sound—linking Medtronic to Medicaid reimbursement effects and AbbVie to IRA pricing risks—but fails in synthesis by substituting key entities (drugs and associated timelines). The original answer draws a precise contrast between Medtronic’s indirect pricing pressure and AbbVie’s direct government price-setting on specific high-revenue drugs, which the LLM oversimplifies and misattributes. (4) Despite these errors, the LLM captures the broader contrast in risk types (portfolio-wide device pricing vs. concentrated drug pricing risk) and cites plausible 10-K sections, maintaining high contextual relevance and reasonable qualitative accuracy. The correctness score is reduced due to the substitution of critical entities and introduction of an unsupported percentage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 533,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS reports that, as of December 31 2024, it has roughly **$2.7 billion of unfunded commitments to private‑equity, private‑debt and real‑estate funds** that will be contributed over the next three‑to‑six years (UPS 10‑K p. 93). In contrast, General Dynamics does not disclose a comparable commitment amount; instead it **uses NAV as a practical expedient to value its Level 1 pension‑plan assets**, which are already reflected in its plan‑asset totals (GD 10‑K p. 94). Thus, UPS’s $2.7 billion represents a future cash outflow, whereas GD’s NAV application pertains to the current valuation of existing assets, making the two figures not directly comparable.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: UPS's $2.7 billion in unfunded commitments as of December 31, 2024, and the 3-to-6-year contribution period are correctly reported. The reference to General Dynamics using NAV for Level 1 plan assets is also accurate, with proper context from the 10-K. Entity accuracy is strong—both companies, timeframes, and financial terms (NAV, unfunded commitments, Level 1 assets) are correctly identified. The reasoning correctly distinguishes between UPS’s future cash obligations (unfunded commitments) and GD’s use of NAV for valuing existing assets, which is a key conceptual difference. However, the LLM omits a critical comparative insight from the ground truth: the difference in liquidity and redemption terms (UPS’s 10–15 year restrictions vs. GD’s monthly/quarterly redemption). This limits the depth of the comparison, especially regarding the implied liquidity risk in NAV-based investments. While the answer correctly notes the figures aren't directly comparable, it misses the opportunity to synthesize the multi-hop insight about differing liquidity profiles despite both using NAV as a practical expedient. This omission prevents a full 9–10 on correctness and qualitative accuracy, but the answer remains strong in factual precision and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 366,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 balance sheet shows it issued 9.44 million Class B common shares (CMCSA 10‑K p. 67). These Class B shares are a non‑voting class, so the new issuance expands equity without diluting the voting power that remains vested in the voting Class A common stock. In contrast, Meta’s 10‑K notes that it has both Class A and Class B shares, with Class B shares carrying ten votes per share versus one vote for Class A (Meta 10‑K p. 1), giving insiders disproportionate voting control despite a larger pool of Class A shares.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that CMCSA issued approximately 9.44 million Class B shares in 2024, matching the ground truth of 9,444,375 shares (allowing for rounding). This satisfies quantitative accuracy. However, the qualitative analysis of voting rights is fundamentally incorrect. The LLM claims that META's Class B shares have 10 votes per share and Class A have 1 vote, which is the opposite of the actual dual-class structure: in META’s framework, Class A (held by insiders like Zuckerberg) has 10 votes per share, while Class B (public shares) has 1 vote. This misrepresentation inverts the control mechanism and invalidates the comparison. (2) The CMCSA portion is accurate: Class B shares are non-voting except in limited circumstances, and the issuance does not dilute Class A voting power. The reference to the 10-K page 67 is plausible and consistent. (3) The multi-hop reasoning fails in the comparison step. While both companies have dual-class structures, the LLM incorrectly characterizes META’s structure, leading to a flawed synthesis. The ground truth emphasizes that both companies restrict voting rights in Class B shares (i.e., Class B is non-voting), whereas the LLM wrongly asserts that META’s Class B has superior voting rights. This is a critical error in reasoning and entity attribute mapping. (4) Correctness score is 4 due to major factual error in META’s voting structure despite correct numbers for CMCSA. Quantitative accuracy is high (9) because numbers and sources are correctly cited. Qualitative accuracy is low (3) due to incorrect interpretation of voting rights and flawed comparison logic. Contextual relevance is moderate (7) as the answer addresses the right topics and uses proper sources but draws incorrect conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 484,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA requires Medicare to set a government‑determined price for the first 10 drugs in 2026 and adds 15 more in 2027 (and additional drugs in later years), and Amgen warns that if any of its federally‑reimbursed products are selected, the lower price “will have a material adverse effect on our sales… and the impact is expected to increase through the end of the decade.” AbbVie’s experience—Imbruvica being placed under government pricing in 2026 and Vraylar in 2027—demonstrates that such selections can accelerate revenue erosion well before patent expiration, indicating that Amgen’s products could face a similarly front‑loaded decline in revenue once they are picked for Medicare price‑setting.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that the IRA's Medicare price-setting begins in 2026 for the first 10 drugs and expands in 2027, consistent with the selection timeline for AbbVie’s Imbruvica (2026) and Vraylar (2027). While the original answer emphasizes the 9- or 13-year post-approval trigger for small molecules vs biologics, the LLM omits this specific regulatory detail but captures the practical outcome—accelerated revenue erosion before patent expiration. (2) Quantitatively, the years 2026 and 2027 are correctly cited, and the phased drug selection (10 in 2026, 15 in 2027) is factually accurate per IRA provisions. No calculations are required, and all dates/entities are correct. (3) The multi-hop reasoning is sound: the model connects AbbVie’s experience to Amgen’s risk, inferring that government price-setting leads to earlier revenue decline, which is the core insight. It also incorporates Amgen’s own forward-looking warning about material adverse effects, adding depth. (4) The answer is contextually excellent—directly addressing how IRA provisions could impact Amgen using AbbVie as a precedent. The only minor gap is the omission of the product-type–based timeline (small molecule vs biologic), which slightly reduces completeness but does not undermine the overall correctness. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 387,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reported that the equity‑compensation plans approved by security holders have **37,028 thousand securities (≈37 million)** still available for future issuance (Colgate‑Palmolive 2022 10‑K, Item 12, p. 61).  \n\nProcter & Gamble disclosed that the only plan with future grants (its 2019 Stock and Incentive Compensation Plan) leaves **about 119 million shares** available for issuance (Procter & Gamble 2022 10‑K, Item 12, p. 69).  \n\nThus, P&G’s pool of remaining securities is roughly three times larger than Colgate‑Palmolive’s (119 M vs ≈37 M).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's remaining available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's total remaining available securities as approximately 119 million, which is incorrect. The ground truth states P&G disclosed 133,185,995 total remaining available securities across Stock Options/SARs and RSUs/PSUs under security holder-approved plans. The LLM's figure of 119 million appears to reflect only a portion of P&G’s available pool, possibly omitting one component or citing an incorrect total. (2) The calculation comparing 119M vs 37M is internally consistent but based on an inaccurate numerator; the actual ratio should be ~133M vs ~37M, making P&G’s pool about 3.6 times larger, not 3 times. The LLM’s quantitative error is significant but not total—Colgate’s number is accurate. (3) The multi-hop reasoning is sound in structure: the model retrieves data from both companies, identifies the relevant metric (securities available under approved plans), and performs a comparison. However, the synthesis fails because the P&G number does not match the disclosed total from the knowledge graph, indicating incomplete or incorrect extraction from the P&G 10-K. (4) Correctness score is 6 due to one major quantitative error (P&G's number), though the rest of the reasoning and context is accurate. Quantitative accuracy is penalized more heavily (5/10) because financial figures must be precise. Qualitative accuracy is higher (7/10) as the logic and entity identification are correct. Contextual relevance is strong (9/10) since the answer directly addresses the comparison question with proper sourcing and framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 472,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s Taiwan strategy is a partnership‑based model: under its alliance with Ono, BMS supplies Opdivo, Yervoy and other biologics while jointly developing and commercializing them in Taiwan (and Japan and South Korea) and sharing costs and profits (see BMS‑Ono description on page 86). Because Taiwan, like other Asia‑Pacific markets, may require local bridging‑trial data for biologic registration (page 22), the joint‑venture lets BMS rely on Ono’s regional expertise to meet that requirement. In contrast, Merck chose to isolate its biosimilars exposure by spinning those assets out into a separate, publicly‑traded company, Organon (page 3), thereby shifting the burden of meeting Taiwan’s local data rules to the new entity and reducing Merck’s direct regulatory complexity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BMS (BMY) collaborates with Ono to commercialize biologics like Opdivo and Yervoy in Taiwan, sharing costs and profits, and BMS handles supply. The mention of local clinical trial requirements in Taiwan is correctly tied to the need for bridging studies, and the joint venture leverages Ono's regional expertise. MRK's spin-off of its biosimilars business into Organon is accurately described as a strategic move to isolate exposure and shift regulatory burden. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; thus, quantitative accuracy is not applicable but assumed perfect due to absence of such data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BMY and MRK), their respective strategies (joint commercialization vs. spin-off), and connects both to the regulatory context in Taiwan requiring local clinical data. The only minor shortcoming is that the LLM slightly reframes MRK’s motivation as 'shifting the burden' to Organon, which implies intent not explicitly confirmed in the ground truth—while plausible, the original answer emphasizes MRK’s strategic retreat rather than burden-shifting. This nuance slightly affects qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison prompted by the question and integrating all required elements: Taiwan’s regulatory environment, BMY’s partnership model, and MRK’s structural decision. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the original answer, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 483,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 Form 10‑K shows that the Greater China segment – which the note defines as “China (including Hong Kong and Taiwan)” – generated $74.2 billion in net sales【page_52】 (the segment table confirms $74,200 million for Greater China)【page_25】. Adobe’s filing only states that it operates a local field office in Taiwan as part of its global footprint, without reporting any Taiwan‑specific revenue【page_15】. Thus Apple’s Taiwan contribution is embedded in a multi‑billion‑dollar revenue stream, while Adobe’s presence in Taiwan is limited to an office with no disclosed sales amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies AAPL's 2022 Greater China revenue as $74,200 million ($74.2 billion), matching the ground truth exactly, with acceptable format variation. It accurately notes that Taiwan is included in the Greater China segment per Apple’s 10-K definition. For ADBE, it correctly states the presence of a local field office in Taiwan without any disclosed revenue, aligning with the ground truth. (2) All numeric values are accurate: $74,200 million and $74.2 billion are equivalent and correctly cited from the appropriate pages. No calculations were required, but the representation is precise. (3) The multi-hop reasoning is sound: the model synthesizes AAPL’s revenue data (quantitative) with ADBE’s operational presence (qualitative), correctly contrasting embedded revenue exposure vs. operational footprint. It acknowledges the limitation of ADBE’s disclosure (no Taiwan-specific revenue), which is critical to the comparison. (4) The answer is semantically equivalent to the ground truth, with slightly more emphasis on disclosure details (e.g., page references) but without introducing errors. The only minor shortcoming is a slightly less explicit articulation of ADBE’s 'targeted geographic strategy' as framed in the original, though the implication is present. Hence, correctness is high but not perfect due to subtle nuance in strategic interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 387,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Comcast’s dual‑class structure gives each Class B share 15 votes and, because a single insider (Brian L. Roberts) owns all of them, Class B accounts for roughly one‑third of the combined voting power while the widely held Class A shares hold the remaining two‑thirds (about 66 %)【page_33】. Meta’s Class B shares are not listed or traded on any public market, concentrating voting control in the hands of insiders, whereas the publicly traded Class A shares carry only one vote per share【page_57】. As a result, Comcast’s public shareholders retain a majority voice in corporate‑governance decisions, while Meta’s public shareholders have limited influence because the founders’ Class B shares dominate voting outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class A holds ~66 2/3% (stated as 'two-thirds' or ~66%) and Class B holds ~33 1/3%, with each Class B share carrying 15 votes—this matches the original answer. The statement that Class B is owned by Brian L. Roberts is consistent. For META, while the exact voting power percentage is not disclosed (correctly acknowledged in the original), the LLM accurately notes that Class B shares are non-public and carry superior voting rights, and that insiders hold concentrated control. (2) The LLM correctly interprets that CMCSA gives public shareholders (Class A) a majority of voting power, whereas at META, public shareholders (Class A) have limited influence due to founder control via Class B—this is a valid inference from the structure described. (3) The only minor shortcoming is that the LLM omits the specific detail that as of December 31, 2023, there were only 23 Class B stockholders of record for META, which adds precision to the claim of concentrated control. This omission slightly reduces completeness but does not affect the core correctness. (4) Multi-hop reasoning is sound: the model compares dual-class structures across two companies, synthesizes voting power distribution, and draws appropriate implications for shareholder influence. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness—excellent but not fully complete on contextual detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 419,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "LLY can obtain six months of pediatric exclusivity that is tacked onto its U.S. data‑protection, orphan‑drug exclusivity and, for non‑biologic products, any remaining patents, and the same six‑month extension is added to a product’s Supplementary Protection Certificate in the EU (LLY 10‑K p. 10). MRK’s pediatric provision also provides a six‑month extension in the U.S., but it is applied to the patent term of all Orange‑Book‑listed patents and to the regulatory data‑exclusivity term for both small‑molecule and biologic products, and the EU adds six months to the SPC term, with MRK specifically noting at least one product is eligible for that pediatric market exclusivity (MRK 10‑K pp. 14‑15).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in terms of quantitative accuracy and contextual relevance. It correctly identifies that both LLY and MRK receive six months of pediatric exclusivity in the U.S. and EU, which aligns with the ground truth. The mention of six-month extensions being applied to U.S. patents, data protection, and EU SPC terms is factually accurate, and the citation of specific 10-K pages supports the claims. However, there is a key qualitative inaccuracy: the LLM incorrectly states that LLY receives the same six-month extension in the EU 'added to a product’s Supplementary Protection Certificate'—this contradicts the original answer, which specifies that only MRK benefits in the EU, not LLY. The original answer makes a clear distinction that MRK benefits in both U.S. and EU frameworks, while LLY's benefit is described only in the U.S. context. This misrepresentation breaks the multi-hop synthesis required by the question, which asks how the two companies benefit *differently*. By attributing EU pediatric exclusivity to LLY without evidence, the LLM fails to accurately contrast the two firms’ regulatory advantages. Despite correct numbers and good structure, this error in entity-specific application reduces the correctness and qualitative accuracy scores. Contextual relevance remains high as the response directly addresses the regulatory frameworks and mechanisms involved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 388,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "Emerson’s foreign‑currency liabilities slipped only modestly – from about **$22 million in 2023 to $20 million in 2024**, a $2 million decline.  By contrast, Lockheed Martin’s foreign‑currency hedge program is massive, with the **aggregate notional of its FX hedges rising from $6.5 billion to $7.5 billion** (a $1 billion increase).  The tiny change in Emerson’s liabilities versus the multi‑billion‑dollar hedge exposure at Lockheed Martin suggests Emerson faces relatively limited FX risk and uses a modest hedge position, while Lockheed Martin is managing a far larger foreign‑exchange exposure through an extensive hedging strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in scale: it reports EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024, respectively, whereas the ground truth states these values are $22 billion and $20 billion — a 1,000-fold difference. This severely undermines the quantitative accuracy. Additionally, while the LMT hedge exposure of $7.5 billion in 2024 is correctly stated, the LLM incorrectly claims it increased from $6.5 billion, which is not supported by the original answer (the original only states LMT had $7.5 billion in hedges at end of 2024, with no mention of 2023 value or change). (2) Calculations: The $2 million decline in EMR liabilities is wrong (should be $2 billion); the $1 billion increase in LMT hedges is fabricated. (3) Multi-hop reasoning: The model attempts to compare EMR and LMT strategies, but due to incorrect numbers, the synthesis is flawed. The conclusion that EMR has 'limited FX risk' due to a $2 million change misrepresents the situation — a $2 billion reduction is significant, but the model underreports it drastically. (4) Despite incorrect numbers, the answer tries to interpret strategic implications — LMT using extensive hedges vs. EMR showing modest change — which aligns somewhat with the question’s intent, giving it partial credit for contextual relevance and qualitative reasoning. However, the magnitude errors make the conclusions invalid. Semantic equivalence fails on key facts. Minor note: company names (Emerson/EMR, Lockheed Martin/LMT) and metric types (liabilities vs. hedges) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 442,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that AENB paid to its parent American Express reduces the bank’s Tier 1 capital – the numerator in the regulatory Tier 1 leverage‑ratio (Tier 1 capital ÷ assets) that AENB must keep above a minimum set by the Federal Reserve (see American Express’s discussion of its Tier 1 Leverage Ratio 【page_67】 and the August 2023 rule requiring covered banks to maintain eligible internal long‑term debt 【page_68】).  Wells Fargo and its insured depository subsidiaries are subject to the same Fed‑mandated leverage‑ratio and supplementary leverage‑ratio requirements, and regulators may restrict or prohibit dividend payments if they would cause the bank’s leverage ratio to fall below the required level (see Wells Fargo’s description of leverage‑ratio requirements 【page_5】 and capital‑distribution restrictions 【page_4】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $3.6 billion dividend amount is correctly stated, and no other numerical values (e.g., ratios, dates) are misstated. The reference to the August 2023 rule is consistent with regulatory timing and context. (2) The answer correctly identifies AENB’s dividend payment reducing Tier 1 capital, which directly impacts the leverage ratio—a key regulatory constraint. It accurately notes that both AENB and WFC are subject to Federal Reserve leverage and supplementary leverage ratio requirements, and that dividend payments can be restricted if they jeopardize these ratios. (3) The multi-hop reasoning is sound: it connects AENB’s capital distribution to its regulatory capital framework, references specific pages from AXP and WFC filings (indicating proper source synthesis), and draws a valid parallel between AENB and WFC’s regulatory environments. (4) The only minor shortcoming is that the LLM focuses more narrowly on Tier 1 leverage ratio and internal long-term debt rules, while the original answer more broadly emphasizes the general principle of capital distribution constraints under Basel III and FRB rules for both institutions. However, the core regulatory logic and factual synthesis are correct. Wording differs but semantic meaning and factual content are equivalent. No calculation errors. Contextual relevance is excellent as it directly addresses the relationship between the dividend and leverage requirements for both entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 422,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s FY 2024 pre‑tax mix – about $62.9 billion earned in the United States and $44.9 billion earned abroad – means a sizable foreign component, but the company notes it has no material operations in jurisdictions whose rates fall below the 15 % Pillar‑Two floor, so it does not expect a material increase in its global tax cost when the OECD rules take effect in FY 2025. Qualcomm, by contrast, says “substantially all” of its income is taxed in the United States (with FDII benefits) and likewise does not anticipate a material impact, giving it an even lower exposure to the Pillar‑Two minimum‑tax regime despite the same FY 2025 implementation timeline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Microsoft's $62.9B U.S. and $44.9B foreign pre-tax income in fiscal 2024 are accurately reported. The fiscal 2025 implementation timeline for Pillar Two is correctly noted for both Microsoft and Qualcomm. (2) The qualitative reasoning is sound: the LLM correctly infers that Microsoft’s lack of material operations in low-tax jurisdictions reduces its Pillar Two exposure, consistent with the company’s stated expectation of no material impact. It also accurately contrasts this with Qualcomm’s situation, noting that 'substantially all' of Qualcomm’s income is U.S.-based and thus similarly insulated from Pillar Two, leading to a minimal expected impact. (3) Multi-hop reasoning is strong—information is synthesized across two companies, their geographic income distributions, tax frameworks, and forward-looking statements. The only minor deviation from the original answer is that the LLM adds specific detail about Qualcomm benefiting from FDII (Foreign-Derived Intangible Income), which is not in the ground truth. While plausible and contextually relevant, this detail was not confirmed in the source knowledge graph, slightly reducing qualitative accuracy. However, it does not contradict the original answer and supports the correct conclusion. (4) The answer is fully contextually relevant, addressing both companies, the Pillar Two framework, implementation timeline, and comparative exposure. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor extrapolation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 452,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "Walmart’s $37.2 billion of unrecorded purchase obligations (about $15.9 billion due within a year) are legally binding contracts for inventory, capital‑expenditure, software, utilities and services that will require cash outflows but are not recorded as liabilities on the balance sheet (WMT 10‑K p. 45). By contrast, Mondelēz’s VAR model only measures one‑day market‑price risk on interest‑rate, currency and commodity instruments and expressly excludes anticipated transactions, trade payables/receivables and other contractual cash‑flow commitments (MDLZ 10‑K p. 65‑66). Consequently, Walmart faces liquidity and price‑volatility risk from its large purchase‑obligation portfolio that the VAR‑based risk metrics used by peers like MDLZ do not capture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: WMT's $37.2 billion in unrecorded purchase obligations is accurately stated. The LLM adds a detail not in the original answer—$15.9 billion due within a year—which may come from the WMT 10-K but was not part of the ground truth; however, this does not contradict it and enhances completeness. No calculation errors. (2) Entity accuracy is strong: WMT and MDLZ are correctly identified, and the reference to DIS in the original answer appears to be an error (likely meant to be MDLZ), which the LLM correctly avoids. The LLM correctly identifies MDLZ’s VAR model exclusions based on its 10-K. (3) Reasoning is sound: the multi-hop logic connecting WMT’s off-balance sheet obligations to the limitations of MDLZ’s VAR model (which excludes firm commitments) is correctly synthesized. (4) The LLM slightly improves on the original by specifying categories like software and services and citing page numbers, enhancing credibility. The only minor gap is that the original mentions DIS’s 10-K as the source for VAR exclusions, which contradicts the entity logic (should be MDLZ), so the LLM’s correction strengthens accuracy. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with enhanced precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 377,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UNH’s 10‑K notes that interest‑rate swaps are used “to match a portion of our floating‑rate assets and liabilities, either directly or through the use of interest‑rate swap contracts” and that $27 billion of its financial liabilities are at rates that vary “either directly or through the use of related interest‑rate swap contracts” (UNH p. 38). By contrast, Amgen’s filing shows it entered into $1.4 billion of swaps that converted the fixed‑rate 3.625 % 2024 Notes to a floating SOFR + 3.4 % rate, and those swaps “matured in connection with the repayment of the 3.625 % 2024 Notes” (AMGN p. 142, 149, 148). Thus UNH uses swaps broadly to manage overall floating‑rate exposure, while Amgen’s swaps were specifically tied to the $1.4 billion repayment of its 3.625 % 2024 Notes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: UNH has $27 billion in floating-rate liabilities managed via interest rate swaps as of December 31, 2024, and uses swaps broadly across its balance sheet; AMGN entered into $1.4 billion of interest rate swaps to convert the fixed-rate 3.625% 2024 Notes to floating-rate (SOFR + 3.4%), and these swaps matured in connection with the repayment of those notes in 2024. (2) Quantitative accuracy is perfect: dollar amounts ($27B, $1.4B), interest rate (3.625%), index (SOFR), and time frame (2024) all match the original answer and are cited correctly with document page references. (3) Multi-hop reasoning is sound—LLM correctly contrasts UNH’s broad, enterprise-wide use of swaps with AMGN’s specific, debt-linked application tied to the 2024 Notes repayment. (4) The only minor shortcoming is that the LLM does not explicitly state that AMGN’s 3.625% Notes were 'fully repaid' in 2024, though it implies it by noting the swaps matured 'in connection with the repayment.' This omission slightly affects completeness but does not undermine the core accuracy. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 362,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % senior notes are bullet‑type debt that mature in 2032, but the indenture provides that an “event of default” will accelerate the notes, making the entire principal and accrued interest payable immediately (AMD 10‑K p. 79). Oracle’s $6 billion revolving credit facility, however, is amortizing with scheduled quarterly repayments and a final maturity of March 8 2027 (or August 16 2027 for the term‑loan component), and an event of default permits the lenders to terminate the facility and accelerate the outstanding balance to that maturity date (or earlier) (Oracle 10‑K p. 88). Thus, both agreements contain default‑triggered acceleration, but AMD’s notes would be repaid in a single lump‑sum upon default, whereas Oracle’s facility involves a structured repayment schedule and a fixed maturity that can be accelerated.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core concept of acceleration upon an Event of Default for both AMD and Oracle, and accurately notes the $6.0 billion size of Oracle's facility. However, it contains a significant quantitative inaccuracy: AMD's 3.924% Senior Notes Due 2032 have an aggregate principal of $1.0 billion (as per ground truth), but the LLM answer fails to mention this amount, omitting a key financial figure required for comparison. Additionally, the LLM incorrectly characterizes Oracle's revolving credit facility as 'amortizing with scheduled quarterly repayments'—this is false. Revolving credit facilities do not amortize; they allow borrowing and reborrowing up to a limit until maturity, with no scheduled repayments before maturity unless initiated by the borrower. The maturity date of March 8, 2027, is correctly cited, but the mention of 'August 16, 2027 for the term-loan component' introduces information not present in the ground truth and potentially confuses the structure. The ground truth emphasizes Oracle's flexibility in prepayment and reborrowing, which the LLM omits. While the LLM captures the lump-sum vs. structured repayment contrast in spirit, the mischaracterization of Oracle's facility as amortizing undermines the accuracy of the comparison. The reasoning is partially sound and addresses the multi-hop nature of the question (comparing default-triggered obligations across two firms), but the flawed description of Oracle’s repayment structure and omission of AMD’s $1.0 billion principal reduce quantitative and qualitative accuracy. The answer remains contextually relevant and conveys a reasonable high-level comparison, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 465,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off insurance trusts hold about **$31 billion** of assets that are kept by an independent trustee and must be invested **under strict guidelines** – limits on asset‑class concentration, single‑issuer exposure, asset‑liability duration, credit quality, yield, liquidity and diversification are all prescribed in the reinsurance contracts and trust agreements. These rules aim to manage a broad set of risks (credit, interest‑rate, equity and liquidity) while still supporting long‑dated insurance liabilities.  \n\nGeneral Dynamics, by contrast, held only **$191 million** of marketable securities in trust at year‑end 2021, and its **investment policy** restricts those securities to **investment‑grade fixed‑income instruments with maturities of five years or less**, giving the GD trust a much smaller scale and a far more limited, low‑risk exposure focused mainly on short‑term credit and interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: $31.0 billion for GE and $191 million for General Dynamics as of December 31, 2021, are accurately reported (format variations like $31 billion vs $31.0 billion are acceptable). (2) The investment policies are correctly described: GE's strict guidelines include asset-class concentration, issuer exposure, duration, credit quality, and diversification—consistent with managing risk for long-dated insurance liabilities. General Dynamics' restriction to investment-grade fixed-income securities with maturities of five years or less is accurately captured, emphasizing a conservative, short-duration strategy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different companies, trust structures, and investment objectives, drawing a valid contrast in scale and risk exposure. (4) The only minor omission is that the LLM does not explicitly mention GE's periodic review for asset allocation changes or the potential inclusion of non-traditional asset classes, which slightly reduces completeness but does not affect the core accuracy. Otherwise, the answer conveys the same meaning as the original, with strong contextual relevance and correct risk characterization (credit, interest rate, liquidity). Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 418,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level‑2 fixed‑income valuations are built on observable market data such as current interest‑rate levels, yield‑curve points and credit‑spread information (supplemented by broker bids or comparable‑security quotes). PayPal’s Level‑2 derivative valuations also rely on observable inputs, but they incorporate a broader set – currency exchange rates, interest‑rate yield curves, option‑price volatility and underlying equity prices. Thus, both firms use Level‑2 pricing, but Lockheed’s models focus on fixed‑income market data, whereas PayPal’s models draw on FX, equity and volatility inputs in addition to yield‑curve data.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest rates, yield curves, and credit spreads for its Level 2 fixed income valuations; PayPal uses currency rates, yield curves, volatility, and equity prices for its Level 2 derivatives. These match the original answer exactly in substance. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct representation of financial concepts—none are misrepresented, hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, their respective asset classes (fixed income vs. derivatives), and the nature of observable inputs used, then synthesizes a valid comparison showing both use Level 2 methodologies with different input focuses. The only minor shortcoming is that the LLM slightly expands on the original by mentioning 'broker bids or comparable-security quotes' and 'FX, equity and volatility inputs' as a 'broader set'—while plausible and consistent with typical Level 2 practices, these characterizations go slightly beyond the original answer’s wording. However, they do not contradict it and are contextually reasonable. (4) The response is fully relevant to the question, directly comparing inputs across both firms within the Level 2 framework. Overall, the answer demonstrates strong semantic equivalence, correct entity usage, and logical reasoning—justifying a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 453,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "AVGO says that a 50‑basis‑point shift in market rates would change the fair value of its $56.3 billion of fixed‑rate senior notes by about **$1.7 billion** (with no effect on the notes’ interest expense)【page_49】. Cisco, on the other hand, uses a **$0.5 billion interest‑rate swap** designated as a fair‑value hedge that converts the fixed‑rate senior notes to floating; the swap’s gain‑or‑loss **substantially offsets the fair‑value change** of the hedged portion of the debt, effectively neutralizing the impact of interest‑rate movements on that debt【page_89】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AVGO's $56.3 billion in fixed-rate senior notes and the $1.7 billion fair value change from a 50 basis point rate shift are accurately reported. CSCO's $0.5 billion interest rate swap is correctly stated, as is its purpose of converting fixed-rate debt to floating and offsetting fair value changes. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and financial impacts match the original answer exactly, with acceptable formatting (e.g., $1.7 billion). (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s exposure (no active fair value hedge on existing debt, only treasury locks for future issuances) with CSCO’s use of an active fair-value hedge via a swap. The LLM captures the core comparison: AVGO has direct sensitivity, while CSCO neutralizes it for the hedged portion. (4) The only minor omission is that the original answer specifies CSCO’s swap hedges a senior note due in fiscal 2025 and that AVGO uses treasury locks for *anticipated future* debt, which adds slight contextual depth. However, the LLM still conveys the essential strategic difference in hedging approaches. Semantic equivalence is maintained, and the answer is fully relevant to the comparative question about sensitivity and hedging impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 378,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMS’s Eliquis alliance is a co‑development/co‑commercialization arrangement in which Pfizer funds roughly 50‑60 % of the development spend and the two companies split profits and losses on a global basis; the agreement includes an upfront payment that is reflected in BMS’s deferred‑income balance (about $180 million in 2023) and unspecified contingent milestones 【page_86†L1-L7】【page_86†L31-L38】. In contrast, Pfizer’s collaboration with Beam for in‑vivo base‑editing programs required a disclosed $300 million upfront cash payment and, if all three target licenses are exercised, could generate up to $1.05 billion in development, regulatory and commercial milestones (total potential consideration of $1.35 billion) 【page_76†L31-L38】. Thus, the Beam deal carries a larger upfront cash outlay and clearly defined milestone ceiling, whereas the Eliquis alliance’s upfront and milestone amounts are smaller and not fully detailed.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial terms of both collaborations and draws a valid comparison. It accurately states that Pfizer paid Beam $300 million upfront and up to $1.05 billion in milestones (total $1.35 billion), matching the ground truth. However, the LLM introduces a specific figure of $180 million in deferred income for BMY in 2023 related to the Eliquis alliance, which is not present in the original answer and may be an over-interpretation or inference from the source document. The original answer does not specify the amount of the upfront payment in Eliquis, only that it exists and is being amortized. This introduces a factual discrepancy not supported by the ground truth. (2) The Beam-related numbers are fully accurate: $300M upfront, $1.05B in potential milestones, and $1.35B total potential value. The Eliquis-related numbers are partially accurate—while the existence of an upfront and milestone payments is correct, the $180M figure is not in the ground truth and thus cannot be verified as a correct response to this specific question. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across two distinct collaborations (Eliquis alliance vs. Beam partnership), compares Pfizer’s financial commitments, and contrasts structure (co-commercialization vs. milestone-driven licensing). The conclusion that the Beam deal involves a larger upfront and clearer milestone structure is logically sound and supported. (4) The contextual relevance is excellent—the answer directly addresses the comparison requested in terms of upfront and milestone obligations. The qualitative reasoning is strong, but the quantitative accuracy is slightly reduced due to the unsupported $180M figure. Hence, correctness is high but not perfect, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 498,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments treats any lease‑extension or termination option that is “reasonably certain” to be exercised as part of the lease term, so the present value of those future payments is recorded as a lease liability (and a corresponding right‑of‑use asset) and the expense is recognized on a straight‑line basis over the extended period (see TI Note 35). Cisco, on the other hand, records its customer‑financing leases as financing receivables and, when it provides a guarantee, either defers the related revenue or records a separate liability for the guarantee; revenue from the financing is recognized ratably over the contract rather than increasing a lease liability for optional extensions (see Cisco Note 52). Thus TI’s approach inflates long‑term lease liabilities and spreads expense evenly, whereas Cisco’s approach creates a guarantee liability (if any) and defers revenue, with lease income recognized over the financing term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' (TI) accounting for lease extension and termination options when 'reasonably certain' to be exercised, using present value of lease payments to recognize lease liabilities and right-of-use assets, impacting long-term liabilities—consistent with the original answer. It also accurately describes Cisco's treatment of customer financing arrangements, noting that Cisco records financing receivables and either defers revenue or records a guarantee liability when applicable, affecting revenue timing. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in how TI and Cisco treat similar contractual options but with different financial statement impacts—liabilities vs. revenue and credit exposure. The mention of 'Note 35' for TI and 'Note 52' for Cisco adds contextual fidelity, though these note numbers were not in the ground truth and cannot be independently verified here; however, they do not detract from factual correctness. (4) The LLM captures the core contrast: TI’s approach affects lease liabilities and expense recognition, while Cisco’s affects revenue deferral and potential guarantee liabilities. The only minor shortcoming is a slightly narrower mention of 'credit exposure' in Cisco’s case compared to the original answer’s reference to collateralization and credit risk, which could have been more explicitly addressed. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 464,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives it control over the channel’s documentary and science‑focused library, which appears as a dedicated “National Geographic” tile on Disney+ (see the description of Disney+ tiles that include National Geographic programming【page_13】).  This exclusive, high‑value content differentiates Disney+ from other streaming services and reduces the need to license large volumes of third‑party titles, thereby keeping the cost of acquiring new subscribers lower.  In contrast, YouTube’s subscription businesses (YouTube Premium and YouTube TV) rely on licensing a broad mix of external content to fuel their offerings, a model that typically drives higher subscriber‑acquisition expenses (YouTube non‑advertising revenue from those subscriptions is highlighted in the Google filing【page_7】).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney’s 73% stake in National Geographic is accurately stated, and the integration of National Geographic as a top-level tile on Disney+ is correctly described, supported by the reference to page_13. The contrast with YouTube’s reliance on licensed content is valid and contextualized with a reference to YouTube Premium and YouTube TV, citing Google’s filing (page_7), which supports the claim about non-advertising revenue from subscriptions. (2) Quantitative accuracy is perfect: the 73% ownership figure is correct and matches the original answer; no other numerical values require calculation. (3) Multi-hop reasoning is sound: the answer correctly links Disney’s ownership stake to content differentiation on Disney+, explains cost advantages from reduced third-party licensing, and contrasts this with YouTube’s licensing model. The implication for lower subscriber acquisition costs is logically derived and consistent with the ground truth. (4) Semantic equivalence is strong—while the LLM adds minor elaboration (e.g., 'documentary and science-focused library'), it does not introduce inaccuracies. The only minor gap is that the original answer emphasizes Disney’s *vertical integration* and *proprietary content* as structural advantages more explicitly, which the LLM implies but doesn’t name directly. This slight omission in framing prevents a perfect 10 on qualitative accuracy, but overall the response is factually complete, contextually relevant, and correctly reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 436,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologics are protected by a statutory 12‑year FDA regulatory exclusivity that extends market protection well beyond any patent term – the company’s own estimates show biologics such as Abecma (2036), Opdivo (2028) and Yervoy (2025) remaining exclusive for many years after approval【page_7†L9-L13】【page_9†L31-L38】. By contrast, Merck’s Januvia/Janumet family, a small‑molecule drug, relies mainly on patents; although the key U.S. patent expired in 2023, court settlements and a later salt‑form patent have delayed U.S. market exclusivity only until May/July 2026, and EU exclusivity was already lost in 2022‑23【page_58†L31-L38】. Thus, BMY’s biologics enjoy a longer, predictable regulatory exclusivity period, whereas MRK’s experience reflects a shorter, patent‑driven delay in market protection for a chemical product.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and exclusivity periods are correct: BMY's 12-year regulatory exclusivity for biologics is accurately stated; Opdivo (2028), Yervoy (2025), and Abecma (2036) are correctly cited as examples with post-approval exclusivity timelines. For MRK, the key patent expiration in 2023 and extended exclusivity until May/July 2026 due to salt-form patent settlements are factually correct. EU exclusivity loss in 2022–2023 is an additional accurate detail not in the original answer but consistent with external knowledge. (2) The comparison between BMY’s reliance on statutory regulatory exclusivity (for biologics) versus MRK’s dependence on patent litigation and secondary patents (for small molecules) is logically sound and captures the core contrast in market protection strategies. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across BMY’s biologic exclusivity framework and MRK’s Januvia-specific patent extensions, linking them to broader regulatory vs. patent-based protection mechanisms. (4) The only minor shortcoming is that the original answer emphasizes how regulatory exclusivity can extend *beyond patent terms*, which the LLM mentions but could have elaborated slightly more explicitly in direct comparison. However, the semantic meaning and factual content are substantially equivalent. Wording differences do not affect accuracy. All entities (BMY, MRK, Opdivo, Yervoy, Januvia, Janumet) are correct, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 433,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 40,000‑share Series F preferred issue can be redeemed by the company at $25,500 per share (plus accrued dividends) if a “rating‑agency event” occurs – i.e., if a rating agency lowers the equity credit assigned to the security (see MetLife 10‑K p. 264). AIG likewise flags that a downgrade by a rating agency could restrict its ability to write new business and hurt customer retention (see AIG 10‑K p. 85). Thus, both insurers are vulnerable to rating‑agency actions: a downgrade could force MetLife to fund a costly redemption, while the same downgrade could impair AIG’s sales and market position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 40,000 shares of Series F preferred stock and the $25,500 redemption price per share (plus accrued dividends) are accurately cited from MetLife's 10-K (p. 264), and the reference to AIG’s 10-K (p. 85) is correctly attributed. These details were not in the original answer but are factually precise and add value. (2) The answer is complete, addressing both MetLife’s redemption obligation triggered by a rating agency event and AIG’s business risks from downgrades. (3) Entity accuracy is strong: both companies are correctly identified, and the financial instruments and risks are properly contextualized. (4) The multi-hop reasoning is sound—linking MetLife’s contingent redemption liability to AIG’s operational exposure due to rating actions demonstrates valid synthesis across filings. The only minor shortcoming is that the original answer emphasizes the shared strategic risk to both insurers due to rating agency criteria changes, while the LLM focuses more on consequences (redemption cost, business restrictions) without explicitly highlighting the parallel in how both risks stem from changes in rating agency treatment. However, this is a nuance in framing, not a factual gap. Overall, the LLM provides a semantically equivalent, slightly more detailed response with excellent contextual relevance and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 398,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "LMT’s 2021 fair‑value schedule shows U.S. government and agency securities recorded in the Level 2 column ($1,147 m) and the accounting note explains that when a quoted price is unavailable the trustee values such fixed‑income securities with “matrix pricing, yield curves and indices” – the very definition of a Level 2 measurement (see LMT p.108‑p.93). In contrast, UPS classifies virtually all of its U.S. government and agency debt securities as Level 1 (quoted market prices) and reserves matrix‑pricing techniques for Level 2 assets such as corporate bonds, municipal bonds and ABS (see UPS p.89). Thus LMT uses matrix pricing for its Level 2 U.S. government securities, while UPS does not, because its U.S. government securities are treated as Level 1.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states LMT reported $121 million in U.S. Government Securities classified as Level 2, but the LLM claims $1,147 million in 'U.S. government and agency securities'—a figure that is both incorrect in amount and conflates 'government' with 'government and agency' securities. This number does not match the ground truth and appears to be either misread or misattributed. (2) The LLM incorrectly asserts that UPS classifies its U.S. government securities as Level 1 and does not use matrix pricing for them, directly contradicting the original answer, which states UPS *does* use matrix pricing for Level 2 marketable securities including U.S. government debt. The LLM’s claim that UPS reserves matrix pricing only for corporate bonds, municipal bonds, and ABS is unsupported by the ground truth and contradicts the shared methodology. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the commonality between LMT and UPS—both use matrix pricing for U.S. government securities when direct quotes are unavailable, per Level 2 classification. Instead, it creates a false contrast. (4) While the answer is relevant to the question and attempts to compare valuation methodologies, the core factual claims about both companies’ practices are incorrect, leading to a low correctness score. The contextual relevance is moderate because the structure and intent align with the question, but the substance is inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 420,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PM values its derivatives with standard models that rely on readily observable market data—such as current FX spot rates and interest‑rate differentials—and classifies those contracts as Level 2 assets in the fair‑value hierarchy (PM 10‑K p. 128‑129). By contrast, MDLZ values its real‑estate fund holdings using appraisal‑ and discounted‑cash‑flow techniques that depend on unobservable inputs and assumptions, placing those investments primarily in Level 3 (MDLZ 10‑K p. 103‑104). Thus PM’s valuations are based on observable market inputs, whereas MDLZ’s real‑estate valuations rely on less‑observable, model‑driven inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that PM uses observable market inputs (FX spot rates, interest rate differentials) in standard models for derivative valuations and classifies them as Level 2, while MDLZ relies on unobservable inputs (appraisal and discounted cash flow techniques) for real estate fund investments, categorizing them as Level 3. These characterizations align with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation approaches across two different companies (PM and MDLZ), links them to appropriate fair value hierarchy levels, and contrasts observability of inputs. The only minor shortcoming is that the original answer explicitly mentions 'Level 1 or 2' for PM, while the LLM specifies only Level 2. This is a slight omission but not incorrect, as Level 2 is the most applicable category for such derivatives. (4) The LLM cites specific page numbers from the 10-Ks (e.g., p.128-129 for PM, p.103-104 for MDLZ), which adds precision not in the original but supports credibility. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only a minor reduction in completeness regarding the full Level 1/2 range. Hence, a 9/10 on correctness and qualitative accuracy is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 420,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior‑subordinated debentures are structured so that the company may **electively defer interest payments** (subject to “dividend‑stopper” trigger events) and, because of its replacement‑capital covenants, can only repay, redeem or purchase the notes after it has raised cash from the sale of replacement securities 【page_130】. In contrast, AIG’s AIGLH junior‑subordinated debentures are ordinary long‑term obligations (8.5 %‑8.0 % coupons, maturing 2030‑2046) that are **guaranteed by AIG Parent** and carry no explicit deferral or repayment‑restriction provisions; AIG relies on its broader liquidity sources, such as a $4.5 billion revolving credit facility, to meet those scheduled payments 【page_289】【page_290】【page_291】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core contrast between MetLife's deferral and replacement capital provisions and AIG's guaranteed long-term obligations, showing sound qualitative understanding and contextual relevance. However, there are key quantitative inaccuracies: the LLM states AIGLH debentures have coupons of '8.5%–8.0%', but the ground truth specifies three tranches with rates of 8.5%, 8.125%, and 7.57%—the 8.0% figure is incorrect. Additionally, the LLM omits the exact principal amounts ($54M, $142M, $31M) and maturities (2030, 2045, 2046) for each tranche, which are critical for precision. While it correctly notes AIG Parent guarantees the debentures, it fails to mention that AIG does *not* guarantee AIGLH borrowings post-distribution, a key distinction in liquidity risk. The claim about AIG’s $4.5 billion credit facility, while potentially true, is not in the ground truth and introduces unverified information, slightly undermining factual fidelity. The reasoning is logically structured and synthesizes multi-hop elements (deferral vs. fixed maturity, guarantees vs. constraints), but the omission of exact figures and introduction of an unverified liquidity source reduce quantitative accuracy. Wording differences are acceptable, but missing specific numbers and including unsupported details prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 370,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA identifies Samsung as a direct rival in both the automotive‑/gaming‑oriented SoC market and the GPU space, underscoring that the same customers Intel hopes to win with its new Intel Foundry Services (IFS) are already being served by a strong Samsung ecosystem【page_15】.  Intel’s filing stresses that IFS must compete head‑to‑head with Samsung’s mature foundry capabilities, yet Intel has lagged on key process nodes—its 10 nm rollout and the later‑than‑planned Intel 4 (formerly 7 nm) node were delayed, eroding performance‑per‑watt, density and time‑to‑market advantages【page_54】【page_55】.  Those historic delays and Samsung’s entrenched position therefore heighten Intel’s strategic challenge of scaling IFS quickly enough to meet the high‑performance SoC and GPU demands that NVIDIA and other customers expect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: NVIDIA competes with Samsung in SoC and GPU markets; Samsung is a mature foundry player and competitor to Intel's IFS; Intel has faced manufacturing delays (10nm and Intel 4); these delays have hurt performance-per-watt, density, and time-to-market; and these factors collectively challenge IFS's ability to scale. (2) There are no numeric values (e.g., dates, dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly links NVIDIA’s competition with Samsung to the broader ecosystem that Intel must penetrate via IFS, and recognizes that Samsung’s dual role (as both product competitor and foundry provider) creates structural challenges for Intel. The mention of 'page_15' and 'page_54/page_55' references suggests grounding in source material, though not required for correctness. (4) The only minor shortcoming is that the LLM does not explicitly state that Samsung is a 'dual threat' in both end-product and manufacturing markets—a nuance present in the original answer—but this concept is implied through context. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1501,
        "completion_tokens": 385,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s $62 billion 2024 buy‑back was limited to its publicly‑traded Class A (one vote per share) and non‑voting Class C shares, leaving the high‑voting, founder‑controlled Class B shares (10 votes each) untouched (Alphabet 10‑K p. 82). Comcast likewise repurchases only its publicly‑traded Class A stock (one vote per share) because its Class B shares – each carrying 15 votes and owned solely by Brian L. Roberts, who controls one‑third of total voting power – have no public market (Comcast 10‑K p. 31). Thus, in both firms the share‑repurchase programs return capital to ordinary shareholders while preserving the voting control held in the high‑vote Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024 (correct dollar amount and year), and the repurchases excluded Class B shares, which carry 10 votes per share and are founder-controlled. The LLM correctly notes that Class B shares are not repurchased, preserving voting control. For Comcast, the LLM accurately states that Class B shares carry 15 votes per share, are owned solely by Brian L. Roberts, and represent one-third of total voting power—matching the 33⅓% in the ground truth. (2) Quantitative accuracy is perfect: $62 billion, 10 votes (Alphabet Class B), 15 votes (Comcast Class B), and ownership concentration are all correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that both companies avoid repurchasing high-vote Class B shares to preserve founder/insider control, while returning capital via repurchases of publicly traded, low/no-vote shares. The explanation that repurchasing Class A shares increases the relative voting power of Class B shares is implied correctly. (4) Minor deduction in qualitative accuracy: the ground truth explicitly mentions that Alphabet’s Class B shares convert to Class A upon sale, which the LLM omits. This is a small but relevant structural detail. However, the core reasoning and conclusion are equivalent. Contextual relevance is perfect—the answer directly addresses the impact of voting rights on repurchase strategies for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 425,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s NSCLC effort centers on an oral, KRAS‑G12C‑targeted small‑molecule (LUMAKRAS) that is being developed for the KRAS‑mutated NSCLC subset – a pill‑based, mutation‑specific approach (see LUMAKRAS entry on page 5 and the NSCLC definition on page 4). By contrast, Bristol‑Myers Squibb’s recent FDA approval of Opdivo Qvantig is a subcutaneous injection of nivolumab‑hyaluronidase that can be used across most existing adult solid‑tumor Opdivo indications, including NSCLC, expanding the market with a more convenient injection route (see Opdivo Qvantig approval on page 44 and product description on page 4).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, administration methods, and product names, and there are no numeric inaccuracies (the original answer does not contain specific numbers such as dollar amounts or percentages, and the LLM does not introduce any incorrect figures). The administration methods are correctly identified: Amgen’s LUMAKRAS is an oral, small-molecule therapy targeting KRAS-G12C in NSCLC, while BMS’s Opdivo Qvantig is a subcutaneous formulation enabling broader delivery convenience. The LLM correctly notes that Opdivo Qvantig applies to most existing adult solid tumor indications, including NSCLC, which aligns with the ground truth’s claim about market expansion via improved administration. However, the LLM answer misses a key element of the original answer’s comparative insight: the strategic contrast between Amgen’s focus on a specific molecular subset (KRAS-mutated NSCLC) and BMS’s strategy of broadening market access through a delivery mechanism innovation across multiple tumor types. While the LLM mentions both approaches, it does not synthesize the divergent strategic implications as clearly as the ground truth—specifically, that BMS is enhancing market positioning in solid tumors via administration convenience, whereas Amgen is targeting a niche biomarker-defined population. This omission reduces the depth of the multi-hop reasoning, though core facts are correct. The answer is contextually relevant and well-supported by referenced document pages, but lacks full qualitative completeness in drawing the strategic comparison implied in the question. Semantic equivalence is mostly preserved, but the higher-level synthesis is weaker.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 460,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "CMCSA’s charter guarantees that the 9 million Class B shares always control roughly one‑third of the company’s votes – “33 ⅓ % of the voting power… generally non‑dilutable” – and each Class B share carries a weighted vote (10‑15 votes per share) that cannot be diluted by issuing more Class A stock【page_91】. Because Class B shares are convertible only on a share‑for‑share basis into Class A, any conversion simply moves the same voting power to Class A without increasing the total, so even a sizable Google holding of Class A common stock cannot overcome the fixed 33 ⅓ % voting block held by Class B and therefore cannot dominate Comcast’s governance【page_81】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "(1) The LLM answer correctly identifies the core concept: CMCSA's Class B shares protect 33 1/3% of voting power in a non-dilutable manner, limiting GOOGL's influence via its Class A stake. However, it introduces a significant factual inaccuracy by claiming Class B shares carry '10-15 votes per share' and that there are '9 million Class B shares', which are not present in the original answer or implied by the question. These specific numbers (9 million shares, 10-15 votes per share) are unsupported by the ground truth and appear to be hallucinated or misattributed from external data (possibly from document excerpts like 'page_91' and 'page_81' cited), undermining quantitative accuracy. (2) The original answer makes no mention of vote weightings or share counts; it only states the 33 1/3% non-dilutable voting power and 1:1 convertibility. The LLM’s addition of weighted voting (10-15x) and exact share count (9 million) introduces false precision and incorrect data, failing the quantitative accuracy check. (3) Despite these errors, the reasoning about conversion mechanics and the structural limitation on GOOGL’s influence is logically sound and semantically aligned with the original: converting Class B to Class A doesn’t increase total voting power, preserving the 33 1/3% block. This shows correct multi-hop synthesis of capital structure and governance impact. (4) Contextual relevance is perfect—the answer directly addresses how CMCSA’s structure limits GOOGL’s influence. Qualitative reasoning is strong, but quantitative inaccuracies prevent a higher score. Correctness is reduced due to unsupported numbers, though core logic remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 452,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2% rise in South Africa’s total tobacco market (PM 10‑K, p. 56) points to a larger market that could expand the scale of PepsiCo’s merger‑related socioeconomic commitments – the $0.5 bn pledge for employee ownership, agricultural development and education tied to its Pioneer Foods acquisition (PEP 10‑K, p. 113‑115) – while the offsetting increase in illicit‑trade prevalence reduces the net legal sales that can fund those obligations. For Altria, the same higher illicit‑trade prevalence raises its illicit‑trade risk exposure, as described in its Illicit Trade section (MO 10‑K, p. 42), because illicit activity can erode lawful sales, trigger regulatory actions and tax‑revenue losses in its international tobacco operations.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 13.2% increase in South Africa's tobacco market volume and links it to both PEP's socioeconomic obligations and MO's illicit trade risk exposure, aligning with the core of the ground truth. However, it incorrectly attributes the $0.5 billion socioeconomic pledge to PepsiCo (PEP), when in fact this commitment is associated with Philip Morris International’s (PM) merger activities, not PepsiCo. This is a significant entity error—PepsiCo is a food and beverage company unrelated to tobacco mergers in South Africa. The reference to 'Pioneer Foods acquisition' by PEP is accurate in isolation (PEP did acquire Pioneer Foods), but the $0.5B socioeconomic pledge tied to tobacco market dynamics and merger obligations in South Africa does not appear in PEP’s filings; it is more plausibly linked to PM or British American Tobacco (BAT), not PEP. (2) Quantitatively, the 13.2% market increase and $0.5B figure are correctly stated, though the latter is misattributed. Page references (PEP 10-K pp. 113–115, MO p. 42, PM p. 56) suggest plausible sourcing, but the synthesis is flawed due to incorrect company linkage. (3) The multi-hop reasoning is partially sound: the model connects market growth → socioeconomic obligation scale → funding challenges due to illicit trade → impact on PEP, and separately links illicit trade to MO’s risk exposure. However, the first chain fails at the entity level—PEP is not a tobacco company and has no merger-related tobacco socioeconomic obligations in South Africa. The MO portion is accurate: Altria (MO) does discuss illicit trade risks in its 10-K, including lost sales, regulatory actions, and tax revenue losses, so that half of the answer is correct. (4) The contextual relevance is high because the structure and intent match the question, and the illicit trade mechanism for MO is well-explained. However, the critical error in assigning tobacco merger obligations to PepsiCo undermines the correctness score. A 7 reflects that key facts and mechanisms are understood, but a major entity and contextual misassignment prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 573,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑law suits stemming from its 2019 IPO have largely been resolved on procedural grounds – the Ninth Circuit in February 2025 reversed the district court and ordered the complaint dismissed with prejudice, leaving only a pending class‑certification motion and no quantifiable loss estimate (the filing notes “unspecified monetary damages” and that the company “is not able to reasonably estimate the amount” of any loss)【page_91】. In contrast, Meta’s privacy‑related litigation has already produced concrete financial exposure: a $725 million settlement of a consumer‑privacy class action, a $5 billion FTC penalty paid in 2020, and a €1.2 billion (≈$1.2 billion) GDPR fine from the Irish regulator, with additional claims still pending【page_112】【page_113】.  Thus, Slack’s risk is primarily procedural with no material liability to date, whereas Meta faces sizable, disclosed monetary liabilities from its privacy lawsuits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's IPO-related litigation was dismissed with prejudice by the Ninth Circuit in 2025 after a partial denial of a motion to dismiss in 2020, and no financial liability was quantified. Meta's $725 million privacy settlement (approved in 2023), $5.0 billion FTC penalty (paid in 2020), and ongoing regulatory actions including a €1.2 billion GDPR fine are accurately reported. The LLM adds the GDPR fine not explicitly mentioned in the original answer but consistent with Meta’s broader privacy liabilities and does not contradict the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts ($725 million, $5 billion, €1.2 billion), years (2020, 2023, 2025), and procedural outcomes (dismissal with prejudice, settlement approval) match or are consistent with the original. Format variations (e.g., $5 billion vs $5.0 billion) are acceptable. (3) Multi-hop reasoning is sound: the model correctly contrasts Slack’s procedural resolution with no material financial loss against Meta’s substantial, realized financial liabilities and ongoing exposure. It synthesizes information across companies, legal domains (securities vs privacy), and procedural stages. (4) The only minor shortcoming is that the original answer emphasizes Meta’s ‘pending appeals in several state attorney general cases,’ which the LLM does not explicitly mention, though it does note ‘additional claims still pending,’ capturing the essence. The addition of the GDPR fine enhances completeness without introducing error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 462,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PMI’s RSU awards vest in a single tranche on the third anniversary of grant, so the $160 million of un‑recognized RSU compensation is slated to be expensed over a weighted‑average of about 17 months (the remainder of the three‑year restriction period)【page_110】.  By contrast, Walmart changed its RSU schedule from a 25 %‑per‑year, four‑year vesting to roughly 8 % each quarter over three years, causing the fair‑value cost to be recognized ratably each quarter and thus accelerating expense recognition relative to the prior annual schedule【page_66】.  Consequently, PMI’s remaining RSU cost is concentrated in a shorter 17‑month window, while Walmart’s new quarterly vesting spreads the expense over three years but at a faster, more continuous pace than the older annual vesting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all numbers are correct: PM's $160 million in unrecognized costs, the 17-month weighted-average recognition period, the shift from 25% annual vesting over four years to 8% quarterly over three years for WMT—all match the original. The format variations (e.g., '8% each quarter' vs '8% quarterly vesting') are semantically equivalent. (2) The LLM correctly identifies the companies (PM/PMI and WMT/Walmart), the relevant RSU vesting structures, and the fiscal context (WMT’s change in fiscal 2023, though not explicitly dated in the answer, is correctly implied). (3) The reasoning is sound: it correctly contrasts PM’s cliff-vesting model (single tranche at three years) leading to back-loaded expense recognition with WMT’s shift to more frequent, ratably recognized quarterly vesting that accelerates cost recognition compared to its prior annual schedule. The conclusion that WMT’s new approach results in faster, more continuous expense recognition is logically derived. (4) The only minor shortcoming is that the LLM omits mention of specific vesting triggers at PM such as death, disability, or age 58, which are part of the multi-hop synthesis in the original answer. While not critical to the main comparison on cost recognition timing, this detail adds nuance to PM’s vesting policy. However, the core impact on compensation cost recognition period is accurately captured. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for the omitted detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 466,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing says it faces a “reasonably possible” $620 million of unrecognized tax‑benefit exposure that could be eliminated within the next 12 months (BA 10‑K p. 75). By contrast, Lockheed Martin notes that the OECD’s Pillar 2 global‑minimum‑tax rules – which will begin to apply in some jurisdictions on 1 Jan 2024 (and in others on 1 Jan 2025) – are not expected to materially raise its global tax cost, although the timing and adoption vary by country (LMT 10‑K p. 36).  In short, Boeing’s risk is a specific, dollar‑amount exposure, while Lockheed’s Pillar 2 impact is judged to be immaterial and largely qualitative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Boeing's $620 million unrecognized tax benefit exposure is accurately cited, and the Pillar 2 implementation dates (January 1, 2024, and 2025) match the context provided in the original answer. The reference to specific 10-K pages (p. 75 for Boeing, p. 36 for Lockheed Martin) adds precision. (2) The answer correctly identifies that Boeing’s risk is a specific dollar amount related to federal tax audits, while Lockheed Martin assesses Pillar 2’s impact as immaterial—this matches the original answer’s conclusion. (3) Multi-hop reasoning is sound: the model synthesizes Boeing’s tax exposure with Lockheed’s forward-looking Pillar 2 assessment under the OECD framework, correctly contrasting a near-term quantified risk (Boeing) with a broader, qualitative, and immaterial expectation (Lockheed). (4) The only minor shortcoming is that the LLM omits Boeing’s reasoning for minimal Pillar 2 impact (lack of material operations in low-tax jurisdictions), which is present in the original answer. However, this does not undermine the core comparison. The answer remains semantically equivalent and contextually complete, with excellent use of source evidence. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 386,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "ASU No. 2023‑07 requires companies to add incremental, disaggregated expense and other segment‑level disclosures. PepsiCo’s 10‑K notes that its reportable segments will be realigned beginning in the first quarter of 2025 (page 7) – so the company will have to present those new segment breakdowns with the additional ASU‑required detail when the reorganization takes effect. Altria already adopted ASU 2023‑07 for its year‑ended 2024 filing (page 62) and will begin providing the required interim segment disclosures in its Q1 2025 interim statements (page 63), meaning both firms will be reporting under the same new standard at the same time.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will reorganize its segments starting Q1 2025 and apply ASU No. 2023-07 with that reorganization, while Altria adopted the standard in 2024 and will begin interim disclosures in Q1 2025. These dates and timelines match the original answer exactly. (2) Quantitative accuracy is perfect: no numerical errors, and the timeline (2025 for PepsiCo’s realignment, 2024 adoption and 2025 interim reporting for Altria) is correctly stated. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across two companies and connects their adoption timelines to the same accounting standard. It correctly infers that both will be reporting under the new standard simultaneously starting Q1 2025, which is a valid conclusion from the data. (4) The only minor shortcoming is that the LLM omits specific details about PepsiCo’s segment reorganization (e.g., combining FLNA and QFNA into PepsiCo Foods North America, and the international realignment into Latin America Foods, EMEA, etc.), which are included in the ground truth. While not critical to the core question about ASU impact and alignment, this reduces completeness slightly. However, the answer still captures the essential alignment in adoption timing and reporting changes, and references the realignment. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 416,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s sotatercept (MK‑7962) is protected by a U.S. compound patent that expires in 2027, with method‑of‑use patents that run to 2037 and a 12‑year data‑exclusivity period that could extend effective protection into the late‑2030s 【page_16†L1-L5】【page_16†L6-L9】. Pfizer’s biologic strategy, by contrast, layers protection – a 12‑year U.S. data‑exclusivity term, up‑to‑five‑year patent‑term extensions (PTE) in the U.S., supplementary protection certificates in Europe and six‑month pediatric exclusivity – allowing its biologics to remain exclusive well beyond the basic patent expiry dates 【page_14†L1-L9】【page_14†L10-L13】. Thus Merck’s timeline is a fixed 2027/2037 horizon, while Pfizer builds in multiple extensions to stretch biologic protection farther.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in precision and completeness. (1) Quantitatively, the LLM correctly identifies Merck's base patent expiration as 2027 and potential protection to 2037, consistent with the original answer. It adds detail about method-of-use patents and 12-year data exclusivity extending into the late 2030s, which is plausible but not explicitly confirmed in the ground truth. The mention of 'late-2030s' is a reasonable inference but slightly exceeds the ground truth's stated 2037 limit. (2) For Pfizer, the LLM accurately describes the use of PTEs (up to five years), supplementary protection certificates (Europe), and pediatric exclusivity, which aligns with the original answer’s emphasis on layered extensions. However, the original answer does not specify 'six-month pediatric exclusivity' or 'up-to-five-year PTE'—these are accurate general facts but not explicitly tied to Pfizer’s strategy in the ground truth. (3) The reasoning is sound: the LLM correctly contrasts Merck’s more defined 2027/2037 timeline with Pfizer’s flexible, multi-layered extension strategy. This captures the core comparative insight. (4) The answer is contextually relevant and addresses both companies’ patent strategies for biologics, including potential extensions. The main limitation is that the LLM introduces specific mechanisms (e.g., method-of-use patents, pediatric exclusivity) not detailed in the ground truth, which, while factually plausible, go beyond the provided information. Thus, the answer is slightly over-specified but not factually incorrect. Scores reflect high accuracy with minor deductions for unsupported specificity and slight over-extension of timelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 475,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin notes that if the cost to finish a fixed‑price contract climbs above the contract price, it must record a “reach‑forward” loss and its profit‑booking rate drops, which directly cuts operating profit and can be material to earnings (LMT p. 64‑66). GE warns that rising material, component and labor prices make its fixed‑price contracts vulnerable to cost overruns, eroding margins, exposing the company to penalties and cash‑flow strain and thereby hampering its ability to meet delivery schedules and execute projects efficiently (GE p. 34‑32).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the financial and operational impacts of cost overruns on fixed-price contracts for both Lockheed Martin and GE, and uses accurate terminology such as 'reach-forward loss' and references to material/labor cost pressures. However, it fails to include the specific quantitative data from the ground truth: Lockheed Martin's cumulative reach-forward losses of $270 million and $280 million as of December 31, 2023. These figures are critical to the question’s multi-hop requirement and are entirely omitted, which significantly undermines quantitative accuracy. (2) No numbers are provided in the LLM answer, despite the original answer containing two precise dollar amounts with a specific date. Even allowing for format variation, the absence of any dollar figures or mention of the $550 million total potential exposure constitutes a major factual omission. (3) The reasoning is sound in structure—correctly linking inflationary pressures to cost overruns, and explaining how these affect profitability (Lockheed) and operational execution (GE). It appropriately cites risks like margin erosion, penalties, and cash-flow strain. However, it references 'RTX's 10-K' in the ground truth as a source for inflation sensitivity, but the LLM answer attributes similar content to GE’s filing without clearly connecting RTX’s input, indicating a potential source conflation or incomplete synthesis across entities. Also, the LLM cites 'GE p. 34-32', which appears to be a typo (likely meant p. 32-34), slightly undermining source credibility. (4) The contextual relevance is high—the answer addresses both companies, the financial and operational impacts, and the role of inflation and complexity. The qualitative reasoning is strong but undermined by the lack of specific data. Correctness score is 6 due to partially correct information: core mechanisms are explained accurately, but missing key multi-hop facts (specific losses, dates, sources) prevents a higher rating.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 542,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ hedges raw‑material price risk with exchange‑traded commodity futures and options, which it classifies as Level 1 financial instruments and values at fair value using quoted market prices (see MDLZ 10‑K p.112; p.94). Costco, on the other hand, discloses that it holds **no** Level 1 financial liabilities and that its derivative exposure (e.g., forward foreign‑exchange contracts) is measured at Level 2 using observable inputs rather than exchange‑traded prices (see Costco 10‑K p.51). Thus MDLZ’s commodity‑future hedges are accounted for at the highest fair‑value hierarchy level, whereas Costco’s derivative positions are confined to Level 2 and do not include Level 1 liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, no specific numbers (e.g., dollar amounts, dates) are incorrect—both companies' disclosures are correctly represented without numerical inaccuracies. The mention of MDLZ using commodity futures/options valued at Level 1 based on quoted prices matches the original. COST's lack of Level 1 financial liabilities is correctly stated, and the reference to Level 2 measurement for its derivatives (e.g., foreign exchange forwards) is factually consistent. (2) The LLM correctly identifies the entities (MDLZ and COST), their respective derivative instruments, and fair value hierarchy levels. While the original answer cites COST’s disclosure date (August 28, 2022), the LLM omits this specific date—this is a minor omission but does not affect the core factual accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MDLZ uses Level 1 instruments (exchange-traded futures) for raw material hedges, while COST has no Level 1 liabilities and uses Level 2 derivatives for different purposes (FX, not commodities), indicating a strategic difference. (4) The LLM adds useful detail (e.g., forward FX contracts at Level 2) not in the original but supported by typical 10-K disclosures, enhancing clarity without introducing error. The only minor gap is not explicitly stating that COST holds *no Level 1 or Level 3* liabilities (LLM only confirms no Level 1), but it correctly infers no exposure to exchange-traded commodity futures. Overall, the answer is semantically equivalent and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 451,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS has 4.6 billion Class A shares authorized, and all of those shares are fully convertible into Class B shares【page_116】. Lockheed Martin’s non‑qualified pension trust held $658 million of assets as of December 31 2024【page_115】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies both key facts from the ground truth: 4.6 billion UPS Class A shares convertible into Class B shares and $658 million in assets held by Lockheed Martin's nonqualified pension trust as of December 31, 2024. All factual elements are accurately represented. (2) Quantitatively, both numbers match the ground truth exactly—4.6 billion and $658 million—with only acceptable formatting variations (e.g., spacing in 'December 31 2024'). No calculations were required, but the values are correctly cited. (3) The multi-hop reasoning is sound: the answer synthesizes data from two different companies (UPS and Lockheed Martin) and two distinct financial disclosures (share structure and pension assets) as required by the question. The use of citation markers [page_116, page_115] suggests proper grounding in source documents. (4) The answer is semantically equivalent to the original, with slightly more precise wording (e.g., 'authorized' and 'fully convertible' adds clarity without altering meaning). All evaluation dimensions are fully satisfied, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1137,
        "completion_tokens": 319,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "Broadcom said that a 50‑basis‑point move in market rates would swing the fair value of its $56.3 billion of fixed‑rate senior notes by about $1.7 billion (2024) – a material sensitivity it does not fully offset, relying only on treasury rate‑lock contracts for future issuances【page_49】. Cisco, by contrast, entered into a $0.5 billion interest‑rate swap designated as a fair‑value hedge that converts the fixed‑rate senior notes to floating (SOFR + spread); the swap’s gain or loss “substantially offsets” the fair‑value change of the hedged portion of the debt, effectively neutralizing its interest‑rate exposure【page_89】【page_92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: a 50 basis point rate change impacting AVGO's $56.3 billion fixed-rate notes by $1.7 billion, and CSCO's $0.5 billion interest rate swap are accurately reported. The date (2024) is consistent with the original answer's November 3, 2024 reference. (2) Quantitative accuracy is perfect—dollar amounts, percentages, and financial impacts match exactly, with acceptable formatting (e.g., $1.7 billion = $1.7 billion). (3) The multi-hop reasoning is sound: the model correctly contrasts AVGO’s lack of full hedging (only using rate locks for future issuances) with CSCO’s active use of a fair-value hedge via a swap tied to SOFR, which offsets fair value changes. This reflects proper synthesis across two companies and their respective hedging strategies. (4) The only minor shortcoming is that the LLM slightly downplays AVGO’s exposure by not explicitly stating that its entire $56.3 billion is unhedged, instead noting it relies on treasury locks for future issuances—which is true but could imply some hedging activity. However, this does not distort the core comparison. Semantically, the answer fully captures the intent and factual content of the original. Contextual relevance is excellent, directly addressing the comparison of sensitivity and hedging strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 380,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model applies a “parametric delta‑gamma” approximation only to the interest‑rate‑sensitive and foreign‑currency‑sensitive derivative portfolio, using the technique to capture the observed inter‑relationships between rates and currencies and to estimate a one‑day fair‑value loss. By contrast, MDLZ’s VAR model also uses a parametric delta‑gamma approximation but extends it to the expected‑return distributions of interest rates, currencies **and** commodity prices, calculating separate VAR for fixed‑income, currency‑exchange and commodity exposures (and valuing currency‑ and commodity‑linked options). Thus MDLZ’s application is broader—covering commodities and option valuation—while PM’s is limited to interest‑rate and FX risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between PM and MDLZ in their application of the parametric delta-gamma approximation technique within their VAR models. (1) It correctly identifies that PM applies the method to interest-rate and foreign-currency-sensitive derivatives, while MDLZ extends it to include commodity prices. This aligns with the ground truth. (2) There are no numeric values (e.g., percentages, dollar amounts, specific dates) in either the question or the original answer, so quantitative accuracy is not applicable in a traditional sense—however, the temporal scope (e.g., 'prior quarter', 'four preceding quarters') is not explicitly mentioned in the LLM answer, which is a minor omission. The LLM does not reference the use of four prior quarters for average, high, and low VAR amounts, which is part of the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MDLZ’s approach is broader due to inclusion of commodities and explicit treatment of non-linear behavior in options (implied by 'valuing currency- and commodity-linked options'). While the LLM does not use the exact phrase 'non-linear behavior', the mention of option valuation reflects this concept. (4) The LLM omits the explicit comparison of time periods used for average, high, and low VAR calculations across the four quarters, which is a minor gap in completeness. However, the core differentiators—scope of risk factors (commodities) and treatment of options—are correctly identified and contrasted. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy (no incorrect numbers) and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 479,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s 10‑K makes clear that “patients around the world deserve access to our life‑saving products,” and the company is using its global scale and local presence to expand adoption of its therapies worldwide. Amgen, however, reports that payer consolidation—especially the leverage of PBMs such as Express Scripts—is forcing it to offer deeper discounts and rebates on drugs like Repatha, which erodes affordability and can limit patient access. Thus, Medtronic is proactively expanding global access, while Amgen is battling payer‑driven pricing pressure that threatens patient affordability and access.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between Medtronic's proactive strategy to expand global patient access and Amgen's challenges with payer-driven pricing pressures, particularly from Express Scripts. (1) All entities are accurately identified: Medtronic, Amgen, Express Scripts, and Repatha are correctly named and contextualized. The fiscal year is not explicitly mentioned (2024 in the ground truth), but this is a minor omission. (2) There are no numeric values, percentages, or dates in either answer, so quantitative accuracy is unaffected—no errors here. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Medtronic leverages global scale and local presence to improve access, while Amgen faces affordability and access issues due to PBM negotiating power. However, the LLM omits key contextual details present in the ground truth: the fact that the top six PBMs control 94% of U.S. pharmacy prescriptions, the role of Rebate Management Organizations, and the specific issue of Medicare patient prescription abandonment due to high co-pays. These omissions reduce completeness and slightly weaken the depth of the qualitative analysis. (4) Despite these omissions, the LLM answer remains semantically equivalent in its central claim and is highly relevant to the question. The phrasing 'patients around the world deserve access' appears to be a paraphrase or slight embellishment of Medtronic’s 10-K language but does not misrepresent the intent. Overall, the answer is factually correct, well-reasoned, and relevant, but loses minor points for missing specific structural and systemic details that explain *why* payer pressure limits access.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 462,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is limited to its one‑vote Class A and non‑voting Class C shares, while its 10‑vote Class B shares – which can be converted into Class A at any time – are excluded from repurchases (see Note 11, p. 81). By shrinking the pool of low‑voting shares and leaving the high‑vote Class B stock untouched, the company preserves insider voting power, a point reinforced by the fact that Class A stock is also listed and actively traded by another large firm such as Comcast (see CMCSA 10‑K, p. 1), underscoring the liquidity of the low‑vote class and the strategic use of repurchases to manage control.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core reasoning and implications of Alphabet's share repurchase strategy. (1) Quantitatively, the LLM omits the specific dollar figures from the ground truth—$62.2 billion repurchased and $36.3 billion remaining under authorization—which are key factual details. While the absence of these numbers does not invalidate the reasoning, their omission reduces quantitative precision. (2) The qualitative analysis is excellent: the LLM correctly identifies that repurchases are limited to Class A and Class C shares, excludes Class B, and explains that Class B shares carry 10 votes and can be converted to Class A, preserving insider voting control. It also correctly notes that Class A shares are publicly traded by Comcast (CMCSA), reinforcing the idea of Class A as a liquid, market-standard voting class. (3) Multi-hop reasoning is sound—linking Alphabet’s repurchase policy to voting power preservation, conversion rights, and cross-company comparison with Comcast demonstrates strong synthesis across entities and concepts. (4) Contextual relevance is perfect: the answer directly addresses the prioritization of stock classes, conversion mechanics, and governance implications. The only deduction is for missing exact figures, but the reasoning and entity accuracy are flawless. Hence, a 9 for correctness, 8 for quantitative accuracy due to missing numbers, and 10s for qualitative and contextual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 401,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s formulary limits—exemplified by the step‑therapy, prior‑authorization and utilization‑criteria requirements that have narrowed patient access to the high‑cost biologic Repatha (LLY 10‑K p. 37)—show how a top PBM can shrink the reimbursed patient pool for expensive biologics. Because Eli Lilly’s biologic revenue growth is heavily dependent on broad payer coverage and patient access (LLY 10‑K p. 24‑27), similar restrictions could depress utilization, force deeper discounts and rebates, and therefore undermine Lilly’s ability to sustain growth in its biologic portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies UnitedHealth Group's formulary restrictions on high-cost biologics using Repatha as a key example, citing Eli Lilly's 10-K (pp. 37, 24–27) for both the access challenges and Lilly’s dependence on patient access—this aligns with the original answer’s emphasis on payer power and access dependency. (2) There are no numeric values, dates, or financial figures in either response, so quantitative accuracy is not compromised; all references to document locations (e.g., 10-K pages) are consistent and correctly attributed. (3) The multi-hop reasoning is sound: the model connects UnitedHealth’s PBM influence → formulary restrictions on Repatha → reduced patient access → implications for Eli Lilly’s biologic revenue growth, acknowledging the structural payer concentration and its business impact. This demonstrates correct synthesis across entities (UnitedHealth, Repatha, Eli Lilly) and causal logic. (4) The only minor gap is that the LLM answer does not explicitly mention the '94% of U.S. pharmacy prescriptions' statistic or name UnitedHealth as part of the 'top six integrated health plans,' which slightly reduces completeness in contextual detail, but the core causal mechanism and business risk are accurately conveyed. Wording differs but meaning is preserved. Thus, correctness is high at 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 408,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle’s $3 billion commercial‑paper program is a stand‑alone short‑term financing facility that it can tap for general corporate purposes; at fiscal‑year end it had $600 million of commercial paper outstanding but no notes issued under the $3 billion program (ORCL 10‑K p. 89‑91). Cisco, by contrast, records its $9 billion of senior fixed‑rate notes as long‑term debt, with a current (short‑term) portion that creates short‑term financing exposure and is managed with interest‑rate hedges (CSCO 10‑K p. 55). Thus both firms are exposed to short‑term debt financing—Oracle through a dedicated commercial‑paper program, Cisco through the current portion of its larger senior‑note issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Oracle had *no* outstanding commercial paper as of May 31, 2022. However, the LLM claims Oracle had $600 million outstanding and that no notes were issued under the $3 billion program—this is contradictory and incorrect. The $600 million figure does not appear in the ground truth and appears to be fabricated or misattributed. For Cisco, the LLM correctly identifies the $9.0 billion in senior fixed-rate notes but fails to mention the key detail that Cisco uses interest rate swaps to convert fixed rates on $1.5 billion of these notes to floating rates based on LIBOR—a critical element of Cisco’s risk management strategy that is absent in the LLM response. (2) The dates are partially correct (Oracle’s fiscal year-end aligns with May 31, Cisco’s with July 30), but the LLM does not specify the year (2022), weakening temporal precision. The $600 million figure is entirely unsupported by the ground truth and directly contradicts it. (3) The multi-hop reasoning is partially sound—both companies are linked through their use of short-term debt mechanisms—but the synthesis is flawed. The LLM incorrectly frames Oracle’s program as having $600 million outstanding while also claiming no notes were issued, which is logically inconsistent. It also fails to recognize that Cisco’s commercial paper (if issued) ranks at par with its senior notes, a structural detail important to understanding debt hierarchy. (4) Contextual relevance is strong—the answer addresses the comparative use of short-term financing and correctly identifies Oracle’s commercial paper program and Cisco’s long-term notes with short-term exposure. However, due to major quantitative errors and omission of key qualitative details (especially the interest rate swaps), the correctness score is low. The answer is partially on track but factually unreliable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 523,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The extension of ASU 2022‑06 through Dec 31 2024 lets both companies keep using the optional expedients that soften the accounting impact of replacing LIBOR‑based contracts. FedEx says the relief “has had no material effect on our financial condition… and we continue to monitor our contracts for potential application of these ASUs” and therefore can maintain its existing LIBOR‑linked interest‑rate swaps and other derivatives designated as fair‑value or cash‑flow hedges without re‑measurement (FedEx Note 3, p. 93). Caterpillar’s risk‑management policy likewise relies on fixed‑to‑floating and floating‑to‑fixed interest‑rate swaps that are designated as fair‑value or cash‑flow hedges (Caterpillar Note B, p. 74‑75), so the deferred sunset of the ASU gives it the same continued relief to keep those LIBOR‑related hedges in place without disruptive accounting changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 is extended until December 31, 2024, which allows optional expedients for LIBOR transition accounting; both FedEx and Caterpillar benefit from continued use of hedging relief. The date 'Dec 31 2024' matches the ground truth's 'December 31, 2024'—format variation is acceptable. (2) Quantitative accuracy is perfect: no numerical errors, and the date is correctly cited. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across both companies, referencing their respective hedging instruments and accounting policies. It cites specific footnotes (FedEx Note 3, p. 93; Caterpillar Note B, pp. 74–75), which adds precision and supports the claims. (4) The LLM captures the core impact—avoiding disruptive accounting changes and allowing continued use of LIBOR-linked derivatives under existing hedge accounting. The only minor shortcoming is that it does not explicitly state that neither company has experienced a material impact (mentioned in the original for FedEx), though it paraphrases this by quoting FedEx’s 'no material effect.' Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 353,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s five‑year credit agreement designates **Citibank, N.A. as the administrative agent and JPMorgan Chase Bank, N.A. as the syndication agent** (and both banks as joint lead arrangers and book‑managers)【page_125】.  The only amendment to that agreement was **Amendment No. 1 dated August 25, 2022**【page_126】; the 2023 five‑year agreement was a new facility that retained the same agent‑syndication structure but had no further amendment in 2023.\n\nCaterpillar’s multi‑facility 364‑day credit facilities name **Citibank, N.A. as the sole agent** (with Citibank Europe and MUFG as local‑currency agents) and do not employ a separate syndication agent【page_128】.  In 2023 the facilities were **amended via a Local‑Currency Addendum to the 2023 facility and a Japan Local‑Currency Addendum to the 2022 facility**, indicating amendment activity in 2023 but none recorded for 2022【page_128】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement had Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent, with both serving as joint lead arrangers and book managers. The amendment on August 25, 2022, is correctly cited, and no 2023 amendment to that agreement occurred. For Caterpillar, Citibank, N.A. acted as agent in its 2022 and 2023 facilities, with Citibank Europe plc and MUFG Bank, Ltd. handling local currency roles. The 2023 amendment activity via Local-Currency Addenda is accurately reported. (2) Quantitative accuracy is perfect: dates (August 25, 2022; September 1, 2022), roles, and amendment details are factually correct. The distinction between a new 2023 facility and an amendment is properly understood. (3) Multi-hop reasoning is sound: the model correctly compares syndication structures (Boeing uses a syndication agent; Caterpillar does not) and tracks amendment activity across years and facilities. The only minor shortcoming is that the original answer notes Caterpillar’s facilities were dated September 1, 2022, while the LLM refers to 2023 facilities being amended and mentions addenda to the 2022 facility—this is still accurate but slightly less precise in framing the original 2022 agreement date. (4) The answer is contextually excellent, directly addressing syndication structure and amendment activity for both firms in 2022 and 2023. Wording differs but meaning is semantically equivalent. A score of 9 is justified due to near-perfect factual and reasoning accuracy, with only a minor nuance in temporal framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 457,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in the hands of its founder/CEO because each Class B share carries ten votes and, together with the founder’s holdings, controls a majority of the combined voting power, limiting other shareholders’ ability to influence corporate matters (Meta 10‑K p.49‑50). Comcast also uses a dual‑class system, but its Class B shares carry 15 votes each, represent roughly one‑third of total voting power, and are convertible share‑for‑share into Class A stock, which over time can dilute the concentrated voting block (Comcast 10‑K p.91). Thus, while both firms have voting‑power concentration, Comcast’s conversion mechanism offers a path to reduce that concentration and may be viewed as less detrimental to investor confidence than Meta’s more permanent, founder‑controlled voting structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the dual-class structures at both META and CMCSA and addresses the core question about investor confidence implications. It appropriately contrasts META's founder-controlled, entrenched voting structure with CMCSA's convertible Class B shares, noting that the conversion mechanism could dilute concentrated control over time—this aligns with the ground truth’s emphasis on structural similarities and differences affecting investor perception. However, there are key quantitative inaccuracies: the LLM states that CMCSA Class B shares carry '15 votes each,' which is not supported by the ground truth (the original answer mentions voting power share but not vote multiples per share). Additionally, the claim that Class B has '15 votes each' contradicts typical Comcast disclosures where Class B shares usually have 15x voting rights *in aggregate*, not per share, or relative to a small float. The ground truth notes CMCSA Class B represents 33⅓% of voting power and specifies the exact number of shares outstanding (9,444,375), which the LLM omits. While the LLM captures the qualitative distinction—conversion as a potential equalizer—it introduces a specific vote-per-share figure not present in the source and potentially misleading. The reasoning is otherwise sound, synthesizing cross-company structures and their governance implications. Wording differs but meaning is semantically close, though the added detail about 'ten votes' for Meta Class B, while commonly known, isn't in the original answer and wasn't required. Overall, core facts are correct, but unsupported numerical claims reduce quantitative accuracy. The answer remains contextually relevant and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 467,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company recorded net sales to equity‑method investees of **$14.471 billion in 2021**【page_89】.  \n\nCoca‑Cola FEMSA’s bottling and distribution operations span **Mexico (central, southeast and northeast regions), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas) and Uruguay**【page_7】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the net sales amount of $14,471 million in 2021 is accurately reported as $14.471 billion, which is a valid format conversion (1 billion = 1,000 million). (2) The regions covered by Coca-Cola FEMSA are listed completely and precisely, including all specified regions in Mexico, Brazil, Argentina, and the correct list of countries. Minor wording differences (e.g., 'parts of São Paulo' vs. 'parts of Rio Grande do Sul') are present in the original but the LLM captures all key regions without omissions or errors. (3) The multi-hop reasoning is sound: the answer synthesizes financial data (net sales to equity-method investees) from one part of the filing and operational geographic coverage from another, correctly attributing each. (4) Semantic equivalence is maintained—wording differs slightly but meaning and factual content are identical. All entities (The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA) and the year 2021 are correctly identified. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 317,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Merck’s Remicade fell 9 % in 2021 to $299 million (down 20 % in 2020) and, together with Simponi ($825 million in 2021), left the company’s immunology segment at roughly $1.12 billion in 2021 versus $1.17 billion in 2020 – a modest decline driven largely by the loss of Remicade volume and price to biosimilars【page_61】. By contrast, AbbVie’s flagship biologic Humira, whose composition‑of‑matter patent expired in 2016 and whose EU patent expired in 2018, is already facing biosimilar competition in Europe and will see U.S. biosimilar entry from 2023, exposing AbbVie to a far larger biosimilar risk given Humira’s blockbuster‑size contribution to its revenue【page_13】【page_15】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Remicade declined 9% in 2021 to $299 million, down 20% in 2020, which matches the original answer. Simponi’s $825 million in 2021 is not in the original answer but is plausible and consistent with external knowledge; the implied immunology segment total of ~$1.12 billion in 2021 (vs $1.17B in 2020) is a reasonable inference and supports the claim of modest decline. (2) The comparison to AbbVie is factually sound: Humira’s patent expirations in 2016 (composition-of-matter) and 2018 (EU) are correct, and U.S. biosimilar entry starting in 2023 is accurate. The characterization of AbbVie’s larger exposure due to Humira’s blockbuster status is logically supported. (3) Multi-hop reasoning is strong: the LLM correctly links Remicade’s biosimilar pressure to Merck’s immunology segment performance, and contrasts Merck’s situation with AbbVie’s broader strategic response. (4) Minor deduction in qualitative accuracy because the original answer emphasizes Merck’s lack of emphasis on patent protection compared to AbbVie, which the LLM omits, though it does note AbbVie’s proactive stance. Overall, the answer is factually correct, contextually relevant, and synthesizes information appropriately across companies and time periods.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 374,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "Honeywell’s Garrett Series B Preferred Stock investment was reflected on the balance sheet as part of “Investments and long‑term receivables,” amounting to $423 million after the December 2021 partial redemptions (see page 103). The Second Amendment to the Series B design‑ation left a present‑value of $207 million for the remaining unredeemed shares as of December 31 2021 (see page 102).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. While it correctly identifies that Honeywell held Garrett's Series B Preferred Stock and that partial redemptions occurred, it incorrectly states the present value of the remaining unredeemed shares as $207 million, whereas the ground truth is $423 million. Additionally, the LLM claims the $423 million balance was *after* the December 2021 partial redemption, which contradicts the ground truth: the $423 million *is* the present value of the remaining redemptions *as of* December 31, 2021, following the $211 million First Partial Redemption. The mention of a 'Second Amendment to the Series B designation' is not supported in the original answer and appears to be fabricated or misattributed. (2) Quantitative inaccuracies include the incorrect present value ($207M vs $423M) and misrepresentation of the timeline. The original answer states that $211M was redeemed in late 2021, with $200M planned for 2022, leaving a present value of $423M — implying the total future obligation was valued at $423M as of year-end 2021, not that only $207M remained. The LLM’s calculation or interpretation is therefore fundamentally flawed. (3) The multi-hop reasoning is unsound: the model fails to correctly synthesize the sequence of redemptions and their impact on long-term receivables. It incorrectly infers that the $423M balance reflects post-redemption value while assigning a separate $207M present value, creating internal inconsistency. (4) Contextual relevance is moderate — the answer addresses the right topic (Honeywell's investment, redemptions, long-term receivables), but due to major factual and quantitative errors, the response misleads rather than informs. Correctness score is low due to critical errors in key financial figures and reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 495,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "Comcast’s Class B shares carry ten votes each and, because all 9.44 million of them are owned by Brian L. Roberts, they represent about one‑third of the company’s total voting power【page_33】. Alphabet’s dual‑class system is analogous—its Class B shares also have ten votes per share, but the firm’s repurchase program targets only Class A and Class C shares (repurchasing $50.3 bn, $59.3 bn and $62.2 bn in 2021‑2023) and leaves the high‑voting Class B stock untouched, preserving the voting control of insiders【page_81】. Thus, in both companies the high‑voting Class B stock is concentrated in a single owner (Roberts at Comcast) or insiders (Alphabet) and is insulated from share‑repurchase activity, maintaining their voting dominance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. It states that CMCSA's Class B shares have 'ten votes each,' but the ground truth specifies 15 votes per share. This is a significant error affecting the accuracy of the voting power description. Additionally, the LLM claims Brian L. Roberts owns 9.44 million shares, which is not present in the original answer and introduces unverified detail. For GOOGL, the LLM incorrectly lists repurchase amounts of $50.3B, $59.3B, and $62.2B for 2021–2023, while the original only provides $62.2B for 2023 and $36.3B remaining in authorization—no data for prior years is in the ground truth, making this a fabrication. (2) The calculation of voting power is not performed in the LLM answer, but it correctly notes that Roberts holds one-third of voting power, aligning with the 33 1/3% in the original. However, the vote count per share is wrong, undermining confidence in the synthesis. The repurchase figures are entirely inconsistent with the source: $62.2B is correct for 2023, but the others are not supported. (3) The multi-hop reasoning is conceptually sound—the model correctly identifies the parallel structure between CMCSA and GOOGL in maintaining insider control via dual-class shares and shielding high-vote shares from repurchases. It draws the correct conclusion that repurchases of low-vote shares preserve insider voting dominance. This shows good qualitative understanding of corporate governance dynamics. (4) Despite strong contextual relevance and logical reasoning, the quantitative inaccuracies—especially the incorrect vote count and fabricated repurchase amounts—severely impact factual correctness. The core insight about dual-class structures and repurchase targeting is preserved, warranting a moderate score. Minor flexibility is allowed for phrasing (e.g., 'insiders' vs specific names), but numbers must be accurate. Thus, correctness is partially compromised by key errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 539,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both companies use essentially the same VAR framework. Mondelēz’s model (MDLZ p. 64) assumes normal markets, a one‑day holding period and a 95 % confidence interval, and it derives the interest‑rate, currency‑exchange (and commodity) return parameters from movements observed over the **prior quarter** (and from each of the four preceding quarters for average‑VAR calculations). Philip Morris’s model (PM p. 81) also assumes normal markets, a one‑day holding period and a **95 % confidence interval**, and it bases the interest‑rate and forward‑currency inter‑relationships on movements **primarily over the preceding quarter** (and the four prior quarters for average/high/low VAR). Thus the time‑horizon for observing rate and currency moves and the confidence level are the same for MDLZ and PM.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all key figures are accurate: both companies use a 95% confidence interval and a one-day holding period, which are correctly reported. The time horizons—'prior quarter' for point-in-time VAR and 'four preceding quarters' for average (and high/low in PM's case) VAR—are accurately reflected. (2) The answer is complete, addressing both parts of the question: the time horizon for observing interest rate and currency movements and the confidence interval. (3) Entity accuracy is correct—MDLZ and PM are properly identified, and the cited page numbers (64 and 81) align with the source documents in the knowledge graph. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it compares two companies' VAR methodologies across multiple dimensions (market assumptions, holding period, confidence level, data observation windows) and correctly concludes methodological consistency. (5) Semantic equivalence is strong—the LLM uses slightly different phrasing (e.g., 'derives the return parameters' vs 'observes movements') but conveys the same factual content. Minor enhancements like mentioning commodity prices only in MDLZ are present and accurate. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 365,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is built on a supply chain that is heavily dependent on contract manufacturers in China Mainland – “substantially all of the Company’s manufacturing is performed … by outsourcing partners located primarily in Asia, including China mainland” (Apple 10‑K p. 9‑11). Microsoft, by contrast, does not rely on Chinese factories; its Greater China activities are managed from a regional operations center in Singapore that provides order‑processing, vendor‑management and logistics support, and the firm focuses on localizing its software and services for the market (Microsoft 10‑K p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple's heavy reliance on China Mainland for manufacturing through contract manufacturers, citing the correct context from the 10-K (p. 9–11), and contrasts this with Microsoft’s lack of manufacturing dependency in China. (2) There are no numerical figures in the question or answer requiring quantitative verification, so quantitative accuracy is not compromised—score is 10 as no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple and Microsoft’s 10-K filings to compare supply chain vs. operational footprint in Greater China. It accurately notes Microsoft’s regional operations center in Singapore (as per Microsoft 10-K p. 16) and its focus on localization of software and services. (4) The only minor omission is that the LLM answer does not explicitly mention Microsoft's product localization efforts such as language adaptation and UI modifications, though it alludes to localization of software and services. It also omits Apple’s exposure to trade tensions and supply chain risks, which is part of the original answer. However, the core contrast—Apple’s supply-chain intensity vs. Microsoft’s regional support and localization infrastructure—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect as it directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 409,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency swaps and forwards with pricing models that draw almost entirely on market‑observable data—such as yield curves, spot and forward exchange rates—so the contracts are placed in the Level 2 tier of the fair‑value hierarchy. By contrast, GE measures its run‑off insurance reserves and pension obligations using cash‑flow, mortality and discount‑rate assumptions that are not directly observable in the market, which forces those liabilities into Level 3, reflecting a heavy reliance on unobservable inputs. The key difference is UPS’s use of observable inputs versus GE’s dependence on significant unobservable assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that UPS uses observable market inputs (yield curves, spot/forward exchange rates) for foreign currency derivatives, justifying their Level 2 classification, while GE relies on unobservable assumptions (cash-flow, mortality, discount rates) for insurance and pension liabilities, placing them in Level 3. This aligns with the original answer’s emphasis on observable vs. unobservable inputs and the resulting estimation uncertainty. (2) There are no numeric values, dates, or financial amounts in the question or answers, so quantitative accuracy is not applicable in a numerical sense—but all qualitative financial concepts (Level 2 vs. Level 3, fair value hierarchy, types of inputs) are correctly represented. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation techniques across two different companies (UPS and GE), applies them to distinct financial instruments (derivatives vs. insurance/pension liabilities), and contrasts them based on the observability of inputs. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'discounted cash flow (DCF) methodologies' or 'long-duration insurance contracts' as in the original, which adds slightly less context about why GE’s models require unobservable inputs. However, referencing 'cash-flow' and 'discount-rate assumptions' captures the essence. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 443,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola does not operate its own bottling in Hong Kong; it relies on Swire Beverages – one of its five largest independent bottling partners – to bottle and distribute its brands there (see KO page 7). By contrast, Colgate‑Palmolive’s results for the Greater China market (part of its Asia‑Pacific segment) show a 6 % increase in net sales to $2.9 billion and a 9 % rise in operating profit to $844 million in 2021, indicating strong regional performance rather than dependence on a single distributor (see CL page 42).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in key quantitative figures. According to the ground truth, Colgate-Palmolive reported $2,867 million (i.e., $2.867 billion) in Asia Pacific net sales in 2021, but the LLM incorrectly states a 6% increase to $2.9 billion—this figure conflates net sales with operating profit and misrepresents both the amount and the metric. More critically, the LLM claims a 9% rise in operating profit to $844 million, which is not supported by the original answer and introduces data not present in the ground truth. These are significant quantitative errors. (2) The Coca-Cola portion is mostly accurate: it correctly identifies Swire Beverages as a major bottling partner in Hong Kong and references the appropriate operational model. However, it omits the broader context from the original answer—specifically, that Coca-Cola’s non-U.S. unit case volume accounted for 83% of global volume in 2021, which was part of the comparative framework. (3) The reasoning partially captures the multi-hop comparison—contrasting Coca-Cola’s reliance on a distribution partner with Colgate-Palmolive’s direct operations—but the flawed financial data undermines the validity of the comparison. The conclusion about Colgate’s 'strong regional performance' is reasonable but based on incorrect numbers. (4) Contextual relevance is high because the answer addresses both companies in the Hong Kong/Asia context and attempts the strategic comparison. However, due to major errors in reported financials (net sales and operating profit), the correctness score is limited to 5—partially correct but with significant factual deficiencies. Quantitative accuracy is low (4) due to incorrect dollar amounts and percentages; qualitative accuracy is moderate (6) as the structure and intent are sound; contextual relevance is strong (8) as the response stays on topic and attempts synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 519,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "Bank of America treats its CDO‑type holdings (ABS, CLOs and similar VIE‑issued securities) as simple exposure items – the firm reports a “maximum loss exposure” that is essentially the amount of the investment and does not describe a detailed pricing model for those assets【page_129】. In contrast, JPMorgan values comparable structured notes with embedded derivatives by running discounted‑cash‑flow analyses that explicitly model the embedded option features (using Black‑Scholes, simulation or hybrid models) and then adjust the result for its own credit risk (DVA)【page_187】. Thus, BAC’s risk is captured mainly through a capped loss‑exposure figure, whereas JPM’s risk assessment is driven by sophisticated valuation models that incorporate market‑observable and unobservable inputs and credit‑risk adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: BAC's treatment of CDOs and similar VIE-issued securities as simple exposure items with maximum loss exposure tied to investment balances is accurately described, and the absence of a detailed pricing model is correctly noted. JPM's use of discounted cash flow analyses, models like Black-Scholes or simulation techniques, and DVA adjustments is also correctly reported. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two firms (BAC and JPM), comparing their approaches to risk exposure and valuation methodology for structured products with embedded derivatives. The distinction between BAC’s static exposure metric and JPM’s dynamic, model-driven approach is logically drawn and well-supported. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'capped loss-exposure figure' vs 'maximum loss exposure'), the meaning is preserved. One minor point preventing a perfect 10 is that the LLM slightly broadens 'CDOs' to include ABS and CLOs without explicit confirmation from the original answer that those are the exact instruments BAC holds, though this is contextually reasonable. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 423,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s Class B common stock is subject to a restricted voting regime – the 10‑K notes that Class B shares have no voting power except on a narrow set of defined matters (e.g., certain mergers or charter amendments) 【page_69】. In contrast, Netflix’s common stock gives each share one vote on all shareholder proposals 【page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core differences in voting rights between CMCSA's Class B Common Stock and NFLX's common stock. It correctly identifies that CMCSA’s Class B shares have limited voting rights only on specific matters such as mergers or charter amendments, citing the correct disclosure context (page_69), and contrasts this with NFLX’s one-vote-per-share structure on all matters (page_61). All entities (CMCSA, NFLX), stock classes, and governance terms are accurately referenced. The answer omits two minor details present in the ground truth: (1) the mention that CMCSA Class B voting is calculated using a conversion rate, and (2) the fact that Class B shares were still outstanding as of 2023, reinforcing the ongoing governance structure. These omissions are not critical to the central comparison but slightly reduce completeness. There are no numerical inaccuracies—no specific numbers beyond structural descriptions are involved, and the qualitative reasoning across the two companies is sound and logically synthesized from separate disclosures. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate with only minor gaps in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 343,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley treats its CDO exposures as interests in variable‑interest entities – the CDOs are not consolidated unless the firm is the servicer or collateral manager – and the resulting beneficial interests are recorded as trading assets measured at fair value (the 10‑K notes on CDOs note the hybrid nature of the instruments and that they are “measured at fair value” 【page_109】, 【page_129】). JPMorgan Chase, by contrast, values structured‑note products that contain embedded derivatives (including CDO‑type notes) using discounted‑cash‑flow analyses that explicitly model the embedded option features with Black‑Scholes or simulation techniques and then adjust for its own credit risk, classifying the fair‑value measurement in Level 2 or Level 3 of the hierarchy 【page_185】, 【page_187】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley treats CDOs as hybrid instruments measured at fair value, noting their classification as trading assets and the variable-interest entity framework, which is consistent with the original answer's emphasis on embedded derivatives and non-consolidation unless the firm acts as servicer or manager. The citation of fair value measurement on pages 109 and 129 supports this. (2) For JPMorgan Chase, the LLM accurately describes the use of discounted cash flow analyses incorporating Black-Scholes or simulation models to value structured notes with embedded derivatives, including adjustments for own credit risk (implied DVA), and correctly notes the Level 2/Level 3 classification, which matches the original answer’s core claims. (3) Multi-hop reasoning is sound: the model synthesizes information across two firms, their respective methodologies, and instrument types (CDOs and structured notes), correctly distinguishing disclosure and valuation approaches. (4) Minor difference: the original answer explicitly mentions 'credit protection sold to the issuer' and potential non-repayment of principal upon credit event for Morgan Stanley, which the LLM omits. However, this nuance is implied in the reference to hybrid nature and fair value treatment. No numeric inaccuracies exist—there are no explicit numbers in either response, so qualitative and contextual fidelity dominate. The LLM answer is slightly more technical but semantically equivalent and fully factually consistent. Thus, correctness is docked only slightly for a minor omission in explanatory depth on Morgan Stanley’s credit risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 469,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott warns that “the expiration or loss of intellectual‑property protection… could affect Abbott’s future revenues and operating income” and that a successful patent‑infringement claim could lead to “significant damages or an injunction preventing the manufacture, sale or use of affected Abbott products” (see ABT 10‑K pages 12 & 14).  In contrast, AbbVie is using its subsidiary Forest Laboratories Holdings Limited to bring or defend lawsuits that protect the exclusivity of Vraylar, a strategy intended to preserve the drug’s market share and revenue (see ABBV 10‑K page 113).  Consequently, Abbott’s exposure to IP challenges threatens its pharmaceutical earnings, while AbbVie’s aggressive enforcement through Forest Laboratories seeks to safeguard its own drug‑revenue stream.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its representation of both Abbott's and AbbVie's positions on intellectual property risks and enforcement, with correct entity identification (Abbott, AbbVie, Forest Laboratories Holdings Limited, Vraylar) and accurate qualitative synthesis. Quantitatively, there are no specific numbers (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, but the LLM correctly references the relevant 10-K pages (ABT 10-K pp. 12 & 14; ABBV 10-K p. 113), which supports verifiability and accuracy. The core facts—Abbott’s exposure to IP expiration risks and AbbVie’s use of litigation via Forest Labs to protect Vraylar—are correct. However, the LLM omits key details present in the ground truth: (1) the specific litigation was filed in December 2019 in the U.S. District Court for the District of Delaware, and (2) the generic competitors involved (Sun Pharmaceutical and Aurobindo Pharma). Additionally, the ground truth emphasizes the interplay between the two companies’ IP strategies and the broader implication that generic entry could affect both firms’ revenue streams due to shared reliance on IP exclusivity. The LLM treats Abbott and AbbVie’s situations in contrast rather than showing their interconnected vulnerability to generic competition, slightly weakening the multi-hop reasoning. Despite this, the answer captures the essential dynamic and remains semantically aligned with the main implications for pharmaceutical revenue. Hence, minor completeness and synthesis shortcomings prevent a top score, but factual and quantitative accuracy are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 441,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment hedging is instrument‑specific: it uses foreign‑currency forwards, cross‑currency swaps (and related options or foreign‑currency debt) to offset the FX risk of its non‑U.S. subsidiaries, with the fair‑value changes recorded in the foreign‑currency translation adjustment (CTA) in AOCI (C_10k pp. 152‑153). Morgan Stanley, by contrast, does not rely on such designated hedges for foreign‑currency exposure; instead it manages market‑risk across its trading portfolios primarily through a statistical VaR framework—historical‑simulation and Monte‑Carlo models that generate daily VaR limits, monitor losses and guide risk‑mitigation actions (MS_10k pp. 58‑61).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Citigroup's use of foreign currency forwards, cross-currency swaps, and related instruments to hedge FX risk in non-USD subsidiaries, with fair value changes recorded in CTA within AOCI under ASC 815—consistent with the original answer. It also accurately describes Morgan Stanley's reliance on VaR models (historical simulation and Monte Carlo) for managing market risk in trading portfolios, including their use for setting limits and guiding risk actions. (2) There are no numeric values in the question or answers that require verification; thus, quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound: the model correctly contrasts Citigroup’s designated hedging instruments with Morgan Stanley’s statistical risk framework, synthesizing information across two firms and their respective 10-K disclosures. The only minor omission is the reference to Southern Company Gas and its use of weather derivatives, which appears in the original answer as a connecting example of broader risk management practices. However, this detail is tangential to the core comparison between Citigroup and Morgan Stanley, so its absence does not undermine the main response. (4) The LLM answer is semantically equivalent to the original in all key aspects, uses correct entities (Citigroup, Morgan Stanley), accurate financial terminology (AOCI, CTA, VaR, hedging), and cites plausible page numbers from 10-K filings. Contextual relevance is full, as it directly addresses the comparative risk management strategies asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 449,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive actively manages its FX exposure by entering into forward, swap and option contracts that hedge purchases, assets, liabilities and net‑investment positions; the resulting gains or losses are reported as immaterial, so the hedges blunt earnings and cash‑flow volatility (see Colgate‑Palmolive Notes 90‑92). Walmart, by contrast, carries large legally‑binding firm‑commitment purchase obligations for inventory and utilities that create cash outflows and can affect cash‑flow stability when prices or volumes shift, and these commitments are not offset by derivative hedges (see Walmart Note 45). Thus, Colgate’s option‑based hedging provides a proactive buffer that stabilizes cash flow, whereas Walmart’s exposure through firm commitments leaves its cash flow more susceptible to fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, while the LLM does not include the specific dollar figures ($37.2 billion total unrecorded obligations, $15.9 billion due within one year) mentioned in the original answer, it correctly characterizes Walmart's firm commitments as large and legally binding, and notes their absence of derivative hedges—this omission is minor given that the question focuses on the comparative use of financial instruments and impact on cash flow stability, not exact numbers. Colgate’s use of option contracts is correctly described, and the reference to immaterial gains/losses aligns with effective hedging. (2) The LLM correctly identifies both companies, their respective risk management strategies, and the financial instruments (or lack thereof). It accurately references Colgate’s use of options (among other derivatives) and Walmart’s unhedged firm commitments. (3) The multi-hop reasoning is sound: the model synthesizes Colgate’s proactive hedging strategy with its stabilizing effect on cash flows and contrasts it with Walmart’s exposure due to unhedged obligations, correctly concluding that Walmart faces greater cash flow volatility. (4) The semantic meaning matches the ground truth: Colgate uses options to stabilize cash flows; Walmart lacks such protection on firm commitments, increasing vulnerability. The only minor shortcoming is the absence of Walmart’s specific obligation amounts, which were present in the original answer and would have strengthened completeness. However, since the question emphasizes the comparative mechanism and impact rather than precise figures, this does not significantly detract from correctness. Wording differences (e.g., mentioning forwards and swaps in addition to options) are acceptable as Colgate does use those instruments, and the focus on options is still maintained in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 520,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "Thermo Fisher adopted ASU 2023‑07 in its 2024 annual filing and applied it retrospectively to all prior periods (effective with the 2024 report), adding expanded segment‑expense tables, a “other items” breakdown and chief‑operating‑decision‑maker information in Note 11. CVS adopted the update on January 1 2024 for its fiscal‑year reporting, but the new interim‑reporting requirements only become effective for periods beginning after December 15 2024; its filing now discloses the CODM’s title and position and explains how the CODM uses segment operating results to evaluate performance and allocate resources, aligning interim disclosures with the annual ones.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: TMO (Thermo Fisher) adopted ASU No. 2023-07 for its 2024 annual report with retrospective application, and CVS adopted it on January 1, 2024, with interim reporting requirements effective for periods after December 15, 2024. The disclosure details for both companies are accurately represented. (2) Quantitative accuracy is perfect: dates (January 1, 2024; December 15, 2024), adoption timelines, and the note numbers (Note 11 for TMO, implied Note 19 for CVS) are consistent with the original answer. Format variations (e.g., 'expanded segment-expense tables' vs 'increased disclosures') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes adoption timing differences and maps specific disclosure requirements to each company. It distinguishes between annual and interim reporting applicability, a key nuance. (4) The only minor shortcoming is that the LLM does not explicitly mention that both companies applied the standard retrospectively to prior periods in the same sentence, though it is implied. Also, the specific mention of 'Note 19' for CVS is omitted, though the content of the disclosures matches. These are minor omissions that do not detract from overall correctness. Wording differences are acceptable under semantic equivalence. The answer fully addresses both parts of the question: adoption timeline differences and required disclosures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 413,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "The Philippines corporate‑income‑tax cut only modestly softened the company’s tax burden – the 2021 effective tax rate rose just 0.1 percentage point to 21.8%, the increase being partially offset by the Philippines rate reduction (PM 10‑K p. 94). In contrast, AMD reported that the Tax Reform Act had no effect on its tax position, with its 2021 effective tax rate unchanged at roughly 14% (AMD 10‑K p. 74).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims ACN's effective tax rate 'rose just 0.1 percentage point to 21.8%', implying the rate increased, which contradicts the ground truth that the Philippines tax cut had a favorable impact on the rate. The ground truth does not state that the rate increased by 0.1 points; rather, it states that the 21.8% rate was favorably impacted by the tax cut. This misrepresents the direction of the impact. Additionally, the LLM introduces a claim that the rate 'rose' due to other factors, which is not supported by the original answer and distorts the causal relationship. (2) The quantitative accuracy is low: while the 21.8% effective tax rate for ACN and the mention of AMD’s 14% rate (not in the ground truth) are cited, the ground truth does not provide AMD’s effective tax rate or state that it was 'unchanged'. The original answer focuses on AMD reporting $0 impact from tax reform, not on its overall effective tax rate. The LLM invents a comparison of effective tax rates that is not in the ground truth. (3) The multi-hop reasoning is partially sound in that it identifies both ACN and AMD and attempts to contrast their tax reform exposures. However, it fails to correctly synthesize the nature of the impact: for ACN, it mischaracterizes the effect as merely softening a rate increase rather than contributing to a favorable outcome; for AMD, it incorrectly shifts focus to overall effective tax rate stability instead of the specific $0 disclosure regarding tax reform. (4) Contextual relevance is high because the answer addresses both companies and the topic of tax reform impact in 2021. However, correctness is severely undermined by factual and directional errors in the quantitative claims and reasoning, warranting a low overall score despite relevant structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 502,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values the bulk of its pension‑plan fixed‑income assets with pricing models that use observable market data (interest‑rate and yield‑curve levels, credit spreads) and classifies them as Level 2, while also making adjustments for unobservable credit‑ and liquidity‑risk factors (see Honeywell 10‑K p.108‑110). 3M follows a similar hierarchy: Level 2 fixed‑income valuations are based on observable inputs via pricing models, but when observable inputs are unavailable the company uses Level 3 discounted‑cash‑flow methods that rely on unobservable assumptions (see 3M 10‑K p.89). Thus, both firms depend mainly on observable inputs for most fixed‑income valuations, with Honeywell adding risk‑adjustments and 3M explicitly separating observable‑input (Level 2) from unobservable‑input (Level 3) approaches.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that both Honeywell and 3M use pricing models for valuing fixed income investments in their pension plans, with primary reliance on observable inputs (e.g., interest rates, yield curves) for Level 2 assets. It accurately notes Honeywell's use of adjustments for unobservable credit and liquidity risks, and 3M's use of Level 3 discounted cash flow models with unobservable inputs when observable data is lacking. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in that sense—but all references to valuation levels (Level 2, Level 3) and methodologies are factually correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Honeywell and 3M), compares their methodologies, and highlights both similarities (use of pricing models, observable inputs, discounted cash flows) and differences (Honeywell’s focus on risk adjustments vs. 3M’s explicit classification by fair value hierarchy levels). (4) The only minor shortcoming is that the LLM omits 3M’s specific mention of 'projected annuity payments' as an unobservable input and does not explicitly note that both companies disclose the use of NAV practical expedients for certain funds—details present in the original answer. However, this does not undermine the core accuracy of the comparison. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 476,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "CMCSA’s Class B shares carry 10‑15 votes each and account for roughly one‑third of the company’s total voting power, a block that is generally non‑dilutable but can be converted share‑for‑share into one‑vote Class A stock at the holder’s option, thereby shifting voting influence from the high‑vote class to the low‑vote class【page_91】. Alphabet, on the other hand, is using a large share‑repurchase program to buy back both voting Class A and non‑voting Class C shares (‑$62.2 bn in 2023 with up to $70 bn more authorized), which reduces the number of outstanding shares and boosts earnings per share but does not alter the voting‑rights structure because the repurchases affect both classes proportionally【page_83】.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. It incorrectly states that CMCSA’s Class B shares carry '10–15 votes each'—the ground truth does not specify vote multiples per share but rather that Class B holds 33 1/3% of total voting power, which is non-dilutable. This misrepresents the voting mechanism. Additionally, the LLM claims Alphabet repurchased up to $70 billion more authorized, while the original answer specifies $36.3 billion remaining under authorization, not $70 billion. The $62.2 billion repurchase amount in 2023 is correct. (2) Quantitative accuracy is partially correct: $62.2 billion in 2023 repurchases is accurate, but the remaining authorization is wrong ($36.3B vs $70B cited). The 33 1/3% voting power for CMCSA Class B is misrepresented as 'roughly one-third' and incorrectly tied to per-share vote counts. (3) Reasoning and multi-hop synthesis are partially sound—the model correctly identifies that CMCSA’s structure involves conversion and protected voting influence, and that GOOGL’s repurchases affect share count and ownership concentration. However, it incorrectly concludes that repurchases do not alter voting-rights structure because they affect both classes proportionally. The ground truth explains that repurchases indirectly influence voting control by reducing the total pool of shares, thereby increasing the relative influence of remaining high-vote Class B shares (which convert to A upon sale). This key dynamic is missed. (4) Contextual relevance is high—the response addresses both companies, equity structures, and control mechanisms. However, due to significant factual and reasoning errors in critical financial figures and governance implications, the overall correctness score is moderate at 5. The answer captures the general direction of both strategies but fails on precise mechanisms and impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 517,
        "total_tokens": 2018
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Al Altria’s 2022 10‑K notes that, while the United States is not a Party to the WHO Framework Convention on Tobacco Control (FCTC), the treaty’s recommendations – and the State Settlement Agreements that already restrict outdoor, transit and brand‑sponsorship advertising – create a “potential” exposure to future advertising limits (see Altria p. 39‑40). In contrast, Philip Morris International reports that outright bans on advertising, marketing, promotions and point‑of‑sale displays have already been implemented in markets such as Australia and Russia (see PMI p. 42). Thus Altria’s strategy can remain largely US‑focused while monitoring and preparing for possible FCTC‑driven constraints, whereas PMI must already rely on non‑advertising tactics, plain‑packaging compliance and accelerated rollout of reduced‑risk products to sustain its international marketing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the U.S. is not a party to the FCTC, limiting direct regulatory impact on Altria, while acknowledging indirect exposure due to FCTC influence and existing U.S. advertising restrictions from the State Settlement Agreements. This matches the original answer’s emphasis on limited current impact but potential future risk. (2) The LLM accurately contrasts Altria’s situation with Philip Morris International’s (PMI) experience in Australia and Russia, where full advertising and point-of-sale display bans are already implemented—consistent with the ground truth. No numeric values are present, but references to specific pages (e.g., Altria p. 39–40, PMI p. 42) suggest precise sourcing and enhance credibility; these are not contradicted by the original. (3) The multi-hop reasoning is sound: it synthesizes Altria’s U.S.-centric regulatory environment with PMI’s international exposure to FCTC-aligned policies, correctly inferring strategic implications—Altria can remain focused and preparatory, while PMI must actively adapt using non-advertising tactics, plain packaging, and reduced-risk product rollouts. (4) The answer captures all key elements: treaty status, current vs. implemented bans, geographic market focus, and strategic adaptation. The only minor shortcoming is a slightly less explicit connection between FCTC guidelines and the bans in Australia/Russia (though implied), and a briefer treatment of the 'implications for international marketing strategies' compared to the original’s comparative depth. However, the core facts, entities, and logic are correct, and the answer remains semantically equivalent in substance. Wording differences are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1554,
        "completion_tokens": 489,
        "total_tokens": 2043
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that the Dodd‑Frank Act’s limits on proprietary trading, higher fees and compliance costs keep it from offering cryptocurrency products that rivals such as JPMorgan can provide, creating a competitive disadvantage (GS 10‑K p. 13). Morgan Stanley, by contrast, warns that its cross‑border cryptocurrency‑related activities are vulnerable to the uncertain, evolving and sometimes restrictive regulatory regimes in emerging‑market jurisdictions, which could impede those services (MS 10‑K p. 24). Thus, GS’s disadvantage is driven by domestic regulatory constraints that limit product availability, whereas MS’s risk is external, stemming from foreign regulatory volatility that could affect the execution of crypto offerings abroad.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank compliance burdens is accurately attributed to restrictions on proprietary trading and higher compliance costs, limiting its cryptocurrency offerings compared to JPMorgan. This is correctly cited from the GS 2024 10-K (page 13). Morgan Stanley's exposure to regulatory risks in emerging markets affecting cross-border crypto activities is also correctly described and cited from MS 10-K (page 24). (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses rely on qualitative disclosures. Thus, quantitative accuracy is not applicable in a traditional sense but is scored highly because no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different firms (Goldman Sachs and Morgan Stanley), identifies distinct sources of regulatory risk (domestic U.S. framework vs. foreign emerging markets), and draws a valid comparative conclusion. The distinction between self-imposed (structural) constraints at GS and external geopolitical risks at MS is logically conveyed, though the LLM uses slightly different phrasing (e.g., 'domestic regulatory constraints' vs. 'foreign regulatory volatility')—this does not affect semantic accuracy. (4) The answer is contextually fully relevant, addressing both parts of the comparative question and maintaining precise alignment with the source disclosures. One minor point preventing a perfect 10 is the absence of explicit mention that JPMorgan's ability to offer crypto products gives it a 'strategic edge,' which is in the original answer—though the implication is clear. Overall, the response demonstrates strong qualitative and contextual fidelity with no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 522,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "ASU 2022‑04 obliges a buyer that uses supplier‑finance programs to disclose the program’s key terms, the balance‑sheet presentation of the related amounts, the confirmed invoice balance at period‑end and, beginning in 2024, a roll‑forward of activity for the year. 3M satisfied the new requirement by adding Note 16, which shows $0.3 billion of confirmed invoices outstanding at December 31 2024 (and 2023) and reports the 2024 roll‑forward of roughly $1.5 billion of invoices confirmed and $1.5 billion paid. GE’s filing likewise notes that it evaluates supply‑chain finance programs and, under the same ASU, must now provide a comparable roll‑forward of confirmed invoices and payments for 2024—even though the specific roll‑forward figures are not detailed in the excerpt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: $0.3 billion confirmed invoices outstanding at 3M as of December 31, 2024, and $1.5 billion of invoices confirmed and paid during 2024 are accurately reported. The adoption date for GE (January 1, 2023) and the 2024 roll-forward requirement are correctly noted. (2) The LLM correctly identifies that both 3M and GE must disclose key terms, balance sheet presentation, period-end balances, and—starting in 2024—the annual roll-forward of supplier finance activity. It accurately references 3M’s Note 16 as the disclosure location, which is consistent with typical 10-K reporting practices. (3) The multi-hop reasoning is sound: the model synthesizes the impact of ASU 2022-04 across two companies and correctly applies the phased implementation timeline (adoption in 2023, roll-forward disclosures starting in 2024). (4) The only minor limitation is that the LLM notes GE’s roll-forward is required but states 'specific roll-forward figures are not detailed in the excerpt'—this is contextually appropriate if the input did not include GE’s specific numbers, but the ground truth implies the requirement applies and is implemented, not that data is missing. This does not constitute a factual error, as the LLM affirms GE must provide the disclosure. Wording differs slightly (e.g., 'satisfied the new requirement' vs. 'began providing'), but semantic meaning is equivalent. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 431,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 2024 net‑sales table shows that roughly $31 billion of its $32 billion total sales come from “Other Countries” (i.e., markets outside the United States and Ireland) 【page_105】. Because the majority of its revenue is earned in those foreign health‑care systems, Medtronic is subject to the same non‑U.S. regulatory and reimbursement environment that Amgen describes – government‑run payers that impose price controls, health‑technology‑assessment‑based pricing, coverage limits and other reimbursement restrictions that shape drug‑pricing strategies internationally 【page_17】【page_20】. Thus, Medtronic’s heavy reliance on “Other Countries” exposes it to comparable pricing pressure, formulary and reimbursement challenges that affect Amgen’s international drug‑pricing approach.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the core issue: MDT's significant revenue exposure in 'Other Countries' subjects it to international regulatory and reimbursement challenges similar to those faced by AMGN. The comparison between MDT and AMGN in terms of price controls, coverage limits, and government payer systems is conceptually accurate and aligns with the ground truth.\n\n2) Quantitative inaccuracy: The LLM states 'roughly $31 billion of its $32 billion total sales' come from 'Other Countries', but the ground truth specifies $32.251 billion from 'Total other countries, excluding Ireland' — not total company revenue. The LLM incorrectly implies that $32 billion is MDT’s total revenue and that $31 billion of it comes from 'Other Countries', which misrepresents both the metric and the calculation. In reality, the $32.251 billion is the international revenue itself, not a subset of a $32 billion total. This is a significant error in financial interpretation, though the number $31 billion is in the right magnitude.\n\n3) The multi-hop reasoning is sound: the model correctly links MDT’s geographic revenue concentration to regulatory pressures (price controls, HTA-based pricing) and draws a valid parallel with AMGN’s exposure in international markets, citing similar mechanisms like volume caps and reference pricing. It synthesizes across both companies and correctly attributes challenges to non-U.S. government payers.\n\n4) Despite the numerical misstatement, the qualitative and contextual analysis is strong. The answer captures the essence of the regulatory and reimbursement parallels between the two firms, even if the financial framing is imprecise. Wording differences (e.g., 'health-technology-assessment-based pricing' vs 'reference pricing') are semantically acceptable. The contextual relevance is high as it directly addresses the comparative exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 510,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s capital‑buffer requirement above the minimum risk‑based ratios is 8.4 % – the sum of a 5.4 % capital‑conservation buffer (SCB), a 3.0 % G‑SIB surcharge and a 0 % counter‑cyclical buffer (CCyB) 【page_134】. JPMorgan Chase Bank, N.A. has only the 2.5 % capital‑conservation buffer (with a 0 % CCyB and no G‑SIB surcharge), so its total buffer is 2.5 % 【page_291】. Thus Schwab’s combined buffer is roughly three‑plus percentage points higher (about three‑times) than JPM’s, driven by a larger SCB and the G‑SIB surcharge, while both firms face a zero CCyB.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Schwab (SCHW) has a 5.4% capital conservation buffer (SCB), a 3.0% G-SIB surcharge, and a total buffer of 8.4%, which contradicts the ground truth: SCHW has a stress capital buffer (SCB) of 2.5%, a capital conservation buffer (CCoB) of 2.5%, and no G-SIB surcharge, totaling 5.0%. The LLM also mislabels the capital conservation buffer as SCB. For JPM, it claims only a 2.5% capital conservation buffer and no SCB or G-SIB surcharge, totaling 2.5%, but the ground truth states JPM has a 2.5% CCoB and a 2.9% SCB, totaling 5.4%. The countercyclical buffer is correctly noted as 0% for both, but the overall totals and component breakdowns are wrong. (2) Calculations are incorrect: LLM computes 5.4% + 3.0% = 8.4% for SCHW (wrong components and sum), and omits JPM’s SCB entirely. The correct totals are 5.0% for SCHW and 5.4% for JPM. (3) Multi-hop reasoning fails: the model does not correctly synthesize the regulatory buffers (SCB, CCoB, CCyB) for each firm as required. It introduces a G-SIB surcharge for SCHW, which is not in the ground truth and is factually incorrect (SCHW is not a G-SIB). It also fails to recognize that both firms have SCBs and CCoBs, misattributing the SCB as part of the CCoB. (4) The contextual relevance is moderate because it attempts to compare buffers and mentions correct concepts (CCyB = 0%, buffer components), but the core quantitative and qualitative inaccuracies severely undermine the answer. Thus, correctness is very low due to major factual and calculation errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 441,
        "total_tokens": 1773
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.78,
    "average_quantitative_accuracy": 8.41,
    "average_qualitative_accuracy": 8.0,
    "average_contextual_relevance": 9.43,
    "score_distribution": {
      "excellent": 377,
      "good": 95,
      "fair": 90,
      "poor": 38
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e5_page_window_relevance_asc",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 20173.37,
    "timestamp": "2026-02-02T21:16:39.115340"
  }
}